data_2jqm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jqm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.1 p -86.19 -7.27 58.68 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -53.21 -49.98 65.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.117 0.967 . . . . 0.0 112.923 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 22.3 tp -73.59 127.46 32.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.56 -0.712 . . . . 0.0 109.537 163.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.3 t -53.31 171.04 0.08 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -164.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.53 111.88 2.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.617 2.367 . . . . 0.0 111.753 -170.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -61.63 107.54 0.83 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.863 2.465 . . . . 0.0 111.725 -167.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 82.01 0.04 89.1 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.53 1.062 . . . . 0.0 114.5 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 89.1 m -117.88 5.1 12.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.381 1.872 . . . . 0.0 110.965 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.0 m -157.25 156.19 32.08 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 119.51 -1.994 . . . . 0.0 114.027 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -82.92 178.45 8.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.109 2.164 . . . . 0.0 113.328 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -73.48 160.76 31.24 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.524 1.53 . . . . 0.0 114.381 -170.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.15 147.74 32.58 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.248 2.619 . . . . 0.0 111.675 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.59 138.68 56.63 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.526 -0.734 . . . . 0.0 110.733 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.5 p -132.31 14.3 4.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.264 1.026 . . . . 0.0 113.263 172.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -81.45 170.87 15.41 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 118.676 0.671 . . . . 0.0 109.212 159.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -62.06 103.86 0.41 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.052 1.741 . . . . 0.0 111.777 -166.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 25.8 mtp -91.14 165.89 13.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 122.384 1.088 . . . . 0.0 112.142 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 30.7 m -161.94 164.72 28.32 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.049 1.34 . . . . 0.0 109.892 166.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.6 127.48 34.09 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 164.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.85 -32.57 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 159.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -133.84 119.89 19.76 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.647 1.579 . . . . 0.0 109.259 167.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -58.9 150.85 57.95 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.913 1.685 . . . . 0.0 112.063 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -62.8 131.27 32.43 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.535 2.157 . . . . 0.0 110.908 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.56 140.11 46.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.083 0.953 . . . . 0.0 109.691 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.31 132.09 52.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.036 0.934 . . . . 0.0 112.303 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 74.6 p -84.9 -13.7 50.03 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.02 1.328 . . . . 0.0 114.121 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 70.36 18.45 75.22 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.262 -0.743 . . . . 0.0 114.624 -162.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.24 16.16 8.38 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.872 1.336 . . . . 0.0 112.448 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.86 11.76 73.03 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.396 -0.815 . . . . 0.0 113.53 -176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 40.6 p -134.08 161.21 35.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.139 1.375 . . . . 0.0 110.942 -168.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.14 132.92 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.265 1.026 . . . . 0.0 109.614 172.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.14 136.1 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.835 1.254 . . . . 0.0 112.121 -170.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 14.5 ptm -151.01 165.64 33.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.498 1.519 . . . . 0.0 114.012 -172.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -132.07 121.57 24.04 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.767 2.427 . . . . 0.0 107.333 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.5 m -112.99 158.12 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.88 0.872 . . . . 0.0 111.589 -172.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -125.12 143.94 50.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.235 1.014 . . . . 0.0 113.426 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.58 151.16 51.37 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.637 2.375 . . . . 0.0 107.89 167.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -119.89 -60.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.627 2.218 . . . . 0.0 115.877 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 175.48 9.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.476 1.11 . . . . 0.0 112.248 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.57 -15.44 0.1 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.459 2.456 . . . . 0.0 118.638 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.83 92.59 49.03 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.635 1.717 . . . . 0.0 114.181 -159.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.28 124.59 10.07 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.816 1.677 . . . . 0.0 108.388 155.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.0 p -153.84 155.78 36.4 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.463 -0.773 . . . . 0.0 112.44 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -78.46 128.53 33.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.159 1.384 . . . . 0.0 107.785 161.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.7 pp -61.82 115.58 16.22 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -164.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -95.17 94.66 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.362 3.375 . . . . 0.0 113.852 -170.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 32.3 t -124.48 109.17 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.719 -0.613 . . . . 0.0 109.955 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.12 159.32 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.483 1.513 . . . . 0.0 110.984 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 83.8 t -131.81 117.36 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 126.51 1.924 . . . . 0.0 106.412 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.55 165.37 20.89 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -165.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -86.07 -8.65 57.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.271 1.829 . . . . 0.0 112.922 163.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -130.19 142.04 50.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.62 1.168 . . . . 0.0 110.914 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.74 -21.85 56.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.991 1.316 . . . . 0.0 113.726 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.7 t -105.6 5.92 31.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.55 1.94 . . . . 0.0 113.903 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 45.02 69.71 0.41 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.708 2.803 . . . . 0.0 116.184 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -82.8 -37.49 24.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.937 0.895 . . . . 0.0 111.861 153.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 36.4 mm -88.98 155.52 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.924 1.289 . . . . 0.0 110.449 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -134.46 93.55 3.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.179 1.791 . . . . 0.0 109.621 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -101.57 -28.16 12.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.832 2.053 . . . . 0.0 114.696 -169.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -99.78 179.96 30.41 Favored Glycine 0 N--CA 1.477 1.368 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -171.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 4.5 mt -117.61 135.51 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.537 2.335 . . . . 0.0 110.168 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.88 132.09 44.74 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.111 0.564 . . . . 0.0 110.319 165.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.06 -49.94 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.2 m -80.41 162.72 24.32 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.607 0.718 . . . . 0.0 110.66 167.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.4 m -63.31 165.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.112 1.765 . . . . 0.0 114.519 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -117.36 81.47 13.74 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.697 1.599 . . . . 0.0 110.917 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.09 -166.95 0.45 Allowed 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 124.412 3.408 . . . . 0.0 112.865 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.9 pt -104.37 169.81 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.284 1.833 . . . . 0.0 110.793 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.07 113.45 8.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.753 0.421 . . . . 0.0 110.099 158.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 82.4 p -73.32 -23.03 60.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.295 1.438 . . . . 0.0 113.361 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 77.4 p -135.0 165.23 25.83 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.946 2.099 . . . . 0.0 108.788 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -63.73 -21.2 66.29 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.018 -1.052 . . . . 0.0 113.471 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -100.39 9.22 42.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.695 1.598 . . . . 0.0 112.567 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -59.18 156.58 11.96 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.812 1.291 . . . . 0.0 113.508 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -148.35 98.72 2.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.982 1.313 . . . . 0.0 112.343 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 53.0 t -92.81 149.55 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.39 1.476 . . . . 0.0 110.438 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.27 124.28 49.27 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.53 2.732 . . . . 0.0 108.697 -174.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.58 136.37 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.671 0.788 . . . . 0.0 111.825 -170.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -95.75 136.54 36.03 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.424 1.49 . . . . 0.0 111.563 152.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.02 154.95 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.212 1.005 . . . . 0.0 111.333 166.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -116.57 113.15 40.67 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.774 2.03 . . . . 0.0 109.779 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -81.09 167.35 18.01 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.949 2.432 . . . . 0.0 111.357 164.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -69.63 173.5 10.76 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.436 2.091 . . . . 0.0 110.773 163.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -62.13 144.74 54.94 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.872 -0.518 . . . . 0.0 110.533 162.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.67 -155.57 18.34 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.782 0.706 . . . . 0.0 111.979 -170.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.58 161.06 21.29 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.459 1.123 . . . . 0.0 112.681 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 49.2 m -160.96 159.29 29.35 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.465 -1.397 . . . . 0.0 111.075 161.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.55 115.07 23.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 29.4 mm -89.59 117.02 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.664 1.586 . . . . 0.0 108.09 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.75 141.48 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.699 0.799 . . . . 0.0 110.707 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 99.4 t -116.24 109.27 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.412 1.885 . . . . 0.0 108.173 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 112.58 -177.35 18.36 Favored Glycine 0 N--CA 1.471 0.991 0 N-CA-C 116.241 1.256 . . . . 0.0 116.241 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 99.5 m -138.07 167.39 21.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.963 1.705 . . . . 0.0 109.282 165.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.21 -174.35 44.34 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 121.732 -0.605 . . . . 0.0 112.537 -169.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.78 -25.79 63.43 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.104 0.962 . . . . 0.0 113.435 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.8 m -75.4 -1.26 23.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.451 2.3 . . . . 0.0 114.846 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -79.88 133.59 36.25 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.748 0.819 . . . . 0.0 111.995 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.7 mt -102.84 163.65 12.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.258 0.623 . . . . 0.0 111.27 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 t -137.84 148.51 45.5 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.72 1.208 . . . . 0.0 112.001 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -146.0 131.07 18.29 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.484 1.514 . . . . 0.0 110.277 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -82.11 136.25 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.279 1.031 . . . . 0.0 111.301 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -134.95 154.45 51.7 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.069 0.938 . . . . 0.0 112.675 166.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -124.62 140.9 52.51 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.683 1.593 . . . . 0.0 107.942 165.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? . . . . . 0 N--CA 1.463 0.179 0 C-N-CA 126.381 1.872 . . . . 0.0 108.67 -177.354 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 3.8 m -97.44 5.35 49.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -171.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -71.96 -43.72 64.71 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.165 1.348 . . . . 0.0 112.755 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.1 136.11 56.33 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 165.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 t -54.56 163.94 0.82 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.36 97.06 1.96 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.869 1.668 . . . . 0.0 111.105 -164.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -46.72 133.55 10.47 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.904 2.482 . . . . 0.0 112.328 -171.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.02 -36.94 1.07 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.035 1.302 . . . . 0.0 114.561 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 10.3 p -72.75 -26.46 61.56 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 118.777 1.288 . . . . 0.0 114.246 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.0 m -134.29 150.6 51.0 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.574 0.75 . . . . 0.0 112.462 -152.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -79.94 175.36 10.7 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.287 1.435 . . . . 0.0 112.927 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.31 154.0 42.4 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -71.09 146.35 49.3 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.046 2.139 . . . . 0.0 112.358 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 8.4 m -63.48 143.06 58.13 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.682 -0.636 . . . . 0.0 112.266 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.3 p -135.45 11.44 3.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.641 1.176 . . . . 0.0 113.525 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.495 ' CG ' ' HZ2' ' A' ' 326' ' ' LYS . 45.8 t0 -71.97 168.98 16.87 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.219 0.918 . . . . 0.0 109.648 161.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -65.36 97.19 0.27 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.424 -0.797 . . . . 0.0 111.899 -172.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 42.7 mtp -86.17 168.0 14.4 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.366 1.079 . . . . 0.0 112.762 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 39.2 m -160.89 163.63 31.83 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.053 1.341 . . . . 0.0 109.963 161.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.82 121.76 25.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.654 0.381 . . . . 0.0 110.119 167.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.01 -29.85 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.267 1.027 . . . . 0.0 110.335 165.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -141.52 132.74 26.42 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.147 1.779 . . . . 0.0 109.303 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -64.81 150.43 94.65 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.379 1.072 . . . . 0.0 112.148 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -62.77 130.88 30.97 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.986 1.791 . . . . 0.0 110.646 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 65.2 p -131.27 137.84 49.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.964 1.306 . . . . 0.0 110.626 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -63.16 126.14 26.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.589 1.556 . . . . 0.0 112.333 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.8 p -70.61 -25.86 63.24 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.95 0.5 . . . . 0.0 111.281 166.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 82.39 -6.17 69.72 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.503 1.525 . . . . 0.0 113.845 -168.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -92.86 18.99 8.14 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.707 1.603 . . . . 0.0 111.37 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 91.9 2.78 68.87 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.738 1.161 . . . . 0.0 115.039 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 28.3 p -127.35 158.56 36.93 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.496 1.648 . . . . 0.0 112.55 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.02 129.78 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.778 1.631 . . . . 0.0 109.611 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.4 p -114.83 130.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.465 1.106 . . . . 0.0 113.085 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.4 ptm -137.97 171.25 14.7 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.809 2.443 . . . . 0.0 111.919 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -135.44 139.45 44.12 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.629 -0.669 . . . . 0.0 109.89 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.93 149.46 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.261 1.024 . . . . 0.0 111.948 -170.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -109.03 137.67 46.58 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.272 1.429 . . . . 0.0 112.833 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.1 t -117.07 133.88 23.08 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 126.977 2.111 . . . . 0.0 107.596 166.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -96.39 -74.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 123.186 2.591 . . . . 0.0 116.984 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.495 ' HZ2' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -151.92 146.15 25.42 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 -169.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 76.72 4.55 81.89 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 115.66 1.024 . . . . 0.0 115.66 171.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.25 99.13 43.52 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.843 1.257 . . . . 0.0 111.531 -172.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.66 130.03 14.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.327 2.018 . . . . 0.0 108.884 167.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.8 p -159.98 156.13 26.6 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -75.32 137.8 41.37 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.481 1.913 . . . . 0.0 108.429 162.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.77 124.55 88.83 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-N 118.29 0.495 . . . . 0.0 112.051 -169.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -107.35 96.13 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.423 2.749 . . . . 0.0 115.723 -165.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 69.3 t -124.89 124.55 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.39 -0.818 . . . . 0.0 109.473 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.34 154.7 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.572 1.549 . . . . 0.0 110.179 -174.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.22 105.06 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.222 1.409 . . . . 0.0 109.271 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -120.63 160.59 22.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.992 1.317 . . . . 0.0 113.865 -163.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.29 -17.12 46.97 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.747 1.619 . . . . 0.0 112.378 164.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -122.7 133.39 54.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.99 1.316 . . . . 0.0 110.929 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -56.76 -19.45 17.02 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.136 1.775 . . . . 0.0 113.108 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.2 t -101.62 4.51 40.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.665 2.386 . . . . 0.0 113.733 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 37.91 74.28 0.09 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 130.534 3.534 . . . . 0.0 117.326 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -105.52 -16.53 14.69 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.937 1.695 . . . . 0.0 112.83 160.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 64.4 mt -109.45 146.29 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.744 1.618 . . . . 0.0 107.62 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.27 112.83 11.36 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.909 -1.119 . . . . 0.0 111.397 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -104.39 -21.53 13.47 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.07 -168.92 42.11 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 118.716 0.689 . . . . 0.0 114.424 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 65.3 mt -134.44 135.4 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.276 1.831 . . . . 0.0 110.528 -174.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.61 118.57 10.38 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.723 1.209 . . . . 0.0 109.333 160.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.62 -29.54 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.666 0.786 . . . . 0.0 112.342 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.8 m -77.38 153.34 33.79 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.056 0.844 . . . . 0.0 109.737 153.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.5 m -60.96 161.81 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.007 1.323 . . . . 0.0 113.598 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -121.85 78.68 40.37 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.023 1.329 . . . . 0.0 111.466 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.39 -168.04 0.57 Allowed 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 124.404 3.402 . . . . 0.0 113.078 171.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 29.3 pt -95.08 164.46 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.211 1.804 . . . . 0.0 111.27 166.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.92 110.01 3.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 160.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.3 t -76.46 -3.0 34.9 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 90.8 m -153.56 157.07 39.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.026 2.53 . . . . 0.0 104.816 161.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -18.04 50.43 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.559 -1.338 . . . . 0.0 114.148 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.51 8.6 30.24 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.683 2.393 . . . . 0.0 113.479 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -60.57 156.88 15.46 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.226 -1.547 . . . . 0.0 114.099 -173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . 0.25 9.4 pt-20 -146.47 80.79 1.56 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 22.2 t -85.55 145.74 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.041 1.336 . . . . 0.0 112.363 -167.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.02 120.19 39.84 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 129.837 3.255 . . . . 0.0 109.108 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.1 mp -137.72 132.55 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.594 1.557 . . . . 0.0 111.125 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 142.6 29.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.004 0.907 . . . . 0.0 112.219 159.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.55 161.5 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.562 1.545 . . . . 0.0 110.522 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -117.94 108.99 41.7 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.746 1.619 . . . . 0.0 109.346 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.6 154.86 44.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.533 2.155 . . . . 0.0 110.638 163.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.29 175.66 10.27 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.224 1.949 . . . . 0.0 110.232 165.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -62.13 133.61 55.47 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.491 -0.756 . . . . 0.0 110.288 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.74 -149.43 16.6 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.564 1.078 . . . . 0.0 113.56 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.23 149.89 47.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.435 2.294 . . . . 0.0 113.172 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.9 m -163.88 153.78 14.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.988 1.315 . . . . 0.0 113.618 162.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -118.58 116.9 27.58 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.554 1.141 . . . . 0.0 108.679 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 27.5 mm -80.74 117.75 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.209 1.403 . . . . 0.0 107.561 174.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.4 mp -111.87 144.11 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.357 0.599 . . . . 0.0 109.946 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 78.6 t -116.02 117.42 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.011 1.724 . . . . 0.0 108.576 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 94.11 -178.66 37.51 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 122.942 1.301 . . . . 0.0 115.213 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 84.6 m -132.28 166.04 22.79 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.277 1.831 . . . . 0.0 109.423 168.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 76.71 -175.8 53.16 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 121.918 0.732 . . . . 0.0 113.663 -176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.22 -21.78 9.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.343 1.857 . . . . 0.0 114.454 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.1 m -86.47 -4.89 59.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.425 2.29 . . . . 0.0 114.61 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -73.72 137.91 44.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.55 1.068 . . . . 0.0 112.446 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 11.1 mt -106.41 162.94 13.26 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.748 0.819 . . . . 0.0 111.571 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.9 t -132.22 154.45 49.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.766 1.226 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -148.99 131.85 16.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.124 2.17 . . . . 0.0 108.9 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -81.64 134.84 35.52 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.928 -1.108 . . . . 0.0 111.597 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -133.23 146.73 51.72 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.297 0.639 . . . . 0.0 109.916 162.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.95 137.86 49.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 172.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? . . . . . 0 N--CA 1.468 0.457 0 C-N-CA 124.548 1.139 . . . . 0.0 110.531 -168.575 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 3.3 m -65.31 0.11 1.57 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.7 -23.58 66.8 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.559 1.527 . . . . 0.0 114.138 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 49.0 tp -85.68 128.2 34.71 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.916 1.235 . . . . 0.0 108.968 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.2 t -53.47 158.74 1.65 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -61.47 105.66 0.55 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.1 2.16 . . . . 0.0 110.774 -167.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -63.11 125.22 23.31 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.237 -0.914 . . . . 0.0 111.118 -170.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.89 -50.52 3.01 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.857 1.218 . . . . 0.0 112.842 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 32.1 m -63.94 -0.07 1.01 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.408 2.283 . . . . 0.0 113.432 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.2 m -157.1 154.02 28.75 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 119.024 -2.297 . . . . 0.0 111.725 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -78.01 170.87 15.88 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.816 1.647 . . . . 0.0 113.34 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 152.21 40.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.465 1.106 . . . . 0.0 113.294 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.6 mpp? -62.12 165.78 5.39 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 129.201 3.0 . . . . 0.0 114.314 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -81.15 142.72 32.97 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.281 -0.887 . . . . 0.0 110.545 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.5 p -135.77 18.61 3.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.587 1.155 . . . . 0.0 113.094 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -81.75 161.28 23.37 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 156.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.14 102.25 0.36 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.53 1.532 . . . . 0.0 112.131 -168.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 28.1 mtp -84.64 172.77 11.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.22 1.008 . . . . 0.0 112.837 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.6 m -159.93 167.25 28.44 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.174 -0.954 . . . . 0.0 112.027 166.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.92 117.95 24.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.579 0.752 . . . . 0.0 109.328 167.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.07 -35.26 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.049 0.94 . . . . 0.0 110.015 159.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -135.71 127.07 28.45 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.321 1.448 . . . . 0.0 108.467 165.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -65.15 152.69 90.98 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.467 1.107 . . . . 0.0 111.903 171.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.46 131.08 30.41 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.637 2.225 . . . . 0.0 111.657 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.0 m -136.85 139.61 41.81 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.278 1.031 . . . . 0.0 110.465 174.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -65.16 132.58 49.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.277 1.031 . . . . 0.0 112.549 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 63.9 p -79.62 -21.55 44.76 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.034 1.334 . . . . 0.0 113.49 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 85.08 -9.29 66.89 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.541 1.543 . . . . 0.0 113.696 -162.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -81.66 -7.59 59.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.573 1.187 . . . . 0.0 112.312 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.35 15.23 48.28 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.329 0.966 . . . . 0.0 112.843 -164.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 32.2 p -127.68 155.95 43.13 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.923 1.289 . . . . 0.0 110.907 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 25.6 m -123.18 127.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.889 1.276 . . . . 0.0 109.53 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.69 130.82 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.866 1.266 . . . . 0.0 111.86 -172.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 7.0 ptp -137.74 167.99 20.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.903 2.081 . . . . 0.0 111.082 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -133.11 129.28 37.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.064 0.946 . . . . 0.0 108.964 170.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.22 151.72 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.328 1.051 . . . . 0.0 110.85 -169.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -113.18 131.83 55.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.795 1.238 . . . . 0.0 111.64 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.39 151.07 39.61 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-O 117.062 -1.447 . . . . 0.0 108.531 159.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -111.03 -72.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.184 2.589 . . . . 0.0 115.279 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 172.9 12.5 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.184 -1.573 . . . . 0.0 113.127 -174.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.12 -24.09 0.11 Allowed Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.913 2.197 . . . . 0.0 117.538 170.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -109.0 96.9 22.09 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 125.909 1.684 . . . . 0.0 111.784 -170.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -62.97 133.9 43.65 Favored 'Trans proline' 0 C--N 1.35 0.637 0 N-CA-C 107.675 -1.702 . . . . 0.0 107.675 154.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.4 p -158.88 154.25 25.72 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.315 -0.865 . . . . 0.0 113.234 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -72.39 141.99 48.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.604 157.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.91 123.28 79.28 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 118.986 0.812 . . . . 0.0 111.233 -175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -98.52 72.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.042 3.162 . . . . 0.0 112.694 -168.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.1 t -104.76 130.62 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.87 162.65 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 125.181 1.392 . . . . 0.0 110.586 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.72 120.25 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.988 1.715 . . . . 0.0 107.768 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.89 164.57 22.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -160.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.66 -16.52 36.33 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.453 1.901 . . . . 0.0 113.116 163.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -124.66 138.37 54.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.731 1.212 . . . . 0.0 110.364 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.79 -15.94 14.61 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.8 t -104.28 8.26 36.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.459 1.503 . . . . 0.0 113.877 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 40.32 67.69 0.47 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 129.347 3.059 . . . . 0.0 116.578 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.8 -27.26 23.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.186 0.994 . . . . 0.0 112.574 155.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 56.4 mt -111.86 136.58 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.896 1.678 . . . . 0.0 108.988 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -110.0 98.57 7.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.896 1.278 . . . . 0.0 112.451 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -80.61 -42.68 21.78 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.188 2.595 . . . . 0.0 114.308 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -93.08 -168.55 39.18 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 119.993 1.27 . . . . 0.0 116.261 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.4 mt -125.85 141.76 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.852 2.461 . . . . 0.0 110.071 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.44 136.04 37.53 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.371 1.069 . . . . 0.0 110.4 167.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.56 -40.76 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.031 0.533 . . . . 0.0 112.374 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 27.5 m -72.53 158.63 35.33 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 157.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 10.6 m -55.51 156.2 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.484 1.114 . . . . 0.0 113.095 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -113.82 84.16 8.22 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.325 1.45 . . . . 0.0 109.175 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -81.44 -167.47 0.5 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 124.695 3.597 . . . . 0.0 112.89 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 26.0 pt -95.17 164.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.363 1.865 . . . . 0.0 111.183 166.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -73.77 110.43 8.06 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 154.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.9 p -75.88 -51.82 11.67 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.958 1.303 . . . . 0.0 111.629 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.15 151.14 23.9 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 155.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -57.92 -23.05 51.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.91 9.33 43.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.454 1.502 . . . . 0.0 112.786 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -58.56 153.41 16.26 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.241 -1.537 . . . . 0.0 113.686 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -135.82 84.88 2.12 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.721 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 23.5 t -87.98 142.14 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.248 1.419 . . . . 0.0 111.663 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.89 123.74 35.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.903 2.881 . . . . 0.0 109.409 176.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.95 140.56 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.384 1.474 . . . . 0.0 111.039 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.5 148.24 30.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.3 1.047 . . . . 0.0 112.933 161.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.6 m -131.07 155.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.679 1.592 . . . . 0.0 110.678 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -109.51 106.12 58.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.999 2.12 . . . . 0.0 109.361 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.73 146.96 30.7 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.228 1.952 . . . . 0.0 110.346 161.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.2 170.12 18.99 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.454 2.103 . . . . 0.0 111.009 167.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -55.03 140.89 36.26 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.526 1.131 . . . . 0.0 111.483 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.35 -148.3 18.83 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -171.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -79.93 162.03 25.19 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.489 1.116 . . . . 0.0 112.452 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 17.6 m -164.25 155.41 15.65 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.773 -1.205 . . . . 0.0 111.961 156.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -113.56 112.0 22.82 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.5 mm -78.9 119.49 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.651 1.181 . . . . 0.0 107.86 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -113.37 140.98 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.522 0.729 . . . . 0.0 109.886 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.4 t -120.01 107.04 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 125.421 1.488 . . . . 0.0 108.468 172.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 119.49 -176.34 16.09 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.251 1.405 . . . . 0.0 115.574 172.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 54.7 m -138.76 161.9 36.06 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.426 1.49 . . . . 0.0 109.267 164.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.49 -172.17 50.79 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 121.86 0.7 . . . . 0.0 112.762 -169.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -29.23 11.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.24 1.816 . . . . 0.0 113.647 173.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.7 m -72.29 -4.43 29.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 128.739 2.815 . . . . 0.0 114.693 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -84.96 122.28 28.99 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.04 0.837 . . . . 0.0 112.564 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 29.6 mt -87.06 161.08 18.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.25 0.62 . . . . 0.0 111.327 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.7 t -141.29 145.33 35.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.996 1.318 . . . . 0.0 111.737 -173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -153.75 115.18 4.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.924 1.29 . . . . 0.0 110.775 -171.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.8 135.01 47.86 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.861 -1.149 . . . . 0.0 112.152 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -124.37 166.85 15.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.441 1.096 . . . . 0.0 110.977 157.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.84 138.33 37.41 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.471 1.508 . . . . 0.0 108.011 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? . . . . . 0 N--CA 1.466 0.333 0 C-N-CA 125.224 1.41 . . . . 0.0 110.784 -173.551 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 118.682 -0.675 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 12.1 m -98.14 0.44 45.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -171.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.52 71.24 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.64 1.109 . . . . 0.0 112.353 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.9 tt -66.57 118.18 9.8 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.2 t -55.09 173.03 0.1 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.141 2.176 . . . . 0.0 116.368 -164.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -60.97 106.36 0.58 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.5 1.92 . . . . 0.0 111.727 -172.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -71.06 141.54 50.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.414 1.486 . . . . 0.0 111.74 -171.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.74 -59.49 1.3 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.292 1.425 . . . . 0.0 113.393 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 14.6 t -68.05 16.38 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.962 2.105 . . . . 0.0 115.213 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 10.0 m -163.69 165.55 23.15 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 120.233 -1.542 . . . . 0.0 112.945 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -86.66 169.23 12.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.781 1.232 . . . . 0.0 113.865 -172.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -70.52 159.18 34.76 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.76 1.624 . . . . 0.0 115.048 -166.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 54.5 mtt -77.23 151.11 35.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.161 2.184 . . . . 0.0 112.062 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.8 m -69.51 142.78 53.62 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.725 -0.609 . . . . 0.0 111.968 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 20.3 p -131.5 7.72 4.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.389 1.076 . . . . 0.0 113.651 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.476 ' CG ' ' HZ3' ' A' ' 326' ' ' LYS . 45.6 t0 -72.54 159.66 33.55 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.523 1.056 . . . . 0.0 109.984 160.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -63.87 100.47 0.3 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.907 1.683 . . . . 0.0 110.984 -168.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 17.2 mtp -83.83 172.99 11.64 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 122.318 1.056 . . . . 0.0 113.604 -169.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.2 m -155.5 172.5 18.14 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.873 0.869 . . . . 0.0 111.372 161.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.58 121.56 42.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.188 0.995 . . . . 0.0 109.765 164.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 27.1 t -63.77 -36.89 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.003 1.321 . . . . 0.0 109.798 167.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -137.92 126.54 23.63 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.23 1.412 . . . . 0.0 109.836 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -62.96 152.19 84.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.618 1.167 . . . . 0.0 112.217 172.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -62.06 131.86 36.66 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.392 2.062 . . . . 0.0 111.647 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 48.1 p -128.56 132.02 48.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.93 1.292 . . . . 0.0 110.874 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -51.35 118.79 3.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.192 1.797 . . . . 0.0 112.062 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 60.9 p -79.64 -8.6 59.31 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.413 1.485 . . . . 0.0 113.41 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.17 -7.2 6.15 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.523 1.059 . . . . 0.0 114.262 -165.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -89.49 5.37 45.7 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.222 1.511 . . . . 0.0 112.14 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 87.05 17.35 59.49 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.232 0.92 . . . . 0.0 113.148 -170.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 38.4 p -131.47 161.52 32.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.907 1.283 . . . . 0.0 111.062 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.96 128.45 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.907 1.283 . . . . 0.0 109.119 170.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.91 133.16 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.664 1.186 . . . . 0.0 111.844 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 22.2 ptm -146.63 162.35 38.62 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.664 2.385 . . . . 0.0 111.861 -166.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -134.74 130.53 36.35 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.524 -0.735 . . . . 0.0 109.655 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 19.9 m -109.92 164.52 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.837 1.255 . . . . 0.0 111.517 -171.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -134.95 125.03 25.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.547 1.539 . . . . 0.0 111.498 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.83 153.15 37.99 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-O 117.21 -1.376 . . . . 0.0 108.374 162.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -109.02 -72.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 123.293 2.662 . . . . 0.0 115.208 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.476 ' HZ3' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -138.3 163.69 31.17 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 121.397 1.908 . . . . 0.0 115.823 -174.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.83 -17.54 0.1 OUTLIER Glycine 0 CA--C 1.538 1.504 0 C-N-CA 127.841 2.638 . . . . 0.0 117.881 171.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -104.22 99.89 19.15 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 119.316 1.558 . . . . 0.0 113.13 -168.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.26 128.46 16.51 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.836 1.69 . . . . 0.0 108.697 155.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.0 p -163.94 155.93 16.94 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.555 -0.715 . . . . 0.0 111.953 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -79.77 128.18 33.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.497 1.519 . . . . 0.0 109.448 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.0 111.01 3.1 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.464 0.706 . . . . 0.0 112.4 -163.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -91.03 85.9 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.726 2.95 . . . . 0.0 113.394 -157.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.42 134.48 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.972 0.909 . . . . 0.0 109.219 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.08 151.72 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.376 1.07 . . . . 0.0 110.232 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.27 109.31 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.889 1.675 . . . . 0.0 107.591 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -117.7 161.24 20.0 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -158.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.28 -11.98 53.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.158 2.183 . . . . 0.0 112.783 162.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -129.81 138.31 50.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.561 1.544 . . . . 0.0 111.073 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 22.5 mt -55.83 -19.18 10.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.587 1.555 . . . . 0.0 114.374 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -105.65 2.36 28.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.95 2.5 . . . . 0.0 114.222 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 49.04 77.58 0.1 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.161 2.584 . . . . 0.0 116.59 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -109.9 -24.34 10.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.393 1.477 . . . . 0.0 112.309 161.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.92 120.54 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.062 1.345 . . . . 0.0 109.018 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.96 114.73 28.89 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.729 0.812 . . . . 0.0 112.916 -169.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -81.39 -51.57 8.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.504 2.722 . . . . 0.0 112.451 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.9 -167.36 40.2 Favored Glycine 0 CA--C 1.537 1.413 0 N-CA-C 116.549 1.379 . . . . 0.0 116.549 -167.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.91 140.44 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 127.035 2.134 . . . . 0.0 110.94 -175.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 7.2 mt -73.05 130.0 39.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.759 1.224 . . . . 0.0 110.466 163.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.09 -45.18 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 122.759 0.424 . . . . 0.0 111.159 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 m -70.03 154.78 41.5 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.67 0.668 . . . . 0.0 110.178 164.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.9 m -56.73 155.89 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.971 0.908 . . . . 0.0 112.253 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -127.79 71.26 78.05 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.049 0.939 . . . . 0.0 111.716 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.23 -169.52 0.75 Allowed 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 124.619 3.546 . . . . 0.0 112.914 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 37.1 pt -87.55 161.29 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 121.502 -0.749 . . . . 0.0 112.196 167.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.85 109.29 2.03 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 156.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.4 p -69.73 -37.2 76.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.617 1.567 . . . . 0.0 112.161 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.46 157.14 30.0 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.082 1.753 . . . . 0.0 109.745 158.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -62.95 -17.95 62.58 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.88 7.88 44.57 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.623 1.169 . . . . 0.0 112.356 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -59.45 150.39 26.78 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.63 -1.294 . . . . 0.0 113.257 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -134.84 80.17 1.83 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.355 1.062 . . . . 0.0 113.289 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.23 146.5 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.031 1.332 . . . . 0.0 111.942 -171.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 27.6 tp -97.96 129.01 44.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 129.405 3.082 . . . . 0.0 110.034 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.2 mp -140.28 148.6 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 109.726 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -121.25 148.07 44.78 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.249 1.023 . . . . 0.0 112.354 157.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.45 156.57 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.689 1.596 . . . . 0.0 110.909 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -116.21 104.96 51.53 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.58 1.952 . . . . 0.0 110.639 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.16 164.62 15.05 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.645 2.897 . . . . 0.0 111.747 163.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.58 -178.93 4.85 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.792 2.995 . . . . 0.0 111.836 166.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -67.0 150.9 48.61 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.525 -0.735 . . . . 0.0 110.551 158.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 94.47 -151.05 20.0 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 -167.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.9 162.5 20.48 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.754 1.222 . . . . 0.0 113.276 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 19.3 m -165.09 159.08 17.4 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.822 -1.174 . . . . 0.0 111.818 157.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -122.25 116.16 23.64 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 11.7 mm -92.1 111.14 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.349 1.06 . . . . 0.0 108.188 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.3 145.41 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.961 0.904 . . . . 0.0 109.957 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.86 113.41 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.415 1.886 . . . . 0.0 109.015 174.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.58 178.16 27.13 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.435 1.017 . . . . 0.0 114.855 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 17.8 m -131.43 159.95 36.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.811 1.645 . . . . 0.0 109.566 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 78.35 -175.74 54.57 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 121.898 0.721 . . . . 0.0 112.966 -172.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -22.17 63.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.033 1.333 . . . . 0.0 112.85 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 72.0 m -63.47 -12.31 30.57 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 168.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -79.4 144.01 34.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.099 1.318 . . . . 0.0 112.799 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 24.9 mt -111.81 164.37 13.14 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.428 1.091 . . . . 0.0 111.24 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.5 t -140.58 146.85 38.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.802 1.241 . . . . 0.0 111.686 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -143.93 112.24 6.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.824 1.65 . . . . 0.0 110.034 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 131.62 46.44 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.98 0.912 . . . . 0.0 111.664 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -121.05 158.46 27.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.35 1.06 . . . . 0.0 110.775 162.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -145.5 140.03 27.23 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? . . . . . 0 C--N 1.332 -0.155 0 C-N-CA 124.994 1.318 . . . . 0.0 108.694 176.843 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.2 m -98.09 2.07 48.29 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.378 1.071 . . . . 0.0 112.984 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.48 82.0 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.074 0.852 . . . . 0.0 112.928 175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.38 135.99 37.57 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.473 1.033 . . . . 0.0 108.974 168.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.1 t -52.76 167.69 0.14 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.143 1.777 . . . . 0.0 114.658 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.92 100.16 0.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.283 1.833 . . . . 0.0 110.204 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.461 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 8.3 mptt -61.09 127.93 33.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.573 2.349 . . . . 0.0 110.995 -168.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.06 -42.93 1.18 Allowed Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.937 1.256 . . . . 0.0 113.662 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 58.3 m -63.28 -5.91 3.95 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.791 2.436 . . . . 0.0 114.04 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 45.1 m -126.43 152.99 45.65 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -78.15 173.56 12.11 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.492 1.517 . . . . 0.0 112.261 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.34 158.28 29.57 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 51.0 mtm -88.9 154.48 20.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.899 2.08 . . . . 0.0 111.52 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.5 m -72.35 141.15 48.78 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.68 -0.637 . . . . 0.0 111.937 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.9 p -132.7 6.56 4.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -68.89 160.82 29.99 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.195 1.362 . . . . 0.0 109.975 160.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.58 95.66 0.23 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.692 1.597 . . . . 0.0 111.9 -169.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 65.6 mtp -80.45 172.62 13.53 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.203 1.401 . . . . 0.0 113.149 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 28.2 m -158.58 170.68 21.65 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.85 1.26 . . . . 0.0 110.45 160.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.55 123.94 36.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.405 0.682 . . . . 0.0 110.936 170.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 63.6 t -67.43 -36.34 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.583 1.553 . . . . 0.0 109.925 165.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -136.44 108.87 7.36 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 126.484 1.914 . . . . 0.0 107.724 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -59.49 143.88 85.27 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.959 0.904 . . . . 0.0 110.151 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.62 140.48 86.87 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.596 2.197 . . . . 0.0 111.612 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' THR . . . . . 0.405 ' HA ' ' CZ2' ' A' ' 389' ' ' TRP . 43.3 p -136.87 130.79 32.27 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.455 1.502 . . . . 0.0 109.71 173.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.93 134.14 52.35 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 124.262 0.976 . . . . 0.0 112.694 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 43.5 p -82.26 -18.34 42.8 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.23 1.012 . . . . 0.0 113.267 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 60.9 22.5 60.17 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.192 0.905 . . . . 0.0 112.55 -163.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -121.38 13.94 11.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.071 1.748 . . . . 0.0 111.024 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 103.07 -3.86 48.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.876 1.703 . . . . 0.0 114.119 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 25.9 p -127.63 161.9 27.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.961 1.38 . . . . 0.0 112.797 -165.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.72 135.12 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.648 1.579 . . . . 0.0 108.601 162.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.63 125.65 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.223 1.009 . . . . 0.0 112.841 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 18.7 ptm -146.01 158.36 43.87 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.941 1.696 . . . . 0.0 113.389 -166.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -138.35 137.47 37.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.921 1.288 . . . . 0.0 109.423 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.27 149.1 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.877 1.271 . . . . 0.0 110.994 -169.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -116.11 134.32 55.06 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.965 1.706 . . . . 0.0 111.359 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.82 148.52 37.53 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.267 1.427 . . . . 0.0 108.374 163.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -105.87 -70.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.252 2.635 . . . . 0.0 116.201 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.09 168.44 19.81 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 120.129 -1.607 . . . . 0.0 113.591 -170.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.44 -16.77 0.09 OUTLIER Glycine 0 CA--C 1.54 1.642 0 C-N-CA 126.641 2.067 . . . . 0.0 117.501 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -119.48 91.76 44.92 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 119.305 1.553 . . . . 0.0 113.153 -163.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.35 131.62 19.34 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.977 1.784 . . . . 0.0 108.577 152.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 1.6 p -161.76 159.06 26.7 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.397 -0.814 . . . . 0.0 112.406 -170.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -73.55 132.19 42.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.896 1.678 . . . . 0.0 108.608 164.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.4 pp -62.66 111.58 5.04 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 118.692 0.678 . . . . 0.0 112.7 -168.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -89.74 75.17 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.251 3.301 . . . . 0.0 112.751 -163.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.95 130.27 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 167.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.83 158.99 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.135 0.974 . . . . 0.0 109.857 172.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.54 116.61 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.765 2.026 . . . . 0.0 106.314 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.34 161.61 31.97 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -160.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.02 -11.49 52.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.124 2.17 . . . . 0.0 112.784 169.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.51 136.64 51.06 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.145 1.778 . . . . 0.0 109.621 176.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.6 mp -60.11 -18.49 47.68 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -94.27 -1.01 54.66 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.126 2.17 . . . . 0.0 114.569 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 46.56 79.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.851 2.46 . . . . 0.0 115.933 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -103.71 -32.64 9.27 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.381 1.472 . . . . 0.0 111.864 158.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.98 115.48 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.628 1.104 . . . . 0.0 110.609 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.03 111.82 22.63 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.029 0.932 . . . . 0.0 113.06 -173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -86.38 -25.15 25.49 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 130.15 3.38 . . . . 0.0 114.459 -170.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -113.15 -163.93 15.74 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 115.766 1.066 . . . . 0.0 115.766 -169.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.62 137.85 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 127.904 2.481 . . . . 0.0 110.415 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.5 mt -74.81 134.49 41.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.757 164.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.0 t -104.78 -49.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.581 0.753 . . . . 0.0 110.356 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 37.5 m -71.66 155.79 40.1 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.118 0.485 . . . . 0.0 110.204 166.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.15 157.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.391 1.076 . . . . 0.0 112.562 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -121.96 75.71 39.01 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.486 1.114 . . . . 0.0 111.136 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -79.98 -164.22 0.27 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.458 3.439 . . . . 0.0 112.284 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.6 pt -96.73 162.24 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.791 1.637 . . . . 0.0 111.958 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.16 112.11 4.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.118 0.967 . . . . 0.0 108.657 157.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 98.9 p -63.77 -30.04 71.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.711 1.204 . . . . 0.0 113.059 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 12.2 m -137.23 155.96 48.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 128.259 2.624 . . . . 0.0 106.691 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -57.74 -19.55 28.49 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -97.09 10.68 38.66 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.331 1.452 . . . . 0.0 113.408 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -60.37 158.23 12.26 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 120.061 -1.649 . . . . 0.0 114.037 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.2 77.83 1.53 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.62 147.85 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.655 1.182 . . . . 0.0 112.171 -172.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 26.6 tp -105.37 132.33 51.7 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 129.709 3.203 . . . . 0.0 110.106 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.7 mp -144.41 138.88 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.859 1.664 . . . . 0.0 111.123 -167.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -99.45 135.69 40.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.821 1.248 . . . . 0.0 111.462 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.15 163.19 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.787 1.235 . . . . 0.0 110.873 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -119.03 112.88 35.98 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.771 2.028 . . . . 0.0 109.587 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.18 153.22 16.41 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 122.934 2.423 . . . . 0.0 111.159 158.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.76 174.27 4.77 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.124 2.549 . . . . 0.0 112.974 165.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.77 140.84 56.23 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.491 1.116 . . . . 0.0 110.155 164.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 96.4 -148.68 19.08 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.3 163.29 23.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.143 0.977 . . . . 0.0 113.451 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 37.6 m -163.17 161.59 25.12 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.792 -1.193 . . . . 0.0 110.785 158.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -121.27 114.87 21.98 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 15.0 mm -83.73 121.58 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.75 141.41 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.656 0.782 . . . . 0.0 109.688 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 81.6 t -122.86 104.36 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 126.353 1.861 . . . . 0.0 108.483 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.59 177.37 20.72 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 122.703 1.169 . . . . 0.0 114.575 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 98.8 m -130.31 164.29 24.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.353 1.461 . . . . 0.0 109.104 165.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.49 -171.53 53.03 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 122.031 0.795 . . . . 0.0 113.068 -173.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -29.98 59.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.099 1.76 . . . . 0.0 113.325 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.8 m -66.68 -11.48 54.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -74.43 123.35 24.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.184 1.356 . . . . 0.0 113.037 -169.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 14.2 mt -84.49 163.29 19.51 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.895 0.478 . . . . 0.0 111.201 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 t -138.41 148.15 44.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.893 1.277 . . . . 0.0 111.12 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -147.58 111.38 5.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.318 1.447 . . . . 0.0 110.611 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 134.24 50.23 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.532 1.133 . . . . 0.0 112.353 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . 0.405 ' CZ2' ' HA ' ' A' ' 311' ' ' THR . 11.1 m95 -126.0 162.97 24.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.277 1.431 . . . . 0.0 112.671 166.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.04 133.51 33.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.164 2.185 . . . . 0.0 108.158 171.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 C-N-CA 124.899 1.279 . . . . 0.0 110.917 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 60.3 p -103.45 -6.54 21.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.691 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -49.16 -57.43 6.7 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.386 1.075 . . . . 0.0 112.55 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.47 124.18 21.61 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 163.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.1 t -50.84 164.61 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.579 1.952 . . . . 0.0 115.687 -165.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -59.07 102.91 0.14 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.272 1.829 . . . . 0.0 110.471 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -60.95 135.53 57.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.02 2.128 . . . . 0.0 111.018 -168.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 73.5 -47.56 1.44 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.533 1.063 . . . . 0.0 113.343 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.7 m -63.41 -16.58 60.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.548 1.939 . . . . 0.0 113.467 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -124.99 143.84 50.69 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.119 1.368 . . . . 0.0 112.241 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -73.47 173.31 9.82 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.872 0.869 . . . . 0.0 112.025 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -68.17 160.93 28.12 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.344 1.058 . . . . 0.0 113.675 -175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 46.3 mtt -88.7 158.4 18.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.894 1.677 . . . . 0.0 112.379 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.0 m -70.82 140.94 51.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.221 0.608 . . . . 0.0 111.906 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 13.3 p -123.21 9.07 9.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.37 1.068 . . . . 0.0 113.289 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.41 ' CG ' ' HZ1' ' A' ' 326' ' ' LYS . 43.1 t0 -70.15 161.31 30.46 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.624 -0.672 . . . . 0.0 111.067 164.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -65.7 91.97 0.14 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.525 1.93 . . . . 0.0 111.433 -167.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 5.8 mtp -76.7 167.13 22.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.767 1.27 . . . . 0.0 113.413 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 27.7 m -159.63 173.6 15.85 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.062 1.345 . . . . 0.0 110.249 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -109.01 128.99 55.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.35 1.06 . . . . 0.0 111.09 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.5 -33.88 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.737 1.615 . . . . 0.0 109.68 163.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -138.9 124.73 19.77 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.097 1.359 . . . . 0.0 109.988 169.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -62.83 143.78 96.93 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.253 1.421 . . . . 0.0 112.061 169.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -58.56 132.07 46.15 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.587 2.191 . . . . 0.0 112.607 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.1 142.86 44.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.534 0.734 . . . . 0.0 110.335 172.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -66.83 134.85 52.94 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.035 0.934 . . . . 0.0 112.836 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.6 p -79.9 -20.94 44.63 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.076 1.351 . . . . 0.0 113.341 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 88.76 -12.37 65.84 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.661 1.601 . . . . 0.0 113.89 -166.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -90.12 9.44 28.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.523 1.529 . . . . 0.0 112.137 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 83.84 14.75 71.96 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 121.127 -0.983 . . . . 0.0 114.054 -171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.7 p -125.02 158.28 34.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.554 1.142 . . . . 0.0 110.929 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.83 131.07 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.045 1.338 . . . . 0.0 109.706 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.06 131.38 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.232 1.413 . . . . 0.0 111.804 -172.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 4.5 ptp -143.29 165.61 27.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.786 2.034 . . . . 0.0 111.858 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -136.96 132.12 33.94 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.473 -0.767 . . . . 0.0 109.5 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.6 m -113.44 163.97 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.386 1.075 . . . . 0.0 111.749 -168.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -125.12 115.53 20.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.358 1.463 . . . . 0.0 110.624 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 t -91.61 134.54 29.11 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 116.857 -1.544 . . . . 0.0 107.343 165.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -97.02 -80.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.447 0 C-N-CA 122.525 2.15 . . . . 0.0 116.381 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.41 ' HZ1' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -155.13 144.97 21.51 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 119.25 -2.156 . . . . 0.0 115.878 -173.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 88.54 0.53 81.96 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.87 1.224 . . . . 0.0 115.23 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.67 98.3 45.85 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.989 1.316 . . . . 0.0 111.486 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.54 123.36 10.1 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.3 2.0 . . . . 0.0 108.433 161.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.9 p -157.0 157.35 34.55 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.128 0.966 . . . . 0.0 113.251 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -69.83 138.82 52.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.075 1.75 . . . . 0.0 108.776 162.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.42 121.77 69.08 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 118.721 0.691 . . . . 0.0 111.855 -173.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -99.98 95.69 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.649 2.233 . . . . 0.0 114.768 -155.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.72 141.98 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.02 0.928 . . . . 0.0 110.932 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.31 159.59 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.95 1.7 . . . . 0.0 110.309 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.4 t -133.35 97.91 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.284 1.834 . . . . 0.0 108.028 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -111.9 160.98 16.88 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -165.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -81.98 -17.2 47.74 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.859 1.664 . . . . 0.0 112.614 162.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -123.89 138.66 54.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.633 1.173 . . . . 0.0 111.745 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.68 -18.65 32.67 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.11 1.364 . . . . 0.0 113.314 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.4 t -91.53 -4.17 55.71 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.124 1.769 . . . . 0.0 114.388 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.51 70.05 0.32 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.133 2.173 . . . . 0.0 114.555 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -104.09 -14.57 15.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.951 0.9 . . . . 0.0 111.929 163.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 56.5 mt -111.74 155.83 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.702 1.601 . . . . 0.0 108.373 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -141.73 123.01 14.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.725 -1.234 . . . . 0.0 112.414 170.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -116.69 -11.38 11.0 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -96.65 -172.59 34.83 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.415 0.926 . . . . 0.0 115.415 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 23.3 mt -126.45 138.06 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.924 2.089 . . . . 0.0 110.775 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 50.5 mt -68.85 132.39 46.68 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.616 0.766 . . . . 0.0 109.815 163.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.42 -41.56 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 118.411 0.551 . . . . 0.0 112.05 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' THR . . . . . 0.454 ' HB ' ' H ' ' A' ' 366' ' ' GLU . 59.9 m -76.88 145.8 38.08 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.655 0.661 . . . . 0.0 109.379 159.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 25.4 t -63.38 154.51 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.444 1.098 . . . . 0.0 111.44 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -117.98 82.99 18.17 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.21 1.404 . . . . 0.0 112.204 -174.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -85.42 -154.34 0.05 OUTLIER 'Trans proline' 0 CA--C 1.554 1.487 0 C-N-CA 125.24 3.96 . . . . 0.0 112.66 172.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.9 pt -107.33 166.6 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.171 2.189 . . . . 0.0 111.761 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.25 118.02 12.54 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 158.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 85.4 p -74.71 -44.11 51.66 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.149 1.38 . . . . 0.0 112.521 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.75 155.14 20.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.005 1.722 . . . . 0.0 108.623 158.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -59.77 -26.49 65.75 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -91.37 9.93 29.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.508 1.523 . . . . 0.0 113.068 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -60.08 150.89 28.08 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.45 -1.406 . . . . 0.0 114.252 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.24 88.84 2.45 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 66.0 t -100.56 144.91 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.16 1.384 . . . . 0.0 111.834 -162.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.6 tp -95.73 126.43 40.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.799 2.84 . . . . 0.0 109.774 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.57 154.04 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.698 1.199 . . . . 0.0 110.812 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . 0.454 ' H ' ' HB ' ' A' ' 351' ' ' THR . 0.3 OUTLIER -128.29 148.2 50.64 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 124.712 1.205 . . . . 0.0 111.229 165.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.59 154.09 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.38 1.472 . . . . 0.0 110.686 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.9 109.84 59.21 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.621 1.569 . . . . 0.0 109.126 173.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.78 144.62 31.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.236 1.958 . . . . 0.0 111.43 163.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.13 168.3 25.12 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.173 2.582 . . . . 0.0 110.852 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -56.76 134.72 55.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.645 1.178 . . . . 0.0 111.897 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.63 -148.62 19.18 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.195 0.902 . . . . 0.0 112.685 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.73 147.71 22.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.16 2.184 . . . . 0.0 113.786 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 29.7 m -163.44 154.12 16.16 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.273 1.429 . . . . 0.0 113.042 159.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -117.22 105.27 12.04 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.666 1.586 . . . . 0.0 108.955 172.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 20.5 mm -78.48 116.57 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 30.3 mt -121.84 139.51 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.118 0.485 . . . . 0.0 110.524 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 68.9 t -115.31 114.49 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.38 1.872 . . . . 0.0 107.886 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 99.89 177.63 30.73 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 122.81 1.228 . . . . 0.0 114.756 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 94.5 m -127.31 163.69 23.4 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.064 1.746 . . . . 0.0 109.767 167.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.41 -173.7 52.85 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 121.746 0.637 . . . . 0.0 113.265 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -25.67 64.44 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.329 1.452 . . . . 0.0 113.251 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.5 m -64.86 -13.72 57.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 170.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -74.11 136.95 42.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.07 1.304 . . . . 0.0 112.266 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 17.3 mt -104.43 154.78 19.44 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.406 0.682 . . . . 0.0 110.607 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.6 t -129.0 145.61 51.2 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.525 1.13 . . . . 0.0 112.161 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -146.16 108.63 4.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.465 1.506 . . . . 0.0 109.585 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -65.21 137.99 57.95 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.607 1.163 . . . . 0.0 111.759 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -142.07 126.19 17.4 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.727 1.211 . . . . 0.0 111.36 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -96.8 131.89 43.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.818 0.847 . . . . 0.0 109.731 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? . . . . . 0 N--CA 1.468 0.445 0 C-N-CA 125.589 1.555 . . . . 0.0 110.663 177.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 117.813 -1.089 . . . . 0.0 113.805 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.1 p -98.98 -7.38 27.03 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.137 1.335 . . . . 0.0 114.393 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.12 -48.37 70.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.678 1.191 . . . . 0.0 112.851 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.08 121.22 14.65 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 2.3 t -52.07 168.85 0.08 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.264 1.826 . . . . 0.0 115.153 -168.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.1 109.88 0.66 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.132 1.773 . . . . 0.0 110.635 -171.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -69.7 138.98 53.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.458 1.903 . . . . 0.0 110.738 -165.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 64.66 -59.35 0.07 OUTLIER Glycine 0 CA--C 1.534 1.246 0 C-N-CA 127.57 2.509 . . . . 0.0 113.836 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 40.4 p -47.03 -21.92 0.28 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 130.951 3.7 . . . . 0.0 115.817 168.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' SER . . . . . 0.468 ' HB2' ' HE3' ' A' ' 331' ' ' LYS . 2.6 p -145.24 161.97 38.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.863 1.211 . . . . 0.0 113.096 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -81.35 170.32 16.15 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -163.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 162.08 29.44 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.477 1.132 . . . . 0.0 113.994 -176.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 43.6 mtt -80.46 161.37 24.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.246 2.218 . . . . 0.0 113.162 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 8.1 m -72.26 146.56 47.15 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.585 -0.697 . . . . 0.0 112.089 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.8 p -136.69 8.39 3.06 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -78.5 158.57 28.56 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.139 1.336 . . . . 0.0 110.013 159.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 101.68 0.14 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.903 1.281 . . . . 0.0 112.006 -168.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 38.2 mtp -81.89 165.91 20.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.684 0.793 . . . . 0.0 112.073 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.7 p -147.93 159.36 43.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.941 0.897 . . . . 0.0 111.455 168.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -77.76 118.64 20.31 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 169.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.23 -30.31 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.225 0.61 . . . . 0.0 109.918 161.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -144.62 130.38 19.15 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.746 1.619 . . . . 0.0 109.125 168.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -63.62 153.09 84.46 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.526 0.73 . . . . 0.0 112.078 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.07 127.31 19.95 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.761 2.307 . . . . 0.0 110.962 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 48.3 p -126.22 133.66 51.44 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.873 1.269 . . . . 0.0 110.952 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -63.69 133.98 54.57 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.186 1.794 . . . . 0.0 112.277 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 6.4 p -71.68 -19.98 62.0 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 165.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.69 17.41 67.01 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-N 118.733 0.697 . . . . 0.0 112.198 -164.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -128.44 9.56 6.08 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.086 1.754 . . . . 0.0 111.616 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.98 6.75 36.82 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.12 -1.378 . . . . 0.0 114.861 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.4 p -128.54 160.38 32.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.789 1.794 . . . . 0.0 112.687 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.2 m -130.43 132.84 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.456 1.502 . . . . 0.0 109.778 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.5 p -120.23 129.85 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.953 1.301 . . . . 0.0 112.958 -169.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 5.8 ptp -140.53 166.33 25.03 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.768 1.627 . . . . 0.0 112.833 -172.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -132.27 138.65 47.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.297 1.039 . . . . 0.0 110.083 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.8 151.29 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.356 1.062 . . . . 0.0 110.776 -169.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -107.8 127.88 54.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.06 1.344 . . . . 0.0 110.577 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.41 138.81 20.01 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 117.257 -1.354 . . . . 0.0 107.734 162.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -104.79 -75.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.427 2.085 . . . . 0.0 115.325 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.47 174.67 10.55 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.042 -1.661 . . . . 0.0 114.274 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.21 3.21 17.1 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 116.952 1.541 . . . . 0.0 116.952 170.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.11 95.1 37.45 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 119.038 1.419 . . . . 0.0 112.9 -162.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -72.1 124.31 9.94 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.103 1.869 . . . . 0.0 108.659 159.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.0 p -161.68 156.64 23.33 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -173.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 296' ' ' SER . 14.1 tptp -73.54 135.68 43.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.837 2.855 . . . . 0.0 109.418 162.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 14.6 pt -63.45 124.25 83.77 Favored Pre-proline 0 N--CA 1.479 1.005 0 CA-C-N 119.85 1.205 . . . . 0.0 111.409 -171.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -105.77 89.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 121.622 1.548 . . . . 0.0 114.57 -157.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 74.3 t -125.98 132.04 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.884 0.873 . . . . 0.0 109.531 173.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.8 158.53 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.859 1.264 . . . . 0.0 110.674 -172.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 35.4 t -127.1 126.75 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.057 1.743 . . . . 0.0 107.552 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -132.01 161.45 33.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.902 1.281 . . . . 0.0 112.795 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.97 -22.65 33.66 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.749 1.22 . . . . 0.0 112.333 166.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -107.61 154.79 20.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.267 1.427 . . . . 0.0 111.479 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.69 -19.28 63.72 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.6 t -117.82 7.06 12.34 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.677 1.191 . . . . 0.0 113.951 -167.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 47.15 70.2 0.43 Allowed 'General case' 0 C--O 1.238 0.497 0 C-N-CA 127.974 2.51 . . . . 0.0 114.691 -170.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -83.81 -43.35 15.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.286 1.034 . . . . 0.0 111.158 154.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 43.4 mm -86.93 153.44 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.585 1.154 . . . . 0.0 109.959 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . 0.263 0.0 OUTLIER -125.15 96.4 4.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 123.171 1.462 . . . . 0.0 110.707 171.237 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -78.2 -55.56 5.17 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 128.732 2.813 . . . . 0.0 111.869 -169.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.28 -168.12 41.38 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.438 1.494 . . . . 0.0 116.273 -166.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.1 mt -124.11 139.91 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 126.604 1.961 . . . . 0.0 111.152 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.65 125.24 26.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.594 1.158 . . . . 0.0 110.487 168.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.5 t -104.15 -54.04 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.528 0.731 . . . . 0.0 109.286 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 50.0 m -71.76 140.61 49.57 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 167.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.67 150.63 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.887 1.275 . . . . 0.0 112.369 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -125.0 70.84 61.28 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.59 1.156 . . . . 0.0 112.556 -167.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.85 -167.12 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.73 3.62 . . . . 0.0 112.575 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.7 pt -83.34 160.35 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.694 1.198 . . . . 0.0 112.748 173.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.1 110.75 4.67 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 156.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.2 p -66.88 -33.06 74.77 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.071 1.749 . . . . 0.0 112.696 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.09 146.8 50.25 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.749 2.02 . . . . 0.0 108.06 167.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -59.84 -17.9 39.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -91.3 0.72 57.48 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.683 1.993 . . . . 0.0 112.758 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.06 151.69 30.15 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.45 -1.406 . . . . 0.0 113.068 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -136.57 82.72 1.96 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.174 0.987 . . . . 0.0 112.963 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 43.9 t -99.42 153.1 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.288 1.435 . . . . 0.0 111.582 -164.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.53 128.68 55.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.217 2.207 . . . . 0.0 109.778 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.1 mp -135.87 141.38 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.401 1.48 . . . . 0.0 109.035 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -114.9 149.6 36.95 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 122.078 0.942 . . . . 0.0 112.85 161.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.23 158.37 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.867 1.667 . . . . 0.0 110.883 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -109.01 102.68 49.72 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.588 1.955 . . . . 0.0 109.638 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.8 145.42 20.08 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.194 2.596 . . . . 0.0 110.815 166.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.82 176.67 9.73 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.002 2.468 . . . . 0.0 111.185 164.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -63.45 152.8 37.3 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.268 1.427 . . . . 0.0 113.739 -171.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 89.46 -162.06 30.34 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.844 1.212 . . . . 0.0 112.257 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.79 159.21 31.28 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.322 1.058 . . . . 0.0 111.81 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 73.2 m -160.33 164.88 32.17 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.151 -1.593 . . . . 0.0 111.174 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -120.86 116.49 25.28 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.849 1.26 . . . . 0.0 109.008 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 24.1 mm -85.38 120.2 35.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 124.714 1.206 . . . . 0.0 107.884 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.62 140.31 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.448 0.699 . . . . 0.0 110.092 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 76.3 t -115.18 115.08 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 126.79 2.036 . . . . 0.0 108.067 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 97.89 179.39 33.2 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 123.442 1.579 . . . . 0.0 115.622 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 29.8 m -134.2 163.66 29.11 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.194 1.398 . . . . 0.0 109.935 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.09 -174.14 54.63 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 122.148 0.86 . . . . 0.0 112.85 -170.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -27.69 61.65 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.855 1.662 . . . . 0.0 112.794 172.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.8 m -65.41 -12.08 48.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -74.62 138.65 43.09 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.753 1.16 . . . . 0.0 111.981 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 21.1 mt -103.86 162.41 13.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.987 0.915 . . . . 0.0 110.973 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.7 t -142.1 146.44 35.4 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.45 1.1 . . . . 0.0 111.664 -172.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -145.39 119.98 9.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.794 1.638 . . . . 0.0 109.931 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -71.01 129.07 38.05 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.579 0.752 . . . . 0.0 111.782 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -123.76 159.21 29.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.731 1.212 . . . . 0.0 111.636 170.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -133.65 118.74 18.53 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.943 1.697 . . . . 0.0 109.033 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? . . . . . 0 N--CA 1.47 0.527 0 C-N-CA 125.611 1.564 . . . . 0.0 111.09 -167.301 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 118.169 -0.919 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 19.2 t -111.46 -2.09 15.67 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.46 -47.69 75.26 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.256 1.389 . . . . 0.0 112.275 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.0 tt -68.13 123.84 21.8 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 159.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 4.8 t -50.01 167.66 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.06 113.65 3.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.507 1.923 . . . . 0.0 110.735 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 295' ' ' THR . 8.6 mptt -62.37 132.97 54.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.444 1.897 . . . . 0.0 110.384 -174.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 65.18 -27.19 0.12 Allowed Glycine 0 CA--C 1.543 1.786 0 C-N-CA 126.757 2.122 . . . . 0.0 115.488 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 293' ' ' LYS . 43.8 m -87.39 -13.64 42.85 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 130.599 3.56 . . . . 0.0 112.068 -173.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.4 m -155.88 153.88 30.38 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 119.853 -1.779 . . . . 0.0 113.569 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -75.54 178.75 5.75 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.43 1.892 . . . . 0.0 114.538 -168.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.86 159.81 14.79 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.822 1.649 . . . . 0.0 114.199 -168.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.27 158.43 26.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.481 2.712 . . . . 0.0 114.873 -170.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.8 m -78.88 145.01 34.39 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.79 0.836 . . . . 0.0 110.585 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 14.17 3.92 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.415 1.086 . . . . 0.0 113.224 167.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -67.66 159.33 30.23 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.818 153.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.5 109.48 4.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.316 0.646 . . . . 0.0 111.064 -167.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 69.9 mtp -95.27 162.25 13.76 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.312 1.053 . . . . 0.0 112.431 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.4 p -151.42 159.47 44.21 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.239 1.416 . . . . 0.0 109.534 166.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.75 129.94 34.8 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 122.045 -0.409 . . . . 0.0 109.904 166.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.66 -29.07 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.118 0.967 . . . . 0.0 109.989 162.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -145.82 133.5 21.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.899 1.68 . . . . 0.0 109.999 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -66.47 147.38 98.97 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.986 0.914 . . . . 0.0 112.465 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.72 133.54 57.0 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.633 2.222 . . . . 0.0 112.186 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 21.7 p -132.89 142.34 48.87 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.976 1.711 . . . . 0.0 110.126 169.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.0 130.3 46.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.649 0.738 . . . . 0.0 110.675 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 75.0 p -78.29 -18.74 54.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.495 1.918 . . . . 0.0 113.034 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 82.62 -4.3 79.22 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.367 0.985 . . . . 0.0 113.845 -163.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -84.25 -0.48 52.46 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 119.612 1.706 . . . . 0.0 111.88 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 76.69 36.22 38.15 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.91 1.243 . . . . 0.0 111.539 -165.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.6 p -146.69 164.16 33.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.194 2.198 . . . . 0.0 108.403 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.26 134.06 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.305 1.442 . . . . 0.0 110.657 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.1 133.5 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.438 1.095 . . . . 0.0 113.611 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.0 ptm -145.94 163.56 34.76 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.224 2.21 . . . . 0.0 112.11 -169.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -130.58 144.22 51.27 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.377 0.671 . . . . 0.0 110.06 172.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.15 146.45 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.145 0.978 . . . . 0.0 111.461 -167.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -109.8 131.04 55.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.989 1.716 . . . . 0.0 111.078 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 14.3 t -108.43 143.32 27.24 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-O 116.973 -1.489 . . . . 0.0 108.156 163.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -101.13 -75.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.506 0 C-N-CA 122.259 1.972 . . . . 0.0 116.843 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 169.13 21.72 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 121.342 1.883 . . . . 0.0 114.771 -173.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 68.99 -5.41 4.74 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.542 1.544 . . . . 0.0 116.639 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -125.64 103.85 27.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.768 1.284 . . . . 0.0 112.67 -164.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -76.56 134.61 15.46 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.984 1.789 . . . . 0.0 109.055 160.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.3 p -158.23 155.15 28.45 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.371 -0.83 . . . . 0.0 112.918 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -77.84 136.98 38.16 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 159.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -58.62 117.28 19.42 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-N 118.783 0.719 . . . . 0.0 111.876 -171.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -97.03 102.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.925 3.083 . . . . 0.0 113.039 -167.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.5 139.13 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.446 1.099 . . . . 0.0 108.909 170.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 3.1 mt -136.96 143.84 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.631 1.173 . . . . 0.0 108.575 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 45.3 t -119.26 108.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.433 1.093 . . . . 0.0 108.187 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -124.36 161.33 26.15 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -162.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.81 -6.96 59.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.221 2.608 . . . . 0.0 112.361 168.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -139.8 149.73 43.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.129 1.772 . . . . 0.0 111.431 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 20.4 mt -64.48 -24.63 67.68 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.672 1.189 . . . . 0.0 113.371 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.4 t -96.07 4.74 52.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.877 1.271 . . . . 0.0 113.72 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.2 75.08 0.1 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.225 3.01 . . . . 0.0 115.652 -171.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.94 -35.01 12.17 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.844 2.057 . . . . 0.0 111.786 164.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.91 153.26 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.747 1.219 . . . . 0.0 109.84 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.92 103.55 5.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.033 -1.042 . . . . 0.0 111.316 175.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -103.85 -13.22 16.48 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -174.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -102.52 -174.38 27.15 Favored Glycine 0 CA--C 1.536 1.403 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.01 144.2 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 127.774 2.43 . . . . 0.0 110.913 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.32 130.35 37.04 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.527 1.131 . . . . 0.0 109.485 165.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -46.97 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 118.99 -0.529 . . . . 0.0 111.122 176.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 32.2 m -65.92 150.66 48.27 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.773 160.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.0 156.98 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.818 1.247 . . . . 0.0 111.951 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -114.9 80.94 7.04 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.387 1.475 . . . . 0.0 111.185 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -80.24 -172.99 1.68 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.143 2.562 . . . . 0.0 112.25 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 28.0 pt -93.5 176.41 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.713 1.605 . . . . 0.0 110.868 167.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.43 113.12 7.25 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 153.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.9 p -67.01 -32.18 73.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.801 1.64 . . . . 0.0 112.871 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.39 152.3 51.72 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.719 2.808 . . . . 0.0 108.159 168.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -63.17 -23.33 67.38 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.589 -1.32 . . . . 0.0 114.245 -173.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -86.26 4.79 37.32 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.935 1.294 . . . . 0.0 113.443 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.79 150.1 7.85 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -135.34 85.88 2.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.535 -1.212 . . . . 0.0 114.122 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 4.4 t -93.13 140.8 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.029 1.332 . . . . 0.0 111.501 -167.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -101.33 121.06 41.23 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 129.179 2.991 . . . . 0.0 109.064 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 1.8 mp -140.81 146.22 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.239 1.416 . . . . 0.0 110.713 -169.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -114.39 139.13 49.74 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.6 1.16 . . . . 0.0 112.608 166.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.94 159.18 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.132 1.773 . . . . 0.0 111.211 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -113.68 108.1 52.05 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.691 1.996 . . . . 0.0 109.453 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.36 150.67 25.58 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.314 2.009 . . . . 0.0 110.315 166.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -59.15 164.77 9.89 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.451 1.434 . . . . 0.0 111.244 163.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -65.57 140.86 58.57 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.711 -0.618 . . . . 0.0 110.473 167.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.49 -151.46 18.22 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.158 0.409 . . . . 0.0 112.427 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -74.46 161.11 30.12 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.447 1.117 . . . . 0.0 112.9 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 24.1 m -170.1 162.08 8.8 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.43 1.892 . . . . 0.0 111.264 166.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -128.61 127.45 42.28 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.446 1.898 . . . . 0.0 107.138 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 23.3 mm -95.15 118.14 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.7 140.04 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.019 0.928 . . . . 0.0 110.503 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 97.2 t -106.36 122.9 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 126.06 1.744 . . . . 0.0 108.359 168.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 85.97 179.85 49.91 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 123.444 1.58 . . . . 0.0 116.335 168.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 72.0 m -138.76 171.69 13.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.974 1.31 . . . . 0.0 109.96 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 85.39 -154.68 28.86 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -171.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -26.32 64.57 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.748 0.819 . . . . 0.0 112.189 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.9 m -76.79 -6.43 52.26 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 129.127 2.971 . . . . 0.0 115.24 -164.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -75.24 124.58 27.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.752 0.421 . . . . 0.0 112.059 -167.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.78 158.58 15.82 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.479 0.312 . . . . 0.0 110.422 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.1 t -131.42 154.24 48.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.434 1.094 . . . . 0.0 111.913 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -142.69 126.14 16.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.158 1.783 . . . . 0.0 109.553 171.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.89 127.29 31.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.361 1.464 . . . . 0.0 111.558 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -136.22 117.78 14.87 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.217 1.007 . . . . 0.0 110.953 170.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -119.0 119.97 35.85 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.9 tttp . . . . . 0 C--O 1.233 0.2 0 C-N-CA 126.009 1.724 . . . . 0.0 111.28 -165.755 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.7 p -104.19 -2.37 25.83 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.48 89.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.205 0.911 . . . . 0.0 113.124 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.7 tt -75.97 128.41 35.0 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 161.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 2.2 t -52.97 168.56 0.12 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.945 2.098 . . . . 0.0 116.036 -167.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.48 105.44 0.63 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.077 1.751 . . . . 0.0 110.628 -172.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.07 124.91 20.97 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.087 1.355 . . . . 0.0 111.226 -171.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.41 -51.6 2.57 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.998 1.285 . . . . 0.0 112.996 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.3 m -62.89 3.08 0.25 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.549 2.74 . . . . 0.0 114.149 174.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.6 m -156.48 149.47 24.05 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 118.996 -2.315 . . . . 0.0 112.658 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -74.19 171.81 12.92 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.636 1.975 . . . . 0.0 113.557 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.09 163.19 28.09 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.354 1.462 . . . . 0.0 113.055 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 58.0 mtt -93.82 164.12 13.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.138 1.775 . . . . 0.0 113.788 -168.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.8 m -76.23 139.38 41.15 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.315 0.646 . . . . 0.0 111.244 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 6.4 p -133.04 20.07 4.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.574 1.15 . . . . 0.0 113.036 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -82.46 164.68 20.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 158.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.02 95.64 0.12 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.39 1.476 . . . . 0.0 111.847 -175.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 32.7 mtp -80.36 171.79 14.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.665 1.186 . . . . 0.0 112.426 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.7 m -158.93 154.53 26.07 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.184 -0.947 . . . . 0.0 111.965 163.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.4 111.8 14.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.886 0.875 . . . . 0.0 109.744 163.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 20.1 t -66.99 -33.52 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.476 1.11 . . . . 0.0 109.868 166.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -129.45 126.68 39.28 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.859 1.664 . . . . 0.0 108.577 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -62.83 152.86 81.63 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.69 1.196 . . . . 0.0 112.164 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.43 124.63 13.62 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.733 2.289 . . . . 0.0 111.049 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 70.5 p -125.17 136.87 54.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.169 1.388 . . . . 0.0 110.692 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.47 127.04 30.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.238 1.015 . . . . 0.0 111.742 173.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 75.7 p -76.32 -22.31 55.12 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.53 1.532 . . . . 0.0 113.087 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 89.22 -11.37 69.79 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.057 1.789 . . . . 0.0 113.817 -163.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -86.01 2.43 46.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.486 1.515 . . . . 0.0 112.303 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 87.66 15.11 62.19 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.937 0.78 . . . . 0.0 112.86 -167.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.6 p -131.14 158.19 41.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.763 1.225 . . . . 0.0 111.345 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.16 132.05 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.226 1.41 . . . . 0.0 109.727 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.65 134.27 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.516 1.127 . . . . 0.0 113.35 -169.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 3.3 ptp -143.14 160.52 40.26 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.282 1.833 . . . . 0.0 113.174 -173.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -119.15 121.71 40.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.478 1.911 . . . . 0.0 107.806 173.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.78 141.88 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.366 1.066 . . . . 0.0 111.527 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -106.14 132.34 52.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.796 1.639 . . . . 0.0 112.278 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.38 147.18 33.79 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.726 1.61 . . . . 0.0 108.649 163.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -108.97 -72.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.255 2.636 . . . . 0.0 115.386 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.44 170.07 17.6 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.241 -1.537 . . . . 0.0 114.202 -171.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 64.57 -23.32 0.1 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 127.633 2.539 . . . . 0.0 117.77 168.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -107.52 97.45 19.71 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.501 1.52 . . . . 0.0 112.05 -170.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.29 131.23 25.99 Favored 'Trans proline' 0 C--N 1.35 0.631 0 N-CA-C 108.005 -1.575 . . . . 0.0 108.005 157.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.6 p -160.9 157.3 26.32 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -72.23 137.76 47.05 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.343 1.457 . . . . 0.0 108.989 159.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.37 119.08 56.56 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 118.69 0.677 . . . . 0.0 112.196 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -97.38 87.41 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.049 3.166 . . . . 0.0 113.833 -166.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 97.1 t -113.49 131.72 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 164.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.23 153.47 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.484 1.114 . . . . 0.0 110.152 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.46 109.41 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.188 1.795 . . . . 0.0 107.129 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -119.66 164.67 15.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -161.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -89.49 -6.75 56.16 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.824 2.05 . . . . 0.0 112.668 165.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -133.79 144.41 49.0 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.054 1.342 . . . . 0.0 110.677 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.55 -11.75 26.98 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.8 t -113.02 12.03 19.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.964 1.706 . . . . 0.0 113.188 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 39.85 60.11 1.75 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.53 2.732 . . . . 0.0 116.152 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.85 63.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.267 0.627 . . . . 0.0 111.927 155.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 38.0 mt -110.6 155.98 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.126 1.771 . . . . 0.0 109.254 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.45 102.0 6.94 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.312 1.045 . . . . 0.0 110.808 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -77.96 -56.39 4.53 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 129.732 3.213 . . . . 0.0 111.423 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -92.35 -167.64 39.77 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 116.593 1.397 . . . . 0.0 116.593 -166.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.5 mt -116.51 135.48 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.242 1.817 . . . . 0.0 110.546 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.3 mt -72.04 122.29 20.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.615 0.766 . . . . 0.0 109.372 165.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 98.4 t -103.02 -52.62 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.177 0.991 . . . . 0.0 110.235 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 50.4 m -67.02 155.23 39.19 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.198 0.523 . . . . 0.0 110.102 164.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 11.3 m -58.1 159.32 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.151 0.98 . . . . 0.0 112.468 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -118.6 85.02 25.86 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.638 1.175 . . . . 0.0 110.125 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -80.48 -165.16 0.32 Allowed 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 124.502 3.468 . . . . 0.0 113.232 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 31.5 pt -105.04 165.99 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.688 1.995 . . . . 0.0 111.218 172.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.66 102.48 1.2 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 155.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 82.8 p -70.61 -35.77 73.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.305 1.442 . . . . 0.0 112.208 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.5 157.62 33.15 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.815 2.046 . . . . 0.0 109.491 158.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -66.68 -23.46 66.14 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -89.75 7.69 35.56 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.03 0.832 . . . . 0.0 112.648 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -56.61 153.07 10.9 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.878 1.323 . . . . 0.0 112.973 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.67 123.33 12.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.907 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.61 145.95 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.702 0.801 . . . . 0.0 110.254 -159.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.4 tp -95.97 126.58 41.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.443 2.297 . . . . 0.0 109.405 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.3 mp -139.28 132.13 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.492 1.117 . . . . 0.0 109.483 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.81 147.98 32.31 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.96 0.886 . . . . 0.0 112.106 159.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.38 160.86 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.733 1.613 . . . . 0.0 110.702 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -115.32 109.12 46.69 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.94 1.696 . . . . 0.0 111.092 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.74 148.9 20.43 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.932 2.421 . . . . 0.0 111.549 162.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -73.15 172.18 16.07 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.772 2.315 . . . . 0.0 111.103 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -57.34 147.84 24.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.239 0.615 . . . . 0.0 111.668 171.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.35 -136.08 12.52 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.15 162.36 14.36 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.03 1.332 . . . . 0.0 112.736 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 38.5 m -162.18 162.98 28.62 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.777 -1.202 . . . . 0.0 110.716 157.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.84 117.89 25.13 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 21.5 mm -91.03 111.25 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.857 1.263 . . . . 0.0 107.941 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.48 142.57 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.704 0.802 . . . . 0.0 109.547 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 97.8 t -123.29 108.34 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.335 1.854 . . . . 0.0 108.765 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.83 175.88 21.61 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.979 1.276 . . . . 0.0 114.36 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 56.4 m -133.86 162.12 32.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.284 1.434 . . . . 0.0 109.759 169.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.5 -171.53 49.39 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 121.601 0.556 . . . . 0.0 112.668 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.33 -27.5 23.71 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.222 1.409 . . . . 0.0 113.956 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.0 m -74.86 -3.91 34.74 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.761 2.424 . . . . 0.0 114.833 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -79.55 125.86 30.13 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.078 0.853 . . . . 0.0 112.618 -174.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.84 163.86 14.85 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.212 0.605 . . . . 0.0 110.827 172.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.6 t -144.13 148.31 34.89 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.262 1.025 . . . . 0.0 111.829 -171.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -147.75 110.05 4.6 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.325 1.45 . . . . 0.0 110.119 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.2 133.61 56.26 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.913 0.885 . . . . 0.0 111.212 173.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -125.3 160.8 28.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.285 1.034 . . . . 0.0 111.298 163.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -129.59 146.25 51.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.225 1.41 . . . . 0.0 108.771 171.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.327 0 C-N-CA 124.886 1.274 . . . . 0.0 109.696 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 9.5 m -109.43 0.86 19.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.323 1.449 . . . . 0.0 113.99 -167.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.64 -48.97 62.66 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.235 0.925 . . . . 0.0 111.031 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.68 131.43 46.31 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 167.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.6 t -62.58 176.66 0.62 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -164.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -64.7 97.39 0.21 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.933 1.693 . . . . 0.0 112.332 -167.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.446 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 0.8 OUTLIER -47.48 125.7 8.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 128.052 2.541 . . . . 0.0 111.794 -178.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 60.35 10.17 15.22 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.559 1.076 . . . . 0.0 115.283 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 13.5 m -139.76 17.0 2.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.657 1.583 . . . . 0.0 109.809 -159.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 2.3 m -171.15 159.07 5.77 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.267 -1.521 . . . . 0.0 112.368 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -86.74 174.66 8.68 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.446 1.099 . . . . 0.0 112.735 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -63.17 159.3 17.85 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -164.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 62.1 mtm -79.22 151.74 31.04 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.914 2.086 . . . . 0.0 110.382 164.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.7 m -70.51 145.49 50.85 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.989 -0.445 . . . . 0.0 111.794 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.1 p -134.3 24.32 3.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.929 1.292 . . . . 0.0 112.634 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -94.59 169.45 10.17 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 160.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -69.62 90.96 0.58 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.195 2.198 . . . . 0.0 111.956 -163.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 37.7 mtp -80.58 170.63 16.08 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.961 0.886 . . . . 0.0 113.348 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 36.5 m -159.44 161.22 35.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.057 0.943 . . . . 0.0 112.018 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.49 120.2 22.14 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.772 0.829 . . . . 0.0 109.641 168.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.64 -34.32 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.216 1.006 . . . . 0.0 110.116 163.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -136.46 132.68 35.7 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.173 1.389 . . . . 0.0 110.007 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -69.32 145.89 96.17 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.526 1.53 . . . . 0.0 112.15 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.0 136.62 57.66 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.864 2.376 . . . . 0.0 112.636 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 71.4 p -141.61 131.6 24.57 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.152 1.781 . . . . 0.0 110.411 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -60.49 131.76 51.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.777 0.831 . . . . 0.0 112.387 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.0 p -66.13 -21.23 66.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.556 1.942 . . . . 0.0 112.717 168.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 98.31 -16.79 59.48 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.909 1.718 . . . . 0.0 112.397 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -74.08 -18.15 60.86 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.419 1.11 . . . . 0.0 111.76 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.55 32.88 6.1 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.569 1.081 . . . . 0.0 111.751 -166.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.8 p -136.85 129.43 30.28 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.905 1.282 . . . . 0.0 108.39 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 21.8 m -106.9 123.06 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.434 0.694 . . . . 0.0 110.068 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.35 129.42 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.072 0.949 . . . . 0.0 111.816 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.9 ptm -149.49 163.04 38.9 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.487 1.915 . . . . 0.0 111.756 -169.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -136.74 136.58 39.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.442 0.697 . . . . 0.0 110.153 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.96 127.66 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.999 0.92 . . . . 0.0 112.874 -164.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -92.94 125.7 37.67 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.573 1.549 . . . . 0.0 112.02 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.1 t -96.56 145.27 29.28 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 117.393 -1.289 . . . . 0.0 107.626 158.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -104.27 -65.88 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 123.056 2.504 . . . . 0.0 115.321 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 175.85 10.32 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.344 -1.472 . . . . 0.0 112.142 -174.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.69 -13.19 0.09 OUTLIER Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.509 2.481 . . . . 0.0 118.129 167.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.89 93.93 22.77 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 119.147 1.474 . . . . 0.0 113.03 -167.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.3 112.15 3.26 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.402 2.068 . . . . 0.0 108.756 156.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.5 p -154.35 159.67 41.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.15 0.98 . . . . 0.0 111.923 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 355' ' ' ILE . 20.6 mtpp -76.83 144.13 39.28 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.214 1.006 . . . . 0.0 109.877 158.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.45 111.46 4.08 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.242 1.017 . . . . 0.0 111.97 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -94.54 89.06 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.952 3.101 . . . . 0.0 112.999 -162.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.86 127.8 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 150.06 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.446 1.098 . . . . 0.0 109.397 -177.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 64.4 t -128.77 105.03 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -117.6 161.24 19.95 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -158.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.62 -14.62 58.68 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.08 2.152 . . . . 0.0 112.783 164.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -134.38 148.23 50.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.612 1.165 . . . . 0.0 112.258 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 16.4 mt -61.96 -19.74 63.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.137 1.375 . . . . 0.0 114.468 -173.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.8 t -104.29 5.83 34.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.606 1.962 . . . . 0.0 113.262 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.48 69.08 0.43 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.016 2.926 . . . . 0.0 116.434 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -81.32 -45.42 16.2 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.365 1.466 . . . . 0.0 112.064 157.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.42 113.73 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.976 1.311 . . . . 0.0 110.338 -172.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.13 107.39 15.67 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.445 0.698 . . . . 0.0 112.331 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 373' ' ' ASP . 12.2 ttpt -72.86 -43.91 62.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.393 2.677 . . . . 0.0 112.955 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -100.28 -165.5 28.7 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.465 1.346 . . . . 0.0 116.465 -165.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.94 148.14 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.182 2.193 . . . . 0.0 110.0 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.32 134.51 34.51 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.464 -0.772 . . . . 0.0 109.666 170.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 81.9 t -98.29 -46.64 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.904 0.882 . . . . 0.0 109.588 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.8 m -71.38 154.9 41.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.396 0.617 . . . . 0.0 110.211 164.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.46 161.56 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.211 1.404 . . . . 0.0 110.541 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -114.17 69.28 1.82 Allowed Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 124.667 1.187 . . . . 0.0 112.763 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.05 -171.36 1.05 Allowed 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 124.412 3.408 . . . . 0.0 113.123 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 44.5 pt -93.17 165.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.58 1.552 . . . . 0.0 113.359 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.21 105.98 1.55 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.054 0.942 . . . . 0.0 109.206 158.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 83.9 p -70.31 -40.18 74.35 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.173 1.389 . . . . 0.0 111.803 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.24 151.45 34.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.33 1.852 . . . . 0.0 108.887 155.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -61.63 -15.7 41.86 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 175.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.76 8.67 44.3 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.232 1.413 . . . . 0.0 112.633 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -58.98 148.15 31.72 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.266 -1.521 . . . . 0.0 113.621 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -129.94 79.43 1.9 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.072 1.349 . . . . 0.0 112.129 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 40.5 t -84.39 143.21 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.45 1.1 . . . . 0.0 111.124 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.5 130.07 42.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.536 2.734 . . . . 0.0 109.787 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.1 133.8 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.117 1.767 . . . . 0.0 110.407 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -91.01 138.23 31.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.18 0.992 . . . . 0.0 110.722 154.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.79 160.56 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.096 0.958 . . . . 0.0 111.333 169.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -121.75 105.32 38.29 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.815 1.646 . . . . 0.0 110.076 -173.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.68 154.8 35.01 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.234 1.956 . . . . 0.0 110.363 159.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.79 171.58 16.22 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.17 1.913 . . . . 0.0 111.155 166.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -65.24 122.97 18.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.834 1.254 . . . . 0.0 109.343 168.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 126.73 -148.14 17.13 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.319 0.961 . . . . 0.0 111.166 -163.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . 0.4 ' O ' ' HE3' ' A' ' 346' ' ' LYS . 8.7 p-10 -94.47 168.82 10.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.828 1.251 . . . . 0.0 112.054 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 33.6 m -168.46 165.24 12.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.536 1.934 . . . . 0.0 110.828 159.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -124.63 117.0 23.3 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.0 mm -90.95 110.92 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.61 143.39 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.948 0.899 . . . . 0.0 110.184 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.6 115.23 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 126.71 2.004 . . . . 0.0 108.684 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 95.82 176.88 36.73 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.32 0.962 . . . . 0.0 114.521 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 47.4 m -136.19 165.06 26.61 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.811 1.644 . . . . 0.0 109.891 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.37 -171.27 46.81 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 121.642 -0.662 . . . . 0.0 112.196 -167.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.47 -26.41 53.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.213 1.005 . . . . 0.0 113.539 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.4 m -74.25 9.9 1.47 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.681 2.792 . . . . 0.0 115.222 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -96.05 144.24 26.49 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.4 1.08 . . . . 0.0 112.986 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 25.9 mt -112.25 165.31 12.28 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.579 1.152 . . . . 0.0 111.384 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 2.3 t -139.11 147.01 41.39 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.949 1.299 . . . . 0.0 111.815 -170.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -146.78 112.59 5.7 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.759 1.624 . . . . 0.0 110.388 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 134.56 54.93 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.128 -0.983 . . . . 0.0 112.367 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -128.82 149.12 50.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.891 0.876 . . . . 0.0 111.892 165.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -133.5 140.72 47.41 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.128 1.371 . . . . 0.0 107.839 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 21.7 tptt . . . . . 0 N--CA 1.466 0.342 0 C-N-CA 124.481 1.112 . . . . 0.0 111.052 -170.716 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.7 m -104.81 -4.58 22.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.138 0.975 . . . . 0.0 113.003 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.54 -9.09 52.48 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.9 tp -101.79 132.18 47.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 159.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.9 t -57.98 174.45 0.26 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.386 1.474 . . . . 0.0 114.252 -172.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.06 95.66 0.17 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.772 1.629 . . . . 0.0 110.997 -169.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.526 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 6.9 mptt -51.89 121.02 5.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.853 2.461 . . . . 0.0 111.057 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 67.25 -25.22 0.2 Allowed Glycine 0 CA--C 1.54 1.635 0 C-N-CA 126.439 1.971 . . . . 0.0 115.599 -173.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 293' ' ' LYS . 44.8 m -87.11 7.99 25.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 129.648 3.179 . . . . 0.0 111.555 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 7.5 m -160.2 155.31 24.75 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 119.311 -2.118 . . . . 0.0 111.587 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -76.09 172.95 11.93 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.067 1.347 . . . . 0.0 112.868 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -63.47 156.17 27.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.192 0.996 . . . . 0.0 113.642 -173.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 37.8 mtt -84.82 151.94 23.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.713 1.605 . . . . 0.0 111.364 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.9 m -67.7 139.87 56.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.207 0.603 . . . . 0.0 111.94 -173.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.3 p -131.75 16.92 4.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.862 1.265 . . . . 0.0 113.196 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.69 169.32 17.13 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 159.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.5 98.68 1.15 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.633 1.173 . . . . 0.0 112.076 -167.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.4 mtp -87.12 172.3 10.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.668 1.187 . . . . 0.0 113.579 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 36.8 m -160.74 170.4 20.83 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.794 1.238 . . . . 0.0 111.286 162.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.64 131.47 35.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.088 0.955 . . . . 0.0 109.324 162.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.1 -37.97 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.877 0.871 . . . . 0.0 109.797 162.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -130.97 126.78 36.91 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.723 1.609 . . . . 0.0 108.409 173.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -60.73 149.98 77.67 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.355 0.662 . . . . 0.0 111.678 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.56 132.59 43.98 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.026 1.817 . . . . 0.0 110.587 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 40.2 p -127.49 129.56 47.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.791 1.636 . . . . 0.0 108.805 172.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.89 136.07 57.89 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.555 0.693 . . . . 0.0 111.441 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.8 p -93.78 -15.15 25.43 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.251 1.421 . . . . 0.0 113.613 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.64 -6.66 8.26 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-O 118.447 -1.196 . . . . 0.0 114.66 -161.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -70.67 -10.21 58.86 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 120.32 2.06 . . . . 0.0 112.112 170.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 91.6 17.51 48.78 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.465 1.031 . . . . 0.0 112.912 -160.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.9 p -134.33 168.47 18.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.267 1.427 . . . . 0.0 111.283 -171.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 19.2 m -121.42 138.93 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.064 1.346 . . . . 0.0 109.292 166.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -114.36 130.07 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.698 1.199 . . . . 0.0 111.63 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.8 ptm -145.69 167.3 23.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.699 1.599 . . . . 0.0 112.797 -171.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -133.72 136.42 44.63 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.212 1.005 . . . . 0.0 109.684 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 21.3 m -116.54 168.25 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.799 1.24 . . . . 0.0 111.848 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -131.39 127.75 38.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.991 1.317 . . . . 0.0 112.053 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.07 146.77 32.5 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.149 1.38 . . . . 0.0 108.224 161.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -107.27 -62.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.163 2.575 . . . . 0.0 115.224 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.26 -174.27 4.88 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.383 1.473 . . . . 0.0 111.988 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 74.35 -36.81 0.97 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 126.593 2.044 . . . . 0.0 116.605 162.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.65 103.86 43.11 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.514 1.126 . . . . 0.0 111.963 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -64.88 128.88 21.82 Favored 'Trans proline' 0 C--N 1.35 0.61 0 N-CA-C 107.851 -1.634 . . . . 0.0 107.851 154.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.0 p -157.57 157.75 34.31 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.7 tptm -75.24 135.7 40.98 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.404 1.481 . . . . 0.0 109.094 164.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.5 119.99 58.51 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -168.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -100.38 81.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.61 2.873 . . . . 0.0 114.159 -164.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 95.1 t -107.5 128.11 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 162.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.68 152.75 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.873 1.269 . . . . 0.0 109.666 176.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.97 115.16 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.307 1.843 . . . . 0.0 106.837 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -127.51 160.25 32.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -161.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.27 -15.12 36.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.702 1.601 . . . . 0.0 112.612 171.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.21 153.75 38.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.683 1.593 . . . . 0.0 110.723 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.16 -14.16 34.55 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 11.5 t -123.93 14.34 9.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.581 1.552 . . . . 0.0 113.415 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 44.56 59.23 3.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.001 2.52 . . . . 0.0 115.917 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -78.09 -32.74 50.78 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.256 0.622 . . . . 0.0 112.182 156.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 45.4 mm -116.07 112.16 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.323 1.849 . . . . 0.0 109.973 -175.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -86.59 103.86 15.48 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.898 0.856 . . . . 0.0 111.846 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -88.2 -19.68 26.56 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.967 2.907 . . . . 0.0 114.439 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -118.59 -165.42 13.28 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 115.901 1.121 . . . . 0.0 115.901 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.2 mt -126.79 139.41 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 127.454 2.302 . . . . 0.0 110.366 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.15 129.65 37.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.848 1.259 . . . . 0.0 110.114 165.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 53.5 t -107.05 -50.92 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.711 0.804 . . . . 0.0 110.564 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.6 m -68.43 154.06 42.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.319 0.58 . . . . 0.0 109.641 163.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.9 m -54.43 154.66 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.702 1.201 . . . . 0.0 112.482 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -118.92 81.11 18.87 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.439 1.096 . . . . 0.0 110.547 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -82.96 -166.47 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 125.08 3.853 . . . . 0.0 112.846 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 39.1 pt -89.21 168.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.203 1.401 . . . . 0.0 111.511 164.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.31 120.34 13.66 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 158.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 85.9 p -73.12 -17.16 61.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.847 1.259 . . . . 0.0 113.838 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 97.5 m -144.06 157.51 44.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.748 2.419 . . . . 0.0 106.73 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -58.97 -21.48 58.71 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.861 -1.15 . . . . 0.0 113.914 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.79 15.32 29.0 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.689 1.996 . . . . 0.0 112.773 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -61.07 158.52 13.45 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 119.998 -1.689 . . . . 0.0 113.862 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -145.4 75.11 1.42 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.279 1.432 . . . . 0.0 113.861 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.5 149.52 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.509 1.524 . . . . 0.0 112.439 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.61 129.49 46.54 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 129.931 3.292 . . . . 0.0 109.301 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.87 134.41 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.281 1.432 . . . . 0.0 111.631 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -90.67 136.95 32.73 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.001 1.321 . . . . 0.0 111.869 154.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.74 159.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.884 1.274 . . . . 0.0 111.477 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -119.81 114.88 33.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.18 1.792 . . . . 0.0 111.128 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.3 159.97 13.09 Favored 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 123.665 2.91 . . . . 0.0 112.203 162.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.27 175.73 10.56 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.476 2.784 . . . . 0.0 111.026 163.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -63.4 145.62 55.22 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.57 -0.706 . . . . 0.0 111.332 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.76 -145.08 15.91 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.895 0.759 . . . . 0.0 111.47 -171.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -91.32 164.55 13.82 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.268 1.427 . . . . 0.0 112.255 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.2 m -161.54 158.88 27.08 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.326 -1.484 . . . . 0.0 111.212 158.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -116.03 116.1 27.29 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.88 111.91 22.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 124.952 1.301 . . . . 0.0 108.101 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.51 142.9 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.66 0.784 . . . . 0.0 109.727 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 94.3 t -116.92 110.22 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.963 1.705 . . . . 0.0 108.994 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.77 -179.39 24.25 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.187 0.898 . . . . 0.0 115.162 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 28.7 m -132.56 163.44 28.86 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.114 1.766 . . . . 0.0 109.388 171.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.33 -171.96 52.45 Favored Glycine 0 CA--C 1.535 1.298 0 O-C-N 121.559 -0.713 . . . . 0.0 112.925 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.26 -29.64 34.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.266 1.426 . . . . 0.0 113.697 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.6 m -73.36 -2.39 22.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.066 2.547 . . . . 0.0 114.801 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -81.66 115.4 20.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.09 0.859 . . . . 0.0 112.999 -172.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -81.63 162.91 22.89 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.879 -0.513 . . . . 0.0 111.277 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.5 t -140.4 147.54 39.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.768 1.227 . . . . 0.0 112.053 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -147.13 120.57 9.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.564 1.546 . . . . 0.0 111.119 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.6 130.17 39.07 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.794 1.238 . . . . 0.0 112.529 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -127.24 164.82 20.87 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.594 1.158 . . . . 0.0 112.224 164.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -133.26 150.51 51.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.41 1.884 . . . . 0.0 108.667 171.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? . . . . . 0 N--CA 1.466 0.366 0 C-N-CA 126.676 1.991 . . . . 0.0 109.498 -174.278 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.6 m -90.57 -7.38 52.99 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -166.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.7 -25.81 66.71 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 57.9 tp -83.1 126.39 32.54 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.081 1.31 . . . . 0.0 108.065 159.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 t -55.05 167.07 0.44 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.782 1.233 . . . . 0.0 113.768 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.28 107.21 0.4 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.806 2.042 . . . . 0.0 111.263 -164.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -58.19 115.87 3.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.499 1.92 . . . . 0.0 110.686 -166.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 68.62 -7.91 2.59 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.449 1.499 . . . . 0.0 115.476 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 96.9 m -101.88 6.65 41.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.367 2.667 . . . . 0.0 110.626 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.3 m -154.32 151.26 28.88 Favored 'General case' 0 C--O 1.23 0.06 0 O-C-N 119.337 -2.102 . . . . 0.0 112.387 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -71.57 170.83 12.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.125 2.17 . . . . 0.0 112.864 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.64 153.42 36.07 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 39.6 mtt -91.05 151.58 20.98 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.893 1.677 . . . . 0.0 111.283 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.88 141.64 55.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.42 0.688 . . . . 0.0 112.621 -170.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.7 p -133.25 17.74 4.06 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -74.57 164.75 26.22 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.543 -0.723 . . . . 0.0 109.193 155.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.59 89.2 0.52 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.989 1.315 . . . . 0.0 111.913 -173.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 68.9 mtp -73.17 173.05 9.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.878 1.671 . . . . 0.0 113.693 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.7 m -157.37 163.46 38.58 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.203 -0.936 . . . . 0.0 111.855 162.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.42 125.93 29.99 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 3.6 t -76.61 -29.99 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 122.961 0.505 . . . . 0.0 109.779 162.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -135.6 126.48 27.55 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.048 1.739 . . . . 0.0 108.667 167.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -59.72 151.01 64.86 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.559 1.143 . . . . 0.0 111.87 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.67 132.42 35.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.05 1.834 . . . . 0.0 110.845 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 m -133.33 141.86 48.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.916 1.286 . . . . 0.0 109.933 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.19 136.82 58.1 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.309 0.644 . . . . 0.0 112.181 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 70.4 p -91.12 -8.02 49.97 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.977 1.311 . . . . 0.0 114.218 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.15 4.94 45.63 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.802 -0.999 . . . . 0.0 114.909 -163.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -111.34 13.3 21.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.05 1.425 . . . . 0.0 112.316 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.59 14.15 71.31 Favored Glycine 0 CA--C 1.536 1.371 0 O-C-N 121.374 -0.829 . . . . 0.0 113.651 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 39.5 p -135.17 164.61 27.3 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.273 1.429 . . . . 0.0 111.296 -171.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.4 m -128.14 135.79 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.527 1.531 . . . . 0.0 110.061 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.44 129.76 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.886 1.275 . . . . 0.0 113.704 -167.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -143.52 164.98 28.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.462 1.505 . . . . 0.0 114.32 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -122.35 125.49 46.04 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.542 2.337 . . . . 0.0 107.65 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.97 138.55 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.018 0.927 . . . . 0.0 111.707 -167.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -111.66 129.13 56.19 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.614 1.165 . . . . 0.0 113.135 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.44 142.73 25.19 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.416 1.486 . . . . 0.0 108.607 165.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -100.45 -72.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.907 2.404 . . . . 0.0 115.714 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 168.15 20.47 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.429 -1.42 . . . . 0.0 113.934 -173.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.84 -12.46 0.37 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.833 2.158 . . . . 0.0 117.879 171.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -117.22 98.63 52.15 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 119.422 1.611 . . . . 0.0 113.621 -163.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -68.44 133.85 29.26 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 148.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -161.76 156.82 23.34 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.851 0.86 . . . . 0.0 111.058 -176.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -70.38 135.4 48.74 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.497 1.119 . . . . 0.0 108.292 162.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.9 pp -60.85 118.41 34.9 Favored Pre-proline 0 CA--C 1.554 1.124 0 CA-C-N 118.252 0.478 . . . . 0.0 111.732 -170.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -94.84 86.75 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.597 2.865 . . . . 0.0 114.034 -159.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 37.1 t -121.73 128.4 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.418 1.487 . . . . 0.0 109.119 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.24 161.81 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.722 1.209 . . . . 0.0 111.988 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 55.2 t -138.93 118.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.406 2.283 . . . . 0.0 107.946 173.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.44 168.4 16.38 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -164.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.43 -8.83 58.19 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.708 2.003 . . . . 0.0 113.294 163.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -131.46 153.01 50.2 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.834 1.253 . . . . 0.0 110.899 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 23.9 mt -61.24 -26.06 67.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.4 t -108.36 10.4 27.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.743 1.617 . . . . 0.0 113.456 -169.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 44.12 67.71 0.64 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.736 2.414 . . . . 0.0 115.53 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -82.51 -38.31 24.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.368 1.067 . . . . 0.0 111.714 156.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.13 158.66 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.456 1.502 . . . . 0.0 109.663 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -125.45 97.79 5.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.576 1.15 . . . . 0.0 110.97 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -92.24 -26.6 18.1 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.328 2.251 . . . . 0.0 113.816 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -110.7 -170.74 19.53 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 29.8 mt -125.02 134.57 66.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 127.225 2.21 . . . . 0.0 110.078 -175.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 14.1 mt -68.69 122.73 19.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.357 1.063 . . . . 0.0 109.815 164.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 77.7 t -95.7 -49.82 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.593 0.757 . . . . 0.0 109.861 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 18.9 m -76.76 157.0 31.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.416 0.627 . . . . 0.0 110.695 171.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.9 156.17 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.428 1.491 . . . . 0.0 113.066 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -122.41 79.57 45.86 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.963 1.305 . . . . 0.0 111.292 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.18 -166.23 0.4 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 124.68 3.587 . . . . 0.0 113.106 171.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 39.9 pt -100.67 164.12 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.069 1.748 . . . . 0.0 111.503 168.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.93 113.78 3.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.329 1.051 . . . . 0.0 109.534 159.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 93.6 p -66.85 -33.4 75.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.159 1.384 . . . . 0.0 112.596 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 2.6 m -143.42 153.54 42.77 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.029 2.532 . . . . 0.0 106.467 -174.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.57 -23.05 66.8 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.411 -1.43 . . . . 0.0 114.649 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.8 8.87 20.94 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.402 1.481 . . . . 0.0 113.355 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.64 154.3 9.08 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.561 -1.337 . . . . 0.0 114.306 -169.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -154.22 114.84 3.97 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.242 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.83 155.37 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.247 1.019 . . . . 0.0 109.441 -170.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.1 120.07 39.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.806 2.443 . . . . 0.0 108.169 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.71 129.11 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.895 0.878 . . . . 0.0 111.151 -171.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -89.51 140.56 29.41 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.725 1.21 . . . . 0.0 111.926 158.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.84 151.19 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.383 1.473 . . . . 0.0 110.53 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -117.08 113.33 39.46 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.03 1.732 . . . . 0.0 110.067 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -80.31 160.84 22.97 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.848 2.365 . . . . 0.0 111.295 162.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.5 171.08 17.85 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.403 2.069 . . . . 0.0 110.272 161.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -62.22 142.01 57.91 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.695 -0.628 . . . . 0.0 111.182 171.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 103.68 -145.5 16.17 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.902 0.763 . . . . 0.0 112.095 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -83.11 162.49 21.3 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.734 1.213 . . . . 0.0 113.08 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 14.3 m -165.81 160.17 16.78 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.812 1.245 . . . . 0.0 111.717 161.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -121.09 118.19 29.11 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 13.9 mm -92.96 122.08 44.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.269 1.428 . . . . 0.0 107.852 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.02 142.35 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.512 0.725 . . . . 0.0 110.631 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.69 110.97 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 127.28 2.232 . . . . 0.0 108.81 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.9 -178.26 22.9 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.596 1.093 . . . . 0.0 114.587 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.4 m -135.71 167.09 21.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.853 2.061 . . . . 0.0 110.146 170.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 79.52 -167.25 51.72 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.568 -0.707 . . . . 0.0 112.683 -173.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -25.93 66.37 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.856 -0.79 . . . . 0.0 112.6 169.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.3 m -74.44 -2.74 26.81 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 129.008 2.923 . . . . 0.0 115.163 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -84.68 130.54 34.69 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.625 0.77 . . . . 0.0 111.876 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 13.7 mt -94.22 156.09 16.72 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.745 0.418 . . . . 0.0 110.37 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.6 t -138.4 148.27 44.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.038 0.935 . . . . 0.0 111.921 -170.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -145.32 118.96 9.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.386 1.474 . . . . 0.0 110.012 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.28 128.04 34.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.462 0.705 . . . . 0.0 110.808 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -127.05 152.57 47.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.077 0.951 . . . . 0.0 110.662 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.19 141.79 51.79 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.626 1.17 . . . . 0.0 108.592 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? . . . . . 0 N--CA 1.465 0.317 0 C-N-CA 125.087 1.355 . . . . 0.0 109.976 -174.232 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 10.2 mmt . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.1 p -118.96 -0.98 11.06 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -172.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.43 -53.92 47.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.226 0.921 . . . . 0.0 113.032 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.32 122.9 16.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.5 t -47.17 158.2 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.699 2.0 . . . . 0.0 116.353 -167.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.37 119.58 8.8 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.074 1.75 . . . . 0.0 111.51 -164.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.409 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 2.4 mptp? -65.44 115.2 5.44 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.195 1.398 . . . . 0.0 110.557 -172.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.79 -48.07 2.6 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.983 1.278 . . . . 0.0 112.902 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 46.3 m -63.25 -1.53 1.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.386 2.274 . . . . 0.0 113.245 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.0 m -155.33 156.76 36.06 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 119.149 -2.22 . . . . 0.0 112.143 170.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -84.44 164.28 18.96 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.411 1.084 . . . . 0.0 113.513 -169.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 151.04 46.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.952 1.301 . . . . 0.0 113.214 -175.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 77.7 mtm -68.31 167.65 14.06 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.046 2.538 . . . . 0.0 114.66 -171.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.6 m -86.0 148.54 25.7 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.89 0.876 . . . . 0.0 111.456 176.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 6.7 p -136.95 23.08 3.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.097 1.359 . . . . 0.0 112.799 172.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -84.21 156.71 21.9 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.26 -0.9 . . . . 0.0 108.988 155.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.53 106.33 1.41 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.542 1.537 . . . . 0.0 111.575 -166.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 63.9 mtp -92.32 171.87 8.77 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.413 1.085 . . . . 0.0 112.839 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.8 m -163.69 162.33 24.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.663 1.185 . . . . 0.0 111.761 167.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.0 116.81 18.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.643 0.777 . . . . 0.0 110.21 169.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.16 -35.1 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.333 1.453 . . . . 0.0 110.288 163.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -134.64 129.84 35.48 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.385 1.474 . . . . 0.0 108.67 165.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -63.18 156.29 69.41 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.663 0.785 . . . . 0.0 112.275 173.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -62.58 132.46 38.02 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.132 1.888 . . . . 0.0 110.797 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 60.4 p -133.79 135.07 43.62 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.957 2.103 . . . . 0.0 108.79 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.55 140.15 58.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.075 0.852 . . . . 0.0 111.829 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 41.0 p -67.77 -17.49 64.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.598 1.959 . . . . 0.0 113.633 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 91.39 -6.66 80.72 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.349 0.976 . . . . 0.0 112.175 -164.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -98.51 1.16 46.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.724 1.21 . . . . 0.0 112.089 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 77.5 43.67 14.92 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 119.069 0.85 . . . . 0.0 111.094 -172.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 63.3 p -144.41 137.04 26.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.561 1.944 . . . . 0.0 108.194 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.8 m -110.66 125.06 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.223 0.919 . . . . 0.0 111.304 -172.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.87 131.03 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.753 1.621 . . . . 0.0 111.873 -173.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 11.2 ptp -141.83 166.1 25.65 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.998 2.119 . . . . 0.0 112.15 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -133.41 134.57 43.81 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.901 0.88 . . . . 0.0 110.38 171.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.8 m -132.01 135.31 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.221 1.008 . . . . 0.0 113.036 -165.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -89.73 131.86 35.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.29 1.836 . . . . 0.0 112.426 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 t -104.64 145.79 31.38 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.016 -1.469 . . . . 0.0 107.866 156.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -105.29 -72.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.617 2.211 . . . . 0.0 115.969 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.89 170.91 16.08 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 119.633 -1.917 . . . . 0.0 114.803 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.5 -4.24 3.01 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 126.18 1.848 . . . . 0.0 117.114 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.58 94.18 48.72 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 118.903 1.352 . . . . 0.0 112.063 -165.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.56 121.97 8.7 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.288 1.992 . . . . 0.0 108.952 163.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.2 p -157.84 154.45 28.03 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -77.13 142.01 39.92 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 156.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 14.5 pt -63.83 118.16 42.59 Favored Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -87.58 91.3 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.349 3.366 . . . . 0.0 113.178 -169.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.19 139.28 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.805 0.842 . . . . 0.0 109.703 169.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.63 147.11 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.371 1.468 . . . . 0.0 108.697 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.17 106.08 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -114.55 162.12 17.14 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -163.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.53 -9.62 57.13 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.854 2.062 . . . . 0.0 112.902 165.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -133.48 140.62 47.36 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.668 1.187 . . . . 0.0 110.528 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.28 -17.45 42.49 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -173.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -106.03 5.09 30.01 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.171 1.788 . . . . 0.0 113.601 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.57 78.91 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 129.557 3.143 . . . . 0.0 116.721 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.34 -36.91 11.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.398 1.479 . . . . 0.0 112.36 156.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 94.7 mt -103.12 136.06 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.135 1.374 . . . . 0.0 109.972 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.02 98.68 8.35 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.827 1.651 . . . . 0.0 110.02 -177.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -84.69 -52.32 6.17 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.249 2.62 . . . . 0.0 112.664 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -87.77 -172.91 47.76 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 116.204 1.242 . . . . 0.0 116.204 -170.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 45.5 mt -126.75 143.15 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.118 1.767 . . . . 0.0 111.048 -172.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 86.6 mt -68.84 138.45 54.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.033 0.933 . . . . 0.0 111.14 168.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.06 -42.8 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.267 0.485 . . . . 0.0 111.433 169.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 m -76.28 149.72 37.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.901 0.773 . . . . 0.0 109.491 158.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.98 157.59 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.296 1.038 . . . . 0.0 111.898 170.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -114.52 78.14 4.74 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.838 1.655 . . . . 0.0 110.647 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.12 -170.93 0.94 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.747 3.632 . . . . 0.0 114.013 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 42.8 pt -95.58 166.89 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.194 1.798 . . . . 0.0 111.657 172.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.15 124.47 24.19 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.681 0.792 . . . . 0.0 109.853 156.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.8 p -80.07 -40.31 27.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.136 1.375 . . . . 0.0 111.984 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.86 148.5 38.47 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.313 1.845 . . . . 0.0 108.399 159.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -59.92 -20.65 58.57 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.08 8.28 38.5 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.209 1.403 . . . . 0.0 112.954 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -61.45 155.12 22.54 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 119.983 -1.698 . . . . 0.0 113.779 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -132.92 95.49 3.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.965 1.306 . . . . 0.0 111.9 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.75 145.65 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.846 1.258 . . . . 0.0 111.922 -160.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 51.8 tp -102.61 127.16 49.82 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.099 2.96 . . . . 0.0 110.668 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.66 147.06 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.174 1.39 . . . . 0.0 110.907 -173.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -120.93 149.55 42.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.367 1.067 . . . . 0.0 113.632 161.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 2.4 m -137.42 158.21 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.855 2.062 . . . . 0.0 110.754 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -111.71 102.54 53.69 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.892 1.677 . . . . 0.0 110.793 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.87 139.12 27.03 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.553 2.169 . . . . 0.0 110.031 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.9 171.54 15.52 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.193 1.929 . . . . 0.0 111.208 170.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -64.55 150.57 46.54 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.703 -0.623 . . . . 0.0 112.21 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.57 -150.36 20.03 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -159.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -89.41 158.56 17.7 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.728 1.611 . . . . 0.0 113.22 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.4 m -158.72 151.26 21.83 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.174 -1.579 . . . . 0.0 112.04 166.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -118.39 109.28 16.08 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.84 108.63 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.91 142.19 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.01 112.32 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 125.355 1.462 . . . . 0.0 108.646 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.4 177.9 20.79 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.262 1.411 . . . . 0.0 114.995 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.5 m -136.08 161.05 36.77 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.043 1.737 . . . . 0.0 109.357 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.53 -166.73 54.58 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 121.558 0.532 . . . . 0.0 112.501 -170.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -27.34 14.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.708 1.603 . . . . 0.0 113.631 172.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.7 m -69.9 -4.15 19.14 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 129.199 3.0 . . . . 0.0 115.308 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -91.72 123.62 35.25 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.8 0.727 . . . . 0.0 112.928 -167.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.48 168.08 11.09 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.411 0.684 . . . . 0.0 111.289 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.1 t -140.09 149.22 42.82 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.172 1.389 . . . . 0.0 111.369 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -145.94 123.16 11.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.291 1.836 . . . . 0.0 109.923 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.43 133.01 39.99 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.268 -0.895 . . . . 0.0 111.85 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -121.59 162.86 19.88 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.332 1.053 . . . . 0.0 111.031 160.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -142.86 145.77 33.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.926 1.29 . . . . 0.0 108.708 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt . . . . . 0 N--CA 1.468 0.462 0 C-N-CA 125.214 1.405 . . . . 0.0 110.221 -177.214 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 56.1 mmm . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.8 p -101.34 -0.47 35.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.93 -31.48 60.36 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.9 tt -98.8 125.25 44.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 161.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.9 t -53.58 162.94 0.73 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.593 1.157 . . . . 0.0 113.883 -171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -49.88 110.49 0.39 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.636 1.974 . . . . 0.0 111.161 -162.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -55.43 124.05 15.91 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.901 1.681 . . . . 0.0 110.421 -168.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 59.92 9.2 9.73 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.98 1.276 . . . . 0.0 115.445 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 20.3 m -134.15 10.01 3.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.762 2.025 . . . . 0.0 110.181 -160.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.6 m -161.48 158.19 26.2 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 119.709 -1.869 . . . . 0.0 110.612 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -79.2 172.23 14.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.102 0.961 . . . . 0.0 112.976 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -71.57 160.12 33.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -77.8 152.66 33.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.409 2.284 . . . . 0.0 112.26 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -71.47 144.64 49.63 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.572 -0.705 . . . . 0.0 112.574 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.8 p -134.56 17.35 3.63 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.149 1.38 . . . . 0.0 113.391 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -75.65 161.19 29.31 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.928 -1.107 . . . . 0.0 109.009 154.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 87.58 0.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.991 1.316 . . . . 0.0 111.347 -168.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 55.9 mtp -70.05 172.97 7.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.906 2.082 . . . . 0.0 114.277 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.8 m -157.85 164.7 36.7 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.98 0.912 . . . . 0.0 111.998 158.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.95 121.61 25.67 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.263 0.625 . . . . 0.0 110.407 166.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.5 -37.14 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.107 1.363 . . . . 0.0 110.121 166.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -131.93 123.13 26.8 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.905 1.282 . . . . 0.0 108.91 169.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -63.43 149.87 90.97 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.132 0.973 . . . . 0.0 111.682 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.45 139.41 70.66 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.716 2.277 . . . . 0.0 112.327 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 49.0 p -141.94 129.59 21.53 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.36 1.864 . . . . 0.0 109.875 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -56.51 126.43 26.49 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.781 0.719 . . . . 0.0 111.679 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.5 p -68.64 -15.6 63.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.8 2.04 . . . . 0.0 113.51 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 93.76 -21.75 39.67 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.748 1.642 . . . . 0.0 112.047 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -74.38 -20.17 60.17 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.386 1.093 . . . . 0.0 112.426 172.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 103.01 18.77 14.16 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.444 1.02 . . . . 0.0 112.503 -168.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.5 p -120.93 149.28 42.88 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 126.548 1.939 . . . . 0.0 108.208 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 33.7 m -118.75 123.61 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.144 0.978 . . . . 0.0 110.096 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.0 p -96.79 127.16 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.968 1.307 . . . . 0.0 111.342 -174.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.1 ptm -147.67 161.43 41.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.526 1.531 . . . . 0.0 112.934 -172.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -134.26 134.21 41.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 110.622 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 23.8 m -131.04 122.36 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.414 1.086 . . . . 0.0 113.353 -162.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -89.75 123.34 33.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.257 2.223 . . . . 0.0 112.247 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.79 146.36 31.25 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 117.235 -1.364 . . . . 0.0 108.235 156.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -101.25 -71.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.722 2.281 . . . . 0.0 115.896 174.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.47 163.96 34.02 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 119.534 -1.979 . . . . 0.0 114.701 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 61.74 7.79 12.89 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.681 1.61 . . . . 0.0 116.333 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.23 88.76 33.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 118.612 1.206 . . . . 0.0 112.319 -162.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.02 118.54 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.15 1.9 . . . . 0.0 108.377 161.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.7 p -157.48 156.59 32.35 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.731 0.777 . . . . 0.0 112.998 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -77.63 142.51 38.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.904 1.682 . . . . 0.0 108.397 163.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.42 123.38 73.3 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 119.287 0.948 . . . . 0.0 111.346 -172.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -102.04 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.583 2.855 . . . . 0.0 113.524 -164.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.24 120.56 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.641 0.776 . . . . 0.0 109.017 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.68 158.47 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.581 1.153 . . . . 0.0 110.465 -174.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.74 104.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.943 2.097 . . . . 0.0 108.085 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.03 159.14 36.88 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.709 1.004 . . . . 0.0 113.709 -160.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.21 -14.33 61.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.718 2.007 . . . . 0.0 112.944 166.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -129.86 140.56 50.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.531 1.532 . . . . 0.0 111.022 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.92 -20.99 60.46 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.4 t -101.22 7.3 43.09 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.866 1.667 . . . . 0.0 113.649 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.18 63.96 1.36 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.799 2.44 . . . . 0.0 115.668 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.13 -50.7 13.92 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.736 0.814 . . . . 0.0 110.876 155.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 15.4 mm -84.41 160.94 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.356 0.598 . . . . 0.0 109.617 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -138.66 61.52 1.57 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.03 -1.044 . . . . 0.0 111.679 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -53.28 -50.81 64.1 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.067 2.547 . . . . 0.0 113.72 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -80.5 -172.0 44.54 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 116.059 1.184 . . . . 0.0 116.059 -168.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.7 mt -123.99 137.35 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.556 1.543 . . . . 0.0 110.175 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.8 mp -77.16 126.62 31.24 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 161.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.97 -46.43 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.557 1.143 . . . . 0.0 109.62 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 31.6 m -73.82 161.01 30.64 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.448 0.642 . . . . 0.0 110.488 167.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.6 t -53.54 153.09 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.94 1.696 . . . . 0.0 111.026 173.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -111.61 76.59 1.59 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.07 1.348 . . . . 0.0 110.991 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -75.74 -174.47 2.04 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.947 3.098 . . . . 0.0 112.8 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.2 pt -91.36 168.16 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.049 1.339 . . . . 0.0 111.715 168.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.92 110.13 2.34 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 154.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.4 p -72.04 -37.3 69.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.166 1.386 . . . . 0.0 112.146 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.37 158.0 29.24 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.573 1.949 . . . . 0.0 109.306 158.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -62.1 -20.06 63.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -100.35 11.1 40.19 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.653 1.581 . . . . 0.0 112.408 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -60.6 148.57 37.77 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.596 -1.315 . . . . 0.0 113.705 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -132.17 82.19 2.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.811 1.644 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 11.5 t -94.91 146.39 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.335 1.054 . . . . 0.0 111.202 -164.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 39.8 tp -104.7 123.38 47.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.417 2.687 . . . . 0.0 111.073 -173.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 2.9 mp -141.14 141.17 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.533 1.933 . . . . 0.0 111.041 -170.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -94.04 139.61 30.75 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.637 1.175 . . . . 0.0 111.94 158.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.04 166.24 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.022 1.329 . . . . 0.0 111.004 168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -129.55 108.61 17.37 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 125.894 1.678 . . . . 0.0 110.11 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.64 149.43 26.82 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.568 2.179 . . . . 0.0 110.231 158.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.81 170.16 20.31 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.224 1.949 . . . . 0.0 111.472 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -57.78 129.59 42.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.003 0.921 . . . . 0.0 110.225 168.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 110.76 -139.05 15.32 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.984 0.802 . . . . 0.0 111.898 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -86.85 167.15 14.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.264 1.025 . . . . 0.0 113.287 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.2 m -178.23 163.46 1.66 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.762 2.425 . . . . 0.0 111.04 158.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -127.2 126.58 43.04 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.628 1.571 . . . . 0.0 107.698 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.0 mm -95.26 122.05 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.214 1.406 . . . . 0.0 108.016 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.1 142.81 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.611 0.764 . . . . 0.0 110.2 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 67.9 t -115.92 109.1 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.943 1.697 . . . . 0.0 108.653 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.05 -173.5 20.72 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 123.358 1.532 . . . . 0.0 115.338 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.0 m -140.4 163.91 31.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.487 1.515 . . . . 0.0 109.843 171.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.19 -167.85 54.02 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 121.65 0.583 . . . . 0.0 112.775 -171.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.51 -29.14 6.28 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 114.028 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.0 m -71.34 -11.77 61.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.401 2.681 . . . . 0.0 114.693 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -79.69 109.45 14.1 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -164.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.16 158.0 33.72 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.11 -0.369 . . . . 0.0 110.779 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 2.7 t -136.26 143.93 44.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.754 1.222 . . . . 0.0 111.006 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -144.67 123.17 12.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.595 1.558 . . . . 0.0 110.134 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.39 124.86 24.99 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.359 -0.838 . . . . 0.0 111.945 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -130.1 123.37 30.25 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.213 0.605 . . . . 0.0 110.397 161.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -123.37 146.76 47.7 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 17.9 tptt . . . . . 0 N--CA 1.463 0.223 0 C-N-CA 124.276 1.031 . . . . 0.0 110.496 -162.066 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.3 p -97.08 -7.05 33.68 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.76 95.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.527 1.058 . . . . 0.0 112.696 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.9 tt -63.06 129.62 41.16 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 7.5 t -49.45 163.45 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.299 1.44 . . . . 0.0 114.537 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -73.53 93.63 2.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.027 1.331 . . . . 0.0 111.134 -160.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.486 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 2.1 mptt -39.01 111.25 0.17 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.519 3.128 . . . . 0.0 112.417 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.01 -32.25 0.52 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.415 1.96 . . . . 0.0 115.111 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 62.7 m -70.98 -3.45 19.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.87 2.468 . . . . 0.0 112.304 171.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.9 m -156.66 154.23 29.78 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 119.311 -2.118 . . . . 0.0 111.199 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -78.71 174.58 11.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.12 1.368 . . . . 0.0 113.178 -173.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -65.27 161.09 20.15 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.041 1.336 . . . . 0.0 114.442 -170.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 71.3 mtm -91.21 150.47 21.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.139 2.175 . . . . 0.0 111.627 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.5 m -69.41 147.57 50.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.077 0.951 . . . . 0.0 112.571 -174.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.6 p -136.38 11.12 3.24 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -76.82 165.04 25.25 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 119.433 1.015 . . . . 0.0 109.553 161.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.48 89.63 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.225 1.41 . . . . 0.0 113.727 -167.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 44.7 mtp -76.64 167.18 22.28 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.639 1.176 . . . . 0.0 113.659 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.5 m -160.69 162.78 32.7 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.875 1.27 . . . . 0.0 110.555 161.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.7 130.57 34.53 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.978 -0.452 . . . . 0.0 110.727 164.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.36 -28.85 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.634 1.573 . . . . 0.0 110.197 167.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -129.99 116.94 19.3 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.531 1.532 . . . . 0.0 108.257 163.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -55.94 150.12 30.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.784 1.234 . . . . 0.0 111.081 169.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.5 138.31 69.79 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.81 1.673 . . . . 0.0 110.808 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' THR . . . . . 0.412 ' HA ' ' CZ2' ' A' ' 389' ' ' TRP . 0.9 OUTLIER -144.28 142.59 30.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.089 0.556 . . . . 0.0 110.158 175.061 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -63.48 126.3 27.03 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.727 1.611 . . . . 0.0 112.413 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 82.5 p -73.84 -25.89 60.31 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.001 1.32 . . . . 0.0 112.68 173.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 84.98 -2.41 88.32 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.501 1.524 . . . . 0.0 114.538 -164.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -87.2 6.06 34.92 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.334 1.453 . . . . 0.0 112.038 171.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 83.1 20.08 61.56 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 121.094 -1.004 . . . . 0.0 112.829 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 33.4 p -131.9 154.22 49.44 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.056 1.343 . . . . 0.0 110.688 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 24.1 m -122.81 128.95 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.685 1.194 . . . . 0.0 109.347 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.41 132.88 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.467 1.107 . . . . 0.0 112.21 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -141.8 162.42 35.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.658 1.583 . . . . 0.0 113.778 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -121.48 114.14 20.83 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.472 2.309 . . . . 0.0 107.006 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.95 138.31 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.693 1.197 . . . . 0.0 111.018 -167.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -119.63 136.64 54.3 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 8.5 t -102.46 150.33 37.52 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 127.301 2.24 . . . . 0.0 108.591 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -102.62 -74.03 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 122.907 2.405 . . . . 0.0 115.888 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.18 162.36 34.46 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.785 1.63 . . . . 0.0 114.498 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 59.94 -0.18 0.88 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 127.193 2.33 . . . . 0.0 118.272 170.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.38 94.67 23.12 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 119.681 1.741 . . . . 0.0 113.304 -164.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.64 115.79 4.45 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.461 2.107 . . . . 0.0 108.935 163.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.0 p -150.77 155.41 39.2 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.924 0.869 . . . . 0.0 112.715 -175.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -74.14 136.36 42.9 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.262 1.425 . . . . 0.0 107.977 163.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.273 2.6 pp -62.27 129.44 92.28 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.415 -169.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -100.43 89.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.005 2.47 . . . . 0.0 113.635 -160.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 94.4 t -118.22 130.71 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.994 1.318 . . . . 0.0 109.602 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.33 151.67 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 111.51 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.7 t -126.82 104.18 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.415 1.886 . . . . 0.0 107.508 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -115.1 161.81 17.88 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -163.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.71 -11.73 58.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.222 1.809 . . . . 0.0 112.722 163.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.65 146.37 49.46 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.724 1.21 . . . . 0.0 111.75 -176.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.05 -16.14 63.66 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -99.63 5.27 45.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.558 1.143 . . . . 0.0 112.983 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 37.8 77.83 0.04 OUTLIER 'General case' 0 C--O 1.239 0.548 0 C-N-CA 129.124 2.97 . . . . 0.0 115.115 -169.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -106.72 -25.43 11.75 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.394 1.877 . . . . 0.0 112.918 166.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.95 119.72 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.599 1.56 . . . . 0.0 109.436 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.1 123.54 50.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -107.85 -16.93 14.2 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -93.52 -177.59 39.96 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 119.853 1.206 . . . . 0.0 116.046 -176.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 86.9 mt -126.63 136.2 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 127.926 2.491 . . . . 0.0 110.058 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mt -72.73 136.99 45.64 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.186 0.995 . . . . 0.0 110.882 168.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.14 -46.66 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.257 0.623 . . . . 0.0 111.466 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 47.6 m -68.99 153.12 44.35 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.384 0.538 . . . . 0.0 109.787 159.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.38 161.28 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.574 1.149 . . . . 0.0 113.028 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -118.04 79.13 13.77 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.284 1.434 . . . . 0.0 111.105 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -78.88 -171.22 1.18 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 123.731 2.954 . . . . 0.0 112.332 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.27 167.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.091 1.357 . . . . 0.0 111.383 171.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.1 117.01 10.2 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 156.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 86.0 p -67.28 -28.41 68.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.589 1.156 . . . . 0.0 112.809 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 21.5 m -137.23 151.28 48.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 128.254 2.621 . . . . 0.0 106.717 -172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.9 -26.63 66.07 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.524 -1.36 . . . . 0.0 113.684 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -89.14 2.51 54.06 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.328 1.851 . . . . 0.0 113.413 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -58.58 154.37 14.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.933 1.349 . . . . 0.0 113.25 -166.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -144.53 95.32 2.69 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.945 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.87 149.54 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.106 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 45.2 tp -93.99 124.62 38.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.485 2.314 . . . . 0.0 109.412 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.23 135.1 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.746 0.818 . . . . 0.0 110.551 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -106.01 140.07 39.57 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.21 1.005 . . . . 0.0 112.402 158.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.19 151.53 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.974 2.11 . . . . 0.0 110.025 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -108.92 113.01 59.85 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.296 1.838 . . . . 0.0 109.774 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.62 159.42 25.22 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.538 2.159 . . . . 0.0 111.108 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.17 173.17 3.43 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.703 2.269 . . . . 0.0 112.176 163.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -64.35 141.0 58.93 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.785 -0.572 . . . . 0.0 110.149 163.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 99.47 -140.59 15.06 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.575 0.607 . . . . 0.0 111.787 -174.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -88.24 164.71 15.49 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.713 1.205 . . . . 0.0 113.393 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 13.2 m -167.31 152.96 7.55 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.38 1.472 . . . . 0.0 111.821 165.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -118.95 113.92 21.75 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 31.9 mm -88.48 115.02 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 125.864 1.666 . . . . 0.0 107.734 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -113.51 140.83 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 122.021 0.915 . . . . 0.0 111.263 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.59 114.07 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 127.02 2.128 . . . . 0.0 108.251 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 98.36 178.09 32.81 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 122.662 1.146 . . . . 0.0 114.76 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 48.6 m -130.45 165.62 22.23 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.279 1.832 . . . . 0.0 109.353 171.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.87 -171.97 54.26 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 121.675 -0.64 . . . . 0.0 113.059 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.23 -23.1 33.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.33 1.452 . . . . 0.0 113.999 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.3 m -82.84 -2.73 55.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.482 2.313 . . . . 0.0 114.909 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -76.79 126.53 31.14 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.456 1.025 . . . . 0.0 113.068 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -90.05 161.89 15.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.147 0.579 . . . . 0.0 111.652 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.3 t -137.78 151.36 48.06 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.192 1.397 . . . . 0.0 112.59 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -150.13 131.77 14.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.314 1.846 . . . . 0.0 110.328 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.51 136.43 36.9 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.969 -1.082 . . . . 0.0 111.98 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . 0.412 ' CZ2' ' HA ' ' A' ' 311' ' ' THR . 21.2 m95 -125.53 152.73 44.64 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.698 0.761 . . . . 0.0 112.243 161.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -133.3 134.15 43.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.053 1.341 . . . . 0.0 108.365 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? . . . . . 0 N--CA 1.467 0.405 0 C-N-CA 125.351 1.46 . . . . 0.0 110.747 -167.269 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 20.0 m -103.23 11.28 37.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.094 1.357 . . . . 0.0 113.344 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -72.25 -39.28 68.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.609 1.095 . . . . 0.0 111.011 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.5 tt -72.68 138.76 46.84 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 164.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.4 t -55.73 176.91 0.06 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.142 1.777 . . . . 0.0 114.973 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -68.58 83.49 0.28 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.846 1.658 . . . . 0.0 110.451 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.428 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 1.8 mptt -38.12 119.53 0.79 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.238 2.615 . . . . 0.0 112.481 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.86 -37.38 1.06 Allowed Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.745 1.64 . . . . 0.0 114.696 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 58.3 m -75.01 1.39 13.09 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.503 2.321 . . . . 0.0 112.593 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.0 m -158.19 149.93 21.53 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 119.037 -2.289 . . . . 0.0 111.715 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -84.71 178.78 7.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.972 1.309 . . . . 0.0 113.302 -169.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -63.93 162.19 14.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.263 1.425 . . . . 0.0 114.254 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -69.92 157.41 37.49 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.641 1.576 . . . . 0.0 111.853 166.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.7 m -75.29 145.8 41.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.194 0.598 . . . . 0.0 110.255 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.0 p -133.67 21.0 3.9 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.909 1.283 . . . . 0.0 112.022 170.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -82.88 168.48 17.04 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 155.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 100.71 0.27 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.244 1.418 . . . . 0.0 112.067 -166.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 16.7 mtp -86.41 166.14 15.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.022 0.915 . . . . 0.0 112.21 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 18.9 m -163.58 163.31 24.57 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.261 1.024 . . . . 0.0 111.122 169.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.8 114.45 22.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.475 0.71 . . . . 0.0 109.129 163.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.26 -37.91 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.571 1.149 . . . . 0.0 109.552 161.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -135.16 120.49 19.04 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.682 1.593 . . . . 0.0 108.405 168.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -59.62 152.8 54.83 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.31 1.044 . . . . 0.0 110.977 172.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.38 137.06 63.0 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.094 1.863 . . . . 0.0 111.489 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.3 m -132.88 135.01 45.33 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.858 1.263 . . . . 0.0 109.225 173.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.06 130.12 43.3 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.253 0.549 . . . . 0.0 111.97 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 70.3 p -79.43 -21.06 46.06 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.709 1.203 . . . . 0.0 113.333 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 80.98 -8.34 57.43 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.761 1.172 . . . . 0.0 114.364 -161.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -87.97 6.26 36.75 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.298 1.439 . . . . 0.0 112.06 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 88.51 14.49 61.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.282 0.944 . . . . 0.0 113.092 -171.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 50.5 p -131.63 161.17 33.34 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.111 1.364 . . . . 0.0 111.259 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.27 133.02 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 125.253 1.421 . . . . 0.0 109.222 169.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.4 p -115.58 131.87 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.908 1.283 . . . . 0.0 112.05 -172.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 15.8 ptm -144.95 163.18 34.95 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.406 2.282 . . . . 0.0 112.069 -169.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -132.61 130.84 40.76 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.756 0.822 . . . . 0.0 108.915 173.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.47 145.15 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.171 0.988 . . . . 0.0 111.379 -165.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -105.17 135.82 45.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.737 1.215 . . . . 0.0 112.429 -175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.6 t -114.74 135.55 22.38 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.891 1.676 . . . . 0.0 107.714 163.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -100.65 -61.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.899 2.399 . . . . 0.0 115.164 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.96 176.11 11.82 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.714 -1.241 . . . . 0.0 113.091 -176.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.66 -23.19 0.18 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 128.097 2.76 . . . . 0.0 118.683 160.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -109.11 104.09 54.09 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 119.257 1.529 . . . . 0.0 112.766 -166.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.76 114.04 3.19 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.583 1.522 . . . . 0.0 108.502 159.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.7 p -148.8 154.55 39.69 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.997 0.903 . . . . 0.0 112.233 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -78.14 134.92 37.6 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.321 1.448 . . . . 0.0 107.573 161.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -60.08 117.71 26.24 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 118.574 0.625 . . . . 0.0 111.308 -171.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -96.93 88.54 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.348 2.699 . . . . 0.0 113.752 -166.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 60.6 t -107.75 136.26 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 164.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.05 161.07 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.897 1.279 . . . . 0.0 111.104 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 93.0 t -139.34 106.24 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.05 1.74 . . . . 0.0 109.071 -174.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.24 163.01 26.56 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -158.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -87.34 -17.73 31.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.468 1.907 . . . . 0.0 112.883 163.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -123.64 153.05 41.3 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.598 1.159 . . . . 0.0 111.108 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 54.1 mt -69.23 -2.38 10.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.445 1.098 . . . . 0.0 113.883 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 2.2 t -129.4 18.61 5.85 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.579 1.551 . . . . 0.0 112.198 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 49.62 31.25 4.09 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.5 -25.87 68.24 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.745 -0.597 . . . . 0.0 112.388 166.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 31.9 mt -121.95 117.52 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.533 2.333 . . . . 0.0 107.693 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.94 115.66 29.88 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.91 0.777 . . . . 0.0 111.279 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -103.16 -10.44 18.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -99.33 -167.97 30.18 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 54.5 mt -132.04 133.69 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 127.86 2.464 . . . . 0.0 110.45 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 23.0 mt -65.25 121.0 13.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.932 1.293 . . . . 0.0 109.942 160.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 50.5 t -102.59 -51.89 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 122.924 0.49 . . . . 0.0 110.635 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.4 m -69.85 163.41 25.92 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.509 0.595 . . . . 0.0 110.424 168.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.4 t -52.81 147.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.587 1.155 . . . . 0.0 110.437 170.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -112.13 78.68 2.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.068 1.347 . . . . 0.0 110.2 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.15 -174.2 2.15 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 123.909 3.073 . . . . 0.0 113.349 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -94.01 168.37 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.521 1.528 . . . . 0.0 110.948 167.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.54 110.99 3.89 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 156.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 83.3 p -73.27 -36.99 66.44 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.094 1.358 . . . . 0.0 112.073 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.79 154.36 37.09 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.721 2.008 . . . . 0.0 109.093 160.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -64.82 -19.0 65.61 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.48 0.87 56.57 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.017 1.727 . . . . 0.0 112.919 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -57.84 149.54 22.27 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.503 -1.373 . . . . 0.0 114.074 -171.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -138.91 86.76 2.16 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.118 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.03 145.88 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.794 1.237 . . . . 0.0 111.6 -170.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 45.8 tp -92.35 126.42 37.43 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.059 2.944 . . . . 0.0 110.502 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.8 145.14 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.662 1.585 . . . . 0.0 109.823 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -116.79 149.57 39.75 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.099 0.952 . . . . 0.0 111.948 159.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.19 154.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 125.564 1.546 . . . . 0.0 110.162 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -103.24 114.18 65.23 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.659 1.184 . . . . 0.0 110.22 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.57 143.8 15.38 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.019 2.48 . . . . 0.0 110.969 162.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -74.86 167.68 26.54 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.862 2.375 . . . . 0.0 111.242 169.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -53.63 140.37 29.15 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.734 1.214 . . . . 0.0 112.206 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.9 -147.57 17.0 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -172.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -82.09 164.16 21.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.61 1.564 . . . . 0.0 112.083 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 33.4 m -161.39 148.25 14.64 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.662 -1.274 . . . . 0.0 112.419 158.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -110.14 106.41 15.86 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.104 0.961 . . . . 0.0 108.499 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.4 mm -84.14 114.97 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 125.836 1.655 . . . . 0.0 107.95 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.2 mt -115.64 143.78 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.502 1.121 . . . . 0.0 109.891 -169.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 52.5 t -120.84 113.84 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.679 1.592 . . . . 0.0 108.556 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 90.42 179.54 43.78 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 53.1 m -132.51 165.83 23.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.696 1.998 . . . . 0.0 109.341 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.17 -170.1 55.04 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.808 -0.557 . . . . 0.0 112.783 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -28.15 56.53 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.762 1.225 . . . . 0.0 113.643 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.0 m -78.21 -3.91 45.06 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 127.513 2.325 . . . . 0.0 115.041 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -78.91 144.33 34.99 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.694 0.679 . . . . 0.0 112.822 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.3 mt -111.07 163.88 13.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.615 0.766 . . . . 0.0 110.922 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.5 t -139.52 154.01 47.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.732 1.213 . . . . 0.0 111.459 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -149.19 135.73 19.43 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.89 1.676 . . . . 0.0 109.892 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.77 131.6 38.97 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.415 -0.803 . . . . 0.0 111.662 -172.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -123.72 166.23 15.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.115 0.966 . . . . 0.0 112.04 167.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -138.98 129.94 26.46 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.073 1.749 . . . . 0.0 108.368 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? . . . . . 0 C--O 1.233 0.214 0 C-N-CA 125.81 1.644 . . . . 0.0 110.7 -176.503 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.0 t -119.49 9.9 11.68 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.801 1.24 . . . . 0.0 113.374 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.57 -46.7 78.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.041 0.837 . . . . 0.0 110.909 167.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.07 129.15 38.88 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 164.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.7 t -57.02 171.33 0.36 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.163 1.385 . . . . 0.0 114.269 -173.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.34 109.08 1.79 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.614 1.965 . . . . 0.0 110.721 -167.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -63.78 114.61 4.14 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.989 2.116 . . . . 0.0 110.578 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 78.91 -40.84 2.12 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.827 1.203 . . . . 0.0 113.322 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 5.2 m -65.69 -0.81 2.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.752 2.421 . . . . 0.0 114.013 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.0 m -153.08 151.69 30.49 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 118.994 -2.316 . . . . 0.0 113.65 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -73.82 173.48 9.82 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.359 1.864 . . . . 0.0 112.827 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -71.47 152.77 42.77 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.338 1.055 . . . . 0.0 113.785 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -70.2 157.55 37.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.819 2.048 . . . . 0.0 112.337 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.4 m -69.82 140.51 53.3 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.546 -0.721 . . . . 0.0 111.735 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 17.2 p -128.18 7.1 5.95 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.496 ' CG ' ' HZ2' ' A' ' 326' ' ' LYS . 44.1 t0 -73.67 166.46 23.24 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.016 0.825 . . . . 0.0 110.888 164.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -71.03 84.15 0.7 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.016 1.727 . . . . 0.0 111.197 -170.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 41.3 mtp -66.63 172.46 4.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.383 1.873 . . . . 0.0 114.337 -174.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.5 m -157.69 159.34 36.81 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.489 1.116 . . . . 0.0 111.249 164.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.97 117.1 19.72 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 169.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.45 -33.49 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.025 0.53 . . . . 0.0 109.659 161.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -137.43 124.08 21.03 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.785 1.634 . . . . 0.0 108.026 164.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -59.18 160.91 10.71 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.211 0.604 . . . . 0.0 111.599 171.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -61.33 135.66 59.23 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.903 1.735 . . . . 0.0 110.589 167.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.0 m -138.48 138.44 38.1 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.766 1.226 . . . . 0.0 108.985 171.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.18 128.57 37.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.09 0.868 . . . . 0.0 111.567 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 73.8 p -79.63 -12.62 59.82 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.252 1.021 . . . . 0.0 113.723 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 75.45 0.69 63.13 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.394 0.997 . . . . 0.0 113.978 -164.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -111.67 14.52 21.21 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.189 1.796 . . . . 0.0 112.32 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.8 15.17 68.38 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.766 0.698 . . . . 0.0 113.501 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.4 p -134.61 162.67 31.64 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.691 1.197 . . . . 0.0 111.176 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.73 130.42 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.597 1.159 . . . . 0.0 109.625 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.33 132.9 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.843 1.257 . . . . 0.0 111.802 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 4.8 ptp -143.84 166.03 26.05 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.117 1.767 . . . . 0.0 112.345 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -133.88 128.71 35.18 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.679 1.192 . . . . 0.0 109.904 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.79 121.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.076 0.951 . . . . 0.0 112.22 -161.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.23 130.13 34.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.512 1.525 . . . . 0.0 112.028 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.29 137.4 19.42 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.985 1.314 . . . . 0.0 108.201 159.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -91.88 -77.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 122.9 2.4 . . . . 0.0 116.256 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.496 ' HZ2' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -150.79 139.16 20.38 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -171.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 83.8 4.74 88.61 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.808 1.194 . . . . 0.0 115.422 174.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.61 89.43 18.53 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 118.664 1.232 . . . . 0.0 112.325 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.1 127.13 13.89 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.215 1.943 . . . . 0.0 108.676 159.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 5.0 p -162.77 162.9 26.88 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -74.4 143.37 44.82 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.04 1.736 . . . . 0.0 109.85 161.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 19.0 pt -66.37 123.91 86.72 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 118.713 0.688 . . . . 0.0 111.213 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -108.48 82.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.292 1.994 . . . . 0.0 115.186 -153.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 80.1 t -114.35 131.48 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.369 -0.832 . . . . 0.0 109.818 172.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.67 128.88 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.33 1.052 . . . . 0.0 110.07 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.9 t -99.99 119.53 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.586 1.555 . . . . 0.0 107.516 170.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -130.26 161.12 31.93 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -166.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.71 -18.26 58.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.331 1.853 . . . . 0.0 112.98 164.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -128.22 146.02 50.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.746 1.218 . . . . 0.0 111.618 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.74 -17.9 38.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.0 t -105.12 5.93 32.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.427 1.491 . . . . 0.0 113.417 -176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 40.16 75.96 0.07 Allowed 'General case' 0 C--O 1.239 0.519 0 C-N-CA 129.042 2.937 . . . . 0.0 115.801 -171.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.74 -51.3 4.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.069 1.347 . . . . 0.0 111.655 157.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 72.1 mt -102.57 104.73 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.697 1.599 . . . . 0.0 109.1 -174.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -84.16 115.58 22.48 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -95.3 -11.58 27.63 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.159 2.583 . . . . 0.0 114.562 -173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -115.12 -168.47 15.65 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.6 mt -129.44 135.38 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.404 2.281 . . . . 0.0 110.184 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.04 122.8 17.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.302 1.041 . . . . 0.0 110.555 164.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 73.5 t -102.22 -50.11 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.848 0.859 . . . . 0.0 109.861 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.0 m -69.35 153.27 43.86 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.279 0.562 . . . . 0.0 110.038 166.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.17 159.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.443 1.097 . . . . 0.0 112.236 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -120.93 75.45 28.39 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.043 0.937 . . . . 0.0 112.454 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -57.35 -167.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.127 1 C-N-CA 126.131 4.554 . . . . 0.0 117.221 162.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 27.5 pt -112.14 166.88 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.703 2.401 . . . . 0.0 111.324 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.31 105.34 2.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.988 0.915 . . . . 0.0 109.022 155.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.5 p -72.79 -50.45 24.22 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.391 1.476 . . . . 0.0 111.314 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.59 152.34 19.15 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.991 1.317 . . . . 0.0 108.825 156.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -60.61 -19.02 56.67 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.11 0.39 56.75 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.107 1.763 . . . . 0.0 112.955 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -58.66 147.4 32.85 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.471 -1.393 . . . . 0.0 113.653 -172.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.79 79.54 1.85 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.519 1.528 . . . . 0.0 111.252 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.35 148.56 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.569 1.148 . . . . 0.0 111.502 -165.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.53 127.23 39.09 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.908 2.883 . . . . 0.0 109.798 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.57 141.76 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.002 1.321 . . . . 0.0 109.86 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -119.19 152.35 36.75 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 122.453 1.12 . . . . 0.0 112.573 162.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.8 m -140.89 156.65 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.943 1.697 . . . . 0.0 110.72 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -109.91 116.3 54.0 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.844 1.658 . . . . 0.0 110.772 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.45 160.83 12.82 Favored 'Trans proline' 0 CA--C 1.551 1.369 0 C-N-CA 123.766 2.978 . . . . 0.0 112.095 161.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -76.23 176.35 10.16 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.415 2.743 . . . . 0.0 110.895 164.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -60.02 145.25 47.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.187 0.595 . . . . 0.0 111.247 168.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.33 -152.02 19.71 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.634 0.635 . . . . 0.0 111.664 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.9 167.17 20.17 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.556 1.169 . . . . 0.0 113.154 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 30.8 m -162.64 152.24 15.75 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.441 1.096 . . . . 0.0 110.905 157.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -107.44 119.36 39.19 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.7 mm -99.37 104.69 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 125.778 1.631 . . . . 0.0 107.594 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.38 141.21 18.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.944 1.298 . . . . 0.0 109.799 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 65.7 t -120.56 111.14 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 126.584 1.954 . . . . 0.0 108.442 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.38 -177.43 26.02 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 123.27 1.483 . . . . 0.0 114.658 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 53.7 m -138.35 167.26 22.25 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.236 1.815 . . . . 0.0 109.575 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.38 -175.02 49.45 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 121.741 0.634 . . . . 0.0 112.674 -170.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -23.15 65.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.676 1.19 . . . . 0.0 113.054 175.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 54.0 m -64.57 -15.59 61.26 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 171.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -71.11 138.8 49.99 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.144 1.338 . . . . 0.0 112.813 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 42.3 mt -103.56 161.57 13.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.728 1.211 . . . . 0.0 110.864 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.1 t -143.05 145.1 32.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.004 0.921 . . . . 0.0 112.248 -171.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -150.22 121.8 8.0 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.704 1.602 . . . . 0.0 110.199 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.71 131.44 39.87 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.468 -1.395 . . . . 0.0 111.815 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -119.28 168.84 10.52 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.793 0.837 . . . . 0.0 111.615 159.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.58 145.93 34.07 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.707 1.603 . . . . 0.0 108.971 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 125.081 1.352 . . . . 0.0 110.633 -174.422 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.8 m -97.5 -7.12 32.18 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.274 1.03 . . . . 0.0 113.562 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.38 80.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.323 0.965 . . . . 0.0 113.009 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 53.6 tp -74.65 126.9 31.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 160.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.5 t -55.99 168.5 0.47 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.501 1.12 . . . . 0.0 113.836 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.99 118.04 5.79 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.799 1.639 . . . . 0.0 110.557 -167.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -70.22 108.01 3.97 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.402 1.481 . . . . 0.0 109.512 -163.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 77.15 -45.2 2.25 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.985 1.278 . . . . 0.0 112.768 -170.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 38.9 m -63.37 7.46 0.1 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 128.636 2.775 . . . . 0.0 113.925 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.1 m -157.14 158.69 36.79 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 118.766 -2.458 . . . . 0.0 112.012 167.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -77.62 172.89 12.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.226 1.41 . . . . 0.0 113.023 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -70.28 154.6 41.73 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -171.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -67.6 157.7 33.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.346 2.258 . . . . 0.0 112.275 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 11.2 m -71.68 141.47 49.88 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.442 -0.786 . . . . 0.0 111.333 174.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 12.7 p -134.67 11.13 3.71 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -84.4 177.58 8.08 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.933 0.788 . . . . 0.0 109.518 163.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -71.2 81.37 0.72 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.372 1.869 . . . . 0.0 111.738 -166.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 20.7 mtp -66.15 167.3 10.32 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.928 1.291 . . . . 0.0 112.814 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 28.7 m -158.51 168.6 26.49 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.108 0.963 . . . . 0.0 111.146 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.01 115.12 26.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.815 1.246 . . . . 0.0 110.479 172.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.86 -34.92 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.917 1.287 . . . . 0.0 110.259 167.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -138.18 126.11 22.6 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.036 1.735 . . . . 0.0 108.629 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -61.27 160.58 22.37 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.206 1.002 . . . . 0.0 111.77 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.69 121.62 8.1 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.679 1.586 . . . . 0.0 110.073 169.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 13.6 p -124.32 140.6 52.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.407 1.083 . . . . 0.0 110.499 170.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -60.69 140.94 57.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.599 0.76 . . . . 0.0 112.13 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 76.2 p -97.86 -15.92 20.0 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.205 1.402 . . . . 0.0 113.221 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 75.35 -10.36 11.48 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.493 -163.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -69.11 -11.33 60.7 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.868 1.834 . . . . 0.0 112.464 173.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 92.83 15.95 50.31 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.354 0.978 . . . . 0.0 112.749 -159.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 24.6 p -132.63 168.54 18.09 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.402 1.481 . . . . 0.0 110.995 -171.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.7 140.13 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.22 1.408 . . . . 0.0 109.047 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.3 p -112.95 132.11 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.703 1.201 . . . . 0.0 110.973 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.6 ptm -144.31 165.7 27.15 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.964 1.305 . . . . 0.0 112.806 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -130.19 134.8 47.55 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.274 1.03 . . . . 0.0 109.641 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.93 170.45 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.783 1.233 . . . . 0.0 111.46 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.45 137.62 51.92 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.28 2.232 . . . . 0.0 110.001 173.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.78 145.7 32.21 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.936 1.694 . . . . 0.0 107.407 161.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.423 ' HG2' ' H ' ' A' ' 326' ' ' LYS . 63.4 Cg_endo -102.83 -70.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 123.208 2.605 . . . . 0.0 115.228 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -143.81 175.56 9.91 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.602 1.561 . . . . 0.0 111.759 -174.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.32 -15.07 0.09 OUTLIER Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.549 2.499 . . . . 0.0 118.358 165.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -112.13 92.05 17.5 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 119.135 1.468 . . . . 0.0 112.768 -165.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.28 116.3 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.832 1.688 . . . . 0.0 108.078 154.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 5.6 p -154.68 157.59 38.33 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.639 -0.663 . . . . 0.0 112.281 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -75.58 140.62 42.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.625 1.57 . . . . 0.0 109.505 165.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 20.5 pt -64.06 121.83 73.9 Favored Pre-proline 0 CA--C 1.557 1.215 0 CA-C-N 119.211 0.914 . . . . 0.0 111.447 -174.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -109.04 85.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.36 2.707 . . . . 0.0 114.471 -164.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 23.3 t -119.54 104.09 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.285 -0.884 . . . . 0.0 110.045 171.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.9 160.31 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.662 1.585 . . . . 0.0 110.2 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -136.27 105.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.591 1.556 . . . . 0.0 108.153 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -122.36 158.37 29.78 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.611 1.165 . . . . 0.0 114.071 -163.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.65 -10.38 59.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.504 2.321 . . . . 0.0 112.875 169.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -137.71 150.72 47.54 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.173 1.389 . . . . 0.0 112.462 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 28.8 mt -63.45 -16.4 60.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.623 1.569 . . . . 0.0 114.721 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.2 t -109.2 7.42 25.41 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.824 -177.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 35.28 65.01 0.41 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 128.502 2.721 . . . . 0.0 114.211 -168.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -75.35 -40.93 57.68 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.426 1.09 . . . . 0.0 111.394 159.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 7.8 mm -99.74 169.85 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 125.3 1.44 . . . . 0.0 109.387 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -146.04 116.98 7.74 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.444 -1.41 . . . . 0.0 112.009 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -98.62 -27.16 14.13 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.345 1.858 . . . . 0.0 113.294 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -95.58 -174.53 36.95 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 -173.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.3 mt -124.51 134.91 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.617 1.967 . . . . 0.0 110.102 -174.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.0 mt -70.49 121.52 17.95 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.14 0.976 . . . . 0.0 109.364 162.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.78 -42.64 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.54 0.736 . . . . 0.0 109.914 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 38.6 m -69.96 153.52 43.14 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.143 0.497 . . . . 0.0 110.411 166.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.5 t -56.09 152.75 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.129 1.372 . . . . 0.0 110.346 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -113.16 82.73 5.75 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.16 0.984 . . . . 0.0 111.845 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.46 -168.87 0.68 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 125.27 3.98 . . . . 0.0 112.693 169.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 36.0 pt -93.0 167.37 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.982 1.713 . . . . 0.0 111.89 167.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.82 111.18 2.69 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 152.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 88.5 p -76.09 -45.07 35.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.052 1.341 . . . . 0.0 111.758 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.43 151.52 22.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.044 1.337 . . . . 0.0 108.735 158.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -59.31 -20.33 53.56 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 170.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -101.94 10.9 39.33 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.636 1.574 . . . . 0.0 112.956 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -58.89 152.28 19.79 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.208 -1.557 . . . . 0.0 113.632 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -133.81 83.35 2.04 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.344 1.058 . . . . 0.0 113.096 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 25.9 t -90.47 152.13 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.943 1.697 . . . . 0.0 112.037 -166.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 25.8 tp -109.17 131.39 55.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 129.024 2.93 . . . . 0.0 110.35 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.5 mp -143.2 132.51 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.278 1.431 . . . . 0.0 111.424 -167.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -92.82 135.04 34.48 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.914 1.286 . . . . 0.0 111.597 157.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.59 155.26 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.789 1.235 . . . . 0.0 111.31 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -111.92 108.11 55.77 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.157 1.783 . . . . 0.0 110.925 -173.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.21 119.17 4.15 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.984 3.123 . . . . 0.0 111.031 160.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -60.1 169.24 5.06 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.413 2.742 . . . . 0.0 113.091 167.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -53.56 138.21 34.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.357 1.063 . . . . 0.0 112.277 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.21 -142.34 15.58 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.775 0.702 . . . . 0.0 112.584 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -75.99 163.92 26.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.159 0.984 . . . . 0.0 112.69 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 18.0 m -175.47 167.3 3.29 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.885 2.074 . . . . 0.0 111.192 161.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -133.66 126.51 30.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.661 1.984 . . . . 0.0 108.098 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.6 mm -81.76 129.04 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.03 141.05 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.222 1.009 . . . . 0.0 109.565 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 95.7 t -115.73 113.47 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.806 1.642 . . . . 0.0 108.929 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 96.22 -177.54 33.78 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 122.205 0.892 . . . . 0.0 115.155 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.7 m -133.26 159.3 40.63 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.232 1.813 . . . . 0.0 110.154 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.16 -174.82 54.39 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.866 0.746 . . . . 0.0 113.237 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -54.04 -24.63 17.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.588 1.555 . . . . 0.0 114.354 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 66.9 m -80.8 -4.1 53.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.714 2.006 . . . . 0.0 113.986 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -73.65 128.85 36.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.671 1.123 . . . . 0.0 112.295 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 23.9 mt -100.3 170.03 8.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.113 0.965 . . . . 0.0 111.232 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.8 t -145.92 162.45 37.75 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -148.12 127.86 13.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.12 2.168 . . . . 0.0 108.273 169.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -73.56 137.28 44.23 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.252 -0.905 . . . . 0.0 111.783 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -141.54 133.26 27.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.442 1.097 . . . . 0.0 109.172 166.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -124.77 153.71 42.03 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 41.1 tptt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 121.786 0.803 . . . . 0.0 111.994 -160.038 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 15.9 m -104.34 4.27 33.35 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.9 -49.23 78.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.062 0.945 . . . . 0.0 111.995 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.2 tt -71.13 132.98 45.85 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.256 -0.903 . . . . 0.0 108.837 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.7 t -56.86 169.79 0.48 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.171 1.788 . . . . 0.0 115.076 -168.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.23 104.59 0.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.601 1.56 . . . . 0.0 111.392 -168.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' A' ' 295' ' ' THR . 0.7 OUTLIER -59.97 135.98 57.87 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.64 1.176 . . . . 0.0 111.458 -169.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 62.33 -23.23 0.07 OUTLIER Glycine 0 CA--C 1.541 1.69 0 C-N-CA 126.975 2.226 . . . . 0.0 115.74 -170.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 293' ' ' LYS . 9.2 m -94.63 3.08 55.53 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 130.164 3.386 . . . . 0.0 111.037 -172.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.7 m -163.34 159.69 22.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 119.83 -1.794 . . . . 0.0 111.907 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -87.0 175.33 8.18 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.899 1.28 . . . . 0.0 113.432 -171.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -72.64 159.43 33.87 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.067 1.347 . . . . 0.0 114.498 -171.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 18.0 mmt -75.28 157.4 34.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.693 1.997 . . . . 0.0 111.702 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.1 m -75.53 144.76 41.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.472 -0.768 . . . . 0.0 110.776 172.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 8.3 p -131.87 5.55 4.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.34 167.18 22.16 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.374 0.988 . . . . 0.0 109.792 161.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -68.77 101.29 1.3 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.089 1.355 . . . . 0.0 112.022 -161.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 24.7 mtp -86.53 168.48 13.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.056 0.931 . . . . 0.0 112.969 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.3 m -161.08 160.99 31.1 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.686 1.194 . . . . 0.0 110.866 165.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.31 112.92 18.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.401 0.68 . . . . 0.0 110.126 168.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.3 t -63.26 -35.16 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.417 1.487 . . . . 0.0 110.24 163.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -133.78 123.99 25.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.448 1.499 . . . . 0.0 108.183 165.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -60.42 152.79 63.36 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.72 0.808 . . . . 0.0 111.475 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.35 133.29 45.41 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.133 1.889 . . . . 0.0 110.956 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.9 m -136.19 137.06 40.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.739 1.215 . . . . 0.0 109.183 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.401 ' CG ' ' HZ3' ' A' ' 391' ' ' LYS . 3.5 t70 -70.08 139.5 52.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.298 0.639 . . . . 0.0 112.454 -175.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.6 p -88.94 -13.08 39.84 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.053 0.941 . . . . 0.0 113.346 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.27 -3.07 3.59 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 119.319 0.963 . . . . 0.0 114.408 -164.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -96.66 10.94 37.11 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.811 1.645 . . . . 0.0 111.519 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 96.98 13.12 47.43 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.179 1.371 . . . . 0.0 114.248 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.6 p -138.13 163.96 30.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.574 1.187 . . . . 0.0 112.225 -170.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.19 132.37 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.489 1.516 . . . . 0.0 109.653 167.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.41 132.47 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.276 1.43 . . . . 0.0 111.693 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.0 ptm -148.37 166.18 28.84 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.342 1.457 . . . . 0.0 113.104 -175.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -136.12 139.44 42.95 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.643 1.177 . . . . 0.0 109.097 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.42 155.92 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.341 1.056 . . . . 0.0 111.474 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -111.76 133.07 54.23 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.876 1.271 . . . . 0.0 112.189 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.39 131.7 21.64 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.148 1.379 . . . . 0.0 107.891 160.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' A' ' 326' ' ' LYS . 94.7 Cg_endo -94.44 -67.77 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.097 2.531 . . . . 0.0 114.891 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -145.82 176.65 9.51 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.546 1.938 . . . . 0.0 110.552 -177.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.29 -14.74 0.09 OUTLIER Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.788 2.137 . . . . 0.0 118.14 169.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.54 90.48 39.43 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.265 1.532 . . . . 0.0 112.894 -162.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.93 115.63 4.38 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.114 1.876 . . . . 0.0 108.203 156.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.4 p -152.25 157.4 41.37 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -172.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.68 130.71 38.15 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.206 1.802 . . . . 0.0 108.973 165.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 15.2 pt -60.4 114.96 11.4 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-N 118.572 0.624 . . . . 0.0 111.837 -166.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -100.16 87.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.569 2.846 . . . . 0.0 114.333 -160.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 44.2 t -112.09 128.75 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 167.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.05 155.08 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.442 1.097 . . . . 0.0 110.619 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.3 t -130.1 117.33 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.19 1.796 . . . . 0.0 107.364 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -126.62 165.78 18.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.126 0.97 . . . . 0.0 113.315 -166.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -83.61 -8.19 59.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.078 1.751 . . . . 0.0 112.382 162.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -137.3 137.46 39.0 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.401 1.48 . . . . 0.0 111.235 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.13 -20.6 41.59 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -97.79 3.16 50.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.563 1.945 . . . . 0.0 113.673 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 39.21 69.47 0.28 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.963 2.905 . . . . 0.0 115.525 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.19 -34.55 16.62 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.035 1.334 . . . . 0.0 112.116 158.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 35.4 mm -96.78 153.14 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.43 1.092 . . . . 0.0 109.37 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.71 103.21 6.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.553 1.541 . . . . 0.0 109.062 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -94.22 -51.57 4.75 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.663 2.385 . . . . 0.0 113.019 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -82.91 -164.93 36.49 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 -169.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.2 140.68 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 127.374 2.27 . . . . 0.0 109.856 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.51 118.54 14.46 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.563 1.145 . . . . 0.0 109.528 161.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 35.1 t -94.7 -51.04 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 122.831 0.453 . . . . 0.0 110.472 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 36.9 m -70.14 157.48 37.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.102 0.477 . . . . 0.0 110.329 171.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.5 m -52.0 147.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.519 1.128 . . . . 0.0 111.916 171.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -123.0 77.69 50.8 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 123.914 0.886 . . . . 0.0 111.209 -174.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -83.29 -173.15 1.56 Allowed 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 124.872 3.714 . . . . 0.0 112.499 170.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 47.9 pt -84.67 165.75 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.66 1.184 . . . . 0.0 112.15 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.76 124.83 23.49 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 156.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 95.6 p -66.66 -29.83 69.94 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.621 0.768 . . . . 0.0 112.801 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 11.7 m -143.86 153.25 42.15 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.832 2.453 . . . . 0.0 106.983 -168.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.33 -21.01 61.54 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.926 -1.109 . . . . 0.0 113.646 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -95.26 4.11 53.84 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.81 2.444 . . . . 0.0 112.929 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -63.29 157.99 21.43 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.236 -1.54 . . . . 0.0 113.872 -171.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -150.69 86.27 1.39 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.86 149.58 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.886 1.274 . . . . 0.0 112.134 -167.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -92.91 126.06 37.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 129.95 3.3 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.2 mp -138.89 141.56 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.462 1.505 . . . . 0.0 110.768 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.47 141.63 32.0 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.131 1.372 . . . . 0.0 112.198 160.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.68 156.65 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.26 1.024 . . . . 0.0 111.418 168.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -113.05 114.3 48.86 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.381 1.472 . . . . 0.0 110.717 -172.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -85.27 160.82 11.31 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.753 2.969 . . . . 0.0 111.446 163.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -74.12 175.99 10.16 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.842 2.362 . . . . 0.0 110.476 160.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -61.59 142.68 56.96 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.653 -0.654 . . . . 0.0 110.635 159.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.96 -146.83 20.01 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 122.128 -0.358 . . . . 0.0 113.055 -173.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -61.81 145.37 52.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.961 2.105 . . . . 0.0 114.522 -171.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 28.9 m -167.64 162.08 13.92 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.491 1.917 . . . . 0.0 112.041 158.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -130.84 128.03 39.81 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.346 1.458 . . . . 0.0 108.46 169.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 29.3 mm -94.95 120.8 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.422 1.489 . . . . 0.0 108.274 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.2 144.95 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.433 1.093 . . . . 0.0 109.492 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.29 116.19 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.456 1.502 . . . . 0.0 109.332 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 89.76 -178.83 44.14 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 122.548 1.082 . . . . 0.0 114.614 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 92.7 m -127.6 164.12 22.71 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.979 1.312 . . . . 0.0 109.852 172.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 80.64 -173.57 54.78 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 121.855 0.697 . . . . 0.0 112.996 -174.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -23.83 66.45 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.956 1.302 . . . . 0.0 112.762 173.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.4 m -63.62 -10.53 19.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 170.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -78.36 125.49 29.43 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.078 1.308 . . . . 0.0 113.146 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 4.4 mt -88.19 162.24 16.79 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.071 -0.393 . . . . 0.0 111.167 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.8 t -142.43 149.04 38.76 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.883 1.273 . . . . 0.0 111.497 -174.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -151.65 126.68 9.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.731 1.612 . . . . 0.0 110.434 -177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -73.28 128.91 36.82 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.28 -0.888 . . . . 0.0 111.442 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -136.39 125.26 24.1 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.282 0.633 . . . . 0.0 110.298 167.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.27 122.76 32.44 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' LYS . . . . . 0.401 ' HZ3' ' CG ' ' A' ' 312' ' ' ASP . 7.4 ttmm . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 124.144 0.978 . . . . 0.0 111.394 -169.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.1 p -86.19 -7.27 58.68 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -53.21 -49.98 65.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.117 0.967 . . . . 0.0 112.923 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 22.3 tp -73.59 127.46 32.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.56 -0.712 . . . . 0.0 109.537 163.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.3 t -53.31 171.04 0.08 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -164.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.53 111.88 2.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.617 2.367 . . . . 0.0 111.753 -170.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -61.63 107.54 0.83 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.863 2.465 . . . . 0.0 111.725 -167.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 82.01 0.04 89.1 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.53 1.062 . . . . 0.0 114.5 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 89.1 m -117.88 5.1 12.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.381 1.872 . . . . 0.0 110.965 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.0 m -157.25 156.19 32.08 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 119.51 -1.994 . . . . 0.0 114.027 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -82.92 178.45 8.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.109 2.164 . . . . 0.0 113.328 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -73.48 160.76 31.24 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.524 1.53 . . . . 0.0 114.381 -170.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.15 147.74 32.58 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.248 2.619 . . . . 0.0 111.675 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.59 138.68 56.63 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.526 -0.734 . . . . 0.0 110.733 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.5 p -132.31 14.3 4.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.264 1.026 . . . . 0.0 113.263 172.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -81.45 170.87 15.41 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 118.676 0.671 . . . . 0.0 109.212 159.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -62.06 103.86 0.41 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.052 1.741 . . . . 0.0 111.777 -166.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 25.8 mtp -91.14 165.89 13.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 122.384 1.088 . . . . 0.0 112.142 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 30.7 m -161.94 164.72 28.32 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.049 1.34 . . . . 0.0 109.892 166.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.6 127.48 34.09 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 164.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.85 -32.57 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 159.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -133.84 119.89 19.76 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.647 1.579 . . . . 0.0 109.259 167.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -58.9 150.85 57.95 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.913 1.685 . . . . 0.0 112.063 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -62.8 131.27 32.43 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.535 2.157 . . . . 0.0 110.908 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.56 140.11 46.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.083 0.953 . . . . 0.0 109.691 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.31 132.09 52.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.036 0.934 . . . . 0.0 112.303 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 74.6 p -84.9 -13.7 50.03 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.02 1.328 . . . . 0.0 114.121 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 398' ' ' LYS . . . 70.36 18.45 75.22 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.262 -0.743 . . . . 0.0 114.624 -162.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.24 16.16 8.38 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.872 1.336 . . . . 0.0 112.448 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.86 11.76 73.03 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.396 -0.815 . . . . 0.0 113.53 -176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 40.6 p -134.08 161.21 35.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.139 1.375 . . . . 0.0 110.942 -168.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.14 132.92 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.265 1.026 . . . . 0.0 109.614 172.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.14 136.1 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.835 1.254 . . . . 0.0 112.121 -170.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 14.5 ptm -151.01 165.64 33.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.498 1.519 . . . . 0.0 114.012 -172.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -132.07 121.57 24.04 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.767 2.427 . . . . 0.0 107.333 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.5 m -112.99 158.12 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.88 0.872 . . . . 0.0 111.589 -172.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -125.12 143.94 50.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.235 1.014 . . . . 0.0 113.426 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.58 151.16 51.37 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.637 2.375 . . . . 0.0 107.89 167.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -119.89 -60.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.627 2.218 . . . . 0.0 115.877 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 175.48 9.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.476 1.11 . . . . 0.0 112.248 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.57 -15.44 0.1 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.459 2.456 . . . . 0.0 118.638 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.83 92.59 49.03 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.635 1.717 . . . . 0.0 114.181 -159.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.28 124.59 10.07 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.816 1.677 . . . . 0.0 108.388 155.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.0 p -153.84 155.78 36.4 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.463 -0.773 . . . . 0.0 112.44 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -78.46 128.53 33.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.159 1.384 . . . . 0.0 107.785 161.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.7 pp -61.82 115.58 16.22 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -164.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -95.17 94.66 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.362 3.375 . . . . 0.0 113.852 -170.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 32.3 t -124.48 109.17 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.719 -0.613 . . . . 0.0 109.955 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.12 159.32 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.483 1.513 . . . . 0.0 110.984 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 83.8 t -131.81 117.36 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 126.51 1.924 . . . . 0.0 106.412 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.55 165.37 20.89 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -165.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -86.07 -8.65 57.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.271 1.829 . . . . 0.0 112.922 163.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -130.19 142.04 50.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.62 1.168 . . . . 0.0 110.914 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.74 -21.85 56.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.991 1.316 . . . . 0.0 113.726 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.7 t -105.6 5.92 31.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.55 1.94 . . . . 0.0 113.903 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 45.02 69.71 0.41 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.708 2.803 . . . . 0.0 116.184 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -82.8 -37.49 24.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.937 0.895 . . . . 0.0 111.861 153.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 36.4 mm -88.98 155.52 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.924 1.289 . . . . 0.0 110.449 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -134.46 93.55 3.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.179 1.791 . . . . 0.0 109.621 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -101.57 -28.16 12.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.832 2.053 . . . . 0.0 114.696 -169.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -99.78 179.96 30.41 Favored Glycine 0 N--CA 1.477 1.368 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -171.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 4.5 mt -117.61 135.51 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.537 2.335 . . . . 0.0 110.168 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.88 132.09 44.74 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.111 0.564 . . . . 0.0 110.319 165.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.06 -49.94 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.2 m -80.41 162.72 24.32 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.607 0.718 . . . . 0.0 110.66 167.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.4 m -63.31 165.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.112 1.765 . . . . 0.0 114.519 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -117.36 81.47 13.74 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.697 1.599 . . . . 0.0 110.917 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.09 -166.95 0.45 Allowed 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 124.412 3.408 . . . . 0.0 112.865 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.9 pt -104.37 169.81 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.284 1.833 . . . . 0.0 110.793 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.07 113.45 8.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.753 0.421 . . . . 0.0 110.099 158.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 82.4 p -73.32 -23.03 60.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.295 1.438 . . . . 0.0 113.361 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 77.4 p -135.0 165.23 25.83 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.946 2.099 . . . . 0.0 108.788 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -63.73 -21.2 66.29 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.018 -1.052 . . . . 0.0 113.471 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -100.39 9.22 42.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.695 1.598 . . . . 0.0 112.567 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -59.18 156.58 11.96 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.812 1.291 . . . . 0.0 113.508 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -148.35 98.72 2.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.982 1.313 . . . . 0.0 112.343 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 53.0 t -92.81 149.55 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.39 1.476 . . . . 0.0 110.438 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.27 124.28 49.27 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.53 2.732 . . . . 0.0 108.697 -174.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.58 136.37 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.671 0.788 . . . . 0.0 111.825 -170.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -95.75 136.54 36.03 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.424 1.49 . . . . 0.0 111.563 152.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.02 154.95 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.212 1.005 . . . . 0.0 111.333 166.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -116.57 113.15 40.67 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.774 2.03 . . . . 0.0 109.779 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -81.09 167.35 18.01 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.949 2.432 . . . . 0.0 111.357 164.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -69.63 173.5 10.76 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.436 2.091 . . . . 0.0 110.773 163.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -62.13 144.74 54.94 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.872 -0.518 . . . . 0.0 110.533 162.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.67 -155.57 18.34 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.782 0.706 . . . . 0.0 111.979 -170.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.58 161.06 21.29 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.459 1.123 . . . . 0.0 112.681 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 49.2 m -160.96 159.29 29.35 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.465 -1.397 . . . . 0.0 111.075 161.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.55 115.07 23.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 29.4 mm -89.59 117.02 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.664 1.586 . . . . 0.0 108.09 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.75 141.48 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.699 0.799 . . . . 0.0 110.707 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 99.4 t -116.24 109.27 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.412 1.885 . . . . 0.0 108.173 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 112.58 -177.35 18.36 Favored Glycine 0 N--CA 1.471 0.991 0 N-CA-C 116.241 1.256 . . . . 0.0 116.241 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 99.5 m -138.07 167.39 21.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.963 1.705 . . . . 0.0 109.282 165.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.21 -174.35 44.34 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 121.732 -0.605 . . . . 0.0 112.537 -169.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.78 -25.79 63.43 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.104 0.962 . . . . 0.0 113.435 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.8 m -75.4 -1.26 23.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.451 2.3 . . . . 0.0 114.846 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -79.88 133.59 36.25 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.748 0.819 . . . . 0.0 111.995 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.7 mt -102.84 163.65 12.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.258 0.623 . . . . 0.0 111.27 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 t -137.84 148.51 45.5 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.72 1.208 . . . . 0.0 112.001 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -146.0 131.07 18.29 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.484 1.514 . . . . 0.0 110.277 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -82.11 136.25 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.279 1.031 . . . . 0.0 111.301 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -134.95 154.45 51.7 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.069 0.938 . . . . 0.0 112.675 166.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -124.62 140.9 52.51 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.683 1.593 . . . . 0.0 107.942 165.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -123.64 125.72 45.31 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.381 1.872 . . . . 0.0 108.67 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -57.69 165.8 1.56 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.557 1.943 . . . . 0.0 112.247 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -67.65 148.4 49.53 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 121.959 0.755 . . . . 0.0 113.24 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 50.9 m -58.37 -9.86 1.79 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.769 1.228 . . . . 0.0 114.044 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 58.4 p -65.08 -17.72 64.7 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.579 1.952 . . . . 0.0 114.568 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.15 -26.17 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.565 1.075 . . . . 0.0 113.458 172.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.11 46.24 93.72 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 118.831 0.742 . . . . 0.0 114.853 168.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.456 ' HE2' ' HA2' ' A' ' 314' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 C-N-CA 125.605 1.562 . . . . 0.0 110.934 170.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 3.8 m -97.44 5.35 49.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -171.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -71.96 -43.72 64.71 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.165 1.348 . . . . 0.0 112.755 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.1 136.11 56.33 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 165.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 t -54.56 163.94 0.82 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.36 97.06 1.96 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.869 1.668 . . . . 0.0 111.105 -164.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -46.72 133.55 10.47 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.904 2.482 . . . . 0.0 112.328 -171.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.02 -36.94 1.07 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.035 1.302 . . . . 0.0 114.561 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 10.3 p -72.75 -26.46 61.56 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 118.777 1.288 . . . . 0.0 114.246 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.0 m -134.29 150.6 51.0 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.574 0.75 . . . . 0.0 112.462 -152.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -79.94 175.36 10.7 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.287 1.435 . . . . 0.0 112.927 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.31 154.0 42.4 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -71.09 146.35 49.3 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.046 2.139 . . . . 0.0 112.358 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 8.4 m -63.48 143.06 58.13 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.682 -0.636 . . . . 0.0 112.266 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.3 p -135.45 11.44 3.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.641 1.176 . . . . 0.0 113.525 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.495 ' CG ' ' HZ2' ' A' ' 326' ' ' LYS . 45.8 t0 -71.97 168.98 16.87 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.219 0.918 . . . . 0.0 109.648 161.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -65.36 97.19 0.27 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.424 -0.797 . . . . 0.0 111.899 -172.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 42.7 mtp -86.17 168.0 14.4 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.366 1.079 . . . . 0.0 112.762 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 39.2 m -160.89 163.63 31.83 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.053 1.341 . . . . 0.0 109.963 161.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.82 121.76 25.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.654 0.381 . . . . 0.0 110.119 167.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.01 -29.85 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.267 1.027 . . . . 0.0 110.335 165.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -141.52 132.74 26.42 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.147 1.779 . . . . 0.0 109.303 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -64.81 150.43 94.65 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.379 1.072 . . . . 0.0 112.148 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -62.77 130.88 30.97 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.986 1.791 . . . . 0.0 110.646 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 65.2 p -131.27 137.84 49.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.964 1.306 . . . . 0.0 110.626 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -63.16 126.14 26.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.589 1.556 . . . . 0.0 112.333 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.8 p -70.61 -25.86 63.24 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.95 0.5 . . . . 0.0 111.281 166.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 82.39 -6.17 69.72 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.503 1.525 . . . . 0.0 113.845 -168.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -92.86 18.99 8.14 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.707 1.603 . . . . 0.0 111.37 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 91.9 2.78 68.87 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.738 1.161 . . . . 0.0 115.039 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 28.3 p -127.35 158.56 36.93 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.496 1.648 . . . . 0.0 112.55 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.02 129.78 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.778 1.631 . . . . 0.0 109.611 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.4 p -114.83 130.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.465 1.106 . . . . 0.0 113.085 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.4 ptm -137.97 171.25 14.7 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.809 2.443 . . . . 0.0 111.919 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -135.44 139.45 44.12 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.629 -0.669 . . . . 0.0 109.89 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.93 149.46 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.261 1.024 . . . . 0.0 111.948 -170.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -109.03 137.67 46.58 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.272 1.429 . . . . 0.0 112.833 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.1 t -117.07 133.88 23.08 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 126.977 2.111 . . . . 0.0 107.596 166.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -96.39 -74.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 123.186 2.591 . . . . 0.0 116.984 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.495 ' HZ2' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -151.92 146.15 25.42 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 -169.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 76.72 4.55 81.89 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 115.66 1.024 . . . . 0.0 115.66 171.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.25 99.13 43.52 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.843 1.257 . . . . 0.0 111.531 -172.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.66 130.03 14.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.327 2.018 . . . . 0.0 108.884 167.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.8 p -159.98 156.13 26.6 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -75.32 137.8 41.37 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.481 1.913 . . . . 0.0 108.429 162.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.77 124.55 88.83 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-N 118.29 0.495 . . . . 0.0 112.051 -169.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -107.35 96.13 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.423 2.749 . . . . 0.0 115.723 -165.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 69.3 t -124.89 124.55 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.39 -0.818 . . . . 0.0 109.473 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.34 154.7 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.572 1.549 . . . . 0.0 110.179 -174.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.22 105.06 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.222 1.409 . . . . 0.0 109.271 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -120.63 160.59 22.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.992 1.317 . . . . 0.0 113.865 -163.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.29 -17.12 46.97 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.747 1.619 . . . . 0.0 112.378 164.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -122.7 133.39 54.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.99 1.316 . . . . 0.0 110.929 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -56.76 -19.45 17.02 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.136 1.775 . . . . 0.0 113.108 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.2 t -101.62 4.51 40.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.665 2.386 . . . . 0.0 113.733 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 37.91 74.28 0.09 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 130.534 3.534 . . . . 0.0 117.326 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -105.52 -16.53 14.69 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.937 1.695 . . . . 0.0 112.83 160.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 64.4 mt -109.45 146.29 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.744 1.618 . . . . 0.0 107.62 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.27 112.83 11.36 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.909 -1.119 . . . . 0.0 111.397 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -104.39 -21.53 13.47 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.07 -168.92 42.11 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 118.716 0.689 . . . . 0.0 114.424 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 65.3 mt -134.44 135.4 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.276 1.831 . . . . 0.0 110.528 -174.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.61 118.57 10.38 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.723 1.209 . . . . 0.0 109.333 160.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.62 -29.54 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.666 0.786 . . . . 0.0 112.342 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.8 m -77.38 153.34 33.79 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.056 0.844 . . . . 0.0 109.737 153.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.5 m -60.96 161.81 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.007 1.323 . . . . 0.0 113.598 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -121.85 78.68 40.37 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.023 1.329 . . . . 0.0 111.466 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.39 -168.04 0.57 Allowed 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 124.404 3.402 . . . . 0.0 113.078 171.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 29.3 pt -95.08 164.46 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.211 1.804 . . . . 0.0 111.27 166.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.92 110.01 3.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 160.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.3 t -76.46 -3.0 34.9 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 90.8 m -153.56 157.07 39.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.026 2.53 . . . . 0.0 104.816 161.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -18.04 50.43 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.559 -1.338 . . . . 0.0 114.148 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.51 8.6 30.24 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.683 2.393 . . . . 0.0 113.479 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -60.57 156.88 15.46 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.226 -1.547 . . . . 0.0 114.099 -173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . 0.25 9.4 pt-20 -146.47 80.79 1.56 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 22.2 t -85.55 145.74 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.041 1.336 . . . . 0.0 112.363 -167.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.02 120.19 39.84 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 129.837 3.255 . . . . 0.0 109.108 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.1 mp -137.72 132.55 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.594 1.557 . . . . 0.0 111.125 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 142.6 29.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.004 0.907 . . . . 0.0 112.219 159.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.55 161.5 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.562 1.545 . . . . 0.0 110.522 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -117.94 108.99 41.7 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.746 1.619 . . . . 0.0 109.346 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.6 154.86 44.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.533 2.155 . . . . 0.0 110.638 163.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.29 175.66 10.27 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.224 1.949 . . . . 0.0 110.232 165.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -62.13 133.61 55.47 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.491 -0.756 . . . . 0.0 110.288 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.74 -149.43 16.6 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.564 1.078 . . . . 0.0 113.56 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.23 149.89 47.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.435 2.294 . . . . 0.0 113.172 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.9 m -163.88 153.78 14.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.988 1.315 . . . . 0.0 113.618 162.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -118.58 116.9 27.58 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.554 1.141 . . . . 0.0 108.679 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 27.5 mm -80.74 117.75 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.209 1.403 . . . . 0.0 107.561 174.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.4 mp -111.87 144.11 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.357 0.599 . . . . 0.0 109.946 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 78.6 t -116.02 117.42 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.011 1.724 . . . . 0.0 108.576 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 94.11 -178.66 37.51 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 122.942 1.301 . . . . 0.0 115.213 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 84.6 m -132.28 166.04 22.79 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.277 1.831 . . . . 0.0 109.423 168.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 76.71 -175.8 53.16 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 121.918 0.732 . . . . 0.0 113.663 -176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.22 -21.78 9.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.343 1.857 . . . . 0.0 114.454 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.1 m -86.47 -4.89 59.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.425 2.29 . . . . 0.0 114.61 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -73.72 137.91 44.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.55 1.068 . . . . 0.0 112.446 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 11.1 mt -106.41 162.94 13.26 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.748 0.819 . . . . 0.0 111.571 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.9 t -132.22 154.45 49.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.766 1.226 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -148.99 131.85 16.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.124 2.17 . . . . 0.0 108.9 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -81.64 134.84 35.52 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.928 -1.108 . . . . 0.0 111.597 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -133.23 146.73 51.72 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.297 0.639 . . . . 0.0 109.916 162.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.95 137.86 49.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 172.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -124.75 129.85 51.28 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.548 1.139 . . . . 0.0 110.531 -168.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.61 167.75 9.53 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.557 1.143 . . . . 0.0 111.207 172.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -84.05 23.98 6.5 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 118.426 -1.208 . . . . 0.0 115.172 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.7 p -117.47 -38.9 3.24 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.291 1.545 . . . . 0.0 112.219 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 3.0 m -73.6 46.69 0.22 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.123 1.369 . . . . 0.0 111.574 167.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.3 tp -117.42 -25.38 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 127.651 2.38 . . . . 0.0 112.477 -174.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -146.08 24.14 1.75 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.741 1.639 . . . . 0.0 113.151 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.522 ' C ' ' HZ1' ' A' ' 398' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.248 1.819 . . . . 0.0 108.857 172.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 3.3 m -65.31 0.11 1.57 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.7 -23.58 66.8 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.559 1.527 . . . . 0.0 114.138 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 49.0 tp -85.68 128.2 34.71 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.916 1.235 . . . . 0.0 108.968 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.2 t -53.47 158.74 1.65 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -61.47 105.66 0.55 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.1 2.16 . . . . 0.0 110.774 -167.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -63.11 125.22 23.31 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.237 -0.914 . . . . 0.0 111.118 -170.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.89 -50.52 3.01 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.857 1.218 . . . . 0.0 112.842 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 32.1 m -63.94 -0.07 1.01 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.408 2.283 . . . . 0.0 113.432 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.2 m -157.1 154.02 28.75 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 119.024 -2.297 . . . . 0.0 111.725 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -78.01 170.87 15.88 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.816 1.647 . . . . 0.0 113.34 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 152.21 40.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.465 1.106 . . . . 0.0 113.294 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.6 mpp? -62.12 165.78 5.39 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 129.201 3.0 . . . . 0.0 114.314 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -81.15 142.72 32.97 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.281 -0.887 . . . . 0.0 110.545 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.5 p -135.77 18.61 3.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.587 1.155 . . . . 0.0 113.094 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -81.75 161.28 23.37 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 156.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.14 102.25 0.36 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.53 1.532 . . . . 0.0 112.131 -168.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 28.1 mtp -84.64 172.77 11.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.22 1.008 . . . . 0.0 112.837 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.6 m -159.93 167.25 28.44 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.174 -0.954 . . . . 0.0 112.027 166.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.92 117.95 24.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.579 0.752 . . . . 0.0 109.328 167.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.07 -35.26 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.049 0.94 . . . . 0.0 110.015 159.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -135.71 127.07 28.45 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.321 1.448 . . . . 0.0 108.467 165.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -65.15 152.69 90.98 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.467 1.107 . . . . 0.0 111.903 171.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.46 131.08 30.41 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.637 2.225 . . . . 0.0 111.657 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.0 m -136.85 139.61 41.81 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.278 1.031 . . . . 0.0 110.465 174.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -65.16 132.58 49.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.277 1.031 . . . . 0.0 112.549 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 63.9 p -79.62 -21.55 44.76 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.034 1.334 . . . . 0.0 113.49 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 85.08 -9.29 66.89 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.541 1.543 . . . . 0.0 113.696 -162.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -81.66 -7.59 59.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.573 1.187 . . . . 0.0 112.312 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.35 15.23 48.28 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.329 0.966 . . . . 0.0 112.843 -164.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 32.2 p -127.68 155.95 43.13 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.923 1.289 . . . . 0.0 110.907 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 25.6 m -123.18 127.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.889 1.276 . . . . 0.0 109.53 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.69 130.82 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.866 1.266 . . . . 0.0 111.86 -172.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 7.0 ptp -137.74 167.99 20.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.903 2.081 . . . . 0.0 111.082 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -133.11 129.28 37.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.064 0.946 . . . . 0.0 108.964 170.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.22 151.72 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.328 1.051 . . . . 0.0 110.85 -169.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -113.18 131.83 55.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.795 1.238 . . . . 0.0 111.64 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.39 151.07 39.61 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-O 117.062 -1.447 . . . . 0.0 108.531 159.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -111.03 -72.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.184 2.589 . . . . 0.0 115.279 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 172.9 12.5 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.184 -1.573 . . . . 0.0 113.127 -174.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.12 -24.09 0.11 Allowed Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.913 2.197 . . . . 0.0 117.538 170.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -109.0 96.9 22.09 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 125.909 1.684 . . . . 0.0 111.784 -170.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -62.97 133.9 43.65 Favored 'Trans proline' 0 C--N 1.35 0.637 0 N-CA-C 107.675 -1.702 . . . . 0.0 107.675 154.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.4 p -158.88 154.25 25.72 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.315 -0.865 . . . . 0.0 113.234 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -72.39 141.99 48.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.604 157.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.91 123.28 79.28 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 118.986 0.812 . . . . 0.0 111.233 -175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -98.52 72.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.042 3.162 . . . . 0.0 112.694 -168.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.1 t -104.76 130.62 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.87 162.65 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 125.181 1.392 . . . . 0.0 110.586 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.72 120.25 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.988 1.715 . . . . 0.0 107.768 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.89 164.57 22.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -160.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.66 -16.52 36.33 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.453 1.901 . . . . 0.0 113.116 163.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -124.66 138.37 54.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.731 1.212 . . . . 0.0 110.364 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.79 -15.94 14.61 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.8 t -104.28 8.26 36.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.459 1.503 . . . . 0.0 113.877 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 40.32 67.69 0.47 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 129.347 3.059 . . . . 0.0 116.578 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.8 -27.26 23.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.186 0.994 . . . . 0.0 112.574 155.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 56.4 mt -111.86 136.58 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.896 1.678 . . . . 0.0 108.988 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -110.0 98.57 7.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.896 1.278 . . . . 0.0 112.451 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -80.61 -42.68 21.78 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.188 2.595 . . . . 0.0 114.308 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -93.08 -168.55 39.18 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 119.993 1.27 . . . . 0.0 116.261 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.4 mt -125.85 141.76 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.852 2.461 . . . . 0.0 110.071 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.44 136.04 37.53 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.371 1.069 . . . . 0.0 110.4 167.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.56 -40.76 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.031 0.533 . . . . 0.0 112.374 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 27.5 m -72.53 158.63 35.33 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 157.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 10.6 m -55.51 156.2 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.484 1.114 . . . . 0.0 113.095 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -113.82 84.16 8.22 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.325 1.45 . . . . 0.0 109.175 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -81.44 -167.47 0.5 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 124.695 3.597 . . . . 0.0 112.89 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 26.0 pt -95.17 164.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.363 1.865 . . . . 0.0 111.183 166.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -73.77 110.43 8.06 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 154.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.9 p -75.88 -51.82 11.67 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.958 1.303 . . . . 0.0 111.629 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.15 151.14 23.9 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 155.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -57.92 -23.05 51.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.91 9.33 43.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.454 1.502 . . . . 0.0 112.786 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -58.56 153.41 16.26 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.241 -1.537 . . . . 0.0 113.686 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -135.82 84.88 2.12 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.721 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 23.5 t -87.98 142.14 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.248 1.419 . . . . 0.0 111.663 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.89 123.74 35.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.903 2.881 . . . . 0.0 109.409 176.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.95 140.56 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.384 1.474 . . . . 0.0 111.039 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.5 148.24 30.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.3 1.047 . . . . 0.0 112.933 161.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.6 m -131.07 155.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.679 1.592 . . . . 0.0 110.678 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -109.51 106.12 58.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.999 2.12 . . . . 0.0 109.361 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.73 146.96 30.7 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.228 1.952 . . . . 0.0 110.346 161.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.2 170.12 18.99 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.454 2.103 . . . . 0.0 111.009 167.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -55.03 140.89 36.26 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.526 1.131 . . . . 0.0 111.483 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.35 -148.3 18.83 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -171.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -79.93 162.03 25.19 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.489 1.116 . . . . 0.0 112.452 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 17.6 m -164.25 155.41 15.65 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.773 -1.205 . . . . 0.0 111.961 156.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -113.56 112.0 22.82 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.5 mm -78.9 119.49 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.651 1.181 . . . . 0.0 107.86 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -113.37 140.98 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.522 0.729 . . . . 0.0 109.886 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.4 t -120.01 107.04 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 125.421 1.488 . . . . 0.0 108.468 172.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 119.49 -176.34 16.09 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.251 1.405 . . . . 0.0 115.574 172.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 54.7 m -138.76 161.9 36.06 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.426 1.49 . . . . 0.0 109.267 164.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.49 -172.17 50.79 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 121.86 0.7 . . . . 0.0 112.762 -169.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -29.23 11.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.24 1.816 . . . . 0.0 113.647 173.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.7 m -72.29 -4.43 29.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 128.739 2.815 . . . . 0.0 114.693 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -84.96 122.28 28.99 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.04 0.837 . . . . 0.0 112.564 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 29.6 mt -87.06 161.08 18.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.25 0.62 . . . . 0.0 111.327 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.7 t -141.29 145.33 35.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.996 1.318 . . . . 0.0 111.737 -173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -153.75 115.18 4.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.924 1.29 . . . . 0.0 110.775 -171.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.8 135.01 47.86 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.861 -1.149 . . . . 0.0 112.152 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -124.37 166.85 15.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.441 1.096 . . . . 0.0 110.977 157.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.84 138.33 37.41 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.471 1.508 . . . . 0.0 108.011 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -122.67 119.54 31.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.224 1.41 . . . . 0.0 110.784 -173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.85 161.86 13.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.897 2.479 . . . . 0.0 112.117 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -75.43 42.06 1.43 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.067 1.317 . . . . 0.0 114.03 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.7 -63.84 0.47 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.413 1.485 . . . . 0.0 112.721 -173.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.0 m -83.42 56.4 3.56 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.927 1.691 . . . . 0.0 111.066 -174.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 6.3 tt -143.9 70.92 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.979 1.711 . . . . 0.0 110.661 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 146.43 2.18 0.6 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.926 1.25 . . . . 0.0 115.409 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.485 ' HZ3' ' C ' ' A' ' 398' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.739 1.616 . . . . 0.0 109.389 172.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 118.682 -0.675 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 12.1 m -98.14 0.44 45.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -171.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.52 71.24 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.64 1.109 . . . . 0.0 112.353 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.9 tt -66.57 118.18 9.8 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.2 t -55.09 173.03 0.1 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.141 2.176 . . . . 0.0 116.368 -164.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -60.97 106.36 0.58 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.5 1.92 . . . . 0.0 111.727 -172.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -71.06 141.54 50.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.414 1.486 . . . . 0.0 111.74 -171.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.74 -59.49 1.3 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.292 1.425 . . . . 0.0 113.393 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 14.6 t -68.05 16.38 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.962 2.105 . . . . 0.0 115.213 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 10.0 m -163.69 165.55 23.15 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 120.233 -1.542 . . . . 0.0 112.945 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -86.66 169.23 12.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.781 1.232 . . . . 0.0 113.865 -172.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -70.52 159.18 34.76 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.76 1.624 . . . . 0.0 115.048 -166.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 54.5 mtt -77.23 151.11 35.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.161 2.184 . . . . 0.0 112.062 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.8 m -69.51 142.78 53.62 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.725 -0.609 . . . . 0.0 111.968 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 20.3 p -131.5 7.72 4.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.389 1.076 . . . . 0.0 113.651 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.476 ' CG ' ' HZ3' ' A' ' 326' ' ' LYS . 45.6 t0 -72.54 159.66 33.55 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.523 1.056 . . . . 0.0 109.984 160.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -63.87 100.47 0.3 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.907 1.683 . . . . 0.0 110.984 -168.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 17.2 mtp -83.83 172.99 11.64 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 122.318 1.056 . . . . 0.0 113.604 -169.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.2 m -155.5 172.5 18.14 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.873 0.869 . . . . 0.0 111.372 161.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.58 121.56 42.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.188 0.995 . . . . 0.0 109.765 164.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 27.1 t -63.77 -36.89 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.003 1.321 . . . . 0.0 109.798 167.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -137.92 126.54 23.63 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.23 1.412 . . . . 0.0 109.836 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -62.96 152.19 84.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.618 1.167 . . . . 0.0 112.217 172.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -62.06 131.86 36.66 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.392 2.062 . . . . 0.0 111.647 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 48.1 p -128.56 132.02 48.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.93 1.292 . . . . 0.0 110.874 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -51.35 118.79 3.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.192 1.797 . . . . 0.0 112.062 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 60.9 p -79.64 -8.6 59.31 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.413 1.485 . . . . 0.0 113.41 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.17 -7.2 6.15 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.523 1.059 . . . . 0.0 114.262 -165.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -89.49 5.37 45.7 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.222 1.511 . . . . 0.0 112.14 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 87.05 17.35 59.49 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.232 0.92 . . . . 0.0 113.148 -170.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 38.4 p -131.47 161.52 32.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.907 1.283 . . . . 0.0 111.062 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.96 128.45 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.907 1.283 . . . . 0.0 109.119 170.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.91 133.16 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.664 1.186 . . . . 0.0 111.844 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 22.2 ptm -146.63 162.35 38.62 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.664 2.385 . . . . 0.0 111.861 -166.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -134.74 130.53 36.35 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.524 -0.735 . . . . 0.0 109.655 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 19.9 m -109.92 164.52 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.837 1.255 . . . . 0.0 111.517 -171.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -134.95 125.03 25.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.547 1.539 . . . . 0.0 111.498 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.83 153.15 37.99 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-O 117.21 -1.376 . . . . 0.0 108.374 162.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -109.02 -72.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 123.293 2.662 . . . . 0.0 115.208 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.476 ' HZ3' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -138.3 163.69 31.17 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 121.397 1.908 . . . . 0.0 115.823 -174.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.83 -17.54 0.1 OUTLIER Glycine 0 CA--C 1.538 1.504 0 C-N-CA 127.841 2.638 . . . . 0.0 117.881 171.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -104.22 99.89 19.15 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 119.316 1.558 . . . . 0.0 113.13 -168.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.26 128.46 16.51 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.836 1.69 . . . . 0.0 108.697 155.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.0 p -163.94 155.93 16.94 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.555 -0.715 . . . . 0.0 111.953 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -79.77 128.18 33.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.497 1.519 . . . . 0.0 109.448 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.0 111.01 3.1 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.464 0.706 . . . . 0.0 112.4 -163.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -91.03 85.9 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.726 2.95 . . . . 0.0 113.394 -157.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.42 134.48 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.972 0.909 . . . . 0.0 109.219 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.08 151.72 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.376 1.07 . . . . 0.0 110.232 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.27 109.31 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.889 1.675 . . . . 0.0 107.591 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -117.7 161.24 20.0 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -158.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.28 -11.98 53.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.158 2.183 . . . . 0.0 112.783 162.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -129.81 138.31 50.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.561 1.544 . . . . 0.0 111.073 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 22.5 mt -55.83 -19.18 10.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.587 1.555 . . . . 0.0 114.374 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -105.65 2.36 28.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.95 2.5 . . . . 0.0 114.222 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 49.04 77.58 0.1 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.161 2.584 . . . . 0.0 116.59 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -109.9 -24.34 10.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.393 1.477 . . . . 0.0 112.309 161.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.92 120.54 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.062 1.345 . . . . 0.0 109.018 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.96 114.73 28.89 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.729 0.812 . . . . 0.0 112.916 -169.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -81.39 -51.57 8.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.504 2.722 . . . . 0.0 112.451 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.9 -167.36 40.2 Favored Glycine 0 CA--C 1.537 1.413 0 N-CA-C 116.549 1.379 . . . . 0.0 116.549 -167.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.91 140.44 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 127.035 2.134 . . . . 0.0 110.94 -175.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 7.2 mt -73.05 130.0 39.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.759 1.224 . . . . 0.0 110.466 163.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.09 -45.18 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 122.759 0.424 . . . . 0.0 111.159 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 m -70.03 154.78 41.5 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.67 0.668 . . . . 0.0 110.178 164.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.9 m -56.73 155.89 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.971 0.908 . . . . 0.0 112.253 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -127.79 71.26 78.05 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.049 0.939 . . . . 0.0 111.716 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.23 -169.52 0.75 Allowed 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 124.619 3.546 . . . . 0.0 112.914 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 37.1 pt -87.55 161.29 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 121.502 -0.749 . . . . 0.0 112.196 167.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.85 109.29 2.03 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 156.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.4 p -69.73 -37.2 76.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.617 1.567 . . . . 0.0 112.161 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.46 157.14 30.0 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.082 1.753 . . . . 0.0 109.745 158.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -62.95 -17.95 62.58 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.88 7.88 44.57 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.623 1.169 . . . . 0.0 112.356 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -59.45 150.39 26.78 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.63 -1.294 . . . . 0.0 113.257 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -134.84 80.17 1.83 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.355 1.062 . . . . 0.0 113.289 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.23 146.5 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.031 1.332 . . . . 0.0 111.942 -171.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 27.6 tp -97.96 129.01 44.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 129.405 3.082 . . . . 0.0 110.034 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.2 mp -140.28 148.6 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 109.726 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -121.25 148.07 44.78 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.249 1.023 . . . . 0.0 112.354 157.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.45 156.57 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.689 1.596 . . . . 0.0 110.909 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -116.21 104.96 51.53 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.58 1.952 . . . . 0.0 110.639 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.16 164.62 15.05 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.645 2.897 . . . . 0.0 111.747 163.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.58 -178.93 4.85 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.792 2.995 . . . . 0.0 111.836 166.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -67.0 150.9 48.61 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.525 -0.735 . . . . 0.0 110.551 158.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 94.47 -151.05 20.0 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 -167.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.9 162.5 20.48 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.754 1.222 . . . . 0.0 113.276 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 19.3 m -165.09 159.08 17.4 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.822 -1.174 . . . . 0.0 111.818 157.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -122.25 116.16 23.64 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 11.7 mm -92.1 111.14 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.349 1.06 . . . . 0.0 108.188 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.3 145.41 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.961 0.904 . . . . 0.0 109.957 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.86 113.41 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.415 1.886 . . . . 0.0 109.015 174.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.58 178.16 27.13 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.435 1.017 . . . . 0.0 114.855 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 17.8 m -131.43 159.95 36.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.811 1.645 . . . . 0.0 109.566 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 78.35 -175.74 54.57 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 121.898 0.721 . . . . 0.0 112.966 -172.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -22.17 63.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.033 1.333 . . . . 0.0 112.85 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 72.0 m -63.47 -12.31 30.57 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 168.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -79.4 144.01 34.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.099 1.318 . . . . 0.0 112.799 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 24.9 mt -111.81 164.37 13.14 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.428 1.091 . . . . 0.0 111.24 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.5 t -140.58 146.85 38.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.802 1.241 . . . . 0.0 111.686 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -143.93 112.24 6.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.824 1.65 . . . . 0.0 110.034 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 131.62 46.44 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.98 0.912 . . . . 0.0 111.664 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -121.05 158.46 27.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.35 1.06 . . . . 0.0 110.775 162.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -145.5 140.03 27.23 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -105.24 112.09 25.07 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.994 1.318 . . . . 0.0 108.694 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -60.45 163.25 5.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.24 3.016 . . . . 0.0 114.471 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -131.01 16.22 5.29 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.97 1.748 . . . . 0.0 113.446 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 17.9 p -69.38 80.28 0.38 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.886 1.674 . . . . 0.0 112.025 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 43.9 p -64.03 28.04 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.763 2.425 . . . . 0.0 116.151 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.3 tp -134.49 -10.21 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 127.638 2.375 . . . . 0.0 112.456 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 174.51 146.25 5.6 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.76 1.172 . . . . 0.0 111.902 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 C-N-CA 125.558 1.543 . . . . 0.0 111.343 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.2 m -98.09 2.07 48.29 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.378 1.071 . . . . 0.0 112.984 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.48 82.0 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.074 0.852 . . . . 0.0 112.928 175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.38 135.99 37.57 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.473 1.033 . . . . 0.0 108.974 168.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.1 t -52.76 167.69 0.14 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.143 1.777 . . . . 0.0 114.658 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.92 100.16 0.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.283 1.833 . . . . 0.0 110.204 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.461 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 8.3 mptt -61.09 127.93 33.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.573 2.349 . . . . 0.0 110.995 -168.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.06 -42.93 1.18 Allowed Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.937 1.256 . . . . 0.0 113.662 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 58.3 m -63.28 -5.91 3.95 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.791 2.436 . . . . 0.0 114.04 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 45.1 m -126.43 152.99 45.65 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -78.15 173.56 12.11 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.492 1.517 . . . . 0.0 112.261 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.34 158.28 29.57 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 51.0 mtm -88.9 154.48 20.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.899 2.08 . . . . 0.0 111.52 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.5 m -72.35 141.15 48.78 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.68 -0.637 . . . . 0.0 111.937 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.9 p -132.7 6.56 4.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -68.89 160.82 29.99 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.195 1.362 . . . . 0.0 109.975 160.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.58 95.66 0.23 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.692 1.597 . . . . 0.0 111.9 -169.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 65.6 mtp -80.45 172.62 13.53 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.203 1.401 . . . . 0.0 113.149 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 28.2 m -158.58 170.68 21.65 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.85 1.26 . . . . 0.0 110.45 160.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.55 123.94 36.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.405 0.682 . . . . 0.0 110.936 170.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 63.6 t -67.43 -36.34 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.583 1.553 . . . . 0.0 109.925 165.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -136.44 108.87 7.36 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 126.484 1.914 . . . . 0.0 107.724 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -59.49 143.88 85.27 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.959 0.904 . . . . 0.0 110.151 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.62 140.48 86.87 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.596 2.197 . . . . 0.0 111.612 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' THR . . . . . 0.405 ' HA ' ' CZ2' ' A' ' 389' ' ' TRP . 43.3 p -136.87 130.79 32.27 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.455 1.502 . . . . 0.0 109.71 173.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.93 134.14 52.35 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 124.262 0.976 . . . . 0.0 112.694 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 43.5 p -82.26 -18.34 42.8 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.23 1.012 . . . . 0.0 113.267 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 60.9 22.5 60.17 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.192 0.905 . . . . 0.0 112.55 -163.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -121.38 13.94 11.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.071 1.748 . . . . 0.0 111.024 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 103.07 -3.86 48.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.876 1.703 . . . . 0.0 114.119 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 25.9 p -127.63 161.9 27.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.961 1.38 . . . . 0.0 112.797 -165.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.72 135.12 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.648 1.579 . . . . 0.0 108.601 162.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.63 125.65 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.223 1.009 . . . . 0.0 112.841 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 18.7 ptm -146.01 158.36 43.87 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.941 1.696 . . . . 0.0 113.389 -166.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -138.35 137.47 37.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.921 1.288 . . . . 0.0 109.423 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.27 149.1 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.877 1.271 . . . . 0.0 110.994 -169.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -116.11 134.32 55.06 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.965 1.706 . . . . 0.0 111.359 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.82 148.52 37.53 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.267 1.427 . . . . 0.0 108.374 163.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -105.87 -70.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.252 2.635 . . . . 0.0 116.201 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.09 168.44 19.81 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 120.129 -1.607 . . . . 0.0 113.591 -170.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.44 -16.77 0.09 OUTLIER Glycine 0 CA--C 1.54 1.642 0 C-N-CA 126.641 2.067 . . . . 0.0 117.501 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -119.48 91.76 44.92 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 119.305 1.553 . . . . 0.0 113.153 -163.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.35 131.62 19.34 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.977 1.784 . . . . 0.0 108.577 152.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 1.6 p -161.76 159.06 26.7 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.397 -0.814 . . . . 0.0 112.406 -170.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -73.55 132.19 42.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.896 1.678 . . . . 0.0 108.608 164.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.4 pp -62.66 111.58 5.04 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 118.692 0.678 . . . . 0.0 112.7 -168.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -89.74 75.17 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.251 3.301 . . . . 0.0 112.751 -163.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.95 130.27 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 167.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.83 158.99 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.135 0.974 . . . . 0.0 109.857 172.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.54 116.61 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.765 2.026 . . . . 0.0 106.314 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.34 161.61 31.97 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -160.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.02 -11.49 52.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.124 2.17 . . . . 0.0 112.784 169.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.51 136.64 51.06 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.145 1.778 . . . . 0.0 109.621 176.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.6 mp -60.11 -18.49 47.68 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -94.27 -1.01 54.66 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.126 2.17 . . . . 0.0 114.569 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 46.56 79.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.851 2.46 . . . . 0.0 115.933 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -103.71 -32.64 9.27 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.381 1.472 . . . . 0.0 111.864 158.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.98 115.48 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.628 1.104 . . . . 0.0 110.609 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.03 111.82 22.63 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.029 0.932 . . . . 0.0 113.06 -173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -86.38 -25.15 25.49 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 130.15 3.38 . . . . 0.0 114.459 -170.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -113.15 -163.93 15.74 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 115.766 1.066 . . . . 0.0 115.766 -169.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.62 137.85 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 127.904 2.481 . . . . 0.0 110.415 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.5 mt -74.81 134.49 41.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.757 164.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.0 t -104.78 -49.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.581 0.753 . . . . 0.0 110.356 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 37.5 m -71.66 155.79 40.1 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.118 0.485 . . . . 0.0 110.204 166.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.15 157.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.391 1.076 . . . . 0.0 112.562 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -121.96 75.71 39.01 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.486 1.114 . . . . 0.0 111.136 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -79.98 -164.22 0.27 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.458 3.439 . . . . 0.0 112.284 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.6 pt -96.73 162.24 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.791 1.637 . . . . 0.0 111.958 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.16 112.11 4.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.118 0.967 . . . . 0.0 108.657 157.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 98.9 p -63.77 -30.04 71.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.711 1.204 . . . . 0.0 113.059 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 12.2 m -137.23 155.96 48.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 128.259 2.624 . . . . 0.0 106.691 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -57.74 -19.55 28.49 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -97.09 10.68 38.66 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.331 1.452 . . . . 0.0 113.408 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -60.37 158.23 12.26 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 120.061 -1.649 . . . . 0.0 114.037 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.2 77.83 1.53 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.62 147.85 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.655 1.182 . . . . 0.0 112.171 -172.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 26.6 tp -105.37 132.33 51.7 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 129.709 3.203 . . . . 0.0 110.106 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.7 mp -144.41 138.88 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.859 1.664 . . . . 0.0 111.123 -167.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -99.45 135.69 40.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.821 1.248 . . . . 0.0 111.462 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.15 163.19 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.787 1.235 . . . . 0.0 110.873 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -119.03 112.88 35.98 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.771 2.028 . . . . 0.0 109.587 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.18 153.22 16.41 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 122.934 2.423 . . . . 0.0 111.159 158.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.76 174.27 4.77 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.124 2.549 . . . . 0.0 112.974 165.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.77 140.84 56.23 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.491 1.116 . . . . 0.0 110.155 164.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 96.4 -148.68 19.08 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.3 163.29 23.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.143 0.977 . . . . 0.0 113.451 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 37.6 m -163.17 161.59 25.12 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.792 -1.193 . . . . 0.0 110.785 158.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -121.27 114.87 21.98 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 15.0 mm -83.73 121.58 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.75 141.41 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.656 0.782 . . . . 0.0 109.688 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 81.6 t -122.86 104.36 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 126.353 1.861 . . . . 0.0 108.483 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.59 177.37 20.72 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 122.703 1.169 . . . . 0.0 114.575 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 98.8 m -130.31 164.29 24.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.353 1.461 . . . . 0.0 109.104 165.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.49 -171.53 53.03 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 122.031 0.795 . . . . 0.0 113.068 -173.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -29.98 59.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.099 1.76 . . . . 0.0 113.325 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.8 m -66.68 -11.48 54.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -74.43 123.35 24.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.184 1.356 . . . . 0.0 113.037 -169.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 14.2 mt -84.49 163.29 19.51 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.895 0.478 . . . . 0.0 111.201 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 t -138.41 148.15 44.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.893 1.277 . . . . 0.0 111.12 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -147.58 111.38 5.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.318 1.447 . . . . 0.0 110.611 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 134.24 50.23 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.532 1.133 . . . . 0.0 112.353 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . 0.405 ' CZ2' ' HA ' ' A' ' 311' ' ' THR . 11.1 m95 -126.0 162.97 24.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.277 1.431 . . . . 0.0 112.671 166.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.04 133.51 33.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.164 2.185 . . . . 0.0 108.158 171.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . 0.441 ' HZ1' ' CD ' ' A' ' 392' ' ' GLU . 0.0 OUTLIER -122.52 140.12 53.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.899 1.279 . . . . 0.0 110.917 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . 0.441 ' CD ' ' HZ1' ' A' ' 391' ' ' LYS . 7.8 pm0 -56.6 164.1 1.57 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 129.016 2.926 . . . . 0.0 114.104 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 123.08 43.75 0.35 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.696 0.665 . . . . 0.0 114.249 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 16.4 t -84.93 178.53 7.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.352 1.076 . . . . 0.0 111.215 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 26.0 t -61.09 1.18 0.18 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.126 1.77 . . . . 0.0 115.059 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.22 7.15 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 127.402 2.281 . . . . 0.0 111.477 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 96.88 -78.86 0.69 Allowed Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.506 1.527 . . . . 0.0 112.79 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp . . . . . 0 C--O 1.257 1.454 0 CA-C-O 116.953 -1.498 . . . . 0.0 109.441 175.611 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 60.3 p -103.45 -6.54 21.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.691 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -49.16 -57.43 6.7 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.386 1.075 . . . . 0.0 112.55 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.47 124.18 21.61 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 163.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.1 t -50.84 164.61 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.579 1.952 . . . . 0.0 115.687 -165.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -59.07 102.91 0.14 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.272 1.829 . . . . 0.0 110.471 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -60.95 135.53 57.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.02 2.128 . . . . 0.0 111.018 -168.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 73.5 -47.56 1.44 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.533 1.063 . . . . 0.0 113.343 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.7 m -63.41 -16.58 60.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.548 1.939 . . . . 0.0 113.467 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -124.99 143.84 50.69 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.119 1.368 . . . . 0.0 112.241 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -73.47 173.31 9.82 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.872 0.869 . . . . 0.0 112.025 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -68.17 160.93 28.12 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.344 1.058 . . . . 0.0 113.675 -175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 46.3 mtt -88.7 158.4 18.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.894 1.677 . . . . 0.0 112.379 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.0 m -70.82 140.94 51.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.221 0.608 . . . . 0.0 111.906 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 13.3 p -123.21 9.07 9.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.37 1.068 . . . . 0.0 113.289 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.41 ' CG ' ' HZ1' ' A' ' 326' ' ' LYS . 43.1 t0 -70.15 161.31 30.46 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.624 -0.672 . . . . 0.0 111.067 164.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -65.7 91.97 0.14 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.525 1.93 . . . . 0.0 111.433 -167.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 5.8 mtp -76.7 167.13 22.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.767 1.27 . . . . 0.0 113.413 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 27.7 m -159.63 173.6 15.85 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.062 1.345 . . . . 0.0 110.249 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -109.01 128.99 55.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.35 1.06 . . . . 0.0 111.09 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.5 -33.88 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.737 1.615 . . . . 0.0 109.68 163.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -138.9 124.73 19.77 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.097 1.359 . . . . 0.0 109.988 169.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -62.83 143.78 96.93 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.253 1.421 . . . . 0.0 112.061 169.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -58.56 132.07 46.15 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.587 2.191 . . . . 0.0 112.607 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.1 142.86 44.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.534 0.734 . . . . 0.0 110.335 172.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -66.83 134.85 52.94 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.035 0.934 . . . . 0.0 112.836 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.6 p -79.9 -20.94 44.63 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.076 1.351 . . . . 0.0 113.341 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 88.76 -12.37 65.84 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.661 1.601 . . . . 0.0 113.89 -166.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -90.12 9.44 28.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.523 1.529 . . . . 0.0 112.137 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 83.84 14.75 71.96 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 121.127 -0.983 . . . . 0.0 114.054 -171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.7 p -125.02 158.28 34.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.554 1.142 . . . . 0.0 110.929 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.83 131.07 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.045 1.338 . . . . 0.0 109.706 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.06 131.38 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.232 1.413 . . . . 0.0 111.804 -172.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 4.5 ptp -143.29 165.61 27.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.786 2.034 . . . . 0.0 111.858 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -136.96 132.12 33.94 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.473 -0.767 . . . . 0.0 109.5 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.6 m -113.44 163.97 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.386 1.075 . . . . 0.0 111.749 -168.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -125.12 115.53 20.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.358 1.463 . . . . 0.0 110.624 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 t -91.61 134.54 29.11 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 116.857 -1.544 . . . . 0.0 107.343 165.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -97.02 -80.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.447 0 C-N-CA 122.525 2.15 . . . . 0.0 116.381 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.41 ' HZ1' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -155.13 144.97 21.51 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 119.25 -2.156 . . . . 0.0 115.878 -173.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 88.54 0.53 81.96 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.87 1.224 . . . . 0.0 115.23 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.67 98.3 45.85 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.989 1.316 . . . . 0.0 111.486 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.54 123.36 10.1 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.3 2.0 . . . . 0.0 108.433 161.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.9 p -157.0 157.35 34.55 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.128 0.966 . . . . 0.0 113.251 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -69.83 138.82 52.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.075 1.75 . . . . 0.0 108.776 162.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.42 121.77 69.08 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 118.721 0.691 . . . . 0.0 111.855 -173.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -99.98 95.69 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.649 2.233 . . . . 0.0 114.768 -155.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.72 141.98 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.02 0.928 . . . . 0.0 110.932 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.31 159.59 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.95 1.7 . . . . 0.0 110.309 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.4 t -133.35 97.91 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.284 1.834 . . . . 0.0 108.028 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -111.9 160.98 16.88 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -165.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -81.98 -17.2 47.74 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.859 1.664 . . . . 0.0 112.614 162.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -123.89 138.66 54.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.633 1.173 . . . . 0.0 111.745 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.68 -18.65 32.67 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.11 1.364 . . . . 0.0 113.314 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.4 t -91.53 -4.17 55.71 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.124 1.769 . . . . 0.0 114.388 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.51 70.05 0.32 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.133 2.173 . . . . 0.0 114.555 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -104.09 -14.57 15.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.951 0.9 . . . . 0.0 111.929 163.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 56.5 mt -111.74 155.83 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.702 1.601 . . . . 0.0 108.373 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -141.73 123.01 14.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.725 -1.234 . . . . 0.0 112.414 170.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -116.69 -11.38 11.0 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -96.65 -172.59 34.83 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.415 0.926 . . . . 0.0 115.415 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 23.3 mt -126.45 138.06 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.924 2.089 . . . . 0.0 110.775 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 50.5 mt -68.85 132.39 46.68 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.616 0.766 . . . . 0.0 109.815 163.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.42 -41.56 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 118.411 0.551 . . . . 0.0 112.05 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' THR . . . . . 0.454 ' HB ' ' H ' ' A' ' 366' ' ' GLU . 59.9 m -76.88 145.8 38.08 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.655 0.661 . . . . 0.0 109.379 159.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 25.4 t -63.38 154.51 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.444 1.098 . . . . 0.0 111.44 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -117.98 82.99 18.17 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.21 1.404 . . . . 0.0 112.204 -174.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -85.42 -154.34 0.05 OUTLIER 'Trans proline' 0 CA--C 1.554 1.487 0 C-N-CA 125.24 3.96 . . . . 0.0 112.66 172.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.9 pt -107.33 166.6 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.171 2.189 . . . . 0.0 111.761 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.25 118.02 12.54 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 158.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 85.4 p -74.71 -44.11 51.66 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.149 1.38 . . . . 0.0 112.521 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.75 155.14 20.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.005 1.722 . . . . 0.0 108.623 158.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -59.77 -26.49 65.75 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -91.37 9.93 29.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.508 1.523 . . . . 0.0 113.068 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -60.08 150.89 28.08 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.45 -1.406 . . . . 0.0 114.252 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.24 88.84 2.45 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 66.0 t -100.56 144.91 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.16 1.384 . . . . 0.0 111.834 -162.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.6 tp -95.73 126.43 40.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.799 2.84 . . . . 0.0 109.774 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.57 154.04 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.698 1.199 . . . . 0.0 110.812 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . 0.454 ' H ' ' HB ' ' A' ' 351' ' ' THR . 0.3 OUTLIER -128.29 148.2 50.64 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 124.712 1.205 . . . . 0.0 111.229 165.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.59 154.09 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.38 1.472 . . . . 0.0 110.686 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.9 109.84 59.21 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.621 1.569 . . . . 0.0 109.126 173.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.78 144.62 31.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.236 1.958 . . . . 0.0 111.43 163.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.13 168.3 25.12 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.173 2.582 . . . . 0.0 110.852 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -56.76 134.72 55.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.645 1.178 . . . . 0.0 111.897 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.63 -148.62 19.18 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.195 0.902 . . . . 0.0 112.685 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.73 147.71 22.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.16 2.184 . . . . 0.0 113.786 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 29.7 m -163.44 154.12 16.16 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.273 1.429 . . . . 0.0 113.042 159.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -117.22 105.27 12.04 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.666 1.586 . . . . 0.0 108.955 172.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 20.5 mm -78.48 116.57 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 30.3 mt -121.84 139.51 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.118 0.485 . . . . 0.0 110.524 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 68.9 t -115.31 114.49 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.38 1.872 . . . . 0.0 107.886 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 99.89 177.63 30.73 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 122.81 1.228 . . . . 0.0 114.756 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 94.5 m -127.31 163.69 23.4 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.064 1.746 . . . . 0.0 109.767 167.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.41 -173.7 52.85 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 121.746 0.637 . . . . 0.0 113.265 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -25.67 64.44 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.329 1.452 . . . . 0.0 113.251 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.5 m -64.86 -13.72 57.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 170.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -74.11 136.95 42.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.07 1.304 . . . . 0.0 112.266 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 17.3 mt -104.43 154.78 19.44 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.406 0.682 . . . . 0.0 110.607 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.6 t -129.0 145.61 51.2 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.525 1.13 . . . . 0.0 112.161 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -146.16 108.63 4.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.465 1.506 . . . . 0.0 109.585 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -65.21 137.99 57.95 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.607 1.163 . . . . 0.0 111.759 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -142.07 126.19 17.4 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.727 1.211 . . . . 0.0 111.36 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -96.8 131.89 43.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.818 0.847 . . . . 0.0 109.731 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -104.17 115.84 31.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.589 1.555 . . . . 0.0 110.663 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.49 159.5 15.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.251 2.221 . . . . 0.0 112.184 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -75.26 38.7 1.18 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.239 1.4 . . . . 0.0 114.533 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.53 -62.79 0.69 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.133 1.773 . . . . 0.0 111.094 -172.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.1 m -80.2 51.24 1.36 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.436 1.895 . . . . 0.0 110.334 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.7 tp -121.86 -9.12 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 129.599 3.16 . . . . 0.0 111.042 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -144.73 34.44 1.58 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.523 1.535 . . . . 0.0 114.272 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.504 ' C ' ' HZ3' ' A' ' 398' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.138 0 C-N-CA 125.282 1.433 . . . . 0.0 109.036 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 117.813 -1.089 . . . . 0.0 113.805 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.1 p -98.98 -7.38 27.03 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.137 1.335 . . . . 0.0 114.393 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.12 -48.37 70.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.678 1.191 . . . . 0.0 112.851 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.08 121.22 14.65 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 2.3 t -52.07 168.85 0.08 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.264 1.826 . . . . 0.0 115.153 -168.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.1 109.88 0.66 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.132 1.773 . . . . 0.0 110.635 -171.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -69.7 138.98 53.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.458 1.903 . . . . 0.0 110.738 -165.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 64.66 -59.35 0.07 OUTLIER Glycine 0 CA--C 1.534 1.246 0 C-N-CA 127.57 2.509 . . . . 0.0 113.836 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 40.4 p -47.03 -21.92 0.28 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 130.951 3.7 . . . . 0.0 115.817 168.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' SER . . . . . 0.468 ' HB2' ' HE3' ' A' ' 331' ' ' LYS . 2.6 p -145.24 161.97 38.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.863 1.211 . . . . 0.0 113.096 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -81.35 170.32 16.15 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -163.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 162.08 29.44 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.477 1.132 . . . . 0.0 113.994 -176.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 43.6 mtt -80.46 161.37 24.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.246 2.218 . . . . 0.0 113.162 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 8.1 m -72.26 146.56 47.15 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.585 -0.697 . . . . 0.0 112.089 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.8 p -136.69 8.39 3.06 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -78.5 158.57 28.56 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.139 1.336 . . . . 0.0 110.013 159.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 101.68 0.14 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.903 1.281 . . . . 0.0 112.006 -168.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 38.2 mtp -81.89 165.91 20.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.684 0.793 . . . . 0.0 112.073 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.7 p -147.93 159.36 43.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.941 0.897 . . . . 0.0 111.455 168.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -77.76 118.64 20.31 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 169.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.23 -30.31 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.225 0.61 . . . . 0.0 109.918 161.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -144.62 130.38 19.15 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.746 1.619 . . . . 0.0 109.125 168.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -63.62 153.09 84.46 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.526 0.73 . . . . 0.0 112.078 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.07 127.31 19.95 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.761 2.307 . . . . 0.0 110.962 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 48.3 p -126.22 133.66 51.44 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.873 1.269 . . . . 0.0 110.952 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -63.69 133.98 54.57 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.186 1.794 . . . . 0.0 112.277 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 6.4 p -71.68 -19.98 62.0 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 165.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.69 17.41 67.01 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-N 118.733 0.697 . . . . 0.0 112.198 -164.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -128.44 9.56 6.08 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.086 1.754 . . . . 0.0 111.616 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.98 6.75 36.82 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.12 -1.378 . . . . 0.0 114.861 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.4 p -128.54 160.38 32.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.789 1.794 . . . . 0.0 112.687 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.2 m -130.43 132.84 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.456 1.502 . . . . 0.0 109.778 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.5 p -120.23 129.85 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.953 1.301 . . . . 0.0 112.958 -169.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 5.8 ptp -140.53 166.33 25.03 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.768 1.627 . . . . 0.0 112.833 -172.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -132.27 138.65 47.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.297 1.039 . . . . 0.0 110.083 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.8 151.29 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.356 1.062 . . . . 0.0 110.776 -169.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -107.8 127.88 54.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.06 1.344 . . . . 0.0 110.577 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.41 138.81 20.01 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 117.257 -1.354 . . . . 0.0 107.734 162.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -104.79 -75.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.427 2.085 . . . . 0.0 115.325 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.47 174.67 10.55 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.042 -1.661 . . . . 0.0 114.274 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.21 3.21 17.1 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 116.952 1.541 . . . . 0.0 116.952 170.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.11 95.1 37.45 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 119.038 1.419 . . . . 0.0 112.9 -162.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -72.1 124.31 9.94 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.103 1.869 . . . . 0.0 108.659 159.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.0 p -161.68 156.64 23.33 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -173.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 296' ' ' SER . 14.1 tptp -73.54 135.68 43.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.837 2.855 . . . . 0.0 109.418 162.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 14.6 pt -63.45 124.25 83.77 Favored Pre-proline 0 N--CA 1.479 1.005 0 CA-C-N 119.85 1.205 . . . . 0.0 111.409 -171.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -105.77 89.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 121.622 1.548 . . . . 0.0 114.57 -157.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 74.3 t -125.98 132.04 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.884 0.873 . . . . 0.0 109.531 173.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.8 158.53 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.859 1.264 . . . . 0.0 110.674 -172.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 35.4 t -127.1 126.75 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.057 1.743 . . . . 0.0 107.552 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -132.01 161.45 33.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.902 1.281 . . . . 0.0 112.795 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.97 -22.65 33.66 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.749 1.22 . . . . 0.0 112.333 166.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -107.61 154.79 20.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.267 1.427 . . . . 0.0 111.479 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.69 -19.28 63.72 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.6 t -117.82 7.06 12.34 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.677 1.191 . . . . 0.0 113.951 -167.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 47.15 70.2 0.43 Allowed 'General case' 0 C--O 1.238 0.497 0 C-N-CA 127.974 2.51 . . . . 0.0 114.691 -170.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -83.81 -43.35 15.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.286 1.034 . . . . 0.0 111.158 154.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 43.4 mm -86.93 153.44 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.585 1.154 . . . . 0.0 109.959 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . 0.263 0.0 OUTLIER -125.15 96.4 4.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 123.171 1.462 . . . . 0.0 110.707 171.237 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -78.2 -55.56 5.17 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 128.732 2.813 . . . . 0.0 111.869 -169.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.28 -168.12 41.38 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.438 1.494 . . . . 0.0 116.273 -166.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.1 mt -124.11 139.91 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 126.604 1.961 . . . . 0.0 111.152 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.65 125.24 26.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.594 1.158 . . . . 0.0 110.487 168.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.5 t -104.15 -54.04 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.528 0.731 . . . . 0.0 109.286 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 50.0 m -71.76 140.61 49.57 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 167.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.67 150.63 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.887 1.275 . . . . 0.0 112.369 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -125.0 70.84 61.28 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.59 1.156 . . . . 0.0 112.556 -167.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.85 -167.12 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.73 3.62 . . . . 0.0 112.575 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.7 pt -83.34 160.35 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.694 1.198 . . . . 0.0 112.748 173.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.1 110.75 4.67 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 156.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.2 p -66.88 -33.06 74.77 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.071 1.749 . . . . 0.0 112.696 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.09 146.8 50.25 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.749 2.02 . . . . 0.0 108.06 167.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -59.84 -17.9 39.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -91.3 0.72 57.48 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.683 1.993 . . . . 0.0 112.758 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.06 151.69 30.15 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.45 -1.406 . . . . 0.0 113.068 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -136.57 82.72 1.96 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.174 0.987 . . . . 0.0 112.963 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 43.9 t -99.42 153.1 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.288 1.435 . . . . 0.0 111.582 -164.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.53 128.68 55.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.217 2.207 . . . . 0.0 109.778 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.1 mp -135.87 141.38 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.401 1.48 . . . . 0.0 109.035 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -114.9 149.6 36.95 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 122.078 0.942 . . . . 0.0 112.85 161.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.23 158.37 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.867 1.667 . . . . 0.0 110.883 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -109.01 102.68 49.72 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.588 1.955 . . . . 0.0 109.638 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.8 145.42 20.08 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.194 2.596 . . . . 0.0 110.815 166.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.82 176.67 9.73 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.002 2.468 . . . . 0.0 111.185 164.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -63.45 152.8 37.3 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.268 1.427 . . . . 0.0 113.739 -171.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 89.46 -162.06 30.34 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.844 1.212 . . . . 0.0 112.257 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.79 159.21 31.28 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.322 1.058 . . . . 0.0 111.81 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 73.2 m -160.33 164.88 32.17 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.151 -1.593 . . . . 0.0 111.174 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -120.86 116.49 25.28 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.849 1.26 . . . . 0.0 109.008 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 24.1 mm -85.38 120.2 35.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 124.714 1.206 . . . . 0.0 107.884 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.62 140.31 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.448 0.699 . . . . 0.0 110.092 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 76.3 t -115.18 115.08 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 126.79 2.036 . . . . 0.0 108.067 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 97.89 179.39 33.2 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 123.442 1.579 . . . . 0.0 115.622 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 29.8 m -134.2 163.66 29.11 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.194 1.398 . . . . 0.0 109.935 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.09 -174.14 54.63 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 122.148 0.86 . . . . 0.0 112.85 -170.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -27.69 61.65 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.855 1.662 . . . . 0.0 112.794 172.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.8 m -65.41 -12.08 48.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -74.62 138.65 43.09 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.753 1.16 . . . . 0.0 111.981 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 21.1 mt -103.86 162.41 13.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.987 0.915 . . . . 0.0 110.973 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.7 t -142.1 146.44 35.4 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.45 1.1 . . . . 0.0 111.664 -172.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -145.39 119.98 9.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.794 1.638 . . . . 0.0 109.931 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -71.01 129.07 38.05 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.579 0.752 . . . . 0.0 111.782 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -123.76 159.21 29.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.731 1.212 . . . . 0.0 111.636 170.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -133.65 118.74 18.53 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.943 1.697 . . . . 0.0 109.033 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -120.8 120.73 36.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.611 1.564 . . . . 0.0 111.09 -167.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -1.03 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 131.446 3.898 . . . . 0.0 116.236 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -89.36 -14.08 60.71 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.031 0.824 . . . . 0.0 112.993 167.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.1 p -115.26 75.91 0.97 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.005 1.722 . . . . 0.0 108.705 172.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 97.5 p -54.54 -30.24 53.33 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -164.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 396' ' ' ILE . 0.1 OUTLIER -71.17 62.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.975 1.31 . . . . 0.0 110.632 160.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 136.59 -88.44 0.22 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.82 1.2 . . . . 0.0 115.134 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 398' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.189 0 CA-C-O 115.573 -2.155 . . . . 0.0 113.32 -163.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 118.169 -0.919 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 19.2 t -111.46 -2.09 15.67 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.46 -47.69 75.26 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.256 1.389 . . . . 0.0 112.275 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.0 tt -68.13 123.84 21.8 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 159.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 4.8 t -50.01 167.66 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.06 113.65 3.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.507 1.923 . . . . 0.0 110.735 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 295' ' ' THR . 8.6 mptt -62.37 132.97 54.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.444 1.897 . . . . 0.0 110.384 -174.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 65.18 -27.19 0.12 Allowed Glycine 0 CA--C 1.543 1.786 0 C-N-CA 126.757 2.122 . . . . 0.0 115.488 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 293' ' ' LYS . 43.8 m -87.39 -13.64 42.85 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 130.599 3.56 . . . . 0.0 112.068 -173.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.4 m -155.88 153.88 30.38 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 119.853 -1.779 . . . . 0.0 113.569 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -75.54 178.75 5.75 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.43 1.892 . . . . 0.0 114.538 -168.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.86 159.81 14.79 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.822 1.649 . . . . 0.0 114.199 -168.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.27 158.43 26.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.481 2.712 . . . . 0.0 114.873 -170.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.8 m -78.88 145.01 34.39 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.79 0.836 . . . . 0.0 110.585 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 14.17 3.92 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.415 1.086 . . . . 0.0 113.224 167.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -67.66 159.33 30.23 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.818 153.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.5 109.48 4.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.316 0.646 . . . . 0.0 111.064 -167.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 69.9 mtp -95.27 162.25 13.76 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.312 1.053 . . . . 0.0 112.431 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.4 p -151.42 159.47 44.21 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.239 1.416 . . . . 0.0 109.534 166.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.75 129.94 34.8 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 122.045 -0.409 . . . . 0.0 109.904 166.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.66 -29.07 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.118 0.967 . . . . 0.0 109.989 162.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -145.82 133.5 21.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.899 1.68 . . . . 0.0 109.999 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -66.47 147.38 98.97 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.986 0.914 . . . . 0.0 112.465 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.72 133.54 57.0 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.633 2.222 . . . . 0.0 112.186 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 21.7 p -132.89 142.34 48.87 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.976 1.711 . . . . 0.0 110.126 169.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.0 130.3 46.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.649 0.738 . . . . 0.0 110.675 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 75.0 p -78.29 -18.74 54.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.495 1.918 . . . . 0.0 113.034 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 82.62 -4.3 79.22 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.367 0.985 . . . . 0.0 113.845 -163.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -84.25 -0.48 52.46 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 119.612 1.706 . . . . 0.0 111.88 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 76.69 36.22 38.15 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.91 1.243 . . . . 0.0 111.539 -165.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.6 p -146.69 164.16 33.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.194 2.198 . . . . 0.0 108.403 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.26 134.06 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.305 1.442 . . . . 0.0 110.657 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.1 133.5 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.438 1.095 . . . . 0.0 113.611 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.0 ptm -145.94 163.56 34.76 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.224 2.21 . . . . 0.0 112.11 -169.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -130.58 144.22 51.27 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.377 0.671 . . . . 0.0 110.06 172.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.15 146.45 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.145 0.978 . . . . 0.0 111.461 -167.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -109.8 131.04 55.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.989 1.716 . . . . 0.0 111.078 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 14.3 t -108.43 143.32 27.24 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-O 116.973 -1.489 . . . . 0.0 108.156 163.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -101.13 -75.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.506 0 C-N-CA 122.259 1.972 . . . . 0.0 116.843 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 169.13 21.72 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 121.342 1.883 . . . . 0.0 114.771 -173.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 68.99 -5.41 4.74 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.542 1.544 . . . . 0.0 116.639 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -125.64 103.85 27.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.768 1.284 . . . . 0.0 112.67 -164.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -76.56 134.61 15.46 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.984 1.789 . . . . 0.0 109.055 160.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.3 p -158.23 155.15 28.45 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.371 -0.83 . . . . 0.0 112.918 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -77.84 136.98 38.16 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 159.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -58.62 117.28 19.42 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-N 118.783 0.719 . . . . 0.0 111.876 -171.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -97.03 102.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.925 3.083 . . . . 0.0 113.039 -167.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.5 139.13 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.446 1.099 . . . . 0.0 108.909 170.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 3.1 mt -136.96 143.84 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.631 1.173 . . . . 0.0 108.575 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 45.3 t -119.26 108.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.433 1.093 . . . . 0.0 108.187 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -124.36 161.33 26.15 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -162.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.81 -6.96 59.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.221 2.608 . . . . 0.0 112.361 168.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -139.8 149.73 43.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.129 1.772 . . . . 0.0 111.431 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 20.4 mt -64.48 -24.63 67.68 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.672 1.189 . . . . 0.0 113.371 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.4 t -96.07 4.74 52.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.877 1.271 . . . . 0.0 113.72 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.2 75.08 0.1 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.225 3.01 . . . . 0.0 115.652 -171.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.94 -35.01 12.17 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.844 2.057 . . . . 0.0 111.786 164.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.91 153.26 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.747 1.219 . . . . 0.0 109.84 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.92 103.55 5.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.033 -1.042 . . . . 0.0 111.316 175.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -103.85 -13.22 16.48 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -174.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -102.52 -174.38 27.15 Favored Glycine 0 CA--C 1.536 1.403 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.01 144.2 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 127.774 2.43 . . . . 0.0 110.913 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.32 130.35 37.04 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.527 1.131 . . . . 0.0 109.485 165.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -46.97 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 118.99 -0.529 . . . . 0.0 111.122 176.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 32.2 m -65.92 150.66 48.27 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.773 160.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.0 156.98 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.818 1.247 . . . . 0.0 111.951 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -114.9 80.94 7.04 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.387 1.475 . . . . 0.0 111.185 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -80.24 -172.99 1.68 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.143 2.562 . . . . 0.0 112.25 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 28.0 pt -93.5 176.41 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.713 1.605 . . . . 0.0 110.868 167.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.43 113.12 7.25 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 153.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.9 p -67.01 -32.18 73.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.801 1.64 . . . . 0.0 112.871 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.39 152.3 51.72 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.719 2.808 . . . . 0.0 108.159 168.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -63.17 -23.33 67.38 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.589 -1.32 . . . . 0.0 114.245 -173.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -86.26 4.79 37.32 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.935 1.294 . . . . 0.0 113.443 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.79 150.1 7.85 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -135.34 85.88 2.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.535 -1.212 . . . . 0.0 114.122 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 4.4 t -93.13 140.8 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.029 1.332 . . . . 0.0 111.501 -167.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -101.33 121.06 41.23 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 129.179 2.991 . . . . 0.0 109.064 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 1.8 mp -140.81 146.22 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.239 1.416 . . . . 0.0 110.713 -169.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -114.39 139.13 49.74 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.6 1.16 . . . . 0.0 112.608 166.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.94 159.18 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.132 1.773 . . . . 0.0 111.211 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -113.68 108.1 52.05 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.691 1.996 . . . . 0.0 109.453 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.36 150.67 25.58 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.314 2.009 . . . . 0.0 110.315 166.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -59.15 164.77 9.89 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.451 1.434 . . . . 0.0 111.244 163.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -65.57 140.86 58.57 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.711 -0.618 . . . . 0.0 110.473 167.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.49 -151.46 18.22 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.158 0.409 . . . . 0.0 112.427 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -74.46 161.11 30.12 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.447 1.117 . . . . 0.0 112.9 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 24.1 m -170.1 162.08 8.8 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.43 1.892 . . . . 0.0 111.264 166.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -128.61 127.45 42.28 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.446 1.898 . . . . 0.0 107.138 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 23.3 mm -95.15 118.14 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.7 140.04 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.019 0.928 . . . . 0.0 110.503 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 97.2 t -106.36 122.9 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 126.06 1.744 . . . . 0.0 108.359 168.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 85.97 179.85 49.91 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 123.444 1.58 . . . . 0.0 116.335 168.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 72.0 m -138.76 171.69 13.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.974 1.31 . . . . 0.0 109.96 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 85.39 -154.68 28.86 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -171.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -26.32 64.57 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.748 0.819 . . . . 0.0 112.189 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.9 m -76.79 -6.43 52.26 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 129.127 2.971 . . . . 0.0 115.24 -164.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -75.24 124.58 27.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.752 0.421 . . . . 0.0 112.059 -167.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.78 158.58 15.82 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.479 0.312 . . . . 0.0 110.422 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.1 t -131.42 154.24 48.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.434 1.094 . . . . 0.0 111.913 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -142.69 126.14 16.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.158 1.783 . . . . 0.0 109.553 171.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.89 127.29 31.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.361 1.464 . . . . 0.0 111.558 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -136.22 117.78 14.87 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.217 1.007 . . . . 0.0 110.953 170.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -119.0 119.97 35.85 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -97.44 132.93 42.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.009 1.724 . . . . 0.0 111.28 -165.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -63.06 161.72 12.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.871 1.668 . . . . 0.0 112.341 172.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -69.66 73.43 0.47 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.227 0.917 . . . . 0.0 111.753 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.36 122.9 18.92 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.903 1.681 . . . . 0.0 112.121 -170.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 79.2 p -58.63 -27.66 64.91 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -167.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 4.8 tt -71.74 -4.8 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.248 1.419 . . . . 0.0 113.377 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.18 -10.26 8.19 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.653 1.597 . . . . 0.0 116.144 165.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.74 2.016 . . . . 0.0 111.274 171.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.7 p -104.19 -2.37 25.83 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.48 89.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.205 0.911 . . . . 0.0 113.124 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.7 tt -75.97 128.41 35.0 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 161.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 2.2 t -52.97 168.56 0.12 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.945 2.098 . . . . 0.0 116.036 -167.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.48 105.44 0.63 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.077 1.751 . . . . 0.0 110.628 -172.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.07 124.91 20.97 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.087 1.355 . . . . 0.0 111.226 -171.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.41 -51.6 2.57 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.998 1.285 . . . . 0.0 112.996 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.3 m -62.89 3.08 0.25 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.549 2.74 . . . . 0.0 114.149 174.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.6 m -156.48 149.47 24.05 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 118.996 -2.315 . . . . 0.0 112.658 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -74.19 171.81 12.92 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.636 1.975 . . . . 0.0 113.557 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.09 163.19 28.09 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.354 1.462 . . . . 0.0 113.055 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 58.0 mtt -93.82 164.12 13.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.138 1.775 . . . . 0.0 113.788 -168.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.8 m -76.23 139.38 41.15 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.315 0.646 . . . . 0.0 111.244 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 6.4 p -133.04 20.07 4.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.574 1.15 . . . . 0.0 113.036 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -82.46 164.68 20.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 158.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.02 95.64 0.12 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.39 1.476 . . . . 0.0 111.847 -175.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 32.7 mtp -80.36 171.79 14.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.665 1.186 . . . . 0.0 112.426 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.7 m -158.93 154.53 26.07 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.184 -0.947 . . . . 0.0 111.965 163.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.4 111.8 14.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.886 0.875 . . . . 0.0 109.744 163.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 20.1 t -66.99 -33.52 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.476 1.11 . . . . 0.0 109.868 166.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -129.45 126.68 39.28 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.859 1.664 . . . . 0.0 108.577 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -62.83 152.86 81.63 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.69 1.196 . . . . 0.0 112.164 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.43 124.63 13.62 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.733 2.289 . . . . 0.0 111.049 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 70.5 p -125.17 136.87 54.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.169 1.388 . . . . 0.0 110.692 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.47 127.04 30.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.238 1.015 . . . . 0.0 111.742 173.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 75.7 p -76.32 -22.31 55.12 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.53 1.532 . . . . 0.0 113.087 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 89.22 -11.37 69.79 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.057 1.789 . . . . 0.0 113.817 -163.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -86.01 2.43 46.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.486 1.515 . . . . 0.0 112.303 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 87.66 15.11 62.19 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.937 0.78 . . . . 0.0 112.86 -167.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.6 p -131.14 158.19 41.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.763 1.225 . . . . 0.0 111.345 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.16 132.05 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.226 1.41 . . . . 0.0 109.727 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.65 134.27 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.516 1.127 . . . . 0.0 113.35 -169.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 3.3 ptp -143.14 160.52 40.26 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.282 1.833 . . . . 0.0 113.174 -173.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -119.15 121.71 40.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.478 1.911 . . . . 0.0 107.806 173.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.78 141.88 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.366 1.066 . . . . 0.0 111.527 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -106.14 132.34 52.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.796 1.639 . . . . 0.0 112.278 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.38 147.18 33.79 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.726 1.61 . . . . 0.0 108.649 163.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -108.97 -72.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.255 2.636 . . . . 0.0 115.386 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.44 170.07 17.6 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.241 -1.537 . . . . 0.0 114.202 -171.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 64.57 -23.32 0.1 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 127.633 2.539 . . . . 0.0 117.77 168.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -107.52 97.45 19.71 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.501 1.52 . . . . 0.0 112.05 -170.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.29 131.23 25.99 Favored 'Trans proline' 0 C--N 1.35 0.631 0 N-CA-C 108.005 -1.575 . . . . 0.0 108.005 157.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.6 p -160.9 157.3 26.32 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -72.23 137.76 47.05 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.343 1.457 . . . . 0.0 108.989 159.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.37 119.08 56.56 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 118.69 0.677 . . . . 0.0 112.196 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -97.38 87.41 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.049 3.166 . . . . 0.0 113.833 -166.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 97.1 t -113.49 131.72 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 164.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.23 153.47 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.484 1.114 . . . . 0.0 110.152 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.46 109.41 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.188 1.795 . . . . 0.0 107.129 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -119.66 164.67 15.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -161.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -89.49 -6.75 56.16 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.824 2.05 . . . . 0.0 112.668 165.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -133.79 144.41 49.0 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.054 1.342 . . . . 0.0 110.677 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.55 -11.75 26.98 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.8 t -113.02 12.03 19.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.964 1.706 . . . . 0.0 113.188 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 39.85 60.11 1.75 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.53 2.732 . . . . 0.0 116.152 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.85 63.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.267 0.627 . . . . 0.0 111.927 155.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 38.0 mt -110.6 155.98 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.126 1.771 . . . . 0.0 109.254 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.45 102.0 6.94 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.312 1.045 . . . . 0.0 110.808 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -77.96 -56.39 4.53 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 129.732 3.213 . . . . 0.0 111.423 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -92.35 -167.64 39.77 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 116.593 1.397 . . . . 0.0 116.593 -166.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.5 mt -116.51 135.48 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.242 1.817 . . . . 0.0 110.546 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.3 mt -72.04 122.29 20.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.615 0.766 . . . . 0.0 109.372 165.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 98.4 t -103.02 -52.62 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.177 0.991 . . . . 0.0 110.235 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 50.4 m -67.02 155.23 39.19 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.198 0.523 . . . . 0.0 110.102 164.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 11.3 m -58.1 159.32 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.151 0.98 . . . . 0.0 112.468 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -118.6 85.02 25.86 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.638 1.175 . . . . 0.0 110.125 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -80.48 -165.16 0.32 Allowed 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 124.502 3.468 . . . . 0.0 113.232 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 31.5 pt -105.04 165.99 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.688 1.995 . . . . 0.0 111.218 172.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.66 102.48 1.2 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 155.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 82.8 p -70.61 -35.77 73.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.305 1.442 . . . . 0.0 112.208 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.5 157.62 33.15 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.815 2.046 . . . . 0.0 109.491 158.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -66.68 -23.46 66.14 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -89.75 7.69 35.56 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.03 0.832 . . . . 0.0 112.648 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -56.61 153.07 10.9 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.878 1.323 . . . . 0.0 112.973 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.67 123.33 12.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.907 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.61 145.95 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.702 0.801 . . . . 0.0 110.254 -159.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.4 tp -95.97 126.58 41.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.443 2.297 . . . . 0.0 109.405 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.3 mp -139.28 132.13 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.492 1.117 . . . . 0.0 109.483 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.81 147.98 32.31 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.96 0.886 . . . . 0.0 112.106 159.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.38 160.86 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.733 1.613 . . . . 0.0 110.702 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -115.32 109.12 46.69 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.94 1.696 . . . . 0.0 111.092 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.74 148.9 20.43 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.932 2.421 . . . . 0.0 111.549 162.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -73.15 172.18 16.07 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.772 2.315 . . . . 0.0 111.103 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -57.34 147.84 24.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.239 0.615 . . . . 0.0 111.668 171.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.35 -136.08 12.52 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.15 162.36 14.36 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.03 1.332 . . . . 0.0 112.736 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 38.5 m -162.18 162.98 28.62 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.777 -1.202 . . . . 0.0 110.716 157.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.84 117.89 25.13 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 21.5 mm -91.03 111.25 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.857 1.263 . . . . 0.0 107.941 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.48 142.57 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.704 0.802 . . . . 0.0 109.547 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 97.8 t -123.29 108.34 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.335 1.854 . . . . 0.0 108.765 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.83 175.88 21.61 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.979 1.276 . . . . 0.0 114.36 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 56.4 m -133.86 162.12 32.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.284 1.434 . . . . 0.0 109.759 169.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.5 -171.53 49.39 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 121.601 0.556 . . . . 0.0 112.668 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.33 -27.5 23.71 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.222 1.409 . . . . 0.0 113.956 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.0 m -74.86 -3.91 34.74 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.761 2.424 . . . . 0.0 114.833 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -79.55 125.86 30.13 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.078 0.853 . . . . 0.0 112.618 -174.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.84 163.86 14.85 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.212 0.605 . . . . 0.0 110.827 172.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.6 t -144.13 148.31 34.89 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.262 1.025 . . . . 0.0 111.829 -171.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -147.75 110.05 4.6 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.325 1.45 . . . . 0.0 110.119 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.2 133.61 56.26 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.913 0.885 . . . . 0.0 111.212 173.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -125.3 160.8 28.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.285 1.034 . . . . 0.0 111.298 163.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -129.59 146.25 51.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.225 1.41 . . . . 0.0 108.771 171.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.63 136.73 49.13 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.886 1.274 . . . . 0.0 109.696 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.5 163.03 21.72 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 129.23 3.012 . . . . 0.0 110.385 -169.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -73.66 41.09 0.98 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.902 1.239 . . . . 0.0 114.434 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.39 -63.68 0.37 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.518 1.527 . . . . 0.0 112.576 -169.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 4.8 m -81.19 65.39 6.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.022 1.329 . . . . 0.0 110.342 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 14.2 tt -134.57 1.91 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.861 2.464 . . . . 0.0 112.636 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -154.02 29.16 0.73 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.609 1.1 . . . . 0.0 114.696 -172.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.496 ' C ' ' HZ1' ' A' ' 398' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.877 0 C-N-CA 125.948 1.699 . . . . 0.0 109.151 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 9.5 m -109.43 0.86 19.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.323 1.449 . . . . 0.0 113.99 -167.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.64 -48.97 62.66 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.235 0.925 . . . . 0.0 111.031 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.68 131.43 46.31 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 167.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.6 t -62.58 176.66 0.62 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -164.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -64.7 97.39 0.21 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.933 1.693 . . . . 0.0 112.332 -167.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.446 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 0.8 OUTLIER -47.48 125.7 8.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 128.052 2.541 . . . . 0.0 111.794 -178.341 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 60.35 10.17 15.22 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.559 1.076 . . . . 0.0 115.283 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 13.5 m -139.76 17.0 2.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.657 1.583 . . . . 0.0 109.809 -159.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 2.3 m -171.15 159.07 5.77 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.267 -1.521 . . . . 0.0 112.368 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -86.74 174.66 8.68 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.446 1.099 . . . . 0.0 112.735 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -63.17 159.3 17.85 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -164.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 62.1 mtm -79.22 151.74 31.04 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.914 2.086 . . . . 0.0 110.382 164.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.7 m -70.51 145.49 50.85 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.989 -0.445 . . . . 0.0 111.794 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.1 p -134.3 24.32 3.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.929 1.292 . . . . 0.0 112.634 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -94.59 169.45 10.17 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 160.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -69.62 90.96 0.58 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.195 2.198 . . . . 0.0 111.956 -163.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 37.7 mtp -80.58 170.63 16.08 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.961 0.886 . . . . 0.0 113.348 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 36.5 m -159.44 161.22 35.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.057 0.943 . . . . 0.0 112.018 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.49 120.2 22.14 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.772 0.829 . . . . 0.0 109.641 168.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.64 -34.32 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.216 1.006 . . . . 0.0 110.116 163.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -136.46 132.68 35.7 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.173 1.389 . . . . 0.0 110.007 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -69.32 145.89 96.17 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.526 1.53 . . . . 0.0 112.15 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.0 136.62 57.66 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.864 2.376 . . . . 0.0 112.636 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 71.4 p -141.61 131.6 24.57 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.152 1.781 . . . . 0.0 110.411 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -60.49 131.76 51.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.777 0.831 . . . . 0.0 112.387 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.0 p -66.13 -21.23 66.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.556 1.942 . . . . 0.0 112.717 168.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 98.31 -16.79 59.48 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.909 1.718 . . . . 0.0 112.397 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -74.08 -18.15 60.86 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.419 1.11 . . . . 0.0 111.76 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.55 32.88 6.1 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.569 1.081 . . . . 0.0 111.751 -166.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.8 p -136.85 129.43 30.28 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.905 1.282 . . . . 0.0 108.39 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 21.8 m -106.9 123.06 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.434 0.694 . . . . 0.0 110.068 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.35 129.42 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.072 0.949 . . . . 0.0 111.816 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.9 ptm -149.49 163.04 38.9 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.487 1.915 . . . . 0.0 111.756 -169.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -136.74 136.58 39.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.442 0.697 . . . . 0.0 110.153 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.96 127.66 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.999 0.92 . . . . 0.0 112.874 -164.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -92.94 125.7 37.67 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.573 1.549 . . . . 0.0 112.02 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.1 t -96.56 145.27 29.28 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 117.393 -1.289 . . . . 0.0 107.626 158.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -104.27 -65.88 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 123.056 2.504 . . . . 0.0 115.321 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 175.85 10.32 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.344 -1.472 . . . . 0.0 112.142 -174.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.69 -13.19 0.09 OUTLIER Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.509 2.481 . . . . 0.0 118.129 167.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.89 93.93 22.77 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 119.147 1.474 . . . . 0.0 113.03 -167.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.3 112.15 3.26 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.402 2.068 . . . . 0.0 108.756 156.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.5 p -154.35 159.67 41.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.15 0.98 . . . . 0.0 111.923 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 355' ' ' ILE . 20.6 mtpp -76.83 144.13 39.28 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.214 1.006 . . . . 0.0 109.877 158.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.45 111.46 4.08 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.242 1.017 . . . . 0.0 111.97 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -94.54 89.06 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.952 3.101 . . . . 0.0 112.999 -162.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.86 127.8 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 150.06 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.446 1.098 . . . . 0.0 109.397 -177.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 64.4 t -128.77 105.03 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -117.6 161.24 19.95 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -158.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.62 -14.62 58.68 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.08 2.152 . . . . 0.0 112.783 164.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -134.38 148.23 50.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.612 1.165 . . . . 0.0 112.258 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 16.4 mt -61.96 -19.74 63.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.137 1.375 . . . . 0.0 114.468 -173.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.8 t -104.29 5.83 34.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.606 1.962 . . . . 0.0 113.262 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.48 69.08 0.43 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.016 2.926 . . . . 0.0 116.434 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -81.32 -45.42 16.2 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.365 1.466 . . . . 0.0 112.064 157.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.42 113.73 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.976 1.311 . . . . 0.0 110.338 -172.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.13 107.39 15.67 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.445 0.698 . . . . 0.0 112.331 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 373' ' ' ASP . 12.2 ttpt -72.86 -43.91 62.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.393 2.677 . . . . 0.0 112.955 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -100.28 -165.5 28.7 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.465 1.346 . . . . 0.0 116.465 -165.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.94 148.14 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.182 2.193 . . . . 0.0 110.0 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.32 134.51 34.51 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.464 -0.772 . . . . 0.0 109.666 170.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 81.9 t -98.29 -46.64 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.904 0.882 . . . . 0.0 109.588 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.8 m -71.38 154.9 41.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.396 0.617 . . . . 0.0 110.211 164.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.46 161.56 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.211 1.404 . . . . 0.0 110.541 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -114.17 69.28 1.82 Allowed Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 124.667 1.187 . . . . 0.0 112.763 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.05 -171.36 1.05 Allowed 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 124.412 3.408 . . . . 0.0 113.123 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 44.5 pt -93.17 165.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.58 1.552 . . . . 0.0 113.359 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.21 105.98 1.55 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.054 0.942 . . . . 0.0 109.206 158.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 83.9 p -70.31 -40.18 74.35 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.173 1.389 . . . . 0.0 111.803 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.24 151.45 34.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.33 1.852 . . . . 0.0 108.887 155.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -61.63 -15.7 41.86 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 175.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.76 8.67 44.3 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.232 1.413 . . . . 0.0 112.633 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -58.98 148.15 31.72 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.266 -1.521 . . . . 0.0 113.621 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -129.94 79.43 1.9 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.072 1.349 . . . . 0.0 112.129 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 40.5 t -84.39 143.21 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.45 1.1 . . . . 0.0 111.124 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.5 130.07 42.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.536 2.734 . . . . 0.0 109.787 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.1 133.8 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.117 1.767 . . . . 0.0 110.407 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -91.01 138.23 31.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.18 0.992 . . . . 0.0 110.722 154.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.79 160.56 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.096 0.958 . . . . 0.0 111.333 169.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -121.75 105.32 38.29 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.815 1.646 . . . . 0.0 110.076 -173.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.68 154.8 35.01 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.234 1.956 . . . . 0.0 110.363 159.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.79 171.58 16.22 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.17 1.913 . . . . 0.0 111.155 166.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -65.24 122.97 18.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.834 1.254 . . . . 0.0 109.343 168.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 126.73 -148.14 17.13 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.319 0.961 . . . . 0.0 111.166 -163.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . 0.4 ' O ' ' HE3' ' A' ' 346' ' ' LYS . 8.7 p-10 -94.47 168.82 10.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.828 1.251 . . . . 0.0 112.054 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 33.6 m -168.46 165.24 12.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.536 1.934 . . . . 0.0 110.828 159.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -124.63 117.0 23.3 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.0 mm -90.95 110.92 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.61 143.39 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.948 0.899 . . . . 0.0 110.184 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.6 115.23 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 126.71 2.004 . . . . 0.0 108.684 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 95.82 176.88 36.73 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.32 0.962 . . . . 0.0 114.521 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 47.4 m -136.19 165.06 26.61 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.811 1.644 . . . . 0.0 109.891 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.37 -171.27 46.81 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 121.642 -0.662 . . . . 0.0 112.196 -167.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.47 -26.41 53.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.213 1.005 . . . . 0.0 113.539 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.4 m -74.25 9.9 1.47 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.681 2.792 . . . . 0.0 115.222 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -96.05 144.24 26.49 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.4 1.08 . . . . 0.0 112.986 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 25.9 mt -112.25 165.31 12.28 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.579 1.152 . . . . 0.0 111.384 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 2.3 t -139.11 147.01 41.39 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.949 1.299 . . . . 0.0 111.815 -170.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -146.78 112.59 5.7 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.759 1.624 . . . . 0.0 110.388 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 134.56 54.93 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.128 -0.983 . . . . 0.0 112.367 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -128.82 149.12 50.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.891 0.876 . . . . 0.0 111.892 165.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -133.5 140.72 47.41 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.128 1.371 . . . . 0.0 107.839 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -135.22 122.01 21.0 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.481 1.112 . . . . 0.0 111.052 -170.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -73.45 164.26 26.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.339 1.055 . . . . 0.0 112.21 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -65.81 16.83 0.2 Allowed Glycine 0 CA--C 1.54 1.606 0 N-CA-C 118.881 2.312 . . . . 0.0 118.881 -163.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 4.8 m -72.25 65.08 0.59 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.415 2.286 . . . . 0.0 112.539 -170.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.2 p -83.96 -4.13 58.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 130.094 3.358 . . . . 0.0 114.055 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 15.2 tt -149.44 168.18 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.9 1.68 . . . . 0.0 109.361 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 81.35 -9.98 51.88 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.913 1.244 . . . . 0.0 115.203 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.432 0 C-N-CA 129.09 2.956 . . . . 0.0 109.42 173.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.7 m -104.81 -4.58 22.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.138 0.975 . . . . 0.0 113.003 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.54 -9.09 52.48 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.9 tp -101.79 132.18 47.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 159.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.9 t -57.98 174.45 0.26 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.386 1.474 . . . . 0.0 114.252 -172.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.06 95.66 0.17 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.772 1.629 . . . . 0.0 110.997 -169.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.526 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 6.9 mptt -51.89 121.02 5.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.853 2.461 . . . . 0.0 111.057 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 67.25 -25.22 0.2 Allowed Glycine 0 CA--C 1.54 1.635 0 C-N-CA 126.439 1.971 . . . . 0.0 115.599 -173.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 293' ' ' LYS . 44.8 m -87.11 7.99 25.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 129.648 3.179 . . . . 0.0 111.555 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 7.5 m -160.2 155.31 24.75 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 119.311 -2.118 . . . . 0.0 111.587 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -76.09 172.95 11.93 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.067 1.347 . . . . 0.0 112.868 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -63.47 156.17 27.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.192 0.996 . . . . 0.0 113.642 -173.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 37.8 mtt -84.82 151.94 23.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.713 1.605 . . . . 0.0 111.364 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.9 m -67.7 139.87 56.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.207 0.603 . . . . 0.0 111.94 -173.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.3 p -131.75 16.92 4.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.862 1.265 . . . . 0.0 113.196 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.69 169.32 17.13 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 159.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.5 98.68 1.15 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.633 1.173 . . . . 0.0 112.076 -167.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.4 mtp -87.12 172.3 10.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.668 1.187 . . . . 0.0 113.579 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 36.8 m -160.74 170.4 20.83 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.794 1.238 . . . . 0.0 111.286 162.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.64 131.47 35.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.088 0.955 . . . . 0.0 109.324 162.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.1 -37.97 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.877 0.871 . . . . 0.0 109.797 162.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -130.97 126.78 36.91 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.723 1.609 . . . . 0.0 108.409 173.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -60.73 149.98 77.67 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.355 0.662 . . . . 0.0 111.678 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.56 132.59 43.98 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.026 1.817 . . . . 0.0 110.587 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 40.2 p -127.49 129.56 47.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.791 1.636 . . . . 0.0 108.805 172.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.89 136.07 57.89 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.555 0.693 . . . . 0.0 111.441 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.8 p -93.78 -15.15 25.43 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.251 1.421 . . . . 0.0 113.613 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.64 -6.66 8.26 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-O 118.447 -1.196 . . . . 0.0 114.66 -161.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -70.67 -10.21 58.86 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 120.32 2.06 . . . . 0.0 112.112 170.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 91.6 17.51 48.78 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.465 1.031 . . . . 0.0 112.912 -160.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.9 p -134.33 168.47 18.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.267 1.427 . . . . 0.0 111.283 -171.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 19.2 m -121.42 138.93 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.064 1.346 . . . . 0.0 109.292 166.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -114.36 130.07 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.698 1.199 . . . . 0.0 111.63 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.8 ptm -145.69 167.3 23.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.699 1.599 . . . . 0.0 112.797 -171.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -133.72 136.42 44.63 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.212 1.005 . . . . 0.0 109.684 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 21.3 m -116.54 168.25 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.799 1.24 . . . . 0.0 111.848 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -131.39 127.75 38.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.991 1.317 . . . . 0.0 112.053 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.07 146.77 32.5 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.149 1.38 . . . . 0.0 108.224 161.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -107.27 -62.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.163 2.575 . . . . 0.0 115.224 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.26 -174.27 4.88 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.383 1.473 . . . . 0.0 111.988 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 74.35 -36.81 0.97 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 126.593 2.044 . . . . 0.0 116.605 162.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.65 103.86 43.11 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.514 1.126 . . . . 0.0 111.963 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -64.88 128.88 21.82 Favored 'Trans proline' 0 C--N 1.35 0.61 0 N-CA-C 107.851 -1.634 . . . . 0.0 107.851 154.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.0 p -157.57 157.75 34.31 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.7 tptm -75.24 135.7 40.98 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.404 1.481 . . . . 0.0 109.094 164.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.5 119.99 58.51 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -168.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -100.38 81.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.61 2.873 . . . . 0.0 114.159 -164.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 95.1 t -107.5 128.11 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 162.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.68 152.75 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.873 1.269 . . . . 0.0 109.666 176.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.97 115.16 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.307 1.843 . . . . 0.0 106.837 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -127.51 160.25 32.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -161.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.27 -15.12 36.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.702 1.601 . . . . 0.0 112.612 171.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.21 153.75 38.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.683 1.593 . . . . 0.0 110.723 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.16 -14.16 34.55 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 11.5 t -123.93 14.34 9.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.581 1.552 . . . . 0.0 113.415 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 44.56 59.23 3.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.001 2.52 . . . . 0.0 115.917 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -78.09 -32.74 50.78 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.256 0.622 . . . . 0.0 112.182 156.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 45.4 mm -116.07 112.16 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.323 1.849 . . . . 0.0 109.973 -175.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -86.59 103.86 15.48 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.898 0.856 . . . . 0.0 111.846 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -88.2 -19.68 26.56 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.967 2.907 . . . . 0.0 114.439 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -118.59 -165.42 13.28 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 115.901 1.121 . . . . 0.0 115.901 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.2 mt -126.79 139.41 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 127.454 2.302 . . . . 0.0 110.366 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.15 129.65 37.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.848 1.259 . . . . 0.0 110.114 165.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 53.5 t -107.05 -50.92 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.711 0.804 . . . . 0.0 110.564 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.6 m -68.43 154.06 42.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.319 0.58 . . . . 0.0 109.641 163.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.9 m -54.43 154.66 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.702 1.201 . . . . 0.0 112.482 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -118.92 81.11 18.87 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.439 1.096 . . . . 0.0 110.547 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -82.96 -166.47 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 125.08 3.853 . . . . 0.0 112.846 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 39.1 pt -89.21 168.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.203 1.401 . . . . 0.0 111.511 164.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.31 120.34 13.66 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 158.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 85.9 p -73.12 -17.16 61.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.847 1.259 . . . . 0.0 113.838 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 97.5 m -144.06 157.51 44.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.748 2.419 . . . . 0.0 106.73 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -58.97 -21.48 58.71 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.861 -1.15 . . . . 0.0 113.914 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.79 15.32 29.0 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.689 1.996 . . . . 0.0 112.773 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -61.07 158.52 13.45 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 119.998 -1.689 . . . . 0.0 113.862 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -145.4 75.11 1.42 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.279 1.432 . . . . 0.0 113.861 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.5 149.52 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.509 1.524 . . . . 0.0 112.439 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.61 129.49 46.54 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 129.931 3.292 . . . . 0.0 109.301 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.87 134.41 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.281 1.432 . . . . 0.0 111.631 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -90.67 136.95 32.73 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.001 1.321 . . . . 0.0 111.869 154.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.74 159.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.884 1.274 . . . . 0.0 111.477 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -119.81 114.88 33.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.18 1.792 . . . . 0.0 111.128 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.3 159.97 13.09 Favored 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 123.665 2.91 . . . . 0.0 112.203 162.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.27 175.73 10.56 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.476 2.784 . . . . 0.0 111.026 163.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -63.4 145.62 55.22 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.57 -0.706 . . . . 0.0 111.332 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.76 -145.08 15.91 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.895 0.759 . . . . 0.0 111.47 -171.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -91.32 164.55 13.82 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.268 1.427 . . . . 0.0 112.255 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.2 m -161.54 158.88 27.08 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.326 -1.484 . . . . 0.0 111.212 158.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -116.03 116.1 27.29 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.88 111.91 22.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 124.952 1.301 . . . . 0.0 108.101 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.51 142.9 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.66 0.784 . . . . 0.0 109.727 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 94.3 t -116.92 110.22 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.963 1.705 . . . . 0.0 108.994 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.77 -179.39 24.25 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.187 0.898 . . . . 0.0 115.162 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 28.7 m -132.56 163.44 28.86 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.114 1.766 . . . . 0.0 109.388 171.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.33 -171.96 52.45 Favored Glycine 0 CA--C 1.535 1.298 0 O-C-N 121.559 -0.713 . . . . 0.0 112.925 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.26 -29.64 34.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.266 1.426 . . . . 0.0 113.697 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.6 m -73.36 -2.39 22.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.066 2.547 . . . . 0.0 114.801 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -81.66 115.4 20.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.09 0.859 . . . . 0.0 112.999 -172.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -81.63 162.91 22.89 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.879 -0.513 . . . . 0.0 111.277 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.5 t -140.4 147.54 39.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.768 1.227 . . . . 0.0 112.053 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -147.13 120.57 9.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.564 1.546 . . . . 0.0 111.119 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.6 130.17 39.07 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.794 1.238 . . . . 0.0 112.529 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -127.24 164.82 20.87 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.594 1.158 . . . . 0.0 112.224 164.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -133.26 150.51 51.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.41 1.884 . . . . 0.0 108.667 171.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -134.89 116.31 14.61 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.676 1.991 . . . . 0.0 109.498 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -60.35 146.31 44.66 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.536 1.934 . . . . 0.0 113.457 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -104.94 148.11 16.47 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.752 1.168 . . . . 0.0 112.909 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' SER . . . . . 0.432 ' HG ' ' C ' ' A' ' 398' ' ' LYS . 8.9 m -70.06 17.35 0.06 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.791 2.436 . . . . 0.0 117.092 -161.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 40.8 m -61.5 -20.69 63.48 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.137 0.575 . . . . 0.0 111.775 158.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.4 tp -149.45 156.65 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.597 1.959 . . . . 0.0 109.49 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 78.08 -81.27 1.31 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.347 0.975 . . . . 0.0 114.498 169.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.432 ' C ' ' HG ' ' A' ' 394' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.393 0 C-N-CA 124.998 1.319 . . . . 0.0 113.594 -169.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.6 m -90.57 -7.38 52.99 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -166.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.7 -25.81 66.71 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 57.9 tp -83.1 126.39 32.54 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.081 1.31 . . . . 0.0 108.065 159.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 t -55.05 167.07 0.44 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.782 1.233 . . . . 0.0 113.768 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -57.28 107.21 0.4 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.806 2.042 . . . . 0.0 111.263 -164.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -58.19 115.87 3.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.499 1.92 . . . . 0.0 110.686 -166.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 68.62 -7.91 2.59 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.449 1.499 . . . . 0.0 115.476 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 96.9 m -101.88 6.65 41.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.367 2.667 . . . . 0.0 110.626 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.3 m -154.32 151.26 28.88 Favored 'General case' 0 C--O 1.23 0.06 0 O-C-N 119.337 -2.102 . . . . 0.0 112.387 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -71.57 170.83 12.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.125 2.17 . . . . 0.0 112.864 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.64 153.42 36.07 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 39.6 mtt -91.05 151.58 20.98 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.893 1.677 . . . . 0.0 111.283 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.88 141.64 55.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.42 0.688 . . . . 0.0 112.621 -170.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.7 p -133.25 17.74 4.06 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -74.57 164.75 26.22 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.543 -0.723 . . . . 0.0 109.193 155.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.59 89.2 0.52 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.989 1.315 . . . . 0.0 111.913 -173.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 68.9 mtp -73.17 173.05 9.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.878 1.671 . . . . 0.0 113.693 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.7 m -157.37 163.46 38.58 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.203 -0.936 . . . . 0.0 111.855 162.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.42 125.93 29.99 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 3.6 t -76.61 -29.99 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 122.961 0.505 . . . . 0.0 109.779 162.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -135.6 126.48 27.55 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.048 1.739 . . . . 0.0 108.667 167.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -59.72 151.01 64.86 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.559 1.143 . . . . 0.0 111.87 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.67 132.42 35.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.05 1.834 . . . . 0.0 110.845 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 m -133.33 141.86 48.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.916 1.286 . . . . 0.0 109.933 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.19 136.82 58.1 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.309 0.644 . . . . 0.0 112.181 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 70.4 p -91.12 -8.02 49.97 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.977 1.311 . . . . 0.0 114.218 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.409 ' HA2' ' HE2' ' A' ' 398' ' ' LYS . . . 69.15 4.94 45.63 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.802 -0.999 . . . . 0.0 114.909 -163.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -111.34 13.3 21.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.05 1.425 . . . . 0.0 112.316 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.59 14.15 71.31 Favored Glycine 0 CA--C 1.536 1.371 0 O-C-N 121.374 -0.829 . . . . 0.0 113.651 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 39.5 p -135.17 164.61 27.3 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.273 1.429 . . . . 0.0 111.296 -171.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.4 m -128.14 135.79 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.527 1.531 . . . . 0.0 110.061 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.44 129.76 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.886 1.275 . . . . 0.0 113.704 -167.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -143.52 164.98 28.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.462 1.505 . . . . 0.0 114.32 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -122.35 125.49 46.04 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.542 2.337 . . . . 0.0 107.65 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.97 138.55 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.018 0.927 . . . . 0.0 111.707 -167.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -111.66 129.13 56.19 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.614 1.165 . . . . 0.0 113.135 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.44 142.73 25.19 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.416 1.486 . . . . 0.0 108.607 165.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -100.45 -72.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.907 2.404 . . . . 0.0 115.714 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 168.15 20.47 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.429 -1.42 . . . . 0.0 113.934 -173.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.84 -12.46 0.37 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.833 2.158 . . . . 0.0 117.879 171.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -117.22 98.63 52.15 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 119.422 1.611 . . . . 0.0 113.621 -163.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -68.44 133.85 29.26 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 148.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -161.76 156.82 23.34 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.851 0.86 . . . . 0.0 111.058 -176.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -70.38 135.4 48.74 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.497 1.119 . . . . 0.0 108.292 162.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.9 pp -60.85 118.41 34.9 Favored Pre-proline 0 CA--C 1.554 1.124 0 CA-C-N 118.252 0.478 . . . . 0.0 111.732 -170.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -94.84 86.75 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.597 2.865 . . . . 0.0 114.034 -159.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 37.1 t -121.73 128.4 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.418 1.487 . . . . 0.0 109.119 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.24 161.81 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.722 1.209 . . . . 0.0 111.988 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 55.2 t -138.93 118.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.406 2.283 . . . . 0.0 107.946 173.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.44 168.4 16.38 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -164.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.43 -8.83 58.19 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.708 2.003 . . . . 0.0 113.294 163.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -131.46 153.01 50.2 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.834 1.253 . . . . 0.0 110.899 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 23.9 mt -61.24 -26.06 67.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.4 t -108.36 10.4 27.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.743 1.617 . . . . 0.0 113.456 -169.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 44.12 67.71 0.64 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.736 2.414 . . . . 0.0 115.53 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -82.51 -38.31 24.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.368 1.067 . . . . 0.0 111.714 156.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.13 158.66 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.456 1.502 . . . . 0.0 109.663 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -125.45 97.79 5.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.576 1.15 . . . . 0.0 110.97 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -92.24 -26.6 18.1 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.328 2.251 . . . . 0.0 113.816 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -110.7 -170.74 19.53 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 29.8 mt -125.02 134.57 66.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 127.225 2.21 . . . . 0.0 110.078 -175.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 14.1 mt -68.69 122.73 19.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.357 1.063 . . . . 0.0 109.815 164.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 77.7 t -95.7 -49.82 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.593 0.757 . . . . 0.0 109.861 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 18.9 m -76.76 157.0 31.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.416 0.627 . . . . 0.0 110.695 171.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.9 156.17 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.428 1.491 . . . . 0.0 113.066 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -122.41 79.57 45.86 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.963 1.305 . . . . 0.0 111.292 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.18 -166.23 0.4 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 124.68 3.587 . . . . 0.0 113.106 171.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 39.9 pt -100.67 164.12 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.069 1.748 . . . . 0.0 111.503 168.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.93 113.78 3.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.329 1.051 . . . . 0.0 109.534 159.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 93.6 p -66.85 -33.4 75.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.159 1.384 . . . . 0.0 112.596 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 2.6 m -143.42 153.54 42.77 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.029 2.532 . . . . 0.0 106.467 -174.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.57 -23.05 66.8 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.411 -1.43 . . . . 0.0 114.649 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.8 8.87 20.94 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.402 1.481 . . . . 0.0 113.355 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.64 154.3 9.08 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.561 -1.337 . . . . 0.0 114.306 -169.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -154.22 114.84 3.97 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.242 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.83 155.37 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.247 1.019 . . . . 0.0 109.441 -170.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.1 120.07 39.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.806 2.443 . . . . 0.0 108.169 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.71 129.11 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.895 0.878 . . . . 0.0 111.151 -171.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -89.51 140.56 29.41 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.725 1.21 . . . . 0.0 111.926 158.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.84 151.19 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.383 1.473 . . . . 0.0 110.53 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -117.08 113.33 39.46 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.03 1.732 . . . . 0.0 110.067 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -80.31 160.84 22.97 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.848 2.365 . . . . 0.0 111.295 162.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.5 171.08 17.85 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.403 2.069 . . . . 0.0 110.272 161.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -62.22 142.01 57.91 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.695 -0.628 . . . . 0.0 111.182 171.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 103.68 -145.5 16.17 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.902 0.763 . . . . 0.0 112.095 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -83.11 162.49 21.3 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.734 1.213 . . . . 0.0 113.08 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 14.3 m -165.81 160.17 16.78 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.812 1.245 . . . . 0.0 111.717 161.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -121.09 118.19 29.11 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 13.9 mm -92.96 122.08 44.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.269 1.428 . . . . 0.0 107.852 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.02 142.35 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.512 0.725 . . . . 0.0 110.631 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.69 110.97 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 127.28 2.232 . . . . 0.0 108.81 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.9 -178.26 22.9 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.596 1.093 . . . . 0.0 114.587 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.4 m -135.71 167.09 21.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.853 2.061 . . . . 0.0 110.146 170.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 79.52 -167.25 51.72 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.568 -0.707 . . . . 0.0 112.683 -173.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -25.93 66.37 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.856 -0.79 . . . . 0.0 112.6 169.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.3 m -74.44 -2.74 26.81 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 129.008 2.923 . . . . 0.0 115.163 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -84.68 130.54 34.69 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.625 0.77 . . . . 0.0 111.876 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 13.7 mt -94.22 156.09 16.72 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.745 0.418 . . . . 0.0 110.37 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.6 t -138.4 148.27 44.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.038 0.935 . . . . 0.0 111.921 -170.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -145.32 118.96 9.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.386 1.474 . . . . 0.0 110.012 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.28 128.04 34.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.462 0.705 . . . . 0.0 110.808 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -127.05 152.57 47.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.077 0.951 . . . . 0.0 110.662 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.19 141.79 51.79 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.626 1.17 . . . . 0.0 108.592 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -125.23 126.79 45.73 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.087 1.355 . . . . 0.0 109.976 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -56.56 166.48 0.9 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.106 2.562 . . . . 0.0 112.552 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -75.73 72.61 1.76 Allowed Glycine 0 CA--C 1.529 0.933 0 O-C-N 121.391 -0.818 . . . . 0.0 111.55 174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 37.2 m -54.44 2.58 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 117.433 2.382 . . . . 0.0 117.433 -170.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 28.7 t -62.73 -10.58 13.21 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.605 -1.309 . . . . 0.0 113.627 159.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 6.2 tp -104.05 5.94 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.395 1.478 . . . . 0.0 112.281 165.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 96.33 173.1 35.45 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 126.286 1.898 . . . . 0.0 113.836 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.409 ' HE2' ' HA2' ' A' ' 314' ' ' GLY . 0.5 OUTLIER . . . . . 0 C--O 1.257 1.487 0 C-N-CA 129.689 3.196 . . . . 0.0 118.054 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 10.2 mmt . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.1 p -118.96 -0.98 11.06 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -172.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.43 -53.92 47.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.226 0.921 . . . . 0.0 113.032 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.32 122.9 16.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.5 t -47.17 158.2 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.699 2.0 . . . . 0.0 116.353 -167.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.37 119.58 8.8 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.074 1.75 . . . . 0.0 111.51 -164.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.409 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 2.4 mptp? -65.44 115.2 5.44 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.195 1.398 . . . . 0.0 110.557 -172.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.79 -48.07 2.6 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.983 1.278 . . . . 0.0 112.902 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 46.3 m -63.25 -1.53 1.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.386 2.274 . . . . 0.0 113.245 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.0 m -155.33 156.76 36.06 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 119.149 -2.22 . . . . 0.0 112.143 170.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -84.44 164.28 18.96 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.411 1.084 . . . . 0.0 113.513 -169.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 151.04 46.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.952 1.301 . . . . 0.0 113.214 -175.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 77.7 mtm -68.31 167.65 14.06 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.046 2.538 . . . . 0.0 114.66 -171.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.6 m -86.0 148.54 25.7 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.89 0.876 . . . . 0.0 111.456 176.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 6.7 p -136.95 23.08 3.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.097 1.359 . . . . 0.0 112.799 172.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -84.21 156.71 21.9 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.26 -0.9 . . . . 0.0 108.988 155.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.53 106.33 1.41 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.542 1.537 . . . . 0.0 111.575 -166.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 63.9 mtp -92.32 171.87 8.77 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.413 1.085 . . . . 0.0 112.839 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.8 m -163.69 162.33 24.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.663 1.185 . . . . 0.0 111.761 167.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.0 116.81 18.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.643 0.777 . . . . 0.0 110.21 169.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.16 -35.1 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.333 1.453 . . . . 0.0 110.288 163.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -134.64 129.84 35.48 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.385 1.474 . . . . 0.0 108.67 165.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -63.18 156.29 69.41 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.663 0.785 . . . . 0.0 112.275 173.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -62.58 132.46 38.02 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.132 1.888 . . . . 0.0 110.797 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 60.4 p -133.79 135.07 43.62 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.957 2.103 . . . . 0.0 108.79 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.55 140.15 58.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.075 0.852 . . . . 0.0 111.829 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 41.0 p -67.77 -17.49 64.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.598 1.959 . . . . 0.0 113.633 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 91.39 -6.66 80.72 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.349 0.976 . . . . 0.0 112.175 -164.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -98.51 1.16 46.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.724 1.21 . . . . 0.0 112.089 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 77.5 43.67 14.92 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 119.069 0.85 . . . . 0.0 111.094 -172.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 63.3 p -144.41 137.04 26.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.561 1.944 . . . . 0.0 108.194 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.8 m -110.66 125.06 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.223 0.919 . . . . 0.0 111.304 -172.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.87 131.03 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.753 1.621 . . . . 0.0 111.873 -173.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 11.2 ptp -141.83 166.1 25.65 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.998 2.119 . . . . 0.0 112.15 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -133.41 134.57 43.81 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.901 0.88 . . . . 0.0 110.38 171.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.8 m -132.01 135.31 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.221 1.008 . . . . 0.0 113.036 -165.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -89.73 131.86 35.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.29 1.836 . . . . 0.0 112.426 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 t -104.64 145.79 31.38 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.016 -1.469 . . . . 0.0 107.866 156.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -105.29 -72.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.617 2.211 . . . . 0.0 115.969 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.89 170.91 16.08 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 119.633 -1.917 . . . . 0.0 114.803 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.5 -4.24 3.01 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 126.18 1.848 . . . . 0.0 117.114 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.58 94.18 48.72 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 118.903 1.352 . . . . 0.0 112.063 -165.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.56 121.97 8.7 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.288 1.992 . . . . 0.0 108.952 163.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.2 p -157.84 154.45 28.03 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -77.13 142.01 39.92 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 156.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 14.5 pt -63.83 118.16 42.59 Favored Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -87.58 91.3 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.349 3.366 . . . . 0.0 113.178 -169.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.19 139.28 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.805 0.842 . . . . 0.0 109.703 169.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.63 147.11 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.371 1.468 . . . . 0.0 108.697 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.17 106.08 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -114.55 162.12 17.14 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -163.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.53 -9.62 57.13 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.854 2.062 . . . . 0.0 112.902 165.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -133.48 140.62 47.36 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.668 1.187 . . . . 0.0 110.528 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.28 -17.45 42.49 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -173.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -106.03 5.09 30.01 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.171 1.788 . . . . 0.0 113.601 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.57 78.91 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 129.557 3.143 . . . . 0.0 116.721 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.34 -36.91 11.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.398 1.479 . . . . 0.0 112.36 156.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 94.7 mt -103.12 136.06 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.135 1.374 . . . . 0.0 109.972 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.02 98.68 8.35 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.827 1.651 . . . . 0.0 110.02 -177.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -84.69 -52.32 6.17 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.249 2.62 . . . . 0.0 112.664 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -87.77 -172.91 47.76 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 116.204 1.242 . . . . 0.0 116.204 -170.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 45.5 mt -126.75 143.15 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.118 1.767 . . . . 0.0 111.048 -172.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 86.6 mt -68.84 138.45 54.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.033 0.933 . . . . 0.0 111.14 168.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.06 -42.8 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.267 0.485 . . . . 0.0 111.433 169.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 m -76.28 149.72 37.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.901 0.773 . . . . 0.0 109.491 158.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.98 157.59 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.296 1.038 . . . . 0.0 111.898 170.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -114.52 78.14 4.74 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.838 1.655 . . . . 0.0 110.647 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.12 -170.93 0.94 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.747 3.632 . . . . 0.0 114.013 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 42.8 pt -95.58 166.89 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.194 1.798 . . . . 0.0 111.657 172.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.15 124.47 24.19 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.681 0.792 . . . . 0.0 109.853 156.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.8 p -80.07 -40.31 27.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.136 1.375 . . . . 0.0 111.984 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.86 148.5 38.47 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.313 1.845 . . . . 0.0 108.399 159.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -59.92 -20.65 58.57 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.08 8.28 38.5 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.209 1.403 . . . . 0.0 112.954 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -61.45 155.12 22.54 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 119.983 -1.698 . . . . 0.0 113.779 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -132.92 95.49 3.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.965 1.306 . . . . 0.0 111.9 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.75 145.65 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.846 1.258 . . . . 0.0 111.922 -160.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 51.8 tp -102.61 127.16 49.82 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.099 2.96 . . . . 0.0 110.668 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.66 147.06 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.174 1.39 . . . . 0.0 110.907 -173.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -120.93 149.55 42.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.367 1.067 . . . . 0.0 113.632 161.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 2.4 m -137.42 158.21 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.855 2.062 . . . . 0.0 110.754 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -111.71 102.54 53.69 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.892 1.677 . . . . 0.0 110.793 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.87 139.12 27.03 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.553 2.169 . . . . 0.0 110.031 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.9 171.54 15.52 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.193 1.929 . . . . 0.0 111.208 170.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -64.55 150.57 46.54 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.703 -0.623 . . . . 0.0 112.21 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.57 -150.36 20.03 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -159.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -89.41 158.56 17.7 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.728 1.611 . . . . 0.0 113.22 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.4 m -158.72 151.26 21.83 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.174 -1.579 . . . . 0.0 112.04 166.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -118.39 109.28 16.08 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.84 108.63 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.91 142.19 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.01 112.32 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 125.355 1.462 . . . . 0.0 108.646 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.4 177.9 20.79 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.262 1.411 . . . . 0.0 114.995 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.5 m -136.08 161.05 36.77 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.043 1.737 . . . . 0.0 109.357 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.53 -166.73 54.58 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 121.558 0.532 . . . . 0.0 112.501 -170.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -27.34 14.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.708 1.603 . . . . 0.0 113.631 172.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.7 m -69.9 -4.15 19.14 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 129.199 3.0 . . . . 0.0 115.308 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -91.72 123.62 35.25 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.8 0.727 . . . . 0.0 112.928 -167.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.48 168.08 11.09 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.411 0.684 . . . . 0.0 111.289 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.1 t -140.09 149.22 42.82 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.172 1.389 . . . . 0.0 111.369 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -145.94 123.16 11.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.291 1.836 . . . . 0.0 109.923 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.43 133.01 39.99 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.268 -0.895 . . . . 0.0 111.85 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -121.59 162.86 19.88 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.332 1.053 . . . . 0.0 111.031 160.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -142.86 145.77 33.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.926 1.29 . . . . 0.0 108.708 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -133.84 114.3 13.2 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.214 1.405 . . . . 0.0 110.221 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -84.23 173.67 10.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.802 0.841 . . . . 0.0 111.918 172.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 76.74 78.11 0.74 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.754 0.693 . . . . 0.0 113.129 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.7 t -57.3 -12.98 2.77 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 73.8 p -90.16 -1.9 58.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.299 1.84 . . . . 0.0 114.163 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.9 tt -66.51 -12.1 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.946 1.248 . . . . 0.0 112.971 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 73.91 -28.84 0.93 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.413 1.958 . . . . 0.0 115.825 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 C-N-CA 125.713 1.605 . . . . 0.0 112.881 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 56.1 mmm . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.8 p -101.34 -0.47 35.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.93 -31.48 60.36 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.9 tt -98.8 125.25 44.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 161.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.9 t -53.58 162.94 0.73 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.593 1.157 . . . . 0.0 113.883 -171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -49.88 110.49 0.39 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.636 1.974 . . . . 0.0 111.161 -162.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -55.43 124.05 15.91 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.901 1.681 . . . . 0.0 110.421 -168.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 59.92 9.2 9.73 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.98 1.276 . . . . 0.0 115.445 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 20.3 m -134.15 10.01 3.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.762 2.025 . . . . 0.0 110.181 -160.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.6 m -161.48 158.19 26.2 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 119.709 -1.869 . . . . 0.0 110.612 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -79.2 172.23 14.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.102 0.961 . . . . 0.0 112.976 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -71.57 160.12 33.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -77.8 152.66 33.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.409 2.284 . . . . 0.0 112.26 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -71.47 144.64 49.63 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.572 -0.705 . . . . 0.0 112.574 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.8 p -134.56 17.35 3.63 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.149 1.38 . . . . 0.0 113.391 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -75.65 161.19 29.31 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.928 -1.107 . . . . 0.0 109.009 154.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 87.58 0.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.991 1.316 . . . . 0.0 111.347 -168.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 55.9 mtp -70.05 172.97 7.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.906 2.082 . . . . 0.0 114.277 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.8 m -157.85 164.7 36.7 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.98 0.912 . . . . 0.0 111.998 158.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.95 121.61 25.67 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.263 0.625 . . . . 0.0 110.407 166.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.5 -37.14 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.107 1.363 . . . . 0.0 110.121 166.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -131.93 123.13 26.8 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.905 1.282 . . . . 0.0 108.91 169.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -63.43 149.87 90.97 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.132 0.973 . . . . 0.0 111.682 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.45 139.41 70.66 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.716 2.277 . . . . 0.0 112.327 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 49.0 p -141.94 129.59 21.53 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.36 1.864 . . . . 0.0 109.875 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -56.51 126.43 26.49 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.781 0.719 . . . . 0.0 111.679 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.5 p -68.64 -15.6 63.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.8 2.04 . . . . 0.0 113.51 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 93.76 -21.75 39.67 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.748 1.642 . . . . 0.0 112.047 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -74.38 -20.17 60.17 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.386 1.093 . . . . 0.0 112.426 172.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 103.01 18.77 14.16 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.444 1.02 . . . . 0.0 112.503 -168.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.5 p -120.93 149.28 42.88 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 126.548 1.939 . . . . 0.0 108.208 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 33.7 m -118.75 123.61 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.144 0.978 . . . . 0.0 110.096 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.0 p -96.79 127.16 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.968 1.307 . . . . 0.0 111.342 -174.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.1 ptm -147.67 161.43 41.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.526 1.531 . . . . 0.0 112.934 -172.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -134.26 134.21 41.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 110.622 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 23.8 m -131.04 122.36 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.414 1.086 . . . . 0.0 113.353 -162.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -89.75 123.34 33.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.257 2.223 . . . . 0.0 112.247 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.79 146.36 31.25 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 117.235 -1.364 . . . . 0.0 108.235 156.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -101.25 -71.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.722 2.281 . . . . 0.0 115.896 174.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.47 163.96 34.02 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 119.534 -1.979 . . . . 0.0 114.701 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 61.74 7.79 12.89 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.681 1.61 . . . . 0.0 116.333 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.23 88.76 33.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 118.612 1.206 . . . . 0.0 112.319 -162.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.02 118.54 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.15 1.9 . . . . 0.0 108.377 161.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.7 p -157.48 156.59 32.35 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.731 0.777 . . . . 0.0 112.998 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -77.63 142.51 38.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.904 1.682 . . . . 0.0 108.397 163.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.42 123.38 73.3 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 119.287 0.948 . . . . 0.0 111.346 -172.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -102.04 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.583 2.855 . . . . 0.0 113.524 -164.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.24 120.56 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.641 0.776 . . . . 0.0 109.017 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.68 158.47 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.581 1.153 . . . . 0.0 110.465 -174.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.74 104.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.943 2.097 . . . . 0.0 108.085 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.03 159.14 36.88 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.709 1.004 . . . . 0.0 113.709 -160.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.21 -14.33 61.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.718 2.007 . . . . 0.0 112.944 166.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -129.86 140.56 50.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.531 1.532 . . . . 0.0 111.022 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.92 -20.99 60.46 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.4 t -101.22 7.3 43.09 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.866 1.667 . . . . 0.0 113.649 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.18 63.96 1.36 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.799 2.44 . . . . 0.0 115.668 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.13 -50.7 13.92 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.736 0.814 . . . . 0.0 110.876 155.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 15.4 mm -84.41 160.94 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.356 0.598 . . . . 0.0 109.617 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -138.66 61.52 1.57 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.03 -1.044 . . . . 0.0 111.679 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -53.28 -50.81 64.1 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.067 2.547 . . . . 0.0 113.72 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -80.5 -172.0 44.54 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 116.059 1.184 . . . . 0.0 116.059 -168.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.7 mt -123.99 137.35 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.556 1.543 . . . . 0.0 110.175 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.8 mp -77.16 126.62 31.24 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 161.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.97 -46.43 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.557 1.143 . . . . 0.0 109.62 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 31.6 m -73.82 161.01 30.64 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.448 0.642 . . . . 0.0 110.488 167.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.6 t -53.54 153.09 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.94 1.696 . . . . 0.0 111.026 173.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -111.61 76.59 1.59 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.07 1.348 . . . . 0.0 110.991 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -75.74 -174.47 2.04 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.947 3.098 . . . . 0.0 112.8 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.2 pt -91.36 168.16 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.049 1.339 . . . . 0.0 111.715 168.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.92 110.13 2.34 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 154.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.4 p -72.04 -37.3 69.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.166 1.386 . . . . 0.0 112.146 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.37 158.0 29.24 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.573 1.949 . . . . 0.0 109.306 158.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -62.1 -20.06 63.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -100.35 11.1 40.19 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.653 1.581 . . . . 0.0 112.408 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -60.6 148.57 37.77 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.596 -1.315 . . . . 0.0 113.705 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -132.17 82.19 2.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.811 1.644 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 11.5 t -94.91 146.39 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.335 1.054 . . . . 0.0 111.202 -164.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 39.8 tp -104.7 123.38 47.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.417 2.687 . . . . 0.0 111.073 -173.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 2.9 mp -141.14 141.17 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.533 1.933 . . . . 0.0 111.041 -170.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -94.04 139.61 30.75 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.637 1.175 . . . . 0.0 111.94 158.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.04 166.24 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.022 1.329 . . . . 0.0 111.004 168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -129.55 108.61 17.37 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 125.894 1.678 . . . . 0.0 110.11 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.64 149.43 26.82 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.568 2.179 . . . . 0.0 110.231 158.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.81 170.16 20.31 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.224 1.949 . . . . 0.0 111.472 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -57.78 129.59 42.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.003 0.921 . . . . 0.0 110.225 168.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 110.76 -139.05 15.32 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.984 0.802 . . . . 0.0 111.898 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -86.85 167.15 14.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.264 1.025 . . . . 0.0 113.287 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.2 m -178.23 163.46 1.66 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.762 2.425 . . . . 0.0 111.04 158.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -127.2 126.58 43.04 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.628 1.571 . . . . 0.0 107.698 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.0 mm -95.26 122.05 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.214 1.406 . . . . 0.0 108.016 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.1 142.81 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.611 0.764 . . . . 0.0 110.2 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 67.9 t -115.92 109.1 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.943 1.697 . . . . 0.0 108.653 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.05 -173.5 20.72 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 123.358 1.532 . . . . 0.0 115.338 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.0 m -140.4 163.91 31.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.487 1.515 . . . . 0.0 109.843 171.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.19 -167.85 54.02 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 121.65 0.583 . . . . 0.0 112.775 -171.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.51 -29.14 6.28 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 114.028 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.0 m -71.34 -11.77 61.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.401 2.681 . . . . 0.0 114.693 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -79.69 109.45 14.1 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -164.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.16 158.0 33.72 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.11 -0.369 . . . . 0.0 110.779 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 2.7 t -136.26 143.93 44.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.754 1.222 . . . . 0.0 111.006 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -144.67 123.17 12.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.595 1.558 . . . . 0.0 110.134 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.39 124.86 24.99 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.359 -0.838 . . . . 0.0 111.945 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -130.1 123.37 30.25 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.213 0.605 . . . . 0.0 110.397 161.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -123.37 146.76 47.7 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -128.59 115.05 17.49 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.276 1.031 . . . . 0.0 110.496 -162.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.27 161.31 27.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.008 0.923 . . . . 0.0 112.131 172.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -70.46 27.73 0.46 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 126.352 1.929 . . . . 0.0 116.676 -169.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' SER . . . . . 0.427 ' O ' ' HE3' ' A' ' 398' ' ' LYS . 60.4 m -66.0 89.96 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.844 1.322 . . . . 0.0 110.756 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 82.7 p -114.62 1.0 14.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.221 1.408 . . . . 0.0 114.682 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 18.6 tt -140.32 154.47 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.54 1.536 . . . . 0.0 110.416 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 79.93 3.51 89.35 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 116.084 1.193 . . . . 0.0 116.084 171.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.454 ' C ' ' HZ3' ' A' ' 398' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.41 1.884 . . . . 0.0 111.754 -175.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.3 p -97.08 -7.05 33.68 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.76 95.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.527 1.058 . . . . 0.0 112.696 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.9 tt -63.06 129.62 41.16 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 7.5 t -49.45 163.45 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.299 1.44 . . . . 0.0 114.537 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -73.53 93.63 2.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.027 1.331 . . . . 0.0 111.134 -160.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.486 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 2.1 mptt -39.01 111.25 0.17 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.519 3.128 . . . . 0.0 112.417 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.01 -32.25 0.52 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.415 1.96 . . . . 0.0 115.111 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 62.7 m -70.98 -3.45 19.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.87 2.468 . . . . 0.0 112.304 171.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.9 m -156.66 154.23 29.78 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 119.311 -2.118 . . . . 0.0 111.199 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -78.71 174.58 11.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.12 1.368 . . . . 0.0 113.178 -173.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -65.27 161.09 20.15 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.041 1.336 . . . . 0.0 114.442 -170.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 71.3 mtm -91.21 150.47 21.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.139 2.175 . . . . 0.0 111.627 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.5 m -69.41 147.57 50.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.077 0.951 . . . . 0.0 112.571 -174.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.6 p -136.38 11.12 3.24 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -76.82 165.04 25.25 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 119.433 1.015 . . . . 0.0 109.553 161.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.48 89.63 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.225 1.41 . . . . 0.0 113.727 -167.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 44.7 mtp -76.64 167.18 22.28 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.639 1.176 . . . . 0.0 113.659 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.5 m -160.69 162.78 32.7 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.875 1.27 . . . . 0.0 110.555 161.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.7 130.57 34.53 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.978 -0.452 . . . . 0.0 110.727 164.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.36 -28.85 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.634 1.573 . . . . 0.0 110.197 167.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -129.99 116.94 19.3 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.531 1.532 . . . . 0.0 108.257 163.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -55.94 150.12 30.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.784 1.234 . . . . 0.0 111.081 169.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.5 138.31 69.79 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.81 1.673 . . . . 0.0 110.808 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' THR . . . . . 0.412 ' HA ' ' CZ2' ' A' ' 389' ' ' TRP . 0.9 OUTLIER -144.28 142.59 30.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.089 0.556 . . . . 0.0 110.158 175.061 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -63.48 126.3 27.03 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.727 1.611 . . . . 0.0 112.413 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 82.5 p -73.84 -25.89 60.31 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.001 1.32 . . . . 0.0 112.68 173.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 84.98 -2.41 88.32 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.501 1.524 . . . . 0.0 114.538 -164.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -87.2 6.06 34.92 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.334 1.453 . . . . 0.0 112.038 171.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 83.1 20.08 61.56 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 121.094 -1.004 . . . . 0.0 112.829 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 33.4 p -131.9 154.22 49.44 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.056 1.343 . . . . 0.0 110.688 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 24.1 m -122.81 128.95 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.685 1.194 . . . . 0.0 109.347 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.41 132.88 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.467 1.107 . . . . 0.0 112.21 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -141.8 162.42 35.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.658 1.583 . . . . 0.0 113.778 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -121.48 114.14 20.83 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.472 2.309 . . . . 0.0 107.006 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.95 138.31 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.693 1.197 . . . . 0.0 111.018 -167.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -119.63 136.64 54.3 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 8.5 t -102.46 150.33 37.52 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 127.301 2.24 . . . . 0.0 108.591 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -102.62 -74.03 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 122.907 2.405 . . . . 0.0 115.888 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.18 162.36 34.46 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.785 1.63 . . . . 0.0 114.498 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 59.94 -0.18 0.88 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 127.193 2.33 . . . . 0.0 118.272 170.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.38 94.67 23.12 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 119.681 1.741 . . . . 0.0 113.304 -164.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.64 115.79 4.45 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.461 2.107 . . . . 0.0 108.935 163.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.0 p -150.77 155.41 39.2 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.924 0.869 . . . . 0.0 112.715 -175.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -74.14 136.36 42.9 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.262 1.425 . . . . 0.0 107.977 163.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . 0.273 2.6 pp -62.27 129.44 92.28 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.415 -169.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -100.43 89.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.005 2.47 . . . . 0.0 113.635 -160.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 94.4 t -118.22 130.71 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.994 1.318 . . . . 0.0 109.602 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.33 151.67 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 111.51 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.7 t -126.82 104.18 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.415 1.886 . . . . 0.0 107.508 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -115.1 161.81 17.88 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -163.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.71 -11.73 58.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.222 1.809 . . . . 0.0 112.722 163.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.65 146.37 49.46 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.724 1.21 . . . . 0.0 111.75 -176.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.05 -16.14 63.66 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -99.63 5.27 45.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.558 1.143 . . . . 0.0 112.983 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 37.8 77.83 0.04 OUTLIER 'General case' 0 C--O 1.239 0.548 0 C-N-CA 129.124 2.97 . . . . 0.0 115.115 -169.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -106.72 -25.43 11.75 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.394 1.877 . . . . 0.0 112.918 166.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.95 119.72 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.599 1.56 . . . . 0.0 109.436 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.1 123.54 50.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -107.85 -16.93 14.2 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -93.52 -177.59 39.96 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 119.853 1.206 . . . . 0.0 116.046 -176.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 86.9 mt -126.63 136.2 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 127.926 2.491 . . . . 0.0 110.058 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mt -72.73 136.99 45.64 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.186 0.995 . . . . 0.0 110.882 168.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.14 -46.66 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.257 0.623 . . . . 0.0 111.466 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 47.6 m -68.99 153.12 44.35 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.384 0.538 . . . . 0.0 109.787 159.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.38 161.28 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.574 1.149 . . . . 0.0 113.028 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -118.04 79.13 13.77 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.284 1.434 . . . . 0.0 111.105 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -78.88 -171.22 1.18 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 123.731 2.954 . . . . 0.0 112.332 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.27 167.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.091 1.357 . . . . 0.0 111.383 171.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.1 117.01 10.2 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 156.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 86.0 p -67.28 -28.41 68.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.589 1.156 . . . . 0.0 112.809 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 21.5 m -137.23 151.28 48.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 128.254 2.621 . . . . 0.0 106.717 -172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.9 -26.63 66.07 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.524 -1.36 . . . . 0.0 113.684 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -89.14 2.51 54.06 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.328 1.851 . . . . 0.0 113.413 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -58.58 154.37 14.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.933 1.349 . . . . 0.0 113.25 -166.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -144.53 95.32 2.69 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.945 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.87 149.54 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.106 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 45.2 tp -93.99 124.62 38.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.485 2.314 . . . . 0.0 109.412 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.23 135.1 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.746 0.818 . . . . 0.0 110.551 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -106.01 140.07 39.57 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.21 1.005 . . . . 0.0 112.402 158.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.19 151.53 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.974 2.11 . . . . 0.0 110.025 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -108.92 113.01 59.85 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.296 1.838 . . . . 0.0 109.774 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.62 159.42 25.22 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.538 2.159 . . . . 0.0 111.108 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.17 173.17 3.43 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.703 2.269 . . . . 0.0 112.176 163.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -64.35 141.0 58.93 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.785 -0.572 . . . . 0.0 110.149 163.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 99.47 -140.59 15.06 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.575 0.607 . . . . 0.0 111.787 -174.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -88.24 164.71 15.49 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.713 1.205 . . . . 0.0 113.393 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 13.2 m -167.31 152.96 7.55 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.38 1.472 . . . . 0.0 111.821 165.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -118.95 113.92 21.75 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 31.9 mm -88.48 115.02 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 125.864 1.666 . . . . 0.0 107.734 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -113.51 140.83 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 122.021 0.915 . . . . 0.0 111.263 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.59 114.07 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 127.02 2.128 . . . . 0.0 108.251 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 98.36 178.09 32.81 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 122.662 1.146 . . . . 0.0 114.76 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 48.6 m -130.45 165.62 22.23 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.279 1.832 . . . . 0.0 109.353 171.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.87 -171.97 54.26 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 121.675 -0.64 . . . . 0.0 113.059 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.23 -23.1 33.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.33 1.452 . . . . 0.0 113.999 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.3 m -82.84 -2.73 55.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.482 2.313 . . . . 0.0 114.909 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -76.79 126.53 31.14 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.456 1.025 . . . . 0.0 113.068 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -90.05 161.89 15.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.147 0.579 . . . . 0.0 111.652 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.3 t -137.78 151.36 48.06 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.192 1.397 . . . . 0.0 112.59 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -150.13 131.77 14.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.314 1.846 . . . . 0.0 110.328 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.51 136.43 36.9 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.969 -1.082 . . . . 0.0 111.98 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . 0.412 ' CZ2' ' HA ' ' A' ' 311' ' ' THR . 21.2 m95 -125.53 152.73 44.64 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.698 0.761 . . . . 0.0 112.243 161.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -133.3 134.15 43.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.053 1.341 . . . . 0.0 108.365 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -127.82 118.9 24.57 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.351 1.46 . . . . 0.0 110.747 -167.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 157.42 16.46 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.329 2.252 . . . . 0.0 111.914 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -76.83 41.73 1.74 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.61 1.1 . . . . 0.0 114.131 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.53 -63.5 0.67 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.905 1.682 . . . . 0.0 110.929 -173.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.4 m -78.22 52.2 1.09 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.78 2.032 . . . . 0.0 110.262 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 15.9 tt -127.92 -14.02 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 130.612 3.565 . . . . 0.0 111.322 167.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -108.06 16.87 35.61 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.579 1.561 . . . . 0.0 114.224 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp . . . . . 0 C--O 1.248 0.997 0 C-N-CA 125.017 1.327 . . . . 0.0 109.687 171.142 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 20.0 m -103.23 11.28 37.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.094 1.357 . . . . 0.0 113.344 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -72.25 -39.28 68.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.609 1.095 . . . . 0.0 111.011 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.5 tt -72.68 138.76 46.84 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 164.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.4 t -55.73 176.91 0.06 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.142 1.777 . . . . 0.0 114.973 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -68.58 83.49 0.28 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.846 1.658 . . . . 0.0 110.451 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.428 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 1.8 mptt -38.12 119.53 0.79 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.238 2.615 . . . . 0.0 112.481 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.86 -37.38 1.06 Allowed Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.745 1.64 . . . . 0.0 114.696 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 58.3 m -75.01 1.39 13.09 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.503 2.321 . . . . 0.0 112.593 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.0 m -158.19 149.93 21.53 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 119.037 -2.289 . . . . 0.0 111.715 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -84.71 178.78 7.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.972 1.309 . . . . 0.0 113.302 -169.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -63.93 162.19 14.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.263 1.425 . . . . 0.0 114.254 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -69.92 157.41 37.49 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.641 1.576 . . . . 0.0 111.853 166.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.7 m -75.29 145.8 41.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.194 0.598 . . . . 0.0 110.255 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.0 p -133.67 21.0 3.9 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.909 1.283 . . . . 0.0 112.022 170.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -82.88 168.48 17.04 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 155.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 100.71 0.27 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.244 1.418 . . . . 0.0 112.067 -166.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 16.7 mtp -86.41 166.14 15.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.022 0.915 . . . . 0.0 112.21 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 18.9 m -163.58 163.31 24.57 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.261 1.024 . . . . 0.0 111.122 169.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.8 114.45 22.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.475 0.71 . . . . 0.0 109.129 163.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.26 -37.91 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.571 1.149 . . . . 0.0 109.552 161.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -135.16 120.49 19.04 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.682 1.593 . . . . 0.0 108.405 168.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -59.62 152.8 54.83 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.31 1.044 . . . . 0.0 110.977 172.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.38 137.06 63.0 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.094 1.863 . . . . 0.0 111.489 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.3 m -132.88 135.01 45.33 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.858 1.263 . . . . 0.0 109.225 173.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.06 130.12 43.3 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.253 0.549 . . . . 0.0 111.97 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 70.3 p -79.43 -21.06 46.06 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.709 1.203 . . . . 0.0 113.333 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 80.98 -8.34 57.43 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.761 1.172 . . . . 0.0 114.364 -161.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -87.97 6.26 36.75 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.298 1.439 . . . . 0.0 112.06 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 88.51 14.49 61.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.282 0.944 . . . . 0.0 113.092 -171.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 50.5 p -131.63 161.17 33.34 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.111 1.364 . . . . 0.0 111.259 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.27 133.02 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 125.253 1.421 . . . . 0.0 109.222 169.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.4 p -115.58 131.87 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.908 1.283 . . . . 0.0 112.05 -172.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 15.8 ptm -144.95 163.18 34.95 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.406 2.282 . . . . 0.0 112.069 -169.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -132.61 130.84 40.76 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.756 0.822 . . . . 0.0 108.915 173.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.47 145.15 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.171 0.988 . . . . 0.0 111.379 -165.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -105.17 135.82 45.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.737 1.215 . . . . 0.0 112.429 -175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.6 t -114.74 135.55 22.38 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.891 1.676 . . . . 0.0 107.714 163.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -100.65 -61.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.899 2.399 . . . . 0.0 115.164 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.96 176.11 11.82 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.714 -1.241 . . . . 0.0 113.091 -176.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.66 -23.19 0.18 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 128.097 2.76 . . . . 0.0 118.683 160.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -109.11 104.09 54.09 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 119.257 1.529 . . . . 0.0 112.766 -166.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.76 114.04 3.19 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.583 1.522 . . . . 0.0 108.502 159.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.7 p -148.8 154.55 39.69 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.997 0.903 . . . . 0.0 112.233 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -78.14 134.92 37.6 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.321 1.448 . . . . 0.0 107.573 161.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -60.08 117.71 26.24 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 118.574 0.625 . . . . 0.0 111.308 -171.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -96.93 88.54 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.348 2.699 . . . . 0.0 113.752 -166.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 60.6 t -107.75 136.26 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 164.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.05 161.07 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.897 1.279 . . . . 0.0 111.104 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 93.0 t -139.34 106.24 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.05 1.74 . . . . 0.0 109.071 -174.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.24 163.01 26.56 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -158.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -87.34 -17.73 31.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.468 1.907 . . . . 0.0 112.883 163.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -123.64 153.05 41.3 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.598 1.159 . . . . 0.0 111.108 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 54.1 mt -69.23 -2.38 10.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.445 1.098 . . . . 0.0 113.883 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 2.2 t -129.4 18.61 5.85 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.579 1.551 . . . . 0.0 112.198 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 49.62 31.25 4.09 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.5 -25.87 68.24 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.745 -0.597 . . . . 0.0 112.388 166.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 31.9 mt -121.95 117.52 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.533 2.333 . . . . 0.0 107.693 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.94 115.66 29.88 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.91 0.777 . . . . 0.0 111.279 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -103.16 -10.44 18.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -99.33 -167.97 30.18 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 54.5 mt -132.04 133.69 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 127.86 2.464 . . . . 0.0 110.45 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 23.0 mt -65.25 121.0 13.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.932 1.293 . . . . 0.0 109.942 160.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 50.5 t -102.59 -51.89 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 122.924 0.49 . . . . 0.0 110.635 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.4 m -69.85 163.41 25.92 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.509 0.595 . . . . 0.0 110.424 168.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.4 t -52.81 147.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.587 1.155 . . . . 0.0 110.437 170.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -112.13 78.68 2.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.068 1.347 . . . . 0.0 110.2 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.15 -174.2 2.15 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 123.909 3.073 . . . . 0.0 113.349 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -94.01 168.37 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.521 1.528 . . . . 0.0 110.948 167.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.54 110.99 3.89 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 156.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 83.3 p -73.27 -36.99 66.44 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.094 1.358 . . . . 0.0 112.073 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.79 154.36 37.09 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.721 2.008 . . . . 0.0 109.093 160.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -64.82 -19.0 65.61 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.48 0.87 56.57 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.017 1.727 . . . . 0.0 112.919 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -57.84 149.54 22.27 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.503 -1.373 . . . . 0.0 114.074 -171.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -138.91 86.76 2.16 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.118 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.03 145.88 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.794 1.237 . . . . 0.0 111.6 -170.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 45.8 tp -92.35 126.42 37.43 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.059 2.944 . . . . 0.0 110.502 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.8 145.14 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.662 1.585 . . . . 0.0 109.823 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -116.79 149.57 39.75 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.099 0.952 . . . . 0.0 111.948 159.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.19 154.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 125.564 1.546 . . . . 0.0 110.162 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -103.24 114.18 65.23 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.659 1.184 . . . . 0.0 110.22 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.57 143.8 15.38 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.019 2.48 . . . . 0.0 110.969 162.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -74.86 167.68 26.54 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.862 2.375 . . . . 0.0 111.242 169.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -53.63 140.37 29.15 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.734 1.214 . . . . 0.0 112.206 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.9 -147.57 17.0 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -172.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -82.09 164.16 21.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.61 1.564 . . . . 0.0 112.083 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 33.4 m -161.39 148.25 14.64 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.662 -1.274 . . . . 0.0 112.419 158.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -110.14 106.41 15.86 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.104 0.961 . . . . 0.0 108.499 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.4 mm -84.14 114.97 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 125.836 1.655 . . . . 0.0 107.95 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.2 mt -115.64 143.78 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.502 1.121 . . . . 0.0 109.891 -169.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 52.5 t -120.84 113.84 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.679 1.592 . . . . 0.0 108.556 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 90.42 179.54 43.78 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 53.1 m -132.51 165.83 23.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.696 1.998 . . . . 0.0 109.341 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.17 -170.1 55.04 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.808 -0.557 . . . . 0.0 112.783 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -28.15 56.53 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.762 1.225 . . . . 0.0 113.643 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.0 m -78.21 -3.91 45.06 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 127.513 2.325 . . . . 0.0 115.041 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -78.91 144.33 34.99 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.694 0.679 . . . . 0.0 112.822 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.3 mt -111.07 163.88 13.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.615 0.766 . . . . 0.0 110.922 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.5 t -139.52 154.01 47.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.732 1.213 . . . . 0.0 111.459 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -149.19 135.73 19.43 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.89 1.676 . . . . 0.0 109.892 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.77 131.6 38.97 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.415 -0.803 . . . . 0.0 111.662 -172.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -123.72 166.23 15.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.115 0.966 . . . . 0.0 112.04 167.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -138.98 129.94 26.46 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.073 1.749 . . . . 0.0 108.368 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -111.82 119.58 39.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.81 1.644 . . . . 0.0 110.7 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.37 163.59 13.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 129.701 3.2 . . . . 0.0 111.202 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -77.28 42.29 1.9 Allowed Glycine 0 CA--C 1.534 1.223 0 O-C-N 120.911 -1.118 . . . . 0.0 114.202 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 3.5 p -138.0 -54.72 0.65 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.638 1.219 . . . . 0.0 113.09 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.8 m -82.98 54.2 2.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.565 1.946 . . . . 0.0 109.474 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 15.9 tt -135.26 -16.89 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 126.436 1.895 . . . . 0.0 113.73 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -135.1 37.13 1.97 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.934 1.254 . . . . 0.0 113.098 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.483 ' C ' ' HZ3' ' A' ' 398' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.674 0 C-N-CA 125.813 1.645 . . . . 0.0 110.288 -173.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.0 t -119.49 9.9 11.68 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.801 1.24 . . . . 0.0 113.374 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.57 -46.7 78.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.041 0.837 . . . . 0.0 110.909 167.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.07 129.15 38.88 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 164.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.7 t -57.02 171.33 0.36 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.163 1.385 . . . . 0.0 114.269 -173.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.34 109.08 1.79 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.614 1.965 . . . . 0.0 110.721 -167.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -63.78 114.61 4.14 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.989 2.116 . . . . 0.0 110.578 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 78.91 -40.84 2.12 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.827 1.203 . . . . 0.0 113.322 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 5.2 m -65.69 -0.81 2.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.752 2.421 . . . . 0.0 114.013 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.0 m -153.08 151.69 30.49 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 118.994 -2.316 . . . . 0.0 113.65 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -73.82 173.48 9.82 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.359 1.864 . . . . 0.0 112.827 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -71.47 152.77 42.77 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.338 1.055 . . . . 0.0 113.785 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -70.2 157.55 37.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.819 2.048 . . . . 0.0 112.337 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.4 m -69.82 140.51 53.3 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.546 -0.721 . . . . 0.0 111.735 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 17.2 p -128.18 7.1 5.95 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.496 ' CG ' ' HZ2' ' A' ' 326' ' ' LYS . 44.1 t0 -73.67 166.46 23.24 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.016 0.825 . . . . 0.0 110.888 164.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -71.03 84.15 0.7 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.016 1.727 . . . . 0.0 111.197 -170.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 41.3 mtp -66.63 172.46 4.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.383 1.873 . . . . 0.0 114.337 -174.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.5 m -157.69 159.34 36.81 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.489 1.116 . . . . 0.0 111.249 164.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.97 117.1 19.72 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 169.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.45 -33.49 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.025 0.53 . . . . 0.0 109.659 161.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -137.43 124.08 21.03 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.785 1.634 . . . . 0.0 108.026 164.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -59.18 160.91 10.71 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.211 0.604 . . . . 0.0 111.599 171.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -61.33 135.66 59.23 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.903 1.735 . . . . 0.0 110.589 167.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.0 m -138.48 138.44 38.1 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.766 1.226 . . . . 0.0 108.985 171.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.18 128.57 37.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.09 0.868 . . . . 0.0 111.567 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 73.8 p -79.63 -12.62 59.82 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.252 1.021 . . . . 0.0 113.723 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 75.45 0.69 63.13 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.394 0.997 . . . . 0.0 113.978 -164.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -111.67 14.52 21.21 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.189 1.796 . . . . 0.0 112.32 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.8 15.17 68.38 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.766 0.698 . . . . 0.0 113.501 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.4 p -134.61 162.67 31.64 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.691 1.197 . . . . 0.0 111.176 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.73 130.42 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.597 1.159 . . . . 0.0 109.625 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.33 132.9 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.843 1.257 . . . . 0.0 111.802 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 4.8 ptp -143.84 166.03 26.05 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.117 1.767 . . . . 0.0 112.345 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -133.88 128.71 35.18 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.679 1.192 . . . . 0.0 109.904 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.79 121.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.076 0.951 . . . . 0.0 112.22 -161.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.23 130.13 34.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.512 1.525 . . . . 0.0 112.028 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.29 137.4 19.42 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.985 1.314 . . . . 0.0 108.201 159.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -91.88 -77.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 122.9 2.4 . . . . 0.0 116.256 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.496 ' HZ2' ' CG ' ' A' ' 302' ' ' ASP . 0.0 OUTLIER -150.79 139.16 20.38 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -171.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 83.8 4.74 88.61 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.808 1.194 . . . . 0.0 115.422 174.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.61 89.43 18.53 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 118.664 1.232 . . . . 0.0 112.325 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.1 127.13 13.89 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.215 1.943 . . . . 0.0 108.676 159.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 5.0 p -162.77 162.9 26.88 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -74.4 143.37 44.82 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.04 1.736 . . . . 0.0 109.85 161.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 19.0 pt -66.37 123.91 86.72 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 118.713 0.688 . . . . 0.0 111.213 -176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -108.48 82.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.292 1.994 . . . . 0.0 115.186 -153.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 80.1 t -114.35 131.48 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.369 -0.832 . . . . 0.0 109.818 172.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.67 128.88 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.33 1.052 . . . . 0.0 110.07 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.9 t -99.99 119.53 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.586 1.555 . . . . 0.0 107.516 170.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -130.26 161.12 31.93 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -166.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.71 -18.26 58.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.331 1.853 . . . . 0.0 112.98 164.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -128.22 146.02 50.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.746 1.218 . . . . 0.0 111.618 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.74 -17.9 38.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.0 t -105.12 5.93 32.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.427 1.491 . . . . 0.0 113.417 -176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 40.16 75.96 0.07 Allowed 'General case' 0 C--O 1.239 0.519 0 C-N-CA 129.042 2.937 . . . . 0.0 115.801 -171.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.74 -51.3 4.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.069 1.347 . . . . 0.0 111.655 157.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 72.1 mt -102.57 104.73 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.697 1.599 . . . . 0.0 109.1 -174.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -84.16 115.58 22.48 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -95.3 -11.58 27.63 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.159 2.583 . . . . 0.0 114.562 -173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -115.12 -168.47 15.65 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.6 mt -129.44 135.38 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.404 2.281 . . . . 0.0 110.184 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.04 122.8 17.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.302 1.041 . . . . 0.0 110.555 164.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 73.5 t -102.22 -50.11 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.848 0.859 . . . . 0.0 109.861 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.0 m -69.35 153.27 43.86 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.279 0.562 . . . . 0.0 110.038 166.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.17 159.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.443 1.097 . . . . 0.0 112.236 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -120.93 75.45 28.39 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.043 0.937 . . . . 0.0 112.454 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -57.35 -167.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.127 1 C-N-CA 126.131 4.554 . . . . 0.0 117.221 162.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 27.5 pt -112.14 166.88 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.703 2.401 . . . . 0.0 111.324 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.31 105.34 2.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.988 0.915 . . . . 0.0 109.022 155.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.5 p -72.79 -50.45 24.22 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.391 1.476 . . . . 0.0 111.314 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.59 152.34 19.15 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.991 1.317 . . . . 0.0 108.825 156.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -60.61 -19.02 56.67 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.11 0.39 56.75 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.107 1.763 . . . . 0.0 112.955 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -58.66 147.4 32.85 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.471 -1.393 . . . . 0.0 113.653 -172.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.79 79.54 1.85 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.519 1.528 . . . . 0.0 111.252 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.35 148.56 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.569 1.148 . . . . 0.0 111.502 -165.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.53 127.23 39.09 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.908 2.883 . . . . 0.0 109.798 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.57 141.76 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.002 1.321 . . . . 0.0 109.86 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -119.19 152.35 36.75 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 122.453 1.12 . . . . 0.0 112.573 162.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.8 m -140.89 156.65 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.943 1.697 . . . . 0.0 110.72 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -109.91 116.3 54.0 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.844 1.658 . . . . 0.0 110.772 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.45 160.83 12.82 Favored 'Trans proline' 0 CA--C 1.551 1.369 0 C-N-CA 123.766 2.978 . . . . 0.0 112.095 161.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -76.23 176.35 10.16 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.415 2.743 . . . . 0.0 110.895 164.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -60.02 145.25 47.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.187 0.595 . . . . 0.0 111.247 168.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.33 -152.02 19.71 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.634 0.635 . . . . 0.0 111.664 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.9 167.17 20.17 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.556 1.169 . . . . 0.0 113.154 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 30.8 m -162.64 152.24 15.75 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.441 1.096 . . . . 0.0 110.905 157.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -107.44 119.36 39.19 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.7 mm -99.37 104.69 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 125.778 1.631 . . . . 0.0 107.594 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.38 141.21 18.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.944 1.298 . . . . 0.0 109.799 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 65.7 t -120.56 111.14 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 126.584 1.954 . . . . 0.0 108.442 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.38 -177.43 26.02 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 123.27 1.483 . . . . 0.0 114.658 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 53.7 m -138.35 167.26 22.25 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.236 1.815 . . . . 0.0 109.575 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.38 -175.02 49.45 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 121.741 0.634 . . . . 0.0 112.674 -170.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -23.15 65.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.676 1.19 . . . . 0.0 113.054 175.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 54.0 m -64.57 -15.59 61.26 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 171.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -71.11 138.8 49.99 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.144 1.338 . . . . 0.0 112.813 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 42.3 mt -103.56 161.57 13.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.728 1.211 . . . . 0.0 110.864 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.1 t -143.05 145.1 32.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.004 0.921 . . . . 0.0 112.248 -171.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -150.22 121.8 8.0 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.704 1.602 . . . . 0.0 110.199 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.71 131.44 39.87 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.468 -1.395 . . . . 0.0 111.815 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -119.28 168.84 10.52 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.793 0.837 . . . . 0.0 111.615 159.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.58 145.93 34.07 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.707 1.603 . . . . 0.0 108.971 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -133.15 124.81 28.18 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.081 1.352 . . . . 0.0 110.633 -174.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.64 164.27 11.88 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.721 2.408 . . . . 0.0 111.908 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -76.1 40.49 1.46 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.919 1.247 . . . . 0.0 114.303 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.66 -62.15 0.37 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.675 1.19 . . . . 0.0 112.999 -169.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 3.6 m -83.74 63.09 7.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.848 1.259 . . . . 0.0 110.386 -169.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.1 tt -129.88 15.42 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.291 1.836 . . . . 0.0 113.367 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -169.53 13.12 0.05 OUTLIER Glycine 0 CA--C 1.532 1.154 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.3 0 CA-C-N 119.383 1.591 . . . . 0.0 110.679 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.8 m -97.5 -7.12 32.18 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.274 1.03 . . . . 0.0 113.562 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.38 80.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.323 0.965 . . . . 0.0 113.009 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 53.6 tp -74.65 126.9 31.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 160.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.5 t -55.99 168.5 0.47 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.501 1.12 . . . . 0.0 113.836 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -59.99 118.04 5.79 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.799 1.639 . . . . 0.0 110.557 -167.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -70.22 108.01 3.97 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.402 1.481 . . . . 0.0 109.512 -163.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 77.15 -45.2 2.25 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.985 1.278 . . . . 0.0 112.768 -170.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 38.9 m -63.37 7.46 0.1 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 128.636 2.775 . . . . 0.0 113.925 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.1 m -157.14 158.69 36.79 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 118.766 -2.458 . . . . 0.0 112.012 167.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -77.62 172.89 12.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.226 1.41 . . . . 0.0 113.023 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -70.28 154.6 41.73 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -171.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -67.6 157.7 33.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.346 2.258 . . . . 0.0 112.275 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 11.2 m -71.68 141.47 49.88 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.442 -0.786 . . . . 0.0 111.333 174.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 12.7 p -134.67 11.13 3.71 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -84.4 177.58 8.08 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.933 0.788 . . . . 0.0 109.518 163.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -71.2 81.37 0.72 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.372 1.869 . . . . 0.0 111.738 -166.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 20.7 mtp -66.15 167.3 10.32 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.928 1.291 . . . . 0.0 112.814 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 28.7 m -158.51 168.6 26.49 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.108 0.963 . . . . 0.0 111.146 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.01 115.12 26.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.815 1.246 . . . . 0.0 110.479 172.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.86 -34.92 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.917 1.287 . . . . 0.0 110.259 167.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -138.18 126.11 22.6 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.036 1.735 . . . . 0.0 108.629 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -61.27 160.58 22.37 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.206 1.002 . . . . 0.0 111.77 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.69 121.62 8.1 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.679 1.586 . . . . 0.0 110.073 169.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 13.6 p -124.32 140.6 52.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.407 1.083 . . . . 0.0 110.499 170.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -60.69 140.94 57.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.599 0.76 . . . . 0.0 112.13 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 76.2 p -97.86 -15.92 20.0 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.205 1.402 . . . . 0.0 113.221 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 75.35 -10.36 11.48 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.493 -163.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -69.11 -11.33 60.7 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.868 1.834 . . . . 0.0 112.464 173.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 92.83 15.95 50.31 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.354 0.978 . . . . 0.0 112.749 -159.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 24.6 p -132.63 168.54 18.09 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.402 1.481 . . . . 0.0 110.995 -171.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.7 140.13 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.22 1.408 . . . . 0.0 109.047 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.3 p -112.95 132.11 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.703 1.201 . . . . 0.0 110.973 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.6 ptm -144.31 165.7 27.15 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.964 1.305 . . . . 0.0 112.806 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -130.19 134.8 47.55 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.274 1.03 . . . . 0.0 109.641 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.93 170.45 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.783 1.233 . . . . 0.0 111.46 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.45 137.62 51.92 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.28 2.232 . . . . 0.0 110.001 173.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.78 145.7 32.21 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.936 1.694 . . . . 0.0 107.407 161.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.423 ' HG2' ' H ' ' A' ' 326' ' ' LYS . 63.4 Cg_endo -102.83 -70.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 123.208 2.605 . . . . 0.0 115.228 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -143.81 175.56 9.91 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.602 1.561 . . . . 0.0 111.759 -174.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.32 -15.07 0.09 OUTLIER Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.549 2.499 . . . . 0.0 118.358 165.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -112.13 92.05 17.5 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 119.135 1.468 . . . . 0.0 112.768 -165.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.28 116.3 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.832 1.688 . . . . 0.0 108.078 154.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 5.6 p -154.68 157.59 38.33 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.639 -0.663 . . . . 0.0 112.281 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -75.58 140.62 42.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.625 1.57 . . . . 0.0 109.505 165.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 20.5 pt -64.06 121.83 73.9 Favored Pre-proline 0 CA--C 1.557 1.215 0 CA-C-N 119.211 0.914 . . . . 0.0 111.447 -174.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -109.04 85.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.36 2.707 . . . . 0.0 114.471 -164.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 23.3 t -119.54 104.09 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.285 -0.884 . . . . 0.0 110.045 171.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.9 160.31 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.662 1.585 . . . . 0.0 110.2 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -136.27 105.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.591 1.556 . . . . 0.0 108.153 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -122.36 158.37 29.78 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.611 1.165 . . . . 0.0 114.071 -163.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.65 -10.38 59.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.504 2.321 . . . . 0.0 112.875 169.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -137.71 150.72 47.54 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.173 1.389 . . . . 0.0 112.462 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 28.8 mt -63.45 -16.4 60.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.623 1.569 . . . . 0.0 114.721 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.2 t -109.2 7.42 25.41 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.824 -177.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 35.28 65.01 0.41 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 128.502 2.721 . . . . 0.0 114.211 -168.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -75.35 -40.93 57.68 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.426 1.09 . . . . 0.0 111.394 159.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 7.8 mm -99.74 169.85 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 125.3 1.44 . . . . 0.0 109.387 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -146.04 116.98 7.74 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.444 -1.41 . . . . 0.0 112.009 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -98.62 -27.16 14.13 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.345 1.858 . . . . 0.0 113.294 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -95.58 -174.53 36.95 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 -173.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.3 mt -124.51 134.91 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.617 1.967 . . . . 0.0 110.102 -174.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.0 mt -70.49 121.52 17.95 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.14 0.976 . . . . 0.0 109.364 162.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.78 -42.64 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.54 0.736 . . . . 0.0 109.914 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 38.6 m -69.96 153.52 43.14 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.143 0.497 . . . . 0.0 110.411 166.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.5 t -56.09 152.75 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.129 1.372 . . . . 0.0 110.346 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -113.16 82.73 5.75 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.16 0.984 . . . . 0.0 111.845 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.46 -168.87 0.68 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 125.27 3.98 . . . . 0.0 112.693 169.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 36.0 pt -93.0 167.37 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.982 1.713 . . . . 0.0 111.89 167.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.82 111.18 2.69 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 152.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 88.5 p -76.09 -45.07 35.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.052 1.341 . . . . 0.0 111.758 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.43 151.52 22.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.044 1.337 . . . . 0.0 108.735 158.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -59.31 -20.33 53.56 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 170.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -101.94 10.9 39.33 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.636 1.574 . . . . 0.0 112.956 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -58.89 152.28 19.79 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.208 -1.557 . . . . 0.0 113.632 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -133.81 83.35 2.04 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.344 1.058 . . . . 0.0 113.096 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 25.9 t -90.47 152.13 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.943 1.697 . . . . 0.0 112.037 -166.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 25.8 tp -109.17 131.39 55.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 129.024 2.93 . . . . 0.0 110.35 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.5 mp -143.2 132.51 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.278 1.431 . . . . 0.0 111.424 -167.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -92.82 135.04 34.48 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.914 1.286 . . . . 0.0 111.597 157.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.59 155.26 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.789 1.235 . . . . 0.0 111.31 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -111.92 108.11 55.77 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.157 1.783 . . . . 0.0 110.925 -173.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.21 119.17 4.15 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.984 3.123 . . . . 0.0 111.031 160.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -60.1 169.24 5.06 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.413 2.742 . . . . 0.0 113.091 167.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -53.56 138.21 34.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.357 1.063 . . . . 0.0 112.277 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.21 -142.34 15.58 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.775 0.702 . . . . 0.0 112.584 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -75.99 163.92 26.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.159 0.984 . . . . 0.0 112.69 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 18.0 m -175.47 167.3 3.29 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.885 2.074 . . . . 0.0 111.192 161.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -133.66 126.51 30.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.661 1.984 . . . . 0.0 108.098 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.6 mm -81.76 129.04 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.03 141.05 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.222 1.009 . . . . 0.0 109.565 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 95.7 t -115.73 113.47 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.806 1.642 . . . . 0.0 108.929 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 96.22 -177.54 33.78 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 122.205 0.892 . . . . 0.0 115.155 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.7 m -133.26 159.3 40.63 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.232 1.813 . . . . 0.0 110.154 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.16 -174.82 54.39 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.866 0.746 . . . . 0.0 113.237 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -54.04 -24.63 17.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.588 1.555 . . . . 0.0 114.354 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 66.9 m -80.8 -4.1 53.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.714 2.006 . . . . 0.0 113.986 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -73.65 128.85 36.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.671 1.123 . . . . 0.0 112.295 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 23.9 mt -100.3 170.03 8.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.113 0.965 . . . . 0.0 111.232 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.8 t -145.92 162.45 37.75 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -148.12 127.86 13.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.12 2.168 . . . . 0.0 108.273 169.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -73.56 137.28 44.23 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.252 -0.905 . . . . 0.0 111.783 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -141.54 133.26 27.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.442 1.097 . . . . 0.0 109.172 166.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -124.77 153.71 42.03 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -133.17 101.55 5.24 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.786 0.803 . . . . 0.0 111.994 -160.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -94.54 170.76 9.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.79 1.636 . . . . 0.0 111.042 167.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -92.42 76.17 1.29 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 123.917 0.77 . . . . 0.0 112.622 -165.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 46.5 p -67.8 -47.37 69.28 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 117.881 0.84 . . . . 0.0 112.462 168.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 10.3 m -69.12 47.53 0.07 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.75 2.42 . . . . 0.0 114.916 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 41.8 pt -60.8 2.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 128.375 2.67 . . . . 0.0 117.768 -170.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 73.39 -54.12 1.93 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.28 1.895 . . . . 0.0 115.842 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.066 1.746 . . . . 0.0 111.878 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 15.9 m -104.34 4.27 33.35 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.9 -49.23 78.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.062 0.945 . . . . 0.0 111.995 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.2 tt -71.13 132.98 45.85 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.256 -0.903 . . . . 0.0 108.837 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.7 t -56.86 169.79 0.48 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.171 1.788 . . . . 0.0 115.076 -168.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.23 104.59 0.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.601 1.56 . . . . 0.0 111.392 -168.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' A' ' 295' ' ' THR . 0.7 OUTLIER -59.97 135.98 57.87 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.64 1.176 . . . . 0.0 111.458 -169.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 62.33 -23.23 0.07 OUTLIER Glycine 0 CA--C 1.541 1.69 0 C-N-CA 126.975 2.226 . . . . 0.0 115.74 -170.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 293' ' ' LYS . 9.2 m -94.63 3.08 55.53 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 130.164 3.386 . . . . 0.0 111.037 -172.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.7 m -163.34 159.69 22.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 119.83 -1.794 . . . . 0.0 111.907 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -87.0 175.33 8.18 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.899 1.28 . . . . 0.0 113.432 -171.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -72.64 159.43 33.87 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.067 1.347 . . . . 0.0 114.498 -171.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 18.0 mmt -75.28 157.4 34.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.693 1.997 . . . . 0.0 111.702 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.1 m -75.53 144.76 41.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.472 -0.768 . . . . 0.0 110.776 172.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 8.3 p -131.87 5.55 4.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.34 167.18 22.16 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.374 0.988 . . . . 0.0 109.792 161.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -68.77 101.29 1.3 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.089 1.355 . . . . 0.0 112.022 -161.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 24.7 mtp -86.53 168.48 13.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.056 0.931 . . . . 0.0 112.969 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.3 m -161.08 160.99 31.1 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.686 1.194 . . . . 0.0 110.866 165.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.31 112.92 18.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.401 0.68 . . . . 0.0 110.126 168.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.3 t -63.26 -35.16 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.417 1.487 . . . . 0.0 110.24 163.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -133.78 123.99 25.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.448 1.499 . . . . 0.0 108.183 165.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -60.42 152.79 63.36 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.72 0.808 . . . . 0.0 111.475 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.35 133.29 45.41 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.133 1.889 . . . . 0.0 110.956 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.9 m -136.19 137.06 40.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.739 1.215 . . . . 0.0 109.183 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.401 ' CG ' ' HZ3' ' A' ' 391' ' ' LYS . 3.5 t70 -70.08 139.5 52.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.298 0.639 . . . . 0.0 112.454 -175.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.6 p -88.94 -13.08 39.84 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.053 0.941 . . . . 0.0 113.346 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.27 -3.07 3.59 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 119.319 0.963 . . . . 0.0 114.408 -164.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -96.66 10.94 37.11 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.811 1.645 . . . . 0.0 111.519 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 96.98 13.12 47.43 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.179 1.371 . . . . 0.0 114.248 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.6 p -138.13 163.96 30.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.574 1.187 . . . . 0.0 112.225 -170.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.19 132.37 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.489 1.516 . . . . 0.0 109.653 167.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.41 132.47 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.276 1.43 . . . . 0.0 111.693 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.0 ptm -148.37 166.18 28.84 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.342 1.457 . . . . 0.0 113.104 -175.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -136.12 139.44 42.95 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.643 1.177 . . . . 0.0 109.097 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.42 155.92 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.341 1.056 . . . . 0.0 111.474 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -111.76 133.07 54.23 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.876 1.271 . . . . 0.0 112.189 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.39 131.7 21.64 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.148 1.379 . . . . 0.0 107.891 160.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' PRO . . . . . 0.415 ' HG2' ' H ' ' A' ' 326' ' ' LYS . 94.7 Cg_endo -94.44 -67.77 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.097 2.531 . . . . 0.0 114.891 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.415 ' H ' ' HG2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -145.82 176.65 9.51 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.546 1.938 . . . . 0.0 110.552 -177.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.29 -14.74 0.09 OUTLIER Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.788 2.137 . . . . 0.0 118.14 169.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.54 90.48 39.43 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.265 1.532 . . . . 0.0 112.894 -162.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.93 115.63 4.38 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.114 1.876 . . . . 0.0 108.203 156.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.4 p -152.25 157.4 41.37 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -172.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.68 130.71 38.15 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.206 1.802 . . . . 0.0 108.973 165.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 15.2 pt -60.4 114.96 11.4 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-N 118.572 0.624 . . . . 0.0 111.837 -166.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -100.16 87.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.569 2.846 . . . . 0.0 114.333 -160.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 44.2 t -112.09 128.75 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 167.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.05 155.08 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.442 1.097 . . . . 0.0 110.619 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.3 t -130.1 117.33 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.19 1.796 . . . . 0.0 107.364 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -126.62 165.78 18.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.126 0.97 . . . . 0.0 113.315 -166.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -83.61 -8.19 59.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.078 1.751 . . . . 0.0 112.382 162.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -137.3 137.46 39.0 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.401 1.48 . . . . 0.0 111.235 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.13 -20.6 41.59 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -97.79 3.16 50.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.563 1.945 . . . . 0.0 113.673 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 39.21 69.47 0.28 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.963 2.905 . . . . 0.0 115.525 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.19 -34.55 16.62 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.035 1.334 . . . . 0.0 112.116 158.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 35.4 mm -96.78 153.14 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.43 1.092 . . . . 0.0 109.37 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.71 103.21 6.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.553 1.541 . . . . 0.0 109.062 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -94.22 -51.57 4.75 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.663 2.385 . . . . 0.0 113.019 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -82.91 -164.93 36.49 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 -169.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.2 140.68 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 127.374 2.27 . . . . 0.0 109.856 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.51 118.54 14.46 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.563 1.145 . . . . 0.0 109.528 161.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 35.1 t -94.7 -51.04 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 122.831 0.453 . . . . 0.0 110.472 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 36.9 m -70.14 157.48 37.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.102 0.477 . . . . 0.0 110.329 171.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.5 m -52.0 147.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.519 1.128 . . . . 0.0 111.916 171.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -123.0 77.69 50.8 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 123.914 0.886 . . . . 0.0 111.209 -174.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -83.29 -173.15 1.56 Allowed 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 124.872 3.714 . . . . 0.0 112.499 170.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 47.9 pt -84.67 165.75 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.66 1.184 . . . . 0.0 112.15 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.76 124.83 23.49 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 156.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 95.6 p -66.66 -29.83 69.94 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.621 0.768 . . . . 0.0 112.801 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 11.7 m -143.86 153.25 42.15 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.832 2.453 . . . . 0.0 106.983 -168.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.33 -21.01 61.54 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.926 -1.109 . . . . 0.0 113.646 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -95.26 4.11 53.84 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.81 2.444 . . . . 0.0 112.929 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -63.29 157.99 21.43 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.236 -1.54 . . . . 0.0 113.872 -171.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -150.69 86.27 1.39 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.86 149.58 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.886 1.274 . . . . 0.0 112.134 -167.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -92.91 126.06 37.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 129.95 3.3 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.2 mp -138.89 141.56 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.462 1.505 . . . . 0.0 110.768 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.47 141.63 32.0 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.131 1.372 . . . . 0.0 112.198 160.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.68 156.65 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.26 1.024 . . . . 0.0 111.418 168.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -113.05 114.3 48.86 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.381 1.472 . . . . 0.0 110.717 -172.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -85.27 160.82 11.31 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.753 2.969 . . . . 0.0 111.446 163.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -74.12 175.99 10.16 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.842 2.362 . . . . 0.0 110.476 160.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -61.59 142.68 56.96 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.653 -0.654 . . . . 0.0 110.635 159.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.96 -146.83 20.01 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 122.128 -0.358 . . . . 0.0 113.055 -173.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -61.81 145.37 52.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.961 2.105 . . . . 0.0 114.522 -171.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 28.9 m -167.64 162.08 13.92 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.491 1.917 . . . . 0.0 112.041 158.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -130.84 128.03 39.81 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.346 1.458 . . . . 0.0 108.46 169.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 29.3 mm -94.95 120.8 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.422 1.489 . . . . 0.0 108.274 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.2 144.95 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.433 1.093 . . . . 0.0 109.492 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.29 116.19 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.456 1.502 . . . . 0.0 109.332 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 89.76 -178.83 44.14 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 122.548 1.082 . . . . 0.0 114.614 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 92.7 m -127.6 164.12 22.71 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.979 1.312 . . . . 0.0 109.852 172.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 80.64 -173.57 54.78 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 121.855 0.697 . . . . 0.0 112.996 -174.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -23.83 66.45 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.956 1.302 . . . . 0.0 112.762 173.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.4 m -63.62 -10.53 19.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 170.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -78.36 125.49 29.43 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.078 1.308 . . . . 0.0 113.146 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 4.4 mt -88.19 162.24 16.79 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.071 -0.393 . . . . 0.0 111.167 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.8 t -142.43 149.04 38.76 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.883 1.273 . . . . 0.0 111.497 -174.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -151.65 126.68 9.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.731 1.612 . . . . 0.0 110.434 -177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -73.28 128.91 36.82 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.28 -0.888 . . . . 0.0 111.442 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -136.39 125.26 24.1 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.282 0.633 . . . . 0.0 110.298 167.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.27 122.76 32.44 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . 0.401 ' HZ3' ' CG ' ' A' ' 312' ' ' ASP . 7.4 ttmm -94.66 138.79 32.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.144 0.978 . . . . 0.0 111.394 -169.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -39.65 111.23 0.18 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.935 3.294 . . . . 0.0 115.075 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -76.37 54.62 3.22 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.585 1.564 . . . . 0.0 114.503 -174.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 25.2 m -61.64 -18.75 60.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.418 1.487 . . . . 0.0 114.651 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.4 m -72.63 41.29 0.09 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.878 2.471 . . . . 0.0 115.824 -167.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.7 tp -69.92 -34.23 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.161 0.891 . . . . 0.0 112.305 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.87 12.18 47.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.906 1.241 . . . . 0.0 116.067 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? . . . . . 0 C--O 1.25 1.114 0 C-N-CA 125.843 1.657 . . . . 0.0 110.471 -173.872 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.1 p -86.19 -7.27 58.68 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -53.21 -49.98 65.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.117 0.967 . . . . 0.0 112.923 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 22.3 tp -73.59 127.46 32.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.56 -0.712 . . . . 0.0 109.537 163.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.3 t -53.31 171.04 0.08 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -164.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.53 111.88 2.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.617 2.367 . . . . 0.0 111.753 -170.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -61.63 107.54 0.83 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.863 2.465 . . . . 0.0 111.725 -167.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 82.01 0.04 89.1 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.53 1.062 . . . . 0.0 114.5 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 89.1 m -117.88 5.1 12.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.381 1.872 . . . . 0.0 110.965 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.0 m -157.25 156.19 32.08 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 119.51 -1.994 . . . . 0.0 114.027 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -82.92 178.45 8.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.109 2.164 . . . . 0.0 113.328 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -73.48 160.76 31.24 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.524 1.53 . . . . 0.0 114.381 -170.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.15 147.74 32.58 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.248 2.619 . . . . 0.0 111.675 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.59 138.68 56.63 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.526 -0.734 . . . . 0.0 110.733 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.5 p -132.31 14.3 4.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.264 1.026 . . . . 0.0 113.263 172.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -81.45 170.87 15.41 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 118.676 0.671 . . . . 0.0 109.212 159.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -62.06 103.86 0.41 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.052 1.741 . . . . 0.0 111.777 -166.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 25.8 mtp -91.14 165.89 13.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 122.384 1.088 . . . . 0.0 112.142 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 30.7 m -161.94 164.72 28.32 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.049 1.34 . . . . 0.0 109.892 166.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.6 127.48 34.09 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 164.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.85 -32.57 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 159.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -133.84 119.89 19.76 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.647 1.579 . . . . 0.0 109.259 167.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -58.9 150.85 57.95 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.913 1.685 . . . . 0.0 112.063 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -62.8 131.27 32.43 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.535 2.157 . . . . 0.0 110.908 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.56 140.11 46.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.083 0.953 . . . . 0.0 109.691 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.31 132.09 52.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.036 0.934 . . . . 0.0 112.303 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 74.6 p -84.9 -13.7 50.03 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.02 1.328 . . . . 0.0 114.121 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 70.36 18.45 75.22 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.262 -0.743 . . . . 0.0 114.624 -162.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.24 16.16 8.38 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.872 1.336 . . . . 0.0 112.448 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.86 11.76 73.03 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.396 -0.815 . . . . 0.0 113.53 -176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 40.6 p -134.08 161.21 35.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.139 1.375 . . . . 0.0 110.942 -168.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.14 132.92 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.265 1.026 . . . . 0.0 109.614 172.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.14 136.1 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.835 1.254 . . . . 0.0 112.121 -170.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 14.5 ptm -151.01 165.64 33.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.498 1.519 . . . . 0.0 114.012 -172.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -132.07 121.57 24.04 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.767 2.427 . . . . 0.0 107.333 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.5 m -112.99 158.12 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.88 0.872 . . . . 0.0 111.589 -172.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -125.12 143.94 50.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.235 1.014 . . . . 0.0 113.426 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.58 151.16 51.37 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.637 2.375 . . . . 0.0 107.89 167.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -119.89 -60.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.627 2.218 . . . . 0.0 115.877 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 175.48 9.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.476 1.11 . . . . 0.0 112.248 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.57 -15.44 0.1 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.459 2.456 . . . . 0.0 118.638 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.83 92.59 49.03 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.635 1.717 . . . . 0.0 114.181 -159.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.28 124.59 10.07 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.816 1.677 . . . . 0.0 108.388 155.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.0 p -153.84 155.78 36.4 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.463 -0.773 . . . . 0.0 112.44 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -78.46 128.53 33.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.159 1.384 . . . . 0.0 107.785 161.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.7 pp -61.82 115.58 16.22 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -164.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -95.17 94.66 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.362 3.375 . . . . 0.0 113.852 -170.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 32.3 t -124.48 109.17 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.719 -0.613 . . . . 0.0 109.955 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.12 159.32 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.483 1.513 . . . . 0.0 110.984 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 83.8 t -131.81 117.36 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 126.51 1.924 . . . . 0.0 106.412 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.55 165.37 20.89 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -165.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -86.07 -8.65 57.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.271 1.829 . . . . 0.0 112.922 163.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -130.19 142.04 50.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.62 1.168 . . . . 0.0 110.914 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.74 -21.85 56.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.991 1.316 . . . . 0.0 113.726 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.7 t -105.6 5.92 31.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.55 1.94 . . . . 0.0 113.903 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.421 ' HB2' HD13 ' A' ' 377' ' ' ILE . . . 45.02 69.71 0.41 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.708 2.803 . . . . 0.0 116.184 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -82.8 -37.49 24.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.937 0.895 . . . . 0.0 111.861 153.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 36.4 mm -88.98 155.52 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.924 1.289 . . . . 0.0 110.449 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -134.46 93.55 3.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.179 1.791 . . . . 0.0 109.621 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -101.57 -28.16 12.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.832 2.053 . . . . 0.0 114.696 -169.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -99.78 179.96 30.41 Favored Glycine 0 N--CA 1.477 1.368 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -171.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 4.5 mt -117.61 135.51 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.537 2.335 . . . . 0.0 110.168 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.88 132.09 44.74 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.111 0.564 . . . . 0.0 110.319 165.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.06 -49.94 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.2 m -80.41 162.72 24.32 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.607 0.718 . . . . 0.0 110.66 167.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.4 m -63.31 165.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.112 1.765 . . . . 0.0 114.519 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -117.36 81.47 13.74 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.697 1.599 . . . . 0.0 110.917 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.09 -166.95 0.45 Allowed 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 124.412 3.408 . . . . 0.0 112.865 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.9 pt -104.37 169.81 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.284 1.833 . . . . 0.0 110.793 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.07 113.45 8.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.753 0.421 . . . . 0.0 110.099 158.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 82.4 p -73.32 -23.03 60.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.295 1.438 . . . . 0.0 113.361 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 77.4 p -135.0 165.23 25.83 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.946 2.099 . . . . 0.0 108.788 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -63.73 -21.2 66.29 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.018 -1.052 . . . . 0.0 113.471 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -100.39 9.22 42.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.695 1.598 . . . . 0.0 112.567 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -59.18 156.58 11.96 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.812 1.291 . . . . 0.0 113.508 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -148.35 98.72 2.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.982 1.313 . . . . 0.0 112.343 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 53.0 t -92.81 149.55 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.39 1.476 . . . . 0.0 110.438 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.27 124.28 49.27 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.53 2.732 . . . . 0.0 108.697 -174.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.58 136.37 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.671 0.788 . . . . 0.0 111.825 -170.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -95.75 136.54 36.03 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.424 1.49 . . . . 0.0 111.563 152.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.02 154.95 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.212 1.005 . . . . 0.0 111.333 166.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -116.57 113.15 40.67 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.774 2.03 . . . . 0.0 109.779 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -81.09 167.35 18.01 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.949 2.432 . . . . 0.0 111.357 164.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -69.63 173.5 10.76 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.436 2.091 . . . . 0.0 110.773 163.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -62.13 144.74 54.94 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.872 -0.518 . . . . 0.0 110.533 162.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.67 -155.57 18.34 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.782 0.706 . . . . 0.0 111.979 -170.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.58 161.06 21.29 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.459 1.123 . . . . 0.0 112.681 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 49.2 m -160.96 159.29 29.35 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.465 -1.397 . . . . 0.0 111.075 161.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.55 115.07 23.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 29.4 mm -89.59 117.02 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.664 1.586 . . . . 0.0 108.09 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 342' ' ' ALA . 2.9 mp -113.75 141.48 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.699 0.799 . . . . 0.0 110.707 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 99.4 t -116.24 109.27 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.412 1.885 . . . . 0.0 108.173 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 112.58 -177.35 18.36 Favored Glycine 0 N--CA 1.471 0.991 0 N-CA-C 116.241 1.256 . . . . 0.0 116.241 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 99.5 m -138.07 167.39 21.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.963 1.705 . . . . 0.0 109.282 165.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.21 -174.35 44.34 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 121.732 -0.605 . . . . 0.0 112.537 -169.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.78 -25.79 63.43 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.104 0.962 . . . . 0.0 113.435 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.8 m -75.4 -1.26 23.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.451 2.3 . . . . 0.0 114.846 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -79.88 133.59 36.25 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.748 0.819 . . . . 0.0 111.995 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.7 mt -102.84 163.65 12.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.258 0.623 . . . . 0.0 111.27 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 t -137.84 148.51 45.5 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.72 1.208 . . . . 0.0 112.001 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -146.0 131.07 18.29 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.484 1.514 . . . . 0.0 110.277 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -82.11 136.25 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.279 1.031 . . . . 0.0 111.301 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -134.95 154.45 51.7 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.069 0.938 . . . . 0.0 112.675 166.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -124.62 140.9 52.51 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.683 1.593 . . . . 0.0 107.942 165.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? . . . . . 0 N--CA 1.463 0.179 0 C-N-CA 126.381 1.872 . . . . 0.0 108.67 -177.354 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 3.8 m -97.44 5.35 49.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -171.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -71.96 -43.72 64.71 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.165 1.348 . . . . 0.0 112.755 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.1 136.11 56.33 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 165.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 t -54.56 163.94 0.82 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.36 97.06 1.96 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.869 1.668 . . . . 0.0 111.105 -164.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -46.72 133.55 10.47 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.904 2.482 . . . . 0.0 112.328 -171.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.02 -36.94 1.07 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.035 1.302 . . . . 0.0 114.561 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 10.3 p -72.75 -26.46 61.56 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 118.777 1.288 . . . . 0.0 114.246 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.0 m -134.29 150.6 51.0 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.574 0.75 . . . . 0.0 112.462 -152.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -79.94 175.36 10.7 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.287 1.435 . . . . 0.0 112.927 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.31 154.0 42.4 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -71.09 146.35 49.3 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.046 2.139 . . . . 0.0 112.358 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 8.4 m -63.48 143.06 58.13 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.682 -0.636 . . . . 0.0 112.266 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.3 p -135.45 11.44 3.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.641 1.176 . . . . 0.0 113.525 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -71.97 168.98 16.87 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.219 0.918 . . . . 0.0 109.648 161.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -65.36 97.19 0.27 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.424 -0.797 . . . . 0.0 111.899 -172.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 42.7 mtp -86.17 168.0 14.4 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.366 1.079 . . . . 0.0 112.762 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 39.2 m -160.89 163.63 31.83 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.053 1.341 . . . . 0.0 109.963 161.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.82 121.76 25.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.654 0.381 . . . . 0.0 110.119 167.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.01 -29.85 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.267 1.027 . . . . 0.0 110.335 165.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -141.52 132.74 26.42 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.147 1.779 . . . . 0.0 109.303 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -64.81 150.43 94.65 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.379 1.072 . . . . 0.0 112.148 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -62.77 130.88 30.97 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.986 1.791 . . . . 0.0 110.646 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 65.2 p -131.27 137.84 49.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.964 1.306 . . . . 0.0 110.626 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -63.16 126.14 26.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.589 1.556 . . . . 0.0 112.333 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.8 p -70.61 -25.86 63.24 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.95 0.5 . . . . 0.0 111.281 166.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 82.39 -6.17 69.72 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.503 1.525 . . . . 0.0 113.845 -168.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -92.86 18.99 8.14 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.707 1.603 . . . . 0.0 111.37 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 91.9 2.78 68.87 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.738 1.161 . . . . 0.0 115.039 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 28.3 p -127.35 158.56 36.93 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.496 1.648 . . . . 0.0 112.55 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.02 129.78 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.778 1.631 . . . . 0.0 109.611 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.4 p -114.83 130.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.465 1.106 . . . . 0.0 113.085 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.4 ptm -137.97 171.25 14.7 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.809 2.443 . . . . 0.0 111.919 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -135.44 139.45 44.12 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.629 -0.669 . . . . 0.0 109.89 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.93 149.46 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.261 1.024 . . . . 0.0 111.948 -170.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -109.03 137.67 46.58 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.272 1.429 . . . . 0.0 112.833 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.1 t -117.07 133.88 23.08 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 126.977 2.111 . . . . 0.0 107.596 166.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -96.39 -74.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 123.186 2.591 . . . . 0.0 116.984 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.92 146.15 25.42 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 -169.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 76.72 4.55 81.89 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 115.66 1.024 . . . . 0.0 115.66 171.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.25 99.13 43.52 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.843 1.257 . . . . 0.0 111.531 -172.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.66 130.03 14.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.327 2.018 . . . . 0.0 108.884 167.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.8 p -159.98 156.13 26.6 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -75.32 137.8 41.37 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.481 1.913 . . . . 0.0 108.429 162.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 2.0 pp -66.77 124.55 88.83 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-N 118.29 0.495 . . . . 0.0 112.051 -169.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 9.7 Cg_endo -107.35 96.13 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.423 2.749 . . . . 0.0 115.723 -165.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 69.3 t -124.89 124.55 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.39 -0.818 . . . . 0.0 109.473 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.34 154.7 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.572 1.549 . . . . 0.0 110.179 -174.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.22 105.06 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.222 1.409 . . . . 0.0 109.271 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -120.63 160.59 22.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.992 1.317 . . . . 0.0 113.865 -163.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.29 -17.12 46.97 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.747 1.619 . . . . 0.0 112.378 164.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -122.7 133.39 54.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.99 1.316 . . . . 0.0 110.929 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -56.76 -19.45 17.02 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.136 1.775 . . . . 0.0 113.108 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.2 t -101.62 4.51 40.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.665 2.386 . . . . 0.0 113.733 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 37.91 74.28 0.09 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 130.534 3.534 . . . . 0.0 117.326 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -105.52 -16.53 14.69 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.937 1.695 . . . . 0.0 112.83 160.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 64.4 mt -109.45 146.29 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.744 1.618 . . . . 0.0 107.62 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.27 112.83 11.36 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.909 -1.119 . . . . 0.0 111.397 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -104.39 -21.53 13.47 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.07 -168.92 42.11 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 118.716 0.689 . . . . 0.0 114.424 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 65.3 mt -134.44 135.4 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.276 1.831 . . . . 0.0 110.528 -174.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.61 118.57 10.38 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.723 1.209 . . . . 0.0 109.333 160.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.62 -29.54 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.666 0.786 . . . . 0.0 112.342 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.8 m -77.38 153.34 33.79 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.056 0.844 . . . . 0.0 109.737 153.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.5 m -60.96 161.81 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.007 1.323 . . . . 0.0 113.598 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -121.85 78.68 40.37 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.023 1.329 . . . . 0.0 111.466 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.39 -168.04 0.57 Allowed 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 124.404 3.402 . . . . 0.0 113.078 171.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 29.3 pt -95.08 164.46 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.211 1.804 . . . . 0.0 111.27 166.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.92 110.01 3.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 160.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.3 t -76.46 -3.0 34.9 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 90.8 m -153.56 157.07 39.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.026 2.53 . . . . 0.0 104.816 161.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -60.6 -18.04 50.43 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.559 -1.338 . . . . 0.0 114.148 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.51 8.6 30.24 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.683 2.393 . . . . 0.0 113.479 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -60.57 156.88 15.46 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.226 -1.547 . . . . 0.0 114.099 -173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . 0.25 9.4 pt-20 -146.47 80.79 1.56 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 22.2 t -85.55 145.74 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.041 1.336 . . . . 0.0 112.363 -167.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.02 120.19 39.84 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 129.837 3.255 . . . . 0.0 109.108 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.1 mp -137.72 132.55 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.594 1.557 . . . . 0.0 111.125 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 142.6 29.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.004 0.907 . . . . 0.0 112.219 159.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.55 161.5 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.562 1.545 . . . . 0.0 110.522 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -117.94 108.99 41.7 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.746 1.619 . . . . 0.0 109.346 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.6 154.86 44.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.533 2.155 . . . . 0.0 110.638 163.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.29 175.66 10.27 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.224 1.949 . . . . 0.0 110.232 165.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -62.13 133.61 55.47 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.491 -0.756 . . . . 0.0 110.288 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.74 -149.43 16.6 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.564 1.078 . . . . 0.0 113.56 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.23 149.89 47.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.435 2.294 . . . . 0.0 113.172 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.9 m -163.88 153.78 14.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.988 1.315 . . . . 0.0 113.618 162.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -118.58 116.9 27.58 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.554 1.141 . . . . 0.0 108.679 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 27.5 mm -80.74 117.75 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.209 1.403 . . . . 0.0 107.561 174.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.4 mp -111.87 144.11 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.357 0.599 . . . . 0.0 109.946 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 78.6 t -116.02 117.42 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.011 1.724 . . . . 0.0 108.576 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 94.11 -178.66 37.51 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 122.942 1.301 . . . . 0.0 115.213 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 84.6 m -132.28 166.04 22.79 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.277 1.831 . . . . 0.0 109.423 168.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 76.71 -175.8 53.16 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 121.918 0.732 . . . . 0.0 113.663 -176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.22 -21.78 9.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.343 1.857 . . . . 0.0 114.454 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.1 m -86.47 -4.89 59.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.425 2.29 . . . . 0.0 114.61 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -73.72 137.91 44.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.55 1.068 . . . . 0.0 112.446 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 11.1 mt -106.41 162.94 13.26 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.748 0.819 . . . . 0.0 111.571 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.9 t -132.22 154.45 49.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.766 1.226 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -148.99 131.85 16.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.124 2.17 . . . . 0.0 108.9 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -81.64 134.84 35.52 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.928 -1.108 . . . . 0.0 111.597 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -133.23 146.73 51.72 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.297 0.639 . . . . 0.0 109.916 162.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.95 137.86 49.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 172.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? . . . . . 0 N--CA 1.468 0.457 0 C-N-CA 124.548 1.139 . . . . 0.0 110.531 -168.575 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 3.3 m -65.31 0.11 1.57 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.7 -23.58 66.8 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.559 1.527 . . . . 0.0 114.138 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 49.0 tp -85.68 128.2 34.71 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.916 1.235 . . . . 0.0 108.968 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.2 t -53.47 158.74 1.65 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.511 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.8 mm? -61.47 105.66 0.55 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.1 2.16 . . . . 0.0 110.774 -167.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -63.11 125.22 23.31 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.237 -0.914 . . . . 0.0 111.118 -170.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.89 -50.52 3.01 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.857 1.218 . . . . 0.0 112.842 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 32.1 m -63.94 -0.07 1.01 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.408 2.283 . . . . 0.0 113.432 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.2 m -157.1 154.02 28.75 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 119.024 -2.297 . . . . 0.0 111.725 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -78.01 170.87 15.88 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.816 1.647 . . . . 0.0 113.34 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 152.21 40.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.465 1.106 . . . . 0.0 113.294 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.6 mpp? -62.12 165.78 5.39 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 129.201 3.0 . . . . 0.0 114.314 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -81.15 142.72 32.97 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.281 -0.887 . . . . 0.0 110.545 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.5 p -135.77 18.61 3.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.587 1.155 . . . . 0.0 113.094 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -81.75 161.28 23.37 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 156.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.14 102.25 0.36 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.53 1.532 . . . . 0.0 112.131 -168.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 28.1 mtp -84.64 172.77 11.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.22 1.008 . . . . 0.0 112.837 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.6 m -159.93 167.25 28.44 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.174 -0.954 . . . . 0.0 112.027 166.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.92 117.95 24.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.579 0.752 . . . . 0.0 109.328 167.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.07 -35.26 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.049 0.94 . . . . 0.0 110.015 159.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -135.71 127.07 28.45 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.321 1.448 . . . . 0.0 108.467 165.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -65.15 152.69 90.98 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.467 1.107 . . . . 0.0 111.903 171.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.46 131.08 30.41 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.637 2.225 . . . . 0.0 111.657 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.0 m -136.85 139.61 41.81 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.278 1.031 . . . . 0.0 110.465 174.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -65.16 132.58 49.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.277 1.031 . . . . 0.0 112.549 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 63.9 p -79.62 -21.55 44.76 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.034 1.334 . . . . 0.0 113.49 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 85.08 -9.29 66.89 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.541 1.543 . . . . 0.0 113.696 -162.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -81.66 -7.59 59.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.573 1.187 . . . . 0.0 112.312 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.35 15.23 48.28 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.329 0.966 . . . . 0.0 112.843 -164.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 32.2 p -127.68 155.95 43.13 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.923 1.289 . . . . 0.0 110.907 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 25.6 m -123.18 127.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.889 1.276 . . . . 0.0 109.53 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.69 130.82 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.866 1.266 . . . . 0.0 111.86 -172.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 7.0 ptp -137.74 167.99 20.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.903 2.081 . . . . 0.0 111.082 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -133.11 129.28 37.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.064 0.946 . . . . 0.0 108.964 170.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.22 151.72 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.328 1.051 . . . . 0.0 110.85 -169.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -113.18 131.83 55.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.795 1.238 . . . . 0.0 111.64 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.39 151.07 39.61 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-O 117.062 -1.447 . . . . 0.0 108.531 159.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -111.03 -72.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.184 2.589 . . . . 0.0 115.279 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 172.9 12.5 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.184 -1.573 . . . . 0.0 113.127 -174.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.12 -24.09 0.11 Allowed Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.913 2.197 . . . . 0.0 117.538 170.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -109.0 96.9 22.09 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 125.909 1.684 . . . . 0.0 111.784 -170.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -62.97 133.9 43.65 Favored 'Trans proline' 0 C--N 1.35 0.637 0 N-CA-C 107.675 -1.702 . . . . 0.0 107.675 154.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.4 p -158.88 154.25 25.72 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.315 -0.865 . . . . 0.0 113.234 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -72.39 141.99 48.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.604 157.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.91 123.28 79.28 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 118.986 0.812 . . . . 0.0 111.233 -175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -98.52 72.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.042 3.162 . . . . 0.0 112.694 -168.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.1 t -104.76 130.62 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.87 162.65 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 125.181 1.392 . . . . 0.0 110.586 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.72 120.25 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.988 1.715 . . . . 0.0 107.768 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.89 164.57 22.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -160.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.66 -16.52 36.33 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.453 1.901 . . . . 0.0 113.116 163.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -124.66 138.37 54.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.731 1.212 . . . . 0.0 110.364 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.79 -15.94 14.61 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.8 t -104.28 8.26 36.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.459 1.503 . . . . 0.0 113.877 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 40.32 67.69 0.47 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 129.347 3.059 . . . . 0.0 116.578 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.8 -27.26 23.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.186 0.994 . . . . 0.0 112.574 155.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 56.4 mt -111.86 136.58 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.896 1.678 . . . . 0.0 108.988 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -110.0 98.57 7.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.896 1.278 . . . . 0.0 112.451 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -80.61 -42.68 21.78 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.188 2.595 . . . . 0.0 114.308 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -93.08 -168.55 39.18 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 119.993 1.27 . . . . 0.0 116.261 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.4 mt -125.85 141.76 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.852 2.461 . . . . 0.0 110.071 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.44 136.04 37.53 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.371 1.069 . . . . 0.0 110.4 167.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.56 -40.76 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.031 0.533 . . . . 0.0 112.374 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 27.5 m -72.53 158.63 35.33 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 157.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 10.6 m -55.51 156.2 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.484 1.114 . . . . 0.0 113.095 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -113.82 84.16 8.22 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.325 1.45 . . . . 0.0 109.175 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -81.44 -167.47 0.5 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 124.695 3.597 . . . . 0.0 112.89 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 26.0 pt -95.17 164.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.363 1.865 . . . . 0.0 111.183 166.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -73.77 110.43 8.06 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 154.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.9 p -75.88 -51.82 11.67 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.958 1.303 . . . . 0.0 111.629 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.15 151.14 23.9 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 155.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -57.92 -23.05 51.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.91 9.33 43.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.454 1.502 . . . . 0.0 112.786 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -58.56 153.41 16.26 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.241 -1.537 . . . . 0.0 113.686 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -135.82 84.88 2.12 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.721 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 23.5 t -87.98 142.14 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.248 1.419 . . . . 0.0 111.663 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.89 123.74 35.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.903 2.881 . . . . 0.0 109.409 176.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.95 140.56 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.384 1.474 . . . . 0.0 111.039 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.5 148.24 30.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.3 1.047 . . . . 0.0 112.933 161.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.6 m -131.07 155.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.679 1.592 . . . . 0.0 110.678 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -109.51 106.12 58.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.999 2.12 . . . . 0.0 109.361 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.73 146.96 30.7 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.228 1.952 . . . . 0.0 110.346 161.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.2 170.12 18.99 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.454 2.103 . . . . 0.0 111.009 167.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -55.03 140.89 36.26 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.526 1.131 . . . . 0.0 111.483 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.35 -148.3 18.83 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -171.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -79.93 162.03 25.19 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.489 1.116 . . . . 0.0 112.452 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 17.6 m -164.25 155.41 15.65 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.773 -1.205 . . . . 0.0 111.961 156.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -113.56 112.0 22.82 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.5 mm -78.9 119.49 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.651 1.181 . . . . 0.0 107.86 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -113.37 140.98 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.522 0.729 . . . . 0.0 109.886 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.4 t -120.01 107.04 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 125.421 1.488 . . . . 0.0 108.468 172.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 119.49 -176.34 16.09 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.251 1.405 . . . . 0.0 115.574 172.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 54.7 m -138.76 161.9 36.06 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.426 1.49 . . . . 0.0 109.267 164.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.49 -172.17 50.79 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 121.86 0.7 . . . . 0.0 112.762 -169.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -29.23 11.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.24 1.816 . . . . 0.0 113.647 173.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.7 m -72.29 -4.43 29.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 128.739 2.815 . . . . 0.0 114.693 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -84.96 122.28 28.99 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.04 0.837 . . . . 0.0 112.564 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 29.6 mt -87.06 161.08 18.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.25 0.62 . . . . 0.0 111.327 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.7 t -141.29 145.33 35.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.996 1.318 . . . . 0.0 111.737 -173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -153.75 115.18 4.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.924 1.29 . . . . 0.0 110.775 -171.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.8 135.01 47.86 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.861 -1.149 . . . . 0.0 112.152 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -124.37 166.85 15.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.441 1.096 . . . . 0.0 110.977 157.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.84 138.33 37.41 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.471 1.508 . . . . 0.0 108.011 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? . . . . . 0 N--CA 1.466 0.333 0 C-N-CA 125.224 1.41 . . . . 0.0 110.784 -173.551 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 118.682 -0.675 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 12.1 m -98.14 0.44 45.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -171.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.52 71.24 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.64 1.109 . . . . 0.0 112.353 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.9 tt -66.57 118.18 9.8 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.2 t -55.09 173.03 0.1 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.141 2.176 . . . . 0.0 116.368 -164.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.407 ' H ' HD22 ' A' ' 292' ' ' LEU . 2.7 mm? -60.97 106.36 0.58 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.5 1.92 . . . . 0.0 111.727 -172.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -71.06 141.54 50.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.414 1.486 . . . . 0.0 111.74 -171.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.74 -59.49 1.3 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.292 1.425 . . . . 0.0 113.393 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 14.6 t -68.05 16.38 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.962 2.105 . . . . 0.0 115.213 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 10.0 m -163.69 165.55 23.15 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 120.233 -1.542 . . . . 0.0 112.945 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -86.66 169.23 12.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.781 1.232 . . . . 0.0 113.865 -172.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -70.52 159.18 34.76 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.76 1.624 . . . . 0.0 115.048 -166.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 54.5 mtt -77.23 151.11 35.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.161 2.184 . . . . 0.0 112.062 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.8 m -69.51 142.78 53.62 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.725 -0.609 . . . . 0.0 111.968 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 20.3 p -131.5 7.72 4.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.389 1.076 . . . . 0.0 113.651 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -72.54 159.66 33.55 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.523 1.056 . . . . 0.0 109.984 160.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -63.87 100.47 0.3 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.907 1.683 . . . . 0.0 110.984 -168.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 17.2 mtp -83.83 172.99 11.64 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 122.318 1.056 . . . . 0.0 113.604 -169.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.2 m -155.5 172.5 18.14 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.873 0.869 . . . . 0.0 111.372 161.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.58 121.56 42.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.188 0.995 . . . . 0.0 109.765 164.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 27.1 t -63.77 -36.89 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.003 1.321 . . . . 0.0 109.798 167.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -137.92 126.54 23.63 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.23 1.412 . . . . 0.0 109.836 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -62.96 152.19 84.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.618 1.167 . . . . 0.0 112.217 172.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -62.06 131.86 36.66 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.392 2.062 . . . . 0.0 111.647 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 48.1 p -128.56 132.02 48.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.93 1.292 . . . . 0.0 110.874 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -51.35 118.79 3.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.192 1.797 . . . . 0.0 112.062 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 60.9 p -79.64 -8.6 59.31 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.413 1.485 . . . . 0.0 113.41 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.17 -7.2 6.15 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.523 1.059 . . . . 0.0 114.262 -165.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -89.49 5.37 45.7 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.222 1.511 . . . . 0.0 112.14 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 87.05 17.35 59.49 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.232 0.92 . . . . 0.0 113.148 -170.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 38.4 p -131.47 161.52 32.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.907 1.283 . . . . 0.0 111.062 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.96 128.45 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.907 1.283 . . . . 0.0 109.119 170.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.91 133.16 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.664 1.186 . . . . 0.0 111.844 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 22.2 ptm -146.63 162.35 38.62 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.664 2.385 . . . . 0.0 111.861 -166.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -134.74 130.53 36.35 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.524 -0.735 . . . . 0.0 109.655 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 19.9 m -109.92 164.52 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.837 1.255 . . . . 0.0 111.517 -171.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -134.95 125.03 25.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.547 1.539 . . . . 0.0 111.498 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.83 153.15 37.99 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-O 117.21 -1.376 . . . . 0.0 108.374 162.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -109.02 -72.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 123.293 2.662 . . . . 0.0 115.208 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.3 163.69 31.17 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 121.397 1.908 . . . . 0.0 115.823 -174.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.83 -17.54 0.1 OUTLIER Glycine 0 CA--C 1.538 1.504 0 C-N-CA 127.841 2.638 . . . . 0.0 117.881 171.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -104.22 99.89 19.15 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 119.316 1.558 . . . . 0.0 113.13 -168.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.26 128.46 16.51 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.836 1.69 . . . . 0.0 108.697 155.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.0 p -163.94 155.93 16.94 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.555 -0.715 . . . . 0.0 111.953 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -79.77 128.18 33.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.497 1.519 . . . . 0.0 109.448 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.0 111.01 3.1 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.464 0.706 . . . . 0.0 112.4 -163.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -91.03 85.9 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.726 2.95 . . . . 0.0 113.394 -157.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.42 134.48 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.972 0.909 . . . . 0.0 109.219 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.08 151.72 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.376 1.07 . . . . 0.0 110.232 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.27 109.31 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.889 1.675 . . . . 0.0 107.591 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -117.7 161.24 20.0 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -158.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.28 -11.98 53.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.158 2.183 . . . . 0.0 112.783 162.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -129.81 138.31 50.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.561 1.544 . . . . 0.0 111.073 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 22.5 mt -55.83 -19.18 10.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.587 1.555 . . . . 0.0 114.374 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -105.65 2.36 28.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.95 2.5 . . . . 0.0 114.222 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 49.04 77.58 0.1 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.161 2.584 . . . . 0.0 116.59 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -109.9 -24.34 10.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.393 1.477 . . . . 0.0 112.309 161.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.92 120.54 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.062 1.345 . . . . 0.0 109.018 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.96 114.73 28.89 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.729 0.812 . . . . 0.0 112.916 -169.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -81.39 -51.57 8.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.504 2.722 . . . . 0.0 112.451 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.9 -167.36 40.2 Favored Glycine 0 CA--C 1.537 1.413 0 N-CA-C 116.549 1.379 . . . . 0.0 116.549 -167.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.91 140.44 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 127.035 2.134 . . . . 0.0 110.94 -175.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 7.2 mt -73.05 130.0 39.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.759 1.224 . . . . 0.0 110.466 163.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.09 -45.18 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 122.759 0.424 . . . . 0.0 111.159 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 m -70.03 154.78 41.5 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.67 0.668 . . . . 0.0 110.178 164.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.9 m -56.73 155.89 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.971 0.908 . . . . 0.0 112.253 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -127.79 71.26 78.05 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.049 0.939 . . . . 0.0 111.716 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.23 -169.52 0.75 Allowed 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 124.619 3.546 . . . . 0.0 112.914 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 37.1 pt -87.55 161.29 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 121.502 -0.749 . . . . 0.0 112.196 167.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.85 109.29 2.03 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 156.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.4 p -69.73 -37.2 76.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.617 1.567 . . . . 0.0 112.161 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.46 157.14 30.0 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.082 1.753 . . . . 0.0 109.745 158.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -62.95 -17.95 62.58 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.88 7.88 44.57 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.623 1.169 . . . . 0.0 112.356 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -59.45 150.39 26.78 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.63 -1.294 . . . . 0.0 113.257 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -134.84 80.17 1.83 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.355 1.062 . . . . 0.0 113.289 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.23 146.5 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.031 1.332 . . . . 0.0 111.942 -171.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 27.6 tp -97.96 129.01 44.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 129.405 3.082 . . . . 0.0 110.034 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.2 mp -140.28 148.6 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 109.726 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -121.25 148.07 44.78 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.249 1.023 . . . . 0.0 112.354 157.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.45 156.57 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.689 1.596 . . . . 0.0 110.909 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -116.21 104.96 51.53 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.58 1.952 . . . . 0.0 110.639 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.16 164.62 15.05 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.645 2.897 . . . . 0.0 111.747 163.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.58 -178.93 4.85 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.792 2.995 . . . . 0.0 111.836 166.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -67.0 150.9 48.61 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.525 -0.735 . . . . 0.0 110.551 158.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 94.47 -151.05 20.0 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 -167.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.9 162.5 20.48 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.754 1.222 . . . . 0.0 113.276 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 19.3 m -165.09 159.08 17.4 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.822 -1.174 . . . . 0.0 111.818 157.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -122.25 116.16 23.64 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 11.7 mm -92.1 111.14 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.349 1.06 . . . . 0.0 108.188 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.3 145.41 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.961 0.904 . . . . 0.0 109.957 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.86 113.41 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.415 1.886 . . . . 0.0 109.015 174.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.58 178.16 27.13 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.435 1.017 . . . . 0.0 114.855 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 17.8 m -131.43 159.95 36.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.811 1.645 . . . . 0.0 109.566 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 78.35 -175.74 54.57 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 121.898 0.721 . . . . 0.0 112.966 -172.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -22.17 63.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.033 1.333 . . . . 0.0 112.85 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 72.0 m -63.47 -12.31 30.57 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 168.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -79.4 144.01 34.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.099 1.318 . . . . 0.0 112.799 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 24.9 mt -111.81 164.37 13.14 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.428 1.091 . . . . 0.0 111.24 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.5 t -140.58 146.85 38.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.802 1.241 . . . . 0.0 111.686 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -143.93 112.24 6.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.824 1.65 . . . . 0.0 110.034 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 131.62 46.44 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.98 0.912 . . . . 0.0 111.664 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -121.05 158.46 27.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.35 1.06 . . . . 0.0 110.775 162.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -145.5 140.03 27.23 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? . . . . . 0 C--N 1.332 -0.155 0 C-N-CA 124.994 1.318 . . . . 0.0 108.694 176.843 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.2 m -98.09 2.07 48.29 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.378 1.071 . . . . 0.0 112.984 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.48 82.0 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.074 0.852 . . . . 0.0 112.928 175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.38 135.99 37.57 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.473 1.033 . . . . 0.0 108.974 168.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.1 t -52.76 167.69 0.14 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.143 1.777 . . . . 0.0 114.658 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.92 100.16 0.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.283 1.833 . . . . 0.0 110.204 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 293' ' ' LYS . 8.3 mptt -61.09 127.93 33.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.573 2.349 . . . . 0.0 110.995 -168.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.06 -42.93 1.18 Allowed Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.937 1.256 . . . . 0.0 113.662 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 58.3 m -63.28 -5.91 3.95 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.791 2.436 . . . . 0.0 114.04 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 45.1 m -126.43 152.99 45.65 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -78.15 173.56 12.11 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.492 1.517 . . . . 0.0 112.261 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.34 158.28 29.57 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 51.0 mtm -88.9 154.48 20.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.899 2.08 . . . . 0.0 111.52 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.5 m -72.35 141.15 48.78 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.68 -0.637 . . . . 0.0 111.937 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.9 p -132.7 6.56 4.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -68.89 160.82 29.99 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.195 1.362 . . . . 0.0 109.975 160.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.58 95.66 0.23 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.692 1.597 . . . . 0.0 111.9 -169.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 65.6 mtp -80.45 172.62 13.53 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.203 1.401 . . . . 0.0 113.149 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 28.2 m -158.58 170.68 21.65 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.85 1.26 . . . . 0.0 110.45 160.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.55 123.94 36.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.405 0.682 . . . . 0.0 110.936 170.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 63.6 t -67.43 -36.34 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.583 1.553 . . . . 0.0 109.925 165.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -136.44 108.87 7.36 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 126.484 1.914 . . . . 0.0 107.724 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -59.49 143.88 85.27 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.959 0.904 . . . . 0.0 110.151 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.62 140.48 86.87 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.596 2.197 . . . . 0.0 111.612 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 389' ' ' TRP . 43.3 p -136.87 130.79 32.27 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.455 1.502 . . . . 0.0 109.71 173.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.93 134.14 52.35 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 124.262 0.976 . . . . 0.0 112.694 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 43.5 p -82.26 -18.34 42.8 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.23 1.012 . . . . 0.0 113.267 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 60.9 22.5 60.17 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.192 0.905 . . . . 0.0 112.55 -163.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -121.38 13.94 11.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.071 1.748 . . . . 0.0 111.024 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 103.07 -3.86 48.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.876 1.703 . . . . 0.0 114.119 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 25.9 p -127.63 161.9 27.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.961 1.38 . . . . 0.0 112.797 -165.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.72 135.12 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.648 1.579 . . . . 0.0 108.601 162.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.63 125.65 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.223 1.009 . . . . 0.0 112.841 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 18.7 ptm -146.01 158.36 43.87 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.941 1.696 . . . . 0.0 113.389 -166.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -138.35 137.47 37.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.921 1.288 . . . . 0.0 109.423 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 362' ' ' GLU . 35.4 m -124.27 149.1 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.877 1.271 . . . . 0.0 110.994 -169.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -116.11 134.32 55.06 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.965 1.706 . . . . 0.0 111.359 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.82 148.52 37.53 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.267 1.427 . . . . 0.0 108.374 163.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -105.87 -70.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.252 2.635 . . . . 0.0 116.201 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.09 168.44 19.81 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 120.129 -1.607 . . . . 0.0 113.591 -170.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.44 -16.77 0.09 OUTLIER Glycine 0 CA--C 1.54 1.642 0 C-N-CA 126.641 2.067 . . . . 0.0 117.501 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -119.48 91.76 44.92 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 119.305 1.553 . . . . 0.0 113.153 -163.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.35 131.62 19.34 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.977 1.784 . . . . 0.0 108.577 152.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 1.6 p -161.76 159.06 26.7 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.397 -0.814 . . . . 0.0 112.406 -170.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -73.55 132.19 42.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.896 1.678 . . . . 0.0 108.608 164.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.4 pp -62.66 111.58 5.04 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 118.692 0.678 . . . . 0.0 112.7 -168.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -89.74 75.17 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.251 3.301 . . . . 0.0 112.751 -163.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.95 130.27 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 167.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.83 158.99 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.135 0.974 . . . . 0.0 109.857 172.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.54 116.61 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.765 2.026 . . . . 0.0 106.314 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.34 161.61 31.97 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -160.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.02 -11.49 52.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.124 2.17 . . . . 0.0 112.784 169.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.51 136.64 51.06 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.145 1.778 . . . . 0.0 109.621 176.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.6 mp -60.11 -18.49 47.68 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -94.27 -1.01 54.66 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.126 2.17 . . . . 0.0 114.569 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 46.56 79.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.851 2.46 . . . . 0.0 115.933 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -103.71 -32.64 9.27 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.381 1.472 . . . . 0.0 111.864 158.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.98 115.48 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.628 1.104 . . . . 0.0 110.609 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.03 111.82 22.63 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.029 0.932 . . . . 0.0 113.06 -173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -86.38 -25.15 25.49 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 130.15 3.38 . . . . 0.0 114.459 -170.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -113.15 -163.93 15.74 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 115.766 1.066 . . . . 0.0 115.766 -169.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.62 137.85 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 127.904 2.481 . . . . 0.0 110.415 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.5 mt -74.81 134.49 41.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.757 164.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.0 t -104.78 -49.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.581 0.753 . . . . 0.0 110.356 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 37.5 m -71.66 155.79 40.1 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.118 0.485 . . . . 0.0 110.204 166.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.15 157.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.391 1.076 . . . . 0.0 112.562 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -121.96 75.71 39.01 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.486 1.114 . . . . 0.0 111.136 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -79.98 -164.22 0.27 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.458 3.439 . . . . 0.0 112.284 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.6 pt -96.73 162.24 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.791 1.637 . . . . 0.0 111.958 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.16 112.11 4.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.118 0.967 . . . . 0.0 108.657 157.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 98.9 p -63.77 -30.04 71.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.711 1.204 . . . . 0.0 113.059 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 12.2 m -137.23 155.96 48.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 128.259 2.624 . . . . 0.0 106.691 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -57.74 -19.55 28.49 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -97.09 10.68 38.66 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.331 1.452 . . . . 0.0 113.408 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -60.37 158.23 12.26 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 120.061 -1.649 . . . . 0.0 114.037 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 11.2 pt-20 -145.2 77.83 1.53 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.62 147.85 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.655 1.182 . . . . 0.0 112.171 -172.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 26.6 tp -105.37 132.33 51.7 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 129.709 3.203 . . . . 0.0 110.106 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.7 mp -144.41 138.88 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.859 1.664 . . . . 0.0 111.123 -167.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -99.45 135.69 40.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.821 1.248 . . . . 0.0 111.462 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.15 163.19 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.787 1.235 . . . . 0.0 110.873 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -119.03 112.88 35.98 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.771 2.028 . . . . 0.0 109.587 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.18 153.22 16.41 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 122.934 2.423 . . . . 0.0 111.159 158.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.76 174.27 4.77 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.124 2.549 . . . . 0.0 112.974 165.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.77 140.84 56.23 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.491 1.116 . . . . 0.0 110.155 164.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 96.4 -148.68 19.08 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.3 163.29 23.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.143 0.977 . . . . 0.0 113.451 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 37.6 m -163.17 161.59 25.12 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.792 -1.193 . . . . 0.0 110.785 158.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -121.27 114.87 21.98 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 15.0 mm -83.73 121.58 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.75 141.41 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.656 0.782 . . . . 0.0 109.688 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 81.6 t -122.86 104.36 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 126.353 1.861 . . . . 0.0 108.483 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.59 177.37 20.72 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 122.703 1.169 . . . . 0.0 114.575 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 98.8 m -130.31 164.29 24.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.353 1.461 . . . . 0.0 109.104 165.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.49 -171.53 53.03 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 122.031 0.795 . . . . 0.0 113.068 -173.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -29.98 59.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.099 1.76 . . . . 0.0 113.325 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.8 m -66.68 -11.48 54.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -74.43 123.35 24.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.184 1.356 . . . . 0.0 113.037 -169.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 14.2 mt -84.49 163.29 19.51 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.895 0.478 . . . . 0.0 111.201 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 t -138.41 148.15 44.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.893 1.277 . . . . 0.0 111.12 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -147.58 111.38 5.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.318 1.447 . . . . 0.0 110.611 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 134.24 50.23 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.532 1.133 . . . . 0.0 112.353 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' TRP . . . . . 0.408 ' CZ2' ' HA ' ' A' ' 311' ' ' THR . 11.1 m95 -126.0 162.97 24.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.277 1.431 . . . . 0.0 112.671 166.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.04 133.51 33.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.164 2.185 . . . . 0.0 108.158 171.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 C-N-CA 124.899 1.279 . . . . 0.0 110.917 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 60.3 p -103.45 -6.54 21.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.691 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -49.16 -57.43 6.7 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.386 1.075 . . . . 0.0 112.55 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.47 124.18 21.61 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 163.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.1 t -50.84 164.61 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.579 1.952 . . . . 0.0 115.687 -165.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.525 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.1 mm? -59.07 102.91 0.14 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.272 1.829 . . . . 0.0 110.471 -172.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -60.95 135.53 57.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.02 2.128 . . . . 0.0 111.018 -168.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 73.5 -47.56 1.44 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.533 1.063 . . . . 0.0 113.343 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.7 m -63.41 -16.58 60.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.548 1.939 . . . . 0.0 113.467 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -124.99 143.84 50.69 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.119 1.368 . . . . 0.0 112.241 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -73.47 173.31 9.82 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.872 0.869 . . . . 0.0 112.025 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -68.17 160.93 28.12 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.344 1.058 . . . . 0.0 113.675 -175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 46.3 mtt -88.7 158.4 18.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.894 1.677 . . . . 0.0 112.379 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.0 m -70.82 140.94 51.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.221 0.608 . . . . 0.0 111.906 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 13.3 p -123.21 9.07 9.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.37 1.068 . . . . 0.0 113.289 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -70.15 161.31 30.46 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.624 -0.672 . . . . 0.0 111.067 164.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -65.7 91.97 0.14 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.525 1.93 . . . . 0.0 111.433 -167.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 5.8 mtp -76.7 167.13 22.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.767 1.27 . . . . 0.0 113.413 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 27.7 m -159.63 173.6 15.85 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.062 1.345 . . . . 0.0 110.249 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -109.01 128.99 55.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.35 1.06 . . . . 0.0 111.09 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.5 -33.88 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.737 1.615 . . . . 0.0 109.68 163.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -138.9 124.73 19.77 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.097 1.359 . . . . 0.0 109.988 169.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -62.83 143.78 96.93 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.253 1.421 . . . . 0.0 112.061 169.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -58.56 132.07 46.15 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.587 2.191 . . . . 0.0 112.607 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.1 142.86 44.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.534 0.734 . . . . 0.0 110.335 172.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -66.83 134.85 52.94 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.035 0.934 . . . . 0.0 112.836 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.6 p -79.9 -20.94 44.63 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.076 1.351 . . . . 0.0 113.341 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 88.76 -12.37 65.84 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.661 1.601 . . . . 0.0 113.89 -166.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -90.12 9.44 28.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.523 1.529 . . . . 0.0 112.137 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 83.84 14.75 71.96 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 121.127 -0.983 . . . . 0.0 114.054 -171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.7 p -125.02 158.28 34.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.554 1.142 . . . . 0.0 110.929 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.83 131.07 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.045 1.338 . . . . 0.0 109.706 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.06 131.38 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.232 1.413 . . . . 0.0 111.804 -172.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 4.5 ptp -143.29 165.61 27.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.786 2.034 . . . . 0.0 111.858 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -136.96 132.12 33.94 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.473 -0.767 . . . . 0.0 109.5 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.6 m -113.44 163.97 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.386 1.075 . . . . 0.0 111.749 -168.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -125.12 115.53 20.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.358 1.463 . . . . 0.0 110.624 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 t -91.61 134.54 29.11 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 116.857 -1.544 . . . . 0.0 107.343 165.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -97.02 -80.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.447 0 C-N-CA 122.525 2.15 . . . . 0.0 116.381 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.13 144.97 21.51 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 119.25 -2.156 . . . . 0.0 115.878 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 88.54 0.53 81.96 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.87 1.224 . . . . 0.0 115.23 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.67 98.3 45.85 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.989 1.316 . . . . 0.0 111.486 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.54 123.36 10.1 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.3 2.0 . . . . 0.0 108.433 161.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.9 p -157.0 157.35 34.55 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.128 0.966 . . . . 0.0 113.251 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -69.83 138.82 52.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.075 1.75 . . . . 0.0 108.776 162.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 1.0 OUTLIER -62.42 121.77 69.08 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 118.721 0.691 . . . . 0.0 111.855 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 11.9 Cg_endo -99.98 95.69 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.649 2.233 . . . . 0.0 114.768 -155.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.72 141.98 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.02 0.928 . . . . 0.0 110.932 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.31 159.59 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.95 1.7 . . . . 0.0 110.309 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.4 t -133.35 97.91 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.284 1.834 . . . . 0.0 108.028 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -111.9 160.98 16.88 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -165.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -81.98 -17.2 47.74 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.859 1.664 . . . . 0.0 112.614 162.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -123.89 138.66 54.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.633 1.173 . . . . 0.0 111.745 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.68 -18.65 32.67 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.11 1.364 . . . . 0.0 113.314 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.4 t -91.53 -4.17 55.71 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.124 1.769 . . . . 0.0 114.388 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.51 70.05 0.32 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.133 2.173 . . . . 0.0 114.555 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -104.09 -14.57 15.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.951 0.9 . . . . 0.0 111.929 163.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 56.5 mt -111.74 155.83 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.702 1.601 . . . . 0.0 108.373 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -141.73 123.01 14.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.725 -1.234 . . . . 0.0 112.414 170.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -116.69 -11.38 11.0 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -96.65 -172.59 34.83 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.415 0.926 . . . . 0.0 115.415 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 23.3 mt -126.45 138.06 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.924 2.089 . . . . 0.0 110.775 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 50.5 mt -68.85 132.39 46.68 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.616 0.766 . . . . 0.0 109.815 163.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.42 -41.56 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 118.411 0.551 . . . . 0.0 112.05 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 59.9 m -76.88 145.8 38.08 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.655 0.661 . . . . 0.0 109.379 159.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 25.4 t -63.38 154.51 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.444 1.098 . . . . 0.0 111.44 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -117.98 82.99 18.17 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.21 1.404 . . . . 0.0 112.204 -174.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -85.42 -154.34 0.05 OUTLIER 'Trans proline' 0 CA--C 1.554 1.487 0 C-N-CA 125.24 3.96 . . . . 0.0 112.66 172.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.9 pt -107.33 166.6 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.171 2.189 . . . . 0.0 111.761 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.25 118.02 12.54 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 158.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 85.4 p -74.71 -44.11 51.66 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.149 1.38 . . . . 0.0 112.521 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.75 155.14 20.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.005 1.722 . . . . 0.0 108.623 158.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -59.77 -26.49 65.75 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -91.37 9.93 29.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.508 1.523 . . . . 0.0 113.068 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -60.08 150.89 28.08 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.45 -1.406 . . . . 0.0 114.252 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.24 88.84 2.45 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 66.0 t -100.56 144.91 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.16 1.384 . . . . 0.0 111.834 -162.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.6 tp -95.73 126.43 40.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.799 2.84 . . . . 0.0 109.774 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.57 154.04 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.698 1.199 . . . . 0.0 110.812 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.29 148.2 50.64 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 124.712 1.205 . . . . 0.0 111.229 165.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.59 154.09 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.38 1.472 . . . . 0.0 110.686 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.9 109.84 59.21 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.621 1.569 . . . . 0.0 109.126 173.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.78 144.62 31.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.236 1.958 . . . . 0.0 111.43 163.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.13 168.3 25.12 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.173 2.582 . . . . 0.0 110.852 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -56.76 134.72 55.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.645 1.178 . . . . 0.0 111.897 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.63 -148.62 19.18 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.195 0.902 . . . . 0.0 112.685 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.73 147.71 22.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.16 2.184 . . . . 0.0 113.786 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 29.7 m -163.44 154.12 16.16 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.273 1.429 . . . . 0.0 113.042 159.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -117.22 105.27 12.04 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.666 1.586 . . . . 0.0 108.955 172.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 20.5 mm -78.48 116.57 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 30.3 mt -121.84 139.51 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.118 0.485 . . . . 0.0 110.524 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 68.9 t -115.31 114.49 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.38 1.872 . . . . 0.0 107.886 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 99.89 177.63 30.73 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 122.81 1.228 . . . . 0.0 114.756 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 94.5 m -127.31 163.69 23.4 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.064 1.746 . . . . 0.0 109.767 167.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.41 -173.7 52.85 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 121.746 0.637 . . . . 0.0 113.265 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -25.67 64.44 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.329 1.452 . . . . 0.0 113.251 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.5 m -64.86 -13.72 57.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 170.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -74.11 136.95 42.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.07 1.304 . . . . 0.0 112.266 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 17.3 mt -104.43 154.78 19.44 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.406 0.682 . . . . 0.0 110.607 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.6 t -129.0 145.61 51.2 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.525 1.13 . . . . 0.0 112.161 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -146.16 108.63 4.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.465 1.506 . . . . 0.0 109.585 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -65.21 137.99 57.95 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.607 1.163 . . . . 0.0 111.759 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -142.07 126.19 17.4 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.727 1.211 . . . . 0.0 111.36 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -96.8 131.89 43.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.818 0.847 . . . . 0.0 109.731 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? . . . . . 0 N--CA 1.468 0.445 0 C-N-CA 125.589 1.555 . . . . 0.0 110.663 177.996 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 117.813 -1.089 . . . . 0.0 113.805 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.1 p -98.98 -7.38 27.03 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.137 1.335 . . . . 0.0 114.393 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.12 -48.37 70.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.678 1.191 . . . . 0.0 112.851 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.08 121.22 14.65 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 2.3 t -52.07 168.85 0.08 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.264 1.826 . . . . 0.0 115.153 -168.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.1 109.88 0.66 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.132 1.773 . . . . 0.0 110.635 -171.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -69.7 138.98 53.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.458 1.903 . . . . 0.0 110.738 -165.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 64.66 -59.35 0.07 OUTLIER Glycine 0 CA--C 1.534 1.246 0 C-N-CA 127.57 2.509 . . . . 0.0 113.836 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 40.4 p -47.03 -21.92 0.28 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 130.951 3.7 . . . . 0.0 115.817 168.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' SER . . . . . 0.508 ' HB2' ' HE3' ' A' ' 331' ' ' LYS . 2.6 p -145.24 161.97 38.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.863 1.211 . . . . 0.0 113.096 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -81.35 170.32 16.15 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -163.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 162.08 29.44 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.477 1.132 . . . . 0.0 113.994 -176.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 43.6 mtt -80.46 161.37 24.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.246 2.218 . . . . 0.0 113.162 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 8.1 m -72.26 146.56 47.15 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.585 -0.697 . . . . 0.0 112.089 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.8 p -136.69 8.39 3.06 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -78.5 158.57 28.56 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.139 1.336 . . . . 0.0 110.013 159.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 101.68 0.14 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.903 1.281 . . . . 0.0 112.006 -168.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 38.2 mtp -81.89 165.91 20.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.684 0.793 . . . . 0.0 112.073 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.7 p -147.93 159.36 43.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.941 0.897 . . . . 0.0 111.455 168.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -77.76 118.64 20.31 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 169.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.23 -30.31 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.225 0.61 . . . . 0.0 109.918 161.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -144.62 130.38 19.15 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.746 1.619 . . . . 0.0 109.125 168.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -63.62 153.09 84.46 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.526 0.73 . . . . 0.0 112.078 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.07 127.31 19.95 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.761 2.307 . . . . 0.0 110.962 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 48.3 p -126.22 133.66 51.44 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.873 1.269 . . . . 0.0 110.952 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -63.69 133.98 54.57 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.186 1.794 . . . . 0.0 112.277 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 6.4 p -71.68 -19.98 62.0 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 165.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.69 17.41 67.01 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-N 118.733 0.697 . . . . 0.0 112.198 -164.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -128.44 9.56 6.08 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.086 1.754 . . . . 0.0 111.616 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.98 6.75 36.82 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.12 -1.378 . . . . 0.0 114.861 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.4 p -128.54 160.38 32.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.789 1.794 . . . . 0.0 112.687 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.2 m -130.43 132.84 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.456 1.502 . . . . 0.0 109.778 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.5 p -120.23 129.85 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.953 1.301 . . . . 0.0 112.958 -169.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 5.8 ptp -140.53 166.33 25.03 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.768 1.627 . . . . 0.0 112.833 -172.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -132.27 138.65 47.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.297 1.039 . . . . 0.0 110.083 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.8 151.29 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.356 1.062 . . . . 0.0 110.776 -169.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -107.8 127.88 54.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.06 1.344 . . . . 0.0 110.577 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.41 138.81 20.01 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 117.257 -1.354 . . . . 0.0 107.734 162.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -104.79 -75.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.427 2.085 . . . . 0.0 115.325 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.47 174.67 10.55 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.042 -1.661 . . . . 0.0 114.274 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.21 3.21 17.1 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 116.952 1.541 . . . . 0.0 116.952 170.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.11 95.1 37.45 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 119.038 1.419 . . . . 0.0 112.9 -162.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -72.1 124.31 9.94 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.103 1.869 . . . . 0.0 108.659 159.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.0 p -161.68 156.64 23.33 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -173.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 296' ' ' SER . 14.1 tptp -73.54 135.68 43.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.837 2.855 . . . . 0.0 109.418 162.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 14.6 pt -63.45 124.25 83.77 Favored Pre-proline 0 N--CA 1.479 1.005 0 CA-C-N 119.85 1.205 . . . . 0.0 111.409 -171.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -105.77 89.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 121.622 1.548 . . . . 0.0 114.57 -157.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 74.3 t -125.98 132.04 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.884 0.873 . . . . 0.0 109.531 173.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.8 158.53 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.859 1.264 . . . . 0.0 110.674 -172.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 35.4 t -127.1 126.75 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.057 1.743 . . . . 0.0 107.552 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -132.01 161.45 33.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.902 1.281 . . . . 0.0 112.795 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.97 -22.65 33.66 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.749 1.22 . . . . 0.0 112.333 166.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -107.61 154.79 20.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.267 1.427 . . . . 0.0 111.479 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.69 -19.28 63.72 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.6 t -117.82 7.06 12.34 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.677 1.191 . . . . 0.0 113.951 -167.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 47.15 70.2 0.43 Allowed 'General case' 0 C--O 1.238 0.497 0 C-N-CA 127.974 2.51 . . . . 0.0 114.691 -170.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -83.81 -43.35 15.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.286 1.034 . . . . 0.0 111.158 154.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 43.4 mm -86.93 153.44 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.585 1.154 . . . . 0.0 109.959 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . 0.263 0.0 OUTLIER -125.15 96.4 4.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 123.171 1.462 . . . . 0.0 110.707 171.237 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -78.2 -55.56 5.17 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 128.732 2.813 . . . . 0.0 111.869 -169.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.28 -168.12 41.38 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.438 1.494 . . . . 0.0 116.273 -166.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.1 mt -124.11 139.91 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 126.604 1.961 . . . . 0.0 111.152 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.65 125.24 26.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.594 1.158 . . . . 0.0 110.487 168.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.5 t -104.15 -54.04 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.528 0.731 . . . . 0.0 109.286 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 50.0 m -71.76 140.61 49.57 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 167.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.67 150.63 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.887 1.275 . . . . 0.0 112.369 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -125.0 70.84 61.28 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.59 1.156 . . . . 0.0 112.556 -167.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.85 -167.12 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.73 3.62 . . . . 0.0 112.575 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.7 pt -83.34 160.35 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.694 1.198 . . . . 0.0 112.748 173.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.1 110.75 4.67 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 156.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.2 p -66.88 -33.06 74.77 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.071 1.749 . . . . 0.0 112.696 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.09 146.8 50.25 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.749 2.02 . . . . 0.0 108.06 167.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -59.84 -17.9 39.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -91.3 0.72 57.48 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.683 1.993 . . . . 0.0 112.758 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.06 151.69 30.15 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.45 -1.406 . . . . 0.0 113.068 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -136.57 82.72 1.96 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.174 0.987 . . . . 0.0 112.963 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 43.9 t -99.42 153.1 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.288 1.435 . . . . 0.0 111.582 -164.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.53 128.68 55.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.217 2.207 . . . . 0.0 109.778 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.1 mp -135.87 141.38 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.401 1.48 . . . . 0.0 109.035 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -114.9 149.6 36.95 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 122.078 0.942 . . . . 0.0 112.85 161.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.23 158.37 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.867 1.667 . . . . 0.0 110.883 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -109.01 102.68 49.72 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.588 1.955 . . . . 0.0 109.638 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.8 145.42 20.08 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.194 2.596 . . . . 0.0 110.815 166.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.82 176.67 9.73 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.002 2.468 . . . . 0.0 111.185 164.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -63.45 152.8 37.3 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.268 1.427 . . . . 0.0 113.739 -171.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 89.46 -162.06 30.34 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.844 1.212 . . . . 0.0 112.257 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.79 159.21 31.28 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.322 1.058 . . . . 0.0 111.81 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 73.2 m -160.33 164.88 32.17 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.151 -1.593 . . . . 0.0 111.174 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -120.86 116.49 25.28 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.849 1.26 . . . . 0.0 109.008 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 24.1 mm -85.38 120.2 35.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 124.714 1.206 . . . . 0.0 107.884 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.62 140.31 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.448 0.699 . . . . 0.0 110.092 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 76.3 t -115.18 115.08 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 126.79 2.036 . . . . 0.0 108.067 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 97.89 179.39 33.2 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 123.442 1.579 . . . . 0.0 115.622 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 29.8 m -134.2 163.66 29.11 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.194 1.398 . . . . 0.0 109.935 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.09 -174.14 54.63 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 122.148 0.86 . . . . 0.0 112.85 -170.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -27.69 61.65 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.855 1.662 . . . . 0.0 112.794 172.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.8 m -65.41 -12.08 48.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -74.62 138.65 43.09 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.753 1.16 . . . . 0.0 111.981 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 21.1 mt -103.86 162.41 13.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.987 0.915 . . . . 0.0 110.973 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.7 t -142.1 146.44 35.4 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.45 1.1 . . . . 0.0 111.664 -172.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -145.39 119.98 9.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.794 1.638 . . . . 0.0 109.931 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -71.01 129.07 38.05 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.579 0.752 . . . . 0.0 111.782 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -123.76 159.21 29.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.731 1.212 . . . . 0.0 111.636 170.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -133.65 118.74 18.53 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.943 1.697 . . . . 0.0 109.033 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? . . . . . 0 N--CA 1.47 0.527 0 C-N-CA 125.611 1.564 . . . . 0.0 111.09 -167.301 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 118.169 -0.919 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 19.2 t -111.46 -2.09 15.67 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.46 -47.69 75.26 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.256 1.389 . . . . 0.0 112.275 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.403 HD22 ' HE3' ' A' ' 293' ' ' LYS . 4.0 tt -68.13 123.84 21.8 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 159.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 4.8 t -50.01 167.66 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.425 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.3 mm? -63.06 113.65 3.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.507 1.923 . . . . 0.0 110.735 -172.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 295' ' ' THR . 8.6 mptt -62.37 132.97 54.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.444 1.897 . . . . 0.0 110.384 -174.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 65.18 -27.19 0.12 Allowed Glycine 0 CA--C 1.543 1.786 0 C-N-CA 126.757 2.122 . . . . 0.0 115.488 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 293' ' ' LYS . 43.8 m -87.39 -13.64 42.85 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 130.599 3.56 . . . . 0.0 112.068 -173.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.4 m -155.88 153.88 30.38 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 119.853 -1.779 . . . . 0.0 113.569 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -75.54 178.75 5.75 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.43 1.892 . . . . 0.0 114.538 -168.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.86 159.81 14.79 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.822 1.649 . . . . 0.0 114.199 -168.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.27 158.43 26.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.481 2.712 . . . . 0.0 114.873 -170.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.8 m -78.88 145.01 34.39 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.79 0.836 . . . . 0.0 110.585 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 14.17 3.92 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.415 1.086 . . . . 0.0 113.224 167.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -67.66 159.33 30.23 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.818 153.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.5 109.48 4.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.316 0.646 . . . . 0.0 111.064 -167.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 69.9 mtp -95.27 162.25 13.76 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.312 1.053 . . . . 0.0 112.431 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.4 p -151.42 159.47 44.21 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.239 1.416 . . . . 0.0 109.534 166.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.75 129.94 34.8 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 122.045 -0.409 . . . . 0.0 109.904 166.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.66 -29.07 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.118 0.967 . . . . 0.0 109.989 162.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -145.82 133.5 21.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.899 1.68 . . . . 0.0 109.999 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -66.47 147.38 98.97 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.986 0.914 . . . . 0.0 112.465 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.72 133.54 57.0 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.633 2.222 . . . . 0.0 112.186 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 21.7 p -132.89 142.34 48.87 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.976 1.711 . . . . 0.0 110.126 169.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.0 130.3 46.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.649 0.738 . . . . 0.0 110.675 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 75.0 p -78.29 -18.74 54.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.495 1.918 . . . . 0.0 113.034 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 82.62 -4.3 79.22 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.367 0.985 . . . . 0.0 113.845 -163.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -84.25 -0.48 52.46 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 119.612 1.706 . . . . 0.0 111.88 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 76.69 36.22 38.15 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.91 1.243 . . . . 0.0 111.539 -165.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.6 p -146.69 164.16 33.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.194 2.198 . . . . 0.0 108.403 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.26 134.06 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.305 1.442 . . . . 0.0 110.657 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.1 133.5 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.438 1.095 . . . . 0.0 113.611 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.0 ptm -145.94 163.56 34.76 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.224 2.21 . . . . 0.0 112.11 -169.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -130.58 144.22 51.27 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.377 0.671 . . . . 0.0 110.06 172.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 362' ' ' GLU . 4.0 m -134.15 146.45 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.145 0.978 . . . . 0.0 111.461 -167.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -109.8 131.04 55.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.989 1.716 . . . . 0.0 111.078 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 14.3 t -108.43 143.32 27.24 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-O 116.973 -1.489 . . . . 0.0 108.156 163.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -101.13 -75.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.506 0 C-N-CA 122.259 1.972 . . . . 0.0 116.843 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 169.13 21.72 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 121.342 1.883 . . . . 0.0 114.771 -173.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 68.99 -5.41 4.74 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.542 1.544 . . . . 0.0 116.639 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -125.64 103.85 27.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.768 1.284 . . . . 0.0 112.67 -164.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -76.56 134.61 15.46 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.984 1.789 . . . . 0.0 109.055 160.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.3 p -158.23 155.15 28.45 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.371 -0.83 . . . . 0.0 112.918 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -77.84 136.98 38.16 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 159.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -58.62 117.28 19.42 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-N 118.783 0.719 . . . . 0.0 111.876 -171.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -97.03 102.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.925 3.083 . . . . 0.0 113.039 -167.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.5 139.13 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.446 1.099 . . . . 0.0 108.909 170.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 3.1 mt -136.96 143.84 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.631 1.173 . . . . 0.0 108.575 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 45.3 t -119.26 108.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.433 1.093 . . . . 0.0 108.187 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -124.36 161.33 26.15 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -162.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.81 -6.96 59.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.221 2.608 . . . . 0.0 112.361 168.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -139.8 149.73 43.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.129 1.772 . . . . 0.0 111.431 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 20.4 mt -64.48 -24.63 67.68 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.672 1.189 . . . . 0.0 113.371 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.4 t -96.07 4.74 52.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.877 1.271 . . . . 0.0 113.72 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.2 75.08 0.1 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.225 3.01 . . . . 0.0 115.652 -171.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.94 -35.01 12.17 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.844 2.057 . . . . 0.0 111.786 164.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.91 153.26 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.747 1.219 . . . . 0.0 109.84 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.92 103.55 5.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.033 -1.042 . . . . 0.0 111.316 175.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -103.85 -13.22 16.48 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -174.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -102.52 -174.38 27.15 Favored Glycine 0 CA--C 1.536 1.403 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.01 144.2 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 127.774 2.43 . . . . 0.0 110.913 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 353' ' ' ASN . 0.6 OUTLIER -77.32 130.35 37.04 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.527 1.131 . . . . 0.0 109.485 165.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -46.97 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 118.99 -0.529 . . . . 0.0 111.122 176.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 32.2 m -65.92 150.66 48.27 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.773 160.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.0 156.98 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.818 1.247 . . . . 0.0 111.951 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.412 ' HB2' HD13 ' A' ' 349' ' ' LEU . 23.2 t-20 -114.9 80.94 7.04 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.387 1.475 . . . . 0.0 111.185 -173.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -80.24 -172.99 1.68 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.143 2.562 . . . . 0.0 112.25 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 28.0 pt -93.5 176.41 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.713 1.605 . . . . 0.0 110.868 167.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.43 113.12 7.25 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 153.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.9 p -67.01 -32.18 73.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.801 1.64 . . . . 0.0 112.871 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.39 152.3 51.72 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.719 2.808 . . . . 0.0 108.159 168.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -63.17 -23.33 67.38 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.589 -1.32 . . . . 0.0 114.245 -173.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -86.26 4.79 37.32 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.935 1.294 . . . . 0.0 113.443 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.79 150.1 7.85 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 6.5 pt-20 -135.34 85.88 2.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.535 -1.212 . . . . 0.0 114.122 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 4.4 t -93.13 140.8 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.029 1.332 . . . . 0.0 111.501 -167.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -101.33 121.06 41.23 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 129.179 2.991 . . . . 0.0 109.064 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 1.8 mp -140.81 146.22 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.239 1.416 . . . . 0.0 110.713 -169.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -114.39 139.13 49.74 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.6 1.16 . . . . 0.0 112.608 166.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.94 159.18 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.132 1.773 . . . . 0.0 111.211 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -113.68 108.1 52.05 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.691 1.996 . . . . 0.0 109.453 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.36 150.67 25.58 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.314 2.009 . . . . 0.0 110.315 166.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -59.15 164.77 9.89 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.451 1.434 . . . . 0.0 111.244 163.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -65.57 140.86 58.57 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.711 -0.618 . . . . 0.0 110.473 167.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.49 -151.46 18.22 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.158 0.409 . . . . 0.0 112.427 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -74.46 161.11 30.12 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.447 1.117 . . . . 0.0 112.9 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 24.1 m -170.1 162.08 8.8 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.43 1.892 . . . . 0.0 111.264 166.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -128.61 127.45 42.28 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.446 1.898 . . . . 0.0 107.138 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 23.3 mm -95.15 118.14 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.7 140.04 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.019 0.928 . . . . 0.0 110.503 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 97.2 t -106.36 122.9 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 126.06 1.744 . . . . 0.0 108.359 168.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 85.97 179.85 49.91 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 123.444 1.58 . . . . 0.0 116.335 168.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 72.0 m -138.76 171.69 13.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.974 1.31 . . . . 0.0 109.96 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 85.39 -154.68 28.86 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -171.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -26.32 64.57 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.748 0.819 . . . . 0.0 112.189 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.9 m -76.79 -6.43 52.26 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 129.127 2.971 . . . . 0.0 115.24 -164.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -75.24 124.58 27.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.752 0.421 . . . . 0.0 112.059 -167.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.78 158.58 15.82 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.479 0.312 . . . . 0.0 110.422 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.1 t -131.42 154.24 48.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.434 1.094 . . . . 0.0 111.913 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -142.69 126.14 16.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.158 1.783 . . . . 0.0 109.553 171.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.89 127.29 31.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.361 1.464 . . . . 0.0 111.558 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -136.22 117.78 14.87 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.217 1.007 . . . . 0.0 110.953 170.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -119.0 119.97 35.85 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.9 tttp . . . . . 0 C--O 1.233 0.2 0 C-N-CA 126.009 1.724 . . . . 0.0 111.28 -165.755 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.7 p -104.19 -2.37 25.83 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.48 89.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.205 0.911 . . . . 0.0 113.124 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.7 tt -75.97 128.41 35.0 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 161.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 2.2 t -52.97 168.56 0.12 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.945 2.098 . . . . 0.0 116.036 -167.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.48 105.44 0.63 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.077 1.751 . . . . 0.0 110.628 -172.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.07 124.91 20.97 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.087 1.355 . . . . 0.0 111.226 -171.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.41 -51.6 2.57 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.998 1.285 . . . . 0.0 112.996 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.3 m -62.89 3.08 0.25 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.549 2.74 . . . . 0.0 114.149 174.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.6 m -156.48 149.47 24.05 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 118.996 -2.315 . . . . 0.0 112.658 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -74.19 171.81 12.92 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.636 1.975 . . . . 0.0 113.557 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.09 163.19 28.09 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.354 1.462 . . . . 0.0 113.055 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 58.0 mtt -93.82 164.12 13.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.138 1.775 . . . . 0.0 113.788 -168.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.8 m -76.23 139.38 41.15 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.315 0.646 . . . . 0.0 111.244 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 6.4 p -133.04 20.07 4.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.574 1.15 . . . . 0.0 113.036 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -82.46 164.68 20.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 158.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.02 95.64 0.12 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.39 1.476 . . . . 0.0 111.847 -175.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 32.7 mtp -80.36 171.79 14.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.665 1.186 . . . . 0.0 112.426 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.7 m -158.93 154.53 26.07 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.184 -0.947 . . . . 0.0 111.965 163.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.4 111.8 14.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.886 0.875 . . . . 0.0 109.744 163.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 20.1 t -66.99 -33.52 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.476 1.11 . . . . 0.0 109.868 166.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -129.45 126.68 39.28 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.859 1.664 . . . . 0.0 108.577 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -62.83 152.86 81.63 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.69 1.196 . . . . 0.0 112.164 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.43 124.63 13.62 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.733 2.289 . . . . 0.0 111.049 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 70.5 p -125.17 136.87 54.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.169 1.388 . . . . 0.0 110.692 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.47 127.04 30.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.238 1.015 . . . . 0.0 111.742 173.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 75.7 p -76.32 -22.31 55.12 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.53 1.532 . . . . 0.0 113.087 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 89.22 -11.37 69.79 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.057 1.789 . . . . 0.0 113.817 -163.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -86.01 2.43 46.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.486 1.515 . . . . 0.0 112.303 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 87.66 15.11 62.19 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.937 0.78 . . . . 0.0 112.86 -167.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.6 p -131.14 158.19 41.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.763 1.225 . . . . 0.0 111.345 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.16 132.05 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.226 1.41 . . . . 0.0 109.727 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.65 134.27 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.516 1.127 . . . . 0.0 113.35 -169.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 3.3 ptp -143.14 160.52 40.26 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.282 1.833 . . . . 0.0 113.174 -173.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -119.15 121.71 40.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.478 1.911 . . . . 0.0 107.806 173.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.78 141.88 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.366 1.066 . . . . 0.0 111.527 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -106.14 132.34 52.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.796 1.639 . . . . 0.0 112.278 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.38 147.18 33.79 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.726 1.61 . . . . 0.0 108.649 163.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -108.97 -72.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.255 2.636 . . . . 0.0 115.386 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.44 170.07 17.6 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.241 -1.537 . . . . 0.0 114.202 -171.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 64.57 -23.32 0.1 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 127.633 2.539 . . . . 0.0 117.77 168.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -107.52 97.45 19.71 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.501 1.52 . . . . 0.0 112.05 -170.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.29 131.23 25.99 Favored 'Trans proline' 0 C--N 1.35 0.631 0 N-CA-C 108.005 -1.575 . . . . 0.0 108.005 157.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.6 p -160.9 157.3 26.32 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -72.23 137.76 47.05 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.343 1.457 . . . . 0.0 108.989 159.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.37 119.08 56.56 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 118.69 0.677 . . . . 0.0 112.196 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -97.38 87.41 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.049 3.166 . . . . 0.0 113.833 -166.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 97.1 t -113.49 131.72 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 164.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.23 153.47 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.484 1.114 . . . . 0.0 110.152 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.46 109.41 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.188 1.795 . . . . 0.0 107.129 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -119.66 164.67 15.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -161.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -89.49 -6.75 56.16 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.824 2.05 . . . . 0.0 112.668 165.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -133.79 144.41 49.0 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.054 1.342 . . . . 0.0 110.677 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.55 -11.75 26.98 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.8 t -113.02 12.03 19.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.964 1.706 . . . . 0.0 113.188 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 39.85 60.11 1.75 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.53 2.732 . . . . 0.0 116.152 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.85 63.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.267 0.627 . . . . 0.0 111.927 155.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 38.0 mt -110.6 155.98 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.126 1.771 . . . . 0.0 109.254 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.45 102.0 6.94 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.312 1.045 . . . . 0.0 110.808 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -77.96 -56.39 4.53 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 129.732 3.213 . . . . 0.0 111.423 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -92.35 -167.64 39.77 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 116.593 1.397 . . . . 0.0 116.593 -166.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.5 mt -116.51 135.48 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.242 1.817 . . . . 0.0 110.546 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.3 mt -72.04 122.29 20.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.615 0.766 . . . . 0.0 109.372 165.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 98.4 t -103.02 -52.62 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.177 0.991 . . . . 0.0 110.235 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 50.4 m -67.02 155.23 39.19 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.198 0.523 . . . . 0.0 110.102 164.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 11.3 m -58.1 159.32 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.151 0.98 . . . . 0.0 112.468 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -118.6 85.02 25.86 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.638 1.175 . . . . 0.0 110.125 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -80.48 -165.16 0.32 Allowed 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 124.502 3.468 . . . . 0.0 113.232 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 31.5 pt -105.04 165.99 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.688 1.995 . . . . 0.0 111.218 172.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.66 102.48 1.2 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 155.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 82.8 p -70.61 -35.77 73.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.305 1.442 . . . . 0.0 112.208 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.5 157.62 33.15 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.815 2.046 . . . . 0.0 109.491 158.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -66.68 -23.46 66.14 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -89.75 7.69 35.56 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.03 0.832 . . . . 0.0 112.648 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -56.61 153.07 10.9 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.878 1.323 . . . . 0.0 112.973 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.67 123.33 12.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.907 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.61 145.95 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.702 0.801 . . . . 0.0 110.254 -159.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.4 tp -95.97 126.58 41.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.443 2.297 . . . . 0.0 109.405 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.3 mp -139.28 132.13 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.492 1.117 . . . . 0.0 109.483 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.81 147.98 32.31 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.96 0.886 . . . . 0.0 112.106 159.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.38 160.86 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.733 1.613 . . . . 0.0 110.702 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -115.32 109.12 46.69 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.94 1.696 . . . . 0.0 111.092 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.74 148.9 20.43 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.932 2.421 . . . . 0.0 111.549 162.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -73.15 172.18 16.07 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.772 2.315 . . . . 0.0 111.103 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -57.34 147.84 24.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.239 0.615 . . . . 0.0 111.668 171.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.35 -136.08 12.52 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.15 162.36 14.36 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.03 1.332 . . . . 0.0 112.736 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 38.5 m -162.18 162.98 28.62 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.777 -1.202 . . . . 0.0 110.716 157.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.84 117.89 25.13 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 21.5 mm -91.03 111.25 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.857 1.263 . . . . 0.0 107.941 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.48 142.57 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.704 0.802 . . . . 0.0 109.547 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 97.8 t -123.29 108.34 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.335 1.854 . . . . 0.0 108.765 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.83 175.88 21.61 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.979 1.276 . . . . 0.0 114.36 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 56.4 m -133.86 162.12 32.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.284 1.434 . . . . 0.0 109.759 169.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.5 -171.53 49.39 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 121.601 0.556 . . . . 0.0 112.668 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.33 -27.5 23.71 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.222 1.409 . . . . 0.0 113.956 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.0 m -74.86 -3.91 34.74 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.761 2.424 . . . . 0.0 114.833 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -79.55 125.86 30.13 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.078 0.853 . . . . 0.0 112.618 -174.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.84 163.86 14.85 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.212 0.605 . . . . 0.0 110.827 172.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.6 t -144.13 148.31 34.89 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.262 1.025 . . . . 0.0 111.829 -171.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -147.75 110.05 4.6 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.325 1.45 . . . . 0.0 110.119 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.2 133.61 56.26 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.913 0.885 . . . . 0.0 111.212 173.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -125.3 160.8 28.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.285 1.034 . . . . 0.0 111.298 163.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -129.59 146.25 51.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.225 1.41 . . . . 0.0 108.771 171.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.327 0 C-N-CA 124.886 1.274 . . . . 0.0 109.696 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 9.5 m -109.43 0.86 19.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.323 1.449 . . . . 0.0 113.99 -167.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.64 -48.97 62.66 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.235 0.925 . . . . 0.0 111.031 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.68 131.43 46.31 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 167.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.6 t -62.58 176.66 0.62 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -164.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.427 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.7 mm? -64.7 97.39 0.21 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.933 1.693 . . . . 0.0 112.332 -167.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 293' ' ' LYS . 0.8 OUTLIER -47.48 125.7 8.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 128.052 2.541 . . . . 0.0 111.794 -178.341 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 60.35 10.17 15.22 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.559 1.076 . . . . 0.0 115.283 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 13.5 m -139.76 17.0 2.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.657 1.583 . . . . 0.0 109.809 -159.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 2.3 m -171.15 159.07 5.77 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.267 -1.521 . . . . 0.0 112.368 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -86.74 174.66 8.68 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.446 1.099 . . . . 0.0 112.735 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -63.17 159.3 17.85 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -164.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 62.1 mtm -79.22 151.74 31.04 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.914 2.086 . . . . 0.0 110.382 164.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.7 m -70.51 145.49 50.85 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.989 -0.445 . . . . 0.0 111.794 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.1 p -134.3 24.32 3.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.929 1.292 . . . . 0.0 112.634 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -94.59 169.45 10.17 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 160.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -69.62 90.96 0.58 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.195 2.198 . . . . 0.0 111.956 -163.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 37.7 mtp -80.58 170.63 16.08 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.961 0.886 . . . . 0.0 113.348 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 36.5 m -159.44 161.22 35.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.057 0.943 . . . . 0.0 112.018 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.49 120.2 22.14 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.772 0.829 . . . . 0.0 109.641 168.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.64 -34.32 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.216 1.006 . . . . 0.0 110.116 163.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -136.46 132.68 35.7 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.173 1.389 . . . . 0.0 110.007 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -69.32 145.89 96.17 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.526 1.53 . . . . 0.0 112.15 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.0 136.62 57.66 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.864 2.376 . . . . 0.0 112.636 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 71.4 p -141.61 131.6 24.57 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.152 1.781 . . . . 0.0 110.411 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -60.49 131.76 51.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.777 0.831 . . . . 0.0 112.387 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.0 p -66.13 -21.23 66.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.556 1.942 . . . . 0.0 112.717 168.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 98.31 -16.79 59.48 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.909 1.718 . . . . 0.0 112.397 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -74.08 -18.15 60.86 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.419 1.11 . . . . 0.0 111.76 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.55 32.88 6.1 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.569 1.081 . . . . 0.0 111.751 -166.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.8 p -136.85 129.43 30.28 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.905 1.282 . . . . 0.0 108.39 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 21.8 m -106.9 123.06 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.434 0.694 . . . . 0.0 110.068 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.35 129.42 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.072 0.949 . . . . 0.0 111.816 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.9 ptm -149.49 163.04 38.9 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.487 1.915 . . . . 0.0 111.756 -169.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -136.74 136.58 39.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.442 0.697 . . . . 0.0 110.153 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.96 127.66 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.999 0.92 . . . . 0.0 112.874 -164.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -92.94 125.7 37.67 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.573 1.549 . . . . 0.0 112.02 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.1 t -96.56 145.27 29.28 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 117.393 -1.289 . . . . 0.0 107.626 158.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -104.27 -65.88 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 123.056 2.504 . . . . 0.0 115.321 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 175.85 10.32 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.344 -1.472 . . . . 0.0 112.142 -174.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.69 -13.19 0.09 OUTLIER Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.509 2.481 . . . . 0.0 118.129 167.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.89 93.93 22.77 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 119.147 1.474 . . . . 0.0 113.03 -167.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.3 112.15 3.26 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.402 2.068 . . . . 0.0 108.756 156.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.5 p -154.35 159.67 41.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.15 0.98 . . . . 0.0 111.923 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 355' ' ' ILE . 20.6 mtpp -76.83 144.13 39.28 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.214 1.006 . . . . 0.0 109.877 158.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.45 111.46 4.08 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.242 1.017 . . . . 0.0 111.97 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -94.54 89.06 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.952 3.101 . . . . 0.0 112.999 -162.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.86 127.8 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 150.06 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.446 1.098 . . . . 0.0 109.397 -177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 64.4 t -128.77 105.03 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -117.6 161.24 19.95 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -158.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.62 -14.62 58.68 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.08 2.152 . . . . 0.0 112.783 164.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -134.38 148.23 50.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.612 1.165 . . . . 0.0 112.258 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 16.4 mt -61.96 -19.74 63.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.137 1.375 . . . . 0.0 114.468 -173.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.8 t -104.29 5.83 34.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.606 1.962 . . . . 0.0 113.262 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.48 69.08 0.43 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.016 2.926 . . . . 0.0 116.434 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -81.32 -45.42 16.2 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.365 1.466 . . . . 0.0 112.064 157.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.42 113.73 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.976 1.311 . . . . 0.0 110.338 -172.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.13 107.39 15.67 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.445 0.698 . . . . 0.0 112.331 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 373' ' ' ASP . 12.2 ttpt -72.86 -43.91 62.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.393 2.677 . . . . 0.0 112.955 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -100.28 -165.5 28.7 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.465 1.346 . . . . 0.0 116.465 -165.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.94 148.14 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.182 2.193 . . . . 0.0 110.0 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.32 134.51 34.51 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.464 -0.772 . . . . 0.0 109.666 170.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 81.9 t -98.29 -46.64 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.904 0.882 . . . . 0.0 109.588 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.8 m -71.38 154.9 41.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.396 0.617 . . . . 0.0 110.211 164.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.46 161.56 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.211 1.404 . . . . 0.0 110.541 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -114.17 69.28 1.82 Allowed Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 124.667 1.187 . . . . 0.0 112.763 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.05 -171.36 1.05 Allowed 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 124.412 3.408 . . . . 0.0 113.123 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 44.5 pt -93.17 165.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.58 1.552 . . . . 0.0 113.359 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.21 105.98 1.55 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.054 0.942 . . . . 0.0 109.206 158.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 83.9 p -70.31 -40.18 74.35 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.173 1.389 . . . . 0.0 111.803 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.24 151.45 34.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.33 1.852 . . . . 0.0 108.887 155.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -61.63 -15.7 41.86 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 175.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.76 8.67 44.3 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.232 1.413 . . . . 0.0 112.633 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -58.98 148.15 31.72 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.266 -1.521 . . . . 0.0 113.621 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -129.94 79.43 1.9 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.072 1.349 . . . . 0.0 112.129 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 40.5 t -84.39 143.21 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.45 1.1 . . . . 0.0 111.124 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.5 130.07 42.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.536 2.734 . . . . 0.0 109.787 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.1 133.8 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.117 1.767 . . . . 0.0 110.407 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -91.01 138.23 31.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.18 0.992 . . . . 0.0 110.722 154.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.79 160.56 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.096 0.958 . . . . 0.0 111.333 169.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -121.75 105.32 38.29 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.815 1.646 . . . . 0.0 110.076 -173.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.68 154.8 35.01 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.234 1.956 . . . . 0.0 110.363 159.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.79 171.58 16.22 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.17 1.913 . . . . 0.0 111.155 166.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -65.24 122.97 18.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.834 1.254 . . . . 0.0 109.343 168.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 126.73 -148.14 17.13 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.319 0.961 . . . . 0.0 111.166 -163.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' ASP . . . . . 0.407 ' O ' ' HE3' ' A' ' 346' ' ' LYS . 8.7 p-10 -94.47 168.82 10.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.828 1.251 . . . . 0.0 112.054 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 33.6 m -168.46 165.24 12.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.536 1.934 . . . . 0.0 110.828 159.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -124.63 117.0 23.3 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.0 mm -90.95 110.92 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.61 143.39 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.948 0.899 . . . . 0.0 110.184 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.6 115.23 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 126.71 2.004 . . . . 0.0 108.684 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 95.82 176.88 36.73 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.32 0.962 . . . . 0.0 114.521 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 47.4 m -136.19 165.06 26.61 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.811 1.644 . . . . 0.0 109.891 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.37 -171.27 46.81 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 121.642 -0.662 . . . . 0.0 112.196 -167.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.47 -26.41 53.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.213 1.005 . . . . 0.0 113.539 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.4 m -74.25 9.9 1.47 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.681 2.792 . . . . 0.0 115.222 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -96.05 144.24 26.49 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.4 1.08 . . . . 0.0 112.986 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 25.9 mt -112.25 165.31 12.28 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.579 1.152 . . . . 0.0 111.384 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 2.3 t -139.11 147.01 41.39 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.949 1.299 . . . . 0.0 111.815 -170.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -146.78 112.59 5.7 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.759 1.624 . . . . 0.0 110.388 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 134.56 54.93 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.128 -0.983 . . . . 0.0 112.367 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -128.82 149.12 50.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.891 0.876 . . . . 0.0 111.892 165.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -133.5 140.72 47.41 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.128 1.371 . . . . 0.0 107.839 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 21.7 tptt . . . . . 0 N--CA 1.466 0.342 0 C-N-CA 124.481 1.112 . . . . 0.0 111.052 -170.716 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.7 m -104.81 -4.58 22.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.138 0.975 . . . . 0.0 113.003 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.54 -9.09 52.48 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.9 tp -101.79 132.18 47.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 159.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.9 t -57.98 174.45 0.26 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.386 1.474 . . . . 0.0 114.252 -172.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.518 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.4 mm? -65.06 95.66 0.17 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.772 1.629 . . . . 0.0 110.997 -169.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.529 ' H ' ' HD2' ' A' ' 293' ' ' LYS . 6.9 mptt -51.89 121.02 5.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.853 2.461 . . . . 0.0 111.057 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 67.25 -25.22 0.2 Allowed Glycine 0 CA--C 1.54 1.635 0 C-N-CA 126.439 1.971 . . . . 0.0 115.599 -173.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 44.8 m -87.11 7.99 25.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 129.648 3.179 . . . . 0.0 111.555 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 7.5 m -160.2 155.31 24.75 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 119.311 -2.118 . . . . 0.0 111.587 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -76.09 172.95 11.93 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.067 1.347 . . . . 0.0 112.868 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -63.47 156.17 27.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.192 0.996 . . . . 0.0 113.642 -173.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 37.8 mtt -84.82 151.94 23.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.713 1.605 . . . . 0.0 111.364 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.9 m -67.7 139.87 56.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.207 0.603 . . . . 0.0 111.94 -173.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.3 p -131.75 16.92 4.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.862 1.265 . . . . 0.0 113.196 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.69 169.32 17.13 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 159.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.5 98.68 1.15 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.633 1.173 . . . . 0.0 112.076 -167.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.4 mtp -87.12 172.3 10.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.668 1.187 . . . . 0.0 113.579 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 36.8 m -160.74 170.4 20.83 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.794 1.238 . . . . 0.0 111.286 162.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.64 131.47 35.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.088 0.955 . . . . 0.0 109.324 162.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.1 -37.97 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.877 0.871 . . . . 0.0 109.797 162.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -130.97 126.78 36.91 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.723 1.609 . . . . 0.0 108.409 173.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -60.73 149.98 77.67 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.355 0.662 . . . . 0.0 111.678 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.56 132.59 43.98 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.026 1.817 . . . . 0.0 110.587 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 40.2 p -127.49 129.56 47.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.791 1.636 . . . . 0.0 108.805 172.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.89 136.07 57.89 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.555 0.693 . . . . 0.0 111.441 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.8 p -93.78 -15.15 25.43 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.251 1.421 . . . . 0.0 113.613 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.64 -6.66 8.26 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-O 118.447 -1.196 . . . . 0.0 114.66 -161.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -70.67 -10.21 58.86 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 120.32 2.06 . . . . 0.0 112.112 170.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 91.6 17.51 48.78 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.465 1.031 . . . . 0.0 112.912 -160.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.9 p -134.33 168.47 18.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.267 1.427 . . . . 0.0 111.283 -171.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 19.2 m -121.42 138.93 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.064 1.346 . . . . 0.0 109.292 166.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -114.36 130.07 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.698 1.199 . . . . 0.0 111.63 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.8 ptm -145.69 167.3 23.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.699 1.599 . . . . 0.0 112.797 -171.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -133.72 136.42 44.63 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.212 1.005 . . . . 0.0 109.684 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 21.3 m -116.54 168.25 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.799 1.24 . . . . 0.0 111.848 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -131.39 127.75 38.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.991 1.317 . . . . 0.0 112.053 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.07 146.77 32.5 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.149 1.38 . . . . 0.0 108.224 161.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -107.27 -62.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.163 2.575 . . . . 0.0 115.224 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.26 -174.27 4.88 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.383 1.473 . . . . 0.0 111.988 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 74.35 -36.81 0.97 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 126.593 2.044 . . . . 0.0 116.605 162.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.65 103.86 43.11 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.514 1.126 . . . . 0.0 111.963 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -64.88 128.88 21.82 Favored 'Trans proline' 0 C--N 1.35 0.61 0 N-CA-C 107.851 -1.634 . . . . 0.0 107.851 154.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.0 p -157.57 157.75 34.31 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.7 tptm -75.24 135.7 40.98 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.404 1.481 . . . . 0.0 109.094 164.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.5 119.99 58.51 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -168.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -100.38 81.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.61 2.873 . . . . 0.0 114.159 -164.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 95.1 t -107.5 128.11 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 162.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.68 152.75 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.873 1.269 . . . . 0.0 109.666 176.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.97 115.16 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.307 1.843 . . . . 0.0 106.837 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -127.51 160.25 32.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -161.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.27 -15.12 36.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.702 1.601 . . . . 0.0 112.612 171.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.21 153.75 38.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.683 1.593 . . . . 0.0 110.723 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.16 -14.16 34.55 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 11.5 t -123.93 14.34 9.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.581 1.552 . . . . 0.0 113.415 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 44.56 59.23 3.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.001 2.52 . . . . 0.0 115.917 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -78.09 -32.74 50.78 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.256 0.622 . . . . 0.0 112.182 156.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 45.4 mm -116.07 112.16 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.323 1.849 . . . . 0.0 109.973 -175.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -86.59 103.86 15.48 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.898 0.856 . . . . 0.0 111.846 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -88.2 -19.68 26.56 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.967 2.907 . . . . 0.0 114.439 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -118.59 -165.42 13.28 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 115.901 1.121 . . . . 0.0 115.901 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.2 mt -126.79 139.41 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 127.454 2.302 . . . . 0.0 110.366 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.15 129.65 37.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.848 1.259 . . . . 0.0 110.114 165.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 53.5 t -107.05 -50.92 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.711 0.804 . . . . 0.0 110.564 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.6 m -68.43 154.06 42.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.319 0.58 . . . . 0.0 109.641 163.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.9 m -54.43 154.66 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.702 1.201 . . . . 0.0 112.482 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -118.92 81.11 18.87 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.439 1.096 . . . . 0.0 110.547 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -82.96 -166.47 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 125.08 3.853 . . . . 0.0 112.846 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 39.1 pt -89.21 168.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.203 1.401 . . . . 0.0 111.511 164.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.31 120.34 13.66 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 158.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 85.9 p -73.12 -17.16 61.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.847 1.259 . . . . 0.0 113.838 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 97.5 m -144.06 157.51 44.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.748 2.419 . . . . 0.0 106.73 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -58.97 -21.48 58.71 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.861 -1.15 . . . . 0.0 113.914 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.79 15.32 29.0 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.689 1.996 . . . . 0.0 112.773 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -61.07 158.52 13.45 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 119.998 -1.689 . . . . 0.0 113.862 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -145.4 75.11 1.42 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.279 1.432 . . . . 0.0 113.861 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.5 149.52 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.509 1.524 . . . . 0.0 112.439 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.61 129.49 46.54 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 129.931 3.292 . . . . 0.0 109.301 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.87 134.41 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.281 1.432 . . . . 0.0 111.631 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -90.67 136.95 32.73 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.001 1.321 . . . . 0.0 111.869 154.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.74 159.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.884 1.274 . . . . 0.0 111.477 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -119.81 114.88 33.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.18 1.792 . . . . 0.0 111.128 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.3 159.97 13.09 Favored 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 123.665 2.91 . . . . 0.0 112.203 162.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.27 175.73 10.56 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.476 2.784 . . . . 0.0 111.026 163.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -63.4 145.62 55.22 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.57 -0.706 . . . . 0.0 111.332 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.76 -145.08 15.91 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.895 0.759 . . . . 0.0 111.47 -171.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -91.32 164.55 13.82 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.268 1.427 . . . . 0.0 112.255 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.2 m -161.54 158.88 27.08 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.326 -1.484 . . . . 0.0 111.212 158.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -116.03 116.1 27.29 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.88 111.91 22.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 124.952 1.301 . . . . 0.0 108.101 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.51 142.9 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.66 0.784 . . . . 0.0 109.727 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 94.3 t -116.92 110.22 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.963 1.705 . . . . 0.0 108.994 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.77 -179.39 24.25 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.187 0.898 . . . . 0.0 115.162 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 28.7 m -132.56 163.44 28.86 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.114 1.766 . . . . 0.0 109.388 171.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.33 -171.96 52.45 Favored Glycine 0 CA--C 1.535 1.298 0 O-C-N 121.559 -0.713 . . . . 0.0 112.925 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.26 -29.64 34.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.266 1.426 . . . . 0.0 113.697 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.6 m -73.36 -2.39 22.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.066 2.547 . . . . 0.0 114.801 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -81.66 115.4 20.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.09 0.859 . . . . 0.0 112.999 -172.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -81.63 162.91 22.89 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.879 -0.513 . . . . 0.0 111.277 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.5 t -140.4 147.54 39.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.768 1.227 . . . . 0.0 112.053 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -147.13 120.57 9.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.564 1.546 . . . . 0.0 111.119 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.6 130.17 39.07 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.794 1.238 . . . . 0.0 112.529 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -127.24 164.82 20.87 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.594 1.158 . . . . 0.0 112.224 164.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -133.26 150.51 51.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.41 1.884 . . . . 0.0 108.667 171.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? . . . . . 0 N--CA 1.466 0.366 0 C-N-CA 126.676 1.991 . . . . 0.0 109.498 -174.278 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 287' ' ' MET . . . . . 0.667 ' N ' HD21 ' A' ' 345' ' ' ASN . 99.0 mmm . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.6 m -90.57 -7.38 52.99 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -166.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.7 -25.81 66.71 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 57.9 tp -83.1 126.39 32.54 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.081 1.31 . . . . 0.0 108.065 159.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 t -55.05 167.07 0.44 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.782 1.233 . . . . 0.0 113.768 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.569 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.0 mm? -57.28 107.21 0.4 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.806 2.042 . . . . 0.0 111.263 -164.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -58.19 115.87 3.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.499 1.92 . . . . 0.0 110.686 -166.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 68.62 -7.91 2.59 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.449 1.499 . . . . 0.0 115.476 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 96.9 m -101.88 6.65 41.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.367 2.667 . . . . 0.0 110.626 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.3 m -154.32 151.26 28.88 Favored 'General case' 0 C--O 1.23 0.06 0 O-C-N 119.337 -2.102 . . . . 0.0 112.387 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -71.57 170.83 12.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.125 2.17 . . . . 0.0 112.864 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.64 153.42 36.07 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 39.6 mtt -91.05 151.58 20.98 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.893 1.677 . . . . 0.0 111.283 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.88 141.64 55.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.42 0.688 . . . . 0.0 112.621 -170.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.7 p -133.25 17.74 4.06 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -74.57 164.75 26.22 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.543 -0.723 . . . . 0.0 109.193 155.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.59 89.2 0.52 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.989 1.315 . . . . 0.0 111.913 -173.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 68.9 mtp -73.17 173.05 9.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.878 1.671 . . . . 0.0 113.693 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.7 m -157.37 163.46 38.58 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.203 -0.936 . . . . 0.0 111.855 162.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.42 125.93 29.99 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 3.6 t -76.61 -29.99 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 122.961 0.505 . . . . 0.0 109.779 162.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -135.6 126.48 27.55 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.048 1.739 . . . . 0.0 108.667 167.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -59.72 151.01 64.86 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.559 1.143 . . . . 0.0 111.87 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.67 132.42 35.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.05 1.834 . . . . 0.0 110.845 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 m -133.33 141.86 48.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.916 1.286 . . . . 0.0 109.933 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.19 136.82 58.1 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.309 0.644 . . . . 0.0 112.181 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 70.4 p -91.12 -8.02 49.97 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.977 1.311 . . . . 0.0 114.218 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.15 4.94 45.63 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.802 -0.999 . . . . 0.0 114.909 -163.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -111.34 13.3 21.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.05 1.425 . . . . 0.0 112.316 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.59 14.15 71.31 Favored Glycine 0 CA--C 1.536 1.371 0 O-C-N 121.374 -0.829 . . . . 0.0 113.651 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 39.5 p -135.17 164.61 27.3 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.273 1.429 . . . . 0.0 111.296 -171.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.4 m -128.14 135.79 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.527 1.531 . . . . 0.0 110.061 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.44 129.76 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.886 1.275 . . . . 0.0 113.704 -167.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -143.52 164.98 28.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.462 1.505 . . . . 0.0 114.32 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -122.35 125.49 46.04 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.542 2.337 . . . . 0.0 107.65 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.97 138.55 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.018 0.927 . . . . 0.0 111.707 -167.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -111.66 129.13 56.19 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.614 1.165 . . . . 0.0 113.135 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.44 142.73 25.19 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.416 1.486 . . . . 0.0 108.607 165.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -100.45 -72.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.907 2.404 . . . . 0.0 115.714 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 168.15 20.47 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.429 -1.42 . . . . 0.0 113.934 -173.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.84 -12.46 0.37 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.833 2.158 . . . . 0.0 117.879 171.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -117.22 98.63 52.15 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 119.422 1.611 . . . . 0.0 113.621 -163.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -68.44 133.85 29.26 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 148.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -161.76 156.82 23.34 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.851 0.86 . . . . 0.0 111.058 -176.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -70.38 135.4 48.74 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.497 1.119 . . . . 0.0 108.292 162.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.9 pp -60.85 118.41 34.9 Favored Pre-proline 0 CA--C 1.554 1.124 0 CA-C-N 118.252 0.478 . . . . 0.0 111.732 -170.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -94.84 86.75 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.597 2.865 . . . . 0.0 114.034 -159.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 37.1 t -121.73 128.4 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.418 1.487 . . . . 0.0 109.119 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.24 161.81 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.722 1.209 . . . . 0.0 111.988 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 55.2 t -138.93 118.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.406 2.283 . . . . 0.0 107.946 173.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.44 168.4 16.38 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -164.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.43 -8.83 58.19 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.708 2.003 . . . . 0.0 113.294 163.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -131.46 153.01 50.2 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.834 1.253 . . . . 0.0 110.899 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 23.9 mt -61.24 -26.06 67.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.4 t -108.36 10.4 27.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.743 1.617 . . . . 0.0 113.456 -169.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 44.12 67.71 0.64 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.736 2.414 . . . . 0.0 115.53 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -82.51 -38.31 24.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.368 1.067 . . . . 0.0 111.714 156.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.13 158.66 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.456 1.502 . . . . 0.0 109.663 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ASN . . . . . 0.667 HD21 ' N ' ' A' ' 287' ' ' MET . 1.3 p-10 -125.45 97.79 5.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.576 1.15 . . . . 0.0 110.97 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -92.24 -26.6 18.1 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.328 2.251 . . . . 0.0 113.816 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -110.7 -170.74 19.53 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 29.8 mt -125.02 134.57 66.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 127.225 2.21 . . . . 0.0 110.078 -175.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 14.1 mt -68.69 122.73 19.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.357 1.063 . . . . 0.0 109.815 164.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 77.7 t -95.7 -49.82 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.593 0.757 . . . . 0.0 109.861 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 18.9 m -76.76 157.0 31.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.416 0.627 . . . . 0.0 110.695 171.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.9 156.17 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.428 1.491 . . . . 0.0 113.066 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -122.41 79.57 45.86 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.963 1.305 . . . . 0.0 111.292 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.18 -166.23 0.4 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 124.68 3.587 . . . . 0.0 113.106 171.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 39.9 pt -100.67 164.12 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.069 1.748 . . . . 0.0 111.503 168.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.93 113.78 3.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.329 1.051 . . . . 0.0 109.534 159.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 93.6 p -66.85 -33.4 75.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.159 1.384 . . . . 0.0 112.596 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 2.6 m -143.42 153.54 42.77 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.029 2.532 . . . . 0.0 106.467 -174.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.57 -23.05 66.8 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.411 -1.43 . . . . 0.0 114.649 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.8 8.87 20.94 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.402 1.481 . . . . 0.0 113.355 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.64 154.3 9.08 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.561 -1.337 . . . . 0.0 114.306 -169.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -154.22 114.84 3.97 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.242 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.83 155.37 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.247 1.019 . . . . 0.0 109.441 -170.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.1 120.07 39.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.806 2.443 . . . . 0.0 108.169 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.71 129.11 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.895 0.878 . . . . 0.0 111.151 -171.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -89.51 140.56 29.41 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.725 1.21 . . . . 0.0 111.926 158.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.84 151.19 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.383 1.473 . . . . 0.0 110.53 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -117.08 113.33 39.46 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.03 1.732 . . . . 0.0 110.067 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -80.31 160.84 22.97 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.848 2.365 . . . . 0.0 111.295 162.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.5 171.08 17.85 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.403 2.069 . . . . 0.0 110.272 161.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -62.22 142.01 57.91 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.695 -0.628 . . . . 0.0 111.182 171.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 103.68 -145.5 16.17 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.902 0.763 . . . . 0.0 112.095 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -83.11 162.49 21.3 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.734 1.213 . . . . 0.0 113.08 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 14.3 m -165.81 160.17 16.78 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.812 1.245 . . . . 0.0 111.717 161.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -121.09 118.19 29.11 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 13.9 mm -92.96 122.08 44.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.269 1.428 . . . . 0.0 107.852 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.02 142.35 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.512 0.725 . . . . 0.0 110.631 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.69 110.97 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 127.28 2.232 . . . . 0.0 108.81 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.9 -178.26 22.9 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.596 1.093 . . . . 0.0 114.587 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.4 m -135.71 167.09 21.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.853 2.061 . . . . 0.0 110.146 170.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 79.52 -167.25 51.72 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.568 -0.707 . . . . 0.0 112.683 -173.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -25.93 66.37 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.856 -0.79 . . . . 0.0 112.6 169.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.3 m -74.44 -2.74 26.81 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 129.008 2.923 . . . . 0.0 115.163 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -84.68 130.54 34.69 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.625 0.77 . . . . 0.0 111.876 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 13.7 mt -94.22 156.09 16.72 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.745 0.418 . . . . 0.0 110.37 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.6 t -138.4 148.27 44.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.038 0.935 . . . . 0.0 111.921 -170.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -145.32 118.96 9.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.386 1.474 . . . . 0.0 110.012 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.28 128.04 34.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.462 0.705 . . . . 0.0 110.808 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -127.05 152.57 47.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.077 0.951 . . . . 0.0 110.662 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.19 141.79 51.79 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.626 1.17 . . . . 0.0 108.592 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? . . . . . 0 N--CA 1.465 0.317 0 C-N-CA 125.087 1.355 . . . . 0.0 109.976 -174.232 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 10.2 mmt . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.1 p -118.96 -0.98 11.06 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -172.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.43 -53.92 47.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.226 0.921 . . . . 0.0 113.032 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.32 122.9 16.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.5 t -47.17 158.2 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.699 2.0 . . . . 0.0 116.353 -167.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.3 mm? -61.37 119.58 8.8 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.074 1.75 . . . . 0.0 111.51 -164.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 293' ' ' LYS . 2.4 mptp? -65.44 115.2 5.44 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.195 1.398 . . . . 0.0 110.557 -172.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.79 -48.07 2.6 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.983 1.278 . . . . 0.0 112.902 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 46.3 m -63.25 -1.53 1.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.386 2.274 . . . . 0.0 113.245 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.0 m -155.33 156.76 36.06 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 119.149 -2.22 . . . . 0.0 112.143 170.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -84.44 164.28 18.96 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.411 1.084 . . . . 0.0 113.513 -169.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 151.04 46.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.952 1.301 . . . . 0.0 113.214 -175.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 77.7 mtm -68.31 167.65 14.06 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.046 2.538 . . . . 0.0 114.66 -171.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.6 m -86.0 148.54 25.7 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.89 0.876 . . . . 0.0 111.456 176.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 6.7 p -136.95 23.08 3.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.097 1.359 . . . . 0.0 112.799 172.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -84.21 156.71 21.9 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.26 -0.9 . . . . 0.0 108.988 155.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' LYS . . . . . 0.45 ' H ' ' HE2' ' A' ' 303' ' ' LYS . 0.2 OUTLIER -65.53 106.33 1.41 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.542 1.537 . . . . 0.0 111.575 -166.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 63.9 mtp -92.32 171.87 8.77 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.413 1.085 . . . . 0.0 112.839 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.8 m -163.69 162.33 24.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.663 1.185 . . . . 0.0 111.761 167.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.0 116.81 18.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.643 0.777 . . . . 0.0 110.21 169.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.16 -35.1 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.333 1.453 . . . . 0.0 110.288 163.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -134.64 129.84 35.48 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.385 1.474 . . . . 0.0 108.67 165.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -63.18 156.29 69.41 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.663 0.785 . . . . 0.0 112.275 173.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -62.58 132.46 38.02 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.132 1.888 . . . . 0.0 110.797 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 60.4 p -133.79 135.07 43.62 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.957 2.103 . . . . 0.0 108.79 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.55 140.15 58.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.075 0.852 . . . . 0.0 111.829 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 41.0 p -67.77 -17.49 64.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.598 1.959 . . . . 0.0 113.633 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 91.39 -6.66 80.72 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.349 0.976 . . . . 0.0 112.175 -164.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -98.51 1.16 46.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.724 1.21 . . . . 0.0 112.089 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 77.5 43.67 14.92 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 119.069 0.85 . . . . 0.0 111.094 -172.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 63.3 p -144.41 137.04 26.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.561 1.944 . . . . 0.0 108.194 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.8 m -110.66 125.06 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.223 0.919 . . . . 0.0 111.304 -172.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.87 131.03 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.753 1.621 . . . . 0.0 111.873 -173.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 11.2 ptp -141.83 166.1 25.65 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.998 2.119 . . . . 0.0 112.15 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -133.41 134.57 43.81 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.901 0.88 . . . . 0.0 110.38 171.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.8 m -132.01 135.31 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.221 1.008 . . . . 0.0 113.036 -165.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -89.73 131.86 35.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.29 1.836 . . . . 0.0 112.426 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 t -104.64 145.79 31.38 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.016 -1.469 . . . . 0.0 107.866 156.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -105.29 -72.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.617 2.211 . . . . 0.0 115.969 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.89 170.91 16.08 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 119.633 -1.917 . . . . 0.0 114.803 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.5 -4.24 3.01 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 126.18 1.848 . . . . 0.0 117.114 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.58 94.18 48.72 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 118.903 1.352 . . . . 0.0 112.063 -165.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.56 121.97 8.7 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.288 1.992 . . . . 0.0 108.952 163.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.2 p -157.84 154.45 28.03 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -77.13 142.01 39.92 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 156.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 14.5 pt -63.83 118.16 42.59 Favored Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -87.58 91.3 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.349 3.366 . . . . 0.0 113.178 -169.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.19 139.28 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.805 0.842 . . . . 0.0 109.703 169.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.63 147.11 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.371 1.468 . . . . 0.0 108.697 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.17 106.08 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -114.55 162.12 17.14 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -163.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.53 -9.62 57.13 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.854 2.062 . . . . 0.0 112.902 165.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -133.48 140.62 47.36 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.668 1.187 . . . . 0.0 110.528 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.28 -17.45 42.49 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -173.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -106.03 5.09 30.01 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.171 1.788 . . . . 0.0 113.601 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.57 78.91 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 129.557 3.143 . . . . 0.0 116.721 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.34 -36.91 11.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.398 1.479 . . . . 0.0 112.36 156.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 94.7 mt -103.12 136.06 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.135 1.374 . . . . 0.0 109.972 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.02 98.68 8.35 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.827 1.651 . . . . 0.0 110.02 -177.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -84.69 -52.32 6.17 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.249 2.62 . . . . 0.0 112.664 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -87.77 -172.91 47.76 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 116.204 1.242 . . . . 0.0 116.204 -170.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 45.5 mt -126.75 143.15 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.118 1.767 . . . . 0.0 111.048 -172.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 86.6 mt -68.84 138.45 54.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.033 0.933 . . . . 0.0 111.14 168.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.06 -42.8 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.267 0.485 . . . . 0.0 111.433 169.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 m -76.28 149.72 37.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.901 0.773 . . . . 0.0 109.491 158.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.98 157.59 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.296 1.038 . . . . 0.0 111.898 170.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -114.52 78.14 4.74 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.838 1.655 . . . . 0.0 110.647 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.12 -170.93 0.94 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.747 3.632 . . . . 0.0 114.013 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 42.8 pt -95.58 166.89 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.194 1.798 . . . . 0.0 111.657 172.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.15 124.47 24.19 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.681 0.792 . . . . 0.0 109.853 156.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.8 p -80.07 -40.31 27.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.136 1.375 . . . . 0.0 111.984 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.86 148.5 38.47 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.313 1.845 . . . . 0.0 108.399 159.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -59.92 -20.65 58.57 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.08 8.28 38.5 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.209 1.403 . . . . 0.0 112.954 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -61.45 155.12 22.54 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 119.983 -1.698 . . . . 0.0 113.779 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -132.92 95.49 3.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.965 1.306 . . . . 0.0 111.9 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.75 145.65 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.846 1.258 . . . . 0.0 111.922 -160.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 51.8 tp -102.61 127.16 49.82 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.099 2.96 . . . . 0.0 110.668 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.66 147.06 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.174 1.39 . . . . 0.0 110.907 -173.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -120.93 149.55 42.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.367 1.067 . . . . 0.0 113.632 161.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 2.4 m -137.42 158.21 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.855 2.062 . . . . 0.0 110.754 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -111.71 102.54 53.69 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.892 1.677 . . . . 0.0 110.793 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.87 139.12 27.03 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.553 2.169 . . . . 0.0 110.031 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.9 171.54 15.52 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.193 1.929 . . . . 0.0 111.208 170.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -64.55 150.57 46.54 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.703 -0.623 . . . . 0.0 112.21 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.57 -150.36 20.03 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -159.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -89.41 158.56 17.7 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.728 1.611 . . . . 0.0 113.22 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.4 m -158.72 151.26 21.83 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.174 -1.579 . . . . 0.0 112.04 166.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -118.39 109.28 16.08 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.84 108.63 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.91 142.19 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.01 112.32 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 125.355 1.462 . . . . 0.0 108.646 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.4 177.9 20.79 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.262 1.411 . . . . 0.0 114.995 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.5 m -136.08 161.05 36.77 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.043 1.737 . . . . 0.0 109.357 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.53 -166.73 54.58 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 121.558 0.532 . . . . 0.0 112.501 -170.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -27.34 14.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.708 1.603 . . . . 0.0 113.631 172.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.7 m -69.9 -4.15 19.14 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 129.199 3.0 . . . . 0.0 115.308 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -91.72 123.62 35.25 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.8 0.727 . . . . 0.0 112.928 -167.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.48 168.08 11.09 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.411 0.684 . . . . 0.0 111.289 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.1 t -140.09 149.22 42.82 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.172 1.389 . . . . 0.0 111.369 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -145.94 123.16 11.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.291 1.836 . . . . 0.0 109.923 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -76.43 133.01 39.99 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.268 -0.895 . . . . 0.0 111.85 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -121.59 162.86 19.88 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.332 1.053 . . . . 0.0 111.031 160.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -142.86 145.77 33.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.926 1.29 . . . . 0.0 108.708 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt . . . . . 0 N--CA 1.468 0.462 0 C-N-CA 125.214 1.405 . . . . 0.0 110.221 -177.214 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 56.1 mmm . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.8 p -101.34 -0.47 35.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.93 -31.48 60.36 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.9 tt -98.8 125.25 44.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 161.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.9 t -53.58 162.94 0.73 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.593 1.157 . . . . 0.0 113.883 -171.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.502 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.7 mm? -49.88 110.49 0.39 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.636 1.974 . . . . 0.0 111.161 -162.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -55.43 124.05 15.91 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.901 1.681 . . . . 0.0 110.421 -168.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 59.92 9.2 9.73 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.98 1.276 . . . . 0.0 115.445 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 20.3 m -134.15 10.01 3.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.762 2.025 . . . . 0.0 110.181 -160.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.6 m -161.48 158.19 26.2 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 119.709 -1.869 . . . . 0.0 110.612 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -79.2 172.23 14.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.102 0.961 . . . . 0.0 112.976 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -71.57 160.12 33.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -77.8 152.66 33.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.409 2.284 . . . . 0.0 112.26 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -71.47 144.64 49.63 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.572 -0.705 . . . . 0.0 112.574 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.8 p -134.56 17.35 3.63 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.149 1.38 . . . . 0.0 113.391 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -75.65 161.19 29.31 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.928 -1.107 . . . . 0.0 109.009 154.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 87.58 0.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.991 1.316 . . . . 0.0 111.347 -168.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 55.9 mtp -70.05 172.97 7.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.906 2.082 . . . . 0.0 114.277 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.8 m -157.85 164.7 36.7 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.98 0.912 . . . . 0.0 111.998 158.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.95 121.61 25.67 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.263 0.625 . . . . 0.0 110.407 166.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.5 -37.14 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.107 1.363 . . . . 0.0 110.121 166.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -131.93 123.13 26.8 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.905 1.282 . . . . 0.0 108.91 169.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -63.43 149.87 90.97 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.132 0.973 . . . . 0.0 111.682 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.45 139.41 70.66 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.716 2.277 . . . . 0.0 112.327 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 49.0 p -141.94 129.59 21.53 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.36 1.864 . . . . 0.0 109.875 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -56.51 126.43 26.49 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.781 0.719 . . . . 0.0 111.679 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.5 p -68.64 -15.6 63.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.8 2.04 . . . . 0.0 113.51 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 93.76 -21.75 39.67 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.748 1.642 . . . . 0.0 112.047 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -74.38 -20.17 60.17 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.386 1.093 . . . . 0.0 112.426 172.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 103.01 18.77 14.16 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.444 1.02 . . . . 0.0 112.503 -168.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.5 p -120.93 149.28 42.88 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 126.548 1.939 . . . . 0.0 108.208 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 33.7 m -118.75 123.61 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.144 0.978 . . . . 0.0 110.096 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.0 p -96.79 127.16 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.968 1.307 . . . . 0.0 111.342 -174.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.1 ptm -147.67 161.43 41.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.526 1.531 . . . . 0.0 112.934 -172.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -134.26 134.21 41.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 110.622 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 23.8 m -131.04 122.36 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.414 1.086 . . . . 0.0 113.353 -162.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -89.75 123.34 33.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.257 2.223 . . . . 0.0 112.247 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.79 146.36 31.25 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 117.235 -1.364 . . . . 0.0 108.235 156.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -101.25 -71.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.722 2.281 . . . . 0.0 115.896 174.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.47 163.96 34.02 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 119.534 -1.979 . . . . 0.0 114.701 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 61.74 7.79 12.89 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.681 1.61 . . . . 0.0 116.333 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.23 88.76 33.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 118.612 1.206 . . . . 0.0 112.319 -162.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.02 118.54 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.15 1.9 . . . . 0.0 108.377 161.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.7 p -157.48 156.59 32.35 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.731 0.777 . . . . 0.0 112.998 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -77.63 142.51 38.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.904 1.682 . . . . 0.0 108.397 163.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.42 123.38 73.3 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 119.287 0.948 . . . . 0.0 111.346 -172.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -102.04 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.583 2.855 . . . . 0.0 113.524 -164.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.24 120.56 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.641 0.776 . . . . 0.0 109.017 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.68 158.47 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.581 1.153 . . . . 0.0 110.465 -174.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.74 104.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.943 2.097 . . . . 0.0 108.085 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.03 159.14 36.88 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.709 1.004 . . . . 0.0 113.709 -160.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.21 -14.33 61.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.718 2.007 . . . . 0.0 112.944 166.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -129.86 140.56 50.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.531 1.532 . . . . 0.0 111.022 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.92 -20.99 60.46 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.4 t -101.22 7.3 43.09 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.866 1.667 . . . . 0.0 113.649 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.18 63.96 1.36 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.799 2.44 . . . . 0.0 115.668 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.13 -50.7 13.92 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.736 0.814 . . . . 0.0 110.876 155.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 15.4 mm -84.41 160.94 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.356 0.598 . . . . 0.0 109.617 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -138.66 61.52 1.57 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.03 -1.044 . . . . 0.0 111.679 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -53.28 -50.81 64.1 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.067 2.547 . . . . 0.0 113.72 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -80.5 -172.0 44.54 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 116.059 1.184 . . . . 0.0 116.059 -168.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.7 mt -123.99 137.35 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.556 1.543 . . . . 0.0 110.175 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.8 mp -77.16 126.62 31.24 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 161.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.97 -46.43 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.557 1.143 . . . . 0.0 109.62 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 31.6 m -73.82 161.01 30.64 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.448 0.642 . . . . 0.0 110.488 167.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 352' ' ' VAL . 3.6 t -53.54 153.09 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.94 1.696 . . . . 0.0 111.026 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -111.61 76.59 1.59 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.07 1.348 . . . . 0.0 110.991 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -75.74 -174.47 2.04 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.947 3.098 . . . . 0.0 112.8 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.2 pt -91.36 168.16 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.049 1.339 . . . . 0.0 111.715 168.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.92 110.13 2.34 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 154.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.4 p -72.04 -37.3 69.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.166 1.386 . . . . 0.0 112.146 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.37 158.0 29.24 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.573 1.949 . . . . 0.0 109.306 158.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -62.1 -20.06 63.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -100.35 11.1 40.19 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.653 1.581 . . . . 0.0 112.408 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -60.6 148.57 37.77 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.596 -1.315 . . . . 0.0 113.705 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -132.17 82.19 2.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.811 1.644 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 11.5 t -94.91 146.39 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.335 1.054 . . . . 0.0 111.202 -164.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 39.8 tp -104.7 123.38 47.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.417 2.687 . . . . 0.0 111.073 -173.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 2.9 mp -141.14 141.17 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.533 1.933 . . . . 0.0 111.041 -170.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -94.04 139.61 30.75 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.637 1.175 . . . . 0.0 111.94 158.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.04 166.24 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.022 1.329 . . . . 0.0 111.004 168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -129.55 108.61 17.37 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 125.894 1.678 . . . . 0.0 110.11 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.64 149.43 26.82 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.568 2.179 . . . . 0.0 110.231 158.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.81 170.16 20.31 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.224 1.949 . . . . 0.0 111.472 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -57.78 129.59 42.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.003 0.921 . . . . 0.0 110.225 168.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 110.76 -139.05 15.32 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.984 0.802 . . . . 0.0 111.898 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -86.85 167.15 14.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.264 1.025 . . . . 0.0 113.287 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.2 m -178.23 163.46 1.66 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.762 2.425 . . . . 0.0 111.04 158.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -127.2 126.58 43.04 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.628 1.571 . . . . 0.0 107.698 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.0 mm -95.26 122.05 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.214 1.406 . . . . 0.0 108.016 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.1 142.81 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.611 0.764 . . . . 0.0 110.2 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 67.9 t -115.92 109.1 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.943 1.697 . . . . 0.0 108.653 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.05 -173.5 20.72 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 123.358 1.532 . . . . 0.0 115.338 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.0 m -140.4 163.91 31.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.487 1.515 . . . . 0.0 109.843 171.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.19 -167.85 54.02 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 121.65 0.583 . . . . 0.0 112.775 -171.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.51 -29.14 6.28 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 114.028 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.0 m -71.34 -11.77 61.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.401 2.681 . . . . 0.0 114.693 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -79.69 109.45 14.1 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -164.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.16 158.0 33.72 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.11 -0.369 . . . . 0.0 110.779 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 2.7 t -136.26 143.93 44.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.754 1.222 . . . . 0.0 111.006 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -144.67 123.17 12.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.595 1.558 . . . . 0.0 110.134 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.39 124.86 24.99 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.359 -0.838 . . . . 0.0 111.945 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -130.1 123.37 30.25 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.213 0.605 . . . . 0.0 110.397 161.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -123.37 146.76 47.7 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 17.9 tptt . . . . . 0 N--CA 1.463 0.223 0 C-N-CA 124.276 1.031 . . . . 0.0 110.496 -162.066 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.3 p -97.08 -7.05 33.68 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.76 95.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.527 1.058 . . . . 0.0 112.696 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.9 tt -63.06 129.62 41.16 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 7.5 t -49.45 163.45 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.299 1.44 . . . . 0.0 114.537 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -73.53 93.63 2.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.027 1.331 . . . . 0.0 111.134 -160.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.616 ' H ' ' HD2' ' A' ' 293' ' ' LYS . 2.1 mptt -39.01 111.25 0.17 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.519 3.128 . . . . 0.0 112.417 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.01 -32.25 0.52 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.415 1.96 . . . . 0.0 115.111 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 62.7 m -70.98 -3.45 19.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.87 2.468 . . . . 0.0 112.304 171.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.9 m -156.66 154.23 29.78 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 119.311 -2.118 . . . . 0.0 111.199 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -78.71 174.58 11.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.12 1.368 . . . . 0.0 113.178 -173.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -65.27 161.09 20.15 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.041 1.336 . . . . 0.0 114.442 -170.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 71.3 mtm -91.21 150.47 21.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.139 2.175 . . . . 0.0 111.627 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.5 m -69.41 147.57 50.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.077 0.951 . . . . 0.0 112.571 -174.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.6 p -136.38 11.12 3.24 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -76.82 165.04 25.25 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 119.433 1.015 . . . . 0.0 109.553 161.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.48 89.63 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.225 1.41 . . . . 0.0 113.727 -167.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 44.7 mtp -76.64 167.18 22.28 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.639 1.176 . . . . 0.0 113.659 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.5 m -160.69 162.78 32.7 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.875 1.27 . . . . 0.0 110.555 161.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.7 130.57 34.53 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.978 -0.452 . . . . 0.0 110.727 164.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.36 -28.85 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.634 1.573 . . . . 0.0 110.197 167.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -129.99 116.94 19.3 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.531 1.532 . . . . 0.0 108.257 163.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -55.94 150.12 30.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.784 1.234 . . . . 0.0 111.081 169.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.5 138.31 69.79 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.81 1.673 . . . . 0.0 110.808 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' THR . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 389' ' ' TRP . 0.9 OUTLIER -144.28 142.59 30.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.089 0.556 . . . . 0.0 110.158 175.061 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -63.48 126.3 27.03 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.727 1.611 . . . . 0.0 112.413 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 82.5 p -73.84 -25.89 60.31 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.001 1.32 . . . . 0.0 112.68 173.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 84.98 -2.41 88.32 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.501 1.524 . . . . 0.0 114.538 -164.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -87.2 6.06 34.92 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.334 1.453 . . . . 0.0 112.038 171.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 83.1 20.08 61.56 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 121.094 -1.004 . . . . 0.0 112.829 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 366' ' ' GLU . 33.4 p -131.9 154.22 49.44 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.056 1.343 . . . . 0.0 110.688 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 24.1 m -122.81 128.95 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.685 1.194 . . . . 0.0 109.347 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.41 132.88 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.467 1.107 . . . . 0.0 112.21 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -141.8 162.42 35.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.658 1.583 . . . . 0.0 113.778 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -121.48 114.14 20.83 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.472 2.309 . . . . 0.0 107.006 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 362' ' ' GLU . 35.4 m -118.95 138.31 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.693 1.197 . . . . 0.0 111.018 -167.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -119.63 136.64 54.3 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 8.5 t -102.46 150.33 37.52 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 127.301 2.24 . . . . 0.0 108.591 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -102.62 -74.03 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 122.907 2.405 . . . . 0.0 115.888 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.18 162.36 34.46 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.785 1.63 . . . . 0.0 114.498 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 59.94 -0.18 0.88 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 127.193 2.33 . . . . 0.0 118.272 170.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.38 94.67 23.12 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 119.681 1.741 . . . . 0.0 113.304 -164.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.64 115.79 4.45 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.461 2.107 . . . . 0.0 108.935 163.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.0 p -150.77 155.41 39.2 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.924 0.869 . . . . 0.0 112.715 -175.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -74.14 136.36 42.9 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.262 1.425 . . . . 0.0 107.977 163.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 333' ' ' PRO 0.273 2.6 pp -62.27 129.44 92.28 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.415 -169.226 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 16.3 Cg_endo -100.43 89.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.005 2.47 . . . . 0.0 113.635 -160.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 94.4 t -118.22 130.71 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.994 1.318 . . . . 0.0 109.602 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.33 151.67 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 111.51 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.7 t -126.82 104.18 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.415 1.886 . . . . 0.0 107.508 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -115.1 161.81 17.88 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -163.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.71 -11.73 58.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.222 1.809 . . . . 0.0 112.722 163.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.65 146.37 49.46 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.724 1.21 . . . . 0.0 111.75 -176.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.05 -16.14 63.66 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -99.63 5.27 45.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.558 1.143 . . . . 0.0 112.983 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.549 ' HB2' HD13 ' A' ' 377' ' ' ILE . . . 37.8 77.83 0.04 OUTLIER 'General case' 0 C--O 1.239 0.548 0 C-N-CA 129.124 2.97 . . . . 0.0 115.115 -169.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -106.72 -25.43 11.75 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.394 1.877 . . . . 0.0 112.918 166.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.95 119.72 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.599 1.56 . . . . 0.0 109.436 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.1 123.54 50.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -107.85 -16.93 14.2 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -93.52 -177.59 39.96 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 119.853 1.206 . . . . 0.0 116.046 -176.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 86.9 mt -126.63 136.2 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 127.926 2.491 . . . . 0.0 110.058 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mt -72.73 136.99 45.64 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.186 0.995 . . . . 0.0 110.882 168.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.14 -46.66 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.257 0.623 . . . . 0.0 111.466 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 47.6 m -68.99 153.12 44.35 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.384 0.538 . . . . 0.0 109.787 159.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.38 161.28 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.574 1.149 . . . . 0.0 113.028 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -118.04 79.13 13.77 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.284 1.434 . . . . 0.0 111.105 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -78.88 -171.22 1.18 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 123.731 2.954 . . . . 0.0 112.332 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.27 167.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.091 1.357 . . . . 0.0 111.383 171.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.1 117.01 10.2 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 156.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 86.0 p -67.28 -28.41 68.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.589 1.156 . . . . 0.0 112.809 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 21.5 m -137.23 151.28 48.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 128.254 2.621 . . . . 0.0 106.717 -172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.9 -26.63 66.07 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.524 -1.36 . . . . 0.0 113.684 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -89.14 2.51 54.06 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.328 1.851 . . . . 0.0 113.413 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -58.58 154.37 14.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.933 1.349 . . . . 0.0 113.25 -166.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 7.7 pt-20 -144.53 95.32 2.69 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.945 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.87 149.54 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.106 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 45.2 tp -93.99 124.62 38.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.485 2.314 . . . . 0.0 109.412 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.23 135.1 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.746 0.818 . . . . 0.0 110.551 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' GLU . . . . . 0.428 ' OE1' ' OG1' ' A' ' 317' ' ' THR . 3.5 pt-20 -106.01 140.07 39.57 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.21 1.005 . . . . 0.0 112.402 158.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.19 151.53 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.974 2.11 . . . . 0.0 110.025 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -108.92 113.01 59.85 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.296 1.838 . . . . 0.0 109.774 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.62 159.42 25.22 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.538 2.159 . . . . 0.0 111.108 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.17 173.17 3.43 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.703 2.269 . . . . 0.0 112.176 163.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -64.35 141.0 58.93 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.785 -0.572 . . . . 0.0 110.149 163.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 99.47 -140.59 15.06 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.575 0.607 . . . . 0.0 111.787 -174.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -88.24 164.71 15.49 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.713 1.205 . . . . 0.0 113.393 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 13.2 m -167.31 152.96 7.55 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.38 1.472 . . . . 0.0 111.821 165.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -118.95 113.92 21.75 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 31.9 mm -88.48 115.02 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 125.864 1.666 . . . . 0.0 107.734 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 342' ' ' ALA . 2.1 mp -113.51 140.83 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 122.021 0.915 . . . . 0.0 111.263 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.59 114.07 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 127.02 2.128 . . . . 0.0 108.251 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 98.36 178.09 32.81 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 122.662 1.146 . . . . 0.0 114.76 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 48.6 m -130.45 165.62 22.23 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.279 1.832 . . . . 0.0 109.353 171.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.87 -171.97 54.26 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 121.675 -0.64 . . . . 0.0 113.059 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.23 -23.1 33.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.33 1.452 . . . . 0.0 113.999 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.3 m -82.84 -2.73 55.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.482 2.313 . . . . 0.0 114.909 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -76.79 126.53 31.14 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.456 1.025 . . . . 0.0 113.068 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -90.05 161.89 15.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.147 0.579 . . . . 0.0 111.652 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.3 t -137.78 151.36 48.06 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.192 1.397 . . . . 0.0 112.59 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -150.13 131.77 14.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.314 1.846 . . . . 0.0 110.328 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -79.51 136.43 36.9 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.969 -1.082 . . . . 0.0 111.98 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' TRP . . . . . 0.41 ' CZ2' ' HA ' ' A' ' 311' ' ' THR . 21.2 m95 -125.53 152.73 44.64 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.698 0.761 . . . . 0.0 112.243 161.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -133.3 134.15 43.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.053 1.341 . . . . 0.0 108.365 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? . . . . . 0 N--CA 1.467 0.405 0 C-N-CA 125.351 1.46 . . . . 0.0 110.747 -167.269 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 20.0 m -103.23 11.28 37.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.094 1.357 . . . . 0.0 113.344 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -72.25 -39.28 68.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.609 1.095 . . . . 0.0 111.011 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.5 tt -72.68 138.76 46.84 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 164.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.4 t -55.73 176.91 0.06 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.142 1.777 . . . . 0.0 114.973 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -68.58 83.49 0.28 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.846 1.658 . . . . 0.0 110.451 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.553 ' H ' ' HD2' ' A' ' 293' ' ' LYS . 1.8 mptt -38.12 119.53 0.79 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.238 2.615 . . . . 0.0 112.481 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.86 -37.38 1.06 Allowed Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.745 1.64 . . . . 0.0 114.696 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 58.3 m -75.01 1.39 13.09 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.503 2.321 . . . . 0.0 112.593 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.0 m -158.19 149.93 21.53 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 119.037 -2.289 . . . . 0.0 111.715 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -84.71 178.78 7.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.972 1.309 . . . . 0.0 113.302 -169.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -63.93 162.19 14.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.263 1.425 . . . . 0.0 114.254 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -69.92 157.41 37.49 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.641 1.576 . . . . 0.0 111.853 166.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.7 m -75.29 145.8 41.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.194 0.598 . . . . 0.0 110.255 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.0 p -133.67 21.0 3.9 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.909 1.283 . . . . 0.0 112.022 170.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -82.88 168.48 17.04 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 155.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 100.71 0.27 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.244 1.418 . . . . 0.0 112.067 -166.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 16.7 mtp -86.41 166.14 15.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.022 0.915 . . . . 0.0 112.21 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 18.9 m -163.58 163.31 24.57 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.261 1.024 . . . . 0.0 111.122 169.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.8 114.45 22.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.475 0.71 . . . . 0.0 109.129 163.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.26 -37.91 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.571 1.149 . . . . 0.0 109.552 161.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -135.16 120.49 19.04 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.682 1.593 . . . . 0.0 108.405 168.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -59.62 152.8 54.83 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.31 1.044 . . . . 0.0 110.977 172.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.38 137.06 63.0 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.094 1.863 . . . . 0.0 111.489 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.3 m -132.88 135.01 45.33 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.858 1.263 . . . . 0.0 109.225 173.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.06 130.12 43.3 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.253 0.549 . . . . 0.0 111.97 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 70.3 p -79.43 -21.06 46.06 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.709 1.203 . . . . 0.0 113.333 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 80.98 -8.34 57.43 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.761 1.172 . . . . 0.0 114.364 -161.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -87.97 6.26 36.75 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.298 1.439 . . . . 0.0 112.06 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 88.51 14.49 61.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.282 0.944 . . . . 0.0 113.092 -171.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 50.5 p -131.63 161.17 33.34 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.111 1.364 . . . . 0.0 111.259 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.27 133.02 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 125.253 1.421 . . . . 0.0 109.222 169.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.4 p -115.58 131.87 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.908 1.283 . . . . 0.0 112.05 -172.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 15.8 ptm -144.95 163.18 34.95 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.406 2.282 . . . . 0.0 112.069 -169.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -132.61 130.84 40.76 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.756 0.822 . . . . 0.0 108.915 173.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.47 145.15 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.171 0.988 . . . . 0.0 111.379 -165.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -105.17 135.82 45.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.737 1.215 . . . . 0.0 112.429 -175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.6 t -114.74 135.55 22.38 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.891 1.676 . . . . 0.0 107.714 163.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -100.65 -61.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.899 2.399 . . . . 0.0 115.164 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.96 176.11 11.82 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.714 -1.241 . . . . 0.0 113.091 -176.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.66 -23.19 0.18 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 128.097 2.76 . . . . 0.0 118.683 160.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -109.11 104.09 54.09 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 119.257 1.529 . . . . 0.0 112.766 -166.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.76 114.04 3.19 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.583 1.522 . . . . 0.0 108.502 159.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.7 p -148.8 154.55 39.69 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.997 0.903 . . . . 0.0 112.233 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -78.14 134.92 37.6 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.321 1.448 . . . . 0.0 107.573 161.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -60.08 117.71 26.24 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 118.574 0.625 . . . . 0.0 111.308 -171.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -96.93 88.54 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.348 2.699 . . . . 0.0 113.752 -166.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 60.6 t -107.75 136.26 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 164.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.05 161.07 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.897 1.279 . . . . 0.0 111.104 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 93.0 t -139.34 106.24 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.05 1.74 . . . . 0.0 109.071 -174.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.24 163.01 26.56 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -158.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -87.34 -17.73 31.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.468 1.907 . . . . 0.0 112.883 163.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -123.64 153.05 41.3 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.598 1.159 . . . . 0.0 111.108 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 54.1 mt -69.23 -2.38 10.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.445 1.098 . . . . 0.0 113.883 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 2.2 t -129.4 18.61 5.85 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.579 1.551 . . . . 0.0 112.198 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 49.62 31.25 4.09 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.5 -25.87 68.24 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.745 -0.597 . . . . 0.0 112.388 166.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 31.9 mt -121.95 117.52 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.533 2.333 . . . . 0.0 107.693 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.94 115.66 29.88 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.91 0.777 . . . . 0.0 111.279 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -103.16 -10.44 18.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -174.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -99.33 -167.97 30.18 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 54.5 mt -132.04 133.69 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 127.86 2.464 . . . . 0.0 110.45 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 23.0 mt -65.25 121.0 13.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.932 1.293 . . . . 0.0 109.942 160.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 50.5 t -102.59 -51.89 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 122.924 0.49 . . . . 0.0 110.635 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.4 m -69.85 163.41 25.92 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.509 0.595 . . . . 0.0 110.424 168.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.4 t -52.81 147.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.587 1.155 . . . . 0.0 110.437 170.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -112.13 78.68 2.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.068 1.347 . . . . 0.0 110.2 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.15 -174.2 2.15 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 123.909 3.073 . . . . 0.0 113.349 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 355' ' ' ILE . 0.2 OUTLIER -94.01 168.37 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.521 1.528 . . . . 0.0 110.948 167.146 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.54 110.99 3.89 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 156.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 83.3 p -73.27 -36.99 66.44 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.094 1.358 . . . . 0.0 112.073 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.79 154.36 37.09 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.721 2.008 . . . . 0.0 109.093 160.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -64.82 -19.0 65.61 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.48 0.87 56.57 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.017 1.727 . . . . 0.0 112.919 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -57.84 149.54 22.27 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.503 -1.373 . . . . 0.0 114.074 -171.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -138.91 86.76 2.16 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.118 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.03 145.88 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.794 1.237 . . . . 0.0 111.6 -170.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 45.8 tp -92.35 126.42 37.43 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.059 2.944 . . . . 0.0 110.502 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.8 145.14 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.662 1.585 . . . . 0.0 109.823 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -116.79 149.57 39.75 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.099 0.952 . . . . 0.0 111.948 159.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.19 154.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 125.564 1.546 . . . . 0.0 110.162 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -103.24 114.18 65.23 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.659 1.184 . . . . 0.0 110.22 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.57 143.8 15.38 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.019 2.48 . . . . 0.0 110.969 162.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -74.86 167.68 26.54 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.862 2.375 . . . . 0.0 111.242 169.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -53.63 140.37 29.15 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.734 1.214 . . . . 0.0 112.206 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.9 -147.57 17.0 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -172.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -82.09 164.16 21.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.61 1.564 . . . . 0.0 112.083 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 33.4 m -161.39 148.25 14.64 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.662 -1.274 . . . . 0.0 112.419 158.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -110.14 106.41 15.86 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.104 0.961 . . . . 0.0 108.499 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.4 mm -84.14 114.97 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 125.836 1.655 . . . . 0.0 107.95 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.2 mt -115.64 143.78 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.502 1.121 . . . . 0.0 109.891 -169.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 52.5 t -120.84 113.84 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.679 1.592 . . . . 0.0 108.556 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 90.42 179.54 43.78 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 53.1 m -132.51 165.83 23.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.696 1.998 . . . . 0.0 109.341 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.17 -170.1 55.04 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.808 -0.557 . . . . 0.0 112.783 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -28.15 56.53 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.762 1.225 . . . . 0.0 113.643 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.0 m -78.21 -3.91 45.06 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 127.513 2.325 . . . . 0.0 115.041 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -78.91 144.33 34.99 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.694 0.679 . . . . 0.0 112.822 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.3 mt -111.07 163.88 13.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.615 0.766 . . . . 0.0 110.922 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.5 t -139.52 154.01 47.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.732 1.213 . . . . 0.0 111.459 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -149.19 135.73 19.43 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.89 1.676 . . . . 0.0 109.892 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.77 131.6 38.97 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.415 -0.803 . . . . 0.0 111.662 -172.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -123.72 166.23 15.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.115 0.966 . . . . 0.0 112.04 167.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -138.98 129.94 26.46 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.073 1.749 . . . . 0.0 108.368 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? . . . . . 0 C--O 1.233 0.214 0 C-N-CA 125.81 1.644 . . . . 0.0 110.7 -176.503 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.0 t -119.49 9.9 11.68 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.801 1.24 . . . . 0.0 113.374 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.44 ' HB1' ' H ' ' A' ' 336' ' ' VAL . . . -65.57 -46.7 78.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.041 0.837 . . . . 0.0 110.909 167.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.07 129.15 38.88 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 164.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.7 t -57.02 171.33 0.36 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.163 1.385 . . . . 0.0 114.269 -173.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.1 mm? -64.34 109.08 1.79 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.614 1.965 . . . . 0.0 110.721 -167.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -63.78 114.61 4.14 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.989 2.116 . . . . 0.0 110.578 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 78.91 -40.84 2.12 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.827 1.203 . . . . 0.0 113.322 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 5.2 m -65.69 -0.81 2.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.752 2.421 . . . . 0.0 114.013 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.0 m -153.08 151.69 30.49 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 118.994 -2.316 . . . . 0.0 113.65 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -73.82 173.48 9.82 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.359 1.864 . . . . 0.0 112.827 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -71.47 152.77 42.77 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.338 1.055 . . . . 0.0 113.785 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -70.2 157.55 37.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.819 2.048 . . . . 0.0 112.337 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.4 m -69.82 140.51 53.3 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.546 -0.721 . . . . 0.0 111.735 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 17.2 p -128.18 7.1 5.95 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -73.67 166.46 23.24 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.016 0.825 . . . . 0.0 110.888 164.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -71.03 84.15 0.7 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.016 1.727 . . . . 0.0 111.197 -170.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 41.3 mtp -66.63 172.46 4.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.383 1.873 . . . . 0.0 114.337 -174.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.5 m -157.69 159.34 36.81 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.489 1.116 . . . . 0.0 111.249 164.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.97 117.1 19.72 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 169.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.45 -33.49 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.025 0.53 . . . . 0.0 109.659 161.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -137.43 124.08 21.03 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.785 1.634 . . . . 0.0 108.026 164.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -59.18 160.91 10.71 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.211 0.604 . . . . 0.0 111.599 171.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -61.33 135.66 59.23 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.903 1.735 . . . . 0.0 110.589 167.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.0 m -138.48 138.44 38.1 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.766 1.226 . . . . 0.0 108.985 171.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.18 128.57 37.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.09 0.868 . . . . 0.0 111.567 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 73.8 p -79.63 -12.62 59.82 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.252 1.021 . . . . 0.0 113.723 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 75.45 0.69 63.13 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.394 0.997 . . . . 0.0 113.978 -164.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -111.67 14.52 21.21 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.189 1.796 . . . . 0.0 112.32 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.8 15.17 68.38 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.766 0.698 . . . . 0.0 113.501 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.4 p -134.61 162.67 31.64 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.691 1.197 . . . . 0.0 111.176 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.73 130.42 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.597 1.159 . . . . 0.0 109.625 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.33 132.9 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.843 1.257 . . . . 0.0 111.802 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 4.8 ptp -143.84 166.03 26.05 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.117 1.767 . . . . 0.0 112.345 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -133.88 128.71 35.18 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.679 1.192 . . . . 0.0 109.904 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.79 121.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.076 0.951 . . . . 0.0 112.22 -161.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.23 130.13 34.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.512 1.525 . . . . 0.0 112.028 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.29 137.4 19.42 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.985 1.314 . . . . 0.0 108.201 159.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -91.88 -77.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 122.9 2.4 . . . . 0.0 116.256 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 139.16 20.38 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -171.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 83.8 4.74 88.61 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.808 1.194 . . . . 0.0 115.422 174.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.61 89.43 18.53 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 118.664 1.232 . . . . 0.0 112.325 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.1 127.13 13.89 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.215 1.943 . . . . 0.0 108.676 159.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 5.0 p -162.77 162.9 26.88 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -74.4 143.37 44.82 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.04 1.736 . . . . 0.0 109.85 161.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 19.0 pt -66.37 123.91 86.72 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 118.713 0.688 . . . . 0.0 111.213 -176.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 1.8 Cg_endo -108.48 82.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.292 1.994 . . . . 0.0 115.186 -153.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 80.1 t -114.35 131.48 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.369 -0.832 . . . . 0.0 109.818 172.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.67 128.88 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.33 1.052 . . . . 0.0 110.07 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' VAL . . . . . 0.44 ' H ' ' HB1' ' A' ' 289' ' ' ALA . 58.9 t -99.99 119.53 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.586 1.555 . . . . 0.0 107.516 170.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -130.26 161.12 31.93 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -166.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.71 -18.26 58.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.331 1.853 . . . . 0.0 112.98 164.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -128.22 146.02 50.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.746 1.218 . . . . 0.0 111.618 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.74 -17.9 38.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.0 t -105.12 5.93 32.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.427 1.491 . . . . 0.0 113.417 -176.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 40.16 75.96 0.07 Allowed 'General case' 0 C--O 1.239 0.519 0 C-N-CA 129.042 2.937 . . . . 0.0 115.801 -171.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.74 -51.3 4.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.069 1.347 . . . . 0.0 111.655 157.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 72.1 mt -102.57 104.73 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.697 1.599 . . . . 0.0 109.1 -174.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -84.16 115.58 22.48 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -95.3 -11.58 27.63 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.159 2.583 . . . . 0.0 114.562 -173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -115.12 -168.47 15.65 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.6 mt -129.44 135.38 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.404 2.281 . . . . 0.0 110.184 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.04 122.8 17.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.302 1.041 . . . . 0.0 110.555 164.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 73.5 t -102.22 -50.11 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.848 0.859 . . . . 0.0 109.861 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.0 m -69.35 153.27 43.86 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.279 0.562 . . . . 0.0 110.038 166.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.17 159.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.443 1.097 . . . . 0.0 112.236 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -120.93 75.45 28.39 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.043 0.937 . . . . 0.0 112.454 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -57.35 -167.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.127 1 C-N-CA 126.131 4.554 . . . . 0.0 117.221 162.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 27.5 pt -112.14 166.88 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.703 2.401 . . . . 0.0 111.324 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.31 105.34 2.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.988 0.915 . . . . 0.0 109.022 155.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.5 p -72.79 -50.45 24.22 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.391 1.476 . . . . 0.0 111.314 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.59 152.34 19.15 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.991 1.317 . . . . 0.0 108.825 156.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -60.61 -19.02 56.67 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.11 0.39 56.75 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.107 1.763 . . . . 0.0 112.955 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -58.66 147.4 32.85 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.471 -1.393 . . . . 0.0 113.653 -172.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.79 79.54 1.85 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.519 1.528 . . . . 0.0 111.252 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.35 148.56 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.569 1.148 . . . . 0.0 111.502 -165.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.53 127.23 39.09 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.908 2.883 . . . . 0.0 109.798 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.57 141.76 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.002 1.321 . . . . 0.0 109.86 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -119.19 152.35 36.75 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 122.453 1.12 . . . . 0.0 112.573 162.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.8 m -140.89 156.65 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.943 1.697 . . . . 0.0 110.72 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -109.91 116.3 54.0 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.844 1.658 . . . . 0.0 110.772 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.45 160.83 12.82 Favored 'Trans proline' 0 CA--C 1.551 1.369 0 C-N-CA 123.766 2.978 . . . . 0.0 112.095 161.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -76.23 176.35 10.16 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.415 2.743 . . . . 0.0 110.895 164.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -60.02 145.25 47.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.187 0.595 . . . . 0.0 111.247 168.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.33 -152.02 19.71 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.634 0.635 . . . . 0.0 111.664 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.9 167.17 20.17 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.556 1.169 . . . . 0.0 113.154 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 30.8 m -162.64 152.24 15.75 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.441 1.096 . . . . 0.0 110.905 157.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -107.44 119.36 39.19 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.7 mm -99.37 104.69 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 125.778 1.631 . . . . 0.0 107.594 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.38 141.21 18.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.944 1.298 . . . . 0.0 109.799 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 65.7 t -120.56 111.14 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 126.584 1.954 . . . . 0.0 108.442 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.38 -177.43 26.02 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 123.27 1.483 . . . . 0.0 114.658 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 53.7 m -138.35 167.26 22.25 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.236 1.815 . . . . 0.0 109.575 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.38 -175.02 49.45 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 121.741 0.634 . . . . 0.0 112.674 -170.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -23.15 65.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.676 1.19 . . . . 0.0 113.054 175.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 54.0 m -64.57 -15.59 61.26 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 171.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -71.11 138.8 49.99 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.144 1.338 . . . . 0.0 112.813 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 42.3 mt -103.56 161.57 13.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.728 1.211 . . . . 0.0 110.864 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.1 t -143.05 145.1 32.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.004 0.921 . . . . 0.0 112.248 -171.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -150.22 121.8 8.0 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.704 1.602 . . . . 0.0 110.199 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.71 131.44 39.87 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.468 -1.395 . . . . 0.0 111.815 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -119.28 168.84 10.52 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.793 0.837 . . . . 0.0 111.615 159.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.58 145.93 34.07 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.707 1.603 . . . . 0.0 108.971 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 125.081 1.352 . . . . 0.0 110.633 -174.422 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.8 m -97.5 -7.12 32.18 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.274 1.03 . . . . 0.0 113.562 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.38 80.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.323 0.965 . . . . 0.0 113.009 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 53.6 tp -74.65 126.9 31.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 160.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.5 t -55.99 168.5 0.47 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.501 1.12 . . . . 0.0 113.836 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.548 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.8 mm? -59.99 118.04 5.79 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.799 1.639 . . . . 0.0 110.557 -167.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -70.22 108.01 3.97 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.402 1.481 . . . . 0.0 109.512 -163.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 77.15 -45.2 2.25 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.985 1.278 . . . . 0.0 112.768 -170.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 38.9 m -63.37 7.46 0.1 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 128.636 2.775 . . . . 0.0 113.925 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.1 m -157.14 158.69 36.79 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 118.766 -2.458 . . . . 0.0 112.012 167.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -77.62 172.89 12.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.226 1.41 . . . . 0.0 113.023 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -70.28 154.6 41.73 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -171.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -67.6 157.7 33.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.346 2.258 . . . . 0.0 112.275 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 11.2 m -71.68 141.47 49.88 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.442 -0.786 . . . . 0.0 111.333 174.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 12.7 p -134.67 11.13 3.71 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -84.4 177.58 8.08 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.933 0.788 . . . . 0.0 109.518 163.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -71.2 81.37 0.72 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.372 1.869 . . . . 0.0 111.738 -166.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 20.7 mtp -66.15 167.3 10.32 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.928 1.291 . . . . 0.0 112.814 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 28.7 m -158.51 168.6 26.49 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.108 0.963 . . . . 0.0 111.146 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.01 115.12 26.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.815 1.246 . . . . 0.0 110.479 172.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.86 -34.92 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.917 1.287 . . . . 0.0 110.259 167.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -138.18 126.11 22.6 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.036 1.735 . . . . 0.0 108.629 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -61.27 160.58 22.37 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.206 1.002 . . . . 0.0 111.77 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.69 121.62 8.1 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.679 1.586 . . . . 0.0 110.073 169.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 13.6 p -124.32 140.6 52.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.407 1.083 . . . . 0.0 110.499 170.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -60.69 140.94 57.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.599 0.76 . . . . 0.0 112.13 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 76.2 p -97.86 -15.92 20.0 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.205 1.402 . . . . 0.0 113.221 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 75.35 -10.36 11.48 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.493 -163.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -69.11 -11.33 60.7 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.868 1.834 . . . . 0.0 112.464 173.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 92.83 15.95 50.31 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.354 0.978 . . . . 0.0 112.749 -159.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 24.6 p -132.63 168.54 18.09 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.402 1.481 . . . . 0.0 110.995 -171.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.7 140.13 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.22 1.408 . . . . 0.0 109.047 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.3 p -112.95 132.11 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.703 1.201 . . . . 0.0 110.973 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.6 ptm -144.31 165.7 27.15 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.964 1.305 . . . . 0.0 112.806 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -130.19 134.8 47.55 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.274 1.03 . . . . 0.0 109.641 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.93 170.45 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.783 1.233 . . . . 0.0 111.46 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.45 137.62 51.92 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.28 2.232 . . . . 0.0 110.001 173.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.78 145.7 32.21 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.936 1.694 . . . . 0.0 107.407 161.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -102.83 -70.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 123.208 2.605 . . . . 0.0 115.228 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.81 175.56 9.91 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.602 1.561 . . . . 0.0 111.759 -174.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.32 -15.07 0.09 OUTLIER Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.549 2.499 . . . . 0.0 118.358 165.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -112.13 92.05 17.5 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 119.135 1.468 . . . . 0.0 112.768 -165.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.28 116.3 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.832 1.688 . . . . 0.0 108.078 154.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 5.6 p -154.68 157.59 38.33 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.639 -0.663 . . . . 0.0 112.281 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -75.58 140.62 42.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.625 1.57 . . . . 0.0 109.505 165.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 20.5 pt -64.06 121.83 73.9 Favored Pre-proline 0 CA--C 1.557 1.215 0 CA-C-N 119.211 0.914 . . . . 0.0 111.447 -174.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 5.3 Cg_endo -109.04 85.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.36 2.707 . . . . 0.0 114.471 -164.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 23.3 t -119.54 104.09 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.285 -0.884 . . . . 0.0 110.045 171.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.9 160.31 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.662 1.585 . . . . 0.0 110.2 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -136.27 105.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.591 1.556 . . . . 0.0 108.153 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -122.36 158.37 29.78 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.611 1.165 . . . . 0.0 114.071 -163.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.65 -10.38 59.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.504 2.321 . . . . 0.0 112.875 169.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -137.71 150.72 47.54 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.173 1.389 . . . . 0.0 112.462 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 28.8 mt -63.45 -16.4 60.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.623 1.569 . . . . 0.0 114.721 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.2 t -109.2 7.42 25.41 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.824 -177.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 35.28 65.01 0.41 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 128.502 2.721 . . . . 0.0 114.211 -168.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -75.35 -40.93 57.68 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.426 1.09 . . . . 0.0 111.394 159.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 7.8 mm -99.74 169.85 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 125.3 1.44 . . . . 0.0 109.387 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -146.04 116.98 7.74 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.444 -1.41 . . . . 0.0 112.009 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -98.62 -27.16 14.13 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.345 1.858 . . . . 0.0 113.294 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -95.58 -174.53 36.95 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 -173.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.3 mt -124.51 134.91 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.617 1.967 . . . . 0.0 110.102 -174.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.0 mt -70.49 121.52 17.95 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.14 0.976 . . . . 0.0 109.364 162.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.78 -42.64 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.54 0.736 . . . . 0.0 109.914 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 38.6 m -69.96 153.52 43.14 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.143 0.497 . . . . 0.0 110.411 166.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.5 t -56.09 152.75 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.129 1.372 . . . . 0.0 110.346 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -113.16 82.73 5.75 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.16 0.984 . . . . 0.0 111.845 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.46 -168.87 0.68 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 125.27 3.98 . . . . 0.0 112.693 169.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 36.0 pt -93.0 167.37 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.982 1.713 . . . . 0.0 111.89 167.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.82 111.18 2.69 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 152.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 88.5 p -76.09 -45.07 35.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.052 1.341 . . . . 0.0 111.758 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.43 151.52 22.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.044 1.337 . . . . 0.0 108.735 158.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -59.31 -20.33 53.56 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 170.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -101.94 10.9 39.33 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.636 1.574 . . . . 0.0 112.956 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -58.89 152.28 19.79 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.208 -1.557 . . . . 0.0 113.632 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -133.81 83.35 2.04 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.344 1.058 . . . . 0.0 113.096 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 25.9 t -90.47 152.13 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.943 1.697 . . . . 0.0 112.037 -166.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 25.8 tp -109.17 131.39 55.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 129.024 2.93 . . . . 0.0 110.35 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.5 mp -143.2 132.51 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.278 1.431 . . . . 0.0 111.424 -167.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -92.82 135.04 34.48 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.914 1.286 . . . . 0.0 111.597 157.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.59 155.26 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.789 1.235 . . . . 0.0 111.31 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -111.92 108.11 55.77 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.157 1.783 . . . . 0.0 110.925 -173.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.21 119.17 4.15 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.984 3.123 . . . . 0.0 111.031 160.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -60.1 169.24 5.06 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.413 2.742 . . . . 0.0 113.091 167.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -53.56 138.21 34.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.357 1.063 . . . . 0.0 112.277 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.21 -142.34 15.58 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.775 0.702 . . . . 0.0 112.584 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -75.99 163.92 26.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.159 0.984 . . . . 0.0 112.69 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 18.0 m -175.47 167.3 3.29 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.885 2.074 . . . . 0.0 111.192 161.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -133.66 126.51 30.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.661 1.984 . . . . 0.0 108.098 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.6 mm -81.76 129.04 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.03 141.05 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.222 1.009 . . . . 0.0 109.565 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 95.7 t -115.73 113.47 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.806 1.642 . . . . 0.0 108.929 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 96.22 -177.54 33.78 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 122.205 0.892 . . . . 0.0 115.155 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.7 m -133.26 159.3 40.63 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.232 1.813 . . . . 0.0 110.154 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.16 -174.82 54.39 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.866 0.746 . . . . 0.0 113.237 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -54.04 -24.63 17.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.588 1.555 . . . . 0.0 114.354 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 66.9 m -80.8 -4.1 53.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.714 2.006 . . . . 0.0 113.986 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -73.65 128.85 36.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.671 1.123 . . . . 0.0 112.295 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 23.9 mt -100.3 170.03 8.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.113 0.965 . . . . 0.0 111.232 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.8 t -145.92 162.45 37.75 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -148.12 127.86 13.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.12 2.168 . . . . 0.0 108.273 169.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -73.56 137.28 44.23 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.252 -0.905 . . . . 0.0 111.783 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -141.54 133.26 27.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.442 1.097 . . . . 0.0 109.172 166.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -124.77 153.71 42.03 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 41.1 tptt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 121.786 0.803 . . . . 0.0 111.994 -160.038 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 15.9 m -104.34 4.27 33.35 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.9 -49.23 78.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.062 0.945 . . . . 0.0 111.995 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.2 tt -71.13 132.98 45.85 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.256 -0.903 . . . . 0.0 108.837 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.7 t -56.86 169.79 0.48 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.171 1.788 . . . . 0.0 115.076 -168.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.0 mm? -65.23 104.59 0.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.601 1.56 . . . . 0.0 111.392 -168.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 295' ' ' THR . 0.7 OUTLIER -59.97 135.98 57.87 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.64 1.176 . . . . 0.0 111.458 -169.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 62.33 -23.23 0.07 OUTLIER Glycine 0 CA--C 1.541 1.69 0 C-N-CA 126.975 2.226 . . . . 0.0 115.74 -170.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 293' ' ' LYS . 9.2 m -94.63 3.08 55.53 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 130.164 3.386 . . . . 0.0 111.037 -172.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.7 m -163.34 159.69 22.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 119.83 -1.794 . . . . 0.0 111.907 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -87.0 175.33 8.18 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.899 1.28 . . . . 0.0 113.432 -171.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -72.64 159.43 33.87 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.067 1.347 . . . . 0.0 114.498 -171.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 18.0 mmt -75.28 157.4 34.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.693 1.997 . . . . 0.0 111.702 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.1 m -75.53 144.76 41.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.472 -0.768 . . . . 0.0 110.776 172.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 8.3 p -131.87 5.55 4.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.34 167.18 22.16 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.374 0.988 . . . . 0.0 109.792 161.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -68.77 101.29 1.3 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.089 1.355 . . . . 0.0 112.022 -161.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 24.7 mtp -86.53 168.48 13.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.056 0.931 . . . . 0.0 112.969 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.3 m -161.08 160.99 31.1 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.686 1.194 . . . . 0.0 110.866 165.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.31 112.92 18.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.401 0.68 . . . . 0.0 110.126 168.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.3 t -63.26 -35.16 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.417 1.487 . . . . 0.0 110.24 163.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -133.78 123.99 25.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.448 1.499 . . . . 0.0 108.183 165.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -60.42 152.79 63.36 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.72 0.808 . . . . 0.0 111.475 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.35 133.29 45.41 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.133 1.889 . . . . 0.0 110.956 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.9 m -136.19 137.06 40.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.739 1.215 . . . . 0.0 109.183 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -70.08 139.5 52.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.298 0.639 . . . . 0.0 112.454 -175.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.6 p -88.94 -13.08 39.84 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.053 0.941 . . . . 0.0 113.346 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.27 -3.07 3.59 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 119.319 0.963 . . . . 0.0 114.408 -164.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -96.66 10.94 37.11 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.811 1.645 . . . . 0.0 111.519 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 96.98 13.12 47.43 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.179 1.371 . . . . 0.0 114.248 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.6 p -138.13 163.96 30.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.574 1.187 . . . . 0.0 112.225 -170.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.19 132.37 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.489 1.516 . . . . 0.0 109.653 167.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.41 132.47 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.276 1.43 . . . . 0.0 111.693 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.0 ptm -148.37 166.18 28.84 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.342 1.457 . . . . 0.0 113.104 -175.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -136.12 139.44 42.95 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.643 1.177 . . . . 0.0 109.097 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.42 155.92 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.341 1.056 . . . . 0.0 111.474 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -111.76 133.07 54.23 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.876 1.271 . . . . 0.0 112.189 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.39 131.7 21.64 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.148 1.379 . . . . 0.0 107.891 160.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' PRO . . . . . 0.4 ' HG2' ' H ' ' A' ' 326' ' ' LYS . 94.7 Cg_endo -94.44 -67.77 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.097 2.531 . . . . 0.0 114.891 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -145.82 176.65 9.51 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.546 1.938 . . . . 0.0 110.552 -177.231 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.29 -14.74 0.09 OUTLIER Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.788 2.137 . . . . 0.0 118.14 169.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.54 90.48 39.43 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.265 1.532 . . . . 0.0 112.894 -162.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.93 115.63 4.38 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.114 1.876 . . . . 0.0 108.203 156.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.4 p -152.25 157.4 41.37 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -172.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.68 130.71 38.15 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.206 1.802 . . . . 0.0 108.973 165.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 15.2 pt -60.4 114.96 11.4 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-N 118.572 0.624 . . . . 0.0 111.837 -166.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -100.16 87.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.569 2.846 . . . . 0.0 114.333 -160.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 44.2 t -112.09 128.75 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 167.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.05 155.08 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.442 1.097 . . . . 0.0 110.619 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.3 t -130.1 117.33 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.19 1.796 . . . . 0.0 107.364 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -126.62 165.78 18.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.126 0.97 . . . . 0.0 113.315 -166.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -83.61 -8.19 59.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.078 1.751 . . . . 0.0 112.382 162.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -137.3 137.46 39.0 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.401 1.48 . . . . 0.0 111.235 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.13 -20.6 41.59 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -97.79 3.16 50.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.563 1.945 . . . . 0.0 113.673 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 39.21 69.47 0.28 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.963 2.905 . . . . 0.0 115.525 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.19 -34.55 16.62 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.035 1.334 . . . . 0.0 112.116 158.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 35.4 mm -96.78 153.14 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.43 1.092 . . . . 0.0 109.37 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.71 103.21 6.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.553 1.541 . . . . 0.0 109.062 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -94.22 -51.57 4.75 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.663 2.385 . . . . 0.0 113.019 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -82.91 -164.93 36.49 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 -169.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.2 140.68 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 127.374 2.27 . . . . 0.0 109.856 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.51 118.54 14.46 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.563 1.145 . . . . 0.0 109.528 161.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 35.1 t -94.7 -51.04 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 122.831 0.453 . . . . 0.0 110.472 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 36.9 m -70.14 157.48 37.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.102 0.477 . . . . 0.0 110.329 171.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.5 m -52.0 147.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.519 1.128 . . . . 0.0 111.916 171.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -123.0 77.69 50.8 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 123.914 0.886 . . . . 0.0 111.209 -174.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -83.29 -173.15 1.56 Allowed 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 124.872 3.714 . . . . 0.0 112.499 170.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 47.9 pt -84.67 165.75 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.66 1.184 . . . . 0.0 112.15 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.76 124.83 23.49 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 156.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 95.6 p -66.66 -29.83 69.94 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.621 0.768 . . . . 0.0 112.801 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 11.7 m -143.86 153.25 42.15 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.832 2.453 . . . . 0.0 106.983 -168.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.33 -21.01 61.54 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.926 -1.109 . . . . 0.0 113.646 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -95.26 4.11 53.84 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.81 2.444 . . . . 0.0 112.929 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -63.29 157.99 21.43 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.236 -1.54 . . . . 0.0 113.872 -171.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -150.69 86.27 1.39 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.86 149.58 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.886 1.274 . . . . 0.0 112.134 -167.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -92.91 126.06 37.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 129.95 3.3 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.2 mp -138.89 141.56 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.462 1.505 . . . . 0.0 110.768 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.47 141.63 32.0 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.131 1.372 . . . . 0.0 112.198 160.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.68 156.65 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.26 1.024 . . . . 0.0 111.418 168.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -113.05 114.3 48.86 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.381 1.472 . . . . 0.0 110.717 -172.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -85.27 160.82 11.31 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.753 2.969 . . . . 0.0 111.446 163.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -74.12 175.99 10.16 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.842 2.362 . . . . 0.0 110.476 160.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -61.59 142.68 56.96 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.653 -0.654 . . . . 0.0 110.635 159.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.96 -146.83 20.01 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 122.128 -0.358 . . . . 0.0 113.055 -173.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -61.81 145.37 52.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.961 2.105 . . . . 0.0 114.522 -171.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 28.9 m -167.64 162.08 13.92 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.491 1.917 . . . . 0.0 112.041 158.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -130.84 128.03 39.81 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.346 1.458 . . . . 0.0 108.46 169.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 29.3 mm -94.95 120.8 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.422 1.489 . . . . 0.0 108.274 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.2 144.95 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.433 1.093 . . . . 0.0 109.492 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.29 116.19 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.456 1.502 . . . . 0.0 109.332 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 89.76 -178.83 44.14 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 122.548 1.082 . . . . 0.0 114.614 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 92.7 m -127.6 164.12 22.71 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.979 1.312 . . . . 0.0 109.852 172.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 80.64 -173.57 54.78 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 121.855 0.697 . . . . 0.0 112.996 -174.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -23.83 66.45 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.956 1.302 . . . . 0.0 112.762 173.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.4 m -63.62 -10.53 19.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 170.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -78.36 125.49 29.43 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.078 1.308 . . . . 0.0 113.146 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 4.4 mt -88.19 162.24 16.79 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.071 -0.393 . . . . 0.0 111.167 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.8 t -142.43 149.04 38.76 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.883 1.273 . . . . 0.0 111.497 -174.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -151.65 126.68 9.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.731 1.612 . . . . 0.0 110.434 -177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -73.28 128.91 36.82 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.28 -0.888 . . . . 0.0 111.442 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -136.39 125.26 24.1 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.282 0.633 . . . . 0.0 110.298 167.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.27 122.76 32.44 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 124.144 0.978 . . . . 0.0 111.394 -169.559 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.1 p -86.19 -7.27 58.68 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -53.21 -49.98 65.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.117 0.967 . . . . 0.0 112.923 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 22.3 tp -73.59 127.46 32.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.56 -0.712 . . . . 0.0 109.537 163.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.3 t -53.31 171.04 0.08 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -164.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.53 111.88 2.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.617 2.367 . . . . 0.0 111.753 -170.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -61.63 107.54 0.83 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.863 2.465 . . . . 0.0 111.725 -167.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 82.01 0.04 89.1 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.53 1.062 . . . . 0.0 114.5 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 89.1 m -117.88 5.1 12.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.381 1.872 . . . . 0.0 110.965 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.0 m -157.25 156.19 32.08 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 119.51 -1.994 . . . . 0.0 114.027 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -82.92 178.45 8.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.109 2.164 . . . . 0.0 113.328 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -73.48 160.76 31.24 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.524 1.53 . . . . 0.0 114.381 -170.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.15 147.74 32.58 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.248 2.619 . . . . 0.0 111.675 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.59 138.68 56.63 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.526 -0.734 . . . . 0.0 110.733 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.5 p -132.31 14.3 4.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.264 1.026 . . . . 0.0 113.263 172.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -81.45 170.87 15.41 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 118.676 0.671 . . . . 0.0 109.212 159.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -62.06 103.86 0.41 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.052 1.741 . . . . 0.0 111.777 -166.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 25.8 mtp -91.14 165.89 13.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 122.384 1.088 . . . . 0.0 112.142 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 30.7 m -161.94 164.72 28.32 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.049 1.34 . . . . 0.0 109.892 166.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.6 127.48 34.09 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 164.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.85 -32.57 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 159.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -133.84 119.89 19.76 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.647 1.579 . . . . 0.0 109.259 167.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -58.9 150.85 57.95 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.913 1.685 . . . . 0.0 112.063 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -62.8 131.27 32.43 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.535 2.157 . . . . 0.0 110.908 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.56 140.11 46.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.083 0.953 . . . . 0.0 109.691 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.31 132.09 52.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.036 0.934 . . . . 0.0 112.303 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 74.6 p -84.9 -13.7 50.03 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.02 1.328 . . . . 0.0 114.121 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.516 ' HA2' ' HE2' ' A' ' 398' ' ' LYS . . . 70.36 18.45 75.22 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.262 -0.743 . . . . 0.0 114.624 -162.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.24 16.16 8.38 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.872 1.336 . . . . 0.0 112.448 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.86 11.76 73.03 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.396 -0.815 . . . . 0.0 113.53 -176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 40.6 p -134.08 161.21 35.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.139 1.375 . . . . 0.0 110.942 -168.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.14 132.92 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.265 1.026 . . . . 0.0 109.614 172.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.14 136.1 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.835 1.254 . . . . 0.0 112.121 -170.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 14.5 ptm -151.01 165.64 33.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.498 1.519 . . . . 0.0 114.012 -172.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -132.07 121.57 24.04 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.767 2.427 . . . . 0.0 107.333 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.5 m -112.99 158.12 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.88 0.872 . . . . 0.0 111.589 -172.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -125.12 143.94 50.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.235 1.014 . . . . 0.0 113.426 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.58 151.16 51.37 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.637 2.375 . . . . 0.0 107.89 167.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -119.89 -60.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.627 2.218 . . . . 0.0 115.877 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 175.48 9.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.476 1.11 . . . . 0.0 112.248 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.57 -15.44 0.1 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.459 2.456 . . . . 0.0 118.638 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.83 92.59 49.03 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.635 1.717 . . . . 0.0 114.181 -159.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.28 124.59 10.07 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.816 1.677 . . . . 0.0 108.388 155.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.0 p -153.84 155.78 36.4 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.463 -0.773 . . . . 0.0 112.44 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -78.46 128.53 33.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.159 1.384 . . . . 0.0 107.785 161.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.7 pp -61.82 115.58 16.22 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -164.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -95.17 94.66 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.362 3.375 . . . . 0.0 113.852 -170.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 32.3 t -124.48 109.17 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.719 -0.613 . . . . 0.0 109.955 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.12 159.32 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.483 1.513 . . . . 0.0 110.984 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 83.8 t -131.81 117.36 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 126.51 1.924 . . . . 0.0 106.412 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.55 165.37 20.89 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -165.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -86.07 -8.65 57.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.271 1.829 . . . . 0.0 112.922 163.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -130.19 142.04 50.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.62 1.168 . . . . 0.0 110.914 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.74 -21.85 56.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.991 1.316 . . . . 0.0 113.726 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.7 t -105.6 5.92 31.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.55 1.94 . . . . 0.0 113.903 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.421 ' HB2' HD13 ' A' ' 377' ' ' ILE . . . 45.02 69.71 0.41 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.708 2.803 . . . . 0.0 116.184 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -82.8 -37.49 24.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.937 0.895 . . . . 0.0 111.861 153.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 36.4 mm -88.98 155.52 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.924 1.289 . . . . 0.0 110.449 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -134.46 93.55 3.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.179 1.791 . . . . 0.0 109.621 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -101.57 -28.16 12.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.832 2.053 . . . . 0.0 114.696 -169.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -99.78 179.96 30.41 Favored Glycine 0 N--CA 1.477 1.368 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -171.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 4.5 mt -117.61 135.51 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.537 2.335 . . . . 0.0 110.168 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.88 132.09 44.74 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.111 0.564 . . . . 0.0 110.319 165.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.06 -49.94 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.2 m -80.41 162.72 24.32 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.607 0.718 . . . . 0.0 110.66 167.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.4 m -63.31 165.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.112 1.765 . . . . 0.0 114.519 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -117.36 81.47 13.74 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.697 1.599 . . . . 0.0 110.917 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.09 -166.95 0.45 Allowed 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 124.412 3.408 . . . . 0.0 112.865 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.9 pt -104.37 169.81 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.284 1.833 . . . . 0.0 110.793 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.07 113.45 8.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.753 0.421 . . . . 0.0 110.099 158.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 82.4 p -73.32 -23.03 60.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.295 1.438 . . . . 0.0 113.361 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 77.4 p -135.0 165.23 25.83 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.946 2.099 . . . . 0.0 108.788 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -63.73 -21.2 66.29 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.018 -1.052 . . . . 0.0 113.471 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -100.39 9.22 42.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.695 1.598 . . . . 0.0 112.567 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -59.18 156.58 11.96 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.812 1.291 . . . . 0.0 113.508 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -148.35 98.72 2.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.982 1.313 . . . . 0.0 112.343 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 53.0 t -92.81 149.55 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.39 1.476 . . . . 0.0 110.438 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.27 124.28 49.27 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.53 2.732 . . . . 0.0 108.697 -174.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.58 136.37 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.671 0.788 . . . . 0.0 111.825 -170.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -95.75 136.54 36.03 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.424 1.49 . . . . 0.0 111.563 152.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.02 154.95 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.212 1.005 . . . . 0.0 111.333 166.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -116.57 113.15 40.67 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.774 2.03 . . . . 0.0 109.779 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -81.09 167.35 18.01 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.949 2.432 . . . . 0.0 111.357 164.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -69.63 173.5 10.76 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.436 2.091 . . . . 0.0 110.773 163.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -62.13 144.74 54.94 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.872 -0.518 . . . . 0.0 110.533 162.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.67 -155.57 18.34 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.782 0.706 . . . . 0.0 111.979 -170.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.58 161.06 21.29 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.459 1.123 . . . . 0.0 112.681 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 49.2 m -160.96 159.29 29.35 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.465 -1.397 . . . . 0.0 111.075 161.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.55 115.07 23.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 29.4 mm -89.59 117.02 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.664 1.586 . . . . 0.0 108.09 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 342' ' ' ALA . 2.9 mp -113.75 141.48 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.699 0.799 . . . . 0.0 110.707 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 99.4 t -116.24 109.27 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.412 1.885 . . . . 0.0 108.173 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 112.58 -177.35 18.36 Favored Glycine 0 N--CA 1.471 0.991 0 N-CA-C 116.241 1.256 . . . . 0.0 116.241 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 99.5 m -138.07 167.39 21.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.963 1.705 . . . . 0.0 109.282 165.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.21 -174.35 44.34 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 121.732 -0.605 . . . . 0.0 112.537 -169.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.78 -25.79 63.43 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.104 0.962 . . . . 0.0 113.435 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.8 m -75.4 -1.26 23.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.451 2.3 . . . . 0.0 114.846 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -79.88 133.59 36.25 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.748 0.819 . . . . 0.0 111.995 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.7 mt -102.84 163.65 12.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.258 0.623 . . . . 0.0 111.27 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 t -137.84 148.51 45.5 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.72 1.208 . . . . 0.0 112.001 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -146.0 131.07 18.29 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.484 1.514 . . . . 0.0 110.277 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -82.11 136.25 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.279 1.031 . . . . 0.0 111.301 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -134.95 154.45 51.7 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.069 0.938 . . . . 0.0 112.675 166.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -124.62 140.9 52.51 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.683 1.593 . . . . 0.0 107.942 165.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -123.64 125.72 45.31 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.381 1.872 . . . . 0.0 108.67 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -57.69 165.8 1.56 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.557 1.943 . . . . 0.0 112.247 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -67.65 148.4 49.53 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 121.959 0.755 . . . . 0.0 113.24 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 50.9 m -58.37 -9.86 1.79 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.769 1.228 . . . . 0.0 114.044 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 58.4 p -65.08 -17.72 64.7 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.579 1.952 . . . . 0.0 114.568 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.15 -26.17 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.565 1.075 . . . . 0.0 113.458 172.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.11 46.24 93.72 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 118.831 0.742 . . . . 0.0 114.853 168.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.516 ' HE2' ' HA2' ' A' ' 314' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 C-N-CA 125.605 1.562 . . . . 0.0 110.934 170.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 3.8 m -97.44 5.35 49.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -171.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -71.96 -43.72 64.71 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.165 1.348 . . . . 0.0 112.755 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.1 136.11 56.33 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 165.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 t -54.56 163.94 0.82 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.36 97.06 1.96 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.869 1.668 . . . . 0.0 111.105 -164.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -46.72 133.55 10.47 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.904 2.482 . . . . 0.0 112.328 -171.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.02 -36.94 1.07 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.035 1.302 . . . . 0.0 114.561 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 10.3 p -72.75 -26.46 61.56 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 118.777 1.288 . . . . 0.0 114.246 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.0 m -134.29 150.6 51.0 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.574 0.75 . . . . 0.0 112.462 -152.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -79.94 175.36 10.7 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.287 1.435 . . . . 0.0 112.927 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.31 154.0 42.4 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -71.09 146.35 49.3 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.046 2.139 . . . . 0.0 112.358 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 8.4 m -63.48 143.06 58.13 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.682 -0.636 . . . . 0.0 112.266 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.3 p -135.45 11.44 3.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.641 1.176 . . . . 0.0 113.525 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -71.97 168.98 16.87 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.219 0.918 . . . . 0.0 109.648 161.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -65.36 97.19 0.27 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.424 -0.797 . . . . 0.0 111.899 -172.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 42.7 mtp -86.17 168.0 14.4 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.366 1.079 . . . . 0.0 112.762 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 39.2 m -160.89 163.63 31.83 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.053 1.341 . . . . 0.0 109.963 161.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.82 121.76 25.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.654 0.381 . . . . 0.0 110.119 167.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.01 -29.85 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.267 1.027 . . . . 0.0 110.335 165.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -141.52 132.74 26.42 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.147 1.779 . . . . 0.0 109.303 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -64.81 150.43 94.65 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.379 1.072 . . . . 0.0 112.148 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -62.77 130.88 30.97 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.986 1.791 . . . . 0.0 110.646 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 65.2 p -131.27 137.84 49.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.964 1.306 . . . . 0.0 110.626 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -63.16 126.14 26.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.589 1.556 . . . . 0.0 112.333 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.8 p -70.61 -25.86 63.24 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.95 0.5 . . . . 0.0 111.281 166.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 82.39 -6.17 69.72 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.503 1.525 . . . . 0.0 113.845 -168.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -92.86 18.99 8.14 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.707 1.603 . . . . 0.0 111.37 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 91.9 2.78 68.87 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.738 1.161 . . . . 0.0 115.039 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 28.3 p -127.35 158.56 36.93 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.496 1.648 . . . . 0.0 112.55 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.02 129.78 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.778 1.631 . . . . 0.0 109.611 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.4 p -114.83 130.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.465 1.106 . . . . 0.0 113.085 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.4 ptm -137.97 171.25 14.7 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.809 2.443 . . . . 0.0 111.919 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -135.44 139.45 44.12 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.629 -0.669 . . . . 0.0 109.89 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.93 149.46 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.261 1.024 . . . . 0.0 111.948 -170.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -109.03 137.67 46.58 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.272 1.429 . . . . 0.0 112.833 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.1 t -117.07 133.88 23.08 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 126.977 2.111 . . . . 0.0 107.596 166.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -96.39 -74.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 123.186 2.591 . . . . 0.0 116.984 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.92 146.15 25.42 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 -169.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 76.72 4.55 81.89 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 115.66 1.024 . . . . 0.0 115.66 171.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.25 99.13 43.52 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.843 1.257 . . . . 0.0 111.531 -172.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.66 130.03 14.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.327 2.018 . . . . 0.0 108.884 167.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.8 p -159.98 156.13 26.6 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -75.32 137.8 41.37 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.481 1.913 . . . . 0.0 108.429 162.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 2.0 pp -66.77 124.55 88.83 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-N 118.29 0.495 . . . . 0.0 112.051 -169.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 9.7 Cg_endo -107.35 96.13 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.423 2.749 . . . . 0.0 115.723 -165.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 69.3 t -124.89 124.55 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.39 -0.818 . . . . 0.0 109.473 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.34 154.7 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.572 1.549 . . . . 0.0 110.179 -174.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.22 105.06 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.222 1.409 . . . . 0.0 109.271 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -120.63 160.59 22.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.992 1.317 . . . . 0.0 113.865 -163.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.29 -17.12 46.97 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.747 1.619 . . . . 0.0 112.378 164.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -122.7 133.39 54.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.99 1.316 . . . . 0.0 110.929 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -56.76 -19.45 17.02 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.136 1.775 . . . . 0.0 113.108 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.2 t -101.62 4.51 40.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.665 2.386 . . . . 0.0 113.733 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 37.91 74.28 0.09 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 130.534 3.534 . . . . 0.0 117.326 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -105.52 -16.53 14.69 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.937 1.695 . . . . 0.0 112.83 160.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 64.4 mt -109.45 146.29 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.744 1.618 . . . . 0.0 107.62 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.27 112.83 11.36 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.909 -1.119 . . . . 0.0 111.397 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -104.39 -21.53 13.47 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.07 -168.92 42.11 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 118.716 0.689 . . . . 0.0 114.424 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 65.3 mt -134.44 135.4 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.276 1.831 . . . . 0.0 110.528 -174.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.61 118.57 10.38 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.723 1.209 . . . . 0.0 109.333 160.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.62 -29.54 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.666 0.786 . . . . 0.0 112.342 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.8 m -77.38 153.34 33.79 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.056 0.844 . . . . 0.0 109.737 153.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.5 m -60.96 161.81 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.007 1.323 . . . . 0.0 113.598 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -121.85 78.68 40.37 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.023 1.329 . . . . 0.0 111.466 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.39 -168.04 0.57 Allowed 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 124.404 3.402 . . . . 0.0 113.078 171.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 29.3 pt -95.08 164.46 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.211 1.804 . . . . 0.0 111.27 166.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.92 110.01 3.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 160.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.3 t -76.46 -3.0 34.9 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 90.8 m -153.56 157.07 39.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.026 2.53 . . . . 0.0 104.816 161.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -60.6 -18.04 50.43 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.559 -1.338 . . . . 0.0 114.148 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.51 8.6 30.24 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.683 2.393 . . . . 0.0 113.479 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -60.57 156.88 15.46 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.226 -1.547 . . . . 0.0 114.099 -173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . 0.25 9.4 pt-20 -146.47 80.79 1.56 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 22.2 t -85.55 145.74 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.041 1.336 . . . . 0.0 112.363 -167.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.02 120.19 39.84 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 129.837 3.255 . . . . 0.0 109.108 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.1 mp -137.72 132.55 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.594 1.557 . . . . 0.0 111.125 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 142.6 29.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.004 0.907 . . . . 0.0 112.219 159.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.55 161.5 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.562 1.545 . . . . 0.0 110.522 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -117.94 108.99 41.7 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.746 1.619 . . . . 0.0 109.346 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.6 154.86 44.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.533 2.155 . . . . 0.0 110.638 163.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.29 175.66 10.27 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.224 1.949 . . . . 0.0 110.232 165.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -62.13 133.61 55.47 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.491 -0.756 . . . . 0.0 110.288 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.74 -149.43 16.6 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.564 1.078 . . . . 0.0 113.56 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.23 149.89 47.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.435 2.294 . . . . 0.0 113.172 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.9 m -163.88 153.78 14.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.988 1.315 . . . . 0.0 113.618 162.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -118.58 116.9 27.58 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.554 1.141 . . . . 0.0 108.679 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 27.5 mm -80.74 117.75 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.209 1.403 . . . . 0.0 107.561 174.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.4 mp -111.87 144.11 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.357 0.599 . . . . 0.0 109.946 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 78.6 t -116.02 117.42 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.011 1.724 . . . . 0.0 108.576 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 94.11 -178.66 37.51 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 122.942 1.301 . . . . 0.0 115.213 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 84.6 m -132.28 166.04 22.79 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.277 1.831 . . . . 0.0 109.423 168.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 76.71 -175.8 53.16 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 121.918 0.732 . . . . 0.0 113.663 -176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.22 -21.78 9.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.343 1.857 . . . . 0.0 114.454 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.1 m -86.47 -4.89 59.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.425 2.29 . . . . 0.0 114.61 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -73.72 137.91 44.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.55 1.068 . . . . 0.0 112.446 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 11.1 mt -106.41 162.94 13.26 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.748 0.819 . . . . 0.0 111.571 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.9 t -132.22 154.45 49.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.766 1.226 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -148.99 131.85 16.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.124 2.17 . . . . 0.0 108.9 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -81.64 134.84 35.52 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.928 -1.108 . . . . 0.0 111.597 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -133.23 146.73 51.72 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.297 0.639 . . . . 0.0 109.916 162.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.95 137.86 49.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 172.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -124.75 129.85 51.28 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.548 1.139 . . . . 0.0 110.531 -168.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.61 167.75 9.53 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.557 1.143 . . . . 0.0 111.207 172.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -84.05 23.98 6.5 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 118.426 -1.208 . . . . 0.0 115.172 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.7 p -117.47 -38.9 3.24 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.291 1.545 . . . . 0.0 112.219 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 3.0 m -73.6 46.69 0.22 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.123 1.369 . . . . 0.0 111.574 167.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.3 tp -117.42 -25.38 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 127.651 2.38 . . . . 0.0 112.477 -174.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -146.08 24.14 1.75 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.741 1.639 . . . . 0.0 113.151 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.248 1.819 . . . . 0.0 108.857 172.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 3.3 m -65.31 0.11 1.57 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.7 -23.58 66.8 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.559 1.527 . . . . 0.0 114.138 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 49.0 tp -85.68 128.2 34.71 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.916 1.235 . . . . 0.0 108.968 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.2 t -53.47 158.74 1.65 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.511 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.8 mm? -61.47 105.66 0.55 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.1 2.16 . . . . 0.0 110.774 -167.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -63.11 125.22 23.31 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.237 -0.914 . . . . 0.0 111.118 -170.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.89 -50.52 3.01 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.857 1.218 . . . . 0.0 112.842 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 32.1 m -63.94 -0.07 1.01 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.408 2.283 . . . . 0.0 113.432 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.2 m -157.1 154.02 28.75 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 119.024 -2.297 . . . . 0.0 111.725 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -78.01 170.87 15.88 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.816 1.647 . . . . 0.0 113.34 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 152.21 40.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.465 1.106 . . . . 0.0 113.294 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.6 mpp? -62.12 165.78 5.39 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 129.201 3.0 . . . . 0.0 114.314 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -81.15 142.72 32.97 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.281 -0.887 . . . . 0.0 110.545 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.5 p -135.77 18.61 3.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.587 1.155 . . . . 0.0 113.094 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -81.75 161.28 23.37 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 156.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.14 102.25 0.36 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.53 1.532 . . . . 0.0 112.131 -168.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 28.1 mtp -84.64 172.77 11.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.22 1.008 . . . . 0.0 112.837 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.6 m -159.93 167.25 28.44 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.174 -0.954 . . . . 0.0 112.027 166.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.92 117.95 24.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.579 0.752 . . . . 0.0 109.328 167.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.07 -35.26 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.049 0.94 . . . . 0.0 110.015 159.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -135.71 127.07 28.45 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.321 1.448 . . . . 0.0 108.467 165.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -65.15 152.69 90.98 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.467 1.107 . . . . 0.0 111.903 171.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.46 131.08 30.41 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.637 2.225 . . . . 0.0 111.657 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.0 m -136.85 139.61 41.81 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.278 1.031 . . . . 0.0 110.465 174.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -65.16 132.58 49.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.277 1.031 . . . . 0.0 112.549 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 63.9 p -79.62 -21.55 44.76 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.034 1.334 . . . . 0.0 113.49 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 85.08 -9.29 66.89 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.541 1.543 . . . . 0.0 113.696 -162.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -81.66 -7.59 59.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.573 1.187 . . . . 0.0 112.312 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.35 15.23 48.28 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.329 0.966 . . . . 0.0 112.843 -164.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 32.2 p -127.68 155.95 43.13 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.923 1.289 . . . . 0.0 110.907 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 25.6 m -123.18 127.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.889 1.276 . . . . 0.0 109.53 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.69 130.82 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.866 1.266 . . . . 0.0 111.86 -172.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 7.0 ptp -137.74 167.99 20.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.903 2.081 . . . . 0.0 111.082 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -133.11 129.28 37.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.064 0.946 . . . . 0.0 108.964 170.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.22 151.72 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.328 1.051 . . . . 0.0 110.85 -169.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -113.18 131.83 55.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.795 1.238 . . . . 0.0 111.64 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.39 151.07 39.61 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-O 117.062 -1.447 . . . . 0.0 108.531 159.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -111.03 -72.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.184 2.589 . . . . 0.0 115.279 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 172.9 12.5 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.184 -1.573 . . . . 0.0 113.127 -174.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.12 -24.09 0.11 Allowed Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.913 2.197 . . . . 0.0 117.538 170.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -109.0 96.9 22.09 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 125.909 1.684 . . . . 0.0 111.784 -170.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -62.97 133.9 43.65 Favored 'Trans proline' 0 C--N 1.35 0.637 0 N-CA-C 107.675 -1.702 . . . . 0.0 107.675 154.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.4 p -158.88 154.25 25.72 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.315 -0.865 . . . . 0.0 113.234 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -72.39 141.99 48.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.604 157.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.91 123.28 79.28 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 118.986 0.812 . . . . 0.0 111.233 -175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -98.52 72.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.042 3.162 . . . . 0.0 112.694 -168.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.1 t -104.76 130.62 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.87 162.65 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 125.181 1.392 . . . . 0.0 110.586 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.72 120.25 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.988 1.715 . . . . 0.0 107.768 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.89 164.57 22.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -160.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.66 -16.52 36.33 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.453 1.901 . . . . 0.0 113.116 163.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -124.66 138.37 54.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.731 1.212 . . . . 0.0 110.364 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.79 -15.94 14.61 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.8 t -104.28 8.26 36.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.459 1.503 . . . . 0.0 113.877 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 40.32 67.69 0.47 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 129.347 3.059 . . . . 0.0 116.578 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.8 -27.26 23.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.186 0.994 . . . . 0.0 112.574 155.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 56.4 mt -111.86 136.58 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.896 1.678 . . . . 0.0 108.988 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -110.0 98.57 7.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.896 1.278 . . . . 0.0 112.451 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -80.61 -42.68 21.78 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.188 2.595 . . . . 0.0 114.308 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -93.08 -168.55 39.18 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 119.993 1.27 . . . . 0.0 116.261 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.4 mt -125.85 141.76 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.852 2.461 . . . . 0.0 110.071 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.44 136.04 37.53 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.371 1.069 . . . . 0.0 110.4 167.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.56 -40.76 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.031 0.533 . . . . 0.0 112.374 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 27.5 m -72.53 158.63 35.33 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 157.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 10.6 m -55.51 156.2 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.484 1.114 . . . . 0.0 113.095 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -113.82 84.16 8.22 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.325 1.45 . . . . 0.0 109.175 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -81.44 -167.47 0.5 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 124.695 3.597 . . . . 0.0 112.89 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 26.0 pt -95.17 164.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.363 1.865 . . . . 0.0 111.183 166.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -73.77 110.43 8.06 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 154.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.9 p -75.88 -51.82 11.67 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.958 1.303 . . . . 0.0 111.629 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.15 151.14 23.9 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 155.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -57.92 -23.05 51.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.91 9.33 43.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.454 1.502 . . . . 0.0 112.786 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -58.56 153.41 16.26 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.241 -1.537 . . . . 0.0 113.686 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -135.82 84.88 2.12 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.721 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 23.5 t -87.98 142.14 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.248 1.419 . . . . 0.0 111.663 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.89 123.74 35.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.903 2.881 . . . . 0.0 109.409 176.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.95 140.56 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.384 1.474 . . . . 0.0 111.039 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.5 148.24 30.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.3 1.047 . . . . 0.0 112.933 161.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.6 m -131.07 155.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.679 1.592 . . . . 0.0 110.678 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -109.51 106.12 58.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.999 2.12 . . . . 0.0 109.361 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.73 146.96 30.7 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.228 1.952 . . . . 0.0 110.346 161.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.2 170.12 18.99 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.454 2.103 . . . . 0.0 111.009 167.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -55.03 140.89 36.26 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.526 1.131 . . . . 0.0 111.483 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.35 -148.3 18.83 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -171.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -79.93 162.03 25.19 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.489 1.116 . . . . 0.0 112.452 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 17.6 m -164.25 155.41 15.65 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.773 -1.205 . . . . 0.0 111.961 156.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -113.56 112.0 22.82 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.5 mm -78.9 119.49 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.651 1.181 . . . . 0.0 107.86 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -113.37 140.98 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.522 0.729 . . . . 0.0 109.886 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.4 t -120.01 107.04 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 125.421 1.488 . . . . 0.0 108.468 172.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 119.49 -176.34 16.09 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.251 1.405 . . . . 0.0 115.574 172.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 54.7 m -138.76 161.9 36.06 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.426 1.49 . . . . 0.0 109.267 164.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.49 -172.17 50.79 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 121.86 0.7 . . . . 0.0 112.762 -169.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -29.23 11.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.24 1.816 . . . . 0.0 113.647 173.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.7 m -72.29 -4.43 29.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 128.739 2.815 . . . . 0.0 114.693 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -84.96 122.28 28.99 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.04 0.837 . . . . 0.0 112.564 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 29.6 mt -87.06 161.08 18.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.25 0.62 . . . . 0.0 111.327 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.7 t -141.29 145.33 35.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.996 1.318 . . . . 0.0 111.737 -173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -153.75 115.18 4.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.924 1.29 . . . . 0.0 110.775 -171.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.8 135.01 47.86 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.861 -1.149 . . . . 0.0 112.152 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -124.37 166.85 15.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.441 1.096 . . . . 0.0 110.977 157.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.84 138.33 37.41 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.471 1.508 . . . . 0.0 108.011 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -122.67 119.54 31.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.224 1.41 . . . . 0.0 110.784 -173.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.85 161.86 13.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.897 2.479 . . . . 0.0 112.117 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -75.43 42.06 1.43 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.067 1.317 . . . . 0.0 114.03 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.7 -63.84 0.47 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.413 1.485 . . . . 0.0 112.721 -173.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.0 m -83.42 56.4 3.56 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.927 1.691 . . . . 0.0 111.066 -174.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 6.3 tt -143.9 70.92 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.979 1.711 . . . . 0.0 110.661 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 146.43 2.18 0.6 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.926 1.25 . . . . 0.0 115.409 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.739 1.616 . . . . 0.0 109.389 172.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 118.682 -0.675 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 12.1 m -98.14 0.44 45.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -171.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.52 71.24 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.64 1.109 . . . . 0.0 112.353 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.9 tt -66.57 118.18 9.8 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.2 t -55.09 173.03 0.1 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.141 2.176 . . . . 0.0 116.368 -164.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.407 ' H ' HD22 ' A' ' 292' ' ' LEU . 2.7 mm? -60.97 106.36 0.58 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.5 1.92 . . . . 0.0 111.727 -172.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -71.06 141.54 50.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.414 1.486 . . . . 0.0 111.74 -171.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.74 -59.49 1.3 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.292 1.425 . . . . 0.0 113.393 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 14.6 t -68.05 16.38 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.962 2.105 . . . . 0.0 115.213 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 10.0 m -163.69 165.55 23.15 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 120.233 -1.542 . . . . 0.0 112.945 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -86.66 169.23 12.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.781 1.232 . . . . 0.0 113.865 -172.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -70.52 159.18 34.76 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.76 1.624 . . . . 0.0 115.048 -166.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 54.5 mtt -77.23 151.11 35.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.161 2.184 . . . . 0.0 112.062 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.8 m -69.51 142.78 53.62 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.725 -0.609 . . . . 0.0 111.968 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 20.3 p -131.5 7.72 4.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.389 1.076 . . . . 0.0 113.651 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -72.54 159.66 33.55 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.523 1.056 . . . . 0.0 109.984 160.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -63.87 100.47 0.3 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.907 1.683 . . . . 0.0 110.984 -168.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 17.2 mtp -83.83 172.99 11.64 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 122.318 1.056 . . . . 0.0 113.604 -169.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.2 m -155.5 172.5 18.14 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.873 0.869 . . . . 0.0 111.372 161.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.58 121.56 42.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.188 0.995 . . . . 0.0 109.765 164.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 27.1 t -63.77 -36.89 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.003 1.321 . . . . 0.0 109.798 167.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -137.92 126.54 23.63 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.23 1.412 . . . . 0.0 109.836 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -62.96 152.19 84.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.618 1.167 . . . . 0.0 112.217 172.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -62.06 131.86 36.66 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.392 2.062 . . . . 0.0 111.647 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 48.1 p -128.56 132.02 48.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.93 1.292 . . . . 0.0 110.874 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -51.35 118.79 3.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.192 1.797 . . . . 0.0 112.062 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 60.9 p -79.64 -8.6 59.31 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.413 1.485 . . . . 0.0 113.41 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.17 -7.2 6.15 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.523 1.059 . . . . 0.0 114.262 -165.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -89.49 5.37 45.7 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.222 1.511 . . . . 0.0 112.14 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 87.05 17.35 59.49 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.232 0.92 . . . . 0.0 113.148 -170.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 38.4 p -131.47 161.52 32.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.907 1.283 . . . . 0.0 111.062 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.96 128.45 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.907 1.283 . . . . 0.0 109.119 170.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.91 133.16 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.664 1.186 . . . . 0.0 111.844 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 22.2 ptm -146.63 162.35 38.62 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.664 2.385 . . . . 0.0 111.861 -166.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -134.74 130.53 36.35 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.524 -0.735 . . . . 0.0 109.655 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 19.9 m -109.92 164.52 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.837 1.255 . . . . 0.0 111.517 -171.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -134.95 125.03 25.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.547 1.539 . . . . 0.0 111.498 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.83 153.15 37.99 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-O 117.21 -1.376 . . . . 0.0 108.374 162.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -109.02 -72.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 123.293 2.662 . . . . 0.0 115.208 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.3 163.69 31.17 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 121.397 1.908 . . . . 0.0 115.823 -174.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.83 -17.54 0.1 OUTLIER Glycine 0 CA--C 1.538 1.504 0 C-N-CA 127.841 2.638 . . . . 0.0 117.881 171.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -104.22 99.89 19.15 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 119.316 1.558 . . . . 0.0 113.13 -168.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.26 128.46 16.51 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.836 1.69 . . . . 0.0 108.697 155.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.0 p -163.94 155.93 16.94 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.555 -0.715 . . . . 0.0 111.953 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -79.77 128.18 33.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.497 1.519 . . . . 0.0 109.448 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.0 111.01 3.1 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.464 0.706 . . . . 0.0 112.4 -163.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -91.03 85.9 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.726 2.95 . . . . 0.0 113.394 -157.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.42 134.48 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.972 0.909 . . . . 0.0 109.219 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.08 151.72 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.376 1.07 . . . . 0.0 110.232 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.27 109.31 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.889 1.675 . . . . 0.0 107.591 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -117.7 161.24 20.0 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -158.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.28 -11.98 53.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.158 2.183 . . . . 0.0 112.783 162.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -129.81 138.31 50.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.561 1.544 . . . . 0.0 111.073 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 22.5 mt -55.83 -19.18 10.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.587 1.555 . . . . 0.0 114.374 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -105.65 2.36 28.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.95 2.5 . . . . 0.0 114.222 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 49.04 77.58 0.1 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.161 2.584 . . . . 0.0 116.59 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -109.9 -24.34 10.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.393 1.477 . . . . 0.0 112.309 161.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.92 120.54 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.062 1.345 . . . . 0.0 109.018 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.96 114.73 28.89 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.729 0.812 . . . . 0.0 112.916 -169.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -81.39 -51.57 8.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.504 2.722 . . . . 0.0 112.451 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.9 -167.36 40.2 Favored Glycine 0 CA--C 1.537 1.413 0 N-CA-C 116.549 1.379 . . . . 0.0 116.549 -167.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.91 140.44 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 127.035 2.134 . . . . 0.0 110.94 -175.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 7.2 mt -73.05 130.0 39.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.759 1.224 . . . . 0.0 110.466 163.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.09 -45.18 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 122.759 0.424 . . . . 0.0 111.159 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 m -70.03 154.78 41.5 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.67 0.668 . . . . 0.0 110.178 164.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.9 m -56.73 155.89 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.971 0.908 . . . . 0.0 112.253 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -127.79 71.26 78.05 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.049 0.939 . . . . 0.0 111.716 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.23 -169.52 0.75 Allowed 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 124.619 3.546 . . . . 0.0 112.914 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 37.1 pt -87.55 161.29 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 121.502 -0.749 . . . . 0.0 112.196 167.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.85 109.29 2.03 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 156.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.4 p -69.73 -37.2 76.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.617 1.567 . . . . 0.0 112.161 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.46 157.14 30.0 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.082 1.753 . . . . 0.0 109.745 158.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -62.95 -17.95 62.58 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.88 7.88 44.57 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.623 1.169 . . . . 0.0 112.356 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -59.45 150.39 26.78 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.63 -1.294 . . . . 0.0 113.257 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -134.84 80.17 1.83 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.355 1.062 . . . . 0.0 113.289 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.23 146.5 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.031 1.332 . . . . 0.0 111.942 -171.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 27.6 tp -97.96 129.01 44.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 129.405 3.082 . . . . 0.0 110.034 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.2 mp -140.28 148.6 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 109.726 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -121.25 148.07 44.78 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.249 1.023 . . . . 0.0 112.354 157.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.45 156.57 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.689 1.596 . . . . 0.0 110.909 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -116.21 104.96 51.53 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.58 1.952 . . . . 0.0 110.639 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.16 164.62 15.05 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.645 2.897 . . . . 0.0 111.747 163.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.58 -178.93 4.85 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.792 2.995 . . . . 0.0 111.836 166.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -67.0 150.9 48.61 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.525 -0.735 . . . . 0.0 110.551 158.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 94.47 -151.05 20.0 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 -167.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.9 162.5 20.48 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.754 1.222 . . . . 0.0 113.276 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 19.3 m -165.09 159.08 17.4 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.822 -1.174 . . . . 0.0 111.818 157.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -122.25 116.16 23.64 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 11.7 mm -92.1 111.14 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.349 1.06 . . . . 0.0 108.188 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.3 145.41 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.961 0.904 . . . . 0.0 109.957 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.86 113.41 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.415 1.886 . . . . 0.0 109.015 174.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.58 178.16 27.13 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.435 1.017 . . . . 0.0 114.855 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 17.8 m -131.43 159.95 36.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.811 1.645 . . . . 0.0 109.566 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 78.35 -175.74 54.57 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 121.898 0.721 . . . . 0.0 112.966 -172.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -22.17 63.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.033 1.333 . . . . 0.0 112.85 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 72.0 m -63.47 -12.31 30.57 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 168.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -79.4 144.01 34.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.099 1.318 . . . . 0.0 112.799 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 24.9 mt -111.81 164.37 13.14 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.428 1.091 . . . . 0.0 111.24 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.5 t -140.58 146.85 38.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.802 1.241 . . . . 0.0 111.686 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -143.93 112.24 6.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.824 1.65 . . . . 0.0 110.034 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 131.62 46.44 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.98 0.912 . . . . 0.0 111.664 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -121.05 158.46 27.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.35 1.06 . . . . 0.0 110.775 162.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -145.5 140.03 27.23 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -105.24 112.09 25.07 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.994 1.318 . . . . 0.0 108.694 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -60.45 163.25 5.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.24 3.016 . . . . 0.0 114.471 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -131.01 16.22 5.29 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.97 1.748 . . . . 0.0 113.446 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 17.9 p -69.38 80.28 0.38 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.886 1.674 . . . . 0.0 112.025 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 43.9 p -64.03 28.04 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.763 2.425 . . . . 0.0 116.151 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.3 tp -134.49 -10.21 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 127.638 2.375 . . . . 0.0 112.456 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 174.51 146.25 5.6 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.76 1.172 . . . . 0.0 111.902 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 C-N-CA 125.558 1.543 . . . . 0.0 111.343 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.2 m -98.09 2.07 48.29 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.378 1.071 . . . . 0.0 112.984 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.48 82.0 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.074 0.852 . . . . 0.0 112.928 175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.38 135.99 37.57 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.473 1.033 . . . . 0.0 108.974 168.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.1 t -52.76 167.69 0.14 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.143 1.777 . . . . 0.0 114.658 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.92 100.16 0.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.283 1.833 . . . . 0.0 110.204 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 293' ' ' LYS . 8.3 mptt -61.09 127.93 33.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.573 2.349 . . . . 0.0 110.995 -168.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.06 -42.93 1.18 Allowed Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.937 1.256 . . . . 0.0 113.662 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 58.3 m -63.28 -5.91 3.95 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.791 2.436 . . . . 0.0 114.04 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 45.1 m -126.43 152.99 45.65 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -78.15 173.56 12.11 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.492 1.517 . . . . 0.0 112.261 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.34 158.28 29.57 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 51.0 mtm -88.9 154.48 20.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.899 2.08 . . . . 0.0 111.52 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.5 m -72.35 141.15 48.78 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.68 -0.637 . . . . 0.0 111.937 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.9 p -132.7 6.56 4.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -68.89 160.82 29.99 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.195 1.362 . . . . 0.0 109.975 160.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.58 95.66 0.23 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.692 1.597 . . . . 0.0 111.9 -169.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 65.6 mtp -80.45 172.62 13.53 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.203 1.401 . . . . 0.0 113.149 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 28.2 m -158.58 170.68 21.65 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.85 1.26 . . . . 0.0 110.45 160.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.55 123.94 36.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.405 0.682 . . . . 0.0 110.936 170.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 63.6 t -67.43 -36.34 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.583 1.553 . . . . 0.0 109.925 165.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -136.44 108.87 7.36 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 126.484 1.914 . . . . 0.0 107.724 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -59.49 143.88 85.27 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.959 0.904 . . . . 0.0 110.151 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.62 140.48 86.87 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.596 2.197 . . . . 0.0 111.612 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 389' ' ' TRP . 43.3 p -136.87 130.79 32.27 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.455 1.502 . . . . 0.0 109.71 173.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.93 134.14 52.35 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 124.262 0.976 . . . . 0.0 112.694 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 43.5 p -82.26 -18.34 42.8 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.23 1.012 . . . . 0.0 113.267 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 60.9 22.5 60.17 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.192 0.905 . . . . 0.0 112.55 -163.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -121.38 13.94 11.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.071 1.748 . . . . 0.0 111.024 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 103.07 -3.86 48.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.876 1.703 . . . . 0.0 114.119 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 25.9 p -127.63 161.9 27.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.961 1.38 . . . . 0.0 112.797 -165.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.72 135.12 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.648 1.579 . . . . 0.0 108.601 162.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.63 125.65 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.223 1.009 . . . . 0.0 112.841 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 18.7 ptm -146.01 158.36 43.87 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.941 1.696 . . . . 0.0 113.389 -166.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -138.35 137.47 37.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.921 1.288 . . . . 0.0 109.423 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 362' ' ' GLU . 35.4 m -124.27 149.1 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.877 1.271 . . . . 0.0 110.994 -169.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -116.11 134.32 55.06 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.965 1.706 . . . . 0.0 111.359 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.82 148.52 37.53 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.267 1.427 . . . . 0.0 108.374 163.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -105.87 -70.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.252 2.635 . . . . 0.0 116.201 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.09 168.44 19.81 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 120.129 -1.607 . . . . 0.0 113.591 -170.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.44 -16.77 0.09 OUTLIER Glycine 0 CA--C 1.54 1.642 0 C-N-CA 126.641 2.067 . . . . 0.0 117.501 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -119.48 91.76 44.92 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 119.305 1.553 . . . . 0.0 113.153 -163.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.35 131.62 19.34 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.977 1.784 . . . . 0.0 108.577 152.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 1.6 p -161.76 159.06 26.7 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.397 -0.814 . . . . 0.0 112.406 -170.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -73.55 132.19 42.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.896 1.678 . . . . 0.0 108.608 164.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.4 pp -62.66 111.58 5.04 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 118.692 0.678 . . . . 0.0 112.7 -168.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -89.74 75.17 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.251 3.301 . . . . 0.0 112.751 -163.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.95 130.27 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 167.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.83 158.99 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.135 0.974 . . . . 0.0 109.857 172.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.54 116.61 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.765 2.026 . . . . 0.0 106.314 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.34 161.61 31.97 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -160.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.02 -11.49 52.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.124 2.17 . . . . 0.0 112.784 169.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.51 136.64 51.06 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.145 1.778 . . . . 0.0 109.621 176.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.6 mp -60.11 -18.49 47.68 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -94.27 -1.01 54.66 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.126 2.17 . . . . 0.0 114.569 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 46.56 79.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.851 2.46 . . . . 0.0 115.933 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -103.71 -32.64 9.27 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.381 1.472 . . . . 0.0 111.864 158.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.98 115.48 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.628 1.104 . . . . 0.0 110.609 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.03 111.82 22.63 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.029 0.932 . . . . 0.0 113.06 -173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -86.38 -25.15 25.49 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 130.15 3.38 . . . . 0.0 114.459 -170.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -113.15 -163.93 15.74 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 115.766 1.066 . . . . 0.0 115.766 -169.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.62 137.85 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 127.904 2.481 . . . . 0.0 110.415 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.5 mt -74.81 134.49 41.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.757 164.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.0 t -104.78 -49.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.581 0.753 . . . . 0.0 110.356 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 37.5 m -71.66 155.79 40.1 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.118 0.485 . . . . 0.0 110.204 166.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.15 157.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.391 1.076 . . . . 0.0 112.562 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -121.96 75.71 39.01 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.486 1.114 . . . . 0.0 111.136 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -79.98 -164.22 0.27 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.458 3.439 . . . . 0.0 112.284 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.6 pt -96.73 162.24 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.791 1.637 . . . . 0.0 111.958 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.16 112.11 4.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.118 0.967 . . . . 0.0 108.657 157.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 98.9 p -63.77 -30.04 71.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.711 1.204 . . . . 0.0 113.059 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 12.2 m -137.23 155.96 48.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 128.259 2.624 . . . . 0.0 106.691 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -57.74 -19.55 28.49 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -97.09 10.68 38.66 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.331 1.452 . . . . 0.0 113.408 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -60.37 158.23 12.26 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 120.061 -1.649 . . . . 0.0 114.037 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 11.2 pt-20 -145.2 77.83 1.53 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.62 147.85 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.655 1.182 . . . . 0.0 112.171 -172.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 26.6 tp -105.37 132.33 51.7 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 129.709 3.203 . . . . 0.0 110.106 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.7 mp -144.41 138.88 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.859 1.664 . . . . 0.0 111.123 -167.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -99.45 135.69 40.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.821 1.248 . . . . 0.0 111.462 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.15 163.19 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.787 1.235 . . . . 0.0 110.873 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -119.03 112.88 35.98 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.771 2.028 . . . . 0.0 109.587 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.18 153.22 16.41 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 122.934 2.423 . . . . 0.0 111.159 158.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.76 174.27 4.77 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.124 2.549 . . . . 0.0 112.974 165.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.77 140.84 56.23 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.491 1.116 . . . . 0.0 110.155 164.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 96.4 -148.68 19.08 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.3 163.29 23.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.143 0.977 . . . . 0.0 113.451 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 37.6 m -163.17 161.59 25.12 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.792 -1.193 . . . . 0.0 110.785 158.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -121.27 114.87 21.98 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 15.0 mm -83.73 121.58 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.75 141.41 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.656 0.782 . . . . 0.0 109.688 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 81.6 t -122.86 104.36 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 126.353 1.861 . . . . 0.0 108.483 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.59 177.37 20.72 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 122.703 1.169 . . . . 0.0 114.575 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 98.8 m -130.31 164.29 24.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.353 1.461 . . . . 0.0 109.104 165.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.49 -171.53 53.03 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 122.031 0.795 . . . . 0.0 113.068 -173.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -29.98 59.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.099 1.76 . . . . 0.0 113.325 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.8 m -66.68 -11.48 54.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -74.43 123.35 24.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.184 1.356 . . . . 0.0 113.037 -169.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 14.2 mt -84.49 163.29 19.51 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.895 0.478 . . . . 0.0 111.201 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 t -138.41 148.15 44.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.893 1.277 . . . . 0.0 111.12 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -147.58 111.38 5.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.318 1.447 . . . . 0.0 110.611 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 134.24 50.23 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.532 1.133 . . . . 0.0 112.353 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' TRP . . . . . 0.408 ' CZ2' ' HA ' ' A' ' 311' ' ' THR . 11.1 m95 -126.0 162.97 24.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.277 1.431 . . . . 0.0 112.671 166.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.04 133.51 33.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.164 2.185 . . . . 0.0 108.158 171.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' LYS . . . . . 0.466 ' HZ2' ' CD ' ' A' ' 392' ' ' GLU . 0.0 OUTLIER -122.52 140.12 53.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.899 1.279 . . . . 0.0 110.917 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLU . . . . . 0.466 ' CD ' ' HZ2' ' A' ' 391' ' ' LYS . 7.8 pm0 -56.6 164.1 1.57 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 129.016 2.926 . . . . 0.0 114.104 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 123.08 43.75 0.35 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.696 0.665 . . . . 0.0 114.249 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 16.4 t -84.93 178.53 7.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.352 1.076 . . . . 0.0 111.215 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 26.0 t -61.09 1.18 0.18 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.126 1.77 . . . . 0.0 115.059 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.22 7.15 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 127.402 2.281 . . . . 0.0 111.477 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 96.88 -78.86 0.69 Allowed Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.506 1.527 . . . . 0.0 112.79 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp . . . . . 0 C--O 1.257 1.454 0 CA-C-O 116.953 -1.498 . . . . 0.0 109.441 175.611 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 60.3 p -103.45 -6.54 21.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.691 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -49.16 -57.43 6.7 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.386 1.075 . . . . 0.0 112.55 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.47 124.18 21.61 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 163.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.1 t -50.84 164.61 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.579 1.952 . . . . 0.0 115.687 -165.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.525 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.1 mm? -59.07 102.91 0.14 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.272 1.829 . . . . 0.0 110.471 -172.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -60.95 135.53 57.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.02 2.128 . . . . 0.0 111.018 -168.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 73.5 -47.56 1.44 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.533 1.063 . . . . 0.0 113.343 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.7 m -63.41 -16.58 60.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.548 1.939 . . . . 0.0 113.467 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -124.99 143.84 50.69 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.119 1.368 . . . . 0.0 112.241 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -73.47 173.31 9.82 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.872 0.869 . . . . 0.0 112.025 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -68.17 160.93 28.12 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.344 1.058 . . . . 0.0 113.675 -175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 46.3 mtt -88.7 158.4 18.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.894 1.677 . . . . 0.0 112.379 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.0 m -70.82 140.94 51.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.221 0.608 . . . . 0.0 111.906 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 13.3 p -123.21 9.07 9.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.37 1.068 . . . . 0.0 113.289 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -70.15 161.31 30.46 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.624 -0.672 . . . . 0.0 111.067 164.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -65.7 91.97 0.14 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.525 1.93 . . . . 0.0 111.433 -167.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 5.8 mtp -76.7 167.13 22.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.767 1.27 . . . . 0.0 113.413 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 27.7 m -159.63 173.6 15.85 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.062 1.345 . . . . 0.0 110.249 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -109.01 128.99 55.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.35 1.06 . . . . 0.0 111.09 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.5 -33.88 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.737 1.615 . . . . 0.0 109.68 163.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -138.9 124.73 19.77 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.097 1.359 . . . . 0.0 109.988 169.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -62.83 143.78 96.93 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.253 1.421 . . . . 0.0 112.061 169.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -58.56 132.07 46.15 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.587 2.191 . . . . 0.0 112.607 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.1 142.86 44.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.534 0.734 . . . . 0.0 110.335 172.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -66.83 134.85 52.94 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.035 0.934 . . . . 0.0 112.836 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.6 p -79.9 -20.94 44.63 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.076 1.351 . . . . 0.0 113.341 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 88.76 -12.37 65.84 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.661 1.601 . . . . 0.0 113.89 -166.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -90.12 9.44 28.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.523 1.529 . . . . 0.0 112.137 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 83.84 14.75 71.96 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 121.127 -0.983 . . . . 0.0 114.054 -171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.7 p -125.02 158.28 34.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.554 1.142 . . . . 0.0 110.929 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.83 131.07 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.045 1.338 . . . . 0.0 109.706 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.06 131.38 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.232 1.413 . . . . 0.0 111.804 -172.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 4.5 ptp -143.29 165.61 27.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.786 2.034 . . . . 0.0 111.858 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -136.96 132.12 33.94 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.473 -0.767 . . . . 0.0 109.5 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.6 m -113.44 163.97 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.386 1.075 . . . . 0.0 111.749 -168.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -125.12 115.53 20.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.358 1.463 . . . . 0.0 110.624 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 t -91.61 134.54 29.11 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 116.857 -1.544 . . . . 0.0 107.343 165.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -97.02 -80.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.447 0 C-N-CA 122.525 2.15 . . . . 0.0 116.381 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.13 144.97 21.51 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 119.25 -2.156 . . . . 0.0 115.878 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 88.54 0.53 81.96 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.87 1.224 . . . . 0.0 115.23 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.67 98.3 45.85 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.989 1.316 . . . . 0.0 111.486 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.54 123.36 10.1 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.3 2.0 . . . . 0.0 108.433 161.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.9 p -157.0 157.35 34.55 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.128 0.966 . . . . 0.0 113.251 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -69.83 138.82 52.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.075 1.75 . . . . 0.0 108.776 162.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 1.0 OUTLIER -62.42 121.77 69.08 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 118.721 0.691 . . . . 0.0 111.855 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 11.9 Cg_endo -99.98 95.69 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.649 2.233 . . . . 0.0 114.768 -155.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.72 141.98 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.02 0.928 . . . . 0.0 110.932 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.31 159.59 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.95 1.7 . . . . 0.0 110.309 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.4 t -133.35 97.91 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.284 1.834 . . . . 0.0 108.028 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -111.9 160.98 16.88 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -165.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -81.98 -17.2 47.74 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.859 1.664 . . . . 0.0 112.614 162.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -123.89 138.66 54.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.633 1.173 . . . . 0.0 111.745 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.68 -18.65 32.67 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.11 1.364 . . . . 0.0 113.314 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.4 t -91.53 -4.17 55.71 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.124 1.769 . . . . 0.0 114.388 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.51 70.05 0.32 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.133 2.173 . . . . 0.0 114.555 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -104.09 -14.57 15.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.951 0.9 . . . . 0.0 111.929 163.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 56.5 mt -111.74 155.83 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.702 1.601 . . . . 0.0 108.373 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -141.73 123.01 14.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.725 -1.234 . . . . 0.0 112.414 170.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -116.69 -11.38 11.0 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -96.65 -172.59 34.83 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.415 0.926 . . . . 0.0 115.415 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 23.3 mt -126.45 138.06 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.924 2.089 . . . . 0.0 110.775 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 50.5 mt -68.85 132.39 46.68 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.616 0.766 . . . . 0.0 109.815 163.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.42 -41.56 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 118.411 0.551 . . . . 0.0 112.05 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 59.9 m -76.88 145.8 38.08 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.655 0.661 . . . . 0.0 109.379 159.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 25.4 t -63.38 154.51 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.444 1.098 . . . . 0.0 111.44 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -117.98 82.99 18.17 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.21 1.404 . . . . 0.0 112.204 -174.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -85.42 -154.34 0.05 OUTLIER 'Trans proline' 0 CA--C 1.554 1.487 0 C-N-CA 125.24 3.96 . . . . 0.0 112.66 172.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.9 pt -107.33 166.6 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.171 2.189 . . . . 0.0 111.761 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.25 118.02 12.54 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 158.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 85.4 p -74.71 -44.11 51.66 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.149 1.38 . . . . 0.0 112.521 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.75 155.14 20.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.005 1.722 . . . . 0.0 108.623 158.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -59.77 -26.49 65.75 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -91.37 9.93 29.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.508 1.523 . . . . 0.0 113.068 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -60.08 150.89 28.08 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.45 -1.406 . . . . 0.0 114.252 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.24 88.84 2.45 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 66.0 t -100.56 144.91 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.16 1.384 . . . . 0.0 111.834 -162.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.6 tp -95.73 126.43 40.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.799 2.84 . . . . 0.0 109.774 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.57 154.04 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.698 1.199 . . . . 0.0 110.812 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.29 148.2 50.64 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 124.712 1.205 . . . . 0.0 111.229 165.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.59 154.09 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.38 1.472 . . . . 0.0 110.686 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.9 109.84 59.21 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.621 1.569 . . . . 0.0 109.126 173.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.78 144.62 31.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.236 1.958 . . . . 0.0 111.43 163.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.13 168.3 25.12 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.173 2.582 . . . . 0.0 110.852 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -56.76 134.72 55.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.645 1.178 . . . . 0.0 111.897 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.63 -148.62 19.18 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.195 0.902 . . . . 0.0 112.685 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.73 147.71 22.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.16 2.184 . . . . 0.0 113.786 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 29.7 m -163.44 154.12 16.16 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.273 1.429 . . . . 0.0 113.042 159.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -117.22 105.27 12.04 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.666 1.586 . . . . 0.0 108.955 172.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 20.5 mm -78.48 116.57 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 30.3 mt -121.84 139.51 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.118 0.485 . . . . 0.0 110.524 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 68.9 t -115.31 114.49 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.38 1.872 . . . . 0.0 107.886 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 99.89 177.63 30.73 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 122.81 1.228 . . . . 0.0 114.756 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 94.5 m -127.31 163.69 23.4 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.064 1.746 . . . . 0.0 109.767 167.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.41 -173.7 52.85 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 121.746 0.637 . . . . 0.0 113.265 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -25.67 64.44 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.329 1.452 . . . . 0.0 113.251 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.5 m -64.86 -13.72 57.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 170.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -74.11 136.95 42.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.07 1.304 . . . . 0.0 112.266 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 17.3 mt -104.43 154.78 19.44 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.406 0.682 . . . . 0.0 110.607 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.6 t -129.0 145.61 51.2 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.525 1.13 . . . . 0.0 112.161 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -146.16 108.63 4.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.465 1.506 . . . . 0.0 109.585 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -65.21 137.99 57.95 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.607 1.163 . . . . 0.0 111.759 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -142.07 126.19 17.4 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.727 1.211 . . . . 0.0 111.36 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -96.8 131.89 43.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.818 0.847 . . . . 0.0 109.731 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -104.17 115.84 31.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.589 1.555 . . . . 0.0 110.663 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.49 159.5 15.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.251 2.221 . . . . 0.0 112.184 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -75.26 38.7 1.18 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.239 1.4 . . . . 0.0 114.533 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.53 -62.79 0.69 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.133 1.773 . . . . 0.0 111.094 -172.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.1 m -80.2 51.24 1.36 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.436 1.895 . . . . 0.0 110.334 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.7 tp -121.86 -9.12 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 129.599 3.16 . . . . 0.0 111.042 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -144.73 34.44 1.58 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.523 1.535 . . . . 0.0 114.272 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.138 0 C-N-CA 125.282 1.433 . . . . 0.0 109.036 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 117.813 -1.089 . . . . 0.0 113.805 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.1 p -98.98 -7.38 27.03 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.137 1.335 . . . . 0.0 114.393 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.12 -48.37 70.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.678 1.191 . . . . 0.0 112.851 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.08 121.22 14.65 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 2.3 t -52.07 168.85 0.08 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.264 1.826 . . . . 0.0 115.153 -168.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.1 109.88 0.66 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.132 1.773 . . . . 0.0 110.635 -171.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -69.7 138.98 53.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.458 1.903 . . . . 0.0 110.738 -165.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 64.66 -59.35 0.07 OUTLIER Glycine 0 CA--C 1.534 1.246 0 C-N-CA 127.57 2.509 . . . . 0.0 113.836 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 40.4 p -47.03 -21.92 0.28 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 130.951 3.7 . . . . 0.0 115.817 168.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' SER . . . . . 0.508 ' HB2' ' HE3' ' A' ' 331' ' ' LYS . 2.6 p -145.24 161.97 38.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.863 1.211 . . . . 0.0 113.096 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -81.35 170.32 16.15 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -163.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 162.08 29.44 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.477 1.132 . . . . 0.0 113.994 -176.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 43.6 mtt -80.46 161.37 24.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.246 2.218 . . . . 0.0 113.162 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 8.1 m -72.26 146.56 47.15 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.585 -0.697 . . . . 0.0 112.089 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.8 p -136.69 8.39 3.06 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -78.5 158.57 28.56 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.139 1.336 . . . . 0.0 110.013 159.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 101.68 0.14 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.903 1.281 . . . . 0.0 112.006 -168.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 38.2 mtp -81.89 165.91 20.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.684 0.793 . . . . 0.0 112.073 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.7 p -147.93 159.36 43.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.941 0.897 . . . . 0.0 111.455 168.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -77.76 118.64 20.31 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 169.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.23 -30.31 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.225 0.61 . . . . 0.0 109.918 161.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -144.62 130.38 19.15 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.746 1.619 . . . . 0.0 109.125 168.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -63.62 153.09 84.46 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.526 0.73 . . . . 0.0 112.078 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.07 127.31 19.95 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.761 2.307 . . . . 0.0 110.962 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 48.3 p -126.22 133.66 51.44 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.873 1.269 . . . . 0.0 110.952 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -63.69 133.98 54.57 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.186 1.794 . . . . 0.0 112.277 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 6.4 p -71.68 -19.98 62.0 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 165.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.69 17.41 67.01 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-N 118.733 0.697 . . . . 0.0 112.198 -164.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -128.44 9.56 6.08 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.086 1.754 . . . . 0.0 111.616 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.98 6.75 36.82 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.12 -1.378 . . . . 0.0 114.861 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.4 p -128.54 160.38 32.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.789 1.794 . . . . 0.0 112.687 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.2 m -130.43 132.84 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.456 1.502 . . . . 0.0 109.778 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.5 p -120.23 129.85 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.953 1.301 . . . . 0.0 112.958 -169.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 5.8 ptp -140.53 166.33 25.03 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.768 1.627 . . . . 0.0 112.833 -172.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -132.27 138.65 47.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.297 1.039 . . . . 0.0 110.083 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.8 151.29 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.356 1.062 . . . . 0.0 110.776 -169.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -107.8 127.88 54.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.06 1.344 . . . . 0.0 110.577 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.41 138.81 20.01 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 117.257 -1.354 . . . . 0.0 107.734 162.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -104.79 -75.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.427 2.085 . . . . 0.0 115.325 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.47 174.67 10.55 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.042 -1.661 . . . . 0.0 114.274 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.21 3.21 17.1 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 116.952 1.541 . . . . 0.0 116.952 170.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.11 95.1 37.45 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 119.038 1.419 . . . . 0.0 112.9 -162.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -72.1 124.31 9.94 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.103 1.869 . . . . 0.0 108.659 159.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.0 p -161.68 156.64 23.33 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -173.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 296' ' ' SER . 14.1 tptp -73.54 135.68 43.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.837 2.855 . . . . 0.0 109.418 162.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 14.6 pt -63.45 124.25 83.77 Favored Pre-proline 0 N--CA 1.479 1.005 0 CA-C-N 119.85 1.205 . . . . 0.0 111.409 -171.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -105.77 89.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 121.622 1.548 . . . . 0.0 114.57 -157.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 74.3 t -125.98 132.04 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.884 0.873 . . . . 0.0 109.531 173.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.8 158.53 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.859 1.264 . . . . 0.0 110.674 -172.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 35.4 t -127.1 126.75 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.057 1.743 . . . . 0.0 107.552 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -132.01 161.45 33.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.902 1.281 . . . . 0.0 112.795 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.97 -22.65 33.66 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.749 1.22 . . . . 0.0 112.333 166.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -107.61 154.79 20.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.267 1.427 . . . . 0.0 111.479 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.69 -19.28 63.72 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.6 t -117.82 7.06 12.34 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.677 1.191 . . . . 0.0 113.951 -167.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 47.15 70.2 0.43 Allowed 'General case' 0 C--O 1.238 0.497 0 C-N-CA 127.974 2.51 . . . . 0.0 114.691 -170.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -83.81 -43.35 15.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.286 1.034 . . . . 0.0 111.158 154.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 43.4 mm -86.93 153.44 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.585 1.154 . . . . 0.0 109.959 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . 0.263 0.0 OUTLIER -125.15 96.4 4.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 123.171 1.462 . . . . 0.0 110.707 171.237 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -78.2 -55.56 5.17 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 128.732 2.813 . . . . 0.0 111.869 -169.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.28 -168.12 41.38 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.438 1.494 . . . . 0.0 116.273 -166.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.1 mt -124.11 139.91 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 126.604 1.961 . . . . 0.0 111.152 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.65 125.24 26.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.594 1.158 . . . . 0.0 110.487 168.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.5 t -104.15 -54.04 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.528 0.731 . . . . 0.0 109.286 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 50.0 m -71.76 140.61 49.57 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 167.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.67 150.63 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.887 1.275 . . . . 0.0 112.369 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -125.0 70.84 61.28 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.59 1.156 . . . . 0.0 112.556 -167.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.85 -167.12 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.73 3.62 . . . . 0.0 112.575 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.7 pt -83.34 160.35 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.694 1.198 . . . . 0.0 112.748 173.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.1 110.75 4.67 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 156.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.2 p -66.88 -33.06 74.77 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.071 1.749 . . . . 0.0 112.696 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.09 146.8 50.25 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.749 2.02 . . . . 0.0 108.06 167.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -59.84 -17.9 39.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -91.3 0.72 57.48 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.683 1.993 . . . . 0.0 112.758 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.06 151.69 30.15 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.45 -1.406 . . . . 0.0 113.068 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -136.57 82.72 1.96 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.174 0.987 . . . . 0.0 112.963 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 43.9 t -99.42 153.1 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.288 1.435 . . . . 0.0 111.582 -164.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.53 128.68 55.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.217 2.207 . . . . 0.0 109.778 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.1 mp -135.87 141.38 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.401 1.48 . . . . 0.0 109.035 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -114.9 149.6 36.95 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 122.078 0.942 . . . . 0.0 112.85 161.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.23 158.37 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.867 1.667 . . . . 0.0 110.883 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -109.01 102.68 49.72 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.588 1.955 . . . . 0.0 109.638 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.8 145.42 20.08 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.194 2.596 . . . . 0.0 110.815 166.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.82 176.67 9.73 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.002 2.468 . . . . 0.0 111.185 164.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -63.45 152.8 37.3 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.268 1.427 . . . . 0.0 113.739 -171.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 89.46 -162.06 30.34 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.844 1.212 . . . . 0.0 112.257 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.79 159.21 31.28 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.322 1.058 . . . . 0.0 111.81 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 73.2 m -160.33 164.88 32.17 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.151 -1.593 . . . . 0.0 111.174 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -120.86 116.49 25.28 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.849 1.26 . . . . 0.0 109.008 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 24.1 mm -85.38 120.2 35.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 124.714 1.206 . . . . 0.0 107.884 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.62 140.31 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.448 0.699 . . . . 0.0 110.092 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 76.3 t -115.18 115.08 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 126.79 2.036 . . . . 0.0 108.067 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 97.89 179.39 33.2 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 123.442 1.579 . . . . 0.0 115.622 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 29.8 m -134.2 163.66 29.11 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.194 1.398 . . . . 0.0 109.935 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.09 -174.14 54.63 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 122.148 0.86 . . . . 0.0 112.85 -170.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -27.69 61.65 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.855 1.662 . . . . 0.0 112.794 172.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.8 m -65.41 -12.08 48.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -74.62 138.65 43.09 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.753 1.16 . . . . 0.0 111.981 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 21.1 mt -103.86 162.41 13.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.987 0.915 . . . . 0.0 110.973 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.7 t -142.1 146.44 35.4 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.45 1.1 . . . . 0.0 111.664 -172.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -145.39 119.98 9.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.794 1.638 . . . . 0.0 109.931 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -71.01 129.07 38.05 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.579 0.752 . . . . 0.0 111.782 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -123.76 159.21 29.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.731 1.212 . . . . 0.0 111.636 170.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -133.65 118.74 18.53 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.943 1.697 . . . . 0.0 109.033 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -120.8 120.73 36.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.611 1.564 . . . . 0.0 111.09 -167.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -1.03 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 131.446 3.898 . . . . 0.0 116.236 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -89.36 -14.08 60.71 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.031 0.824 . . . . 0.0 112.993 167.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.1 p -115.26 75.91 0.97 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.005 1.722 . . . . 0.0 108.705 172.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 97.5 p -54.54 -30.24 53.33 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -164.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.796 HD13 ' H ' ' A' ' 396' ' ' ILE . 0.1 OUTLIER -71.17 62.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.975 1.31 . . . . 0.0 110.632 160.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 136.59 -88.44 0.22 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.82 1.2 . . . . 0.0 115.134 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 398' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.189 0 CA-C-O 115.573 -2.155 . . . . 0.0 113.32 -163.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 118.169 -0.919 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 19.2 t -111.46 -2.09 15.67 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.46 -47.69 75.26 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.256 1.389 . . . . 0.0 112.275 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.403 HD22 ' HE3' ' A' ' 293' ' ' LYS . 4.0 tt -68.13 123.84 21.8 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 159.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 4.8 t -50.01 167.66 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.425 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.3 mm? -63.06 113.65 3.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.507 1.923 . . . . 0.0 110.735 -172.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 295' ' ' THR . 8.6 mptt -62.37 132.97 54.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.444 1.897 . . . . 0.0 110.384 -174.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 65.18 -27.19 0.12 Allowed Glycine 0 CA--C 1.543 1.786 0 C-N-CA 126.757 2.122 . . . . 0.0 115.488 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 293' ' ' LYS . 43.8 m -87.39 -13.64 42.85 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 130.599 3.56 . . . . 0.0 112.068 -173.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.4 m -155.88 153.88 30.38 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 119.853 -1.779 . . . . 0.0 113.569 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -75.54 178.75 5.75 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.43 1.892 . . . . 0.0 114.538 -168.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.86 159.81 14.79 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.822 1.649 . . . . 0.0 114.199 -168.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.27 158.43 26.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.481 2.712 . . . . 0.0 114.873 -170.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.8 m -78.88 145.01 34.39 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.79 0.836 . . . . 0.0 110.585 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 14.17 3.92 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.415 1.086 . . . . 0.0 113.224 167.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -67.66 159.33 30.23 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.818 153.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.5 109.48 4.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.316 0.646 . . . . 0.0 111.064 -167.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 69.9 mtp -95.27 162.25 13.76 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.312 1.053 . . . . 0.0 112.431 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.4 p -151.42 159.47 44.21 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.239 1.416 . . . . 0.0 109.534 166.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.75 129.94 34.8 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 122.045 -0.409 . . . . 0.0 109.904 166.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.66 -29.07 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.118 0.967 . . . . 0.0 109.989 162.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -145.82 133.5 21.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.899 1.68 . . . . 0.0 109.999 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -66.47 147.38 98.97 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.986 0.914 . . . . 0.0 112.465 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.72 133.54 57.0 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.633 2.222 . . . . 0.0 112.186 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 21.7 p -132.89 142.34 48.87 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.976 1.711 . . . . 0.0 110.126 169.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.0 130.3 46.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.649 0.738 . . . . 0.0 110.675 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 75.0 p -78.29 -18.74 54.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.495 1.918 . . . . 0.0 113.034 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 82.62 -4.3 79.22 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.367 0.985 . . . . 0.0 113.845 -163.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -84.25 -0.48 52.46 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 119.612 1.706 . . . . 0.0 111.88 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 76.69 36.22 38.15 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.91 1.243 . . . . 0.0 111.539 -165.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.6 p -146.69 164.16 33.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.194 2.198 . . . . 0.0 108.403 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.26 134.06 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.305 1.442 . . . . 0.0 110.657 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.1 133.5 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.438 1.095 . . . . 0.0 113.611 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.0 ptm -145.94 163.56 34.76 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.224 2.21 . . . . 0.0 112.11 -169.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -130.58 144.22 51.27 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.377 0.671 . . . . 0.0 110.06 172.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 362' ' ' GLU . 4.0 m -134.15 146.45 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.145 0.978 . . . . 0.0 111.461 -167.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -109.8 131.04 55.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.989 1.716 . . . . 0.0 111.078 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 14.3 t -108.43 143.32 27.24 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-O 116.973 -1.489 . . . . 0.0 108.156 163.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -101.13 -75.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.506 0 C-N-CA 122.259 1.972 . . . . 0.0 116.843 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 169.13 21.72 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 121.342 1.883 . . . . 0.0 114.771 -173.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 68.99 -5.41 4.74 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.542 1.544 . . . . 0.0 116.639 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -125.64 103.85 27.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.768 1.284 . . . . 0.0 112.67 -164.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -76.56 134.61 15.46 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.984 1.789 . . . . 0.0 109.055 160.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.3 p -158.23 155.15 28.45 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.371 -0.83 . . . . 0.0 112.918 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -77.84 136.98 38.16 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 159.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -58.62 117.28 19.42 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-N 118.783 0.719 . . . . 0.0 111.876 -171.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -97.03 102.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.925 3.083 . . . . 0.0 113.039 -167.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.5 139.13 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.446 1.099 . . . . 0.0 108.909 170.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 3.1 mt -136.96 143.84 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.631 1.173 . . . . 0.0 108.575 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 45.3 t -119.26 108.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.433 1.093 . . . . 0.0 108.187 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -124.36 161.33 26.15 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -162.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.81 -6.96 59.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.221 2.608 . . . . 0.0 112.361 168.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -139.8 149.73 43.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.129 1.772 . . . . 0.0 111.431 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 20.4 mt -64.48 -24.63 67.68 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.672 1.189 . . . . 0.0 113.371 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.4 t -96.07 4.74 52.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.877 1.271 . . . . 0.0 113.72 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.2 75.08 0.1 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.225 3.01 . . . . 0.0 115.652 -171.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.94 -35.01 12.17 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.844 2.057 . . . . 0.0 111.786 164.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.91 153.26 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.747 1.219 . . . . 0.0 109.84 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.92 103.55 5.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.033 -1.042 . . . . 0.0 111.316 175.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -103.85 -13.22 16.48 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -174.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -102.52 -174.38 27.15 Favored Glycine 0 CA--C 1.536 1.403 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.01 144.2 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 127.774 2.43 . . . . 0.0 110.913 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 353' ' ' ASN . 0.6 OUTLIER -77.32 130.35 37.04 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.527 1.131 . . . . 0.0 109.485 165.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -46.97 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 118.99 -0.529 . . . . 0.0 111.122 176.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 32.2 m -65.92 150.66 48.27 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.773 160.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.0 156.98 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.818 1.247 . . . . 0.0 111.951 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.412 ' HB2' HD13 ' A' ' 349' ' ' LEU . 23.2 t-20 -114.9 80.94 7.04 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.387 1.475 . . . . 0.0 111.185 -173.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -80.24 -172.99 1.68 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.143 2.562 . . . . 0.0 112.25 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 28.0 pt -93.5 176.41 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.713 1.605 . . . . 0.0 110.868 167.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.43 113.12 7.25 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 153.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.9 p -67.01 -32.18 73.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.801 1.64 . . . . 0.0 112.871 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.39 152.3 51.72 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.719 2.808 . . . . 0.0 108.159 168.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -63.17 -23.33 67.38 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.589 -1.32 . . . . 0.0 114.245 -173.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -86.26 4.79 37.32 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.935 1.294 . . . . 0.0 113.443 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.79 150.1 7.85 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 6.5 pt-20 -135.34 85.88 2.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.535 -1.212 . . . . 0.0 114.122 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 4.4 t -93.13 140.8 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.029 1.332 . . . . 0.0 111.501 -167.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -101.33 121.06 41.23 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 129.179 2.991 . . . . 0.0 109.064 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 1.8 mp -140.81 146.22 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.239 1.416 . . . . 0.0 110.713 -169.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -114.39 139.13 49.74 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.6 1.16 . . . . 0.0 112.608 166.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.94 159.18 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.132 1.773 . . . . 0.0 111.211 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -113.68 108.1 52.05 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.691 1.996 . . . . 0.0 109.453 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.36 150.67 25.58 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.314 2.009 . . . . 0.0 110.315 166.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -59.15 164.77 9.89 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.451 1.434 . . . . 0.0 111.244 163.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -65.57 140.86 58.57 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.711 -0.618 . . . . 0.0 110.473 167.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.49 -151.46 18.22 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.158 0.409 . . . . 0.0 112.427 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -74.46 161.11 30.12 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.447 1.117 . . . . 0.0 112.9 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 24.1 m -170.1 162.08 8.8 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.43 1.892 . . . . 0.0 111.264 166.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -128.61 127.45 42.28 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.446 1.898 . . . . 0.0 107.138 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 23.3 mm -95.15 118.14 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.7 140.04 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.019 0.928 . . . . 0.0 110.503 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 97.2 t -106.36 122.9 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 126.06 1.744 . . . . 0.0 108.359 168.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 85.97 179.85 49.91 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 123.444 1.58 . . . . 0.0 116.335 168.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 72.0 m -138.76 171.69 13.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.974 1.31 . . . . 0.0 109.96 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 85.39 -154.68 28.86 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -171.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -26.32 64.57 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.748 0.819 . . . . 0.0 112.189 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.9 m -76.79 -6.43 52.26 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 129.127 2.971 . . . . 0.0 115.24 -164.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -75.24 124.58 27.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.752 0.421 . . . . 0.0 112.059 -167.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.78 158.58 15.82 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.479 0.312 . . . . 0.0 110.422 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.1 t -131.42 154.24 48.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.434 1.094 . . . . 0.0 111.913 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -142.69 126.14 16.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.158 1.783 . . . . 0.0 109.553 171.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.89 127.29 31.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.361 1.464 . . . . 0.0 111.558 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -136.22 117.78 14.87 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.217 1.007 . . . . 0.0 110.953 170.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -119.0 119.97 35.85 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -97.44 132.93 42.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.009 1.724 . . . . 0.0 111.28 -165.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -63.06 161.72 12.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.871 1.668 . . . . 0.0 112.341 172.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -69.66 73.43 0.47 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.227 0.917 . . . . 0.0 111.753 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.36 122.9 18.92 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.903 1.681 . . . . 0.0 112.121 -170.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 79.2 p -58.63 -27.66 64.91 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -167.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 4.8 tt -71.74 -4.8 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.248 1.419 . . . . 0.0 113.377 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.18 -10.26 8.19 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.653 1.597 . . . . 0.0 116.144 165.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.74 2.016 . . . . 0.0 111.274 171.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.7 p -104.19 -2.37 25.83 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.48 89.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.205 0.911 . . . . 0.0 113.124 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.7 tt -75.97 128.41 35.0 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 161.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 2.2 t -52.97 168.56 0.12 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.945 2.098 . . . . 0.0 116.036 -167.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.48 105.44 0.63 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.077 1.751 . . . . 0.0 110.628 -172.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.07 124.91 20.97 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.087 1.355 . . . . 0.0 111.226 -171.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.41 -51.6 2.57 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.998 1.285 . . . . 0.0 112.996 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.3 m -62.89 3.08 0.25 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.549 2.74 . . . . 0.0 114.149 174.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.6 m -156.48 149.47 24.05 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 118.996 -2.315 . . . . 0.0 112.658 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -74.19 171.81 12.92 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.636 1.975 . . . . 0.0 113.557 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.09 163.19 28.09 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.354 1.462 . . . . 0.0 113.055 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 58.0 mtt -93.82 164.12 13.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.138 1.775 . . . . 0.0 113.788 -168.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.8 m -76.23 139.38 41.15 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.315 0.646 . . . . 0.0 111.244 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 6.4 p -133.04 20.07 4.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.574 1.15 . . . . 0.0 113.036 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -82.46 164.68 20.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 158.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.02 95.64 0.12 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.39 1.476 . . . . 0.0 111.847 -175.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 32.7 mtp -80.36 171.79 14.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.665 1.186 . . . . 0.0 112.426 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.7 m -158.93 154.53 26.07 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.184 -0.947 . . . . 0.0 111.965 163.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.4 111.8 14.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.886 0.875 . . . . 0.0 109.744 163.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 20.1 t -66.99 -33.52 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.476 1.11 . . . . 0.0 109.868 166.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -129.45 126.68 39.28 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.859 1.664 . . . . 0.0 108.577 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -62.83 152.86 81.63 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.69 1.196 . . . . 0.0 112.164 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.43 124.63 13.62 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.733 2.289 . . . . 0.0 111.049 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 70.5 p -125.17 136.87 54.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.169 1.388 . . . . 0.0 110.692 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.47 127.04 30.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.238 1.015 . . . . 0.0 111.742 173.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 75.7 p -76.32 -22.31 55.12 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.53 1.532 . . . . 0.0 113.087 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 89.22 -11.37 69.79 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.057 1.789 . . . . 0.0 113.817 -163.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -86.01 2.43 46.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.486 1.515 . . . . 0.0 112.303 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 87.66 15.11 62.19 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.937 0.78 . . . . 0.0 112.86 -167.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.6 p -131.14 158.19 41.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.763 1.225 . . . . 0.0 111.345 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.16 132.05 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.226 1.41 . . . . 0.0 109.727 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.65 134.27 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.516 1.127 . . . . 0.0 113.35 -169.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 3.3 ptp -143.14 160.52 40.26 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.282 1.833 . . . . 0.0 113.174 -173.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -119.15 121.71 40.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.478 1.911 . . . . 0.0 107.806 173.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.78 141.88 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.366 1.066 . . . . 0.0 111.527 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -106.14 132.34 52.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.796 1.639 . . . . 0.0 112.278 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.38 147.18 33.79 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.726 1.61 . . . . 0.0 108.649 163.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -108.97 -72.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.255 2.636 . . . . 0.0 115.386 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.44 170.07 17.6 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.241 -1.537 . . . . 0.0 114.202 -171.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 64.57 -23.32 0.1 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 127.633 2.539 . . . . 0.0 117.77 168.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -107.52 97.45 19.71 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.501 1.52 . . . . 0.0 112.05 -170.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.29 131.23 25.99 Favored 'Trans proline' 0 C--N 1.35 0.631 0 N-CA-C 108.005 -1.575 . . . . 0.0 108.005 157.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.6 p -160.9 157.3 26.32 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -72.23 137.76 47.05 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.343 1.457 . . . . 0.0 108.989 159.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.37 119.08 56.56 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 118.69 0.677 . . . . 0.0 112.196 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -97.38 87.41 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.049 3.166 . . . . 0.0 113.833 -166.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 97.1 t -113.49 131.72 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 164.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.23 153.47 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.484 1.114 . . . . 0.0 110.152 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.46 109.41 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.188 1.795 . . . . 0.0 107.129 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -119.66 164.67 15.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -161.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -89.49 -6.75 56.16 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.824 2.05 . . . . 0.0 112.668 165.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -133.79 144.41 49.0 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.054 1.342 . . . . 0.0 110.677 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.55 -11.75 26.98 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.8 t -113.02 12.03 19.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.964 1.706 . . . . 0.0 113.188 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 39.85 60.11 1.75 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.53 2.732 . . . . 0.0 116.152 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.85 63.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.267 0.627 . . . . 0.0 111.927 155.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 38.0 mt -110.6 155.98 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.126 1.771 . . . . 0.0 109.254 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.45 102.0 6.94 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.312 1.045 . . . . 0.0 110.808 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -77.96 -56.39 4.53 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 129.732 3.213 . . . . 0.0 111.423 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -92.35 -167.64 39.77 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 116.593 1.397 . . . . 0.0 116.593 -166.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.5 mt -116.51 135.48 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.242 1.817 . . . . 0.0 110.546 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.3 mt -72.04 122.29 20.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.615 0.766 . . . . 0.0 109.372 165.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 98.4 t -103.02 -52.62 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.177 0.991 . . . . 0.0 110.235 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 50.4 m -67.02 155.23 39.19 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.198 0.523 . . . . 0.0 110.102 164.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 11.3 m -58.1 159.32 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.151 0.98 . . . . 0.0 112.468 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -118.6 85.02 25.86 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.638 1.175 . . . . 0.0 110.125 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -80.48 -165.16 0.32 Allowed 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 124.502 3.468 . . . . 0.0 113.232 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 31.5 pt -105.04 165.99 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.688 1.995 . . . . 0.0 111.218 172.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.66 102.48 1.2 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 155.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 82.8 p -70.61 -35.77 73.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.305 1.442 . . . . 0.0 112.208 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.5 157.62 33.15 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.815 2.046 . . . . 0.0 109.491 158.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -66.68 -23.46 66.14 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -89.75 7.69 35.56 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.03 0.832 . . . . 0.0 112.648 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -56.61 153.07 10.9 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.878 1.323 . . . . 0.0 112.973 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.67 123.33 12.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.907 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.61 145.95 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.702 0.801 . . . . 0.0 110.254 -159.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.4 tp -95.97 126.58 41.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.443 2.297 . . . . 0.0 109.405 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.3 mp -139.28 132.13 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.492 1.117 . . . . 0.0 109.483 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.81 147.98 32.31 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.96 0.886 . . . . 0.0 112.106 159.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.38 160.86 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.733 1.613 . . . . 0.0 110.702 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -115.32 109.12 46.69 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.94 1.696 . . . . 0.0 111.092 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.74 148.9 20.43 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.932 2.421 . . . . 0.0 111.549 162.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -73.15 172.18 16.07 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.772 2.315 . . . . 0.0 111.103 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -57.34 147.84 24.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.239 0.615 . . . . 0.0 111.668 171.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.35 -136.08 12.52 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.15 162.36 14.36 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.03 1.332 . . . . 0.0 112.736 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 38.5 m -162.18 162.98 28.62 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.777 -1.202 . . . . 0.0 110.716 157.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.84 117.89 25.13 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 21.5 mm -91.03 111.25 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.857 1.263 . . . . 0.0 107.941 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.48 142.57 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.704 0.802 . . . . 0.0 109.547 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 97.8 t -123.29 108.34 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.335 1.854 . . . . 0.0 108.765 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.83 175.88 21.61 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.979 1.276 . . . . 0.0 114.36 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 56.4 m -133.86 162.12 32.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.284 1.434 . . . . 0.0 109.759 169.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.5 -171.53 49.39 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 121.601 0.556 . . . . 0.0 112.668 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.33 -27.5 23.71 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.222 1.409 . . . . 0.0 113.956 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.0 m -74.86 -3.91 34.74 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.761 2.424 . . . . 0.0 114.833 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -79.55 125.86 30.13 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.078 0.853 . . . . 0.0 112.618 -174.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.84 163.86 14.85 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.212 0.605 . . . . 0.0 110.827 172.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.6 t -144.13 148.31 34.89 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.262 1.025 . . . . 0.0 111.829 -171.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -147.75 110.05 4.6 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.325 1.45 . . . . 0.0 110.119 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.2 133.61 56.26 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.913 0.885 . . . . 0.0 111.212 173.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -125.3 160.8 28.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.285 1.034 . . . . 0.0 111.298 163.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -129.59 146.25 51.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.225 1.41 . . . . 0.0 108.771 171.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.63 136.73 49.13 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.886 1.274 . . . . 0.0 109.696 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.5 163.03 21.72 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 129.23 3.012 . . . . 0.0 110.385 -169.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -73.66 41.09 0.98 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.902 1.239 . . . . 0.0 114.434 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.39 -63.68 0.37 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.518 1.527 . . . . 0.0 112.576 -169.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 4.8 m -81.19 65.39 6.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.022 1.329 . . . . 0.0 110.342 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 14.2 tt -134.57 1.91 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.861 2.464 . . . . 0.0 112.636 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -154.02 29.16 0.73 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.609 1.1 . . . . 0.0 114.696 -172.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.877 0 C-N-CA 125.948 1.699 . . . . 0.0 109.151 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 9.5 m -109.43 0.86 19.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.323 1.449 . . . . 0.0 113.99 -167.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.64 -48.97 62.66 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.235 0.925 . . . . 0.0 111.031 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.68 131.43 46.31 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 167.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.6 t -62.58 176.66 0.62 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -164.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.427 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.7 mm? -64.7 97.39 0.21 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.933 1.693 . . . . 0.0 112.332 -167.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 293' ' ' LYS . 0.8 OUTLIER -47.48 125.7 8.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 128.052 2.541 . . . . 0.0 111.794 -178.341 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 60.35 10.17 15.22 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.559 1.076 . . . . 0.0 115.283 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 13.5 m -139.76 17.0 2.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.657 1.583 . . . . 0.0 109.809 -159.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 2.3 m -171.15 159.07 5.77 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.267 -1.521 . . . . 0.0 112.368 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -86.74 174.66 8.68 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.446 1.099 . . . . 0.0 112.735 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -63.17 159.3 17.85 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -164.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 62.1 mtm -79.22 151.74 31.04 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.914 2.086 . . . . 0.0 110.382 164.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.7 m -70.51 145.49 50.85 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.989 -0.445 . . . . 0.0 111.794 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.1 p -134.3 24.32 3.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.929 1.292 . . . . 0.0 112.634 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -94.59 169.45 10.17 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 160.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -69.62 90.96 0.58 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.195 2.198 . . . . 0.0 111.956 -163.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 37.7 mtp -80.58 170.63 16.08 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.961 0.886 . . . . 0.0 113.348 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 36.5 m -159.44 161.22 35.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.057 0.943 . . . . 0.0 112.018 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.49 120.2 22.14 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.772 0.829 . . . . 0.0 109.641 168.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.64 -34.32 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.216 1.006 . . . . 0.0 110.116 163.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -136.46 132.68 35.7 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.173 1.389 . . . . 0.0 110.007 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -69.32 145.89 96.17 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.526 1.53 . . . . 0.0 112.15 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.0 136.62 57.66 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.864 2.376 . . . . 0.0 112.636 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 71.4 p -141.61 131.6 24.57 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.152 1.781 . . . . 0.0 110.411 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -60.49 131.76 51.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.777 0.831 . . . . 0.0 112.387 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.0 p -66.13 -21.23 66.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.556 1.942 . . . . 0.0 112.717 168.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 98.31 -16.79 59.48 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.909 1.718 . . . . 0.0 112.397 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -74.08 -18.15 60.86 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.419 1.11 . . . . 0.0 111.76 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.55 32.88 6.1 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.569 1.081 . . . . 0.0 111.751 -166.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.8 p -136.85 129.43 30.28 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.905 1.282 . . . . 0.0 108.39 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 21.8 m -106.9 123.06 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.434 0.694 . . . . 0.0 110.068 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.35 129.42 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.072 0.949 . . . . 0.0 111.816 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.9 ptm -149.49 163.04 38.9 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.487 1.915 . . . . 0.0 111.756 -169.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -136.74 136.58 39.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.442 0.697 . . . . 0.0 110.153 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.96 127.66 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.999 0.92 . . . . 0.0 112.874 -164.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -92.94 125.7 37.67 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.573 1.549 . . . . 0.0 112.02 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.1 t -96.56 145.27 29.28 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 117.393 -1.289 . . . . 0.0 107.626 158.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -104.27 -65.88 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 123.056 2.504 . . . . 0.0 115.321 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 175.85 10.32 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.344 -1.472 . . . . 0.0 112.142 -174.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.69 -13.19 0.09 OUTLIER Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.509 2.481 . . . . 0.0 118.129 167.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.89 93.93 22.77 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 119.147 1.474 . . . . 0.0 113.03 -167.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.3 112.15 3.26 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.402 2.068 . . . . 0.0 108.756 156.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.5 p -154.35 159.67 41.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.15 0.98 . . . . 0.0 111.923 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 355' ' ' ILE . 20.6 mtpp -76.83 144.13 39.28 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.214 1.006 . . . . 0.0 109.877 158.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.45 111.46 4.08 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.242 1.017 . . . . 0.0 111.97 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -94.54 89.06 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.952 3.101 . . . . 0.0 112.999 -162.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.86 127.8 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 150.06 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.446 1.098 . . . . 0.0 109.397 -177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 64.4 t -128.77 105.03 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -117.6 161.24 19.95 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -158.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.62 -14.62 58.68 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.08 2.152 . . . . 0.0 112.783 164.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -134.38 148.23 50.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.612 1.165 . . . . 0.0 112.258 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 16.4 mt -61.96 -19.74 63.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.137 1.375 . . . . 0.0 114.468 -173.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.8 t -104.29 5.83 34.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.606 1.962 . . . . 0.0 113.262 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.48 69.08 0.43 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.016 2.926 . . . . 0.0 116.434 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -81.32 -45.42 16.2 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.365 1.466 . . . . 0.0 112.064 157.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.42 113.73 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.976 1.311 . . . . 0.0 110.338 -172.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.13 107.39 15.67 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.445 0.698 . . . . 0.0 112.331 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 373' ' ' ASP . 12.2 ttpt -72.86 -43.91 62.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.393 2.677 . . . . 0.0 112.955 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -100.28 -165.5 28.7 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.465 1.346 . . . . 0.0 116.465 -165.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.94 148.14 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.182 2.193 . . . . 0.0 110.0 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.32 134.51 34.51 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.464 -0.772 . . . . 0.0 109.666 170.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 81.9 t -98.29 -46.64 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.904 0.882 . . . . 0.0 109.588 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.8 m -71.38 154.9 41.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.396 0.617 . . . . 0.0 110.211 164.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.46 161.56 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.211 1.404 . . . . 0.0 110.541 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -114.17 69.28 1.82 Allowed Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 124.667 1.187 . . . . 0.0 112.763 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.05 -171.36 1.05 Allowed 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 124.412 3.408 . . . . 0.0 113.123 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 44.5 pt -93.17 165.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.58 1.552 . . . . 0.0 113.359 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.21 105.98 1.55 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.054 0.942 . . . . 0.0 109.206 158.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 83.9 p -70.31 -40.18 74.35 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.173 1.389 . . . . 0.0 111.803 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.24 151.45 34.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.33 1.852 . . . . 0.0 108.887 155.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -61.63 -15.7 41.86 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 175.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.76 8.67 44.3 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.232 1.413 . . . . 0.0 112.633 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -58.98 148.15 31.72 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.266 -1.521 . . . . 0.0 113.621 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -129.94 79.43 1.9 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.072 1.349 . . . . 0.0 112.129 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 40.5 t -84.39 143.21 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.45 1.1 . . . . 0.0 111.124 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.5 130.07 42.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.536 2.734 . . . . 0.0 109.787 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.1 133.8 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.117 1.767 . . . . 0.0 110.407 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -91.01 138.23 31.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.18 0.992 . . . . 0.0 110.722 154.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.79 160.56 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.096 0.958 . . . . 0.0 111.333 169.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -121.75 105.32 38.29 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.815 1.646 . . . . 0.0 110.076 -173.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.68 154.8 35.01 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.234 1.956 . . . . 0.0 110.363 159.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.79 171.58 16.22 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.17 1.913 . . . . 0.0 111.155 166.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -65.24 122.97 18.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.834 1.254 . . . . 0.0 109.343 168.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 126.73 -148.14 17.13 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.319 0.961 . . . . 0.0 111.166 -163.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ASP . . . . . 0.407 ' O ' ' HE3' ' A' ' 346' ' ' LYS . 8.7 p-10 -94.47 168.82 10.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.828 1.251 . . . . 0.0 112.054 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 33.6 m -168.46 165.24 12.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.536 1.934 . . . . 0.0 110.828 159.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -124.63 117.0 23.3 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.0 mm -90.95 110.92 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.61 143.39 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.948 0.899 . . . . 0.0 110.184 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.6 115.23 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 126.71 2.004 . . . . 0.0 108.684 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 95.82 176.88 36.73 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.32 0.962 . . . . 0.0 114.521 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 47.4 m -136.19 165.06 26.61 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.811 1.644 . . . . 0.0 109.891 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.37 -171.27 46.81 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 121.642 -0.662 . . . . 0.0 112.196 -167.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.47 -26.41 53.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.213 1.005 . . . . 0.0 113.539 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.4 m -74.25 9.9 1.47 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.681 2.792 . . . . 0.0 115.222 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -96.05 144.24 26.49 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.4 1.08 . . . . 0.0 112.986 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 25.9 mt -112.25 165.31 12.28 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.579 1.152 . . . . 0.0 111.384 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 2.3 t -139.11 147.01 41.39 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.949 1.299 . . . . 0.0 111.815 -170.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -146.78 112.59 5.7 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.759 1.624 . . . . 0.0 110.388 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 134.56 54.93 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.128 -0.983 . . . . 0.0 112.367 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -128.82 149.12 50.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.891 0.876 . . . . 0.0 111.892 165.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -133.5 140.72 47.41 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.128 1.371 . . . . 0.0 107.839 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -135.22 122.01 21.0 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.481 1.112 . . . . 0.0 111.052 -170.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -73.45 164.26 26.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.339 1.055 . . . . 0.0 112.21 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -65.81 16.83 0.2 Allowed Glycine 0 CA--C 1.54 1.606 0 N-CA-C 118.881 2.312 . . . . 0.0 118.881 -163.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 4.8 m -72.25 65.08 0.59 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.415 2.286 . . . . 0.0 112.539 -170.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.2 p -83.96 -4.13 58.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 130.094 3.358 . . . . 0.0 114.055 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 15.2 tt -149.44 168.18 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.9 1.68 . . . . 0.0 109.361 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 81.35 -9.98 51.88 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.913 1.244 . . . . 0.0 115.203 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.432 0 C-N-CA 129.09 2.956 . . . . 0.0 109.42 173.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.7 m -104.81 -4.58 22.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.138 0.975 . . . . 0.0 113.003 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.54 -9.09 52.48 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.9 tp -101.79 132.18 47.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 159.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.9 t -57.98 174.45 0.26 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.386 1.474 . . . . 0.0 114.252 -172.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.518 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.4 mm? -65.06 95.66 0.17 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.772 1.629 . . . . 0.0 110.997 -169.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.529 ' H ' ' HD2' ' A' ' 293' ' ' LYS . 6.9 mptt -51.89 121.02 5.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.853 2.461 . . . . 0.0 111.057 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 67.25 -25.22 0.2 Allowed Glycine 0 CA--C 1.54 1.635 0 C-N-CA 126.439 1.971 . . . . 0.0 115.599 -173.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 44.8 m -87.11 7.99 25.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 129.648 3.179 . . . . 0.0 111.555 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 7.5 m -160.2 155.31 24.75 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 119.311 -2.118 . . . . 0.0 111.587 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -76.09 172.95 11.93 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.067 1.347 . . . . 0.0 112.868 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -63.47 156.17 27.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.192 0.996 . . . . 0.0 113.642 -173.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 37.8 mtt -84.82 151.94 23.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.713 1.605 . . . . 0.0 111.364 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.9 m -67.7 139.87 56.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.207 0.603 . . . . 0.0 111.94 -173.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.3 p -131.75 16.92 4.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.862 1.265 . . . . 0.0 113.196 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.69 169.32 17.13 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 159.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.5 98.68 1.15 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.633 1.173 . . . . 0.0 112.076 -167.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.4 mtp -87.12 172.3 10.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.668 1.187 . . . . 0.0 113.579 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 36.8 m -160.74 170.4 20.83 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.794 1.238 . . . . 0.0 111.286 162.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.64 131.47 35.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.088 0.955 . . . . 0.0 109.324 162.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.1 -37.97 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.877 0.871 . . . . 0.0 109.797 162.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -130.97 126.78 36.91 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.723 1.609 . . . . 0.0 108.409 173.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -60.73 149.98 77.67 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.355 0.662 . . . . 0.0 111.678 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.56 132.59 43.98 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.026 1.817 . . . . 0.0 110.587 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 40.2 p -127.49 129.56 47.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.791 1.636 . . . . 0.0 108.805 172.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.89 136.07 57.89 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.555 0.693 . . . . 0.0 111.441 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.8 p -93.78 -15.15 25.43 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.251 1.421 . . . . 0.0 113.613 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.64 -6.66 8.26 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-O 118.447 -1.196 . . . . 0.0 114.66 -161.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -70.67 -10.21 58.86 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 120.32 2.06 . . . . 0.0 112.112 170.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 91.6 17.51 48.78 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.465 1.031 . . . . 0.0 112.912 -160.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.9 p -134.33 168.47 18.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.267 1.427 . . . . 0.0 111.283 -171.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 19.2 m -121.42 138.93 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.064 1.346 . . . . 0.0 109.292 166.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -114.36 130.07 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.698 1.199 . . . . 0.0 111.63 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.8 ptm -145.69 167.3 23.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.699 1.599 . . . . 0.0 112.797 -171.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -133.72 136.42 44.63 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.212 1.005 . . . . 0.0 109.684 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 21.3 m -116.54 168.25 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.799 1.24 . . . . 0.0 111.848 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -131.39 127.75 38.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.991 1.317 . . . . 0.0 112.053 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.07 146.77 32.5 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.149 1.38 . . . . 0.0 108.224 161.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -107.27 -62.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.163 2.575 . . . . 0.0 115.224 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.26 -174.27 4.88 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.383 1.473 . . . . 0.0 111.988 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 74.35 -36.81 0.97 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 126.593 2.044 . . . . 0.0 116.605 162.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.65 103.86 43.11 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.514 1.126 . . . . 0.0 111.963 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -64.88 128.88 21.82 Favored 'Trans proline' 0 C--N 1.35 0.61 0 N-CA-C 107.851 -1.634 . . . . 0.0 107.851 154.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.0 p -157.57 157.75 34.31 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.7 tptm -75.24 135.7 40.98 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.404 1.481 . . . . 0.0 109.094 164.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.5 119.99 58.51 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -168.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -100.38 81.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.61 2.873 . . . . 0.0 114.159 -164.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 95.1 t -107.5 128.11 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 162.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.68 152.75 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.873 1.269 . . . . 0.0 109.666 176.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.97 115.16 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.307 1.843 . . . . 0.0 106.837 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -127.51 160.25 32.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -161.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.27 -15.12 36.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.702 1.601 . . . . 0.0 112.612 171.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.21 153.75 38.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.683 1.593 . . . . 0.0 110.723 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.16 -14.16 34.55 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 11.5 t -123.93 14.34 9.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.581 1.552 . . . . 0.0 113.415 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 44.56 59.23 3.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.001 2.52 . . . . 0.0 115.917 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -78.09 -32.74 50.78 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.256 0.622 . . . . 0.0 112.182 156.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 45.4 mm -116.07 112.16 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.323 1.849 . . . . 0.0 109.973 -175.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -86.59 103.86 15.48 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.898 0.856 . . . . 0.0 111.846 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -88.2 -19.68 26.56 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.967 2.907 . . . . 0.0 114.439 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -118.59 -165.42 13.28 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 115.901 1.121 . . . . 0.0 115.901 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.2 mt -126.79 139.41 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 127.454 2.302 . . . . 0.0 110.366 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.15 129.65 37.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.848 1.259 . . . . 0.0 110.114 165.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 53.5 t -107.05 -50.92 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.711 0.804 . . . . 0.0 110.564 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.6 m -68.43 154.06 42.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.319 0.58 . . . . 0.0 109.641 163.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.9 m -54.43 154.66 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.702 1.201 . . . . 0.0 112.482 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -118.92 81.11 18.87 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.439 1.096 . . . . 0.0 110.547 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -82.96 -166.47 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 125.08 3.853 . . . . 0.0 112.846 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 39.1 pt -89.21 168.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.203 1.401 . . . . 0.0 111.511 164.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.31 120.34 13.66 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 158.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 85.9 p -73.12 -17.16 61.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.847 1.259 . . . . 0.0 113.838 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 97.5 m -144.06 157.51 44.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.748 2.419 . . . . 0.0 106.73 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -58.97 -21.48 58.71 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.861 -1.15 . . . . 0.0 113.914 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.79 15.32 29.0 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.689 1.996 . . . . 0.0 112.773 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -61.07 158.52 13.45 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 119.998 -1.689 . . . . 0.0 113.862 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -145.4 75.11 1.42 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.279 1.432 . . . . 0.0 113.861 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.5 149.52 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.509 1.524 . . . . 0.0 112.439 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.61 129.49 46.54 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 129.931 3.292 . . . . 0.0 109.301 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.87 134.41 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.281 1.432 . . . . 0.0 111.631 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -90.67 136.95 32.73 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.001 1.321 . . . . 0.0 111.869 154.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.74 159.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.884 1.274 . . . . 0.0 111.477 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -119.81 114.88 33.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.18 1.792 . . . . 0.0 111.128 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.3 159.97 13.09 Favored 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 123.665 2.91 . . . . 0.0 112.203 162.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.27 175.73 10.56 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.476 2.784 . . . . 0.0 111.026 163.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -63.4 145.62 55.22 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.57 -0.706 . . . . 0.0 111.332 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.76 -145.08 15.91 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.895 0.759 . . . . 0.0 111.47 -171.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -91.32 164.55 13.82 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.268 1.427 . . . . 0.0 112.255 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.2 m -161.54 158.88 27.08 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.326 -1.484 . . . . 0.0 111.212 158.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -116.03 116.1 27.29 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.88 111.91 22.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 124.952 1.301 . . . . 0.0 108.101 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.51 142.9 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.66 0.784 . . . . 0.0 109.727 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 94.3 t -116.92 110.22 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.963 1.705 . . . . 0.0 108.994 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.77 -179.39 24.25 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.187 0.898 . . . . 0.0 115.162 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 28.7 m -132.56 163.44 28.86 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.114 1.766 . . . . 0.0 109.388 171.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.33 -171.96 52.45 Favored Glycine 0 CA--C 1.535 1.298 0 O-C-N 121.559 -0.713 . . . . 0.0 112.925 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.26 -29.64 34.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.266 1.426 . . . . 0.0 113.697 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.6 m -73.36 -2.39 22.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.066 2.547 . . . . 0.0 114.801 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -81.66 115.4 20.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.09 0.859 . . . . 0.0 112.999 -172.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -81.63 162.91 22.89 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.879 -0.513 . . . . 0.0 111.277 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.5 t -140.4 147.54 39.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.768 1.227 . . . . 0.0 112.053 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -147.13 120.57 9.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.564 1.546 . . . . 0.0 111.119 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.6 130.17 39.07 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.794 1.238 . . . . 0.0 112.529 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -127.24 164.82 20.87 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.594 1.158 . . . . 0.0 112.224 164.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -133.26 150.51 51.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.41 1.884 . . . . 0.0 108.667 171.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -134.89 116.31 14.61 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.676 1.991 . . . . 0.0 109.498 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -60.35 146.31 44.66 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.536 1.934 . . . . 0.0 113.457 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -104.94 148.11 16.47 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.752 1.168 . . . . 0.0 112.909 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 8.9 m -70.06 17.35 0.06 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.791 2.436 . . . . 0.0 117.092 -161.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 40.8 m -61.5 -20.69 63.48 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.137 0.575 . . . . 0.0 111.775 158.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.4 tp -149.45 156.65 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.597 1.959 . . . . 0.0 109.49 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 78.08 -81.27 1.31 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.347 0.975 . . . . 0.0 114.498 169.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.393 0 C-N-CA 124.998 1.319 . . . . 0.0 113.594 -169.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' MET . . . . . 0.667 ' N ' HD21 ' A' ' 345' ' ' ASN . 99.0 mmm . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.6 m -90.57 -7.38 52.99 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -166.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.7 -25.81 66.71 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 57.9 tp -83.1 126.39 32.54 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.081 1.31 . . . . 0.0 108.065 159.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 t -55.05 167.07 0.44 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.782 1.233 . . . . 0.0 113.768 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.569 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.0 mm? -57.28 107.21 0.4 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.806 2.042 . . . . 0.0 111.263 -164.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -58.19 115.87 3.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.499 1.92 . . . . 0.0 110.686 -166.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 68.62 -7.91 2.59 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.449 1.499 . . . . 0.0 115.476 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 96.9 m -101.88 6.65 41.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.367 2.667 . . . . 0.0 110.626 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.3 m -154.32 151.26 28.88 Favored 'General case' 0 C--O 1.23 0.06 0 O-C-N 119.337 -2.102 . . . . 0.0 112.387 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -71.57 170.83 12.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.125 2.17 . . . . 0.0 112.864 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.64 153.42 36.07 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 39.6 mtt -91.05 151.58 20.98 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.893 1.677 . . . . 0.0 111.283 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.88 141.64 55.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.42 0.688 . . . . 0.0 112.621 -170.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.7 p -133.25 17.74 4.06 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -74.57 164.75 26.22 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.543 -0.723 . . . . 0.0 109.193 155.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.59 89.2 0.52 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.989 1.315 . . . . 0.0 111.913 -173.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 68.9 mtp -73.17 173.05 9.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.878 1.671 . . . . 0.0 113.693 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.7 m -157.37 163.46 38.58 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.203 -0.936 . . . . 0.0 111.855 162.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.42 125.93 29.99 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 3.6 t -76.61 -29.99 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 122.961 0.505 . . . . 0.0 109.779 162.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -135.6 126.48 27.55 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.048 1.739 . . . . 0.0 108.667 167.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -59.72 151.01 64.86 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.559 1.143 . . . . 0.0 111.87 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.67 132.42 35.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.05 1.834 . . . . 0.0 110.845 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 m -133.33 141.86 48.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.916 1.286 . . . . 0.0 109.933 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.19 136.82 58.1 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.309 0.644 . . . . 0.0 112.181 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 70.4 p -91.12 -8.02 49.97 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.977 1.311 . . . . 0.0 114.218 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.434 ' HA2' ' HE2' ' A' ' 398' ' ' LYS . . . 69.15 4.94 45.63 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.802 -0.999 . . . . 0.0 114.909 -163.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -111.34 13.3 21.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.05 1.425 . . . . 0.0 112.316 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.59 14.15 71.31 Favored Glycine 0 CA--C 1.536 1.371 0 O-C-N 121.374 -0.829 . . . . 0.0 113.651 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 39.5 p -135.17 164.61 27.3 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.273 1.429 . . . . 0.0 111.296 -171.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.4 m -128.14 135.79 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.527 1.531 . . . . 0.0 110.061 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.44 129.76 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.886 1.275 . . . . 0.0 113.704 -167.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -143.52 164.98 28.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.462 1.505 . . . . 0.0 114.32 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -122.35 125.49 46.04 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.542 2.337 . . . . 0.0 107.65 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.97 138.55 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.018 0.927 . . . . 0.0 111.707 -167.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -111.66 129.13 56.19 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.614 1.165 . . . . 0.0 113.135 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.44 142.73 25.19 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.416 1.486 . . . . 0.0 108.607 165.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -100.45 -72.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.907 2.404 . . . . 0.0 115.714 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 168.15 20.47 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.429 -1.42 . . . . 0.0 113.934 -173.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.84 -12.46 0.37 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.833 2.158 . . . . 0.0 117.879 171.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -117.22 98.63 52.15 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 119.422 1.611 . . . . 0.0 113.621 -163.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -68.44 133.85 29.26 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 148.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -161.76 156.82 23.34 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.851 0.86 . . . . 0.0 111.058 -176.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -70.38 135.4 48.74 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.497 1.119 . . . . 0.0 108.292 162.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.9 pp -60.85 118.41 34.9 Favored Pre-proline 0 CA--C 1.554 1.124 0 CA-C-N 118.252 0.478 . . . . 0.0 111.732 -170.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -94.84 86.75 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.597 2.865 . . . . 0.0 114.034 -159.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 37.1 t -121.73 128.4 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.418 1.487 . . . . 0.0 109.119 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.24 161.81 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.722 1.209 . . . . 0.0 111.988 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 55.2 t -138.93 118.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.406 2.283 . . . . 0.0 107.946 173.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.44 168.4 16.38 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -164.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.43 -8.83 58.19 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.708 2.003 . . . . 0.0 113.294 163.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -131.46 153.01 50.2 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.834 1.253 . . . . 0.0 110.899 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 23.9 mt -61.24 -26.06 67.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.4 t -108.36 10.4 27.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.743 1.617 . . . . 0.0 113.456 -169.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 44.12 67.71 0.64 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.736 2.414 . . . . 0.0 115.53 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -82.51 -38.31 24.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.368 1.067 . . . . 0.0 111.714 156.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.13 158.66 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.456 1.502 . . . . 0.0 109.663 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ASN . . . . . 0.667 HD21 ' N ' ' A' ' 287' ' ' MET . 1.3 p-10 -125.45 97.79 5.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.576 1.15 . . . . 0.0 110.97 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -92.24 -26.6 18.1 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.328 2.251 . . . . 0.0 113.816 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -110.7 -170.74 19.53 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 29.8 mt -125.02 134.57 66.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 127.225 2.21 . . . . 0.0 110.078 -175.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 14.1 mt -68.69 122.73 19.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.357 1.063 . . . . 0.0 109.815 164.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 77.7 t -95.7 -49.82 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.593 0.757 . . . . 0.0 109.861 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 18.9 m -76.76 157.0 31.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.416 0.627 . . . . 0.0 110.695 171.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.9 156.17 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.428 1.491 . . . . 0.0 113.066 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -122.41 79.57 45.86 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.963 1.305 . . . . 0.0 111.292 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.18 -166.23 0.4 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 124.68 3.587 . . . . 0.0 113.106 171.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 39.9 pt -100.67 164.12 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.069 1.748 . . . . 0.0 111.503 168.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.93 113.78 3.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.329 1.051 . . . . 0.0 109.534 159.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 93.6 p -66.85 -33.4 75.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.159 1.384 . . . . 0.0 112.596 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 2.6 m -143.42 153.54 42.77 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.029 2.532 . . . . 0.0 106.467 -174.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.57 -23.05 66.8 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.411 -1.43 . . . . 0.0 114.649 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.8 8.87 20.94 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.402 1.481 . . . . 0.0 113.355 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.64 154.3 9.08 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.561 -1.337 . . . . 0.0 114.306 -169.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -154.22 114.84 3.97 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.242 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.83 155.37 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.247 1.019 . . . . 0.0 109.441 -170.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.1 120.07 39.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.806 2.443 . . . . 0.0 108.169 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.71 129.11 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.895 0.878 . . . . 0.0 111.151 -171.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -89.51 140.56 29.41 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.725 1.21 . . . . 0.0 111.926 158.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.84 151.19 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.383 1.473 . . . . 0.0 110.53 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -117.08 113.33 39.46 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.03 1.732 . . . . 0.0 110.067 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -80.31 160.84 22.97 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.848 2.365 . . . . 0.0 111.295 162.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.5 171.08 17.85 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.403 2.069 . . . . 0.0 110.272 161.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -62.22 142.01 57.91 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.695 -0.628 . . . . 0.0 111.182 171.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 103.68 -145.5 16.17 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.902 0.763 . . . . 0.0 112.095 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -83.11 162.49 21.3 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.734 1.213 . . . . 0.0 113.08 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 14.3 m -165.81 160.17 16.78 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.812 1.245 . . . . 0.0 111.717 161.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -121.09 118.19 29.11 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 13.9 mm -92.96 122.08 44.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.269 1.428 . . . . 0.0 107.852 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.02 142.35 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.512 0.725 . . . . 0.0 110.631 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.69 110.97 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 127.28 2.232 . . . . 0.0 108.81 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.9 -178.26 22.9 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.596 1.093 . . . . 0.0 114.587 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.4 m -135.71 167.09 21.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.853 2.061 . . . . 0.0 110.146 170.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 79.52 -167.25 51.72 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.568 -0.707 . . . . 0.0 112.683 -173.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -25.93 66.37 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.856 -0.79 . . . . 0.0 112.6 169.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.3 m -74.44 -2.74 26.81 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 129.008 2.923 . . . . 0.0 115.163 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -84.68 130.54 34.69 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.625 0.77 . . . . 0.0 111.876 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 13.7 mt -94.22 156.09 16.72 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.745 0.418 . . . . 0.0 110.37 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.6 t -138.4 148.27 44.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.038 0.935 . . . . 0.0 111.921 -170.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -145.32 118.96 9.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.386 1.474 . . . . 0.0 110.012 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.28 128.04 34.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.462 0.705 . . . . 0.0 110.808 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -127.05 152.57 47.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.077 0.951 . . . . 0.0 110.662 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.19 141.79 51.79 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.626 1.17 . . . . 0.0 108.592 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -125.23 126.79 45.73 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.087 1.355 . . . . 0.0 109.976 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -56.56 166.48 0.9 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.106 2.562 . . . . 0.0 112.552 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -75.73 72.61 1.76 Allowed Glycine 0 CA--C 1.529 0.933 0 O-C-N 121.391 -0.818 . . . . 0.0 111.55 174.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 37.2 m -54.44 2.58 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 117.433 2.382 . . . . 0.0 117.433 -170.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 28.7 t -62.73 -10.58 13.21 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.605 -1.309 . . . . 0.0 113.627 159.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 6.2 tp -104.05 5.94 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.395 1.478 . . . . 0.0 112.281 165.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 96.33 173.1 35.45 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 126.286 1.898 . . . . 0.0 113.836 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.434 ' HE2' ' HA2' ' A' ' 314' ' ' GLY . 0.5 OUTLIER . . . . . 0 C--O 1.257 1.487 0 C-N-CA 129.689 3.196 . . . . 0.0 118.054 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 10.2 mmt . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.1 p -118.96 -0.98 11.06 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -172.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.43 -53.92 47.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.226 0.921 . . . . 0.0 113.032 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.32 122.9 16.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.5 t -47.17 158.2 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.699 2.0 . . . . 0.0 116.353 -167.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.3 mm? -61.37 119.58 8.8 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.074 1.75 . . . . 0.0 111.51 -164.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 293' ' ' LYS . 2.4 mptp? -65.44 115.2 5.44 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.195 1.398 . . . . 0.0 110.557 -172.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.79 -48.07 2.6 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.983 1.278 . . . . 0.0 112.902 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 46.3 m -63.25 -1.53 1.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.386 2.274 . . . . 0.0 113.245 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.0 m -155.33 156.76 36.06 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 119.149 -2.22 . . . . 0.0 112.143 170.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -84.44 164.28 18.96 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.411 1.084 . . . . 0.0 113.513 -169.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 151.04 46.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.952 1.301 . . . . 0.0 113.214 -175.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 77.7 mtm -68.31 167.65 14.06 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.046 2.538 . . . . 0.0 114.66 -171.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.6 m -86.0 148.54 25.7 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.89 0.876 . . . . 0.0 111.456 176.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 6.7 p -136.95 23.08 3.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.097 1.359 . . . . 0.0 112.799 172.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -84.21 156.71 21.9 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.26 -0.9 . . . . 0.0 108.988 155.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' LYS . . . . . 0.45 ' H ' ' HE2' ' A' ' 303' ' ' LYS . 0.2 OUTLIER -65.53 106.33 1.41 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.542 1.537 . . . . 0.0 111.575 -166.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 63.9 mtp -92.32 171.87 8.77 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.413 1.085 . . . . 0.0 112.839 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.8 m -163.69 162.33 24.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.663 1.185 . . . . 0.0 111.761 167.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.0 116.81 18.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.643 0.777 . . . . 0.0 110.21 169.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.16 -35.1 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.333 1.453 . . . . 0.0 110.288 163.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -134.64 129.84 35.48 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.385 1.474 . . . . 0.0 108.67 165.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -63.18 156.29 69.41 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.663 0.785 . . . . 0.0 112.275 173.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -62.58 132.46 38.02 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.132 1.888 . . . . 0.0 110.797 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 60.4 p -133.79 135.07 43.62 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.957 2.103 . . . . 0.0 108.79 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.55 140.15 58.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.075 0.852 . . . . 0.0 111.829 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 41.0 p -67.77 -17.49 64.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.598 1.959 . . . . 0.0 113.633 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 91.39 -6.66 80.72 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.349 0.976 . . . . 0.0 112.175 -164.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -98.51 1.16 46.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.724 1.21 . . . . 0.0 112.089 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 77.5 43.67 14.92 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 119.069 0.85 . . . . 0.0 111.094 -172.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 63.3 p -144.41 137.04 26.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.561 1.944 . . . . 0.0 108.194 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.8 m -110.66 125.06 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.223 0.919 . . . . 0.0 111.304 -172.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.87 131.03 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.753 1.621 . . . . 0.0 111.873 -173.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 11.2 ptp -141.83 166.1 25.65 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.998 2.119 . . . . 0.0 112.15 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -133.41 134.57 43.81 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.901 0.88 . . . . 0.0 110.38 171.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.8 m -132.01 135.31 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.221 1.008 . . . . 0.0 113.036 -165.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -89.73 131.86 35.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.29 1.836 . . . . 0.0 112.426 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 t -104.64 145.79 31.38 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.016 -1.469 . . . . 0.0 107.866 156.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -105.29 -72.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.617 2.211 . . . . 0.0 115.969 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.89 170.91 16.08 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 119.633 -1.917 . . . . 0.0 114.803 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.5 -4.24 3.01 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 126.18 1.848 . . . . 0.0 117.114 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.58 94.18 48.72 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 118.903 1.352 . . . . 0.0 112.063 -165.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.56 121.97 8.7 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.288 1.992 . . . . 0.0 108.952 163.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.2 p -157.84 154.45 28.03 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -77.13 142.01 39.92 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 156.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 14.5 pt -63.83 118.16 42.59 Favored Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -87.58 91.3 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.349 3.366 . . . . 0.0 113.178 -169.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.19 139.28 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.805 0.842 . . . . 0.0 109.703 169.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.63 147.11 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.371 1.468 . . . . 0.0 108.697 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.17 106.08 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -114.55 162.12 17.14 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -163.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.53 -9.62 57.13 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.854 2.062 . . . . 0.0 112.902 165.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -133.48 140.62 47.36 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.668 1.187 . . . . 0.0 110.528 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.28 -17.45 42.49 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -173.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -106.03 5.09 30.01 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.171 1.788 . . . . 0.0 113.601 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.57 78.91 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 129.557 3.143 . . . . 0.0 116.721 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.34 -36.91 11.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.398 1.479 . . . . 0.0 112.36 156.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 94.7 mt -103.12 136.06 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.135 1.374 . . . . 0.0 109.972 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.02 98.68 8.35 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.827 1.651 . . . . 0.0 110.02 -177.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -84.69 -52.32 6.17 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.249 2.62 . . . . 0.0 112.664 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -87.77 -172.91 47.76 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 116.204 1.242 . . . . 0.0 116.204 -170.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 45.5 mt -126.75 143.15 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.118 1.767 . . . . 0.0 111.048 -172.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 86.6 mt -68.84 138.45 54.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.033 0.933 . . . . 0.0 111.14 168.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.06 -42.8 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.267 0.485 . . . . 0.0 111.433 169.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 m -76.28 149.72 37.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.901 0.773 . . . . 0.0 109.491 158.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.98 157.59 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.296 1.038 . . . . 0.0 111.898 170.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -114.52 78.14 4.74 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.838 1.655 . . . . 0.0 110.647 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.12 -170.93 0.94 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.747 3.632 . . . . 0.0 114.013 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 42.8 pt -95.58 166.89 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.194 1.798 . . . . 0.0 111.657 172.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.15 124.47 24.19 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.681 0.792 . . . . 0.0 109.853 156.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.8 p -80.07 -40.31 27.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.136 1.375 . . . . 0.0 111.984 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.86 148.5 38.47 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.313 1.845 . . . . 0.0 108.399 159.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -59.92 -20.65 58.57 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.08 8.28 38.5 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.209 1.403 . . . . 0.0 112.954 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -61.45 155.12 22.54 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 119.983 -1.698 . . . . 0.0 113.779 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -132.92 95.49 3.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.965 1.306 . . . . 0.0 111.9 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.75 145.65 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.846 1.258 . . . . 0.0 111.922 -160.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 51.8 tp -102.61 127.16 49.82 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.099 2.96 . . . . 0.0 110.668 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.66 147.06 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.174 1.39 . . . . 0.0 110.907 -173.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -120.93 149.55 42.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.367 1.067 . . . . 0.0 113.632 161.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 2.4 m -137.42 158.21 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.855 2.062 . . . . 0.0 110.754 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -111.71 102.54 53.69 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.892 1.677 . . . . 0.0 110.793 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.87 139.12 27.03 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.553 2.169 . . . . 0.0 110.031 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.9 171.54 15.52 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.193 1.929 . . . . 0.0 111.208 170.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -64.55 150.57 46.54 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.703 -0.623 . . . . 0.0 112.21 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.57 -150.36 20.03 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -159.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -89.41 158.56 17.7 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.728 1.611 . . . . 0.0 113.22 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.4 m -158.72 151.26 21.83 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.174 -1.579 . . . . 0.0 112.04 166.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -118.39 109.28 16.08 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.84 108.63 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.91 142.19 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.01 112.32 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 125.355 1.462 . . . . 0.0 108.646 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.4 177.9 20.79 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.262 1.411 . . . . 0.0 114.995 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.5 m -136.08 161.05 36.77 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.043 1.737 . . . . 0.0 109.357 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.53 -166.73 54.58 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 121.558 0.532 . . . . 0.0 112.501 -170.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -27.34 14.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.708 1.603 . . . . 0.0 113.631 172.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.7 m -69.9 -4.15 19.14 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 129.199 3.0 . . . . 0.0 115.308 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -91.72 123.62 35.25 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.8 0.727 . . . . 0.0 112.928 -167.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.48 168.08 11.09 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.411 0.684 . . . . 0.0 111.289 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.1 t -140.09 149.22 42.82 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.172 1.389 . . . . 0.0 111.369 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -145.94 123.16 11.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.291 1.836 . . . . 0.0 109.923 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -76.43 133.01 39.99 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.268 -0.895 . . . . 0.0 111.85 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -121.59 162.86 19.88 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.332 1.053 . . . . 0.0 111.031 160.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -142.86 145.77 33.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.926 1.29 . . . . 0.0 108.708 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -133.84 114.3 13.2 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.214 1.405 . . . . 0.0 110.221 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -84.23 173.67 10.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.802 0.841 . . . . 0.0 111.918 172.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 76.74 78.11 0.74 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.754 0.693 . . . . 0.0 113.129 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.7 t -57.3 -12.98 2.77 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 73.8 p -90.16 -1.9 58.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.299 1.84 . . . . 0.0 114.163 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.9 tt -66.51 -12.1 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.946 1.248 . . . . 0.0 112.971 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 73.91 -28.84 0.93 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.413 1.958 . . . . 0.0 115.825 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 C-N-CA 125.713 1.605 . . . . 0.0 112.881 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 56.1 mmm . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.8 p -101.34 -0.47 35.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.93 -31.48 60.36 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.9 tt -98.8 125.25 44.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 161.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.9 t -53.58 162.94 0.73 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.593 1.157 . . . . 0.0 113.883 -171.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.502 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.7 mm? -49.88 110.49 0.39 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.636 1.974 . . . . 0.0 111.161 -162.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -55.43 124.05 15.91 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.901 1.681 . . . . 0.0 110.421 -168.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 59.92 9.2 9.73 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.98 1.276 . . . . 0.0 115.445 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 20.3 m -134.15 10.01 3.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.762 2.025 . . . . 0.0 110.181 -160.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.6 m -161.48 158.19 26.2 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 119.709 -1.869 . . . . 0.0 110.612 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -79.2 172.23 14.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.102 0.961 . . . . 0.0 112.976 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -71.57 160.12 33.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -77.8 152.66 33.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.409 2.284 . . . . 0.0 112.26 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -71.47 144.64 49.63 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.572 -0.705 . . . . 0.0 112.574 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.8 p -134.56 17.35 3.63 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.149 1.38 . . . . 0.0 113.391 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -75.65 161.19 29.31 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.928 -1.107 . . . . 0.0 109.009 154.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 87.58 0.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.991 1.316 . . . . 0.0 111.347 -168.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 55.9 mtp -70.05 172.97 7.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.906 2.082 . . . . 0.0 114.277 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.8 m -157.85 164.7 36.7 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.98 0.912 . . . . 0.0 111.998 158.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.95 121.61 25.67 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.263 0.625 . . . . 0.0 110.407 166.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.5 -37.14 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.107 1.363 . . . . 0.0 110.121 166.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -131.93 123.13 26.8 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.905 1.282 . . . . 0.0 108.91 169.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -63.43 149.87 90.97 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.132 0.973 . . . . 0.0 111.682 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.45 139.41 70.66 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.716 2.277 . . . . 0.0 112.327 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 49.0 p -141.94 129.59 21.53 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.36 1.864 . . . . 0.0 109.875 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -56.51 126.43 26.49 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.781 0.719 . . . . 0.0 111.679 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.5 p -68.64 -15.6 63.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.8 2.04 . . . . 0.0 113.51 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 93.76 -21.75 39.67 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.748 1.642 . . . . 0.0 112.047 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -74.38 -20.17 60.17 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.386 1.093 . . . . 0.0 112.426 172.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 103.01 18.77 14.16 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.444 1.02 . . . . 0.0 112.503 -168.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.5 p -120.93 149.28 42.88 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 126.548 1.939 . . . . 0.0 108.208 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 33.7 m -118.75 123.61 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.144 0.978 . . . . 0.0 110.096 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.0 p -96.79 127.16 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.968 1.307 . . . . 0.0 111.342 -174.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.1 ptm -147.67 161.43 41.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.526 1.531 . . . . 0.0 112.934 -172.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -134.26 134.21 41.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 110.622 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 23.8 m -131.04 122.36 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.414 1.086 . . . . 0.0 113.353 -162.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -89.75 123.34 33.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.257 2.223 . . . . 0.0 112.247 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.79 146.36 31.25 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 117.235 -1.364 . . . . 0.0 108.235 156.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -101.25 -71.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.722 2.281 . . . . 0.0 115.896 174.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.47 163.96 34.02 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 119.534 -1.979 . . . . 0.0 114.701 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 61.74 7.79 12.89 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.681 1.61 . . . . 0.0 116.333 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.23 88.76 33.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 118.612 1.206 . . . . 0.0 112.319 -162.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.02 118.54 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.15 1.9 . . . . 0.0 108.377 161.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.7 p -157.48 156.59 32.35 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.731 0.777 . . . . 0.0 112.998 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -77.63 142.51 38.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.904 1.682 . . . . 0.0 108.397 163.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.42 123.38 73.3 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 119.287 0.948 . . . . 0.0 111.346 -172.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -102.04 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.583 2.855 . . . . 0.0 113.524 -164.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.24 120.56 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.641 0.776 . . . . 0.0 109.017 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.68 158.47 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.581 1.153 . . . . 0.0 110.465 -174.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.74 104.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.943 2.097 . . . . 0.0 108.085 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.03 159.14 36.88 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.709 1.004 . . . . 0.0 113.709 -160.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.21 -14.33 61.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.718 2.007 . . . . 0.0 112.944 166.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -129.86 140.56 50.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.531 1.532 . . . . 0.0 111.022 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.92 -20.99 60.46 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.4 t -101.22 7.3 43.09 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.866 1.667 . . . . 0.0 113.649 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.18 63.96 1.36 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.799 2.44 . . . . 0.0 115.668 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.13 -50.7 13.92 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.736 0.814 . . . . 0.0 110.876 155.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 15.4 mm -84.41 160.94 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.356 0.598 . . . . 0.0 109.617 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -138.66 61.52 1.57 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.03 -1.044 . . . . 0.0 111.679 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -53.28 -50.81 64.1 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.067 2.547 . . . . 0.0 113.72 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -80.5 -172.0 44.54 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 116.059 1.184 . . . . 0.0 116.059 -168.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.7 mt -123.99 137.35 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.556 1.543 . . . . 0.0 110.175 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.8 mp -77.16 126.62 31.24 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 161.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.97 -46.43 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.557 1.143 . . . . 0.0 109.62 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 31.6 m -73.82 161.01 30.64 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.448 0.642 . . . . 0.0 110.488 167.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 352' ' ' VAL . 3.6 t -53.54 153.09 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.94 1.696 . . . . 0.0 111.026 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -111.61 76.59 1.59 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.07 1.348 . . . . 0.0 110.991 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -75.74 -174.47 2.04 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.947 3.098 . . . . 0.0 112.8 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.2 pt -91.36 168.16 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.049 1.339 . . . . 0.0 111.715 168.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.92 110.13 2.34 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 154.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.4 p -72.04 -37.3 69.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.166 1.386 . . . . 0.0 112.146 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.37 158.0 29.24 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.573 1.949 . . . . 0.0 109.306 158.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -62.1 -20.06 63.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -100.35 11.1 40.19 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.653 1.581 . . . . 0.0 112.408 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -60.6 148.57 37.77 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.596 -1.315 . . . . 0.0 113.705 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -132.17 82.19 2.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.811 1.644 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 11.5 t -94.91 146.39 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.335 1.054 . . . . 0.0 111.202 -164.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 39.8 tp -104.7 123.38 47.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.417 2.687 . . . . 0.0 111.073 -173.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 2.9 mp -141.14 141.17 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.533 1.933 . . . . 0.0 111.041 -170.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -94.04 139.61 30.75 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.637 1.175 . . . . 0.0 111.94 158.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.04 166.24 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.022 1.329 . . . . 0.0 111.004 168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -129.55 108.61 17.37 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 125.894 1.678 . . . . 0.0 110.11 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.64 149.43 26.82 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.568 2.179 . . . . 0.0 110.231 158.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.81 170.16 20.31 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.224 1.949 . . . . 0.0 111.472 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -57.78 129.59 42.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.003 0.921 . . . . 0.0 110.225 168.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 110.76 -139.05 15.32 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.984 0.802 . . . . 0.0 111.898 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -86.85 167.15 14.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.264 1.025 . . . . 0.0 113.287 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.2 m -178.23 163.46 1.66 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.762 2.425 . . . . 0.0 111.04 158.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -127.2 126.58 43.04 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.628 1.571 . . . . 0.0 107.698 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.0 mm -95.26 122.05 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.214 1.406 . . . . 0.0 108.016 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.1 142.81 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.611 0.764 . . . . 0.0 110.2 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 67.9 t -115.92 109.1 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.943 1.697 . . . . 0.0 108.653 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.05 -173.5 20.72 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 123.358 1.532 . . . . 0.0 115.338 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.0 m -140.4 163.91 31.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.487 1.515 . . . . 0.0 109.843 171.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.19 -167.85 54.02 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 121.65 0.583 . . . . 0.0 112.775 -171.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.51 -29.14 6.28 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 114.028 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.0 m -71.34 -11.77 61.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.401 2.681 . . . . 0.0 114.693 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -79.69 109.45 14.1 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -164.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.16 158.0 33.72 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.11 -0.369 . . . . 0.0 110.779 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 2.7 t -136.26 143.93 44.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.754 1.222 . . . . 0.0 111.006 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -144.67 123.17 12.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.595 1.558 . . . . 0.0 110.134 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.39 124.86 24.99 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.359 -0.838 . . . . 0.0 111.945 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -130.1 123.37 30.25 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.213 0.605 . . . . 0.0 110.397 161.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -123.37 146.76 47.7 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -128.59 115.05 17.49 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.276 1.031 . . . . 0.0 110.496 -162.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.27 161.31 27.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.008 0.923 . . . . 0.0 112.131 172.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -70.46 27.73 0.46 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 126.352 1.929 . . . . 0.0 116.676 -169.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' SER . . . . . 0.457 ' O ' ' HE3' ' A' ' 398' ' ' LYS . 60.4 m -66.0 89.96 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.844 1.322 . . . . 0.0 110.756 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 82.7 p -114.62 1.0 14.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.221 1.408 . . . . 0.0 114.682 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 18.6 tt -140.32 154.47 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.54 1.536 . . . . 0.0 110.416 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 79.93 3.51 89.35 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 116.084 1.193 . . . . 0.0 116.084 171.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 394' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.41 1.884 . . . . 0.0 111.754 -175.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.3 p -97.08 -7.05 33.68 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.76 95.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.527 1.058 . . . . 0.0 112.696 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.9 tt -63.06 129.62 41.16 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 7.5 t -49.45 163.45 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.299 1.44 . . . . 0.0 114.537 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -73.53 93.63 2.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.027 1.331 . . . . 0.0 111.134 -160.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.616 ' H ' ' HD2' ' A' ' 293' ' ' LYS . 2.1 mptt -39.01 111.25 0.17 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.519 3.128 . . . . 0.0 112.417 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.01 -32.25 0.52 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.415 1.96 . . . . 0.0 115.111 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 62.7 m -70.98 -3.45 19.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.87 2.468 . . . . 0.0 112.304 171.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.9 m -156.66 154.23 29.78 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 119.311 -2.118 . . . . 0.0 111.199 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -78.71 174.58 11.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.12 1.368 . . . . 0.0 113.178 -173.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -65.27 161.09 20.15 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.041 1.336 . . . . 0.0 114.442 -170.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 71.3 mtm -91.21 150.47 21.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.139 2.175 . . . . 0.0 111.627 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.5 m -69.41 147.57 50.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.077 0.951 . . . . 0.0 112.571 -174.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.6 p -136.38 11.12 3.24 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -76.82 165.04 25.25 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 119.433 1.015 . . . . 0.0 109.553 161.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.48 89.63 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.225 1.41 . . . . 0.0 113.727 -167.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 44.7 mtp -76.64 167.18 22.28 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.639 1.176 . . . . 0.0 113.659 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.5 m -160.69 162.78 32.7 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.875 1.27 . . . . 0.0 110.555 161.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.7 130.57 34.53 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.978 -0.452 . . . . 0.0 110.727 164.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.36 -28.85 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.634 1.573 . . . . 0.0 110.197 167.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -129.99 116.94 19.3 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.531 1.532 . . . . 0.0 108.257 163.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -55.94 150.12 30.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.784 1.234 . . . . 0.0 111.081 169.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.5 138.31 69.79 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.81 1.673 . . . . 0.0 110.808 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' THR . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 389' ' ' TRP . 0.9 OUTLIER -144.28 142.59 30.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.089 0.556 . . . . 0.0 110.158 175.061 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -63.48 126.3 27.03 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.727 1.611 . . . . 0.0 112.413 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 82.5 p -73.84 -25.89 60.31 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.001 1.32 . . . . 0.0 112.68 173.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 84.98 -2.41 88.32 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.501 1.524 . . . . 0.0 114.538 -164.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -87.2 6.06 34.92 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.334 1.453 . . . . 0.0 112.038 171.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 83.1 20.08 61.56 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 121.094 -1.004 . . . . 0.0 112.829 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 366' ' ' GLU . 33.4 p -131.9 154.22 49.44 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.056 1.343 . . . . 0.0 110.688 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 24.1 m -122.81 128.95 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.685 1.194 . . . . 0.0 109.347 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.41 132.88 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.467 1.107 . . . . 0.0 112.21 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -141.8 162.42 35.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.658 1.583 . . . . 0.0 113.778 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -121.48 114.14 20.83 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.472 2.309 . . . . 0.0 107.006 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 362' ' ' GLU . 35.4 m -118.95 138.31 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.693 1.197 . . . . 0.0 111.018 -167.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -119.63 136.64 54.3 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 8.5 t -102.46 150.33 37.52 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 127.301 2.24 . . . . 0.0 108.591 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -102.62 -74.03 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 122.907 2.405 . . . . 0.0 115.888 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.18 162.36 34.46 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.785 1.63 . . . . 0.0 114.498 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 59.94 -0.18 0.88 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 127.193 2.33 . . . . 0.0 118.272 170.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.38 94.67 23.12 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 119.681 1.741 . . . . 0.0 113.304 -164.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.64 115.79 4.45 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.461 2.107 . . . . 0.0 108.935 163.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.0 p -150.77 155.41 39.2 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.924 0.869 . . . . 0.0 112.715 -175.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -74.14 136.36 42.9 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.262 1.425 . . . . 0.0 107.977 163.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 333' ' ' PRO 0.273 2.6 pp -62.27 129.44 92.28 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.415 -169.226 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 16.3 Cg_endo -100.43 89.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.005 2.47 . . . . 0.0 113.635 -160.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 94.4 t -118.22 130.71 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.994 1.318 . . . . 0.0 109.602 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.33 151.67 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 111.51 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.7 t -126.82 104.18 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.415 1.886 . . . . 0.0 107.508 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -115.1 161.81 17.88 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -163.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.71 -11.73 58.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.222 1.809 . . . . 0.0 112.722 163.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.65 146.37 49.46 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.724 1.21 . . . . 0.0 111.75 -176.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.05 -16.14 63.66 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -99.63 5.27 45.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.558 1.143 . . . . 0.0 112.983 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.549 ' HB2' HD13 ' A' ' 377' ' ' ILE . . . 37.8 77.83 0.04 OUTLIER 'General case' 0 C--O 1.239 0.548 0 C-N-CA 129.124 2.97 . . . . 0.0 115.115 -169.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -106.72 -25.43 11.75 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.394 1.877 . . . . 0.0 112.918 166.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.95 119.72 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.599 1.56 . . . . 0.0 109.436 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.1 123.54 50.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -107.85 -16.93 14.2 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -93.52 -177.59 39.96 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 119.853 1.206 . . . . 0.0 116.046 -176.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 86.9 mt -126.63 136.2 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 127.926 2.491 . . . . 0.0 110.058 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mt -72.73 136.99 45.64 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.186 0.995 . . . . 0.0 110.882 168.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.14 -46.66 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.257 0.623 . . . . 0.0 111.466 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 47.6 m -68.99 153.12 44.35 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.384 0.538 . . . . 0.0 109.787 159.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.38 161.28 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.574 1.149 . . . . 0.0 113.028 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -118.04 79.13 13.77 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.284 1.434 . . . . 0.0 111.105 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -78.88 -171.22 1.18 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 123.731 2.954 . . . . 0.0 112.332 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.27 167.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.091 1.357 . . . . 0.0 111.383 171.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.1 117.01 10.2 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 156.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 86.0 p -67.28 -28.41 68.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.589 1.156 . . . . 0.0 112.809 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 21.5 m -137.23 151.28 48.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 128.254 2.621 . . . . 0.0 106.717 -172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.9 -26.63 66.07 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.524 -1.36 . . . . 0.0 113.684 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -89.14 2.51 54.06 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.328 1.851 . . . . 0.0 113.413 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -58.58 154.37 14.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.933 1.349 . . . . 0.0 113.25 -166.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 7.7 pt-20 -144.53 95.32 2.69 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.945 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.87 149.54 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.106 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 45.2 tp -93.99 124.62 38.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.485 2.314 . . . . 0.0 109.412 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.23 135.1 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.746 0.818 . . . . 0.0 110.551 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' GLU . . . . . 0.428 ' OE1' ' OG1' ' A' ' 317' ' ' THR . 3.5 pt-20 -106.01 140.07 39.57 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.21 1.005 . . . . 0.0 112.402 158.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.19 151.53 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.974 2.11 . . . . 0.0 110.025 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -108.92 113.01 59.85 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.296 1.838 . . . . 0.0 109.774 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.62 159.42 25.22 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.538 2.159 . . . . 0.0 111.108 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.17 173.17 3.43 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.703 2.269 . . . . 0.0 112.176 163.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -64.35 141.0 58.93 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.785 -0.572 . . . . 0.0 110.149 163.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 99.47 -140.59 15.06 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.575 0.607 . . . . 0.0 111.787 -174.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -88.24 164.71 15.49 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.713 1.205 . . . . 0.0 113.393 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 13.2 m -167.31 152.96 7.55 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.38 1.472 . . . . 0.0 111.821 165.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -118.95 113.92 21.75 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 31.9 mm -88.48 115.02 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 125.864 1.666 . . . . 0.0 107.734 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 342' ' ' ALA . 2.1 mp -113.51 140.83 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 122.021 0.915 . . . . 0.0 111.263 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.59 114.07 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 127.02 2.128 . . . . 0.0 108.251 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 98.36 178.09 32.81 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 122.662 1.146 . . . . 0.0 114.76 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 48.6 m -130.45 165.62 22.23 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.279 1.832 . . . . 0.0 109.353 171.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.87 -171.97 54.26 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 121.675 -0.64 . . . . 0.0 113.059 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.23 -23.1 33.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.33 1.452 . . . . 0.0 113.999 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.3 m -82.84 -2.73 55.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.482 2.313 . . . . 0.0 114.909 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -76.79 126.53 31.14 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.456 1.025 . . . . 0.0 113.068 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -90.05 161.89 15.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.147 0.579 . . . . 0.0 111.652 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.3 t -137.78 151.36 48.06 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.192 1.397 . . . . 0.0 112.59 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -150.13 131.77 14.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.314 1.846 . . . . 0.0 110.328 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -79.51 136.43 36.9 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.969 -1.082 . . . . 0.0 111.98 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' TRP . . . . . 0.41 ' CZ2' ' HA ' ' A' ' 311' ' ' THR . 21.2 m95 -125.53 152.73 44.64 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.698 0.761 . . . . 0.0 112.243 161.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -133.3 134.15 43.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.053 1.341 . . . . 0.0 108.365 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -127.82 118.9 24.57 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.351 1.46 . . . . 0.0 110.747 -167.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 157.42 16.46 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.329 2.252 . . . . 0.0 111.914 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -76.83 41.73 1.74 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.61 1.1 . . . . 0.0 114.131 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.53 -63.5 0.67 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.905 1.682 . . . . 0.0 110.929 -173.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.4 m -78.22 52.2 1.09 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.78 2.032 . . . . 0.0 110.262 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 15.9 tt -127.92 -14.02 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 130.612 3.565 . . . . 0.0 111.322 167.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -108.06 16.87 35.61 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.579 1.561 . . . . 0.0 114.224 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp . . . . . 0 C--O 1.248 0.997 0 C-N-CA 125.017 1.327 . . . . 0.0 109.687 171.142 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 20.0 m -103.23 11.28 37.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.094 1.357 . . . . 0.0 113.344 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -72.25 -39.28 68.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.609 1.095 . . . . 0.0 111.011 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.5 tt -72.68 138.76 46.84 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 164.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.4 t -55.73 176.91 0.06 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.142 1.777 . . . . 0.0 114.973 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -68.58 83.49 0.28 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.846 1.658 . . . . 0.0 110.451 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.553 ' H ' ' HD2' ' A' ' 293' ' ' LYS . 1.8 mptt -38.12 119.53 0.79 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.238 2.615 . . . . 0.0 112.481 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.86 -37.38 1.06 Allowed Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.745 1.64 . . . . 0.0 114.696 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 58.3 m -75.01 1.39 13.09 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.503 2.321 . . . . 0.0 112.593 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.0 m -158.19 149.93 21.53 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 119.037 -2.289 . . . . 0.0 111.715 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -84.71 178.78 7.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.972 1.309 . . . . 0.0 113.302 -169.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -63.93 162.19 14.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.263 1.425 . . . . 0.0 114.254 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -69.92 157.41 37.49 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.641 1.576 . . . . 0.0 111.853 166.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.7 m -75.29 145.8 41.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.194 0.598 . . . . 0.0 110.255 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.0 p -133.67 21.0 3.9 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.909 1.283 . . . . 0.0 112.022 170.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -82.88 168.48 17.04 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 155.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 100.71 0.27 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.244 1.418 . . . . 0.0 112.067 -166.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 16.7 mtp -86.41 166.14 15.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.022 0.915 . . . . 0.0 112.21 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 18.9 m -163.58 163.31 24.57 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.261 1.024 . . . . 0.0 111.122 169.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.8 114.45 22.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.475 0.71 . . . . 0.0 109.129 163.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.26 -37.91 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.571 1.149 . . . . 0.0 109.552 161.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -135.16 120.49 19.04 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.682 1.593 . . . . 0.0 108.405 168.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -59.62 152.8 54.83 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.31 1.044 . . . . 0.0 110.977 172.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.38 137.06 63.0 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.094 1.863 . . . . 0.0 111.489 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.3 m -132.88 135.01 45.33 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.858 1.263 . . . . 0.0 109.225 173.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.06 130.12 43.3 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.253 0.549 . . . . 0.0 111.97 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 70.3 p -79.43 -21.06 46.06 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.709 1.203 . . . . 0.0 113.333 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 80.98 -8.34 57.43 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.761 1.172 . . . . 0.0 114.364 -161.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -87.97 6.26 36.75 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.298 1.439 . . . . 0.0 112.06 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 88.51 14.49 61.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.282 0.944 . . . . 0.0 113.092 -171.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 50.5 p -131.63 161.17 33.34 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.111 1.364 . . . . 0.0 111.259 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.27 133.02 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 125.253 1.421 . . . . 0.0 109.222 169.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.4 p -115.58 131.87 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.908 1.283 . . . . 0.0 112.05 -172.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 15.8 ptm -144.95 163.18 34.95 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.406 2.282 . . . . 0.0 112.069 -169.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -132.61 130.84 40.76 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.756 0.822 . . . . 0.0 108.915 173.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.47 145.15 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.171 0.988 . . . . 0.0 111.379 -165.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -105.17 135.82 45.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.737 1.215 . . . . 0.0 112.429 -175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.6 t -114.74 135.55 22.38 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.891 1.676 . . . . 0.0 107.714 163.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -100.65 -61.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.899 2.399 . . . . 0.0 115.164 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.96 176.11 11.82 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.714 -1.241 . . . . 0.0 113.091 -176.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.66 -23.19 0.18 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 128.097 2.76 . . . . 0.0 118.683 160.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -109.11 104.09 54.09 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 119.257 1.529 . . . . 0.0 112.766 -166.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.76 114.04 3.19 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.583 1.522 . . . . 0.0 108.502 159.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.7 p -148.8 154.55 39.69 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.997 0.903 . . . . 0.0 112.233 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -78.14 134.92 37.6 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.321 1.448 . . . . 0.0 107.573 161.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -60.08 117.71 26.24 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 118.574 0.625 . . . . 0.0 111.308 -171.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -96.93 88.54 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.348 2.699 . . . . 0.0 113.752 -166.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 60.6 t -107.75 136.26 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 164.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.05 161.07 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.897 1.279 . . . . 0.0 111.104 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 93.0 t -139.34 106.24 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.05 1.74 . . . . 0.0 109.071 -174.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.24 163.01 26.56 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -158.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -87.34 -17.73 31.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.468 1.907 . . . . 0.0 112.883 163.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -123.64 153.05 41.3 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.598 1.159 . . . . 0.0 111.108 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 54.1 mt -69.23 -2.38 10.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.445 1.098 . . . . 0.0 113.883 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 2.2 t -129.4 18.61 5.85 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.579 1.551 . . . . 0.0 112.198 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 49.62 31.25 4.09 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.5 -25.87 68.24 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.745 -0.597 . . . . 0.0 112.388 166.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 31.9 mt -121.95 117.52 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.533 2.333 . . . . 0.0 107.693 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.94 115.66 29.88 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.91 0.777 . . . . 0.0 111.279 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -103.16 -10.44 18.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -174.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -99.33 -167.97 30.18 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 54.5 mt -132.04 133.69 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 127.86 2.464 . . . . 0.0 110.45 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 23.0 mt -65.25 121.0 13.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.932 1.293 . . . . 0.0 109.942 160.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 50.5 t -102.59 -51.89 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 122.924 0.49 . . . . 0.0 110.635 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.4 m -69.85 163.41 25.92 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.509 0.595 . . . . 0.0 110.424 168.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.4 t -52.81 147.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.587 1.155 . . . . 0.0 110.437 170.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -112.13 78.68 2.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.068 1.347 . . . . 0.0 110.2 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.15 -174.2 2.15 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 123.909 3.073 . . . . 0.0 113.349 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 355' ' ' ILE . 0.2 OUTLIER -94.01 168.37 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.521 1.528 . . . . 0.0 110.948 167.146 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.54 110.99 3.89 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 156.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 83.3 p -73.27 -36.99 66.44 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.094 1.358 . . . . 0.0 112.073 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.79 154.36 37.09 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.721 2.008 . . . . 0.0 109.093 160.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -64.82 -19.0 65.61 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.48 0.87 56.57 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.017 1.727 . . . . 0.0 112.919 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -57.84 149.54 22.27 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.503 -1.373 . . . . 0.0 114.074 -171.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -138.91 86.76 2.16 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.118 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.03 145.88 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.794 1.237 . . . . 0.0 111.6 -170.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 45.8 tp -92.35 126.42 37.43 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.059 2.944 . . . . 0.0 110.502 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.8 145.14 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.662 1.585 . . . . 0.0 109.823 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -116.79 149.57 39.75 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.099 0.952 . . . . 0.0 111.948 159.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.19 154.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 125.564 1.546 . . . . 0.0 110.162 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -103.24 114.18 65.23 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.659 1.184 . . . . 0.0 110.22 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.57 143.8 15.38 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.019 2.48 . . . . 0.0 110.969 162.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -74.86 167.68 26.54 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.862 2.375 . . . . 0.0 111.242 169.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -53.63 140.37 29.15 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.734 1.214 . . . . 0.0 112.206 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.9 -147.57 17.0 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -172.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -82.09 164.16 21.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.61 1.564 . . . . 0.0 112.083 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 33.4 m -161.39 148.25 14.64 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.662 -1.274 . . . . 0.0 112.419 158.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -110.14 106.41 15.86 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.104 0.961 . . . . 0.0 108.499 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.4 mm -84.14 114.97 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 125.836 1.655 . . . . 0.0 107.95 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.2 mt -115.64 143.78 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.502 1.121 . . . . 0.0 109.891 -169.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 52.5 t -120.84 113.84 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.679 1.592 . . . . 0.0 108.556 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 90.42 179.54 43.78 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 53.1 m -132.51 165.83 23.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.696 1.998 . . . . 0.0 109.341 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.17 -170.1 55.04 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.808 -0.557 . . . . 0.0 112.783 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -28.15 56.53 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.762 1.225 . . . . 0.0 113.643 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.0 m -78.21 -3.91 45.06 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 127.513 2.325 . . . . 0.0 115.041 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -78.91 144.33 34.99 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.694 0.679 . . . . 0.0 112.822 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.3 mt -111.07 163.88 13.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.615 0.766 . . . . 0.0 110.922 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.5 t -139.52 154.01 47.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.732 1.213 . . . . 0.0 111.459 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -149.19 135.73 19.43 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.89 1.676 . . . . 0.0 109.892 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.77 131.6 38.97 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.415 -0.803 . . . . 0.0 111.662 -172.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -123.72 166.23 15.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.115 0.966 . . . . 0.0 112.04 167.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -138.98 129.94 26.46 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.073 1.749 . . . . 0.0 108.368 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -111.82 119.58 39.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.81 1.644 . . . . 0.0 110.7 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.37 163.59 13.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 129.701 3.2 . . . . 0.0 111.202 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -77.28 42.29 1.9 Allowed Glycine 0 CA--C 1.534 1.223 0 O-C-N 120.911 -1.118 . . . . 0.0 114.202 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 3.5 p -138.0 -54.72 0.65 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.638 1.219 . . . . 0.0 113.09 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.8 m -82.98 54.2 2.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.565 1.946 . . . . 0.0 109.474 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 15.9 tt -135.26 -16.89 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 126.436 1.895 . . . . 0.0 113.73 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -135.1 37.13 1.97 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.934 1.254 . . . . 0.0 113.098 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.674 0 C-N-CA 125.813 1.645 . . . . 0.0 110.288 -173.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.0 t -119.49 9.9 11.68 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.801 1.24 . . . . 0.0 113.374 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.44 ' HB1' ' H ' ' A' ' 336' ' ' VAL . . . -65.57 -46.7 78.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.041 0.837 . . . . 0.0 110.909 167.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.07 129.15 38.88 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 164.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.7 t -57.02 171.33 0.36 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.163 1.385 . . . . 0.0 114.269 -173.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.1 mm? -64.34 109.08 1.79 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.614 1.965 . . . . 0.0 110.721 -167.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -63.78 114.61 4.14 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.989 2.116 . . . . 0.0 110.578 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 78.91 -40.84 2.12 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.827 1.203 . . . . 0.0 113.322 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 5.2 m -65.69 -0.81 2.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.752 2.421 . . . . 0.0 114.013 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.0 m -153.08 151.69 30.49 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 118.994 -2.316 . . . . 0.0 113.65 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -73.82 173.48 9.82 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.359 1.864 . . . . 0.0 112.827 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -71.47 152.77 42.77 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.338 1.055 . . . . 0.0 113.785 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -70.2 157.55 37.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.819 2.048 . . . . 0.0 112.337 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.4 m -69.82 140.51 53.3 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.546 -0.721 . . . . 0.0 111.735 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 17.2 p -128.18 7.1 5.95 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -73.67 166.46 23.24 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.016 0.825 . . . . 0.0 110.888 164.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -71.03 84.15 0.7 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.016 1.727 . . . . 0.0 111.197 -170.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 41.3 mtp -66.63 172.46 4.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.383 1.873 . . . . 0.0 114.337 -174.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.5 m -157.69 159.34 36.81 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.489 1.116 . . . . 0.0 111.249 164.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.97 117.1 19.72 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 169.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.45 -33.49 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.025 0.53 . . . . 0.0 109.659 161.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -137.43 124.08 21.03 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.785 1.634 . . . . 0.0 108.026 164.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -59.18 160.91 10.71 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.211 0.604 . . . . 0.0 111.599 171.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -61.33 135.66 59.23 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.903 1.735 . . . . 0.0 110.589 167.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.0 m -138.48 138.44 38.1 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.766 1.226 . . . . 0.0 108.985 171.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.18 128.57 37.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.09 0.868 . . . . 0.0 111.567 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 73.8 p -79.63 -12.62 59.82 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.252 1.021 . . . . 0.0 113.723 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 75.45 0.69 63.13 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.394 0.997 . . . . 0.0 113.978 -164.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -111.67 14.52 21.21 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.189 1.796 . . . . 0.0 112.32 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.8 15.17 68.38 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.766 0.698 . . . . 0.0 113.501 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.4 p -134.61 162.67 31.64 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.691 1.197 . . . . 0.0 111.176 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.73 130.42 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.597 1.159 . . . . 0.0 109.625 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.33 132.9 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.843 1.257 . . . . 0.0 111.802 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 4.8 ptp -143.84 166.03 26.05 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.117 1.767 . . . . 0.0 112.345 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -133.88 128.71 35.18 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.679 1.192 . . . . 0.0 109.904 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.79 121.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.076 0.951 . . . . 0.0 112.22 -161.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.23 130.13 34.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.512 1.525 . . . . 0.0 112.028 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.29 137.4 19.42 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.985 1.314 . . . . 0.0 108.201 159.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -91.88 -77.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 122.9 2.4 . . . . 0.0 116.256 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 139.16 20.38 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -171.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 83.8 4.74 88.61 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.808 1.194 . . . . 0.0 115.422 174.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.61 89.43 18.53 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 118.664 1.232 . . . . 0.0 112.325 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.1 127.13 13.89 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.215 1.943 . . . . 0.0 108.676 159.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 5.0 p -162.77 162.9 26.88 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -74.4 143.37 44.82 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.04 1.736 . . . . 0.0 109.85 161.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 19.0 pt -66.37 123.91 86.72 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 118.713 0.688 . . . . 0.0 111.213 -176.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 1.8 Cg_endo -108.48 82.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.292 1.994 . . . . 0.0 115.186 -153.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 80.1 t -114.35 131.48 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.369 -0.832 . . . . 0.0 109.818 172.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.67 128.88 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.33 1.052 . . . . 0.0 110.07 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' VAL . . . . . 0.44 ' H ' ' HB1' ' A' ' 289' ' ' ALA . 58.9 t -99.99 119.53 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.586 1.555 . . . . 0.0 107.516 170.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -130.26 161.12 31.93 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -166.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.71 -18.26 58.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.331 1.853 . . . . 0.0 112.98 164.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -128.22 146.02 50.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.746 1.218 . . . . 0.0 111.618 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.74 -17.9 38.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.0 t -105.12 5.93 32.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.427 1.491 . . . . 0.0 113.417 -176.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 40.16 75.96 0.07 Allowed 'General case' 0 C--O 1.239 0.519 0 C-N-CA 129.042 2.937 . . . . 0.0 115.801 -171.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.74 -51.3 4.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.069 1.347 . . . . 0.0 111.655 157.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 72.1 mt -102.57 104.73 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.697 1.599 . . . . 0.0 109.1 -174.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -84.16 115.58 22.48 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -95.3 -11.58 27.63 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.159 2.583 . . . . 0.0 114.562 -173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -115.12 -168.47 15.65 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.6 mt -129.44 135.38 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.404 2.281 . . . . 0.0 110.184 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.04 122.8 17.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.302 1.041 . . . . 0.0 110.555 164.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 73.5 t -102.22 -50.11 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.848 0.859 . . . . 0.0 109.861 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.0 m -69.35 153.27 43.86 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.279 0.562 . . . . 0.0 110.038 166.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.17 159.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.443 1.097 . . . . 0.0 112.236 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -120.93 75.45 28.39 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.043 0.937 . . . . 0.0 112.454 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -57.35 -167.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.127 1 C-N-CA 126.131 4.554 . . . . 0.0 117.221 162.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 27.5 pt -112.14 166.88 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.703 2.401 . . . . 0.0 111.324 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.31 105.34 2.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.988 0.915 . . . . 0.0 109.022 155.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.5 p -72.79 -50.45 24.22 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.391 1.476 . . . . 0.0 111.314 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.59 152.34 19.15 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.991 1.317 . . . . 0.0 108.825 156.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -60.61 -19.02 56.67 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.11 0.39 56.75 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.107 1.763 . . . . 0.0 112.955 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -58.66 147.4 32.85 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.471 -1.393 . . . . 0.0 113.653 -172.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.79 79.54 1.85 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.519 1.528 . . . . 0.0 111.252 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.35 148.56 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.569 1.148 . . . . 0.0 111.502 -165.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.53 127.23 39.09 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.908 2.883 . . . . 0.0 109.798 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.57 141.76 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.002 1.321 . . . . 0.0 109.86 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -119.19 152.35 36.75 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 122.453 1.12 . . . . 0.0 112.573 162.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.8 m -140.89 156.65 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.943 1.697 . . . . 0.0 110.72 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -109.91 116.3 54.0 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.844 1.658 . . . . 0.0 110.772 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.45 160.83 12.82 Favored 'Trans proline' 0 CA--C 1.551 1.369 0 C-N-CA 123.766 2.978 . . . . 0.0 112.095 161.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -76.23 176.35 10.16 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.415 2.743 . . . . 0.0 110.895 164.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -60.02 145.25 47.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.187 0.595 . . . . 0.0 111.247 168.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.33 -152.02 19.71 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.634 0.635 . . . . 0.0 111.664 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.9 167.17 20.17 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.556 1.169 . . . . 0.0 113.154 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 30.8 m -162.64 152.24 15.75 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.441 1.096 . . . . 0.0 110.905 157.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -107.44 119.36 39.19 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.7 mm -99.37 104.69 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 125.778 1.631 . . . . 0.0 107.594 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.38 141.21 18.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.944 1.298 . . . . 0.0 109.799 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 65.7 t -120.56 111.14 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 126.584 1.954 . . . . 0.0 108.442 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.38 -177.43 26.02 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 123.27 1.483 . . . . 0.0 114.658 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 53.7 m -138.35 167.26 22.25 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.236 1.815 . . . . 0.0 109.575 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.38 -175.02 49.45 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 121.741 0.634 . . . . 0.0 112.674 -170.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -23.15 65.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.676 1.19 . . . . 0.0 113.054 175.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 54.0 m -64.57 -15.59 61.26 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 171.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -71.11 138.8 49.99 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.144 1.338 . . . . 0.0 112.813 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 42.3 mt -103.56 161.57 13.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.728 1.211 . . . . 0.0 110.864 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.1 t -143.05 145.1 32.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.004 0.921 . . . . 0.0 112.248 -171.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -150.22 121.8 8.0 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.704 1.602 . . . . 0.0 110.199 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.71 131.44 39.87 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.468 -1.395 . . . . 0.0 111.815 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -119.28 168.84 10.52 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.793 0.837 . . . . 0.0 111.615 159.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.58 145.93 34.07 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.707 1.603 . . . . 0.0 108.971 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -133.15 124.81 28.18 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.081 1.352 . . . . 0.0 110.633 -174.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.64 164.27 11.88 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.721 2.408 . . . . 0.0 111.908 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -76.1 40.49 1.46 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.919 1.247 . . . . 0.0 114.303 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.66 -62.15 0.37 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.675 1.19 . . . . 0.0 112.999 -169.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 3.6 m -83.74 63.09 7.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.848 1.259 . . . . 0.0 110.386 -169.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.1 tt -129.88 15.42 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.291 1.836 . . . . 0.0 113.367 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -169.53 13.12 0.05 OUTLIER Glycine 0 CA--C 1.532 1.154 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.3 0 CA-C-N 119.383 1.591 . . . . 0.0 110.679 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.8 m -97.5 -7.12 32.18 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.274 1.03 . . . . 0.0 113.562 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.38 80.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.323 0.965 . . . . 0.0 113.009 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 53.6 tp -74.65 126.9 31.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 160.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.5 t -55.99 168.5 0.47 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.501 1.12 . . . . 0.0 113.836 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.548 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.8 mm? -59.99 118.04 5.79 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.799 1.639 . . . . 0.0 110.557 -167.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -70.22 108.01 3.97 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.402 1.481 . . . . 0.0 109.512 -163.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 77.15 -45.2 2.25 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.985 1.278 . . . . 0.0 112.768 -170.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 38.9 m -63.37 7.46 0.1 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 128.636 2.775 . . . . 0.0 113.925 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.1 m -157.14 158.69 36.79 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 118.766 -2.458 . . . . 0.0 112.012 167.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -77.62 172.89 12.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.226 1.41 . . . . 0.0 113.023 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -70.28 154.6 41.73 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -171.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -67.6 157.7 33.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.346 2.258 . . . . 0.0 112.275 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 11.2 m -71.68 141.47 49.88 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.442 -0.786 . . . . 0.0 111.333 174.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 12.7 p -134.67 11.13 3.71 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -84.4 177.58 8.08 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.933 0.788 . . . . 0.0 109.518 163.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -71.2 81.37 0.72 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.372 1.869 . . . . 0.0 111.738 -166.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 20.7 mtp -66.15 167.3 10.32 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.928 1.291 . . . . 0.0 112.814 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 28.7 m -158.51 168.6 26.49 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.108 0.963 . . . . 0.0 111.146 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.01 115.12 26.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.815 1.246 . . . . 0.0 110.479 172.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.86 -34.92 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.917 1.287 . . . . 0.0 110.259 167.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -138.18 126.11 22.6 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.036 1.735 . . . . 0.0 108.629 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -61.27 160.58 22.37 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.206 1.002 . . . . 0.0 111.77 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.69 121.62 8.1 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.679 1.586 . . . . 0.0 110.073 169.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 13.6 p -124.32 140.6 52.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.407 1.083 . . . . 0.0 110.499 170.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -60.69 140.94 57.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.599 0.76 . . . . 0.0 112.13 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 76.2 p -97.86 -15.92 20.0 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.205 1.402 . . . . 0.0 113.221 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 75.35 -10.36 11.48 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.493 -163.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -69.11 -11.33 60.7 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.868 1.834 . . . . 0.0 112.464 173.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 92.83 15.95 50.31 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.354 0.978 . . . . 0.0 112.749 -159.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 24.6 p -132.63 168.54 18.09 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.402 1.481 . . . . 0.0 110.995 -171.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.7 140.13 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.22 1.408 . . . . 0.0 109.047 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.3 p -112.95 132.11 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.703 1.201 . . . . 0.0 110.973 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.6 ptm -144.31 165.7 27.15 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.964 1.305 . . . . 0.0 112.806 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -130.19 134.8 47.55 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.274 1.03 . . . . 0.0 109.641 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.93 170.45 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.783 1.233 . . . . 0.0 111.46 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.45 137.62 51.92 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.28 2.232 . . . . 0.0 110.001 173.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.78 145.7 32.21 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.936 1.694 . . . . 0.0 107.407 161.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -102.83 -70.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 123.208 2.605 . . . . 0.0 115.228 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.81 175.56 9.91 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.602 1.561 . . . . 0.0 111.759 -174.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.32 -15.07 0.09 OUTLIER Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.549 2.499 . . . . 0.0 118.358 165.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -112.13 92.05 17.5 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 119.135 1.468 . . . . 0.0 112.768 -165.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.28 116.3 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.832 1.688 . . . . 0.0 108.078 154.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 5.6 p -154.68 157.59 38.33 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.639 -0.663 . . . . 0.0 112.281 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -75.58 140.62 42.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.625 1.57 . . . . 0.0 109.505 165.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 20.5 pt -64.06 121.83 73.9 Favored Pre-proline 0 CA--C 1.557 1.215 0 CA-C-N 119.211 0.914 . . . . 0.0 111.447 -174.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 5.3 Cg_endo -109.04 85.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.36 2.707 . . . . 0.0 114.471 -164.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 23.3 t -119.54 104.09 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.285 -0.884 . . . . 0.0 110.045 171.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.9 160.31 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.662 1.585 . . . . 0.0 110.2 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -136.27 105.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.591 1.556 . . . . 0.0 108.153 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -122.36 158.37 29.78 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.611 1.165 . . . . 0.0 114.071 -163.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.65 -10.38 59.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.504 2.321 . . . . 0.0 112.875 169.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -137.71 150.72 47.54 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.173 1.389 . . . . 0.0 112.462 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 28.8 mt -63.45 -16.4 60.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.623 1.569 . . . . 0.0 114.721 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.2 t -109.2 7.42 25.41 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.824 -177.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 35.28 65.01 0.41 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 128.502 2.721 . . . . 0.0 114.211 -168.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -75.35 -40.93 57.68 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.426 1.09 . . . . 0.0 111.394 159.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 7.8 mm -99.74 169.85 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 125.3 1.44 . . . . 0.0 109.387 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -146.04 116.98 7.74 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.444 -1.41 . . . . 0.0 112.009 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -98.62 -27.16 14.13 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.345 1.858 . . . . 0.0 113.294 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -95.58 -174.53 36.95 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 -173.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.3 mt -124.51 134.91 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.617 1.967 . . . . 0.0 110.102 -174.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.0 mt -70.49 121.52 17.95 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.14 0.976 . . . . 0.0 109.364 162.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.78 -42.64 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.54 0.736 . . . . 0.0 109.914 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 38.6 m -69.96 153.52 43.14 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.143 0.497 . . . . 0.0 110.411 166.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.5 t -56.09 152.75 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.129 1.372 . . . . 0.0 110.346 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -113.16 82.73 5.75 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.16 0.984 . . . . 0.0 111.845 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.46 -168.87 0.68 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 125.27 3.98 . . . . 0.0 112.693 169.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 36.0 pt -93.0 167.37 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.982 1.713 . . . . 0.0 111.89 167.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.82 111.18 2.69 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 152.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 88.5 p -76.09 -45.07 35.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.052 1.341 . . . . 0.0 111.758 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.43 151.52 22.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.044 1.337 . . . . 0.0 108.735 158.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -59.31 -20.33 53.56 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 170.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -101.94 10.9 39.33 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.636 1.574 . . . . 0.0 112.956 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -58.89 152.28 19.79 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.208 -1.557 . . . . 0.0 113.632 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -133.81 83.35 2.04 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.344 1.058 . . . . 0.0 113.096 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 25.9 t -90.47 152.13 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.943 1.697 . . . . 0.0 112.037 -166.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 25.8 tp -109.17 131.39 55.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 129.024 2.93 . . . . 0.0 110.35 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.5 mp -143.2 132.51 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.278 1.431 . . . . 0.0 111.424 -167.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -92.82 135.04 34.48 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.914 1.286 . . . . 0.0 111.597 157.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.59 155.26 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.789 1.235 . . . . 0.0 111.31 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -111.92 108.11 55.77 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.157 1.783 . . . . 0.0 110.925 -173.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.21 119.17 4.15 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.984 3.123 . . . . 0.0 111.031 160.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -60.1 169.24 5.06 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.413 2.742 . . . . 0.0 113.091 167.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -53.56 138.21 34.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.357 1.063 . . . . 0.0 112.277 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.21 -142.34 15.58 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.775 0.702 . . . . 0.0 112.584 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -75.99 163.92 26.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.159 0.984 . . . . 0.0 112.69 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 18.0 m -175.47 167.3 3.29 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.885 2.074 . . . . 0.0 111.192 161.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -133.66 126.51 30.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.661 1.984 . . . . 0.0 108.098 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.6 mm -81.76 129.04 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.03 141.05 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.222 1.009 . . . . 0.0 109.565 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 95.7 t -115.73 113.47 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.806 1.642 . . . . 0.0 108.929 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 96.22 -177.54 33.78 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 122.205 0.892 . . . . 0.0 115.155 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.7 m -133.26 159.3 40.63 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.232 1.813 . . . . 0.0 110.154 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.16 -174.82 54.39 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.866 0.746 . . . . 0.0 113.237 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -54.04 -24.63 17.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.588 1.555 . . . . 0.0 114.354 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 66.9 m -80.8 -4.1 53.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.714 2.006 . . . . 0.0 113.986 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -73.65 128.85 36.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.671 1.123 . . . . 0.0 112.295 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 23.9 mt -100.3 170.03 8.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.113 0.965 . . . . 0.0 111.232 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.8 t -145.92 162.45 37.75 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -148.12 127.86 13.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.12 2.168 . . . . 0.0 108.273 169.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -73.56 137.28 44.23 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.252 -0.905 . . . . 0.0 111.783 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -141.54 133.26 27.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.442 1.097 . . . . 0.0 109.172 166.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -124.77 153.71 42.03 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -133.17 101.55 5.24 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.786 0.803 . . . . 0.0 111.994 -160.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -94.54 170.76 9.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.79 1.636 . . . . 0.0 111.042 167.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -92.42 76.17 1.29 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 123.917 0.77 . . . . 0.0 112.622 -165.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 46.5 p -67.8 -47.37 69.28 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 117.881 0.84 . . . . 0.0 112.462 168.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 10.3 m -69.12 47.53 0.07 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.75 2.42 . . . . 0.0 114.916 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 41.8 pt -60.8 2.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 128.375 2.67 . . . . 0.0 117.768 -170.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 73.39 -54.12 1.93 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.28 1.895 . . . . 0.0 115.842 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.066 1.746 . . . . 0.0 111.878 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 15.9 m -104.34 4.27 33.35 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.9 -49.23 78.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.062 0.945 . . . . 0.0 111.995 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.2 tt -71.13 132.98 45.85 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.256 -0.903 . . . . 0.0 108.837 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.7 t -56.86 169.79 0.48 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.171 1.788 . . . . 0.0 115.076 -168.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.0 mm? -65.23 104.59 0.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.601 1.56 . . . . 0.0 111.392 -168.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 295' ' ' THR . 0.7 OUTLIER -59.97 135.98 57.87 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.64 1.176 . . . . 0.0 111.458 -169.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 62.33 -23.23 0.07 OUTLIER Glycine 0 CA--C 1.541 1.69 0 C-N-CA 126.975 2.226 . . . . 0.0 115.74 -170.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 293' ' ' LYS . 9.2 m -94.63 3.08 55.53 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 130.164 3.386 . . . . 0.0 111.037 -172.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.7 m -163.34 159.69 22.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 119.83 -1.794 . . . . 0.0 111.907 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -87.0 175.33 8.18 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.899 1.28 . . . . 0.0 113.432 -171.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -72.64 159.43 33.87 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.067 1.347 . . . . 0.0 114.498 -171.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 18.0 mmt -75.28 157.4 34.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.693 1.997 . . . . 0.0 111.702 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.1 m -75.53 144.76 41.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.472 -0.768 . . . . 0.0 110.776 172.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 8.3 p -131.87 5.55 4.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.34 167.18 22.16 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.374 0.988 . . . . 0.0 109.792 161.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -68.77 101.29 1.3 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.089 1.355 . . . . 0.0 112.022 -161.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 24.7 mtp -86.53 168.48 13.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.056 0.931 . . . . 0.0 112.969 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.3 m -161.08 160.99 31.1 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.686 1.194 . . . . 0.0 110.866 165.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.31 112.92 18.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.401 0.68 . . . . 0.0 110.126 168.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.3 t -63.26 -35.16 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.417 1.487 . . . . 0.0 110.24 163.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -133.78 123.99 25.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.448 1.499 . . . . 0.0 108.183 165.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -60.42 152.79 63.36 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.72 0.808 . . . . 0.0 111.475 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.35 133.29 45.41 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.133 1.889 . . . . 0.0 110.956 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.9 m -136.19 137.06 40.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.739 1.215 . . . . 0.0 109.183 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -70.08 139.5 52.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.298 0.639 . . . . 0.0 112.454 -175.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.6 p -88.94 -13.08 39.84 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.053 0.941 . . . . 0.0 113.346 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.27 -3.07 3.59 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 119.319 0.963 . . . . 0.0 114.408 -164.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -96.66 10.94 37.11 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.811 1.645 . . . . 0.0 111.519 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 96.98 13.12 47.43 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.179 1.371 . . . . 0.0 114.248 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.6 p -138.13 163.96 30.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.574 1.187 . . . . 0.0 112.225 -170.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.19 132.37 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.489 1.516 . . . . 0.0 109.653 167.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.41 132.47 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.276 1.43 . . . . 0.0 111.693 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.0 ptm -148.37 166.18 28.84 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.342 1.457 . . . . 0.0 113.104 -175.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -136.12 139.44 42.95 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.643 1.177 . . . . 0.0 109.097 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.42 155.92 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.341 1.056 . . . . 0.0 111.474 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -111.76 133.07 54.23 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.876 1.271 . . . . 0.0 112.189 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.39 131.7 21.64 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.148 1.379 . . . . 0.0 107.891 160.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' PRO . . . . . 0.4 ' HG2' ' H ' ' A' ' 326' ' ' LYS . 94.7 Cg_endo -94.44 -67.77 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.097 2.531 . . . . 0.0 114.891 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -145.82 176.65 9.51 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.546 1.938 . . . . 0.0 110.552 -177.231 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.29 -14.74 0.09 OUTLIER Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.788 2.137 . . . . 0.0 118.14 169.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.54 90.48 39.43 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.265 1.532 . . . . 0.0 112.894 -162.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.93 115.63 4.38 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.114 1.876 . . . . 0.0 108.203 156.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.4 p -152.25 157.4 41.37 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -172.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.68 130.71 38.15 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.206 1.802 . . . . 0.0 108.973 165.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 15.2 pt -60.4 114.96 11.4 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-N 118.572 0.624 . . . . 0.0 111.837 -166.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -100.16 87.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.569 2.846 . . . . 0.0 114.333 -160.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 44.2 t -112.09 128.75 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 167.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.05 155.08 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.442 1.097 . . . . 0.0 110.619 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.3 t -130.1 117.33 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.19 1.796 . . . . 0.0 107.364 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -126.62 165.78 18.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.126 0.97 . . . . 0.0 113.315 -166.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -83.61 -8.19 59.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.078 1.751 . . . . 0.0 112.382 162.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -137.3 137.46 39.0 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.401 1.48 . . . . 0.0 111.235 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.13 -20.6 41.59 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -97.79 3.16 50.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.563 1.945 . . . . 0.0 113.673 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 39.21 69.47 0.28 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.963 2.905 . . . . 0.0 115.525 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.19 -34.55 16.62 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.035 1.334 . . . . 0.0 112.116 158.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 35.4 mm -96.78 153.14 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.43 1.092 . . . . 0.0 109.37 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.71 103.21 6.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.553 1.541 . . . . 0.0 109.062 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -94.22 -51.57 4.75 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.663 2.385 . . . . 0.0 113.019 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -82.91 -164.93 36.49 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 -169.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.2 140.68 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 127.374 2.27 . . . . 0.0 109.856 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.51 118.54 14.46 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.563 1.145 . . . . 0.0 109.528 161.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 35.1 t -94.7 -51.04 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 122.831 0.453 . . . . 0.0 110.472 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 36.9 m -70.14 157.48 37.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.102 0.477 . . . . 0.0 110.329 171.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.5 m -52.0 147.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.519 1.128 . . . . 0.0 111.916 171.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -123.0 77.69 50.8 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 123.914 0.886 . . . . 0.0 111.209 -174.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -83.29 -173.15 1.56 Allowed 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 124.872 3.714 . . . . 0.0 112.499 170.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 47.9 pt -84.67 165.75 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.66 1.184 . . . . 0.0 112.15 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.76 124.83 23.49 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 156.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 95.6 p -66.66 -29.83 69.94 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.621 0.768 . . . . 0.0 112.801 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 11.7 m -143.86 153.25 42.15 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.832 2.453 . . . . 0.0 106.983 -168.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.33 -21.01 61.54 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.926 -1.109 . . . . 0.0 113.646 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -95.26 4.11 53.84 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.81 2.444 . . . . 0.0 112.929 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -63.29 157.99 21.43 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.236 -1.54 . . . . 0.0 113.872 -171.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -150.69 86.27 1.39 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.86 149.58 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.886 1.274 . . . . 0.0 112.134 -167.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -92.91 126.06 37.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 129.95 3.3 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.2 mp -138.89 141.56 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.462 1.505 . . . . 0.0 110.768 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.47 141.63 32.0 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.131 1.372 . . . . 0.0 112.198 160.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.68 156.65 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.26 1.024 . . . . 0.0 111.418 168.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -113.05 114.3 48.86 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.381 1.472 . . . . 0.0 110.717 -172.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -85.27 160.82 11.31 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.753 2.969 . . . . 0.0 111.446 163.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -74.12 175.99 10.16 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.842 2.362 . . . . 0.0 110.476 160.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -61.59 142.68 56.96 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.653 -0.654 . . . . 0.0 110.635 159.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.96 -146.83 20.01 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 122.128 -0.358 . . . . 0.0 113.055 -173.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -61.81 145.37 52.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.961 2.105 . . . . 0.0 114.522 -171.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 28.9 m -167.64 162.08 13.92 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.491 1.917 . . . . 0.0 112.041 158.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -130.84 128.03 39.81 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.346 1.458 . . . . 0.0 108.46 169.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 29.3 mm -94.95 120.8 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.422 1.489 . . . . 0.0 108.274 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.2 144.95 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.433 1.093 . . . . 0.0 109.492 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.29 116.19 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.456 1.502 . . . . 0.0 109.332 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 89.76 -178.83 44.14 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 122.548 1.082 . . . . 0.0 114.614 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 92.7 m -127.6 164.12 22.71 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.979 1.312 . . . . 0.0 109.852 172.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 80.64 -173.57 54.78 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 121.855 0.697 . . . . 0.0 112.996 -174.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -23.83 66.45 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.956 1.302 . . . . 0.0 112.762 173.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.4 m -63.62 -10.53 19.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 170.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -78.36 125.49 29.43 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.078 1.308 . . . . 0.0 113.146 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 4.4 mt -88.19 162.24 16.79 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.071 -0.393 . . . . 0.0 111.167 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.8 t -142.43 149.04 38.76 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.883 1.273 . . . . 0.0 111.497 -174.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -151.65 126.68 9.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.731 1.612 . . . . 0.0 110.434 -177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -73.28 128.91 36.82 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.28 -0.888 . . . . 0.0 111.442 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -136.39 125.26 24.1 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.282 0.633 . . . . 0.0 110.298 167.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.27 122.76 32.44 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -94.66 138.79 32.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.144 0.978 . . . . 0.0 111.394 -169.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -39.65 111.23 0.18 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.935 3.294 . . . . 0.0 115.075 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -76.37 54.62 3.22 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.585 1.564 . . . . 0.0 114.503 -174.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 25.2 m -61.64 -18.75 60.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.418 1.487 . . . . 0.0 114.651 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.4 m -72.63 41.29 0.09 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.878 2.471 . . . . 0.0 115.824 -167.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.7 tp -69.92 -34.23 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.161 0.891 . . . . 0.0 112.305 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.87 12.18 47.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.906 1.241 . . . . 0.0 116.067 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? . . . . . 0 C--O 1.25 1.114 0 C-N-CA 125.843 1.657 . . . . 0.0 110.471 -173.872 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.1 p -86.19 -7.27 58.68 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -53.21 -49.98 65.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.117 0.967 . . . . 0.0 112.923 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 22.3 tp -73.59 127.46 32.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.56 -0.712 . . . . 0.0 109.537 163.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.3 t -53.31 171.04 0.08 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -164.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.53 111.88 2.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.617 2.367 . . . . 0.0 111.753 -170.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -61.63 107.54 0.83 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.863 2.465 . . . . 0.0 111.725 -167.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 82.01 0.04 89.1 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.53 1.062 . . . . 0.0 114.5 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 89.1 m -117.88 5.1 12.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.381 1.872 . . . . 0.0 110.965 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.0 m -157.25 156.19 32.08 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 119.51 -1.994 . . . . 0.0 114.027 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -82.92 178.45 8.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.109 2.164 . . . . 0.0 113.328 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -73.48 160.76 31.24 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.524 1.53 . . . . 0.0 114.381 -170.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.15 147.74 32.58 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.248 2.619 . . . . 0.0 111.675 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.59 138.68 56.63 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.526 -0.734 . . . . 0.0 110.733 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.5 p -132.31 14.3 4.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.264 1.026 . . . . 0.0 113.263 172.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -81.45 170.87 15.41 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 118.676 0.671 . . . . 0.0 109.212 159.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -62.06 103.86 0.41 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.052 1.741 . . . . 0.0 111.777 -166.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 25.8 mtp -91.14 165.89 13.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 122.384 1.088 . . . . 0.0 112.142 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 30.7 m -161.94 164.72 28.32 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.049 1.34 . . . . 0.0 109.892 166.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.6 127.48 34.09 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 164.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.85 -32.57 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 159.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -133.84 119.89 19.76 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.647 1.579 . . . . 0.0 109.259 167.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -58.9 150.85 57.95 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.913 1.685 . . . . 0.0 112.063 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -62.8 131.27 32.43 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.535 2.157 . . . . 0.0 110.908 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.56 140.11 46.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.083 0.953 . . . . 0.0 109.691 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.31 132.09 52.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.036 0.934 . . . . 0.0 112.303 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 74.6 p -84.9 -13.7 50.03 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.02 1.328 . . . . 0.0 114.121 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 70.36 18.45 75.22 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.262 -0.743 . . . . 0.0 114.624 -162.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.24 16.16 8.38 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.872 1.336 . . . . 0.0 112.448 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.86 11.76 73.03 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.396 -0.815 . . . . 0.0 113.53 -176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 40.6 p -134.08 161.21 35.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.139 1.375 . . . . 0.0 110.942 -168.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.14 132.92 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.265 1.026 . . . . 0.0 109.614 172.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.14 136.1 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.835 1.254 . . . . 0.0 112.121 -170.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 14.5 ptm -151.01 165.64 33.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.498 1.519 . . . . 0.0 114.012 -172.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -132.07 121.57 24.04 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.767 2.427 . . . . 0.0 107.333 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.5 m -112.99 158.12 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.88 0.872 . . . . 0.0 111.589 -172.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -125.12 143.94 50.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.235 1.014 . . . . 0.0 113.426 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.58 151.16 51.37 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.637 2.375 . . . . 0.0 107.89 167.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -119.89 -60.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.627 2.218 . . . . 0.0 115.877 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 175.48 9.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.476 1.11 . . . . 0.0 112.248 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.57 -15.44 0.1 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.459 2.456 . . . . 0.0 118.638 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.83 92.59 49.03 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.635 1.717 . . . . 0.0 114.181 -159.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.28 124.59 10.07 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.816 1.677 . . . . 0.0 108.388 155.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.0 p -153.84 155.78 36.4 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.463 -0.773 . . . . 0.0 112.44 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -78.46 128.53 33.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.159 1.384 . . . . 0.0 107.785 161.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.7 pp -61.82 115.58 16.22 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -164.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -95.17 94.66 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.362 3.375 . . . . 0.0 113.852 -170.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 32.3 t -124.48 109.17 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.719 -0.613 . . . . 0.0 109.955 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.12 159.32 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.483 1.513 . . . . 0.0 110.984 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 83.8 t -131.81 117.36 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 126.51 1.924 . . . . 0.0 106.412 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.55 165.37 20.89 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -165.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -86.07 -8.65 57.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.271 1.829 . . . . 0.0 112.922 163.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -130.19 142.04 50.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.62 1.168 . . . . 0.0 110.914 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.74 -21.85 56.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.991 1.316 . . . . 0.0 113.726 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.7 t -105.6 5.92 31.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.55 1.94 . . . . 0.0 113.903 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.421 ' HB2' HD13 ' A' ' 377' ' ' ILE . . . 45.02 69.71 0.41 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.708 2.803 . . . . 0.0 116.184 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -82.8 -37.49 24.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.937 0.895 . . . . 0.0 111.861 153.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 36.4 mm -88.98 155.52 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.924 1.289 . . . . 0.0 110.449 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -134.46 93.55 3.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.179 1.791 . . . . 0.0 109.621 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -101.57 -28.16 12.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.832 2.053 . . . . 0.0 114.696 -169.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -99.78 179.96 30.41 Favored Glycine 0 N--CA 1.477 1.368 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -171.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 4.5 mt -117.61 135.51 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.537 2.335 . . . . 0.0 110.168 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.88 132.09 44.74 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.111 0.564 . . . . 0.0 110.319 165.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.06 -49.94 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.2 m -80.41 162.72 24.32 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.607 0.718 . . . . 0.0 110.66 167.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.4 m -63.31 165.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.112 1.765 . . . . 0.0 114.519 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -117.36 81.47 13.74 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.697 1.599 . . . . 0.0 110.917 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.09 -166.95 0.45 Allowed 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 124.412 3.408 . . . . 0.0 112.865 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.9 pt -104.37 169.81 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.284 1.833 . . . . 0.0 110.793 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.07 113.45 8.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.753 0.421 . . . . 0.0 110.099 158.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 82.4 p -73.32 -23.03 60.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.295 1.438 . . . . 0.0 113.361 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 77.4 p -135.0 165.23 25.83 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.946 2.099 . . . . 0.0 108.788 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -63.73 -21.2 66.29 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.018 -1.052 . . . . 0.0 113.471 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -100.39 9.22 42.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.695 1.598 . . . . 0.0 112.567 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -59.18 156.58 11.96 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.812 1.291 . . . . 0.0 113.508 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -148.35 98.72 2.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.982 1.313 . . . . 0.0 112.343 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 53.0 t -92.81 149.55 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.39 1.476 . . . . 0.0 110.438 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.27 124.28 49.27 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.53 2.732 . . . . 0.0 108.697 -174.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.58 136.37 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.671 0.788 . . . . 0.0 111.825 -170.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -95.75 136.54 36.03 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.424 1.49 . . . . 0.0 111.563 152.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.02 154.95 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.212 1.005 . . . . 0.0 111.333 166.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -116.57 113.15 40.67 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.774 2.03 . . . . 0.0 109.779 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -81.09 167.35 18.01 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.949 2.432 . . . . 0.0 111.357 164.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -69.63 173.5 10.76 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.436 2.091 . . . . 0.0 110.773 163.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -62.13 144.74 54.94 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.872 -0.518 . . . . 0.0 110.533 162.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.67 -155.57 18.34 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.782 0.706 . . . . 0.0 111.979 -170.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.58 161.06 21.29 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.459 1.123 . . . . 0.0 112.681 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 49.2 m -160.96 159.29 29.35 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.465 -1.397 . . . . 0.0 111.075 161.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.55 115.07 23.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 29.4 mm -89.59 117.02 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.664 1.586 . . . . 0.0 108.09 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 342' ' ' ALA . 2.9 mp -113.75 141.48 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.699 0.799 . . . . 0.0 110.707 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 99.4 t -116.24 109.27 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.412 1.885 . . . . 0.0 108.173 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 112.58 -177.35 18.36 Favored Glycine 0 N--CA 1.471 0.991 0 N-CA-C 116.241 1.256 . . . . 0.0 116.241 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 99.5 m -138.07 167.39 21.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.963 1.705 . . . . 0.0 109.282 165.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.21 -174.35 44.34 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 121.732 -0.605 . . . . 0.0 112.537 -169.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.78 -25.79 63.43 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.104 0.962 . . . . 0.0 113.435 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.8 m -75.4 -1.26 23.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.451 2.3 . . . . 0.0 114.846 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -79.88 133.59 36.25 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.748 0.819 . . . . 0.0 111.995 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.7 mt -102.84 163.65 12.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.258 0.623 . . . . 0.0 111.27 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 t -137.84 148.51 45.5 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.72 1.208 . . . . 0.0 112.001 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -146.0 131.07 18.29 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.484 1.514 . . . . 0.0 110.277 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -82.11 136.25 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.279 1.031 . . . . 0.0 111.301 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -134.95 154.45 51.7 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.069 0.938 . . . . 0.0 112.675 166.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -124.62 140.9 52.51 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.683 1.593 . . . . 0.0 107.942 165.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? . . . . . 0 N--CA 1.463 0.179 0 C-N-CA 126.381 1.872 . . . . 0.0 108.67 -177.354 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 3.8 m -97.44 5.35 49.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -171.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -71.96 -43.72 64.71 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.165 1.348 . . . . 0.0 112.755 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.1 136.11 56.33 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 165.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 t -54.56 163.94 0.82 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.36 97.06 1.96 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.869 1.668 . . . . 0.0 111.105 -164.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -46.72 133.55 10.47 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.904 2.482 . . . . 0.0 112.328 -171.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.02 -36.94 1.07 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.035 1.302 . . . . 0.0 114.561 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 10.3 p -72.75 -26.46 61.56 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 118.777 1.288 . . . . 0.0 114.246 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.0 m -134.29 150.6 51.0 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.574 0.75 . . . . 0.0 112.462 -152.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -79.94 175.36 10.7 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.287 1.435 . . . . 0.0 112.927 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.31 154.0 42.4 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -71.09 146.35 49.3 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.046 2.139 . . . . 0.0 112.358 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 8.4 m -63.48 143.06 58.13 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.682 -0.636 . . . . 0.0 112.266 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.3 p -135.45 11.44 3.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.641 1.176 . . . . 0.0 113.525 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -71.97 168.98 16.87 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.219 0.918 . . . . 0.0 109.648 161.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -65.36 97.19 0.27 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.424 -0.797 . . . . 0.0 111.899 -172.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 42.7 mtp -86.17 168.0 14.4 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.366 1.079 . . . . 0.0 112.762 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 39.2 m -160.89 163.63 31.83 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.053 1.341 . . . . 0.0 109.963 161.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.82 121.76 25.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.654 0.381 . . . . 0.0 110.119 167.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.01 -29.85 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.267 1.027 . . . . 0.0 110.335 165.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -141.52 132.74 26.42 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.147 1.779 . . . . 0.0 109.303 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -64.81 150.43 94.65 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.379 1.072 . . . . 0.0 112.148 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -62.77 130.88 30.97 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.986 1.791 . . . . 0.0 110.646 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 65.2 p -131.27 137.84 49.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.964 1.306 . . . . 0.0 110.626 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -63.16 126.14 26.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.589 1.556 . . . . 0.0 112.333 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.8 p -70.61 -25.86 63.24 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.95 0.5 . . . . 0.0 111.281 166.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 82.39 -6.17 69.72 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.503 1.525 . . . . 0.0 113.845 -168.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -92.86 18.99 8.14 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.707 1.603 . . . . 0.0 111.37 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 91.9 2.78 68.87 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.738 1.161 . . . . 0.0 115.039 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 28.3 p -127.35 158.56 36.93 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.496 1.648 . . . . 0.0 112.55 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.02 129.78 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.778 1.631 . . . . 0.0 109.611 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.4 p -114.83 130.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.465 1.106 . . . . 0.0 113.085 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.4 ptm -137.97 171.25 14.7 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.809 2.443 . . . . 0.0 111.919 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -135.44 139.45 44.12 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.629 -0.669 . . . . 0.0 109.89 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.93 149.46 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.261 1.024 . . . . 0.0 111.948 -170.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -109.03 137.67 46.58 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.272 1.429 . . . . 0.0 112.833 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.1 t -117.07 133.88 23.08 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 126.977 2.111 . . . . 0.0 107.596 166.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -96.39 -74.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 123.186 2.591 . . . . 0.0 116.984 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.92 146.15 25.42 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 -169.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 76.72 4.55 81.89 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 115.66 1.024 . . . . 0.0 115.66 171.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.25 99.13 43.52 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.843 1.257 . . . . 0.0 111.531 -172.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.66 130.03 14.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.327 2.018 . . . . 0.0 108.884 167.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.8 p -159.98 156.13 26.6 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -75.32 137.8 41.37 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.481 1.913 . . . . 0.0 108.429 162.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 2.0 pp -66.77 124.55 88.83 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-N 118.29 0.495 . . . . 0.0 112.051 -169.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 9.7 Cg_endo -107.35 96.13 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.423 2.749 . . . . 0.0 115.723 -165.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 69.3 t -124.89 124.55 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.39 -0.818 . . . . 0.0 109.473 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.34 154.7 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.572 1.549 . . . . 0.0 110.179 -174.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.22 105.06 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.222 1.409 . . . . 0.0 109.271 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -120.63 160.59 22.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.992 1.317 . . . . 0.0 113.865 -163.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.29 -17.12 46.97 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.747 1.619 . . . . 0.0 112.378 164.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -122.7 133.39 54.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.99 1.316 . . . . 0.0 110.929 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -56.76 -19.45 17.02 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.136 1.775 . . . . 0.0 113.108 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.2 t -101.62 4.51 40.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.665 2.386 . . . . 0.0 113.733 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 37.91 74.28 0.09 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 130.534 3.534 . . . . 0.0 117.326 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -105.52 -16.53 14.69 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.937 1.695 . . . . 0.0 112.83 160.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 64.4 mt -109.45 146.29 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.744 1.618 . . . . 0.0 107.62 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.27 112.83 11.36 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.909 -1.119 . . . . 0.0 111.397 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -104.39 -21.53 13.47 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.07 -168.92 42.11 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 118.716 0.689 . . . . 0.0 114.424 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 65.3 mt -134.44 135.4 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.276 1.831 . . . . 0.0 110.528 -174.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.61 118.57 10.38 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.723 1.209 . . . . 0.0 109.333 160.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.62 -29.54 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.666 0.786 . . . . 0.0 112.342 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.8 m -77.38 153.34 33.79 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.056 0.844 . . . . 0.0 109.737 153.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.5 m -60.96 161.81 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.007 1.323 . . . . 0.0 113.598 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -121.85 78.68 40.37 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.023 1.329 . . . . 0.0 111.466 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.39 -168.04 0.57 Allowed 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 124.404 3.402 . . . . 0.0 113.078 171.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 29.3 pt -95.08 164.46 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.211 1.804 . . . . 0.0 111.27 166.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.92 110.01 3.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 160.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.3 t -76.46 -3.0 34.9 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 90.8 m -153.56 157.07 39.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.026 2.53 . . . . 0.0 104.816 161.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -18.04 50.43 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.559 -1.338 . . . . 0.0 114.148 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.51 8.6 30.24 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.683 2.393 . . . . 0.0 113.479 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -60.57 156.88 15.46 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.226 -1.547 . . . . 0.0 114.099 -173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . 0.25 9.4 pt-20 -146.47 80.79 1.56 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 22.2 t -85.55 145.74 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.041 1.336 . . . . 0.0 112.363 -167.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.02 120.19 39.84 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 129.837 3.255 . . . . 0.0 109.108 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.1 mp -137.72 132.55 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.594 1.557 . . . . 0.0 111.125 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 142.6 29.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.004 0.907 . . . . 0.0 112.219 159.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.55 161.5 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.562 1.545 . . . . 0.0 110.522 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -117.94 108.99 41.7 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.746 1.619 . . . . 0.0 109.346 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.6 154.86 44.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.533 2.155 . . . . 0.0 110.638 163.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.29 175.66 10.27 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.224 1.949 . . . . 0.0 110.232 165.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -62.13 133.61 55.47 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.491 -0.756 . . . . 0.0 110.288 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.74 -149.43 16.6 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.564 1.078 . . . . 0.0 113.56 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.23 149.89 47.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.435 2.294 . . . . 0.0 113.172 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.9 m -163.88 153.78 14.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.988 1.315 . . . . 0.0 113.618 162.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -118.58 116.9 27.58 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.554 1.141 . . . . 0.0 108.679 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 27.5 mm -80.74 117.75 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.209 1.403 . . . . 0.0 107.561 174.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.4 mp -111.87 144.11 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.357 0.599 . . . . 0.0 109.946 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 78.6 t -116.02 117.42 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.011 1.724 . . . . 0.0 108.576 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 94.11 -178.66 37.51 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 122.942 1.301 . . . . 0.0 115.213 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 84.6 m -132.28 166.04 22.79 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.277 1.831 . . . . 0.0 109.423 168.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 76.71 -175.8 53.16 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 121.918 0.732 . . . . 0.0 113.663 -176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.22 -21.78 9.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.343 1.857 . . . . 0.0 114.454 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.1 m -86.47 -4.89 59.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.425 2.29 . . . . 0.0 114.61 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -73.72 137.91 44.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.55 1.068 . . . . 0.0 112.446 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 11.1 mt -106.41 162.94 13.26 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.748 0.819 . . . . 0.0 111.571 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.9 t -132.22 154.45 49.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.766 1.226 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -148.99 131.85 16.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.124 2.17 . . . . 0.0 108.9 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -81.64 134.84 35.52 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.928 -1.108 . . . . 0.0 111.597 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -133.23 146.73 51.72 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.297 0.639 . . . . 0.0 109.916 162.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.95 137.86 49.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 172.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? . . . . . 0 N--CA 1.468 0.457 0 C-N-CA 124.548 1.139 . . . . 0.0 110.531 -168.575 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 3.3 m -65.31 0.11 1.57 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.7 -23.58 66.8 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.559 1.527 . . . . 0.0 114.138 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 49.0 tp -85.68 128.2 34.71 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.916 1.235 . . . . 0.0 108.968 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.2 t -53.47 158.74 1.65 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.511 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.8 mm? -61.47 105.66 0.55 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.1 2.16 . . . . 0.0 110.774 -167.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -63.11 125.22 23.31 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.237 -0.914 . . . . 0.0 111.118 -170.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.89 -50.52 3.01 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.857 1.218 . . . . 0.0 112.842 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 32.1 m -63.94 -0.07 1.01 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.408 2.283 . . . . 0.0 113.432 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.2 m -157.1 154.02 28.75 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 119.024 -2.297 . . . . 0.0 111.725 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -78.01 170.87 15.88 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.816 1.647 . . . . 0.0 113.34 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 152.21 40.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.465 1.106 . . . . 0.0 113.294 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.6 mpp? -62.12 165.78 5.39 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 129.201 3.0 . . . . 0.0 114.314 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -81.15 142.72 32.97 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.281 -0.887 . . . . 0.0 110.545 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.5 p -135.77 18.61 3.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.587 1.155 . . . . 0.0 113.094 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -81.75 161.28 23.37 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 156.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.14 102.25 0.36 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.53 1.532 . . . . 0.0 112.131 -168.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 28.1 mtp -84.64 172.77 11.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.22 1.008 . . . . 0.0 112.837 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.6 m -159.93 167.25 28.44 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.174 -0.954 . . . . 0.0 112.027 166.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.92 117.95 24.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.579 0.752 . . . . 0.0 109.328 167.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.07 -35.26 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.049 0.94 . . . . 0.0 110.015 159.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -135.71 127.07 28.45 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.321 1.448 . . . . 0.0 108.467 165.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -65.15 152.69 90.98 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.467 1.107 . . . . 0.0 111.903 171.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.46 131.08 30.41 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.637 2.225 . . . . 0.0 111.657 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.0 m -136.85 139.61 41.81 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.278 1.031 . . . . 0.0 110.465 174.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -65.16 132.58 49.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.277 1.031 . . . . 0.0 112.549 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 63.9 p -79.62 -21.55 44.76 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.034 1.334 . . . . 0.0 113.49 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 85.08 -9.29 66.89 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.541 1.543 . . . . 0.0 113.696 -162.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -81.66 -7.59 59.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.573 1.187 . . . . 0.0 112.312 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.35 15.23 48.28 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.329 0.966 . . . . 0.0 112.843 -164.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 32.2 p -127.68 155.95 43.13 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.923 1.289 . . . . 0.0 110.907 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 25.6 m -123.18 127.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.889 1.276 . . . . 0.0 109.53 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.69 130.82 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.866 1.266 . . . . 0.0 111.86 -172.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 7.0 ptp -137.74 167.99 20.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.903 2.081 . . . . 0.0 111.082 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -133.11 129.28 37.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.064 0.946 . . . . 0.0 108.964 170.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.22 151.72 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.328 1.051 . . . . 0.0 110.85 -169.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -113.18 131.83 55.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.795 1.238 . . . . 0.0 111.64 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.39 151.07 39.61 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-O 117.062 -1.447 . . . . 0.0 108.531 159.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -111.03 -72.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.184 2.589 . . . . 0.0 115.279 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 172.9 12.5 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.184 -1.573 . . . . 0.0 113.127 -174.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.12 -24.09 0.11 Allowed Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.913 2.197 . . . . 0.0 117.538 170.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -109.0 96.9 22.09 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 125.909 1.684 . . . . 0.0 111.784 -170.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -62.97 133.9 43.65 Favored 'Trans proline' 0 C--N 1.35 0.637 0 N-CA-C 107.675 -1.702 . . . . 0.0 107.675 154.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.4 p -158.88 154.25 25.72 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.315 -0.865 . . . . 0.0 113.234 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -72.39 141.99 48.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.604 157.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.91 123.28 79.28 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 118.986 0.812 . . . . 0.0 111.233 -175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -98.52 72.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.042 3.162 . . . . 0.0 112.694 -168.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.1 t -104.76 130.62 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.87 162.65 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 125.181 1.392 . . . . 0.0 110.586 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.72 120.25 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.988 1.715 . . . . 0.0 107.768 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.89 164.57 22.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -160.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.66 -16.52 36.33 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.453 1.901 . . . . 0.0 113.116 163.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -124.66 138.37 54.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.731 1.212 . . . . 0.0 110.364 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.79 -15.94 14.61 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.8 t -104.28 8.26 36.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.459 1.503 . . . . 0.0 113.877 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 40.32 67.69 0.47 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 129.347 3.059 . . . . 0.0 116.578 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.8 -27.26 23.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.186 0.994 . . . . 0.0 112.574 155.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 56.4 mt -111.86 136.58 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.896 1.678 . . . . 0.0 108.988 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -110.0 98.57 7.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.896 1.278 . . . . 0.0 112.451 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -80.61 -42.68 21.78 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.188 2.595 . . . . 0.0 114.308 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -93.08 -168.55 39.18 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 119.993 1.27 . . . . 0.0 116.261 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.4 mt -125.85 141.76 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.852 2.461 . . . . 0.0 110.071 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.44 136.04 37.53 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.371 1.069 . . . . 0.0 110.4 167.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.56 -40.76 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.031 0.533 . . . . 0.0 112.374 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 27.5 m -72.53 158.63 35.33 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 157.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 10.6 m -55.51 156.2 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.484 1.114 . . . . 0.0 113.095 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -113.82 84.16 8.22 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.325 1.45 . . . . 0.0 109.175 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -81.44 -167.47 0.5 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 124.695 3.597 . . . . 0.0 112.89 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 26.0 pt -95.17 164.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.363 1.865 . . . . 0.0 111.183 166.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -73.77 110.43 8.06 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 154.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.9 p -75.88 -51.82 11.67 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.958 1.303 . . . . 0.0 111.629 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.15 151.14 23.9 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 155.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -57.92 -23.05 51.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.91 9.33 43.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.454 1.502 . . . . 0.0 112.786 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -58.56 153.41 16.26 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.241 -1.537 . . . . 0.0 113.686 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -135.82 84.88 2.12 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.721 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 23.5 t -87.98 142.14 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.248 1.419 . . . . 0.0 111.663 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.89 123.74 35.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.903 2.881 . . . . 0.0 109.409 176.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.95 140.56 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.384 1.474 . . . . 0.0 111.039 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.5 148.24 30.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.3 1.047 . . . . 0.0 112.933 161.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.6 m -131.07 155.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.679 1.592 . . . . 0.0 110.678 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -109.51 106.12 58.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.999 2.12 . . . . 0.0 109.361 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.73 146.96 30.7 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.228 1.952 . . . . 0.0 110.346 161.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.2 170.12 18.99 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.454 2.103 . . . . 0.0 111.009 167.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -55.03 140.89 36.26 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.526 1.131 . . . . 0.0 111.483 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.35 -148.3 18.83 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -171.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -79.93 162.03 25.19 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.489 1.116 . . . . 0.0 112.452 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 17.6 m -164.25 155.41 15.65 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.773 -1.205 . . . . 0.0 111.961 156.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -113.56 112.0 22.82 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.5 mm -78.9 119.49 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.651 1.181 . . . . 0.0 107.86 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -113.37 140.98 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.522 0.729 . . . . 0.0 109.886 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.4 t -120.01 107.04 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 125.421 1.488 . . . . 0.0 108.468 172.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 119.49 -176.34 16.09 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.251 1.405 . . . . 0.0 115.574 172.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 54.7 m -138.76 161.9 36.06 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.426 1.49 . . . . 0.0 109.267 164.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.49 -172.17 50.79 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 121.86 0.7 . . . . 0.0 112.762 -169.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -29.23 11.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.24 1.816 . . . . 0.0 113.647 173.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.7 m -72.29 -4.43 29.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 128.739 2.815 . . . . 0.0 114.693 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -84.96 122.28 28.99 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.04 0.837 . . . . 0.0 112.564 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 29.6 mt -87.06 161.08 18.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.25 0.62 . . . . 0.0 111.327 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.7 t -141.29 145.33 35.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.996 1.318 . . . . 0.0 111.737 -173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -153.75 115.18 4.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.924 1.29 . . . . 0.0 110.775 -171.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.8 135.01 47.86 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.861 -1.149 . . . . 0.0 112.152 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -124.37 166.85 15.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.441 1.096 . . . . 0.0 110.977 157.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.84 138.33 37.41 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.471 1.508 . . . . 0.0 108.011 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? . . . . . 0 N--CA 1.466 0.333 0 C-N-CA 125.224 1.41 . . . . 0.0 110.784 -173.551 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 118.682 -0.675 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 12.1 m -98.14 0.44 45.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -171.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.52 71.24 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.64 1.109 . . . . 0.0 112.353 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.9 tt -66.57 118.18 9.8 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.2 t -55.09 173.03 0.1 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.141 2.176 . . . . 0.0 116.368 -164.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.407 ' H ' HD22 ' A' ' 292' ' ' LEU . 2.7 mm? -60.97 106.36 0.58 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.5 1.92 . . . . 0.0 111.727 -172.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -71.06 141.54 50.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.414 1.486 . . . . 0.0 111.74 -171.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.74 -59.49 1.3 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.292 1.425 . . . . 0.0 113.393 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 14.6 t -68.05 16.38 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.962 2.105 . . . . 0.0 115.213 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 10.0 m -163.69 165.55 23.15 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 120.233 -1.542 . . . . 0.0 112.945 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -86.66 169.23 12.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.781 1.232 . . . . 0.0 113.865 -172.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -70.52 159.18 34.76 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.76 1.624 . . . . 0.0 115.048 -166.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 54.5 mtt -77.23 151.11 35.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.161 2.184 . . . . 0.0 112.062 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.8 m -69.51 142.78 53.62 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.725 -0.609 . . . . 0.0 111.968 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 20.3 p -131.5 7.72 4.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.389 1.076 . . . . 0.0 113.651 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -72.54 159.66 33.55 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.523 1.056 . . . . 0.0 109.984 160.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -63.87 100.47 0.3 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.907 1.683 . . . . 0.0 110.984 -168.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 17.2 mtp -83.83 172.99 11.64 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 122.318 1.056 . . . . 0.0 113.604 -169.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.2 m -155.5 172.5 18.14 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.873 0.869 . . . . 0.0 111.372 161.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.58 121.56 42.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.188 0.995 . . . . 0.0 109.765 164.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 27.1 t -63.77 -36.89 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.003 1.321 . . . . 0.0 109.798 167.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -137.92 126.54 23.63 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.23 1.412 . . . . 0.0 109.836 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -62.96 152.19 84.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.618 1.167 . . . . 0.0 112.217 172.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -62.06 131.86 36.66 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.392 2.062 . . . . 0.0 111.647 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 48.1 p -128.56 132.02 48.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.93 1.292 . . . . 0.0 110.874 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -51.35 118.79 3.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.192 1.797 . . . . 0.0 112.062 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 60.9 p -79.64 -8.6 59.31 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.413 1.485 . . . . 0.0 113.41 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.17 -7.2 6.15 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.523 1.059 . . . . 0.0 114.262 -165.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -89.49 5.37 45.7 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.222 1.511 . . . . 0.0 112.14 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 87.05 17.35 59.49 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.232 0.92 . . . . 0.0 113.148 -170.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 38.4 p -131.47 161.52 32.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.907 1.283 . . . . 0.0 111.062 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.96 128.45 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.907 1.283 . . . . 0.0 109.119 170.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.91 133.16 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.664 1.186 . . . . 0.0 111.844 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 22.2 ptm -146.63 162.35 38.62 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.664 2.385 . . . . 0.0 111.861 -166.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -134.74 130.53 36.35 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.524 -0.735 . . . . 0.0 109.655 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 19.9 m -109.92 164.52 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.837 1.255 . . . . 0.0 111.517 -171.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -134.95 125.03 25.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.547 1.539 . . . . 0.0 111.498 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.83 153.15 37.99 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-O 117.21 -1.376 . . . . 0.0 108.374 162.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -109.02 -72.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 123.293 2.662 . . . . 0.0 115.208 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.3 163.69 31.17 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 121.397 1.908 . . . . 0.0 115.823 -174.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.83 -17.54 0.1 OUTLIER Glycine 0 CA--C 1.538 1.504 0 C-N-CA 127.841 2.638 . . . . 0.0 117.881 171.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -104.22 99.89 19.15 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 119.316 1.558 . . . . 0.0 113.13 -168.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.26 128.46 16.51 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.836 1.69 . . . . 0.0 108.697 155.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.0 p -163.94 155.93 16.94 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.555 -0.715 . . . . 0.0 111.953 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -79.77 128.18 33.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.497 1.519 . . . . 0.0 109.448 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.0 111.01 3.1 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.464 0.706 . . . . 0.0 112.4 -163.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -91.03 85.9 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.726 2.95 . . . . 0.0 113.394 -157.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.42 134.48 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.972 0.909 . . . . 0.0 109.219 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.08 151.72 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.376 1.07 . . . . 0.0 110.232 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.27 109.31 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.889 1.675 . . . . 0.0 107.591 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -117.7 161.24 20.0 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -158.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.28 -11.98 53.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.158 2.183 . . . . 0.0 112.783 162.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -129.81 138.31 50.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.561 1.544 . . . . 0.0 111.073 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 22.5 mt -55.83 -19.18 10.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.587 1.555 . . . . 0.0 114.374 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -105.65 2.36 28.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.95 2.5 . . . . 0.0 114.222 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 49.04 77.58 0.1 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.161 2.584 . . . . 0.0 116.59 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -109.9 -24.34 10.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.393 1.477 . . . . 0.0 112.309 161.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.92 120.54 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.062 1.345 . . . . 0.0 109.018 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.96 114.73 28.89 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.729 0.812 . . . . 0.0 112.916 -169.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -81.39 -51.57 8.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.504 2.722 . . . . 0.0 112.451 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.9 -167.36 40.2 Favored Glycine 0 CA--C 1.537 1.413 0 N-CA-C 116.549 1.379 . . . . 0.0 116.549 -167.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.91 140.44 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 127.035 2.134 . . . . 0.0 110.94 -175.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 7.2 mt -73.05 130.0 39.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.759 1.224 . . . . 0.0 110.466 163.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.09 -45.18 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 122.759 0.424 . . . . 0.0 111.159 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 m -70.03 154.78 41.5 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.67 0.668 . . . . 0.0 110.178 164.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.9 m -56.73 155.89 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.971 0.908 . . . . 0.0 112.253 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -127.79 71.26 78.05 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.049 0.939 . . . . 0.0 111.716 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.23 -169.52 0.75 Allowed 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 124.619 3.546 . . . . 0.0 112.914 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 37.1 pt -87.55 161.29 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 121.502 -0.749 . . . . 0.0 112.196 167.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.85 109.29 2.03 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 156.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.4 p -69.73 -37.2 76.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.617 1.567 . . . . 0.0 112.161 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.46 157.14 30.0 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.082 1.753 . . . . 0.0 109.745 158.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -62.95 -17.95 62.58 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.88 7.88 44.57 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.623 1.169 . . . . 0.0 112.356 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -59.45 150.39 26.78 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.63 -1.294 . . . . 0.0 113.257 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -134.84 80.17 1.83 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.355 1.062 . . . . 0.0 113.289 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.23 146.5 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.031 1.332 . . . . 0.0 111.942 -171.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 27.6 tp -97.96 129.01 44.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 129.405 3.082 . . . . 0.0 110.034 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.2 mp -140.28 148.6 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 109.726 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -121.25 148.07 44.78 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.249 1.023 . . . . 0.0 112.354 157.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.45 156.57 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.689 1.596 . . . . 0.0 110.909 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -116.21 104.96 51.53 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.58 1.952 . . . . 0.0 110.639 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.16 164.62 15.05 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.645 2.897 . . . . 0.0 111.747 163.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.58 -178.93 4.85 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.792 2.995 . . . . 0.0 111.836 166.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -67.0 150.9 48.61 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.525 -0.735 . . . . 0.0 110.551 158.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 94.47 -151.05 20.0 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 -167.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.9 162.5 20.48 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.754 1.222 . . . . 0.0 113.276 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 19.3 m -165.09 159.08 17.4 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.822 -1.174 . . . . 0.0 111.818 157.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -122.25 116.16 23.64 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 11.7 mm -92.1 111.14 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.349 1.06 . . . . 0.0 108.188 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.3 145.41 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.961 0.904 . . . . 0.0 109.957 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.86 113.41 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.415 1.886 . . . . 0.0 109.015 174.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.58 178.16 27.13 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.435 1.017 . . . . 0.0 114.855 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 17.8 m -131.43 159.95 36.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.811 1.645 . . . . 0.0 109.566 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 78.35 -175.74 54.57 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 121.898 0.721 . . . . 0.0 112.966 -172.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -22.17 63.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.033 1.333 . . . . 0.0 112.85 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 72.0 m -63.47 -12.31 30.57 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 168.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -79.4 144.01 34.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.099 1.318 . . . . 0.0 112.799 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 24.9 mt -111.81 164.37 13.14 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.428 1.091 . . . . 0.0 111.24 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.5 t -140.58 146.85 38.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.802 1.241 . . . . 0.0 111.686 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -143.93 112.24 6.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.824 1.65 . . . . 0.0 110.034 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 131.62 46.44 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.98 0.912 . . . . 0.0 111.664 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -121.05 158.46 27.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.35 1.06 . . . . 0.0 110.775 162.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -145.5 140.03 27.23 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? . . . . . 0 C--N 1.332 -0.155 0 C-N-CA 124.994 1.318 . . . . 0.0 108.694 176.843 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.2 m -98.09 2.07 48.29 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.378 1.071 . . . . 0.0 112.984 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.48 82.0 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.074 0.852 . . . . 0.0 112.928 175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.38 135.99 37.57 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.473 1.033 . . . . 0.0 108.974 168.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.1 t -52.76 167.69 0.14 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.143 1.777 . . . . 0.0 114.658 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.92 100.16 0.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.283 1.833 . . . . 0.0 110.204 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.427 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 8.3 mptt -61.09 127.93 33.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.573 2.349 . . . . 0.0 110.995 -168.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.06 -42.93 1.18 Allowed Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.937 1.256 . . . . 0.0 113.662 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 58.3 m -63.28 -5.91 3.95 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.791 2.436 . . . . 0.0 114.04 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 45.1 m -126.43 152.99 45.65 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -78.15 173.56 12.11 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.492 1.517 . . . . 0.0 112.261 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.34 158.28 29.57 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 51.0 mtm -88.9 154.48 20.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.899 2.08 . . . . 0.0 111.52 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.5 m -72.35 141.15 48.78 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.68 -0.637 . . . . 0.0 111.937 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.9 p -132.7 6.56 4.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -68.89 160.82 29.99 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.195 1.362 . . . . 0.0 109.975 160.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.58 95.66 0.23 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.692 1.597 . . . . 0.0 111.9 -169.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 65.6 mtp -80.45 172.62 13.53 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.203 1.401 . . . . 0.0 113.149 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 28.2 m -158.58 170.68 21.65 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.85 1.26 . . . . 0.0 110.45 160.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.55 123.94 36.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.405 0.682 . . . . 0.0 110.936 170.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 63.6 t -67.43 -36.34 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.583 1.553 . . . . 0.0 109.925 165.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -136.44 108.87 7.36 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 126.484 1.914 . . . . 0.0 107.724 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -59.49 143.88 85.27 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.959 0.904 . . . . 0.0 110.151 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.62 140.48 86.87 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.596 2.197 . . . . 0.0 111.612 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 389' ' ' TRP . 43.3 p -136.87 130.79 32.27 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.455 1.502 . . . . 0.0 109.71 173.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.93 134.14 52.35 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 124.262 0.976 . . . . 0.0 112.694 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 43.5 p -82.26 -18.34 42.8 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.23 1.012 . . . . 0.0 113.267 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 60.9 22.5 60.17 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.192 0.905 . . . . 0.0 112.55 -163.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -121.38 13.94 11.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.071 1.748 . . . . 0.0 111.024 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 103.07 -3.86 48.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.876 1.703 . . . . 0.0 114.119 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 25.9 p -127.63 161.9 27.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.961 1.38 . . . . 0.0 112.797 -165.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.72 135.12 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.648 1.579 . . . . 0.0 108.601 162.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.63 125.65 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.223 1.009 . . . . 0.0 112.841 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 18.7 ptm -146.01 158.36 43.87 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.941 1.696 . . . . 0.0 113.389 -166.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -138.35 137.47 37.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.921 1.288 . . . . 0.0 109.423 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 362' ' ' GLU . 35.4 m -124.27 149.1 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.877 1.271 . . . . 0.0 110.994 -169.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -116.11 134.32 55.06 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.965 1.706 . . . . 0.0 111.359 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.82 148.52 37.53 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.267 1.427 . . . . 0.0 108.374 163.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -105.87 -70.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.252 2.635 . . . . 0.0 116.201 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.09 168.44 19.81 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 120.129 -1.607 . . . . 0.0 113.591 -170.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.44 -16.77 0.09 OUTLIER Glycine 0 CA--C 1.54 1.642 0 C-N-CA 126.641 2.067 . . . . 0.0 117.501 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -119.48 91.76 44.92 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 119.305 1.553 . . . . 0.0 113.153 -163.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.35 131.62 19.34 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.977 1.784 . . . . 0.0 108.577 152.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 1.6 p -161.76 159.06 26.7 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.397 -0.814 . . . . 0.0 112.406 -170.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -73.55 132.19 42.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.896 1.678 . . . . 0.0 108.608 164.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.4 pp -62.66 111.58 5.04 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 118.692 0.678 . . . . 0.0 112.7 -168.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -89.74 75.17 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.251 3.301 . . . . 0.0 112.751 -163.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.95 130.27 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 167.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.83 158.99 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.135 0.974 . . . . 0.0 109.857 172.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.54 116.61 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.765 2.026 . . . . 0.0 106.314 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.34 161.61 31.97 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -160.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.02 -11.49 52.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.124 2.17 . . . . 0.0 112.784 169.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.51 136.64 51.06 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.145 1.778 . . . . 0.0 109.621 176.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.6 mp -60.11 -18.49 47.68 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -94.27 -1.01 54.66 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.126 2.17 . . . . 0.0 114.569 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 46.56 79.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.851 2.46 . . . . 0.0 115.933 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -103.71 -32.64 9.27 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.381 1.472 . . . . 0.0 111.864 158.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.98 115.48 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.628 1.104 . . . . 0.0 110.609 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.03 111.82 22.63 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.029 0.932 . . . . 0.0 113.06 -173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -86.38 -25.15 25.49 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 130.15 3.38 . . . . 0.0 114.459 -170.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -113.15 -163.93 15.74 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 115.766 1.066 . . . . 0.0 115.766 -169.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.62 137.85 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 127.904 2.481 . . . . 0.0 110.415 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.5 mt -74.81 134.49 41.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.757 164.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.0 t -104.78 -49.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.581 0.753 . . . . 0.0 110.356 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 37.5 m -71.66 155.79 40.1 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.118 0.485 . . . . 0.0 110.204 166.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.15 157.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.391 1.076 . . . . 0.0 112.562 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -121.96 75.71 39.01 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.486 1.114 . . . . 0.0 111.136 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -79.98 -164.22 0.27 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.458 3.439 . . . . 0.0 112.284 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.6 pt -96.73 162.24 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.791 1.637 . . . . 0.0 111.958 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.16 112.11 4.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.118 0.967 . . . . 0.0 108.657 157.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 98.9 p -63.77 -30.04 71.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.711 1.204 . . . . 0.0 113.059 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 12.2 m -137.23 155.96 48.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 128.259 2.624 . . . . 0.0 106.691 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -57.74 -19.55 28.49 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -97.09 10.68 38.66 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.331 1.452 . . . . 0.0 113.408 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -60.37 158.23 12.26 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 120.061 -1.649 . . . . 0.0 114.037 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 11.2 pt-20 -145.2 77.83 1.53 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.62 147.85 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.655 1.182 . . . . 0.0 112.171 -172.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 26.6 tp -105.37 132.33 51.7 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 129.709 3.203 . . . . 0.0 110.106 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.7 mp -144.41 138.88 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.859 1.664 . . . . 0.0 111.123 -167.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -99.45 135.69 40.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.821 1.248 . . . . 0.0 111.462 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.15 163.19 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.787 1.235 . . . . 0.0 110.873 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -119.03 112.88 35.98 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.771 2.028 . . . . 0.0 109.587 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.18 153.22 16.41 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 122.934 2.423 . . . . 0.0 111.159 158.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.76 174.27 4.77 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.124 2.549 . . . . 0.0 112.974 165.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.77 140.84 56.23 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.491 1.116 . . . . 0.0 110.155 164.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 96.4 -148.68 19.08 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.3 163.29 23.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.143 0.977 . . . . 0.0 113.451 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 37.6 m -163.17 161.59 25.12 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.792 -1.193 . . . . 0.0 110.785 158.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -121.27 114.87 21.98 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 15.0 mm -83.73 121.58 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.75 141.41 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.656 0.782 . . . . 0.0 109.688 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 81.6 t -122.86 104.36 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 126.353 1.861 . . . . 0.0 108.483 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.59 177.37 20.72 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 122.703 1.169 . . . . 0.0 114.575 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 98.8 m -130.31 164.29 24.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.353 1.461 . . . . 0.0 109.104 165.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.49 -171.53 53.03 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 122.031 0.795 . . . . 0.0 113.068 -173.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -29.98 59.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.099 1.76 . . . . 0.0 113.325 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.8 m -66.68 -11.48 54.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -74.43 123.35 24.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.184 1.356 . . . . 0.0 113.037 -169.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 14.2 mt -84.49 163.29 19.51 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.895 0.478 . . . . 0.0 111.201 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 t -138.41 148.15 44.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.893 1.277 . . . . 0.0 111.12 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -147.58 111.38 5.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.318 1.447 . . . . 0.0 110.611 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 134.24 50.23 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.532 1.133 . . . . 0.0 112.353 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . 0.408 ' CZ2' ' HA ' ' A' ' 311' ' ' THR . 11.1 m95 -126.0 162.97 24.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.277 1.431 . . . . 0.0 112.671 166.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.04 133.51 33.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.164 2.185 . . . . 0.0 108.158 171.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 C-N-CA 124.899 1.279 . . . . 0.0 110.917 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 60.3 p -103.45 -6.54 21.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.691 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -49.16 -57.43 6.7 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.386 1.075 . . . . 0.0 112.55 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.47 124.18 21.61 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 163.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.1 t -50.84 164.61 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.579 1.952 . . . . 0.0 115.687 -165.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.525 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.1 mm? -59.07 102.91 0.14 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.272 1.829 . . . . 0.0 110.471 -172.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -60.95 135.53 57.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.02 2.128 . . . . 0.0 111.018 -168.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 73.5 -47.56 1.44 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.533 1.063 . . . . 0.0 113.343 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.7 m -63.41 -16.58 60.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.548 1.939 . . . . 0.0 113.467 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -124.99 143.84 50.69 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.119 1.368 . . . . 0.0 112.241 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -73.47 173.31 9.82 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.872 0.869 . . . . 0.0 112.025 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -68.17 160.93 28.12 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.344 1.058 . . . . 0.0 113.675 -175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 46.3 mtt -88.7 158.4 18.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.894 1.677 . . . . 0.0 112.379 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.0 m -70.82 140.94 51.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.221 0.608 . . . . 0.0 111.906 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 13.3 p -123.21 9.07 9.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.37 1.068 . . . . 0.0 113.289 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -70.15 161.31 30.46 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.624 -0.672 . . . . 0.0 111.067 164.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -65.7 91.97 0.14 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.525 1.93 . . . . 0.0 111.433 -167.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 5.8 mtp -76.7 167.13 22.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.767 1.27 . . . . 0.0 113.413 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 27.7 m -159.63 173.6 15.85 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.062 1.345 . . . . 0.0 110.249 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -109.01 128.99 55.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.35 1.06 . . . . 0.0 111.09 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.5 -33.88 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.737 1.615 . . . . 0.0 109.68 163.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -138.9 124.73 19.77 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.097 1.359 . . . . 0.0 109.988 169.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -62.83 143.78 96.93 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.253 1.421 . . . . 0.0 112.061 169.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -58.56 132.07 46.15 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.587 2.191 . . . . 0.0 112.607 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.1 142.86 44.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.534 0.734 . . . . 0.0 110.335 172.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -66.83 134.85 52.94 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.035 0.934 . . . . 0.0 112.836 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.6 p -79.9 -20.94 44.63 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.076 1.351 . . . . 0.0 113.341 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 88.76 -12.37 65.84 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.661 1.601 . . . . 0.0 113.89 -166.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -90.12 9.44 28.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.523 1.529 . . . . 0.0 112.137 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 83.84 14.75 71.96 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 121.127 -0.983 . . . . 0.0 114.054 -171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.7 p -125.02 158.28 34.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.554 1.142 . . . . 0.0 110.929 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.83 131.07 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.045 1.338 . . . . 0.0 109.706 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.06 131.38 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.232 1.413 . . . . 0.0 111.804 -172.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 4.5 ptp -143.29 165.61 27.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.786 2.034 . . . . 0.0 111.858 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -136.96 132.12 33.94 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.473 -0.767 . . . . 0.0 109.5 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.6 m -113.44 163.97 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.386 1.075 . . . . 0.0 111.749 -168.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -125.12 115.53 20.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.358 1.463 . . . . 0.0 110.624 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 t -91.61 134.54 29.11 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 116.857 -1.544 . . . . 0.0 107.343 165.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -97.02 -80.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.447 0 C-N-CA 122.525 2.15 . . . . 0.0 116.381 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.13 144.97 21.51 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 119.25 -2.156 . . . . 0.0 115.878 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 88.54 0.53 81.96 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.87 1.224 . . . . 0.0 115.23 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.67 98.3 45.85 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.989 1.316 . . . . 0.0 111.486 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.54 123.36 10.1 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.3 2.0 . . . . 0.0 108.433 161.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.9 p -157.0 157.35 34.55 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.128 0.966 . . . . 0.0 113.251 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -69.83 138.82 52.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.075 1.75 . . . . 0.0 108.776 162.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 1.0 OUTLIER -62.42 121.77 69.08 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 118.721 0.691 . . . . 0.0 111.855 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 11.9 Cg_endo -99.98 95.69 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.649 2.233 . . . . 0.0 114.768 -155.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.72 141.98 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.02 0.928 . . . . 0.0 110.932 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.31 159.59 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.95 1.7 . . . . 0.0 110.309 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.4 t -133.35 97.91 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.284 1.834 . . . . 0.0 108.028 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -111.9 160.98 16.88 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -165.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -81.98 -17.2 47.74 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.859 1.664 . . . . 0.0 112.614 162.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -123.89 138.66 54.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.633 1.173 . . . . 0.0 111.745 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.68 -18.65 32.67 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.11 1.364 . . . . 0.0 113.314 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.4 t -91.53 -4.17 55.71 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.124 1.769 . . . . 0.0 114.388 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.51 70.05 0.32 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.133 2.173 . . . . 0.0 114.555 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -104.09 -14.57 15.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.951 0.9 . . . . 0.0 111.929 163.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 56.5 mt -111.74 155.83 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.702 1.601 . . . . 0.0 108.373 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -141.73 123.01 14.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.725 -1.234 . . . . 0.0 112.414 170.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -116.69 -11.38 11.0 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -96.65 -172.59 34.83 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.415 0.926 . . . . 0.0 115.415 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 23.3 mt -126.45 138.06 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.924 2.089 . . . . 0.0 110.775 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 50.5 mt -68.85 132.39 46.68 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.616 0.766 . . . . 0.0 109.815 163.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.42 -41.56 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 118.411 0.551 . . . . 0.0 112.05 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 59.9 m -76.88 145.8 38.08 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.655 0.661 . . . . 0.0 109.379 159.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 25.4 t -63.38 154.51 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.444 1.098 . . . . 0.0 111.44 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -117.98 82.99 18.17 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.21 1.404 . . . . 0.0 112.204 -174.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -85.42 -154.34 0.05 OUTLIER 'Trans proline' 0 CA--C 1.554 1.487 0 C-N-CA 125.24 3.96 . . . . 0.0 112.66 172.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.9 pt -107.33 166.6 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.171 2.189 . . . . 0.0 111.761 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.25 118.02 12.54 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 158.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 85.4 p -74.71 -44.11 51.66 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.149 1.38 . . . . 0.0 112.521 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.75 155.14 20.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.005 1.722 . . . . 0.0 108.623 158.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -59.77 -26.49 65.75 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -91.37 9.93 29.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.508 1.523 . . . . 0.0 113.068 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -60.08 150.89 28.08 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.45 -1.406 . . . . 0.0 114.252 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.24 88.84 2.45 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 66.0 t -100.56 144.91 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.16 1.384 . . . . 0.0 111.834 -162.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.6 tp -95.73 126.43 40.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.799 2.84 . . . . 0.0 109.774 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.57 154.04 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.698 1.199 . . . . 0.0 110.812 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.29 148.2 50.64 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 124.712 1.205 . . . . 0.0 111.229 165.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.59 154.09 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.38 1.472 . . . . 0.0 110.686 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.9 109.84 59.21 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.621 1.569 . . . . 0.0 109.126 173.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.78 144.62 31.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.236 1.958 . . . . 0.0 111.43 163.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.13 168.3 25.12 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.173 2.582 . . . . 0.0 110.852 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -56.76 134.72 55.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.645 1.178 . . . . 0.0 111.897 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.63 -148.62 19.18 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.195 0.902 . . . . 0.0 112.685 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.73 147.71 22.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.16 2.184 . . . . 0.0 113.786 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 29.7 m -163.44 154.12 16.16 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.273 1.429 . . . . 0.0 113.042 159.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -117.22 105.27 12.04 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.666 1.586 . . . . 0.0 108.955 172.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 20.5 mm -78.48 116.57 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 30.3 mt -121.84 139.51 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.118 0.485 . . . . 0.0 110.524 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 68.9 t -115.31 114.49 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.38 1.872 . . . . 0.0 107.886 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 99.89 177.63 30.73 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 122.81 1.228 . . . . 0.0 114.756 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 94.5 m -127.31 163.69 23.4 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.064 1.746 . . . . 0.0 109.767 167.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.41 -173.7 52.85 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 121.746 0.637 . . . . 0.0 113.265 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -25.67 64.44 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.329 1.452 . . . . 0.0 113.251 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.5 m -64.86 -13.72 57.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 170.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -74.11 136.95 42.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.07 1.304 . . . . 0.0 112.266 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 17.3 mt -104.43 154.78 19.44 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.406 0.682 . . . . 0.0 110.607 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.6 t -129.0 145.61 51.2 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.525 1.13 . . . . 0.0 112.161 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -146.16 108.63 4.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.465 1.506 . . . . 0.0 109.585 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -65.21 137.99 57.95 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.607 1.163 . . . . 0.0 111.759 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -142.07 126.19 17.4 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.727 1.211 . . . . 0.0 111.36 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -96.8 131.89 43.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.818 0.847 . . . . 0.0 109.731 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? . . . . . 0 N--CA 1.468 0.445 0 C-N-CA 125.589 1.555 . . . . 0.0 110.663 177.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 117.813 -1.089 . . . . 0.0 113.805 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.1 p -98.98 -7.38 27.03 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.137 1.335 . . . . 0.0 114.393 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.12 -48.37 70.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.678 1.191 . . . . 0.0 112.851 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.08 121.22 14.65 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 2.3 t -52.07 168.85 0.08 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.264 1.826 . . . . 0.0 115.153 -168.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.1 109.88 0.66 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.132 1.773 . . . . 0.0 110.635 -171.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -69.7 138.98 53.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.458 1.903 . . . . 0.0 110.738 -165.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 64.66 -59.35 0.07 OUTLIER Glycine 0 CA--C 1.534 1.246 0 C-N-CA 127.57 2.509 . . . . 0.0 113.836 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 40.4 p -47.03 -21.92 0.28 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 130.951 3.7 . . . . 0.0 115.817 168.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . 0.508 ' HB2' ' HE3' ' A' ' 331' ' ' LYS . 2.6 p -145.24 161.97 38.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.863 1.211 . . . . 0.0 113.096 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -81.35 170.32 16.15 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -163.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 162.08 29.44 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.477 1.132 . . . . 0.0 113.994 -176.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 43.6 mtt -80.46 161.37 24.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.246 2.218 . . . . 0.0 113.162 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 8.1 m -72.26 146.56 47.15 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.585 -0.697 . . . . 0.0 112.089 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.8 p -136.69 8.39 3.06 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -78.5 158.57 28.56 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.139 1.336 . . . . 0.0 110.013 159.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 101.68 0.14 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.903 1.281 . . . . 0.0 112.006 -168.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 38.2 mtp -81.89 165.91 20.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.684 0.793 . . . . 0.0 112.073 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.7 p -147.93 159.36 43.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.941 0.897 . . . . 0.0 111.455 168.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -77.76 118.64 20.31 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 169.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.23 -30.31 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.225 0.61 . . . . 0.0 109.918 161.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -144.62 130.38 19.15 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.746 1.619 . . . . 0.0 109.125 168.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -63.62 153.09 84.46 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.526 0.73 . . . . 0.0 112.078 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.07 127.31 19.95 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.761 2.307 . . . . 0.0 110.962 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 48.3 p -126.22 133.66 51.44 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.873 1.269 . . . . 0.0 110.952 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -63.69 133.98 54.57 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.186 1.794 . . . . 0.0 112.277 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 6.4 p -71.68 -19.98 62.0 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 165.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.69 17.41 67.01 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-N 118.733 0.697 . . . . 0.0 112.198 -164.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -128.44 9.56 6.08 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.086 1.754 . . . . 0.0 111.616 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.98 6.75 36.82 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.12 -1.378 . . . . 0.0 114.861 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.4 p -128.54 160.38 32.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.789 1.794 . . . . 0.0 112.687 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.2 m -130.43 132.84 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.456 1.502 . . . . 0.0 109.778 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.5 p -120.23 129.85 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.953 1.301 . . . . 0.0 112.958 -169.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 5.8 ptp -140.53 166.33 25.03 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.768 1.627 . . . . 0.0 112.833 -172.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -132.27 138.65 47.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.297 1.039 . . . . 0.0 110.083 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.8 151.29 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.356 1.062 . . . . 0.0 110.776 -169.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -107.8 127.88 54.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.06 1.344 . . . . 0.0 110.577 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.41 138.81 20.01 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 117.257 -1.354 . . . . 0.0 107.734 162.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -104.79 -75.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.427 2.085 . . . . 0.0 115.325 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.47 174.67 10.55 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.042 -1.661 . . . . 0.0 114.274 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.21 3.21 17.1 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 116.952 1.541 . . . . 0.0 116.952 170.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.11 95.1 37.45 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 119.038 1.419 . . . . 0.0 112.9 -162.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -72.1 124.31 9.94 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.103 1.869 . . . . 0.0 108.659 159.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.0 p -161.68 156.64 23.33 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -173.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 296' ' ' SER . 14.1 tptp -73.54 135.68 43.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.837 2.855 . . . . 0.0 109.418 162.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 14.6 pt -63.45 124.25 83.77 Favored Pre-proline 0 N--CA 1.479 1.005 0 CA-C-N 119.85 1.205 . . . . 0.0 111.409 -171.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -105.77 89.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 121.622 1.548 . . . . 0.0 114.57 -157.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 74.3 t -125.98 132.04 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.884 0.873 . . . . 0.0 109.531 173.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.8 158.53 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.859 1.264 . . . . 0.0 110.674 -172.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 35.4 t -127.1 126.75 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.057 1.743 . . . . 0.0 107.552 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -132.01 161.45 33.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.902 1.281 . . . . 0.0 112.795 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.97 -22.65 33.66 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.749 1.22 . . . . 0.0 112.333 166.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -107.61 154.79 20.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.267 1.427 . . . . 0.0 111.479 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.69 -19.28 63.72 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.6 t -117.82 7.06 12.34 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.677 1.191 . . . . 0.0 113.951 -167.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 47.15 70.2 0.43 Allowed 'General case' 0 C--O 1.238 0.497 0 C-N-CA 127.974 2.51 . . . . 0.0 114.691 -170.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -83.81 -43.35 15.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.286 1.034 . . . . 0.0 111.158 154.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 43.4 mm -86.93 153.44 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.585 1.154 . . . . 0.0 109.959 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . 0.263 0.0 OUTLIER -125.15 96.4 4.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 123.171 1.462 . . . . 0.0 110.707 171.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -78.2 -55.56 5.17 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 128.732 2.813 . . . . 0.0 111.869 -169.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.28 -168.12 41.38 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.438 1.494 . . . . 0.0 116.273 -166.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.1 mt -124.11 139.91 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 126.604 1.961 . . . . 0.0 111.152 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.65 125.24 26.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.594 1.158 . . . . 0.0 110.487 168.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.5 t -104.15 -54.04 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.528 0.731 . . . . 0.0 109.286 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 50.0 m -71.76 140.61 49.57 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 167.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.67 150.63 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.887 1.275 . . . . 0.0 112.369 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -125.0 70.84 61.28 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.59 1.156 . . . . 0.0 112.556 -167.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.85 -167.12 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.73 3.62 . . . . 0.0 112.575 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.7 pt -83.34 160.35 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.694 1.198 . . . . 0.0 112.748 173.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.1 110.75 4.67 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 156.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.2 p -66.88 -33.06 74.77 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.071 1.749 . . . . 0.0 112.696 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.09 146.8 50.25 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.749 2.02 . . . . 0.0 108.06 167.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -59.84 -17.9 39.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -91.3 0.72 57.48 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.683 1.993 . . . . 0.0 112.758 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.06 151.69 30.15 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.45 -1.406 . . . . 0.0 113.068 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -136.57 82.72 1.96 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.174 0.987 . . . . 0.0 112.963 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 43.9 t -99.42 153.1 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.288 1.435 . . . . 0.0 111.582 -164.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.53 128.68 55.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.217 2.207 . . . . 0.0 109.778 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.1 mp -135.87 141.38 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.401 1.48 . . . . 0.0 109.035 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -114.9 149.6 36.95 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 122.078 0.942 . . . . 0.0 112.85 161.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.23 158.37 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.867 1.667 . . . . 0.0 110.883 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -109.01 102.68 49.72 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.588 1.955 . . . . 0.0 109.638 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.8 145.42 20.08 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.194 2.596 . . . . 0.0 110.815 166.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.82 176.67 9.73 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.002 2.468 . . . . 0.0 111.185 164.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -63.45 152.8 37.3 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.268 1.427 . . . . 0.0 113.739 -171.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 89.46 -162.06 30.34 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.844 1.212 . . . . 0.0 112.257 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.79 159.21 31.28 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.322 1.058 . . . . 0.0 111.81 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 73.2 m -160.33 164.88 32.17 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.151 -1.593 . . . . 0.0 111.174 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -120.86 116.49 25.28 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.849 1.26 . . . . 0.0 109.008 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 24.1 mm -85.38 120.2 35.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 124.714 1.206 . . . . 0.0 107.884 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.62 140.31 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.448 0.699 . . . . 0.0 110.092 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 76.3 t -115.18 115.08 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 126.79 2.036 . . . . 0.0 108.067 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 97.89 179.39 33.2 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 123.442 1.579 . . . . 0.0 115.622 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 29.8 m -134.2 163.66 29.11 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.194 1.398 . . . . 0.0 109.935 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.09 -174.14 54.63 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 122.148 0.86 . . . . 0.0 112.85 -170.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -27.69 61.65 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.855 1.662 . . . . 0.0 112.794 172.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.8 m -65.41 -12.08 48.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -74.62 138.65 43.09 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.753 1.16 . . . . 0.0 111.981 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 21.1 mt -103.86 162.41 13.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.987 0.915 . . . . 0.0 110.973 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.7 t -142.1 146.44 35.4 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.45 1.1 . . . . 0.0 111.664 -172.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -145.39 119.98 9.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.794 1.638 . . . . 0.0 109.931 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -71.01 129.07 38.05 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.579 0.752 . . . . 0.0 111.782 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -123.76 159.21 29.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.731 1.212 . . . . 0.0 111.636 170.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -133.65 118.74 18.53 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.943 1.697 . . . . 0.0 109.033 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? . . . . . 0 N--CA 1.47 0.527 0 C-N-CA 125.611 1.564 . . . . 0.0 111.09 -167.301 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 118.169 -0.919 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 19.2 t -111.46 -2.09 15.67 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.46 -47.69 75.26 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.256 1.389 . . . . 0.0 112.275 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.403 HD22 ' HE3' ' A' ' 293' ' ' LYS . 4.0 tt -68.13 123.84 21.8 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 159.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 4.8 t -50.01 167.66 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.425 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.3 mm? -63.06 113.65 3.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.507 1.923 . . . . 0.0 110.735 -172.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 295' ' ' THR . 8.6 mptt -62.37 132.97 54.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.444 1.897 . . . . 0.0 110.384 -174.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 65.18 -27.19 0.12 Allowed Glycine 0 CA--C 1.543 1.786 0 C-N-CA 126.757 2.122 . . . . 0.0 115.488 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 293' ' ' LYS . 43.8 m -87.39 -13.64 42.85 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 130.599 3.56 . . . . 0.0 112.068 -173.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.4 m -155.88 153.88 30.38 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 119.853 -1.779 . . . . 0.0 113.569 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -75.54 178.75 5.75 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.43 1.892 . . . . 0.0 114.538 -168.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.86 159.81 14.79 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.822 1.649 . . . . 0.0 114.199 -168.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.27 158.43 26.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.481 2.712 . . . . 0.0 114.873 -170.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.8 m -78.88 145.01 34.39 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.79 0.836 . . . . 0.0 110.585 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 14.17 3.92 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.415 1.086 . . . . 0.0 113.224 167.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -67.66 159.33 30.23 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.818 153.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.5 109.48 4.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.316 0.646 . . . . 0.0 111.064 -167.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 69.9 mtp -95.27 162.25 13.76 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.312 1.053 . . . . 0.0 112.431 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.4 p -151.42 159.47 44.21 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.239 1.416 . . . . 0.0 109.534 166.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.75 129.94 34.8 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 122.045 -0.409 . . . . 0.0 109.904 166.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.66 -29.07 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.118 0.967 . . . . 0.0 109.989 162.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -145.82 133.5 21.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.899 1.68 . . . . 0.0 109.999 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -66.47 147.38 98.97 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.986 0.914 . . . . 0.0 112.465 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.72 133.54 57.0 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.633 2.222 . . . . 0.0 112.186 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 21.7 p -132.89 142.34 48.87 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.976 1.711 . . . . 0.0 110.126 169.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.0 130.3 46.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.649 0.738 . . . . 0.0 110.675 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 75.0 p -78.29 -18.74 54.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.495 1.918 . . . . 0.0 113.034 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 82.62 -4.3 79.22 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.367 0.985 . . . . 0.0 113.845 -163.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -84.25 -0.48 52.46 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 119.612 1.706 . . . . 0.0 111.88 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 76.69 36.22 38.15 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.91 1.243 . . . . 0.0 111.539 -165.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.6 p -146.69 164.16 33.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.194 2.198 . . . . 0.0 108.403 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.26 134.06 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.305 1.442 . . . . 0.0 110.657 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.1 133.5 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.438 1.095 . . . . 0.0 113.611 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.0 ptm -145.94 163.56 34.76 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.224 2.21 . . . . 0.0 112.11 -169.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -130.58 144.22 51.27 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.377 0.671 . . . . 0.0 110.06 172.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 362' ' ' GLU . 4.0 m -134.15 146.45 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.145 0.978 . . . . 0.0 111.461 -167.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -109.8 131.04 55.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.989 1.716 . . . . 0.0 111.078 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 14.3 t -108.43 143.32 27.24 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-O 116.973 -1.489 . . . . 0.0 108.156 163.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -101.13 -75.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.506 0 C-N-CA 122.259 1.972 . . . . 0.0 116.843 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 169.13 21.72 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 121.342 1.883 . . . . 0.0 114.771 -173.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 68.99 -5.41 4.74 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.542 1.544 . . . . 0.0 116.639 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -125.64 103.85 27.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.768 1.284 . . . . 0.0 112.67 -164.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -76.56 134.61 15.46 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.984 1.789 . . . . 0.0 109.055 160.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.3 p -158.23 155.15 28.45 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.371 -0.83 . . . . 0.0 112.918 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -77.84 136.98 38.16 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 159.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -58.62 117.28 19.42 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-N 118.783 0.719 . . . . 0.0 111.876 -171.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -97.03 102.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.925 3.083 . . . . 0.0 113.039 -167.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.5 139.13 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.446 1.099 . . . . 0.0 108.909 170.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 3.1 mt -136.96 143.84 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.631 1.173 . . . . 0.0 108.575 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 45.3 t -119.26 108.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.433 1.093 . . . . 0.0 108.187 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -124.36 161.33 26.15 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -162.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.81 -6.96 59.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.221 2.608 . . . . 0.0 112.361 168.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -139.8 149.73 43.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.129 1.772 . . . . 0.0 111.431 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 20.4 mt -64.48 -24.63 67.68 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.672 1.189 . . . . 0.0 113.371 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.4 t -96.07 4.74 52.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.877 1.271 . . . . 0.0 113.72 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.2 75.08 0.1 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.225 3.01 . . . . 0.0 115.652 -171.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.94 -35.01 12.17 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.844 2.057 . . . . 0.0 111.786 164.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.91 153.26 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.747 1.219 . . . . 0.0 109.84 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.92 103.55 5.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.033 -1.042 . . . . 0.0 111.316 175.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -103.85 -13.22 16.48 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -174.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -102.52 -174.38 27.15 Favored Glycine 0 CA--C 1.536 1.403 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.01 144.2 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 127.774 2.43 . . . . 0.0 110.913 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 353' ' ' ASN . 0.6 OUTLIER -77.32 130.35 37.04 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.527 1.131 . . . . 0.0 109.485 165.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -46.97 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 118.99 -0.529 . . . . 0.0 111.122 176.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 32.2 m -65.92 150.66 48.27 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.773 160.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.0 156.98 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.818 1.247 . . . . 0.0 111.951 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.412 ' HB2' HD13 ' A' ' 349' ' ' LEU . 23.2 t-20 -114.9 80.94 7.04 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.387 1.475 . . . . 0.0 111.185 -173.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -80.24 -172.99 1.68 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.143 2.562 . . . . 0.0 112.25 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 28.0 pt -93.5 176.41 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.713 1.605 . . . . 0.0 110.868 167.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.43 113.12 7.25 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 153.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.9 p -67.01 -32.18 73.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.801 1.64 . . . . 0.0 112.871 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.39 152.3 51.72 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.719 2.808 . . . . 0.0 108.159 168.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -63.17 -23.33 67.38 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.589 -1.32 . . . . 0.0 114.245 -173.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -86.26 4.79 37.32 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.935 1.294 . . . . 0.0 113.443 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.79 150.1 7.85 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 6.5 pt-20 -135.34 85.88 2.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.535 -1.212 . . . . 0.0 114.122 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 4.4 t -93.13 140.8 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.029 1.332 . . . . 0.0 111.501 -167.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -101.33 121.06 41.23 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 129.179 2.991 . . . . 0.0 109.064 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 1.8 mp -140.81 146.22 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.239 1.416 . . . . 0.0 110.713 -169.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -114.39 139.13 49.74 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.6 1.16 . . . . 0.0 112.608 166.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.94 159.18 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.132 1.773 . . . . 0.0 111.211 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -113.68 108.1 52.05 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.691 1.996 . . . . 0.0 109.453 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.36 150.67 25.58 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.314 2.009 . . . . 0.0 110.315 166.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -59.15 164.77 9.89 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.451 1.434 . . . . 0.0 111.244 163.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -65.57 140.86 58.57 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.711 -0.618 . . . . 0.0 110.473 167.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.49 -151.46 18.22 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.158 0.409 . . . . 0.0 112.427 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -74.46 161.11 30.12 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.447 1.117 . . . . 0.0 112.9 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 24.1 m -170.1 162.08 8.8 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.43 1.892 . . . . 0.0 111.264 166.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -128.61 127.45 42.28 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.446 1.898 . . . . 0.0 107.138 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 23.3 mm -95.15 118.14 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.7 140.04 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.019 0.928 . . . . 0.0 110.503 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 97.2 t -106.36 122.9 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 126.06 1.744 . . . . 0.0 108.359 168.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 85.97 179.85 49.91 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 123.444 1.58 . . . . 0.0 116.335 168.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 72.0 m -138.76 171.69 13.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.974 1.31 . . . . 0.0 109.96 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 85.39 -154.68 28.86 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -171.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -26.32 64.57 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.748 0.819 . . . . 0.0 112.189 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.9 m -76.79 -6.43 52.26 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 129.127 2.971 . . . . 0.0 115.24 -164.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -75.24 124.58 27.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.752 0.421 . . . . 0.0 112.059 -167.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.78 158.58 15.82 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.479 0.312 . . . . 0.0 110.422 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.1 t -131.42 154.24 48.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.434 1.094 . . . . 0.0 111.913 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -142.69 126.14 16.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.158 1.783 . . . . 0.0 109.553 171.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.89 127.29 31.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.361 1.464 . . . . 0.0 111.558 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -136.22 117.78 14.87 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.217 1.007 . . . . 0.0 110.953 170.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -119.0 119.97 35.85 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.9 tttp . . . . . 0 C--O 1.233 0.2 0 C-N-CA 126.009 1.724 . . . . 0.0 111.28 -165.755 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.7 p -104.19 -2.37 25.83 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.48 89.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.205 0.911 . . . . 0.0 113.124 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.7 tt -75.97 128.41 35.0 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 161.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 2.2 t -52.97 168.56 0.12 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.945 2.098 . . . . 0.0 116.036 -167.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.48 105.44 0.63 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.077 1.751 . . . . 0.0 110.628 -172.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.07 124.91 20.97 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.087 1.355 . . . . 0.0 111.226 -171.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.41 -51.6 2.57 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.998 1.285 . . . . 0.0 112.996 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.3 m -62.89 3.08 0.25 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.549 2.74 . . . . 0.0 114.149 174.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.6 m -156.48 149.47 24.05 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 118.996 -2.315 . . . . 0.0 112.658 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -74.19 171.81 12.92 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.636 1.975 . . . . 0.0 113.557 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.09 163.19 28.09 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.354 1.462 . . . . 0.0 113.055 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 58.0 mtt -93.82 164.12 13.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.138 1.775 . . . . 0.0 113.788 -168.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.8 m -76.23 139.38 41.15 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.315 0.646 . . . . 0.0 111.244 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 6.4 p -133.04 20.07 4.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.574 1.15 . . . . 0.0 113.036 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -82.46 164.68 20.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 158.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.02 95.64 0.12 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.39 1.476 . . . . 0.0 111.847 -175.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 32.7 mtp -80.36 171.79 14.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.665 1.186 . . . . 0.0 112.426 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.7 m -158.93 154.53 26.07 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.184 -0.947 . . . . 0.0 111.965 163.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.4 111.8 14.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.886 0.875 . . . . 0.0 109.744 163.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 20.1 t -66.99 -33.52 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.476 1.11 . . . . 0.0 109.868 166.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -129.45 126.68 39.28 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.859 1.664 . . . . 0.0 108.577 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -62.83 152.86 81.63 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.69 1.196 . . . . 0.0 112.164 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.43 124.63 13.62 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.733 2.289 . . . . 0.0 111.049 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 70.5 p -125.17 136.87 54.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.169 1.388 . . . . 0.0 110.692 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.47 127.04 30.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.238 1.015 . . . . 0.0 111.742 173.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 75.7 p -76.32 -22.31 55.12 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.53 1.532 . . . . 0.0 113.087 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 89.22 -11.37 69.79 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.057 1.789 . . . . 0.0 113.817 -163.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -86.01 2.43 46.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.486 1.515 . . . . 0.0 112.303 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 87.66 15.11 62.19 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.937 0.78 . . . . 0.0 112.86 -167.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.6 p -131.14 158.19 41.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.763 1.225 . . . . 0.0 111.345 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.16 132.05 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.226 1.41 . . . . 0.0 109.727 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.65 134.27 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.516 1.127 . . . . 0.0 113.35 -169.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 3.3 ptp -143.14 160.52 40.26 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.282 1.833 . . . . 0.0 113.174 -173.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -119.15 121.71 40.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.478 1.911 . . . . 0.0 107.806 173.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.78 141.88 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.366 1.066 . . . . 0.0 111.527 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -106.14 132.34 52.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.796 1.639 . . . . 0.0 112.278 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.38 147.18 33.79 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.726 1.61 . . . . 0.0 108.649 163.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -108.97 -72.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.255 2.636 . . . . 0.0 115.386 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.44 170.07 17.6 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.241 -1.537 . . . . 0.0 114.202 -171.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 64.57 -23.32 0.1 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 127.633 2.539 . . . . 0.0 117.77 168.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -107.52 97.45 19.71 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.501 1.52 . . . . 0.0 112.05 -170.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.29 131.23 25.99 Favored 'Trans proline' 0 C--N 1.35 0.631 0 N-CA-C 108.005 -1.575 . . . . 0.0 108.005 157.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.6 p -160.9 157.3 26.32 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -72.23 137.76 47.05 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.343 1.457 . . . . 0.0 108.989 159.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.37 119.08 56.56 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 118.69 0.677 . . . . 0.0 112.196 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -97.38 87.41 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.049 3.166 . . . . 0.0 113.833 -166.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 97.1 t -113.49 131.72 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 164.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.23 153.47 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.484 1.114 . . . . 0.0 110.152 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.46 109.41 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.188 1.795 . . . . 0.0 107.129 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -119.66 164.67 15.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -161.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -89.49 -6.75 56.16 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.824 2.05 . . . . 0.0 112.668 165.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -133.79 144.41 49.0 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.054 1.342 . . . . 0.0 110.677 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.55 -11.75 26.98 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.8 t -113.02 12.03 19.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.964 1.706 . . . . 0.0 113.188 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 39.85 60.11 1.75 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.53 2.732 . . . . 0.0 116.152 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.85 63.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.267 0.627 . . . . 0.0 111.927 155.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 38.0 mt -110.6 155.98 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.126 1.771 . . . . 0.0 109.254 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.45 102.0 6.94 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.312 1.045 . . . . 0.0 110.808 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -77.96 -56.39 4.53 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 129.732 3.213 . . . . 0.0 111.423 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -92.35 -167.64 39.77 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 116.593 1.397 . . . . 0.0 116.593 -166.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.5 mt -116.51 135.48 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.242 1.817 . . . . 0.0 110.546 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.3 mt -72.04 122.29 20.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.615 0.766 . . . . 0.0 109.372 165.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 98.4 t -103.02 -52.62 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.177 0.991 . . . . 0.0 110.235 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 50.4 m -67.02 155.23 39.19 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.198 0.523 . . . . 0.0 110.102 164.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 11.3 m -58.1 159.32 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.151 0.98 . . . . 0.0 112.468 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -118.6 85.02 25.86 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.638 1.175 . . . . 0.0 110.125 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -80.48 -165.16 0.32 Allowed 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 124.502 3.468 . . . . 0.0 113.232 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 31.5 pt -105.04 165.99 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.688 1.995 . . . . 0.0 111.218 172.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.66 102.48 1.2 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 155.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 82.8 p -70.61 -35.77 73.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.305 1.442 . . . . 0.0 112.208 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.5 157.62 33.15 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.815 2.046 . . . . 0.0 109.491 158.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -66.68 -23.46 66.14 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -89.75 7.69 35.56 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.03 0.832 . . . . 0.0 112.648 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -56.61 153.07 10.9 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.878 1.323 . . . . 0.0 112.973 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.67 123.33 12.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.907 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.61 145.95 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.702 0.801 . . . . 0.0 110.254 -159.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.4 tp -95.97 126.58 41.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.443 2.297 . . . . 0.0 109.405 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.3 mp -139.28 132.13 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.492 1.117 . . . . 0.0 109.483 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.81 147.98 32.31 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.96 0.886 . . . . 0.0 112.106 159.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.38 160.86 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.733 1.613 . . . . 0.0 110.702 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -115.32 109.12 46.69 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.94 1.696 . . . . 0.0 111.092 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.74 148.9 20.43 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.932 2.421 . . . . 0.0 111.549 162.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -73.15 172.18 16.07 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.772 2.315 . . . . 0.0 111.103 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -57.34 147.84 24.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.239 0.615 . . . . 0.0 111.668 171.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.35 -136.08 12.52 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.15 162.36 14.36 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.03 1.332 . . . . 0.0 112.736 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 38.5 m -162.18 162.98 28.62 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.777 -1.202 . . . . 0.0 110.716 157.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.84 117.89 25.13 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 21.5 mm -91.03 111.25 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.857 1.263 . . . . 0.0 107.941 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.48 142.57 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.704 0.802 . . . . 0.0 109.547 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 97.8 t -123.29 108.34 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.335 1.854 . . . . 0.0 108.765 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.83 175.88 21.61 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.979 1.276 . . . . 0.0 114.36 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 56.4 m -133.86 162.12 32.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.284 1.434 . . . . 0.0 109.759 169.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.5 -171.53 49.39 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 121.601 0.556 . . . . 0.0 112.668 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.33 -27.5 23.71 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.222 1.409 . . . . 0.0 113.956 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.0 m -74.86 -3.91 34.74 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.761 2.424 . . . . 0.0 114.833 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -79.55 125.86 30.13 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.078 0.853 . . . . 0.0 112.618 -174.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.84 163.86 14.85 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.212 0.605 . . . . 0.0 110.827 172.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.6 t -144.13 148.31 34.89 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.262 1.025 . . . . 0.0 111.829 -171.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -147.75 110.05 4.6 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.325 1.45 . . . . 0.0 110.119 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.2 133.61 56.26 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.913 0.885 . . . . 0.0 111.212 173.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -125.3 160.8 28.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.285 1.034 . . . . 0.0 111.298 163.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -129.59 146.25 51.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.225 1.41 . . . . 0.0 108.771 171.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.327 0 C-N-CA 124.886 1.274 . . . . 0.0 109.696 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 9.5 m -109.43 0.86 19.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.323 1.449 . . . . 0.0 113.99 -167.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.64 -48.97 62.66 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.235 0.925 . . . . 0.0 111.031 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.68 131.43 46.31 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 167.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.6 t -62.58 176.66 0.62 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -164.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.427 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.7 mm? -64.7 97.39 0.21 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.933 1.693 . . . . 0.0 112.332 -167.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.516 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 0.8 OUTLIER -47.48 125.7 8.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 128.052 2.541 . . . . 0.0 111.794 -178.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 60.35 10.17 15.22 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.559 1.076 . . . . 0.0 115.283 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 13.5 m -139.76 17.0 2.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.657 1.583 . . . . 0.0 109.809 -159.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 2.3 m -171.15 159.07 5.77 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.267 -1.521 . . . . 0.0 112.368 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -86.74 174.66 8.68 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.446 1.099 . . . . 0.0 112.735 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -63.17 159.3 17.85 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -164.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 62.1 mtm -79.22 151.74 31.04 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.914 2.086 . . . . 0.0 110.382 164.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.7 m -70.51 145.49 50.85 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.989 -0.445 . . . . 0.0 111.794 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.1 p -134.3 24.32 3.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.929 1.292 . . . . 0.0 112.634 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -94.59 169.45 10.17 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 160.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -69.62 90.96 0.58 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.195 2.198 . . . . 0.0 111.956 -163.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 37.7 mtp -80.58 170.63 16.08 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.961 0.886 . . . . 0.0 113.348 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 36.5 m -159.44 161.22 35.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.057 0.943 . . . . 0.0 112.018 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.49 120.2 22.14 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.772 0.829 . . . . 0.0 109.641 168.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.64 -34.32 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.216 1.006 . . . . 0.0 110.116 163.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -136.46 132.68 35.7 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.173 1.389 . . . . 0.0 110.007 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -69.32 145.89 96.17 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.526 1.53 . . . . 0.0 112.15 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.0 136.62 57.66 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.864 2.376 . . . . 0.0 112.636 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 71.4 p -141.61 131.6 24.57 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.152 1.781 . . . . 0.0 110.411 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -60.49 131.76 51.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.777 0.831 . . . . 0.0 112.387 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.0 p -66.13 -21.23 66.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.556 1.942 . . . . 0.0 112.717 168.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 98.31 -16.79 59.48 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.909 1.718 . . . . 0.0 112.397 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -74.08 -18.15 60.86 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.419 1.11 . . . . 0.0 111.76 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.55 32.88 6.1 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.569 1.081 . . . . 0.0 111.751 -166.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.8 p -136.85 129.43 30.28 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.905 1.282 . . . . 0.0 108.39 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 21.8 m -106.9 123.06 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.434 0.694 . . . . 0.0 110.068 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.35 129.42 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.072 0.949 . . . . 0.0 111.816 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.9 ptm -149.49 163.04 38.9 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.487 1.915 . . . . 0.0 111.756 -169.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -136.74 136.58 39.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.442 0.697 . . . . 0.0 110.153 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.96 127.66 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.999 0.92 . . . . 0.0 112.874 -164.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -92.94 125.7 37.67 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.573 1.549 . . . . 0.0 112.02 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.1 t -96.56 145.27 29.28 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 117.393 -1.289 . . . . 0.0 107.626 158.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -104.27 -65.88 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 123.056 2.504 . . . . 0.0 115.321 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 175.85 10.32 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.344 -1.472 . . . . 0.0 112.142 -174.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.69 -13.19 0.09 OUTLIER Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.509 2.481 . . . . 0.0 118.129 167.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.89 93.93 22.77 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 119.147 1.474 . . . . 0.0 113.03 -167.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.3 112.15 3.26 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.402 2.068 . . . . 0.0 108.756 156.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.5 p -154.35 159.67 41.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.15 0.98 . . . . 0.0 111.923 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 355' ' ' ILE . 20.6 mtpp -76.83 144.13 39.28 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.214 1.006 . . . . 0.0 109.877 158.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.45 111.46 4.08 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.242 1.017 . . . . 0.0 111.97 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -94.54 89.06 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.952 3.101 . . . . 0.0 112.999 -162.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.86 127.8 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 150.06 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.446 1.098 . . . . 0.0 109.397 -177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 64.4 t -128.77 105.03 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -117.6 161.24 19.95 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -158.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.62 -14.62 58.68 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.08 2.152 . . . . 0.0 112.783 164.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -134.38 148.23 50.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.612 1.165 . . . . 0.0 112.258 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 16.4 mt -61.96 -19.74 63.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.137 1.375 . . . . 0.0 114.468 -173.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.8 t -104.29 5.83 34.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.606 1.962 . . . . 0.0 113.262 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.48 69.08 0.43 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.016 2.926 . . . . 0.0 116.434 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -81.32 -45.42 16.2 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.365 1.466 . . . . 0.0 112.064 157.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.42 113.73 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.976 1.311 . . . . 0.0 110.338 -172.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.13 107.39 15.67 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.445 0.698 . . . . 0.0 112.331 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 373' ' ' ASP . 12.2 ttpt -72.86 -43.91 62.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.393 2.677 . . . . 0.0 112.955 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -100.28 -165.5 28.7 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.465 1.346 . . . . 0.0 116.465 -165.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.94 148.14 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.182 2.193 . . . . 0.0 110.0 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.32 134.51 34.51 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.464 -0.772 . . . . 0.0 109.666 170.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 81.9 t -98.29 -46.64 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.904 0.882 . . . . 0.0 109.588 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.8 m -71.38 154.9 41.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.396 0.617 . . . . 0.0 110.211 164.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.46 161.56 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.211 1.404 . . . . 0.0 110.541 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -114.17 69.28 1.82 Allowed Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 124.667 1.187 . . . . 0.0 112.763 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.05 -171.36 1.05 Allowed 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 124.412 3.408 . . . . 0.0 113.123 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 44.5 pt -93.17 165.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.58 1.552 . . . . 0.0 113.359 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.21 105.98 1.55 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.054 0.942 . . . . 0.0 109.206 158.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 83.9 p -70.31 -40.18 74.35 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.173 1.389 . . . . 0.0 111.803 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.24 151.45 34.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.33 1.852 . . . . 0.0 108.887 155.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -61.63 -15.7 41.86 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 175.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.76 8.67 44.3 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.232 1.413 . . . . 0.0 112.633 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -58.98 148.15 31.72 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.266 -1.521 . . . . 0.0 113.621 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -129.94 79.43 1.9 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.072 1.349 . . . . 0.0 112.129 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 40.5 t -84.39 143.21 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.45 1.1 . . . . 0.0 111.124 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.5 130.07 42.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.536 2.734 . . . . 0.0 109.787 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.1 133.8 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.117 1.767 . . . . 0.0 110.407 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -91.01 138.23 31.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.18 0.992 . . . . 0.0 110.722 154.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.79 160.56 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.096 0.958 . . . . 0.0 111.333 169.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -121.75 105.32 38.29 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.815 1.646 . . . . 0.0 110.076 -173.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.68 154.8 35.01 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.234 1.956 . . . . 0.0 110.363 159.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.79 171.58 16.22 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.17 1.913 . . . . 0.0 111.155 166.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -65.24 122.97 18.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.834 1.254 . . . . 0.0 109.343 168.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 126.73 -148.14 17.13 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.319 0.961 . . . . 0.0 111.166 -163.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . 0.407 ' O ' ' HE3' ' A' ' 346' ' ' LYS . 8.7 p-10 -94.47 168.82 10.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.828 1.251 . . . . 0.0 112.054 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 33.6 m -168.46 165.24 12.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.536 1.934 . . . . 0.0 110.828 159.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -124.63 117.0 23.3 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.0 mm -90.95 110.92 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.61 143.39 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.948 0.899 . . . . 0.0 110.184 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.6 115.23 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 126.71 2.004 . . . . 0.0 108.684 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 95.82 176.88 36.73 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.32 0.962 . . . . 0.0 114.521 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 47.4 m -136.19 165.06 26.61 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.811 1.644 . . . . 0.0 109.891 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.37 -171.27 46.81 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 121.642 -0.662 . . . . 0.0 112.196 -167.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.47 -26.41 53.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.213 1.005 . . . . 0.0 113.539 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.4 m -74.25 9.9 1.47 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.681 2.792 . . . . 0.0 115.222 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -96.05 144.24 26.49 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.4 1.08 . . . . 0.0 112.986 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 25.9 mt -112.25 165.31 12.28 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.579 1.152 . . . . 0.0 111.384 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 2.3 t -139.11 147.01 41.39 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.949 1.299 . . . . 0.0 111.815 -170.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -146.78 112.59 5.7 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.759 1.624 . . . . 0.0 110.388 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 134.56 54.93 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.128 -0.983 . . . . 0.0 112.367 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -128.82 149.12 50.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.891 0.876 . . . . 0.0 111.892 165.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -133.5 140.72 47.41 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.128 1.371 . . . . 0.0 107.839 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 21.7 tptt . . . . . 0 N--CA 1.466 0.342 0 C-N-CA 124.481 1.112 . . . . 0.0 111.052 -170.716 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.7 m -104.81 -4.58 22.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.138 0.975 . . . . 0.0 113.003 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.54 -9.09 52.48 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.9 tp -101.79 132.18 47.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 159.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.9 t -57.98 174.45 0.26 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.386 1.474 . . . . 0.0 114.252 -172.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.518 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.4 mm? -65.06 95.66 0.17 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.772 1.629 . . . . 0.0 110.997 -169.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.529 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 6.9 mptt -51.89 121.02 5.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.853 2.461 . . . . 0.0 111.057 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 67.25 -25.22 0.2 Allowed Glycine 0 CA--C 1.54 1.635 0 C-N-CA 126.439 1.971 . . . . 0.0 115.599 -173.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 44.8 m -87.11 7.99 25.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 129.648 3.179 . . . . 0.0 111.555 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 7.5 m -160.2 155.31 24.75 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 119.311 -2.118 . . . . 0.0 111.587 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -76.09 172.95 11.93 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.067 1.347 . . . . 0.0 112.868 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -63.47 156.17 27.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.192 0.996 . . . . 0.0 113.642 -173.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 37.8 mtt -84.82 151.94 23.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.713 1.605 . . . . 0.0 111.364 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.9 m -67.7 139.87 56.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.207 0.603 . . . . 0.0 111.94 -173.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.3 p -131.75 16.92 4.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.862 1.265 . . . . 0.0 113.196 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.69 169.32 17.13 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 159.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.5 98.68 1.15 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.633 1.173 . . . . 0.0 112.076 -167.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.4 mtp -87.12 172.3 10.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.668 1.187 . . . . 0.0 113.579 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 36.8 m -160.74 170.4 20.83 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.794 1.238 . . . . 0.0 111.286 162.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.64 131.47 35.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.088 0.955 . . . . 0.0 109.324 162.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.1 -37.97 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.877 0.871 . . . . 0.0 109.797 162.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -130.97 126.78 36.91 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.723 1.609 . . . . 0.0 108.409 173.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -60.73 149.98 77.67 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.355 0.662 . . . . 0.0 111.678 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.56 132.59 43.98 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.026 1.817 . . . . 0.0 110.587 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 40.2 p -127.49 129.56 47.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.791 1.636 . . . . 0.0 108.805 172.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.89 136.07 57.89 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.555 0.693 . . . . 0.0 111.441 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.8 p -93.78 -15.15 25.43 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.251 1.421 . . . . 0.0 113.613 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.64 -6.66 8.26 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-O 118.447 -1.196 . . . . 0.0 114.66 -161.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -70.67 -10.21 58.86 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 120.32 2.06 . . . . 0.0 112.112 170.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 91.6 17.51 48.78 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.465 1.031 . . . . 0.0 112.912 -160.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.9 p -134.33 168.47 18.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.267 1.427 . . . . 0.0 111.283 -171.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 19.2 m -121.42 138.93 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.064 1.346 . . . . 0.0 109.292 166.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -114.36 130.07 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.698 1.199 . . . . 0.0 111.63 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.8 ptm -145.69 167.3 23.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.699 1.599 . . . . 0.0 112.797 -171.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -133.72 136.42 44.63 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.212 1.005 . . . . 0.0 109.684 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 21.3 m -116.54 168.25 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.799 1.24 . . . . 0.0 111.848 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -131.39 127.75 38.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.991 1.317 . . . . 0.0 112.053 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.07 146.77 32.5 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.149 1.38 . . . . 0.0 108.224 161.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -107.27 -62.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.163 2.575 . . . . 0.0 115.224 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.26 -174.27 4.88 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.383 1.473 . . . . 0.0 111.988 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 74.35 -36.81 0.97 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 126.593 2.044 . . . . 0.0 116.605 162.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.65 103.86 43.11 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.514 1.126 . . . . 0.0 111.963 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -64.88 128.88 21.82 Favored 'Trans proline' 0 C--N 1.35 0.61 0 N-CA-C 107.851 -1.634 . . . . 0.0 107.851 154.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.0 p -157.57 157.75 34.31 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.7 tptm -75.24 135.7 40.98 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.404 1.481 . . . . 0.0 109.094 164.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.5 119.99 58.51 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -168.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -100.38 81.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.61 2.873 . . . . 0.0 114.159 -164.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 95.1 t -107.5 128.11 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 162.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.68 152.75 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.873 1.269 . . . . 0.0 109.666 176.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.97 115.16 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.307 1.843 . . . . 0.0 106.837 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -127.51 160.25 32.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -161.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.27 -15.12 36.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.702 1.601 . . . . 0.0 112.612 171.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.21 153.75 38.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.683 1.593 . . . . 0.0 110.723 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.16 -14.16 34.55 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 11.5 t -123.93 14.34 9.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.581 1.552 . . . . 0.0 113.415 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 44.56 59.23 3.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.001 2.52 . . . . 0.0 115.917 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -78.09 -32.74 50.78 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.256 0.622 . . . . 0.0 112.182 156.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 45.4 mm -116.07 112.16 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.323 1.849 . . . . 0.0 109.973 -175.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -86.59 103.86 15.48 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.898 0.856 . . . . 0.0 111.846 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -88.2 -19.68 26.56 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.967 2.907 . . . . 0.0 114.439 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -118.59 -165.42 13.28 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 115.901 1.121 . . . . 0.0 115.901 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.2 mt -126.79 139.41 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 127.454 2.302 . . . . 0.0 110.366 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.15 129.65 37.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.848 1.259 . . . . 0.0 110.114 165.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 53.5 t -107.05 -50.92 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.711 0.804 . . . . 0.0 110.564 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.6 m -68.43 154.06 42.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.319 0.58 . . . . 0.0 109.641 163.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.9 m -54.43 154.66 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.702 1.201 . . . . 0.0 112.482 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -118.92 81.11 18.87 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.439 1.096 . . . . 0.0 110.547 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -82.96 -166.47 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 125.08 3.853 . . . . 0.0 112.846 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 39.1 pt -89.21 168.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.203 1.401 . . . . 0.0 111.511 164.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.31 120.34 13.66 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 158.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 85.9 p -73.12 -17.16 61.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.847 1.259 . . . . 0.0 113.838 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 97.5 m -144.06 157.51 44.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.748 2.419 . . . . 0.0 106.73 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -58.97 -21.48 58.71 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.861 -1.15 . . . . 0.0 113.914 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.79 15.32 29.0 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.689 1.996 . . . . 0.0 112.773 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -61.07 158.52 13.45 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 119.998 -1.689 . . . . 0.0 113.862 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -145.4 75.11 1.42 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.279 1.432 . . . . 0.0 113.861 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.5 149.52 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.509 1.524 . . . . 0.0 112.439 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.61 129.49 46.54 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 129.931 3.292 . . . . 0.0 109.301 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.87 134.41 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.281 1.432 . . . . 0.0 111.631 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -90.67 136.95 32.73 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.001 1.321 . . . . 0.0 111.869 154.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.74 159.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.884 1.274 . . . . 0.0 111.477 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -119.81 114.88 33.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.18 1.792 . . . . 0.0 111.128 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.3 159.97 13.09 Favored 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 123.665 2.91 . . . . 0.0 112.203 162.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.27 175.73 10.56 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.476 2.784 . . . . 0.0 111.026 163.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -63.4 145.62 55.22 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.57 -0.706 . . . . 0.0 111.332 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.76 -145.08 15.91 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.895 0.759 . . . . 0.0 111.47 -171.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -91.32 164.55 13.82 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.268 1.427 . . . . 0.0 112.255 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.2 m -161.54 158.88 27.08 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.326 -1.484 . . . . 0.0 111.212 158.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -116.03 116.1 27.29 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.88 111.91 22.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 124.952 1.301 . . . . 0.0 108.101 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.51 142.9 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.66 0.784 . . . . 0.0 109.727 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 94.3 t -116.92 110.22 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.963 1.705 . . . . 0.0 108.994 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.77 -179.39 24.25 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.187 0.898 . . . . 0.0 115.162 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 28.7 m -132.56 163.44 28.86 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.114 1.766 . . . . 0.0 109.388 171.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.33 -171.96 52.45 Favored Glycine 0 CA--C 1.535 1.298 0 O-C-N 121.559 -0.713 . . . . 0.0 112.925 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.26 -29.64 34.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.266 1.426 . . . . 0.0 113.697 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.6 m -73.36 -2.39 22.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.066 2.547 . . . . 0.0 114.801 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -81.66 115.4 20.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.09 0.859 . . . . 0.0 112.999 -172.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -81.63 162.91 22.89 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.879 -0.513 . . . . 0.0 111.277 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.5 t -140.4 147.54 39.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.768 1.227 . . . . 0.0 112.053 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -147.13 120.57 9.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.564 1.546 . . . . 0.0 111.119 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.6 130.17 39.07 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.794 1.238 . . . . 0.0 112.529 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -127.24 164.82 20.87 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.594 1.158 . . . . 0.0 112.224 164.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -133.26 150.51 51.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.41 1.884 . . . . 0.0 108.667 171.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? . . . . . 0 N--CA 1.466 0.366 0 C-N-CA 126.676 1.991 . . . . 0.0 109.498 -174.278 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.6 m -90.57 -7.38 52.99 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -166.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.7 -25.81 66.71 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 57.9 tp -83.1 126.39 32.54 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.081 1.31 . . . . 0.0 108.065 159.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 t -55.05 167.07 0.44 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.782 1.233 . . . . 0.0 113.768 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.569 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.0 mm? -57.28 107.21 0.4 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.806 2.042 . . . . 0.0 111.263 -164.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -58.19 115.87 3.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.499 1.92 . . . . 0.0 110.686 -166.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 68.62 -7.91 2.59 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.449 1.499 . . . . 0.0 115.476 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 96.9 m -101.88 6.65 41.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.367 2.667 . . . . 0.0 110.626 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.3 m -154.32 151.26 28.88 Favored 'General case' 0 C--O 1.23 0.06 0 O-C-N 119.337 -2.102 . . . . 0.0 112.387 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -71.57 170.83 12.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.125 2.17 . . . . 0.0 112.864 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.64 153.42 36.07 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 39.6 mtt -91.05 151.58 20.98 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.893 1.677 . . . . 0.0 111.283 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.88 141.64 55.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.42 0.688 . . . . 0.0 112.621 -170.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.7 p -133.25 17.74 4.06 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -74.57 164.75 26.22 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.543 -0.723 . . . . 0.0 109.193 155.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.59 89.2 0.52 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.989 1.315 . . . . 0.0 111.913 -173.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 68.9 mtp -73.17 173.05 9.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.878 1.671 . . . . 0.0 113.693 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.7 m -157.37 163.46 38.58 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.203 -0.936 . . . . 0.0 111.855 162.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.42 125.93 29.99 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 3.6 t -76.61 -29.99 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 122.961 0.505 . . . . 0.0 109.779 162.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -135.6 126.48 27.55 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.048 1.739 . . . . 0.0 108.667 167.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -59.72 151.01 64.86 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.559 1.143 . . . . 0.0 111.87 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.67 132.42 35.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.05 1.834 . . . . 0.0 110.845 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 m -133.33 141.86 48.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.916 1.286 . . . . 0.0 109.933 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.19 136.82 58.1 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.309 0.644 . . . . 0.0 112.181 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 70.4 p -91.12 -8.02 49.97 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.977 1.311 . . . . 0.0 114.218 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 69.15 4.94 45.63 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.802 -0.999 . . . . 0.0 114.909 -163.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -111.34 13.3 21.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.05 1.425 . . . . 0.0 112.316 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.59 14.15 71.31 Favored Glycine 0 CA--C 1.536 1.371 0 O-C-N 121.374 -0.829 . . . . 0.0 113.651 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 39.5 p -135.17 164.61 27.3 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.273 1.429 . . . . 0.0 111.296 -171.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.4 m -128.14 135.79 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.527 1.531 . . . . 0.0 110.061 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.44 129.76 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.886 1.275 . . . . 0.0 113.704 -167.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -143.52 164.98 28.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.462 1.505 . . . . 0.0 114.32 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -122.35 125.49 46.04 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.542 2.337 . . . . 0.0 107.65 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.97 138.55 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.018 0.927 . . . . 0.0 111.707 -167.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -111.66 129.13 56.19 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.614 1.165 . . . . 0.0 113.135 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.44 142.73 25.19 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.416 1.486 . . . . 0.0 108.607 165.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -100.45 -72.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.907 2.404 . . . . 0.0 115.714 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 168.15 20.47 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.429 -1.42 . . . . 0.0 113.934 -173.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.84 -12.46 0.37 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.833 2.158 . . . . 0.0 117.879 171.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -117.22 98.63 52.15 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 119.422 1.611 . . . . 0.0 113.621 -163.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -68.44 133.85 29.26 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 148.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -161.76 156.82 23.34 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.851 0.86 . . . . 0.0 111.058 -176.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -70.38 135.4 48.74 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.497 1.119 . . . . 0.0 108.292 162.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.9 pp -60.85 118.41 34.9 Favored Pre-proline 0 CA--C 1.554 1.124 0 CA-C-N 118.252 0.478 . . . . 0.0 111.732 -170.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -94.84 86.75 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.597 2.865 . . . . 0.0 114.034 -159.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 37.1 t -121.73 128.4 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.418 1.487 . . . . 0.0 109.119 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.24 161.81 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.722 1.209 . . . . 0.0 111.988 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 55.2 t -138.93 118.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.406 2.283 . . . . 0.0 107.946 173.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.44 168.4 16.38 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -164.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.43 -8.83 58.19 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.708 2.003 . . . . 0.0 113.294 163.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -131.46 153.01 50.2 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.834 1.253 . . . . 0.0 110.899 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 23.9 mt -61.24 -26.06 67.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.4 t -108.36 10.4 27.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.743 1.617 . . . . 0.0 113.456 -169.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 44.12 67.71 0.64 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.736 2.414 . . . . 0.0 115.53 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -82.51 -38.31 24.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.368 1.067 . . . . 0.0 111.714 156.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.13 158.66 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.456 1.502 . . . . 0.0 109.663 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -125.45 97.79 5.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.576 1.15 . . . . 0.0 110.97 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -92.24 -26.6 18.1 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.328 2.251 . . . . 0.0 113.816 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -110.7 -170.74 19.53 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 29.8 mt -125.02 134.57 66.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 127.225 2.21 . . . . 0.0 110.078 -175.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 14.1 mt -68.69 122.73 19.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.357 1.063 . . . . 0.0 109.815 164.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 77.7 t -95.7 -49.82 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.593 0.757 . . . . 0.0 109.861 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 18.9 m -76.76 157.0 31.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.416 0.627 . . . . 0.0 110.695 171.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.9 156.17 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.428 1.491 . . . . 0.0 113.066 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -122.41 79.57 45.86 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.963 1.305 . . . . 0.0 111.292 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.18 -166.23 0.4 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 124.68 3.587 . . . . 0.0 113.106 171.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 39.9 pt -100.67 164.12 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.069 1.748 . . . . 0.0 111.503 168.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.93 113.78 3.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.329 1.051 . . . . 0.0 109.534 159.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 93.6 p -66.85 -33.4 75.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.159 1.384 . . . . 0.0 112.596 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 2.6 m -143.42 153.54 42.77 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.029 2.532 . . . . 0.0 106.467 -174.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.57 -23.05 66.8 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.411 -1.43 . . . . 0.0 114.649 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.8 8.87 20.94 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.402 1.481 . . . . 0.0 113.355 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.64 154.3 9.08 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.561 -1.337 . . . . 0.0 114.306 -169.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -154.22 114.84 3.97 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.242 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.83 155.37 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.247 1.019 . . . . 0.0 109.441 -170.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.1 120.07 39.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.806 2.443 . . . . 0.0 108.169 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.71 129.11 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.895 0.878 . . . . 0.0 111.151 -171.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -89.51 140.56 29.41 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.725 1.21 . . . . 0.0 111.926 158.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.84 151.19 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.383 1.473 . . . . 0.0 110.53 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -117.08 113.33 39.46 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.03 1.732 . . . . 0.0 110.067 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -80.31 160.84 22.97 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.848 2.365 . . . . 0.0 111.295 162.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.5 171.08 17.85 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.403 2.069 . . . . 0.0 110.272 161.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -62.22 142.01 57.91 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.695 -0.628 . . . . 0.0 111.182 171.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 103.68 -145.5 16.17 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.902 0.763 . . . . 0.0 112.095 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -83.11 162.49 21.3 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.734 1.213 . . . . 0.0 113.08 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 14.3 m -165.81 160.17 16.78 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.812 1.245 . . . . 0.0 111.717 161.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -121.09 118.19 29.11 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 13.9 mm -92.96 122.08 44.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.269 1.428 . . . . 0.0 107.852 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.02 142.35 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.512 0.725 . . . . 0.0 110.631 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.69 110.97 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 127.28 2.232 . . . . 0.0 108.81 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.9 -178.26 22.9 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.596 1.093 . . . . 0.0 114.587 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.4 m -135.71 167.09 21.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.853 2.061 . . . . 0.0 110.146 170.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 79.52 -167.25 51.72 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.568 -0.707 . . . . 0.0 112.683 -173.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -25.93 66.37 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.856 -0.79 . . . . 0.0 112.6 169.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.3 m -74.44 -2.74 26.81 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 129.008 2.923 . . . . 0.0 115.163 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -84.68 130.54 34.69 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.625 0.77 . . . . 0.0 111.876 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 13.7 mt -94.22 156.09 16.72 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.745 0.418 . . . . 0.0 110.37 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.6 t -138.4 148.27 44.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.038 0.935 . . . . 0.0 111.921 -170.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -145.32 118.96 9.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.386 1.474 . . . . 0.0 110.012 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.28 128.04 34.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.462 0.705 . . . . 0.0 110.808 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -127.05 152.57 47.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.077 0.951 . . . . 0.0 110.662 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.19 141.79 51.79 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.626 1.17 . . . . 0.0 108.592 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? . . . . . 0 N--CA 1.465 0.317 0 C-N-CA 125.087 1.355 . . . . 0.0 109.976 -174.232 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 10.2 mmt . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.1 p -118.96 -0.98 11.06 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -172.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.43 -53.92 47.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.226 0.921 . . . . 0.0 113.032 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.32 122.9 16.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.5 t -47.17 158.2 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.699 2.0 . . . . 0.0 116.353 -167.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.3 mm? -61.37 119.58 8.8 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.074 1.75 . . . . 0.0 111.51 -164.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 2.4 mptp? -65.44 115.2 5.44 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.195 1.398 . . . . 0.0 110.557 -172.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.79 -48.07 2.6 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.983 1.278 . . . . 0.0 112.902 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 46.3 m -63.25 -1.53 1.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.386 2.274 . . . . 0.0 113.245 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.0 m -155.33 156.76 36.06 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 119.149 -2.22 . . . . 0.0 112.143 170.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -84.44 164.28 18.96 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.411 1.084 . . . . 0.0 113.513 -169.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 151.04 46.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.952 1.301 . . . . 0.0 113.214 -175.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 77.7 mtm -68.31 167.65 14.06 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.046 2.538 . . . . 0.0 114.66 -171.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.6 m -86.0 148.54 25.7 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.89 0.876 . . . . 0.0 111.456 176.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 6.7 p -136.95 23.08 3.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.097 1.359 . . . . 0.0 112.799 172.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -84.21 156.71 21.9 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.26 -0.9 . . . . 0.0 108.988 155.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . 0.45 ' H ' ' HE2' ' A' ' 303' ' ' LYS . 0.2 OUTLIER -65.53 106.33 1.41 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.542 1.537 . . . . 0.0 111.575 -166.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 63.9 mtp -92.32 171.87 8.77 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.413 1.085 . . . . 0.0 112.839 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.8 m -163.69 162.33 24.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.663 1.185 . . . . 0.0 111.761 167.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.0 116.81 18.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.643 0.777 . . . . 0.0 110.21 169.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.16 -35.1 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.333 1.453 . . . . 0.0 110.288 163.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -134.64 129.84 35.48 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.385 1.474 . . . . 0.0 108.67 165.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -63.18 156.29 69.41 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.663 0.785 . . . . 0.0 112.275 173.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -62.58 132.46 38.02 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.132 1.888 . . . . 0.0 110.797 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 60.4 p -133.79 135.07 43.62 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.957 2.103 . . . . 0.0 108.79 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.55 140.15 58.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.075 0.852 . . . . 0.0 111.829 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 41.0 p -67.77 -17.49 64.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.598 1.959 . . . . 0.0 113.633 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 91.39 -6.66 80.72 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.349 0.976 . . . . 0.0 112.175 -164.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -98.51 1.16 46.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.724 1.21 . . . . 0.0 112.089 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 77.5 43.67 14.92 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 119.069 0.85 . . . . 0.0 111.094 -172.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 63.3 p -144.41 137.04 26.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.561 1.944 . . . . 0.0 108.194 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.8 m -110.66 125.06 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.223 0.919 . . . . 0.0 111.304 -172.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.87 131.03 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.753 1.621 . . . . 0.0 111.873 -173.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 11.2 ptp -141.83 166.1 25.65 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.998 2.119 . . . . 0.0 112.15 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -133.41 134.57 43.81 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.901 0.88 . . . . 0.0 110.38 171.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.8 m -132.01 135.31 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.221 1.008 . . . . 0.0 113.036 -165.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -89.73 131.86 35.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.29 1.836 . . . . 0.0 112.426 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 t -104.64 145.79 31.38 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.016 -1.469 . . . . 0.0 107.866 156.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -105.29 -72.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.617 2.211 . . . . 0.0 115.969 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.89 170.91 16.08 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 119.633 -1.917 . . . . 0.0 114.803 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.5 -4.24 3.01 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 126.18 1.848 . . . . 0.0 117.114 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.58 94.18 48.72 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 118.903 1.352 . . . . 0.0 112.063 -165.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.56 121.97 8.7 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.288 1.992 . . . . 0.0 108.952 163.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.2 p -157.84 154.45 28.03 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -77.13 142.01 39.92 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 156.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 14.5 pt -63.83 118.16 42.59 Favored Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -87.58 91.3 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.349 3.366 . . . . 0.0 113.178 -169.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.19 139.28 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.805 0.842 . . . . 0.0 109.703 169.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.63 147.11 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.371 1.468 . . . . 0.0 108.697 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.17 106.08 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -114.55 162.12 17.14 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -163.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.53 -9.62 57.13 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.854 2.062 . . . . 0.0 112.902 165.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -133.48 140.62 47.36 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.668 1.187 . . . . 0.0 110.528 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.28 -17.45 42.49 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -173.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -106.03 5.09 30.01 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.171 1.788 . . . . 0.0 113.601 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.57 78.91 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 129.557 3.143 . . . . 0.0 116.721 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.34 -36.91 11.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.398 1.479 . . . . 0.0 112.36 156.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 94.7 mt -103.12 136.06 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.135 1.374 . . . . 0.0 109.972 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.02 98.68 8.35 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.827 1.651 . . . . 0.0 110.02 -177.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -84.69 -52.32 6.17 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.249 2.62 . . . . 0.0 112.664 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -87.77 -172.91 47.76 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 116.204 1.242 . . . . 0.0 116.204 -170.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 45.5 mt -126.75 143.15 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.118 1.767 . . . . 0.0 111.048 -172.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 86.6 mt -68.84 138.45 54.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.033 0.933 . . . . 0.0 111.14 168.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.06 -42.8 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.267 0.485 . . . . 0.0 111.433 169.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 m -76.28 149.72 37.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.901 0.773 . . . . 0.0 109.491 158.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.98 157.59 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.296 1.038 . . . . 0.0 111.898 170.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -114.52 78.14 4.74 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.838 1.655 . . . . 0.0 110.647 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.12 -170.93 0.94 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.747 3.632 . . . . 0.0 114.013 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 42.8 pt -95.58 166.89 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.194 1.798 . . . . 0.0 111.657 172.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.15 124.47 24.19 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.681 0.792 . . . . 0.0 109.853 156.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.8 p -80.07 -40.31 27.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.136 1.375 . . . . 0.0 111.984 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.86 148.5 38.47 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.313 1.845 . . . . 0.0 108.399 159.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -59.92 -20.65 58.57 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.08 8.28 38.5 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.209 1.403 . . . . 0.0 112.954 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -61.45 155.12 22.54 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 119.983 -1.698 . . . . 0.0 113.779 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -132.92 95.49 3.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.965 1.306 . . . . 0.0 111.9 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.75 145.65 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.846 1.258 . . . . 0.0 111.922 -160.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 51.8 tp -102.61 127.16 49.82 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.099 2.96 . . . . 0.0 110.668 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.66 147.06 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.174 1.39 . . . . 0.0 110.907 -173.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -120.93 149.55 42.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.367 1.067 . . . . 0.0 113.632 161.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 2.4 m -137.42 158.21 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.855 2.062 . . . . 0.0 110.754 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -111.71 102.54 53.69 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.892 1.677 . . . . 0.0 110.793 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.87 139.12 27.03 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.553 2.169 . . . . 0.0 110.031 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.9 171.54 15.52 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.193 1.929 . . . . 0.0 111.208 170.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -64.55 150.57 46.54 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.703 -0.623 . . . . 0.0 112.21 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.57 -150.36 20.03 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -159.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -89.41 158.56 17.7 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.728 1.611 . . . . 0.0 113.22 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.4 m -158.72 151.26 21.83 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.174 -1.579 . . . . 0.0 112.04 166.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -118.39 109.28 16.08 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.84 108.63 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.91 142.19 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.01 112.32 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 125.355 1.462 . . . . 0.0 108.646 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.4 177.9 20.79 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.262 1.411 . . . . 0.0 114.995 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.5 m -136.08 161.05 36.77 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.043 1.737 . . . . 0.0 109.357 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.53 -166.73 54.58 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 121.558 0.532 . . . . 0.0 112.501 -170.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -27.34 14.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.708 1.603 . . . . 0.0 113.631 172.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.7 m -69.9 -4.15 19.14 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 129.199 3.0 . . . . 0.0 115.308 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -91.72 123.62 35.25 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.8 0.727 . . . . 0.0 112.928 -167.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.48 168.08 11.09 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.411 0.684 . . . . 0.0 111.289 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.1 t -140.09 149.22 42.82 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.172 1.389 . . . . 0.0 111.369 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -145.94 123.16 11.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.291 1.836 . . . . 0.0 109.923 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.43 133.01 39.99 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.268 -0.895 . . . . 0.0 111.85 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -121.59 162.86 19.88 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.332 1.053 . . . . 0.0 111.031 160.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -142.86 145.77 33.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.926 1.29 . . . . 0.0 108.708 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt . . . . . 0 N--CA 1.468 0.462 0 C-N-CA 125.214 1.405 . . . . 0.0 110.221 -177.214 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 56.1 mmm . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.8 p -101.34 -0.47 35.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.93 -31.48 60.36 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.9 tt -98.8 125.25 44.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 161.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.9 t -53.58 162.94 0.73 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.593 1.157 . . . . 0.0 113.883 -171.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.502 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.7 mm? -49.88 110.49 0.39 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.636 1.974 . . . . 0.0 111.161 -162.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -55.43 124.05 15.91 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.901 1.681 . . . . 0.0 110.421 -168.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 59.92 9.2 9.73 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.98 1.276 . . . . 0.0 115.445 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 20.3 m -134.15 10.01 3.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.762 2.025 . . . . 0.0 110.181 -160.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.6 m -161.48 158.19 26.2 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 119.709 -1.869 . . . . 0.0 110.612 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -79.2 172.23 14.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.102 0.961 . . . . 0.0 112.976 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -71.57 160.12 33.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -77.8 152.66 33.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.409 2.284 . . . . 0.0 112.26 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -71.47 144.64 49.63 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.572 -0.705 . . . . 0.0 112.574 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.8 p -134.56 17.35 3.63 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.149 1.38 . . . . 0.0 113.391 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -75.65 161.19 29.31 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.928 -1.107 . . . . 0.0 109.009 154.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 87.58 0.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.991 1.316 . . . . 0.0 111.347 -168.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 55.9 mtp -70.05 172.97 7.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.906 2.082 . . . . 0.0 114.277 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.8 m -157.85 164.7 36.7 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.98 0.912 . . . . 0.0 111.998 158.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.95 121.61 25.67 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.263 0.625 . . . . 0.0 110.407 166.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.5 -37.14 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.107 1.363 . . . . 0.0 110.121 166.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -131.93 123.13 26.8 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.905 1.282 . . . . 0.0 108.91 169.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -63.43 149.87 90.97 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.132 0.973 . . . . 0.0 111.682 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.45 139.41 70.66 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.716 2.277 . . . . 0.0 112.327 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 49.0 p -141.94 129.59 21.53 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.36 1.864 . . . . 0.0 109.875 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -56.51 126.43 26.49 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.781 0.719 . . . . 0.0 111.679 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.5 p -68.64 -15.6 63.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.8 2.04 . . . . 0.0 113.51 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 93.76 -21.75 39.67 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.748 1.642 . . . . 0.0 112.047 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -74.38 -20.17 60.17 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.386 1.093 . . . . 0.0 112.426 172.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 103.01 18.77 14.16 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.444 1.02 . . . . 0.0 112.503 -168.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.5 p -120.93 149.28 42.88 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 126.548 1.939 . . . . 0.0 108.208 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 33.7 m -118.75 123.61 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.144 0.978 . . . . 0.0 110.096 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.0 p -96.79 127.16 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.968 1.307 . . . . 0.0 111.342 -174.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.1 ptm -147.67 161.43 41.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.526 1.531 . . . . 0.0 112.934 -172.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -134.26 134.21 41.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 110.622 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 23.8 m -131.04 122.36 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.414 1.086 . . . . 0.0 113.353 -162.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -89.75 123.34 33.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.257 2.223 . . . . 0.0 112.247 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.79 146.36 31.25 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 117.235 -1.364 . . . . 0.0 108.235 156.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -101.25 -71.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.722 2.281 . . . . 0.0 115.896 174.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.47 163.96 34.02 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 119.534 -1.979 . . . . 0.0 114.701 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 61.74 7.79 12.89 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.681 1.61 . . . . 0.0 116.333 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.23 88.76 33.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 118.612 1.206 . . . . 0.0 112.319 -162.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.02 118.54 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.15 1.9 . . . . 0.0 108.377 161.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.7 p -157.48 156.59 32.35 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.731 0.777 . . . . 0.0 112.998 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -77.63 142.51 38.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.904 1.682 . . . . 0.0 108.397 163.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.42 123.38 73.3 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 119.287 0.948 . . . . 0.0 111.346 -172.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -102.04 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.583 2.855 . . . . 0.0 113.524 -164.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.24 120.56 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.641 0.776 . . . . 0.0 109.017 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.68 158.47 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.581 1.153 . . . . 0.0 110.465 -174.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.74 104.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.943 2.097 . . . . 0.0 108.085 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.03 159.14 36.88 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.709 1.004 . . . . 0.0 113.709 -160.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.21 -14.33 61.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.718 2.007 . . . . 0.0 112.944 166.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -129.86 140.56 50.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.531 1.532 . . . . 0.0 111.022 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.92 -20.99 60.46 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.4 t -101.22 7.3 43.09 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.866 1.667 . . . . 0.0 113.649 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.18 63.96 1.36 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.799 2.44 . . . . 0.0 115.668 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.13 -50.7 13.92 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.736 0.814 . . . . 0.0 110.876 155.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 15.4 mm -84.41 160.94 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.356 0.598 . . . . 0.0 109.617 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -138.66 61.52 1.57 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.03 -1.044 . . . . 0.0 111.679 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -53.28 -50.81 64.1 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.067 2.547 . . . . 0.0 113.72 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -80.5 -172.0 44.54 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 116.059 1.184 . . . . 0.0 116.059 -168.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.7 mt -123.99 137.35 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.556 1.543 . . . . 0.0 110.175 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.8 mp -77.16 126.62 31.24 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 161.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.97 -46.43 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.557 1.143 . . . . 0.0 109.62 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 31.6 m -73.82 161.01 30.64 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.448 0.642 . . . . 0.0 110.488 167.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 352' ' ' VAL . 3.6 t -53.54 153.09 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.94 1.696 . . . . 0.0 111.026 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -111.61 76.59 1.59 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.07 1.348 . . . . 0.0 110.991 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -75.74 -174.47 2.04 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.947 3.098 . . . . 0.0 112.8 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.2 pt -91.36 168.16 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.049 1.339 . . . . 0.0 111.715 168.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.92 110.13 2.34 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 154.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.4 p -72.04 -37.3 69.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.166 1.386 . . . . 0.0 112.146 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.37 158.0 29.24 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.573 1.949 . . . . 0.0 109.306 158.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -62.1 -20.06 63.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -100.35 11.1 40.19 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.653 1.581 . . . . 0.0 112.408 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -60.6 148.57 37.77 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.596 -1.315 . . . . 0.0 113.705 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -132.17 82.19 2.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.811 1.644 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 11.5 t -94.91 146.39 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.335 1.054 . . . . 0.0 111.202 -164.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 39.8 tp -104.7 123.38 47.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.417 2.687 . . . . 0.0 111.073 -173.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 2.9 mp -141.14 141.17 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.533 1.933 . . . . 0.0 111.041 -170.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -94.04 139.61 30.75 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.637 1.175 . . . . 0.0 111.94 158.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.04 166.24 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.022 1.329 . . . . 0.0 111.004 168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -129.55 108.61 17.37 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 125.894 1.678 . . . . 0.0 110.11 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.64 149.43 26.82 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.568 2.179 . . . . 0.0 110.231 158.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.81 170.16 20.31 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.224 1.949 . . . . 0.0 111.472 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -57.78 129.59 42.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.003 0.921 . . . . 0.0 110.225 168.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 110.76 -139.05 15.32 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.984 0.802 . . . . 0.0 111.898 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -86.85 167.15 14.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.264 1.025 . . . . 0.0 113.287 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.2 m -178.23 163.46 1.66 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.762 2.425 . . . . 0.0 111.04 158.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -127.2 126.58 43.04 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.628 1.571 . . . . 0.0 107.698 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.0 mm -95.26 122.05 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.214 1.406 . . . . 0.0 108.016 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.1 142.81 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.611 0.764 . . . . 0.0 110.2 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 67.9 t -115.92 109.1 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.943 1.697 . . . . 0.0 108.653 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.05 -173.5 20.72 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 123.358 1.532 . . . . 0.0 115.338 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.0 m -140.4 163.91 31.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.487 1.515 . . . . 0.0 109.843 171.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.19 -167.85 54.02 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 121.65 0.583 . . . . 0.0 112.775 -171.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.51 -29.14 6.28 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 114.028 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.0 m -71.34 -11.77 61.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.401 2.681 . . . . 0.0 114.693 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -79.69 109.45 14.1 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -164.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.16 158.0 33.72 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.11 -0.369 . . . . 0.0 110.779 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 2.7 t -136.26 143.93 44.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.754 1.222 . . . . 0.0 111.006 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -144.67 123.17 12.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.595 1.558 . . . . 0.0 110.134 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.39 124.86 24.99 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.359 -0.838 . . . . 0.0 111.945 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -130.1 123.37 30.25 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.213 0.605 . . . . 0.0 110.397 161.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -123.37 146.76 47.7 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 17.9 tptt . . . . . 0 N--CA 1.463 0.223 0 C-N-CA 124.276 1.031 . . . . 0.0 110.496 -162.066 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.3 p -97.08 -7.05 33.68 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.76 95.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.527 1.058 . . . . 0.0 112.696 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.9 tt -63.06 129.62 41.16 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 7.5 t -49.45 163.45 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.299 1.44 . . . . 0.0 114.537 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -73.53 93.63 2.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.027 1.331 . . . . 0.0 111.134 -160.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.616 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 2.1 mptt -39.01 111.25 0.17 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.519 3.128 . . . . 0.0 112.417 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.01 -32.25 0.52 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.415 1.96 . . . . 0.0 115.111 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 62.7 m -70.98 -3.45 19.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.87 2.468 . . . . 0.0 112.304 171.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.9 m -156.66 154.23 29.78 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 119.311 -2.118 . . . . 0.0 111.199 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -78.71 174.58 11.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.12 1.368 . . . . 0.0 113.178 -173.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -65.27 161.09 20.15 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.041 1.336 . . . . 0.0 114.442 -170.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 71.3 mtm -91.21 150.47 21.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.139 2.175 . . . . 0.0 111.627 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.5 m -69.41 147.57 50.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.077 0.951 . . . . 0.0 112.571 -174.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.6 p -136.38 11.12 3.24 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -76.82 165.04 25.25 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 119.433 1.015 . . . . 0.0 109.553 161.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.48 89.63 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.225 1.41 . . . . 0.0 113.727 -167.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 44.7 mtp -76.64 167.18 22.28 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.639 1.176 . . . . 0.0 113.659 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.5 m -160.69 162.78 32.7 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.875 1.27 . . . . 0.0 110.555 161.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.7 130.57 34.53 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.978 -0.452 . . . . 0.0 110.727 164.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.36 -28.85 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.634 1.573 . . . . 0.0 110.197 167.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -129.99 116.94 19.3 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.531 1.532 . . . . 0.0 108.257 163.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -55.94 150.12 30.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.784 1.234 . . . . 0.0 111.081 169.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.5 138.31 69.79 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.81 1.673 . . . . 0.0 110.808 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 389' ' ' TRP . 0.9 OUTLIER -144.28 142.59 30.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.089 0.556 . . . . 0.0 110.158 175.061 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -63.48 126.3 27.03 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.727 1.611 . . . . 0.0 112.413 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 82.5 p -73.84 -25.89 60.31 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.001 1.32 . . . . 0.0 112.68 173.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 84.98 -2.41 88.32 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.501 1.524 . . . . 0.0 114.538 -164.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -87.2 6.06 34.92 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.334 1.453 . . . . 0.0 112.038 171.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 83.1 20.08 61.56 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 121.094 -1.004 . . . . 0.0 112.829 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 366' ' ' GLU . 33.4 p -131.9 154.22 49.44 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.056 1.343 . . . . 0.0 110.688 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 24.1 m -122.81 128.95 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.685 1.194 . . . . 0.0 109.347 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.41 132.88 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.467 1.107 . . . . 0.0 112.21 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -141.8 162.42 35.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.658 1.583 . . . . 0.0 113.778 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -121.48 114.14 20.83 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.472 2.309 . . . . 0.0 107.006 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 362' ' ' GLU . 35.4 m -118.95 138.31 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.693 1.197 . . . . 0.0 111.018 -167.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -119.63 136.64 54.3 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 8.5 t -102.46 150.33 37.52 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 127.301 2.24 . . . . 0.0 108.591 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -102.62 -74.03 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 122.907 2.405 . . . . 0.0 115.888 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.18 162.36 34.46 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.785 1.63 . . . . 0.0 114.498 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 59.94 -0.18 0.88 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 127.193 2.33 . . . . 0.0 118.272 170.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.38 94.67 23.12 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 119.681 1.741 . . . . 0.0 113.304 -164.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.64 115.79 4.45 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.461 2.107 . . . . 0.0 108.935 163.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.0 p -150.77 155.41 39.2 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.924 0.869 . . . . 0.0 112.715 -175.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -74.14 136.36 42.9 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.262 1.425 . . . . 0.0 107.977 163.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 333' ' ' PRO 0.273 2.6 pp -62.27 129.44 92.28 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.415 -169.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 16.3 Cg_endo -100.43 89.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.005 2.47 . . . . 0.0 113.635 -160.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 94.4 t -118.22 130.71 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.994 1.318 . . . . 0.0 109.602 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.33 151.67 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 111.51 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.7 t -126.82 104.18 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.415 1.886 . . . . 0.0 107.508 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -115.1 161.81 17.88 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -163.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.71 -11.73 58.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.222 1.809 . . . . 0.0 112.722 163.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.65 146.37 49.46 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.724 1.21 . . . . 0.0 111.75 -176.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.05 -16.14 63.66 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -99.63 5.27 45.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.558 1.143 . . . . 0.0 112.983 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.549 ' HB2' HD13 ' A' ' 377' ' ' ILE . . . 37.8 77.83 0.04 OUTLIER 'General case' 0 C--O 1.239 0.548 0 C-N-CA 129.124 2.97 . . . . 0.0 115.115 -169.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -106.72 -25.43 11.75 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.394 1.877 . . . . 0.0 112.918 166.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.95 119.72 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.599 1.56 . . . . 0.0 109.436 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.1 123.54 50.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -107.85 -16.93 14.2 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -93.52 -177.59 39.96 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 119.853 1.206 . . . . 0.0 116.046 -176.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 86.9 mt -126.63 136.2 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 127.926 2.491 . . . . 0.0 110.058 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mt -72.73 136.99 45.64 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.186 0.995 . . . . 0.0 110.882 168.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.14 -46.66 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.257 0.623 . . . . 0.0 111.466 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 47.6 m -68.99 153.12 44.35 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.384 0.538 . . . . 0.0 109.787 159.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.38 161.28 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.574 1.149 . . . . 0.0 113.028 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -118.04 79.13 13.77 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.284 1.434 . . . . 0.0 111.105 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -78.88 -171.22 1.18 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 123.731 2.954 . . . . 0.0 112.332 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.27 167.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.091 1.357 . . . . 0.0 111.383 171.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.1 117.01 10.2 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 156.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 86.0 p -67.28 -28.41 68.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.589 1.156 . . . . 0.0 112.809 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 21.5 m -137.23 151.28 48.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 128.254 2.621 . . . . 0.0 106.717 -172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.9 -26.63 66.07 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.524 -1.36 . . . . 0.0 113.684 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -89.14 2.51 54.06 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.328 1.851 . . . . 0.0 113.413 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -58.58 154.37 14.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.933 1.349 . . . . 0.0 113.25 -166.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 7.7 pt-20 -144.53 95.32 2.69 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.945 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.87 149.54 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.106 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 45.2 tp -93.99 124.62 38.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.485 2.314 . . . . 0.0 109.412 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.23 135.1 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.746 0.818 . . . . 0.0 110.551 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . 0.428 ' OE1' ' OG1' ' A' ' 317' ' ' THR . 3.5 pt-20 -106.01 140.07 39.57 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.21 1.005 . . . . 0.0 112.402 158.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.19 151.53 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.974 2.11 . . . . 0.0 110.025 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -108.92 113.01 59.85 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.296 1.838 . . . . 0.0 109.774 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.62 159.42 25.22 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.538 2.159 . . . . 0.0 111.108 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.17 173.17 3.43 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.703 2.269 . . . . 0.0 112.176 163.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -64.35 141.0 58.93 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.785 -0.572 . . . . 0.0 110.149 163.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 99.47 -140.59 15.06 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.575 0.607 . . . . 0.0 111.787 -174.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -88.24 164.71 15.49 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.713 1.205 . . . . 0.0 113.393 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 13.2 m -167.31 152.96 7.55 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.38 1.472 . . . . 0.0 111.821 165.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -118.95 113.92 21.75 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 31.9 mm -88.48 115.02 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 125.864 1.666 . . . . 0.0 107.734 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 342' ' ' ALA . 2.1 mp -113.51 140.83 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 122.021 0.915 . . . . 0.0 111.263 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.59 114.07 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 127.02 2.128 . . . . 0.0 108.251 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 98.36 178.09 32.81 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 122.662 1.146 . . . . 0.0 114.76 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 48.6 m -130.45 165.62 22.23 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.279 1.832 . . . . 0.0 109.353 171.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.87 -171.97 54.26 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 121.675 -0.64 . . . . 0.0 113.059 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.23 -23.1 33.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.33 1.452 . . . . 0.0 113.999 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.3 m -82.84 -2.73 55.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.482 2.313 . . . . 0.0 114.909 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -76.79 126.53 31.14 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.456 1.025 . . . . 0.0 113.068 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -90.05 161.89 15.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.147 0.579 . . . . 0.0 111.652 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.3 t -137.78 151.36 48.06 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.192 1.397 . . . . 0.0 112.59 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -150.13 131.77 14.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.314 1.846 . . . . 0.0 110.328 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.51 136.43 36.9 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.969 -1.082 . . . . 0.0 111.98 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . 0.41 ' CZ2' ' HA ' ' A' ' 311' ' ' THR . 21.2 m95 -125.53 152.73 44.64 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.698 0.761 . . . . 0.0 112.243 161.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -133.3 134.15 43.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.053 1.341 . . . . 0.0 108.365 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? . . . . . 0 N--CA 1.467 0.405 0 C-N-CA 125.351 1.46 . . . . 0.0 110.747 -167.269 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 20.0 m -103.23 11.28 37.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.094 1.357 . . . . 0.0 113.344 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -72.25 -39.28 68.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.609 1.095 . . . . 0.0 111.011 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.5 tt -72.68 138.76 46.84 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 164.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.4 t -55.73 176.91 0.06 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.142 1.777 . . . . 0.0 114.973 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -68.58 83.49 0.28 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.846 1.658 . . . . 0.0 110.451 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.553 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 1.8 mptt -38.12 119.53 0.79 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.238 2.615 . . . . 0.0 112.481 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.86 -37.38 1.06 Allowed Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.745 1.64 . . . . 0.0 114.696 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 58.3 m -75.01 1.39 13.09 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.503 2.321 . . . . 0.0 112.593 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.0 m -158.19 149.93 21.53 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 119.037 -2.289 . . . . 0.0 111.715 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -84.71 178.78 7.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.972 1.309 . . . . 0.0 113.302 -169.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -63.93 162.19 14.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.263 1.425 . . . . 0.0 114.254 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -69.92 157.41 37.49 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.641 1.576 . . . . 0.0 111.853 166.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.7 m -75.29 145.8 41.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.194 0.598 . . . . 0.0 110.255 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.0 p -133.67 21.0 3.9 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.909 1.283 . . . . 0.0 112.022 170.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -82.88 168.48 17.04 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 155.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 100.71 0.27 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.244 1.418 . . . . 0.0 112.067 -166.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 16.7 mtp -86.41 166.14 15.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.022 0.915 . . . . 0.0 112.21 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 18.9 m -163.58 163.31 24.57 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.261 1.024 . . . . 0.0 111.122 169.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.8 114.45 22.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.475 0.71 . . . . 0.0 109.129 163.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.26 -37.91 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.571 1.149 . . . . 0.0 109.552 161.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -135.16 120.49 19.04 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.682 1.593 . . . . 0.0 108.405 168.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -59.62 152.8 54.83 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.31 1.044 . . . . 0.0 110.977 172.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.38 137.06 63.0 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.094 1.863 . . . . 0.0 111.489 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.3 m -132.88 135.01 45.33 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.858 1.263 . . . . 0.0 109.225 173.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.06 130.12 43.3 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.253 0.549 . . . . 0.0 111.97 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 70.3 p -79.43 -21.06 46.06 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.709 1.203 . . . . 0.0 113.333 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 80.98 -8.34 57.43 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.761 1.172 . . . . 0.0 114.364 -161.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -87.97 6.26 36.75 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.298 1.439 . . . . 0.0 112.06 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 88.51 14.49 61.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.282 0.944 . . . . 0.0 113.092 -171.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 50.5 p -131.63 161.17 33.34 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.111 1.364 . . . . 0.0 111.259 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.27 133.02 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 125.253 1.421 . . . . 0.0 109.222 169.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.4 p -115.58 131.87 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.908 1.283 . . . . 0.0 112.05 -172.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 15.8 ptm -144.95 163.18 34.95 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.406 2.282 . . . . 0.0 112.069 -169.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -132.61 130.84 40.76 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.756 0.822 . . . . 0.0 108.915 173.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.47 145.15 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.171 0.988 . . . . 0.0 111.379 -165.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -105.17 135.82 45.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.737 1.215 . . . . 0.0 112.429 -175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.6 t -114.74 135.55 22.38 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.891 1.676 . . . . 0.0 107.714 163.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -100.65 -61.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.899 2.399 . . . . 0.0 115.164 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.96 176.11 11.82 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.714 -1.241 . . . . 0.0 113.091 -176.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.66 -23.19 0.18 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 128.097 2.76 . . . . 0.0 118.683 160.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -109.11 104.09 54.09 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 119.257 1.529 . . . . 0.0 112.766 -166.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.76 114.04 3.19 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.583 1.522 . . . . 0.0 108.502 159.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.7 p -148.8 154.55 39.69 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.997 0.903 . . . . 0.0 112.233 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -78.14 134.92 37.6 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.321 1.448 . . . . 0.0 107.573 161.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -60.08 117.71 26.24 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 118.574 0.625 . . . . 0.0 111.308 -171.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -96.93 88.54 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.348 2.699 . . . . 0.0 113.752 -166.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 60.6 t -107.75 136.26 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 164.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.05 161.07 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.897 1.279 . . . . 0.0 111.104 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 93.0 t -139.34 106.24 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.05 1.74 . . . . 0.0 109.071 -174.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.24 163.01 26.56 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -158.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -87.34 -17.73 31.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.468 1.907 . . . . 0.0 112.883 163.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -123.64 153.05 41.3 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.598 1.159 . . . . 0.0 111.108 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 54.1 mt -69.23 -2.38 10.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.445 1.098 . . . . 0.0 113.883 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 2.2 t -129.4 18.61 5.85 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.579 1.551 . . . . 0.0 112.198 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 49.62 31.25 4.09 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.5 -25.87 68.24 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.745 -0.597 . . . . 0.0 112.388 166.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 31.9 mt -121.95 117.52 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.533 2.333 . . . . 0.0 107.693 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.94 115.66 29.88 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.91 0.777 . . . . 0.0 111.279 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -103.16 -10.44 18.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -174.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -99.33 -167.97 30.18 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 54.5 mt -132.04 133.69 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 127.86 2.464 . . . . 0.0 110.45 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 23.0 mt -65.25 121.0 13.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.932 1.293 . . . . 0.0 109.942 160.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 50.5 t -102.59 -51.89 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 122.924 0.49 . . . . 0.0 110.635 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.4 m -69.85 163.41 25.92 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.509 0.595 . . . . 0.0 110.424 168.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.4 t -52.81 147.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.587 1.155 . . . . 0.0 110.437 170.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -112.13 78.68 2.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.068 1.347 . . . . 0.0 110.2 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.15 -174.2 2.15 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 123.909 3.073 . . . . 0.0 113.349 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.546 ' H ' HD13 ' A' ' 355' ' ' ILE . 0.2 OUTLIER -94.01 168.37 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.521 1.528 . . . . 0.0 110.948 167.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.54 110.99 3.89 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 156.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 83.3 p -73.27 -36.99 66.44 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.094 1.358 . . . . 0.0 112.073 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.79 154.36 37.09 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.721 2.008 . . . . 0.0 109.093 160.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -64.82 -19.0 65.61 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.48 0.87 56.57 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.017 1.727 . . . . 0.0 112.919 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -57.84 149.54 22.27 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.503 -1.373 . . . . 0.0 114.074 -171.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -138.91 86.76 2.16 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.118 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.03 145.88 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.794 1.237 . . . . 0.0 111.6 -170.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 45.8 tp -92.35 126.42 37.43 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.059 2.944 . . . . 0.0 110.502 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.8 145.14 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.662 1.585 . . . . 0.0 109.823 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -116.79 149.57 39.75 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.099 0.952 . . . . 0.0 111.948 159.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.19 154.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 125.564 1.546 . . . . 0.0 110.162 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -103.24 114.18 65.23 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.659 1.184 . . . . 0.0 110.22 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.57 143.8 15.38 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.019 2.48 . . . . 0.0 110.969 162.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -74.86 167.68 26.54 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.862 2.375 . . . . 0.0 111.242 169.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -53.63 140.37 29.15 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.734 1.214 . . . . 0.0 112.206 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.9 -147.57 17.0 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -172.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -82.09 164.16 21.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.61 1.564 . . . . 0.0 112.083 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 33.4 m -161.39 148.25 14.64 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.662 -1.274 . . . . 0.0 112.419 158.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -110.14 106.41 15.86 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.104 0.961 . . . . 0.0 108.499 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.4 mm -84.14 114.97 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 125.836 1.655 . . . . 0.0 107.95 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.2 mt -115.64 143.78 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.502 1.121 . . . . 0.0 109.891 -169.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 52.5 t -120.84 113.84 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.679 1.592 . . . . 0.0 108.556 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 90.42 179.54 43.78 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 53.1 m -132.51 165.83 23.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.696 1.998 . . . . 0.0 109.341 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.17 -170.1 55.04 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.808 -0.557 . . . . 0.0 112.783 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -28.15 56.53 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.762 1.225 . . . . 0.0 113.643 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.0 m -78.21 -3.91 45.06 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 127.513 2.325 . . . . 0.0 115.041 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -78.91 144.33 34.99 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.694 0.679 . . . . 0.0 112.822 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.3 mt -111.07 163.88 13.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.615 0.766 . . . . 0.0 110.922 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.5 t -139.52 154.01 47.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.732 1.213 . . . . 0.0 111.459 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -149.19 135.73 19.43 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.89 1.676 . . . . 0.0 109.892 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.77 131.6 38.97 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.415 -0.803 . . . . 0.0 111.662 -172.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -123.72 166.23 15.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.115 0.966 . . . . 0.0 112.04 167.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -138.98 129.94 26.46 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.073 1.749 . . . . 0.0 108.368 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? . . . . . 0 C--O 1.233 0.214 0 C-N-CA 125.81 1.644 . . . . 0.0 110.7 -176.503 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.0 t -119.49 9.9 11.68 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.801 1.24 . . . . 0.0 113.374 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.44 ' HB1' ' H ' ' A' ' 336' ' ' VAL . . . -65.57 -46.7 78.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.041 0.837 . . . . 0.0 110.909 167.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.07 129.15 38.88 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 164.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.7 t -57.02 171.33 0.36 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.163 1.385 . . . . 0.0 114.269 -173.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.1 mm? -64.34 109.08 1.79 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.614 1.965 . . . . 0.0 110.721 -167.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -63.78 114.61 4.14 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.989 2.116 . . . . 0.0 110.578 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 78.91 -40.84 2.12 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.827 1.203 . . . . 0.0 113.322 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 5.2 m -65.69 -0.81 2.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.752 2.421 . . . . 0.0 114.013 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.0 m -153.08 151.69 30.49 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 118.994 -2.316 . . . . 0.0 113.65 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -73.82 173.48 9.82 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.359 1.864 . . . . 0.0 112.827 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -71.47 152.77 42.77 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.338 1.055 . . . . 0.0 113.785 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -70.2 157.55 37.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.819 2.048 . . . . 0.0 112.337 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.4 m -69.82 140.51 53.3 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.546 -0.721 . . . . 0.0 111.735 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 17.2 p -128.18 7.1 5.95 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -73.67 166.46 23.24 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.016 0.825 . . . . 0.0 110.888 164.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -71.03 84.15 0.7 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.016 1.727 . . . . 0.0 111.197 -170.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 41.3 mtp -66.63 172.46 4.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.383 1.873 . . . . 0.0 114.337 -174.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.5 m -157.69 159.34 36.81 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.489 1.116 . . . . 0.0 111.249 164.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.97 117.1 19.72 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 169.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.45 -33.49 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.025 0.53 . . . . 0.0 109.659 161.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -137.43 124.08 21.03 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.785 1.634 . . . . 0.0 108.026 164.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -59.18 160.91 10.71 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.211 0.604 . . . . 0.0 111.599 171.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -61.33 135.66 59.23 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.903 1.735 . . . . 0.0 110.589 167.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.0 m -138.48 138.44 38.1 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.766 1.226 . . . . 0.0 108.985 171.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.18 128.57 37.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.09 0.868 . . . . 0.0 111.567 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 73.8 p -79.63 -12.62 59.82 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.252 1.021 . . . . 0.0 113.723 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 75.45 0.69 63.13 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.394 0.997 . . . . 0.0 113.978 -164.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -111.67 14.52 21.21 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.189 1.796 . . . . 0.0 112.32 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.8 15.17 68.38 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.766 0.698 . . . . 0.0 113.501 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.4 p -134.61 162.67 31.64 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.691 1.197 . . . . 0.0 111.176 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.73 130.42 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.597 1.159 . . . . 0.0 109.625 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.33 132.9 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.843 1.257 . . . . 0.0 111.802 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 4.8 ptp -143.84 166.03 26.05 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.117 1.767 . . . . 0.0 112.345 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -133.88 128.71 35.18 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.679 1.192 . . . . 0.0 109.904 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.79 121.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.076 0.951 . . . . 0.0 112.22 -161.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.23 130.13 34.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.512 1.525 . . . . 0.0 112.028 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.29 137.4 19.42 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.985 1.314 . . . . 0.0 108.201 159.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -91.88 -77.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 122.9 2.4 . . . . 0.0 116.256 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 139.16 20.38 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -171.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 83.8 4.74 88.61 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.808 1.194 . . . . 0.0 115.422 174.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.61 89.43 18.53 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 118.664 1.232 . . . . 0.0 112.325 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.1 127.13 13.89 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.215 1.943 . . . . 0.0 108.676 159.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 5.0 p -162.77 162.9 26.88 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -74.4 143.37 44.82 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.04 1.736 . . . . 0.0 109.85 161.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 19.0 pt -66.37 123.91 86.72 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 118.713 0.688 . . . . 0.0 111.213 -176.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 1.8 Cg_endo -108.48 82.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.292 1.994 . . . . 0.0 115.186 -153.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 80.1 t -114.35 131.48 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.369 -0.832 . . . . 0.0 109.818 172.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.67 128.88 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.33 1.052 . . . . 0.0 110.07 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . 0.44 ' H ' ' HB1' ' A' ' 289' ' ' ALA . 58.9 t -99.99 119.53 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.586 1.555 . . . . 0.0 107.516 170.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -130.26 161.12 31.93 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -166.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.71 -18.26 58.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.331 1.853 . . . . 0.0 112.98 164.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -128.22 146.02 50.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.746 1.218 . . . . 0.0 111.618 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.74 -17.9 38.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.0 t -105.12 5.93 32.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.427 1.491 . . . . 0.0 113.417 -176.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 40.16 75.96 0.07 Allowed 'General case' 0 C--O 1.239 0.519 0 C-N-CA 129.042 2.937 . . . . 0.0 115.801 -171.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.74 -51.3 4.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.069 1.347 . . . . 0.0 111.655 157.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 72.1 mt -102.57 104.73 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.697 1.599 . . . . 0.0 109.1 -174.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -84.16 115.58 22.48 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -95.3 -11.58 27.63 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.159 2.583 . . . . 0.0 114.562 -173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -115.12 -168.47 15.65 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.6 mt -129.44 135.38 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.404 2.281 . . . . 0.0 110.184 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.04 122.8 17.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.302 1.041 . . . . 0.0 110.555 164.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 73.5 t -102.22 -50.11 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.848 0.859 . . . . 0.0 109.861 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.0 m -69.35 153.27 43.86 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.279 0.562 . . . . 0.0 110.038 166.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.17 159.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.443 1.097 . . . . 0.0 112.236 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -120.93 75.45 28.39 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.043 0.937 . . . . 0.0 112.454 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -57.35 -167.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.127 1 C-N-CA 126.131 4.554 . . . . 0.0 117.221 162.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 27.5 pt -112.14 166.88 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.703 2.401 . . . . 0.0 111.324 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.31 105.34 2.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.988 0.915 . . . . 0.0 109.022 155.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.5 p -72.79 -50.45 24.22 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.391 1.476 . . . . 0.0 111.314 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.59 152.34 19.15 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.991 1.317 . . . . 0.0 108.825 156.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -60.61 -19.02 56.67 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.11 0.39 56.75 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.107 1.763 . . . . 0.0 112.955 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -58.66 147.4 32.85 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.471 -1.393 . . . . 0.0 113.653 -172.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.79 79.54 1.85 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.519 1.528 . . . . 0.0 111.252 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.35 148.56 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.569 1.148 . . . . 0.0 111.502 -165.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.53 127.23 39.09 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.908 2.883 . . . . 0.0 109.798 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.57 141.76 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.002 1.321 . . . . 0.0 109.86 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -119.19 152.35 36.75 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 122.453 1.12 . . . . 0.0 112.573 162.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.8 m -140.89 156.65 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.943 1.697 . . . . 0.0 110.72 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -109.91 116.3 54.0 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.844 1.658 . . . . 0.0 110.772 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.45 160.83 12.82 Favored 'Trans proline' 0 CA--C 1.551 1.369 0 C-N-CA 123.766 2.978 . . . . 0.0 112.095 161.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -76.23 176.35 10.16 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.415 2.743 . . . . 0.0 110.895 164.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -60.02 145.25 47.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.187 0.595 . . . . 0.0 111.247 168.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.33 -152.02 19.71 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.634 0.635 . . . . 0.0 111.664 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.9 167.17 20.17 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.556 1.169 . . . . 0.0 113.154 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 30.8 m -162.64 152.24 15.75 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.441 1.096 . . . . 0.0 110.905 157.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -107.44 119.36 39.19 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.7 mm -99.37 104.69 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 125.778 1.631 . . . . 0.0 107.594 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.38 141.21 18.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.944 1.298 . . . . 0.0 109.799 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 65.7 t -120.56 111.14 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 126.584 1.954 . . . . 0.0 108.442 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.38 -177.43 26.02 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 123.27 1.483 . . . . 0.0 114.658 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 53.7 m -138.35 167.26 22.25 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.236 1.815 . . . . 0.0 109.575 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.38 -175.02 49.45 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 121.741 0.634 . . . . 0.0 112.674 -170.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -23.15 65.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.676 1.19 . . . . 0.0 113.054 175.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 54.0 m -64.57 -15.59 61.26 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 171.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -71.11 138.8 49.99 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.144 1.338 . . . . 0.0 112.813 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 42.3 mt -103.56 161.57 13.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.728 1.211 . . . . 0.0 110.864 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.1 t -143.05 145.1 32.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.004 0.921 . . . . 0.0 112.248 -171.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -150.22 121.8 8.0 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.704 1.602 . . . . 0.0 110.199 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.71 131.44 39.87 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.468 -1.395 . . . . 0.0 111.815 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -119.28 168.84 10.52 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.793 0.837 . . . . 0.0 111.615 159.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.58 145.93 34.07 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.707 1.603 . . . . 0.0 108.971 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 125.081 1.352 . . . . 0.0 110.633 -174.422 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.8 m -97.5 -7.12 32.18 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.274 1.03 . . . . 0.0 113.562 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.38 80.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.323 0.965 . . . . 0.0 113.009 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 53.6 tp -74.65 126.9 31.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 160.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.5 t -55.99 168.5 0.47 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.501 1.12 . . . . 0.0 113.836 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.548 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.8 mm? -59.99 118.04 5.79 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.799 1.639 . . . . 0.0 110.557 -167.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -70.22 108.01 3.97 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.402 1.481 . . . . 0.0 109.512 -163.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 77.15 -45.2 2.25 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.985 1.278 . . . . 0.0 112.768 -170.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 38.9 m -63.37 7.46 0.1 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 128.636 2.775 . . . . 0.0 113.925 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.1 m -157.14 158.69 36.79 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 118.766 -2.458 . . . . 0.0 112.012 167.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -77.62 172.89 12.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.226 1.41 . . . . 0.0 113.023 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -70.28 154.6 41.73 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -171.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -67.6 157.7 33.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.346 2.258 . . . . 0.0 112.275 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 11.2 m -71.68 141.47 49.88 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.442 -0.786 . . . . 0.0 111.333 174.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 12.7 p -134.67 11.13 3.71 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -84.4 177.58 8.08 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.933 0.788 . . . . 0.0 109.518 163.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -71.2 81.37 0.72 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.372 1.869 . . . . 0.0 111.738 -166.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 20.7 mtp -66.15 167.3 10.32 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.928 1.291 . . . . 0.0 112.814 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 28.7 m -158.51 168.6 26.49 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.108 0.963 . . . . 0.0 111.146 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.01 115.12 26.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.815 1.246 . . . . 0.0 110.479 172.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.86 -34.92 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.917 1.287 . . . . 0.0 110.259 167.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -138.18 126.11 22.6 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.036 1.735 . . . . 0.0 108.629 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -61.27 160.58 22.37 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.206 1.002 . . . . 0.0 111.77 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.69 121.62 8.1 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.679 1.586 . . . . 0.0 110.073 169.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 13.6 p -124.32 140.6 52.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.407 1.083 . . . . 0.0 110.499 170.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -60.69 140.94 57.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.599 0.76 . . . . 0.0 112.13 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 76.2 p -97.86 -15.92 20.0 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.205 1.402 . . . . 0.0 113.221 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 75.35 -10.36 11.48 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.493 -163.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -69.11 -11.33 60.7 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.868 1.834 . . . . 0.0 112.464 173.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 92.83 15.95 50.31 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.354 0.978 . . . . 0.0 112.749 -159.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 24.6 p -132.63 168.54 18.09 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.402 1.481 . . . . 0.0 110.995 -171.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.7 140.13 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.22 1.408 . . . . 0.0 109.047 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.3 p -112.95 132.11 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.703 1.201 . . . . 0.0 110.973 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.6 ptm -144.31 165.7 27.15 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.964 1.305 . . . . 0.0 112.806 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -130.19 134.8 47.55 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.274 1.03 . . . . 0.0 109.641 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.93 170.45 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.783 1.233 . . . . 0.0 111.46 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.45 137.62 51.92 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.28 2.232 . . . . 0.0 110.001 173.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.78 145.7 32.21 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.936 1.694 . . . . 0.0 107.407 161.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -102.83 -70.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 123.208 2.605 . . . . 0.0 115.228 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.81 175.56 9.91 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.602 1.561 . . . . 0.0 111.759 -174.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.32 -15.07 0.09 OUTLIER Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.549 2.499 . . . . 0.0 118.358 165.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -112.13 92.05 17.5 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 119.135 1.468 . . . . 0.0 112.768 -165.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.28 116.3 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.832 1.688 . . . . 0.0 108.078 154.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 5.6 p -154.68 157.59 38.33 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.639 -0.663 . . . . 0.0 112.281 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -75.58 140.62 42.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.625 1.57 . . . . 0.0 109.505 165.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 20.5 pt -64.06 121.83 73.9 Favored Pre-proline 0 CA--C 1.557 1.215 0 CA-C-N 119.211 0.914 . . . . 0.0 111.447 -174.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 5.3 Cg_endo -109.04 85.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.36 2.707 . . . . 0.0 114.471 -164.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 23.3 t -119.54 104.09 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.285 -0.884 . . . . 0.0 110.045 171.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.9 160.31 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.662 1.585 . . . . 0.0 110.2 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -136.27 105.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.591 1.556 . . . . 0.0 108.153 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -122.36 158.37 29.78 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.611 1.165 . . . . 0.0 114.071 -163.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.65 -10.38 59.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.504 2.321 . . . . 0.0 112.875 169.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -137.71 150.72 47.54 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.173 1.389 . . . . 0.0 112.462 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 28.8 mt -63.45 -16.4 60.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.623 1.569 . . . . 0.0 114.721 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.2 t -109.2 7.42 25.41 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.824 -177.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 35.28 65.01 0.41 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 128.502 2.721 . . . . 0.0 114.211 -168.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -75.35 -40.93 57.68 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.426 1.09 . . . . 0.0 111.394 159.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 7.8 mm -99.74 169.85 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 125.3 1.44 . . . . 0.0 109.387 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -146.04 116.98 7.74 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.444 -1.41 . . . . 0.0 112.009 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -98.62 -27.16 14.13 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.345 1.858 . . . . 0.0 113.294 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -95.58 -174.53 36.95 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 -173.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.3 mt -124.51 134.91 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.617 1.967 . . . . 0.0 110.102 -174.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.0 mt -70.49 121.52 17.95 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.14 0.976 . . . . 0.0 109.364 162.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.78 -42.64 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.54 0.736 . . . . 0.0 109.914 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 38.6 m -69.96 153.52 43.14 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.143 0.497 . . . . 0.0 110.411 166.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.5 t -56.09 152.75 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.129 1.372 . . . . 0.0 110.346 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -113.16 82.73 5.75 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.16 0.984 . . . . 0.0 111.845 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.46 -168.87 0.68 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 125.27 3.98 . . . . 0.0 112.693 169.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 36.0 pt -93.0 167.37 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.982 1.713 . . . . 0.0 111.89 167.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.82 111.18 2.69 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 152.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 88.5 p -76.09 -45.07 35.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.052 1.341 . . . . 0.0 111.758 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.43 151.52 22.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.044 1.337 . . . . 0.0 108.735 158.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -59.31 -20.33 53.56 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 170.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -101.94 10.9 39.33 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.636 1.574 . . . . 0.0 112.956 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -58.89 152.28 19.79 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.208 -1.557 . . . . 0.0 113.632 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -133.81 83.35 2.04 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.344 1.058 . . . . 0.0 113.096 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 25.9 t -90.47 152.13 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.943 1.697 . . . . 0.0 112.037 -166.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 25.8 tp -109.17 131.39 55.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 129.024 2.93 . . . . 0.0 110.35 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.5 mp -143.2 132.51 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.278 1.431 . . . . 0.0 111.424 -167.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -92.82 135.04 34.48 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.914 1.286 . . . . 0.0 111.597 157.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.59 155.26 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.789 1.235 . . . . 0.0 111.31 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -111.92 108.11 55.77 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.157 1.783 . . . . 0.0 110.925 -173.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.21 119.17 4.15 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.984 3.123 . . . . 0.0 111.031 160.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -60.1 169.24 5.06 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.413 2.742 . . . . 0.0 113.091 167.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -53.56 138.21 34.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.357 1.063 . . . . 0.0 112.277 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.21 -142.34 15.58 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.775 0.702 . . . . 0.0 112.584 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -75.99 163.92 26.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.159 0.984 . . . . 0.0 112.69 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 18.0 m -175.47 167.3 3.29 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.885 2.074 . . . . 0.0 111.192 161.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -133.66 126.51 30.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.661 1.984 . . . . 0.0 108.098 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.6 mm -81.76 129.04 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.03 141.05 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.222 1.009 . . . . 0.0 109.565 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 95.7 t -115.73 113.47 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.806 1.642 . . . . 0.0 108.929 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 96.22 -177.54 33.78 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 122.205 0.892 . . . . 0.0 115.155 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.7 m -133.26 159.3 40.63 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.232 1.813 . . . . 0.0 110.154 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.16 -174.82 54.39 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.866 0.746 . . . . 0.0 113.237 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -54.04 -24.63 17.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.588 1.555 . . . . 0.0 114.354 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 66.9 m -80.8 -4.1 53.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.714 2.006 . . . . 0.0 113.986 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -73.65 128.85 36.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.671 1.123 . . . . 0.0 112.295 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 23.9 mt -100.3 170.03 8.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.113 0.965 . . . . 0.0 111.232 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.8 t -145.92 162.45 37.75 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -148.12 127.86 13.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.12 2.168 . . . . 0.0 108.273 169.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -73.56 137.28 44.23 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.252 -0.905 . . . . 0.0 111.783 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -141.54 133.26 27.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.442 1.097 . . . . 0.0 109.172 166.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -124.77 153.71 42.03 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 41.1 tptt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 121.786 0.803 . . . . 0.0 111.994 -160.038 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 15.9 m -104.34 4.27 33.35 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.9 -49.23 78.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.062 0.945 . . . . 0.0 111.995 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.2 tt -71.13 132.98 45.85 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.256 -0.903 . . . . 0.0 108.837 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.7 t -56.86 169.79 0.48 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.171 1.788 . . . . 0.0 115.076 -168.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.0 mm? -65.23 104.59 0.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.601 1.56 . . . . 0.0 111.392 -168.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 295' ' ' THR . 0.7 OUTLIER -59.97 135.98 57.87 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.64 1.176 . . . . 0.0 111.458 -169.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 62.33 -23.23 0.07 OUTLIER Glycine 0 CA--C 1.541 1.69 0 C-N-CA 126.975 2.226 . . . . 0.0 115.74 -170.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 293' ' ' LYS . 9.2 m -94.63 3.08 55.53 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 130.164 3.386 . . . . 0.0 111.037 -172.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.7 m -163.34 159.69 22.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 119.83 -1.794 . . . . 0.0 111.907 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -87.0 175.33 8.18 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.899 1.28 . . . . 0.0 113.432 -171.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -72.64 159.43 33.87 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.067 1.347 . . . . 0.0 114.498 -171.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 18.0 mmt -75.28 157.4 34.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.693 1.997 . . . . 0.0 111.702 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.1 m -75.53 144.76 41.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.472 -0.768 . . . . 0.0 110.776 172.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 8.3 p -131.87 5.55 4.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.34 167.18 22.16 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.374 0.988 . . . . 0.0 109.792 161.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -68.77 101.29 1.3 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.089 1.355 . . . . 0.0 112.022 -161.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 24.7 mtp -86.53 168.48 13.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.056 0.931 . . . . 0.0 112.969 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.3 m -161.08 160.99 31.1 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.686 1.194 . . . . 0.0 110.866 165.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.31 112.92 18.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.401 0.68 . . . . 0.0 110.126 168.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.3 t -63.26 -35.16 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.417 1.487 . . . . 0.0 110.24 163.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -133.78 123.99 25.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.448 1.499 . . . . 0.0 108.183 165.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -60.42 152.79 63.36 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.72 0.808 . . . . 0.0 111.475 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.35 133.29 45.41 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.133 1.889 . . . . 0.0 110.956 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.9 m -136.19 137.06 40.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.739 1.215 . . . . 0.0 109.183 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -70.08 139.5 52.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.298 0.639 . . . . 0.0 112.454 -175.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.6 p -88.94 -13.08 39.84 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.053 0.941 . . . . 0.0 113.346 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.27 -3.07 3.59 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 119.319 0.963 . . . . 0.0 114.408 -164.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -96.66 10.94 37.11 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.811 1.645 . . . . 0.0 111.519 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 96.98 13.12 47.43 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.179 1.371 . . . . 0.0 114.248 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.6 p -138.13 163.96 30.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.574 1.187 . . . . 0.0 112.225 -170.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.19 132.37 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.489 1.516 . . . . 0.0 109.653 167.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.41 132.47 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.276 1.43 . . . . 0.0 111.693 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.0 ptm -148.37 166.18 28.84 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.342 1.457 . . . . 0.0 113.104 -175.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -136.12 139.44 42.95 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.643 1.177 . . . . 0.0 109.097 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.42 155.92 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.341 1.056 . . . . 0.0 111.474 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -111.76 133.07 54.23 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.876 1.271 . . . . 0.0 112.189 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.39 131.7 21.64 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.148 1.379 . . . . 0.0 107.891 160.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' PRO . . . . . 0.4 ' HG2' ' H ' ' A' ' 326' ' ' LYS . 94.7 Cg_endo -94.44 -67.77 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.097 2.531 . . . . 0.0 114.891 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -145.82 176.65 9.51 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.546 1.938 . . . . 0.0 110.552 -177.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.29 -14.74 0.09 OUTLIER Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.788 2.137 . . . . 0.0 118.14 169.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.54 90.48 39.43 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.265 1.532 . . . . 0.0 112.894 -162.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.93 115.63 4.38 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.114 1.876 . . . . 0.0 108.203 156.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.4 p -152.25 157.4 41.37 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -172.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.68 130.71 38.15 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.206 1.802 . . . . 0.0 108.973 165.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 15.2 pt -60.4 114.96 11.4 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-N 118.572 0.624 . . . . 0.0 111.837 -166.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -100.16 87.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.569 2.846 . . . . 0.0 114.333 -160.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 44.2 t -112.09 128.75 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 167.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.05 155.08 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.442 1.097 . . . . 0.0 110.619 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.3 t -130.1 117.33 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.19 1.796 . . . . 0.0 107.364 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -126.62 165.78 18.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.126 0.97 . . . . 0.0 113.315 -166.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -83.61 -8.19 59.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.078 1.751 . . . . 0.0 112.382 162.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -137.3 137.46 39.0 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.401 1.48 . . . . 0.0 111.235 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.13 -20.6 41.59 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -97.79 3.16 50.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.563 1.945 . . . . 0.0 113.673 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 39.21 69.47 0.28 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.963 2.905 . . . . 0.0 115.525 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.19 -34.55 16.62 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.035 1.334 . . . . 0.0 112.116 158.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 35.4 mm -96.78 153.14 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.43 1.092 . . . . 0.0 109.37 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.71 103.21 6.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.553 1.541 . . . . 0.0 109.062 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -94.22 -51.57 4.75 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.663 2.385 . . . . 0.0 113.019 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -82.91 -164.93 36.49 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 -169.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.2 140.68 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 127.374 2.27 . . . . 0.0 109.856 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.51 118.54 14.46 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.563 1.145 . . . . 0.0 109.528 161.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 35.1 t -94.7 -51.04 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 122.831 0.453 . . . . 0.0 110.472 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 36.9 m -70.14 157.48 37.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.102 0.477 . . . . 0.0 110.329 171.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.5 m -52.0 147.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.519 1.128 . . . . 0.0 111.916 171.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -123.0 77.69 50.8 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 123.914 0.886 . . . . 0.0 111.209 -174.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -83.29 -173.15 1.56 Allowed 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 124.872 3.714 . . . . 0.0 112.499 170.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 47.9 pt -84.67 165.75 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.66 1.184 . . . . 0.0 112.15 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.76 124.83 23.49 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 156.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 95.6 p -66.66 -29.83 69.94 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.621 0.768 . . . . 0.0 112.801 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 11.7 m -143.86 153.25 42.15 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.832 2.453 . . . . 0.0 106.983 -168.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.33 -21.01 61.54 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.926 -1.109 . . . . 0.0 113.646 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -95.26 4.11 53.84 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.81 2.444 . . . . 0.0 112.929 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -63.29 157.99 21.43 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.236 -1.54 . . . . 0.0 113.872 -171.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -150.69 86.27 1.39 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.86 149.58 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.886 1.274 . . . . 0.0 112.134 -167.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -92.91 126.06 37.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 129.95 3.3 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.2 mp -138.89 141.56 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.462 1.505 . . . . 0.0 110.768 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.47 141.63 32.0 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.131 1.372 . . . . 0.0 112.198 160.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.68 156.65 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.26 1.024 . . . . 0.0 111.418 168.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -113.05 114.3 48.86 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.381 1.472 . . . . 0.0 110.717 -172.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -85.27 160.82 11.31 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.753 2.969 . . . . 0.0 111.446 163.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -74.12 175.99 10.16 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.842 2.362 . . . . 0.0 110.476 160.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -61.59 142.68 56.96 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.653 -0.654 . . . . 0.0 110.635 159.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.96 -146.83 20.01 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 122.128 -0.358 . . . . 0.0 113.055 -173.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -61.81 145.37 52.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.961 2.105 . . . . 0.0 114.522 -171.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 28.9 m -167.64 162.08 13.92 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.491 1.917 . . . . 0.0 112.041 158.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -130.84 128.03 39.81 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.346 1.458 . . . . 0.0 108.46 169.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 29.3 mm -94.95 120.8 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.422 1.489 . . . . 0.0 108.274 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.2 144.95 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.433 1.093 . . . . 0.0 109.492 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.29 116.19 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.456 1.502 . . . . 0.0 109.332 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 89.76 -178.83 44.14 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 122.548 1.082 . . . . 0.0 114.614 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 92.7 m -127.6 164.12 22.71 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.979 1.312 . . . . 0.0 109.852 172.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 80.64 -173.57 54.78 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 121.855 0.697 . . . . 0.0 112.996 -174.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -23.83 66.45 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.956 1.302 . . . . 0.0 112.762 173.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.4 m -63.62 -10.53 19.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 170.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -78.36 125.49 29.43 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.078 1.308 . . . . 0.0 113.146 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 4.4 mt -88.19 162.24 16.79 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.071 -0.393 . . . . 0.0 111.167 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.8 t -142.43 149.04 38.76 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.883 1.273 . . . . 0.0 111.497 -174.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -151.65 126.68 9.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.731 1.612 . . . . 0.0 110.434 -177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -73.28 128.91 36.82 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.28 -0.888 . . . . 0.0 111.442 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -136.39 125.26 24.1 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.282 0.633 . . . . 0.0 110.298 167.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.27 122.76 32.44 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 124.144 0.978 . . . . 0.0 111.394 -169.559 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 14.2 mmt . . . . . 0 N--CA 1.475 0.806 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.1 p -86.19 -7.27 58.68 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -53.21 -49.98 65.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.117 0.967 . . . . 0.0 112.923 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 22.3 tp -73.59 127.46 32.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.56 -0.712 . . . . 0.0 109.537 163.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.3 t -53.31 171.04 0.08 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -164.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -62.53 111.88 2.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.617 2.367 . . . . 0.0 111.753 -170.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -61.63 107.54 0.83 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.863 2.465 . . . . 0.0 111.725 -167.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 82.01 0.04 89.1 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.53 1.062 . . . . 0.0 114.5 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 89.1 m -117.88 5.1 12.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.381 1.872 . . . . 0.0 110.965 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.0 m -157.25 156.19 32.08 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 119.51 -1.994 . . . . 0.0 114.027 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -82.92 178.45 8.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.109 2.164 . . . . 0.0 113.328 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -73.48 160.76 31.24 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.524 1.53 . . . . 0.0 114.381 -170.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.15 147.74 32.58 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.248 2.619 . . . . 0.0 111.675 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.59 138.68 56.63 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.526 -0.734 . . . . 0.0 110.733 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.5 p -132.31 14.3 4.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.264 1.026 . . . . 0.0 113.263 172.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -81.45 170.87 15.41 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 118.676 0.671 . . . . 0.0 109.212 159.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -62.06 103.86 0.41 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.052 1.741 . . . . 0.0 111.777 -166.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 25.8 mtp -91.14 165.89 13.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 122.384 1.088 . . . . 0.0 112.142 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 30.7 m -161.94 164.72 28.32 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.049 1.34 . . . . 0.0 109.892 166.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.6 127.48 34.09 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 164.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.85 -32.57 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 159.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -133.84 119.89 19.76 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.647 1.579 . . . . 0.0 109.259 167.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -58.9 150.85 57.95 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.913 1.685 . . . . 0.0 112.063 170.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -62.8 131.27 32.43 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.535 2.157 . . . . 0.0 110.908 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.56 140.11 46.97 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.083 0.953 . . . . 0.0 109.691 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.31 132.09 52.59 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.036 0.934 . . . . 0.0 112.303 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 74.6 p -84.9 -13.7 50.03 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.02 1.328 . . . . 0.0 114.121 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.516 ' HA2' ' HE2' ' A' ' 398' ' ' LYS . . . 70.36 18.45 75.22 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.262 -0.743 . . . . 0.0 114.624 -162.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.24 16.16 8.38 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 118.872 1.336 . . . . 0.0 112.448 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 85.86 11.76 73.03 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.396 -0.815 . . . . 0.0 113.53 -176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 40.6 p -134.08 161.21 35.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.139 1.375 . . . . 0.0 110.942 -168.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.14 132.92 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.265 1.026 . . . . 0.0 109.614 172.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.0 p -112.14 136.1 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.835 1.254 . . . . 0.0 112.121 -170.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 14.5 ptm -151.01 165.64 33.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.498 1.519 . . . . 0.0 114.012 -172.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -132.07 121.57 24.04 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.767 2.427 . . . . 0.0 107.333 175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.5 m -112.99 158.12 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.88 0.872 . . . . 0.0 111.589 -172.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -125.12 143.94 50.68 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.235 1.014 . . . . 0.0 113.426 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.2 t -119.58 151.16 51.37 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 127.637 2.375 . . . . 0.0 107.89 167.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -119.89 -60.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 122.627 2.218 . . . . 0.0 115.877 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 175.48 9.52 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.476 1.11 . . . . 0.0 112.248 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.57 -15.44 0.1 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.459 2.456 . . . . 0.0 118.638 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.83 92.59 49.03 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.635 1.717 . . . . 0.0 114.181 -159.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.28 124.59 10.07 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.816 1.677 . . . . 0.0 108.388 155.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.0 p -153.84 155.78 36.4 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.463 -0.773 . . . . 0.0 112.44 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -78.46 128.53 33.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.159 1.384 . . . . 0.0 107.785 161.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.7 pp -61.82 115.58 16.22 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -164.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -95.17 94.66 0.1 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.362 3.375 . . . . 0.0 113.852 -170.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 32.3 t -124.48 109.17 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.719 -0.613 . . . . 0.0 109.955 173.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.12 159.32 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.483 1.513 . . . . 0.0 110.984 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 83.8 t -131.81 117.36 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 126.51 1.924 . . . . 0.0 106.412 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.55 165.37 20.89 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -165.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -86.07 -8.65 57.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.271 1.829 . . . . 0.0 112.922 163.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -130.19 142.04 50.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.62 1.168 . . . . 0.0 110.914 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.74 -21.85 56.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.991 1.316 . . . . 0.0 113.726 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.7 t -105.6 5.92 31.69 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.55 1.94 . . . . 0.0 113.903 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.421 ' HB2' HD13 ' A' ' 377' ' ' ILE . . . 45.02 69.71 0.41 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.708 2.803 . . . . 0.0 116.184 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -82.8 -37.49 24.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.937 0.895 . . . . 0.0 111.861 153.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 36.4 mm -88.98 155.52 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.924 1.289 . . . . 0.0 110.449 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -134.46 93.55 3.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.179 1.791 . . . . 0.0 109.621 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -101.57 -28.16 12.68 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.832 2.053 . . . . 0.0 114.696 -169.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -99.78 179.96 30.41 Favored Glycine 0 N--CA 1.477 1.368 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -171.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 4.5 mt -117.61 135.51 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 127.537 2.335 . . . . 0.0 110.168 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.88 132.09 44.74 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.111 0.564 . . . . 0.0 110.319 165.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.06 -49.94 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.2 m -80.41 162.72 24.32 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.607 0.718 . . . . 0.0 110.66 167.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.4 m -63.31 165.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.112 1.765 . . . . 0.0 114.519 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -117.36 81.47 13.74 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.697 1.599 . . . . 0.0 110.917 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.09 -166.95 0.45 Allowed 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 124.412 3.408 . . . . 0.0 112.865 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.9 pt -104.37 169.81 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.284 1.833 . . . . 0.0 110.793 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -71.07 113.45 8.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.753 0.421 . . . . 0.0 110.099 158.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 82.4 p -73.32 -23.03 60.2 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.295 1.438 . . . . 0.0 113.361 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 77.4 p -135.0 165.23 25.83 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.946 2.099 . . . . 0.0 108.788 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -63.73 -21.2 66.29 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.018 -1.052 . . . . 0.0 113.471 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -100.39 9.22 42.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.695 1.598 . . . . 0.0 112.567 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -59.18 156.58 11.96 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.812 1.291 . . . . 0.0 113.508 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -148.35 98.72 2.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.982 1.313 . . . . 0.0 112.343 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 53.0 t -92.81 149.55 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.39 1.476 . . . . 0.0 110.438 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.27 124.28 49.27 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.53 2.732 . . . . 0.0 108.697 -174.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.58 136.37 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.671 0.788 . . . . 0.0 111.825 -170.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -95.75 136.54 36.03 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.424 1.49 . . . . 0.0 111.563 152.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.02 154.95 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.212 1.005 . . . . 0.0 111.333 166.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -116.57 113.15 40.67 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.774 2.03 . . . . 0.0 109.779 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -81.09 167.35 18.01 Favored 'Trans proline' 0 CA--C 1.55 1.282 0 C-N-CA 122.949 2.432 . . . . 0.0 111.357 164.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -69.63 173.5 10.76 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.436 2.091 . . . . 0.0 110.773 163.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -62.13 144.74 54.94 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.872 -0.518 . . . . 0.0 110.533 162.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.67 -155.57 18.34 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.782 0.706 . . . . 0.0 111.979 -170.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -83.58 161.06 21.29 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.459 1.123 . . . . 0.0 112.681 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 49.2 m -160.96 159.29 29.35 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.465 -1.397 . . . . 0.0 111.075 161.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -118.55 115.07 23.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 29.4 mm -89.59 117.02 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.664 1.586 . . . . 0.0 108.09 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 342' ' ' ALA . 2.9 mp -113.75 141.48 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.699 0.799 . . . . 0.0 110.707 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 99.4 t -116.24 109.27 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.412 1.885 . . . . 0.0 108.173 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 112.58 -177.35 18.36 Favored Glycine 0 N--CA 1.471 0.991 0 N-CA-C 116.241 1.256 . . . . 0.0 116.241 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 99.5 m -138.07 167.39 21.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.963 1.705 . . . . 0.0 109.282 165.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.21 -174.35 44.34 Favored Glycine 0 CA--C 1.535 1.339 0 O-C-N 121.732 -0.605 . . . . 0.0 112.537 -169.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.78 -25.79 63.43 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.104 0.962 . . . . 0.0 113.435 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.8 m -75.4 -1.26 23.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.451 2.3 . . . . 0.0 114.846 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -79.88 133.59 36.25 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.748 0.819 . . . . 0.0 111.995 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.7 mt -102.84 163.65 12.09 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.258 0.623 . . . . 0.0 111.27 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 t -137.84 148.51 45.5 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.72 1.208 . . . . 0.0 112.001 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -146.0 131.07 18.29 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.484 1.514 . . . . 0.0 110.277 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -82.11 136.25 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.279 1.031 . . . . 0.0 111.301 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -134.95 154.45 51.7 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.069 0.938 . . . . 0.0 112.675 166.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -124.62 140.9 52.51 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.683 1.593 . . . . 0.0 107.942 165.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -123.64 125.72 45.31 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.381 1.872 . . . . 0.0 108.67 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -57.69 165.8 1.56 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.557 1.943 . . . . 0.0 112.247 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -67.65 148.4 49.53 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 121.959 0.755 . . . . 0.0 113.24 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 50.9 m -58.37 -9.86 1.79 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.769 1.228 . . . . 0.0 114.044 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 58.4 p -65.08 -17.72 64.7 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.579 1.952 . . . . 0.0 114.568 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.15 -26.17 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.565 1.075 . . . . 0.0 113.458 172.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.11 46.24 93.72 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-N 118.831 0.742 . . . . 0.0 114.853 168.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.516 ' HE2' ' HA2' ' A' ' 314' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.055 0 C-N-CA 125.605 1.562 . . . . 0.0 110.934 170.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 3.8 m -97.44 5.35 49.86 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -171.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -71.96 -43.72 64.71 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 120.165 1.348 . . . . 0.0 112.755 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.1 136.11 56.33 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 165.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 t -54.56 163.94 0.82 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.36 97.06 1.96 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.869 1.668 . . . . 0.0 111.105 -164.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -46.72 133.55 10.47 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.904 2.482 . . . . 0.0 112.328 -171.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.02 -36.94 1.07 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.035 1.302 . . . . 0.0 114.561 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 10.3 p -72.75 -26.46 61.56 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 118.777 1.288 . . . . 0.0 114.246 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 31.0 m -134.29 150.6 51.0 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.574 0.75 . . . . 0.0 112.462 -152.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -79.94 175.36 10.7 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.287 1.435 . . . . 0.0 112.927 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.31 154.0 42.4 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -71.09 146.35 49.3 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.046 2.139 . . . . 0.0 112.358 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 8.4 m -63.48 143.06 58.13 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.682 -0.636 . . . . 0.0 112.266 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.3 p -135.45 11.44 3.49 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.641 1.176 . . . . 0.0 113.525 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -71.97 168.98 16.87 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.219 0.918 . . . . 0.0 109.648 161.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -65.36 97.19 0.27 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.424 -0.797 . . . . 0.0 111.899 -172.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 42.7 mtp -86.17 168.0 14.4 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.366 1.079 . . . . 0.0 112.762 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 39.2 m -160.89 163.63 31.83 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.053 1.341 . . . . 0.0 109.963 161.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.82 121.76 25.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.654 0.381 . . . . 0.0 110.119 167.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.01 -29.85 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.267 1.027 . . . . 0.0 110.335 165.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -141.52 132.74 26.42 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.147 1.779 . . . . 0.0 109.303 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -64.81 150.43 94.65 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.379 1.072 . . . . 0.0 112.148 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -62.77 130.88 30.97 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.986 1.791 . . . . 0.0 110.646 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 65.2 p -131.27 137.84 49.03 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.964 1.306 . . . . 0.0 110.626 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -63.16 126.14 26.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.589 1.556 . . . . 0.0 112.333 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.8 p -70.61 -25.86 63.24 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.95 0.5 . . . . 0.0 111.281 166.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 82.39 -6.17 69.72 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.503 1.525 . . . . 0.0 113.845 -168.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -92.86 18.99 8.14 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.707 1.603 . . . . 0.0 111.37 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 91.9 2.78 68.87 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.738 1.161 . . . . 0.0 115.039 -173.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 28.3 p -127.35 158.56 36.93 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.496 1.648 . . . . 0.0 112.55 -169.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.02 129.78 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.778 1.631 . . . . 0.0 109.611 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.4 p -114.83 130.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.465 1.106 . . . . 0.0 113.085 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.4 ptm -137.97 171.25 14.7 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.809 2.443 . . . . 0.0 111.919 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -135.44 139.45 44.12 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.629 -0.669 . . . . 0.0 109.89 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.93 149.46 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.261 1.024 . . . . 0.0 111.948 -170.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -109.03 137.67 46.58 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.272 1.429 . . . . 0.0 112.833 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.1 t -117.07 133.88 23.08 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 126.977 2.111 . . . . 0.0 107.596 166.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -96.39 -74.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 123.186 2.591 . . . . 0.0 116.984 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.92 146.15 25.42 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 -169.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 76.72 4.55 81.89 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 115.66 1.024 . . . . 0.0 115.66 171.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -122.25 99.13 43.52 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.843 1.257 . . . . 0.0 111.531 -172.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.66 130.03 14.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.327 2.018 . . . . 0.0 108.884 167.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.8 p -159.98 156.13 26.6 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -75.32 137.8 41.37 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.481 1.913 . . . . 0.0 108.429 162.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 2.0 pp -66.77 124.55 88.83 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-N 118.29 0.495 . . . . 0.0 112.051 -169.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 9.7 Cg_endo -107.35 96.13 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.423 2.749 . . . . 0.0 115.723 -165.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 69.3 t -124.89 124.55 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.39 -0.818 . . . . 0.0 109.473 168.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.34 154.7 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.572 1.549 . . . . 0.0 110.179 -174.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.22 105.06 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.222 1.409 . . . . 0.0 109.271 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -120.63 160.59 22.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.992 1.317 . . . . 0.0 113.865 -163.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -82.29 -17.12 46.97 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.747 1.619 . . . . 0.0 112.378 164.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -122.7 133.39 54.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.99 1.316 . . . . 0.0 110.929 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -56.76 -19.45 17.02 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.136 1.775 . . . . 0.0 113.108 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.2 t -101.62 4.51 40.92 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.665 2.386 . . . . 0.0 113.733 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 37.91 74.28 0.09 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 130.534 3.534 . . . . 0.0 117.326 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -105.52 -16.53 14.69 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.937 1.695 . . . . 0.0 112.83 160.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 64.4 mt -109.45 146.29 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.744 1.618 . . . . 0.0 107.62 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.27 112.83 11.36 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.909 -1.119 . . . . 0.0 111.397 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -104.39 -21.53 13.47 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.07 -168.92 42.11 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 118.716 0.689 . . . . 0.0 114.424 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 65.3 mt -134.44 135.4 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.276 1.831 . . . . 0.0 110.528 -174.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 11.5 mt -66.61 118.57 10.38 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.723 1.209 . . . . 0.0 109.333 160.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.62 -29.54 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.666 0.786 . . . . 0.0 112.342 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.8 m -77.38 153.34 33.79 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.056 0.844 . . . . 0.0 109.737 153.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 12.5 m -60.96 161.81 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.007 1.323 . . . . 0.0 113.598 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -121.85 78.68 40.37 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.023 1.329 . . . . 0.0 111.466 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.39 -168.04 0.57 Allowed 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 124.404 3.402 . . . . 0.0 113.078 171.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 29.3 pt -95.08 164.46 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.211 1.804 . . . . 0.0 111.27 166.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.92 110.01 3.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 160.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 23.3 t -76.46 -3.0 34.9 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 90.8 m -153.56 157.07 39.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.026 2.53 . . . . 0.0 104.816 161.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -18.04 50.43 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.559 -1.338 . . . . 0.0 114.148 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -89.51 8.6 30.24 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.683 2.393 . . . . 0.0 113.479 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -60.57 156.88 15.46 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.226 -1.547 . . . . 0.0 114.099 -173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . 0.25 9.4 pt-20 -146.47 80.79 1.56 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 22.2 t -85.55 145.74 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.041 1.336 . . . . 0.0 112.363 -167.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.02 120.19 39.84 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 129.837 3.255 . . . . 0.0 109.108 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.1 mp -137.72 132.55 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.594 1.557 . . . . 0.0 111.125 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 142.6 29.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.004 0.907 . . . . 0.0 112.219 159.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.55 161.5 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.562 1.545 . . . . 0.0 110.522 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -117.94 108.99 41.7 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.746 1.619 . . . . 0.0 109.346 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.6 154.86 44.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.533 2.155 . . . . 0.0 110.638 163.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.29 175.66 10.27 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.224 1.949 . . . . 0.0 110.232 165.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -62.13 133.61 55.47 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.491 -0.756 . . . . 0.0 110.288 170.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.74 -149.43 16.6 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.564 1.078 . . . . 0.0 113.56 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.23 149.89 47.03 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.435 2.294 . . . . 0.0 113.172 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.9 m -163.88 153.78 14.81 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.988 1.315 . . . . 0.0 113.618 162.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -118.58 116.9 27.58 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.554 1.141 . . . . 0.0 108.679 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 27.5 mm -80.74 117.75 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.209 1.403 . . . . 0.0 107.561 174.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.4 mp -111.87 144.11 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.357 0.599 . . . . 0.0 109.946 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 78.6 t -116.02 117.42 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.011 1.724 . . . . 0.0 108.576 175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 94.11 -178.66 37.51 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 122.942 1.301 . . . . 0.0 115.213 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 84.6 m -132.28 166.04 22.79 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.277 1.831 . . . . 0.0 109.423 168.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 76.71 -175.8 53.16 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 121.918 0.732 . . . . 0.0 113.663 -176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.22 -21.78 9.89 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.343 1.857 . . . . 0.0 114.454 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.1 m -86.47 -4.89 59.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.425 2.29 . . . . 0.0 114.61 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -73.72 137.91 44.31 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.55 1.068 . . . . 0.0 112.446 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 11.1 mt -106.41 162.94 13.26 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.748 0.819 . . . . 0.0 111.571 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.9 t -132.22 154.45 49.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.766 1.226 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -148.99 131.85 16.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.124 2.17 . . . . 0.0 108.9 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -81.64 134.84 35.52 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.928 -1.108 . . . . 0.0 111.597 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -133.23 146.73 51.72 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.297 0.639 . . . . 0.0 109.916 162.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.95 137.86 49.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 172.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -124.75 129.85 51.28 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.548 1.139 . . . . 0.0 110.531 -168.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.61 167.75 9.53 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.557 1.143 . . . . 0.0 111.207 172.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -84.05 23.98 6.5 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 118.426 -1.208 . . . . 0.0 115.172 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 34.7 p -117.47 -38.9 3.24 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.291 1.545 . . . . 0.0 112.219 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 3.0 m -73.6 46.69 0.22 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.123 1.369 . . . . 0.0 111.574 167.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.3 tp -117.42 -25.38 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 127.651 2.38 . . . . 0.0 112.477 -174.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -146.08 24.14 1.75 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.741 1.639 . . . . 0.0 113.151 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.248 1.819 . . . . 0.0 108.857 172.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 3.3 m -65.31 0.11 1.57 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.7 -23.58 66.8 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.559 1.527 . . . . 0.0 114.138 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 49.0 tp -85.68 128.2 34.71 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 119.916 1.235 . . . . 0.0 108.968 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.2 t -53.47 158.74 1.65 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.511 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.8 mm? -61.47 105.66 0.55 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.1 2.16 . . . . 0.0 110.774 -167.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -63.11 125.22 23.31 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.237 -0.914 . . . . 0.0 111.118 -170.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.89 -50.52 3.01 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.857 1.218 . . . . 0.0 112.842 -174.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 32.1 m -63.94 -0.07 1.01 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.408 2.283 . . . . 0.0 113.432 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 15.2 m -157.1 154.02 28.75 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 119.024 -2.297 . . . . 0.0 111.725 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -78.01 170.87 15.88 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.816 1.647 . . . . 0.0 113.34 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 152.21 40.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.465 1.106 . . . . 0.0 113.294 -178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.6 mpp? -62.12 165.78 5.39 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 129.201 3.0 . . . . 0.0 114.314 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -81.15 142.72 32.97 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.281 -0.887 . . . . 0.0 110.545 171.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.5 p -135.77 18.61 3.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.587 1.155 . . . . 0.0 113.094 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -81.75 161.28 23.37 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 156.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.14 102.25 0.36 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.53 1.532 . . . . 0.0 112.131 -168.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 28.1 mtp -84.64 172.77 11.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.22 1.008 . . . . 0.0 112.837 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 20.6 m -159.93 167.25 28.44 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.174 -0.954 . . . . 0.0 112.027 166.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.92 117.95 24.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.579 0.752 . . . . 0.0 109.328 167.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.07 -35.26 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.049 0.94 . . . . 0.0 110.015 159.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -135.71 127.07 28.45 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.321 1.448 . . . . 0.0 108.467 165.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -65.15 152.69 90.98 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.467 1.107 . . . . 0.0 111.903 171.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.46 131.08 30.41 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.637 2.225 . . . . 0.0 111.657 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.0 m -136.85 139.61 41.81 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.278 1.031 . . . . 0.0 110.465 174.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -65.16 132.58 49.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.277 1.031 . . . . 0.0 112.549 -177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 63.9 p -79.62 -21.55 44.76 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.034 1.334 . . . . 0.0 113.49 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 85.08 -9.29 66.89 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.541 1.543 . . . . 0.0 113.696 -162.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -81.66 -7.59 59.61 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.573 1.187 . . . . 0.0 112.312 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 94.35 15.23 48.28 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.329 0.966 . . . . 0.0 112.843 -164.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 32.2 p -127.68 155.95 43.13 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.923 1.289 . . . . 0.0 110.907 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 25.6 m -123.18 127.01 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.889 1.276 . . . . 0.0 109.53 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.69 130.82 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.866 1.266 . . . . 0.0 111.86 -172.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 7.0 ptp -137.74 167.99 20.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.903 2.081 . . . . 0.0 111.082 -175.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -133.11 129.28 37.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.064 0.946 . . . . 0.0 108.964 170.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.22 151.72 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.328 1.051 . . . . 0.0 110.85 -169.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -113.18 131.83 55.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.795 1.238 . . . . 0.0 111.64 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.39 151.07 39.61 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-O 117.062 -1.447 . . . . 0.0 108.531 159.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -111.03 -72.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.184 2.589 . . . . 0.0 115.279 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 172.9 12.5 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 120.184 -1.573 . . . . 0.0 113.127 -174.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.12 -24.09 0.11 Allowed Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.913 2.197 . . . . 0.0 117.538 170.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -109.0 96.9 22.09 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 125.909 1.684 . . . . 0.0 111.784 -170.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -62.97 133.9 43.65 Favored 'Trans proline' 0 C--N 1.35 0.637 0 N-CA-C 107.675 -1.702 . . . . 0.0 107.675 154.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.4 p -158.88 154.25 25.72 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.315 -0.865 . . . . 0.0 113.234 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.1 tptm -72.39 141.99 48.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.604 157.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.91 123.28 79.28 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 118.986 0.812 . . . . 0.0 111.233 -175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -98.52 72.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.042 3.162 . . . . 0.0 112.694 -168.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 90.1 t -104.76 130.62 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.87 162.65 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 125.181 1.392 . . . . 0.0 110.586 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.4 t -136.72 120.25 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.988 1.715 . . . . 0.0 107.768 174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -128.89 164.57 22.83 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -160.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.66 -16.52 36.33 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.453 1.901 . . . . 0.0 113.116 163.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -124.66 138.37 54.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.731 1.212 . . . . 0.0 110.364 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.79 -15.94 14.61 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.8 t -104.28 8.26 36.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.459 1.503 . . . . 0.0 113.877 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 40.32 67.69 0.47 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 129.347 3.059 . . . . 0.0 116.578 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.8 -27.26 23.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.186 0.994 . . . . 0.0 112.574 155.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 56.4 mt -111.86 136.58 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.896 1.678 . . . . 0.0 108.988 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -110.0 98.57 7.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.896 1.278 . . . . 0.0 112.451 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -80.61 -42.68 21.78 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.188 2.595 . . . . 0.0 114.308 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -93.08 -168.55 39.18 Favored Glycine 0 N--CA 1.481 1.645 0 CA-C-N 119.993 1.27 . . . . 0.0 116.261 -171.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.4 mt -125.85 141.76 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.852 2.461 . . . . 0.0 110.071 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.8 mt -78.44 136.04 37.53 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.371 1.069 . . . . 0.0 110.4 167.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.56 -40.76 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.031 0.533 . . . . 0.0 112.374 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 27.5 m -72.53 158.63 35.33 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 157.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 10.6 m -55.51 156.2 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.484 1.114 . . . . 0.0 113.095 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -113.82 84.16 8.22 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.325 1.45 . . . . 0.0 109.175 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -81.44 -167.47 0.5 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 124.695 3.597 . . . . 0.0 112.89 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 26.0 pt -95.17 164.33 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.363 1.865 . . . . 0.0 111.183 166.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -73.77 110.43 8.06 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 154.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.9 p -75.88 -51.82 11.67 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.958 1.303 . . . . 0.0 111.629 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.15 151.14 23.9 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 155.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -57.92 -23.05 51.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.91 9.33 43.14 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.454 1.502 . . . . 0.0 112.786 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -58.56 153.41 16.26 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.241 -1.537 . . . . 0.0 113.686 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -135.82 84.88 2.12 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.721 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 23.5 t -87.98 142.14 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.248 1.419 . . . . 0.0 111.663 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.89 123.74 35.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.903 2.881 . . . . 0.0 109.409 176.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.95 140.56 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.384 1.474 . . . . 0.0 111.039 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.5 148.24 30.53 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.3 1.047 . . . . 0.0 112.933 161.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.6 m -131.07 155.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.679 1.592 . . . . 0.0 110.678 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -109.51 106.12 58.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.999 2.12 . . . . 0.0 109.361 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.73 146.96 30.7 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.228 1.952 . . . . 0.0 110.346 161.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -71.2 170.12 18.99 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.454 2.103 . . . . 0.0 111.009 167.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -55.03 140.89 36.26 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.526 1.131 . . . . 0.0 111.483 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.35 -148.3 18.83 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -171.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -79.93 162.03 25.19 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.489 1.116 . . . . 0.0 112.452 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 17.6 m -164.25 155.41 15.65 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.773 -1.205 . . . . 0.0 111.961 156.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -113.56 112.0 22.82 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.5 mm -78.9 119.49 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.651 1.181 . . . . 0.0 107.86 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -113.37 140.98 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.522 0.729 . . . . 0.0 109.886 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.4 t -120.01 107.04 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 125.421 1.488 . . . . 0.0 108.468 172.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 119.49 -176.34 16.09 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.251 1.405 . . . . 0.0 115.574 172.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 54.7 m -138.76 161.9 36.06 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.426 1.49 . . . . 0.0 109.267 164.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.49 -172.17 50.79 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 121.86 0.7 . . . . 0.0 112.762 -169.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -29.23 11.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.24 1.816 . . . . 0.0 113.647 173.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.7 m -72.29 -4.43 29.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 128.739 2.815 . . . . 0.0 114.693 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -84.96 122.28 28.99 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.04 0.837 . . . . 0.0 112.564 -175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 29.6 mt -87.06 161.08 18.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.25 0.62 . . . . 0.0 111.327 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.7 t -141.29 145.33 35.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.996 1.318 . . . . 0.0 111.737 -173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -153.75 115.18 4.17 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.924 1.29 . . . . 0.0 110.775 -171.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.8 135.01 47.86 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.861 -1.149 . . . . 0.0 112.152 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -124.37 166.85 15.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.441 1.096 . . . . 0.0 110.977 157.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.84 138.33 37.41 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.471 1.508 . . . . 0.0 108.011 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -122.67 119.54 31.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.224 1.41 . . . . 0.0 110.784 -173.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.85 161.86 13.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.897 2.479 . . . . 0.0 112.117 -176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -75.43 42.06 1.43 Allowed Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.067 1.317 . . . . 0.0 114.03 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.7 -63.84 0.47 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.413 1.485 . . . . 0.0 112.721 -173.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.0 m -83.42 56.4 3.56 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.927 1.691 . . . . 0.0 111.066 -174.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 6.3 tt -143.9 70.92 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.979 1.711 . . . . 0.0 110.661 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 146.43 2.18 0.6 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.926 1.25 . . . . 0.0 115.409 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.739 1.616 . . . . 0.0 109.389 172.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 118.682 -0.675 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 12.1 m -98.14 0.44 45.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -171.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.52 71.24 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.64 1.109 . . . . 0.0 112.353 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.9 tt -66.57 118.18 9.8 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.2 t -55.09 173.03 0.1 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 127.141 2.176 . . . . 0.0 116.368 -164.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.407 ' H ' HD22 ' A' ' 292' ' ' LEU . 2.7 mm? -60.97 106.36 0.58 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.5 1.92 . . . . 0.0 111.727 -172.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -71.06 141.54 50.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.414 1.486 . . . . 0.0 111.74 -171.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.74 -59.49 1.3 Allowed Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.292 1.425 . . . . 0.0 113.393 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 14.6 t -68.05 16.38 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.962 2.105 . . . . 0.0 115.213 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 10.0 m -163.69 165.55 23.15 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 120.233 -1.542 . . . . 0.0 112.945 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -86.66 169.23 12.89 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.781 1.232 . . . . 0.0 113.865 -172.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -70.52 159.18 34.76 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.76 1.624 . . . . 0.0 115.048 -166.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 54.5 mtt -77.23 151.11 35.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.161 2.184 . . . . 0.0 112.062 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.8 m -69.51 142.78 53.62 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.725 -0.609 . . . . 0.0 111.968 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 20.3 p -131.5 7.72 4.54 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.389 1.076 . . . . 0.0 113.651 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -72.54 159.66 33.55 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.523 1.056 . . . . 0.0 109.984 160.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -63.87 100.47 0.3 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.907 1.683 . . . . 0.0 110.984 -168.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 17.2 mtp -83.83 172.99 11.64 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 122.318 1.056 . . . . 0.0 113.604 -169.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.2 m -155.5 172.5 18.14 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.873 0.869 . . . . 0.0 111.372 161.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.58 121.56 42.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.188 0.995 . . . . 0.0 109.765 164.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 27.1 t -63.77 -36.89 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.003 1.321 . . . . 0.0 109.798 167.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -137.92 126.54 23.63 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.23 1.412 . . . . 0.0 109.836 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -62.96 152.19 84.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.618 1.167 . . . . 0.0 112.217 172.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -62.06 131.86 36.66 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.392 2.062 . . . . 0.0 111.647 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 48.1 p -128.56 132.02 48.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.93 1.292 . . . . 0.0 110.874 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -51.35 118.79 3.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.192 1.797 . . . . 0.0 112.062 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 60.9 p -79.64 -8.6 59.31 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.413 1.485 . . . . 0.0 113.41 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.17 -7.2 6.15 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.523 1.059 . . . . 0.0 114.262 -165.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -89.49 5.37 45.7 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.222 1.511 . . . . 0.0 112.14 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 87.05 17.35 59.49 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.232 0.92 . . . . 0.0 113.148 -170.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 38.4 p -131.47 161.52 32.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.907 1.283 . . . . 0.0 111.062 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.96 128.45 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.907 1.283 . . . . 0.0 109.119 170.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.91 133.16 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.664 1.186 . . . . 0.0 111.844 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 22.2 ptm -146.63 162.35 38.62 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.664 2.385 . . . . 0.0 111.861 -166.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -134.74 130.53 36.35 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.524 -0.735 . . . . 0.0 109.655 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 19.9 m -109.92 164.52 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.837 1.255 . . . . 0.0 111.517 -171.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -134.95 125.03 25.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.547 1.539 . . . . 0.0 111.498 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.5 t -98.83 153.15 37.99 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-O 117.21 -1.376 . . . . 0.0 108.374 162.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -109.02 -72.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.306 0 C-N-CA 123.293 2.662 . . . . 0.0 115.208 176.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.3 163.69 31.17 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 121.397 1.908 . . . . 0.0 115.823 -174.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.83 -17.54 0.1 OUTLIER Glycine 0 CA--C 1.538 1.504 0 C-N-CA 127.841 2.638 . . . . 0.0 117.881 171.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -104.22 99.89 19.15 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 119.316 1.558 . . . . 0.0 113.13 -168.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.26 128.46 16.51 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.836 1.69 . . . . 0.0 108.697 155.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.0 p -163.94 155.93 16.94 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.555 -0.715 . . . . 0.0 111.953 -173.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -79.77 128.18 33.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.497 1.519 . . . . 0.0 109.448 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.0 111.01 3.1 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.464 0.706 . . . . 0.0 112.4 -163.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -91.03 85.9 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.726 2.95 . . . . 0.0 113.394 -157.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.42 134.48 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.972 0.909 . . . . 0.0 109.219 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.08 151.72 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.376 1.07 . . . . 0.0 110.232 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.27 109.31 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.889 1.675 . . . . 0.0 107.591 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -117.7 161.24 20.0 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -158.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.28 -11.98 53.49 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.158 2.183 . . . . 0.0 112.783 162.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -129.81 138.31 50.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.561 1.544 . . . . 0.0 111.073 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 22.5 mt -55.83 -19.18 10.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.587 1.555 . . . . 0.0 114.374 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -105.65 2.36 28.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.95 2.5 . . . . 0.0 114.222 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 49.04 77.58 0.1 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.161 2.584 . . . . 0.0 116.59 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -109.9 -24.34 10.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.393 1.477 . . . . 0.0 112.309 161.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.92 120.54 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.062 1.345 . . . . 0.0 109.018 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.96 114.73 28.89 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.729 0.812 . . . . 0.0 112.916 -169.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -81.39 -51.57 8.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.504 2.722 . . . . 0.0 112.451 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.9 -167.36 40.2 Favored Glycine 0 CA--C 1.537 1.413 0 N-CA-C 116.549 1.379 . . . . 0.0 116.549 -167.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.91 140.44 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 127.035 2.134 . . . . 0.0 110.94 -175.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 7.2 mt -73.05 130.0 39.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.759 1.224 . . . . 0.0 110.466 163.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.09 -45.18 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 122.759 0.424 . . . . 0.0 111.159 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 m -70.03 154.78 41.5 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.67 0.668 . . . . 0.0 110.178 164.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.9 m -56.73 155.89 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.971 0.908 . . . . 0.0 112.253 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -127.79 71.26 78.05 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.049 0.939 . . . . 0.0 111.716 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.23 -169.52 0.75 Allowed 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 124.619 3.546 . . . . 0.0 112.914 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 37.1 pt -87.55 161.29 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 121.502 -0.749 . . . . 0.0 112.196 167.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.85 109.29 2.03 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 156.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.4 p -69.73 -37.2 76.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.617 1.567 . . . . 0.0 112.161 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.46 157.14 30.0 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 126.082 1.753 . . . . 0.0 109.745 158.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -62.95 -17.95 62.58 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.88 7.88 44.57 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.623 1.169 . . . . 0.0 112.356 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -59.45 150.39 26.78 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.63 -1.294 . . . . 0.0 113.257 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -134.84 80.17 1.83 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.355 1.062 . . . . 0.0 113.289 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.23 146.5 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.031 1.332 . . . . 0.0 111.942 -171.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 27.6 tp -97.96 129.01 44.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 129.405 3.082 . . . . 0.0 110.034 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.2 mp -140.28 148.6 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.945 1.698 . . . . 0.0 109.726 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -121.25 148.07 44.78 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.249 1.023 . . . . 0.0 112.354 157.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.45 156.57 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.689 1.596 . . . . 0.0 110.909 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -116.21 104.96 51.53 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.58 1.952 . . . . 0.0 110.639 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.16 164.62 15.05 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.645 2.897 . . . . 0.0 111.747 163.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.58 -178.93 4.85 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.792 2.995 . . . . 0.0 111.836 166.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -67.0 150.9 48.61 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.525 -0.735 . . . . 0.0 110.551 158.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 94.47 -151.05 20.0 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 -167.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.9 162.5 20.48 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.754 1.222 . . . . 0.0 113.276 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 19.3 m -165.09 159.08 17.4 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.822 -1.174 . . . . 0.0 111.818 157.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -122.25 116.16 23.64 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 11.7 mm -92.1 111.14 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.349 1.06 . . . . 0.0 108.188 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.3 145.41 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.961 0.904 . . . . 0.0 109.957 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 98.5 t -121.86 113.41 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.415 1.886 . . . . 0.0 109.015 174.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.58 178.16 27.13 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.435 1.017 . . . . 0.0 114.855 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 17.8 m -131.43 159.95 36.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.811 1.645 . . . . 0.0 109.566 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 78.35 -175.74 54.57 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-O 121.898 0.721 . . . . 0.0 112.966 -172.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -22.17 63.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.033 1.333 . . . . 0.0 112.85 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 72.0 m -63.47 -12.31 30.57 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 168.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -79.4 144.01 34.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.099 1.318 . . . . 0.0 112.799 -173.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 24.9 mt -111.81 164.37 13.14 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.428 1.091 . . . . 0.0 111.24 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.5 t -140.58 146.85 38.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.802 1.241 . . . . 0.0 111.686 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -143.93 112.24 6.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.824 1.65 . . . . 0.0 110.034 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.53 131.62 46.44 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.98 0.912 . . . . 0.0 111.664 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -121.05 158.46 27.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.35 1.06 . . . . 0.0 110.775 162.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -145.5 140.03 27.23 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -105.24 112.09 25.07 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.994 1.318 . . . . 0.0 108.694 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -60.45 163.25 5.4 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.24 3.016 . . . . 0.0 114.471 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -131.01 16.22 5.29 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.97 1.748 . . . . 0.0 113.446 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 17.9 p -69.38 80.28 0.38 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.886 1.674 . . . . 0.0 112.025 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 43.9 p -64.03 28.04 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.763 2.425 . . . . 0.0 116.151 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.3 tp -134.49 -10.21 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 127.638 2.375 . . . . 0.0 112.456 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 174.51 146.25 5.6 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.76 1.172 . . . . 0.0 111.902 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 C-N-CA 125.558 1.543 . . . . 0.0 111.343 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.2 m -98.09 2.07 48.29 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.378 1.071 . . . . 0.0 112.984 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -67.82 -37.48 82.0 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.074 0.852 . . . . 0.0 112.928 175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.38 135.99 37.57 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.473 1.033 . . . . 0.0 108.974 168.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.1 t -52.76 167.69 0.14 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.143 1.777 . . . . 0.0 114.658 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.92 100.16 0.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.283 1.833 . . . . 0.0 110.204 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.427 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 8.3 mptt -61.09 127.93 33.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.573 2.349 . . . . 0.0 110.995 -168.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.06 -42.93 1.18 Allowed Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.937 1.256 . . . . 0.0 113.662 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 58.3 m -63.28 -5.91 3.95 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.791 2.436 . . . . 0.0 114.04 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 45.1 m -126.43 152.99 45.65 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -78.15 173.56 12.11 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.492 1.517 . . . . 0.0 112.261 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.34 158.28 29.57 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 51.0 mtm -88.9 154.48 20.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.899 2.08 . . . . 0.0 111.52 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.5 m -72.35 141.15 48.78 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.68 -0.637 . . . . 0.0 111.937 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.9 p -132.7 6.56 4.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -68.89 160.82 29.99 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.195 1.362 . . . . 0.0 109.975 160.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.58 95.66 0.23 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.692 1.597 . . . . 0.0 111.9 -169.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 65.6 mtp -80.45 172.62 13.53 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.203 1.401 . . . . 0.0 113.149 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 28.2 m -158.58 170.68 21.65 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.85 1.26 . . . . 0.0 110.45 160.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.55 123.94 36.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.405 0.682 . . . . 0.0 110.936 170.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 63.6 t -67.43 -36.34 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.583 1.553 . . . . 0.0 109.925 165.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -136.44 108.87 7.36 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 126.484 1.914 . . . . 0.0 107.724 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -59.49 143.88 85.27 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.959 0.904 . . . . 0.0 110.151 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.62 140.48 86.87 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.596 2.197 . . . . 0.0 111.612 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 389' ' ' TRP . 43.3 p -136.87 130.79 32.27 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.455 1.502 . . . . 0.0 109.71 173.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -65.93 134.14 52.35 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 124.262 0.976 . . . . 0.0 112.694 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 43.5 p -82.26 -18.34 42.8 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.23 1.012 . . . . 0.0 113.267 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 60.9 22.5 60.17 Favored Glycine 0 CA--C 1.538 1.492 0 CA-C-N 119.192 0.905 . . . . 0.0 112.55 -163.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -121.38 13.94 11.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.071 1.748 . . . . 0.0 111.024 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 103.07 -3.86 48.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.876 1.703 . . . . 0.0 114.119 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 25.9 p -127.63 161.9 27.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.961 1.38 . . . . 0.0 112.797 -165.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.72 135.12 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.648 1.579 . . . . 0.0 108.601 162.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.63 125.65 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.223 1.009 . . . . 0.0 112.841 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 18.7 ptm -146.01 158.36 43.87 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.941 1.696 . . . . 0.0 113.389 -166.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -138.35 137.47 37.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.921 1.288 . . . . 0.0 109.423 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 362' ' ' GLU . 35.4 m -124.27 149.1 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.877 1.271 . . . . 0.0 110.994 -169.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -116.11 134.32 55.06 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.965 1.706 . . . . 0.0 111.359 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.82 148.52 37.53 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.267 1.427 . . . . 0.0 108.374 163.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -105.87 -70.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.252 2.635 . . . . 0.0 116.201 175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.09 168.44 19.81 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 120.129 -1.607 . . . . 0.0 113.591 -170.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.44 -16.77 0.09 OUTLIER Glycine 0 CA--C 1.54 1.642 0 C-N-CA 126.641 2.067 . . . . 0.0 117.501 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -119.48 91.76 44.92 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 119.305 1.553 . . . . 0.0 113.153 -163.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.35 131.62 19.34 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.977 1.784 . . . . 0.0 108.577 152.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 1.6 p -161.76 159.06 26.7 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.397 -0.814 . . . . 0.0 112.406 -170.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -73.55 132.19 42.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.896 1.678 . . . . 0.0 108.608 164.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.4 pp -62.66 111.58 5.04 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-N 118.692 0.678 . . . . 0.0 112.7 -168.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -89.74 75.17 1.25 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.251 3.301 . . . . 0.0 112.751 -163.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.95 130.27 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 167.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.83 158.99 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.135 0.974 . . . . 0.0 109.857 172.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.54 116.61 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.765 2.026 . . . . 0.0 106.314 174.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -131.34 161.61 31.97 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -160.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.02 -11.49 52.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.124 2.17 . . . . 0.0 112.784 169.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.51 136.64 51.06 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.145 1.778 . . . . 0.0 109.621 176.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.6 mp -60.11 -18.49 47.68 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -94.27 -1.01 54.66 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.126 2.17 . . . . 0.0 114.569 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 46.56 79.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.851 2.46 . . . . 0.0 115.933 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -103.71 -32.64 9.27 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.381 1.472 . . . . 0.0 111.864 158.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 28.0 mm -118.98 115.48 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 119.628 1.104 . . . . 0.0 110.609 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.03 111.82 22.63 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.029 0.932 . . . . 0.0 113.06 -173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -86.38 -25.15 25.49 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 130.15 3.38 . . . . 0.0 114.459 -170.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -113.15 -163.93 15.74 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 115.766 1.066 . . . . 0.0 115.766 -169.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.62 137.85 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 127.904 2.481 . . . . 0.0 110.415 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.5 mt -74.81 134.49 41.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.757 164.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 4.0 t -104.78 -49.4 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.581 0.753 . . . . 0.0 110.356 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 37.5 m -71.66 155.79 40.1 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.118 0.485 . . . . 0.0 110.204 166.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 15.6 m -56.15 157.82 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.391 1.076 . . . . 0.0 112.562 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -121.96 75.71 39.01 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.486 1.114 . . . . 0.0 111.136 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -79.98 -164.22 0.27 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.458 3.439 . . . . 0.0 112.284 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.6 pt -96.73 162.24 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.791 1.637 . . . . 0.0 111.958 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.16 112.11 4.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.118 0.967 . . . . 0.0 108.657 157.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 98.9 p -63.77 -30.04 71.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.711 1.204 . . . . 0.0 113.059 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 12.2 m -137.23 155.96 48.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 128.259 2.624 . . . . 0.0 106.691 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -57.74 -19.55 28.49 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -97.09 10.68 38.66 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.331 1.452 . . . . 0.0 113.408 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -60.37 158.23 12.26 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 120.061 -1.649 . . . . 0.0 114.037 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 11.2 pt-20 -145.2 77.83 1.53 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.62 147.85 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.655 1.182 . . . . 0.0 112.171 -172.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 26.6 tp -105.37 132.33 51.7 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 129.709 3.203 . . . . 0.0 110.106 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.7 mp -144.41 138.88 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.859 1.664 . . . . 0.0 111.123 -167.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -99.45 135.69 40.48 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.821 1.248 . . . . 0.0 111.462 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.15 163.19 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.787 1.235 . . . . 0.0 110.873 170.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -119.03 112.88 35.98 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.771 2.028 . . . . 0.0 109.587 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.18 153.22 16.41 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 122.934 2.423 . . . . 0.0 111.159 158.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.76 174.27 4.77 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.124 2.549 . . . . 0.0 112.974 165.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.77 140.84 56.23 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.491 1.116 . . . . 0.0 110.155 164.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 96.4 -148.68 19.08 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -172.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.3 163.29 23.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.143 0.977 . . . . 0.0 113.451 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 37.6 m -163.17 161.59 25.12 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.792 -1.193 . . . . 0.0 110.785 158.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -121.27 114.87 21.98 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 15.0 mm -83.73 121.58 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.75 141.41 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 123.656 0.782 . . . . 0.0 109.688 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 81.6 t -122.86 104.36 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 126.353 1.861 . . . . 0.0 108.483 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.59 177.37 20.72 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 122.703 1.169 . . . . 0.0 114.575 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 98.8 m -130.31 164.29 24.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.353 1.461 . . . . 0.0 109.104 165.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.49 -171.53 53.03 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 122.031 0.795 . . . . 0.0 113.068 -173.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -29.98 59.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.099 1.76 . . . . 0.0 113.325 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.8 m -66.68 -11.48 54.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -74.43 123.35 24.52 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.184 1.356 . . . . 0.0 113.037 -169.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 14.2 mt -84.49 163.29 19.51 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.895 0.478 . . . . 0.0 111.201 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 t -138.41 148.15 44.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.893 1.277 . . . . 0.0 111.12 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -147.58 111.38 5.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.318 1.447 . . . . 0.0 110.611 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 134.24 50.23 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.532 1.133 . . . . 0.0 112.353 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . 0.408 ' CZ2' ' HA ' ' A' ' 311' ' ' THR . 11.1 m95 -126.0 162.97 24.04 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.277 1.431 . . . . 0.0 112.671 166.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.04 133.51 33.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.164 2.185 . . . . 0.0 108.158 171.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . 0.466 ' HZ2' ' CD ' ' A' ' 392' ' ' GLU . 0.0 OUTLIER -122.52 140.12 53.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.899 1.279 . . . . 0.0 110.917 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . 0.466 ' CD ' ' HZ2' ' A' ' 391' ' ' LYS . 7.8 pm0 -56.6 164.1 1.57 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 129.016 2.926 . . . . 0.0 114.104 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 123.08 43.75 0.35 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.696 0.665 . . . . 0.0 114.249 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 16.4 t -84.93 178.53 7.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.352 1.076 . . . . 0.0 111.215 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 26.0 t -61.09 1.18 0.18 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.126 1.77 . . . . 0.0 115.059 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.22 7.15 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 127.402 2.281 . . . . 0.0 111.477 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 96.88 -78.86 0.69 Allowed Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.506 1.527 . . . . 0.0 112.79 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp . . . . . 0 C--O 1.257 1.454 0 CA-C-O 116.953 -1.498 . . . . 0.0 109.441 175.611 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 60.3 p -103.45 -6.54 21.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 117.779 -1.105 . . . . 0.0 113.691 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -49.16 -57.43 6.7 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 124.386 1.075 . . . . 0.0 112.55 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.47 124.18 21.61 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 163.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.1 t -50.84 164.61 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.579 1.952 . . . . 0.0 115.687 -165.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.525 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.1 mm? -59.07 102.91 0.14 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.272 1.829 . . . . 0.0 110.471 -172.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -60.95 135.53 57.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.02 2.128 . . . . 0.0 111.018 -168.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 73.5 -47.56 1.44 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.533 1.063 . . . . 0.0 113.343 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.7 m -63.41 -16.58 60.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.548 1.939 . . . . 0.0 113.467 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 22.9 m -124.99 143.84 50.69 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.119 1.368 . . . . 0.0 112.241 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -73.47 173.31 9.82 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.872 0.869 . . . . 0.0 112.025 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -68.17 160.93 28.12 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.344 1.058 . . . . 0.0 113.675 -175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 46.3 mtt -88.7 158.4 18.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.894 1.677 . . . . 0.0 112.379 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.0 m -70.82 140.94 51.34 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.221 0.608 . . . . 0.0 111.906 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 13.3 p -123.21 9.07 9.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.37 1.068 . . . . 0.0 113.289 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -70.15 161.31 30.46 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.624 -0.672 . . . . 0.0 111.067 164.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -65.7 91.97 0.14 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.525 1.93 . . . . 0.0 111.433 -167.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 5.8 mtp -76.7 167.13 22.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.767 1.27 . . . . 0.0 113.413 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 27.7 m -159.63 173.6 15.85 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.062 1.345 . . . . 0.0 110.249 167.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -109.01 128.99 55.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.35 1.06 . . . . 0.0 111.09 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.1 t -72.5 -33.88 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.737 1.615 . . . . 0.0 109.68 163.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -138.9 124.73 19.77 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.097 1.359 . . . . 0.0 109.988 169.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -62.83 143.78 96.93 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.253 1.421 . . . . 0.0 112.061 169.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -58.56 132.07 46.15 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.587 2.191 . . . . 0.0 112.607 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.1 142.86 44.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.534 0.734 . . . . 0.0 110.335 172.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -66.83 134.85 52.94 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.035 0.934 . . . . 0.0 112.836 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.6 p -79.9 -20.94 44.63 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.076 1.351 . . . . 0.0 113.341 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 88.76 -12.37 65.84 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.661 1.601 . . . . 0.0 113.89 -166.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -90.12 9.44 28.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.523 1.529 . . . . 0.0 112.137 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 83.84 14.75 71.96 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 121.127 -0.983 . . . . 0.0 114.054 -171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 21.7 p -125.02 158.28 34.1 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.554 1.142 . . . . 0.0 110.929 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.83 131.07 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.045 1.338 . . . . 0.0 109.706 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.06 131.38 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.232 1.413 . . . . 0.0 111.804 -172.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 4.5 ptp -143.29 165.61 27.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.786 2.034 . . . . 0.0 111.858 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -136.96 132.12 33.94 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.473 -0.767 . . . . 0.0 109.5 172.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.6 m -113.44 163.97 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.386 1.075 . . . . 0.0 111.749 -168.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -125.12 115.53 20.61 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.358 1.463 . . . . 0.0 110.624 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 t -91.61 134.54 29.11 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 116.857 -1.544 . . . . 0.0 107.343 165.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -97.02 -80.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.447 0 C-N-CA 122.525 2.15 . . . . 0.0 116.381 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.13 144.97 21.51 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 119.25 -2.156 . . . . 0.0 115.878 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 88.54 0.53 81.96 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.87 1.224 . . . . 0.0 115.23 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -121.67 98.3 45.85 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.989 1.316 . . . . 0.0 111.486 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.54 123.36 10.1 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.3 2.0 . . . . 0.0 108.433 161.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.9 p -157.0 157.35 34.55 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.128 0.966 . . . . 0.0 113.251 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -69.83 138.82 52.92 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.075 1.75 . . . . 0.0 108.776 162.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 1.0 OUTLIER -62.42 121.77 69.08 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 118.721 0.691 . . . . 0.0 111.855 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 11.9 Cg_endo -99.98 95.69 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.649 2.233 . . . . 0.0 114.768 -155.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.72 141.98 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.02 0.928 . . . . 0.0 110.932 172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.31 159.59 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.95 1.7 . . . . 0.0 110.309 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 58.4 t -133.35 97.91 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.284 1.834 . . . . 0.0 108.028 171.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -111.9 160.98 16.88 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -165.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -81.98 -17.2 47.74 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.859 1.664 . . . . 0.0 112.614 162.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -123.89 138.66 54.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.633 1.173 . . . . 0.0 111.745 -176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.68 -18.65 32.67 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.11 1.364 . . . . 0.0 113.314 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.4 t -91.53 -4.17 55.71 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.124 1.769 . . . . 0.0 114.388 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.51 70.05 0.32 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.133 2.173 . . . . 0.0 114.555 -170.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -104.09 -14.57 15.85 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.951 0.9 . . . . 0.0 111.929 163.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 56.5 mt -111.74 155.83 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.702 1.601 . . . . 0.0 108.373 170.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -141.73 123.01 14.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.725 -1.234 . . . . 0.0 112.414 170.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -116.69 -11.38 11.0 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -96.65 -172.59 34.83 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.415 0.926 . . . . 0.0 115.415 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 23.3 mt -126.45 138.06 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.924 2.089 . . . . 0.0 110.775 -174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 50.5 mt -68.85 132.39 46.68 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.616 0.766 . . . . 0.0 109.815 163.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.42 -41.56 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 118.411 0.551 . . . . 0.0 112.05 174.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 59.9 m -76.88 145.8 38.08 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.655 0.661 . . . . 0.0 109.379 159.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 25.4 t -63.38 154.51 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.444 1.098 . . . . 0.0 111.44 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -117.98 82.99 18.17 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.21 1.404 . . . . 0.0 112.204 -174.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -85.42 -154.34 0.05 OUTLIER 'Trans proline' 0 CA--C 1.554 1.487 0 C-N-CA 125.24 3.96 . . . . 0.0 112.66 172.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.9 pt -107.33 166.6 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.171 2.189 . . . . 0.0 111.761 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.25 118.02 12.54 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 158.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 85.4 p -74.71 -44.11 51.66 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.149 1.38 . . . . 0.0 112.521 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.75 155.14 20.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.005 1.722 . . . . 0.0 108.623 158.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -59.77 -26.49 65.75 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -91.37 9.93 29.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.508 1.523 . . . . 0.0 113.068 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -60.08 150.89 28.08 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 120.45 -1.406 . . . . 0.0 114.252 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -135.24 88.84 2.45 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 66.0 t -100.56 144.91 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.16 1.384 . . . . 0.0 111.834 -162.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.6 tp -95.73 126.43 40.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.799 2.84 . . . . 0.0 109.774 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.57 154.04 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.698 1.199 . . . . 0.0 110.812 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.29 148.2 50.64 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 124.712 1.205 . . . . 0.0 111.229 165.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 27.0 m -132.59 154.09 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.38 1.472 . . . . 0.0 110.686 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.9 109.84 59.21 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.621 1.569 . . . . 0.0 109.126 173.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.78 144.62 31.33 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.236 1.958 . . . . 0.0 111.43 163.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.13 168.3 25.12 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.173 2.582 . . . . 0.0 110.852 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -56.76 134.72 55.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.645 1.178 . . . . 0.0 111.897 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.63 -148.62 19.18 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.195 0.902 . . . . 0.0 112.685 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.73 147.71 22.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.16 2.184 . . . . 0.0 113.786 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 29.7 m -163.44 154.12 16.16 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.273 1.429 . . . . 0.0 113.042 159.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -117.22 105.27 12.04 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.666 1.586 . . . . 0.0 108.955 172.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 20.5 mm -78.48 116.57 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 30.3 mt -121.84 139.51 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.118 0.485 . . . . 0.0 110.524 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 68.9 t -115.31 114.49 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.38 1.872 . . . . 0.0 107.886 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 99.89 177.63 30.73 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 122.81 1.228 . . . . 0.0 114.756 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 94.5 m -127.31 163.69 23.4 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.064 1.746 . . . . 0.0 109.767 167.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.41 -173.7 52.85 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 121.746 0.637 . . . . 0.0 113.265 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -25.67 64.44 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.329 1.452 . . . . 0.0 113.251 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.5 m -64.86 -13.72 57.17 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 170.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -74.11 136.95 42.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.07 1.304 . . . . 0.0 112.266 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 17.3 mt -104.43 154.78 19.44 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.406 0.682 . . . . 0.0 110.607 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.6 t -129.0 145.61 51.2 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.525 1.13 . . . . 0.0 112.161 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -146.16 108.63 4.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.465 1.506 . . . . 0.0 109.585 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -65.21 137.99 57.95 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.607 1.163 . . . . 0.0 111.759 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 26.4 m95 -142.07 126.19 17.4 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.727 1.211 . . . . 0.0 111.36 168.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -96.8 131.89 43.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.818 0.847 . . . . 0.0 109.731 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -104.17 115.84 31.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.589 1.555 . . . . 0.0 110.663 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.49 159.5 15.1 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.251 2.221 . . . . 0.0 112.184 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -75.26 38.7 1.18 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.239 1.4 . . . . 0.0 114.533 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.53 -62.79 0.69 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.133 1.773 . . . . 0.0 111.094 -172.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.1 m -80.2 51.24 1.36 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.436 1.895 . . . . 0.0 110.334 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.7 tp -121.86 -9.12 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 129.599 3.16 . . . . 0.0 111.042 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -144.73 34.44 1.58 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.523 1.535 . . . . 0.0 114.272 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.138 0 C-N-CA 125.282 1.433 . . . . 0.0 109.036 174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 117.813 -1.089 . . . . 0.0 113.805 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.1 p -98.98 -7.38 27.03 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.137 1.335 . . . . 0.0 114.393 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.12 -48.37 70.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.678 1.191 . . . . 0.0 112.851 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.08 121.22 14.65 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 2.3 t -52.07 168.85 0.08 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.264 1.826 . . . . 0.0 115.153 -168.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.1 109.88 0.66 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.132 1.773 . . . . 0.0 110.635 -171.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -69.7 138.98 53.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.458 1.903 . . . . 0.0 110.738 -165.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 64.66 -59.35 0.07 OUTLIER Glycine 0 CA--C 1.534 1.246 0 C-N-CA 127.57 2.509 . . . . 0.0 113.836 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 40.4 p -47.03 -21.92 0.28 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 130.951 3.7 . . . . 0.0 115.817 168.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . 0.508 ' HB2' ' HE3' ' A' ' 331' ' ' LYS . 2.6 p -145.24 161.97 38.26 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.863 1.211 . . . . 0.0 113.096 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -81.35 170.32 16.15 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -163.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 162.08 29.44 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.477 1.132 . . . . 0.0 113.994 -176.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 43.6 mtt -80.46 161.37 24.93 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.246 2.218 . . . . 0.0 113.162 -178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 8.1 m -72.26 146.56 47.15 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.585 -0.697 . . . . 0.0 112.089 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.8 p -136.69 8.39 3.06 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -78.5 158.57 28.56 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 120.139 1.336 . . . . 0.0 110.013 159.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.43 101.68 0.14 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.903 1.281 . . . . 0.0 112.006 -168.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 38.2 mtp -81.89 165.91 20.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.684 0.793 . . . . 0.0 112.073 -175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 10.7 p -147.93 159.36 43.96 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.941 0.897 . . . . 0.0 111.455 168.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -77.76 118.64 20.31 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 169.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 99.6 t -76.23 -30.31 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.225 0.61 . . . . 0.0 109.918 161.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -144.62 130.38 19.15 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.746 1.619 . . . . 0.0 109.125 168.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -63.62 153.09 84.46 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.526 0.73 . . . . 0.0 112.078 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -63.07 127.31 19.95 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.761 2.307 . . . . 0.0 110.962 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 48.3 p -126.22 133.66 51.44 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.873 1.269 . . . . 0.0 110.952 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -63.69 133.98 54.57 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.186 1.794 . . . . 0.0 112.277 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 6.4 p -71.68 -19.98 62.0 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 165.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.69 17.41 67.01 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-N 118.733 0.697 . . . . 0.0 112.198 -164.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -128.44 9.56 6.08 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.086 1.754 . . . . 0.0 111.616 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 105.98 6.75 36.82 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.12 -1.378 . . . . 0.0 114.861 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 20.4 p -128.54 160.38 32.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.789 1.794 . . . . 0.0 112.687 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.2 m -130.43 132.84 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.456 1.502 . . . . 0.0 109.778 169.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.5 p -120.23 129.85 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.953 1.301 . . . . 0.0 112.958 -169.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 5.8 ptp -140.53 166.33 25.03 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.768 1.627 . . . . 0.0 112.833 -172.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -132.27 138.65 47.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.297 1.039 . . . . 0.0 110.083 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.8 151.29 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.356 1.062 . . . . 0.0 110.776 -169.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -107.8 127.88 54.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.06 1.344 . . . . 0.0 110.577 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.41 138.81 20.01 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 117.257 -1.354 . . . . 0.0 107.734 162.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -104.79 -75.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 122.427 2.085 . . . . 0.0 115.325 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.47 174.67 10.55 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.042 -1.661 . . . . 0.0 114.274 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.21 3.21 17.1 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 116.952 1.541 . . . . 0.0 116.952 170.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -127.11 95.1 37.45 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 119.038 1.419 . . . . 0.0 112.9 -162.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -72.1 124.31 9.94 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.103 1.869 . . . . 0.0 108.659 159.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 6.0 p -161.68 156.64 23.33 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -173.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 296' ' ' SER . 14.1 tptp -73.54 135.68 43.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.837 2.855 . . . . 0.0 109.418 162.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 14.6 pt -63.45 124.25 83.77 Favored Pre-proline 0 N--CA 1.479 1.005 0 CA-C-N 119.85 1.205 . . . . 0.0 111.409 -171.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -105.77 89.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 121.622 1.548 . . . . 0.0 114.57 -157.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 74.3 t -125.98 132.04 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.884 0.873 . . . . 0.0 109.531 173.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.8 158.53 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.859 1.264 . . . . 0.0 110.674 -172.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 35.4 t -127.1 126.75 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.057 1.743 . . . . 0.0 107.552 173.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -132.01 161.45 33.15 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.902 1.281 . . . . 0.0 112.795 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.97 -22.65 33.66 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.749 1.22 . . . . 0.0 112.333 166.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -107.61 154.79 20.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.267 1.427 . . . . 0.0 111.479 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.69 -19.28 63.72 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -173.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.6 t -117.82 7.06 12.34 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.677 1.191 . . . . 0.0 113.951 -167.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 47.15 70.2 0.43 Allowed 'General case' 0 C--O 1.238 0.497 0 C-N-CA 127.974 2.51 . . . . 0.0 114.691 -170.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -83.81 -43.35 15.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.286 1.034 . . . . 0.0 111.158 154.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 43.4 mm -86.93 153.44 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.585 1.154 . . . . 0.0 109.959 173.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . 0.263 0.0 OUTLIER -125.15 96.4 4.83 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 123.171 1.462 . . . . 0.0 110.707 171.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -78.2 -55.56 5.17 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 128.732 2.813 . . . . 0.0 111.869 -169.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -91.28 -168.12 41.38 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.438 1.494 . . . . 0.0 116.273 -166.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.1 mt -124.11 139.91 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 126.604 1.961 . . . . 0.0 111.152 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.65 125.24 26.27 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.594 1.158 . . . . 0.0 110.487 168.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.5 t -104.15 -54.04 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.528 0.731 . . . . 0.0 109.286 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 50.0 m -71.76 140.61 49.57 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 167.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.67 150.63 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.887 1.275 . . . . 0.0 112.369 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -125.0 70.84 61.28 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.59 1.156 . . . . 0.0 112.556 -167.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.85 -167.12 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.73 3.62 . . . . 0.0 112.575 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 45.7 pt -83.34 160.35 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.694 1.198 . . . . 0.0 112.748 173.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.1 110.75 4.67 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 156.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.2 p -66.88 -33.06 74.77 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.071 1.749 . . . . 0.0 112.696 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.09 146.8 50.25 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 126.749 2.02 . . . . 0.0 108.06 167.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -59.84 -17.9 39.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -91.3 0.72 57.48 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.683 1.993 . . . . 0.0 112.758 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -61.06 151.69 30.15 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.45 -1.406 . . . . 0.0 113.068 -175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -136.57 82.72 1.96 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.174 0.987 . . . . 0.0 112.963 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 43.9 t -99.42 153.1 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.288 1.435 . . . . 0.0 111.582 -164.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 6.9 tt -108.53 128.68 55.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.217 2.207 . . . . 0.0 109.778 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.1 mp -135.87 141.38 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.401 1.48 . . . . 0.0 109.035 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -114.9 149.6 36.95 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 122.078 0.942 . . . . 0.0 112.85 161.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 30.5 m -134.23 158.37 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 125.867 1.667 . . . . 0.0 110.883 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -109.01 102.68 49.72 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.588 1.955 . . . . 0.0 109.638 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.8 145.42 20.08 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.194 2.596 . . . . 0.0 110.815 166.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.82 176.67 9.73 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.002 2.468 . . . . 0.0 111.185 164.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -63.45 152.8 37.3 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.268 1.427 . . . . 0.0 113.739 -171.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 89.46 -162.06 30.34 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.844 1.212 . . . . 0.0 112.257 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.79 159.21 31.28 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.322 1.058 . . . . 0.0 111.81 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 73.2 m -160.33 164.88 32.17 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.151 -1.593 . . . . 0.0 111.174 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -120.86 116.49 25.28 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 124.849 1.26 . . . . 0.0 109.008 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 24.1 mm -85.38 120.2 35.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 124.714 1.206 . . . . 0.0 107.884 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.62 140.31 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.448 0.699 . . . . 0.0 110.092 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 76.3 t -115.18 115.08 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 126.79 2.036 . . . . 0.0 108.067 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 97.89 179.39 33.2 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 123.442 1.579 . . . . 0.0 115.622 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 29.8 m -134.2 163.66 29.11 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.194 1.398 . . . . 0.0 109.935 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.09 -174.14 54.63 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 122.148 0.86 . . . . 0.0 112.85 -170.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -27.69 61.65 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.855 1.662 . . . . 0.0 112.794 172.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.8 m -65.41 -12.08 48.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 173.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -74.62 138.65 43.09 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.753 1.16 . . . . 0.0 111.981 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 21.1 mt -103.86 162.41 13.14 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.987 0.915 . . . . 0.0 110.973 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.7 t -142.1 146.44 35.4 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.45 1.1 . . . . 0.0 111.664 -172.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -145.39 119.98 9.77 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.794 1.638 . . . . 0.0 109.931 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -71.01 129.07 38.05 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.579 0.752 . . . . 0.0 111.782 176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -123.76 159.21 29.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.731 1.212 . . . . 0.0 111.636 170.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -133.65 118.74 18.53 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.943 1.697 . . . . 0.0 109.033 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -120.8 120.73 36.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.611 1.564 . . . . 0.0 111.09 -167.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -1.03 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 131.446 3.898 . . . . 0.0 116.236 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -89.36 -14.08 60.71 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.031 0.824 . . . . 0.0 112.993 167.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.1 p -115.26 75.91 0.97 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.005 1.722 . . . . 0.0 108.705 172.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 97.5 p -54.54 -30.24 53.33 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -164.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.796 HD13 ' H ' ' A' ' 396' ' ' ILE . 0.1 OUTLIER -71.17 62.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.975 1.31 . . . . 0.0 110.632 160.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 136.59 -88.44 0.22 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.82 1.2 . . . . 0.0 115.134 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 398' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.189 0 CA-C-O 115.573 -2.155 . . . . 0.0 113.32 -163.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 118.169 -0.919 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 19.2 t -111.46 -2.09 15.67 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -65.46 -47.69 75.26 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.256 1.389 . . . . 0.0 112.275 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.403 HD22 ' HE3' ' A' ' 293' ' ' LYS . 4.0 tt -68.13 123.84 21.8 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 159.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 4.8 t -50.01 167.66 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.425 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.3 mm? -63.06 113.65 3.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.507 1.923 . . . . 0.0 110.735 -172.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 295' ' ' THR . 8.6 mptt -62.37 132.97 54.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.444 1.897 . . . . 0.0 110.384 -174.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 65.18 -27.19 0.12 Allowed Glycine 0 CA--C 1.543 1.786 0 C-N-CA 126.757 2.122 . . . . 0.0 115.488 -171.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 293' ' ' LYS . 43.8 m -87.39 -13.64 42.85 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 130.599 3.56 . . . . 0.0 112.068 -173.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.4 m -155.88 153.88 30.38 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 119.853 -1.779 . . . . 0.0 113.569 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -75.54 178.75 5.75 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.43 1.892 . . . . 0.0 114.538 -168.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.86 159.81 14.79 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.822 1.649 . . . . 0.0 114.199 -168.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.27 158.43 26.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.481 2.712 . . . . 0.0 114.873 -170.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.8 m -78.88 145.01 34.39 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.79 0.836 . . . . 0.0 110.585 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.02 14.17 3.92 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.415 1.086 . . . . 0.0 113.224 167.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -67.66 159.33 30.23 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 118.166 -1.414 . . . . 0.0 108.818 153.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.5 109.48 4.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.316 0.646 . . . . 0.0 111.064 -167.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 69.9 mtp -95.27 162.25 13.76 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 122.312 1.053 . . . . 0.0 112.431 -174.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 15.4 p -151.42 159.47 44.21 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.239 1.416 . . . . 0.0 109.534 166.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.75 129.94 34.8 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 122.045 -0.409 . . . . 0.0 109.904 166.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.66 -29.07 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.118 0.967 . . . . 0.0 109.989 162.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -145.82 133.5 21.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.899 1.68 . . . . 0.0 109.999 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -66.47 147.38 98.97 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.986 0.914 . . . . 0.0 112.465 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.72 133.54 57.0 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.633 2.222 . . . . 0.0 112.186 172.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 21.7 p -132.89 142.34 48.87 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.976 1.711 . . . . 0.0 110.126 169.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.0 130.3 46.06 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.649 0.738 . . . . 0.0 110.675 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 75.0 p -78.29 -18.74 54.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.495 1.918 . . . . 0.0 113.034 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 82.62 -4.3 79.22 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.367 0.985 . . . . 0.0 113.845 -163.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -84.25 -0.48 52.46 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 119.612 1.706 . . . . 0.0 111.88 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 76.69 36.22 38.15 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.91 1.243 . . . . 0.0 111.539 -165.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.6 p -146.69 164.16 33.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.194 2.198 . . . . 0.0 108.403 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.26 134.06 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.305 1.442 . . . . 0.0 110.657 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.1 133.5 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.438 1.095 . . . . 0.0 113.611 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.0 ptm -145.94 163.56 34.76 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 127.224 2.21 . . . . 0.0 112.11 -169.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -130.58 144.22 51.27 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.377 0.671 . . . . 0.0 110.06 172.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 362' ' ' GLU . 4.0 m -134.15 146.45 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.145 0.978 . . . . 0.0 111.461 -167.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -109.8 131.04 55.42 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.989 1.716 . . . . 0.0 111.078 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 14.3 t -108.43 143.32 27.24 Favored Pre-proline 0 N--CA 1.479 1.025 0 CA-C-O 116.973 -1.489 . . . . 0.0 108.156 163.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -101.13 -75.65 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.506 0 C-N-CA 122.259 1.972 . . . . 0.0 116.843 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 169.13 21.72 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 121.342 1.883 . . . . 0.0 114.771 -173.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 68.99 -5.41 4.74 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.542 1.544 . . . . 0.0 116.639 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -125.64 103.85 27.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 118.768 1.284 . . . . 0.0 112.67 -164.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -76.56 134.61 15.46 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.984 1.789 . . . . 0.0 109.055 160.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.3 p -158.23 155.15 28.45 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.371 -0.83 . . . . 0.0 112.918 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -77.84 136.98 38.16 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 159.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -58.62 117.28 19.42 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-N 118.783 0.719 . . . . 0.0 111.876 -171.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -97.03 102.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.925 3.083 . . . . 0.0 113.039 -167.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 2.5 p -129.5 139.13 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.446 1.099 . . . . 0.0 108.909 170.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 3.1 mt -136.96 143.84 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.631 1.173 . . . . 0.0 108.575 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 45.3 t -119.26 108.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.433 1.093 . . . . 0.0 108.187 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -124.36 161.33 26.15 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -162.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.81 -6.96 59.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.221 2.608 . . . . 0.0 112.361 168.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -139.8 149.73 43.87 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.129 1.772 . . . . 0.0 111.431 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 20.4 mt -64.48 -24.63 67.68 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.672 1.189 . . . . 0.0 113.371 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.4 t -96.07 4.74 52.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.877 1.271 . . . . 0.0 113.72 -172.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.2 75.08 0.1 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.225 3.01 . . . . 0.0 115.652 -171.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.94 -35.01 12.17 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.844 2.057 . . . . 0.0 111.786 164.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.91 153.26 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.747 1.219 . . . . 0.0 109.84 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.92 103.55 5.88 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.033 -1.042 . . . . 0.0 111.316 175.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -103.85 -13.22 16.48 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -174.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -102.52 -174.38 27.15 Favored Glycine 0 CA--C 1.536 1.403 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 13.3 mt -126.01 144.2 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 127.774 2.43 . . . . 0.0 110.913 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 353' ' ' ASN . 0.6 OUTLIER -77.32 130.35 37.04 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.527 1.131 . . . . 0.0 109.485 165.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -46.97 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 118.99 -0.529 . . . . 0.0 111.122 176.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 32.2 m -65.92 150.66 48.27 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 119.623 -0.831 . . . . 0.0 108.773 160.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 14.7 p -57.0 156.98 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.818 1.247 . . . . 0.0 111.951 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.412 ' HB2' HD13 ' A' ' 349' ' ' LEU . 23.2 t-20 -114.9 80.94 7.04 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.387 1.475 . . . . 0.0 111.185 -173.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -80.24 -172.99 1.68 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.143 2.562 . . . . 0.0 112.25 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 28.0 pt -93.5 176.41 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.713 1.605 . . . . 0.0 110.868 167.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.43 113.12 7.25 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 153.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.9 p -67.01 -32.18 73.24 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.801 1.64 . . . . 0.0 112.871 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.39 152.3 51.72 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 128.719 2.808 . . . . 0.0 108.159 168.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -63.17 -23.33 67.38 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.589 -1.32 . . . . 0.0 114.245 -173.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -86.26 4.79 37.32 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.935 1.294 . . . . 0.0 113.443 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.79 150.1 7.85 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -170.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 6.5 pt-20 -135.34 85.88 2.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.535 -1.212 . . . . 0.0 114.122 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 4.4 t -93.13 140.8 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.029 1.332 . . . . 0.0 111.501 -167.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -101.33 121.06 41.23 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 129.179 2.991 . . . . 0.0 109.064 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 1.8 mp -140.81 146.22 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.239 1.416 . . . . 0.0 110.713 -169.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -114.39 139.13 49.74 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.6 1.16 . . . . 0.0 112.608 166.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.94 159.18 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.132 1.773 . . . . 0.0 111.211 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -113.68 108.1 52.05 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.691 1.996 . . . . 0.0 109.453 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.36 150.67 25.58 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.314 2.009 . . . . 0.0 110.315 166.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -59.15 164.77 9.89 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 121.451 1.434 . . . . 0.0 111.244 163.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -65.57 140.86 58.57 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.711 -0.618 . . . . 0.0 110.473 167.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.49 -151.46 18.22 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.158 0.409 . . . . 0.0 112.427 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -74.46 161.11 30.12 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.447 1.117 . . . . 0.0 112.9 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 24.1 m -170.1 162.08 8.8 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.43 1.892 . . . . 0.0 111.264 166.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -128.61 127.45 42.28 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.446 1.898 . . . . 0.0 107.138 168.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 23.3 mm -95.15 118.14 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 4.4 mp -110.7 140.04 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.019 0.928 . . . . 0.0 110.503 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 97.2 t -106.36 122.9 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 126.06 1.744 . . . . 0.0 108.359 168.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 85.97 179.85 49.91 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 123.444 1.58 . . . . 0.0 116.335 168.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 72.0 m -138.76 171.69 13.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.974 1.31 . . . . 0.0 109.96 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 85.39 -154.68 28.86 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -171.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -26.32 64.57 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.748 0.819 . . . . 0.0 112.189 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 69.9 m -76.79 -6.43 52.26 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 129.127 2.971 . . . . 0.0 115.24 -164.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -75.24 124.58 27.31 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.752 0.421 . . . . 0.0 112.059 -167.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 8.0 mt -92.78 158.58 15.82 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.479 0.312 . . . . 0.0 110.422 174.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.1 t -131.42 154.24 48.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.434 1.094 . . . . 0.0 111.913 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -142.69 126.14 16.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.158 1.783 . . . . 0.0 109.553 171.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.89 127.29 31.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.361 1.464 . . . . 0.0 111.558 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -136.22 117.78 14.87 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.217 1.007 . . . . 0.0 110.953 170.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -119.0 119.97 35.85 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -97.44 132.93 42.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.009 1.724 . . . . 0.0 111.28 -165.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -63.06 161.72 12.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.871 1.668 . . . . 0.0 112.341 172.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -69.66 73.43 0.47 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.227 0.917 . . . . 0.0 111.753 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.36 122.9 18.92 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.903 1.681 . . . . 0.0 112.121 -170.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 79.2 p -58.63 -27.66 64.91 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -167.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 4.8 tt -71.74 -4.8 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.248 1.419 . . . . 0.0 113.377 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.18 -10.26 8.19 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.653 1.597 . . . . 0.0 116.144 165.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.74 2.016 . . . . 0.0 111.274 171.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 11.5 mmt . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 82.7 p -104.19 -2.37 25.83 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.1 -40.48 89.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.205 0.911 . . . . 0.0 113.124 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.7 tt -75.97 128.41 35.0 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 161.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 2.2 t -52.97 168.56 0.12 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.945 2.098 . . . . 0.0 116.036 -167.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -62.48 105.44 0.63 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.077 1.751 . . . . 0.0 110.628 -172.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.07 124.91 20.97 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.087 1.355 . . . . 0.0 111.226 -171.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 75.41 -51.6 2.57 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.998 1.285 . . . . 0.0 112.996 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.3 m -62.89 3.08 0.25 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 128.549 2.74 . . . . 0.0 114.149 174.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.6 m -156.48 149.47 24.05 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 118.996 -2.315 . . . . 0.0 112.658 174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -74.19 171.81 12.92 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.636 1.975 . . . . 0.0 113.557 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.09 163.19 28.09 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.354 1.462 . . . . 0.0 113.055 -177.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 58.0 mtt -93.82 164.12 13.25 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.138 1.775 . . . . 0.0 113.788 -168.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.8 m -76.23 139.38 41.15 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.315 0.646 . . . . 0.0 111.244 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 6.4 p -133.04 20.07 4.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.574 1.15 . . . . 0.0 113.036 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -82.46 164.68 20.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 158.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.02 95.64 0.12 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.39 1.476 . . . . 0.0 111.847 -175.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 32.7 mtp -80.36 171.79 14.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.665 1.186 . . . . 0.0 112.426 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 23.7 m -158.93 154.53 26.07 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.184 -0.947 . . . . 0.0 111.965 163.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.4 111.8 14.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.886 0.875 . . . . 0.0 109.744 163.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 20.1 t -66.99 -33.52 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.476 1.11 . . . . 0.0 109.868 166.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -129.45 126.68 39.28 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.859 1.664 . . . . 0.0 108.577 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -62.83 152.86 81.63 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.69 1.196 . . . . 0.0 112.164 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.43 124.63 13.62 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.733 2.289 . . . . 0.0 111.049 174.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 70.5 p -125.17 136.87 54.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.169 1.388 . . . . 0.0 110.692 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -57.47 127.04 30.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.238 1.015 . . . . 0.0 111.742 173.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 75.7 p -76.32 -22.31 55.12 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.53 1.532 . . . . 0.0 113.087 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 89.22 -11.37 69.79 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 126.057 1.789 . . . . 0.0 113.817 -163.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -86.01 2.43 46.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.486 1.515 . . . . 0.0 112.303 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 87.66 15.11 62.19 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.937 0.78 . . . . 0.0 112.86 -167.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.6 p -131.14 158.19 41.13 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.763 1.225 . . . . 0.0 111.345 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.16 132.05 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.226 1.41 . . . . 0.0 109.727 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.9 p -120.65 134.27 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.516 1.127 . . . . 0.0 113.35 -169.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 3.3 ptp -143.14 160.52 40.26 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.282 1.833 . . . . 0.0 113.174 -173.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -119.15 121.71 40.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.478 1.911 . . . . 0.0 107.806 173.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.78 141.88 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.366 1.066 . . . . 0.0 111.527 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -106.14 132.34 52.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.796 1.639 . . . . 0.0 112.278 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.4 t -103.38 147.18 33.79 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.726 1.61 . . . . 0.0 108.649 163.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -108.97 -72.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.255 2.636 . . . . 0.0 115.386 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.44 170.07 17.6 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.241 -1.537 . . . . 0.0 114.202 -171.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 64.57 -23.32 0.1 OUTLIER Glycine 0 CA--C 1.538 1.509 0 C-N-CA 127.633 2.539 . . . . 0.0 117.77 168.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -107.52 97.45 19.71 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.501 1.52 . . . . 0.0 112.05 -170.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.29 131.23 25.99 Favored 'Trans proline' 0 C--N 1.35 0.631 0 N-CA-C 108.005 -1.575 . . . . 0.0 108.005 157.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.6 p -160.9 157.3 26.32 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -72.23 137.76 47.05 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.343 1.457 . . . . 0.0 108.989 159.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.37 119.08 56.56 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 118.69 0.677 . . . . 0.0 112.196 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -97.38 87.41 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.049 3.166 . . . . 0.0 113.833 -166.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 97.1 t -113.49 131.72 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 164.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.23 153.47 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.484 1.114 . . . . 0.0 110.152 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.46 109.41 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.188 1.795 . . . . 0.0 107.129 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -119.66 164.67 15.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -161.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -89.49 -6.75 56.16 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.824 2.05 . . . . 0.0 112.668 165.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -133.79 144.41 49.0 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.054 1.342 . . . . 0.0 110.677 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.55 -11.75 26.98 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 12.8 t -113.02 12.03 19.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.964 1.706 . . . . 0.0 113.188 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 39.85 60.11 1.75 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 128.53 2.732 . . . . 0.0 116.152 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -73.67 -30.85 63.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.267 0.627 . . . . 0.0 111.927 155.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 38.0 mt -110.6 155.98 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.126 1.771 . . . . 0.0 109.254 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.45 102.0 6.94 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.312 1.045 . . . . 0.0 110.808 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -77.96 -56.39 4.53 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 129.732 3.213 . . . . 0.0 111.423 -177.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -92.35 -167.64 39.77 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 116.593 1.397 . . . . 0.0 116.593 -166.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.5 mt -116.51 135.48 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.242 1.817 . . . . 0.0 110.546 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.3 mt -72.04 122.29 20.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.615 0.766 . . . . 0.0 109.372 165.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 98.4 t -103.02 -52.62 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.177 0.991 . . . . 0.0 110.235 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 50.4 m -67.02 155.23 39.19 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.198 0.523 . . . . 0.0 110.102 164.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 11.3 m -58.1 159.32 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.151 0.98 . . . . 0.0 112.468 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -118.6 85.02 25.86 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.638 1.175 . . . . 0.0 110.125 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -80.48 -165.16 0.32 Allowed 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 124.502 3.468 . . . . 0.0 113.232 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 31.5 pt -105.04 165.99 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 126.688 1.995 . . . . 0.0 111.218 172.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.66 102.48 1.2 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 155.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 82.8 p -70.61 -35.77 73.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.305 1.442 . . . . 0.0 112.208 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.5 157.62 33.15 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.815 2.046 . . . . 0.0 109.491 158.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -66.68 -23.46 66.14 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -89.75 7.69 35.56 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.03 0.832 . . . . 0.0 112.648 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -56.61 153.07 10.9 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.878 1.323 . . . . 0.0 112.973 -176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -144.67 123.33 12.54 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.907 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.61 145.95 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.702 0.801 . . . . 0.0 110.254 -159.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.4 tp -95.97 126.58 41.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.443 2.297 . . . . 0.0 109.405 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.3 mp -139.28 132.13 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.492 1.117 . . . . 0.0 109.483 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -109.81 147.98 32.31 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.96 0.886 . . . . 0.0 112.106 159.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.38 160.86 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.733 1.613 . . . . 0.0 110.702 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -115.32 109.12 46.69 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.94 1.696 . . . . 0.0 111.092 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.74 148.9 20.43 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.932 2.421 . . . . 0.0 111.549 162.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -73.15 172.18 16.07 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.772 2.315 . . . . 0.0 111.103 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -57.34 147.84 24.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.239 0.615 . . . . 0.0 111.668 171.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.35 -136.08 12.52 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.15 162.36 14.36 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.03 1.332 . . . . 0.0 112.736 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 38.5 m -162.18 162.98 28.62 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.777 -1.202 . . . . 0.0 110.716 157.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -124.84 117.89 25.13 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 21.5 mm -91.03 111.25 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.857 1.263 . . . . 0.0 107.941 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.48 142.57 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.704 0.802 . . . . 0.0 109.547 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 97.8 t -123.29 108.34 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.335 1.854 . . . . 0.0 108.765 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 108.83 175.88 21.61 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.979 1.276 . . . . 0.0 114.36 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 56.4 m -133.86 162.12 32.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.284 1.434 . . . . 0.0 109.759 169.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 72.5 -171.53 49.39 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 121.601 0.556 . . . . 0.0 112.668 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.33 -27.5 23.71 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.222 1.409 . . . . 0.0 113.956 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.0 m -74.86 -3.91 34.74 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.761 2.424 . . . . 0.0 114.833 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -79.55 125.86 30.13 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.078 0.853 . . . . 0.0 112.618 -174.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 24.6 mt -89.84 163.86 14.85 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.212 0.605 . . . . 0.0 110.827 172.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.6 t -144.13 148.31 34.89 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.262 1.025 . . . . 0.0 111.829 -171.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -147.75 110.05 4.6 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.325 1.45 . . . . 0.0 110.119 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.2 133.61 56.26 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.913 0.885 . . . . 0.0 111.212 173.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -125.3 160.8 28.42 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.285 1.034 . . . . 0.0 111.298 163.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -129.59 146.25 51.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.225 1.41 . . . . 0.0 108.771 171.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.63 136.73 49.13 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.886 1.274 . . . . 0.0 109.696 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.5 163.03 21.72 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 129.23 3.012 . . . . 0.0 110.385 -169.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -73.66 41.09 0.98 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.902 1.239 . . . . 0.0 114.434 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.39 -63.68 0.37 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.518 1.527 . . . . 0.0 112.576 -169.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 4.8 m -81.19 65.39 6.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.022 1.329 . . . . 0.0 110.342 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 14.2 tt -134.57 1.91 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 127.861 2.464 . . . . 0.0 112.636 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -154.02 29.16 0.73 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.609 1.1 . . . . 0.0 114.696 -172.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.877 0 C-N-CA 125.948 1.699 . . . . 0.0 109.151 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 9.5 m -109.43 0.86 19.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.323 1.449 . . . . 0.0 113.99 -167.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -68.64 -48.97 62.66 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.235 0.925 . . . . 0.0 111.031 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.68 131.43 46.31 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 167.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.6 t -62.58 176.66 0.62 Allowed 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -164.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.427 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.7 mm? -64.7 97.39 0.21 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.933 1.693 . . . . 0.0 112.332 -167.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.516 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 0.8 OUTLIER -47.48 125.7 8.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 128.052 2.541 . . . . 0.0 111.794 -178.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 60.35 10.17 15.22 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.559 1.076 . . . . 0.0 115.283 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 13.5 m -139.76 17.0 2.51 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.657 1.583 . . . . 0.0 109.809 -159.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 2.3 m -171.15 159.07 5.77 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.267 -1.521 . . . . 0.0 112.368 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -86.74 174.66 8.68 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.446 1.099 . . . . 0.0 112.735 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -63.17 159.3 17.85 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -164.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 62.1 mtm -79.22 151.74 31.04 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.914 2.086 . . . . 0.0 110.382 164.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.7 m -70.51 145.49 50.85 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.989 -0.445 . . . . 0.0 111.794 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.1 p -134.3 24.32 3.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.929 1.292 . . . . 0.0 112.634 177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -94.59 169.45 10.17 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 160.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -69.62 90.96 0.58 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.195 2.198 . . . . 0.0 111.956 -163.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 37.7 mtp -80.58 170.63 16.08 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.961 0.886 . . . . 0.0 113.348 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 36.5 m -159.44 161.22 35.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.057 0.943 . . . . 0.0 112.018 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -77.49 120.2 22.14 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.772 0.829 . . . . 0.0 109.641 168.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.64 -34.32 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.216 1.006 . . . . 0.0 110.116 163.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -136.46 132.68 35.7 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.173 1.389 . . . . 0.0 110.007 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -69.32 145.89 96.17 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.526 1.53 . . . . 0.0 112.15 171.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.0 136.62 57.66 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.864 2.376 . . . . 0.0 112.636 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 71.4 p -141.61 131.6 24.57 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.152 1.781 . . . . 0.0 110.411 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -60.49 131.76 51.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.777 0.831 . . . . 0.0 112.387 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 71.0 p -66.13 -21.23 66.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.556 1.942 . . . . 0.0 112.717 168.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 98.31 -16.79 59.48 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.909 1.718 . . . . 0.0 112.397 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -74.08 -18.15 60.86 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.419 1.11 . . . . 0.0 111.76 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 97.55 32.88 6.1 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.569 1.081 . . . . 0.0 111.751 -166.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.8 p -136.85 129.43 30.28 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.905 1.282 . . . . 0.0 108.39 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 21.8 m -106.9 123.06 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.434 0.694 . . . . 0.0 110.068 -173.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.35 129.42 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.072 0.949 . . . . 0.0 111.816 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 19.9 ptm -149.49 163.04 38.9 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.487 1.915 . . . . 0.0 111.756 -169.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -136.74 136.58 39.08 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.442 0.697 . . . . 0.0 110.153 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.96 127.66 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.999 0.92 . . . . 0.0 112.874 -164.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -92.94 125.7 37.67 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.573 1.549 . . . . 0.0 112.02 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.1 t -96.56 145.27 29.28 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 117.393 -1.289 . . . . 0.0 107.626 158.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -104.27 -65.88 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 123.056 2.504 . . . . 0.0 115.321 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 175.85 10.32 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.344 -1.472 . . . . 0.0 112.142 -174.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 62.69 -13.19 0.09 OUTLIER Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.509 2.481 . . . . 0.0 118.129 167.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.89 93.93 22.77 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 119.147 1.474 . . . . 0.0 113.03 -167.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.3 112.15 3.26 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.402 2.068 . . . . 0.0 108.756 156.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.5 p -154.35 159.67 41.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.15 0.98 . . . . 0.0 111.923 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 355' ' ' ILE . 20.6 mtpp -76.83 144.13 39.28 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.214 1.006 . . . . 0.0 109.877 158.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.45 111.46 4.08 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.242 1.017 . . . . 0.0 111.97 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -94.54 89.06 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.952 3.101 . . . . 0.0 112.999 -162.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 38.4 t -118.86 127.8 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.98 150.06 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.446 1.098 . . . . 0.0 109.397 -177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 64.4 t -128.77 105.03 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -117.6 161.24 19.95 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -158.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.62 -14.62 58.68 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.08 2.152 . . . . 0.0 112.783 164.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -134.38 148.23 50.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.612 1.165 . . . . 0.0 112.258 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 16.4 mt -61.96 -19.74 63.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.137 1.375 . . . . 0.0 114.468 -173.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.8 t -104.29 5.83 34.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.606 1.962 . . . . 0.0 113.262 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.48 69.08 0.43 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 129.016 2.926 . . . . 0.0 116.434 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -81.32 -45.42 16.2 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.365 1.466 . . . . 0.0 112.064 157.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.42 113.73 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.976 1.311 . . . . 0.0 110.338 -172.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.13 107.39 15.67 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.445 0.698 . . . . 0.0 112.331 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 373' ' ' ASP . 12.2 ttpt -72.86 -43.91 62.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.393 2.677 . . . . 0.0 112.955 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -100.28 -165.5 28.7 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.465 1.346 . . . . 0.0 116.465 -165.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.94 148.14 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.182 2.193 . . . . 0.0 110.0 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.32 134.51 34.51 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.464 -0.772 . . . . 0.0 109.666 170.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 81.9 t -98.29 -46.64 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.904 0.882 . . . . 0.0 109.588 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.8 m -71.38 154.9 41.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.396 0.617 . . . . 0.0 110.211 164.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.46 161.56 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 125.211 1.404 . . . . 0.0 110.541 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -114.17 69.28 1.82 Allowed Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 124.667 1.187 . . . . 0.0 112.763 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.05 -171.36 1.05 Allowed 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 124.412 3.408 . . . . 0.0 113.123 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 331' ' ' LYS . 44.5 pt -93.17 165.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.58 1.552 . . . . 0.0 113.359 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -66.21 105.98 1.55 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.054 0.942 . . . . 0.0 109.206 158.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 83.9 p -70.31 -40.18 74.35 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.173 1.389 . . . . 0.0 111.803 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.24 151.45 34.47 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.33 1.852 . . . . 0.0 108.887 155.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -61.63 -15.7 41.86 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 175.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.76 8.67 44.3 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.232 1.413 . . . . 0.0 112.633 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -58.98 148.15 31.72 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.266 -1.521 . . . . 0.0 113.621 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -129.94 79.43 1.9 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.072 1.349 . . . . 0.0 112.129 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 40.5 t -84.39 143.21 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.45 1.1 . . . . 0.0 111.124 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.5 130.07 42.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.536 2.734 . . . . 0.0 109.787 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.1 133.8 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.117 1.767 . . . . 0.0 110.407 -173.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -91.01 138.23 31.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.18 0.992 . . . . 0.0 110.722 154.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.79 160.56 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.096 0.958 . . . . 0.0 111.333 169.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -121.75 105.32 38.29 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.815 1.646 . . . . 0.0 110.076 -173.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.68 154.8 35.01 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.234 1.956 . . . . 0.0 110.363 159.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.79 171.58 16.22 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.17 1.913 . . . . 0.0 111.155 166.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -65.24 122.97 18.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.834 1.254 . . . . 0.0 109.343 168.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 126.73 -148.14 17.13 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.319 0.961 . . . . 0.0 111.166 -163.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . 0.407 ' O ' ' HE3' ' A' ' 346' ' ' LYS . 8.7 p-10 -94.47 168.82 10.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.828 1.251 . . . . 0.0 112.054 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 33.6 m -168.46 165.24 12.62 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.536 1.934 . . . . 0.0 110.828 159.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -124.63 117.0 23.3 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 10.0 mm -90.95 110.92 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.61 143.39 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.948 0.899 . . . . 0.0 110.184 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.6 115.23 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 126.71 2.004 . . . . 0.0 108.684 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 95.82 176.88 36.73 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.32 0.962 . . . . 0.0 114.521 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 47.4 m -136.19 165.06 26.61 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.811 1.644 . . . . 0.0 109.891 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 71.37 -171.27 46.81 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 121.642 -0.662 . . . . 0.0 112.196 -167.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.47 -26.41 53.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.213 1.005 . . . . 0.0 113.539 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.4 m -74.25 9.9 1.47 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.681 2.792 . . . . 0.0 115.222 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -96.05 144.24 26.49 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.4 1.08 . . . . 0.0 112.986 -174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 25.9 mt -112.25 165.31 12.28 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.579 1.152 . . . . 0.0 111.384 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 2.3 t -139.11 147.01 41.39 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.949 1.299 . . . . 0.0 111.815 -170.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -146.78 112.59 5.7 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.759 1.624 . . . . 0.0 110.388 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 134.56 54.93 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.128 -0.983 . . . . 0.0 112.367 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -128.82 149.12 50.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.891 0.876 . . . . 0.0 111.892 165.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -133.5 140.72 47.41 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.128 1.371 . . . . 0.0 107.839 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -135.22 122.01 21.0 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.481 1.112 . . . . 0.0 111.052 -170.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -73.45 164.26 26.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.339 1.055 . . . . 0.0 112.21 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -65.81 16.83 0.2 Allowed Glycine 0 CA--C 1.54 1.606 0 N-CA-C 118.881 2.312 . . . . 0.0 118.881 -163.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 4.8 m -72.25 65.08 0.59 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.415 2.286 . . . . 0.0 112.539 -170.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.2 p -83.96 -4.13 58.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 130.094 3.358 . . . . 0.0 114.055 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 15.2 tt -149.44 168.18 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.9 1.68 . . . . 0.0 109.361 175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 81.35 -9.98 51.88 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.913 1.244 . . . . 0.0 115.203 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.432 0 C-N-CA 129.09 2.956 . . . . 0.0 109.42 173.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.7 m -104.81 -4.58 22.12 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.138 0.975 . . . . 0.0 113.003 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -69.54 -9.09 52.48 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 171.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.9 tp -101.79 132.18 47.69 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 159.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.9 t -57.98 174.45 0.26 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.386 1.474 . . . . 0.0 114.252 -172.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.518 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.4 mm? -65.06 95.66 0.17 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.772 1.629 . . . . 0.0 110.997 -169.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.529 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 6.9 mptt -51.89 121.02 5.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.853 2.461 . . . . 0.0 111.057 -173.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 67.25 -25.22 0.2 Allowed Glycine 0 CA--C 1.54 1.635 0 C-N-CA 126.439 1.971 . . . . 0.0 115.599 -173.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 44.8 m -87.11 7.99 25.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 129.648 3.179 . . . . 0.0 111.555 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 7.5 m -160.2 155.31 24.75 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 119.311 -2.118 . . . . 0.0 111.587 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -76.09 172.95 11.93 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.067 1.347 . . . . 0.0 112.868 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -63.47 156.17 27.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.192 0.996 . . . . 0.0 113.642 -173.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 37.8 mtt -84.82 151.94 23.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.713 1.605 . . . . 0.0 111.364 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.9 m -67.7 139.87 56.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.207 0.603 . . . . 0.0 111.94 -173.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.3 p -131.75 16.92 4.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.862 1.265 . . . . 0.0 113.196 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.69 169.32 17.13 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 159.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.5 98.68 1.15 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.633 1.173 . . . . 0.0 112.076 -167.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 22.4 mtp -87.12 172.3 10.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.668 1.187 . . . . 0.0 113.579 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 36.8 m -160.74 170.4 20.83 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.794 1.238 . . . . 0.0 111.286 162.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.64 131.47 35.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.088 0.955 . . . . 0.0 109.324 162.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.1 -37.97 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.877 0.871 . . . . 0.0 109.797 162.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -130.97 126.78 36.91 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.723 1.609 . . . . 0.0 108.409 173.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -60.73 149.98 77.67 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.355 0.662 . . . . 0.0 111.678 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.56 132.59 43.98 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.026 1.817 . . . . 0.0 110.587 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 40.2 p -127.49 129.56 47.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.791 1.636 . . . . 0.0 108.805 172.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.89 136.07 57.89 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.555 0.693 . . . . 0.0 111.441 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.8 p -93.78 -15.15 25.43 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.251 1.421 . . . . 0.0 113.613 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 71.64 -6.66 8.26 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-O 118.447 -1.196 . . . . 0.0 114.66 -161.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -70.67 -10.21 58.86 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 120.32 2.06 . . . . 0.0 112.112 170.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 91.6 17.51 48.78 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.465 1.031 . . . . 0.0 112.912 -160.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.9 p -134.33 168.47 18.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.267 1.427 . . . . 0.0 111.283 -171.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 19.2 m -121.42 138.93 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.064 1.346 . . . . 0.0 109.292 166.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.5 p -114.36 130.07 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.698 1.199 . . . . 0.0 111.63 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.8 ptm -145.69 167.3 23.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.699 1.599 . . . . 0.0 112.797 -171.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -133.72 136.42 44.63 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.212 1.005 . . . . 0.0 109.684 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 21.3 m -116.54 168.25 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.799 1.24 . . . . 0.0 111.848 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -131.39 127.75 38.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.991 1.317 . . . . 0.0 112.053 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.07 146.77 32.5 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.149 1.38 . . . . 0.0 108.224 161.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -107.27 -62.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.163 2.575 . . . . 0.0 115.224 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.26 -174.27 4.88 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.383 1.473 . . . . 0.0 111.988 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 74.35 -36.81 0.97 Allowed Glycine 0 CA--C 1.533 1.202 0 C-N-CA 126.593 2.044 . . . . 0.0 116.605 162.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.65 103.86 43.11 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.514 1.126 . . . . 0.0 111.963 -169.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -64.88 128.88 21.82 Favored 'Trans proline' 0 C--N 1.35 0.61 0 N-CA-C 107.851 -1.634 . . . . 0.0 107.851 154.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.0 p -157.57 157.75 34.31 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 8.7 tptm -75.24 135.7 40.98 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.404 1.481 . . . . 0.0 109.094 164.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.5 119.99 58.51 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -168.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -100.38 81.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.61 2.873 . . . . 0.0 114.159 -164.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 95.1 t -107.5 128.11 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 162.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.68 152.75 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 124.873 1.269 . . . . 0.0 109.666 176.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.97 115.16 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.307 1.843 . . . . 0.0 106.837 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -127.51 160.25 32.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -161.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -88.27 -15.12 36.66 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.702 1.601 . . . . 0.0 112.612 171.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -122.21 153.75 38.41 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.683 1.593 . . . . 0.0 110.723 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.16 -14.16 34.55 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 11.5 t -123.93 14.34 9.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.581 1.552 . . . . 0.0 113.415 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 44.56 59.23 3.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.001 2.52 . . . . 0.0 115.917 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -78.09 -32.74 50.78 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.256 0.622 . . . . 0.0 112.182 156.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 45.4 mm -116.07 112.16 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.323 1.849 . . . . 0.0 109.973 -175.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -86.59 103.86 15.48 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.898 0.856 . . . . 0.0 111.846 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -88.2 -19.68 26.56 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.967 2.907 . . . . 0.0 114.439 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -118.59 -165.42 13.28 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 115.901 1.121 . . . . 0.0 115.901 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.2 mt -126.79 139.41 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 127.454 2.302 . . . . 0.0 110.366 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.15 129.65 37.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.848 1.259 . . . . 0.0 110.114 165.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 53.5 t -107.05 -50.92 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.711 0.804 . . . . 0.0 110.564 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 87.6 m -68.43 154.06 42.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.319 0.58 . . . . 0.0 109.641 163.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.9 m -54.43 154.66 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.702 1.201 . . . . 0.0 112.482 175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -118.92 81.11 18.87 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.439 1.096 . . . . 0.0 110.547 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -82.96 -166.47 0.39 Allowed 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 125.08 3.853 . . . . 0.0 112.846 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 39.1 pt -89.21 168.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.203 1.401 . . . . 0.0 111.511 164.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.31 120.34 13.66 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 158.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 85.9 p -73.12 -17.16 61.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.847 1.259 . . . . 0.0 113.838 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 97.5 m -144.06 157.51 44.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.748 2.419 . . . . 0.0 106.73 171.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -58.97 -21.48 58.71 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.861 -1.15 . . . . 0.0 113.914 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.79 15.32 29.0 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.689 1.996 . . . . 0.0 112.773 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -61.07 158.52 13.45 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 119.998 -1.689 . . . . 0.0 113.862 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -145.4 75.11 1.42 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.279 1.432 . . . . 0.0 113.861 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.5 149.52 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.509 1.524 . . . . 0.0 112.439 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.61 129.49 46.54 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 129.931 3.292 . . . . 0.0 109.301 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.87 134.41 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.281 1.432 . . . . 0.0 111.631 -172.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -90.67 136.95 32.73 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.001 1.321 . . . . 0.0 111.869 154.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.74 159.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.884 1.274 . . . . 0.0 111.477 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -119.81 114.88 33.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.18 1.792 . . . . 0.0 111.128 -172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.3 159.97 13.09 Favored 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 123.665 2.91 . . . . 0.0 112.203 162.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.27 175.73 10.56 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.476 2.784 . . . . 0.0 111.026 163.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -63.4 145.62 55.22 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.57 -0.706 . . . . 0.0 111.332 169.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 106.76 -145.08 15.91 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.895 0.759 . . . . 0.0 111.47 -171.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -91.32 164.55 13.82 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.268 1.427 . . . . 0.0 112.255 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.2 m -161.54 158.88 27.08 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.326 -1.484 . . . . 0.0 111.212 158.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -116.03 116.1 27.29 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.88 111.91 22.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 124.952 1.301 . . . . 0.0 108.101 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.51 142.9 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.66 0.784 . . . . 0.0 109.727 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 94.3 t -116.92 110.22 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.963 1.705 . . . . 0.0 108.994 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 104.77 -179.39 24.25 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.187 0.898 . . . . 0.0 115.162 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 28.7 m -132.56 163.44 28.86 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.114 1.766 . . . . 0.0 109.388 171.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.33 -171.96 52.45 Favored Glycine 0 CA--C 1.535 1.298 0 O-C-N 121.559 -0.713 . . . . 0.0 112.925 -172.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.26 -29.64 34.01 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.266 1.426 . . . . 0.0 113.697 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.6 m -73.36 -2.39 22.01 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.066 2.547 . . . . 0.0 114.801 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -81.66 115.4 20.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.09 0.859 . . . . 0.0 112.999 -172.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -81.63 162.91 22.89 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.879 -0.513 . . . . 0.0 111.277 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.5 t -140.4 147.54 39.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.768 1.227 . . . . 0.0 112.053 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -147.13 120.57 9.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.564 1.546 . . . . 0.0 111.119 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.6 130.17 39.07 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.794 1.238 . . . . 0.0 112.529 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -127.24 164.82 20.87 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.594 1.158 . . . . 0.0 112.224 164.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -133.26 150.51 51.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.41 1.884 . . . . 0.0 108.667 171.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -134.89 116.31 14.61 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.676 1.991 . . . . 0.0 109.498 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -60.35 146.31 44.66 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.536 1.934 . . . . 0.0 113.457 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -104.94 148.11 16.47 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.752 1.168 . . . . 0.0 112.909 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 8.9 m -70.06 17.35 0.06 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.791 2.436 . . . . 0.0 117.092 -161.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 40.8 m -61.5 -20.69 63.48 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.137 0.575 . . . . 0.0 111.775 158.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.4 tp -149.45 156.65 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 126.597 1.959 . . . . 0.0 109.49 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 78.08 -81.27 1.31 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.347 0.975 . . . . 0.0 114.498 169.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.393 0 C-N-CA 124.998 1.319 . . . . 0.0 113.594 -169.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 99.0 mmm . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.6 m -90.57 -7.38 52.99 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -166.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.7 -25.81 66.71 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 57.9 tp -83.1 126.39 32.54 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.081 1.31 . . . . 0.0 108.065 159.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.4 t -55.05 167.07 0.44 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.782 1.233 . . . . 0.0 113.768 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.569 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.0 mm? -57.28 107.21 0.4 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.806 2.042 . . . . 0.0 111.263 -164.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -58.19 115.87 3.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.499 1.92 . . . . 0.0 110.686 -166.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 68.62 -7.91 2.59 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.449 1.499 . . . . 0.0 115.476 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 96.9 m -101.88 6.65 41.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.367 2.667 . . . . 0.0 110.626 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.3 m -154.32 151.26 28.88 Favored 'General case' 0 C--O 1.23 0.06 0 O-C-N 119.337 -2.102 . . . . 0.0 112.387 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -71.57 170.83 12.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.125 2.17 . . . . 0.0 112.864 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.64 153.42 36.07 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 39.6 mtt -91.05 151.58 20.98 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.893 1.677 . . . . 0.0 111.283 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.88 141.64 55.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.42 0.688 . . . . 0.0 112.621 -170.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.7 p -133.25 17.74 4.06 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -74.57 164.75 26.22 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.543 -0.723 . . . . 0.0 109.193 155.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.59 89.2 0.52 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.989 1.315 . . . . 0.0 111.913 -173.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 68.9 mtp -73.17 173.05 9.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.878 1.671 . . . . 0.0 113.693 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 34.7 m -157.37 163.46 38.58 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.203 -0.936 . . . . 0.0 111.855 162.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.42 125.93 29.99 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 164.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 3.6 t -76.61 -29.99 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 122.961 0.505 . . . . 0.0 109.779 162.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -135.6 126.48 27.55 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.048 1.739 . . . . 0.0 108.667 167.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -59.72 151.01 64.86 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.559 1.143 . . . . 0.0 111.87 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.67 132.42 35.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.05 1.834 . . . . 0.0 110.845 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 2.6 m -133.33 141.86 48.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.916 1.286 . . . . 0.0 109.933 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.19 136.82 58.1 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.309 0.644 . . . . 0.0 112.181 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 70.4 p -91.12 -8.02 49.97 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.977 1.311 . . . . 0.0 114.218 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.434 ' HA2' ' HE2' ' A' ' 398' ' ' LYS . . . 69.15 4.94 45.63 Favored Glycine 0 CA--C 1.538 1.503 0 CA-C-O 118.802 -0.999 . . . . 0.0 114.909 -163.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -111.34 13.3 21.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.05 1.425 . . . . 0.0 112.316 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.59 14.15 71.31 Favored Glycine 0 CA--C 1.536 1.371 0 O-C-N 121.374 -0.829 . . . . 0.0 113.651 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 39.5 p -135.17 164.61 27.3 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.273 1.429 . . . . 0.0 111.296 -171.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 4.4 m -128.14 135.79 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.527 1.531 . . . . 0.0 110.061 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.44 129.76 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.886 1.275 . . . . 0.0 113.704 -167.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -143.52 164.98 28.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.462 1.505 . . . . 0.0 114.32 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -122.35 125.49 46.04 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.542 2.337 . . . . 0.0 107.65 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.97 138.55 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.018 0.927 . . . . 0.0 111.707 -167.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -111.66 129.13 56.19 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.614 1.165 . . . . 0.0 113.135 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.44 142.73 25.19 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.416 1.486 . . . . 0.0 108.607 165.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -100.45 -72.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.907 2.404 . . . . 0.0 115.714 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 168.15 20.47 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 120.429 -1.42 . . . . 0.0 113.934 -173.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 65.84 -12.46 0.37 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.833 2.158 . . . . 0.0 117.879 171.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -117.22 98.63 52.15 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 119.422 1.611 . . . . 0.0 113.621 -163.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -68.44 133.85 29.26 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 148.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -161.76 156.82 23.34 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.851 0.86 . . . . 0.0 111.058 -176.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -70.38 135.4 48.74 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.497 1.119 . . . . 0.0 108.292 162.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.9 pp -60.85 118.41 34.9 Favored Pre-proline 0 CA--C 1.554 1.124 0 CA-C-N 118.252 0.478 . . . . 0.0 111.732 -170.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -94.84 86.75 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.597 2.865 . . . . 0.0 114.034 -159.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 37.1 t -121.73 128.4 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.418 1.487 . . . . 0.0 109.119 177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.24 161.81 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.722 1.209 . . . . 0.0 111.988 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 55.2 t -138.93 118.51 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.406 2.283 . . . . 0.0 107.946 173.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.44 168.4 16.38 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -164.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -85.43 -8.83 58.19 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.708 2.003 . . . . 0.0 113.294 163.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -131.46 153.01 50.2 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.834 1.253 . . . . 0.0 110.899 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 23.9 mt -61.24 -26.06 67.49 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -173.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 14.4 t -108.36 10.4 27.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.743 1.617 . . . . 0.0 113.456 -169.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 44.12 67.71 0.64 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.736 2.414 . . . . 0.0 115.53 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -82.51 -38.31 24.02 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.368 1.067 . . . . 0.0 111.714 156.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.13 158.66 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 125.456 1.502 . . . . 0.0 109.663 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -125.45 97.79 5.34 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.576 1.15 . . . . 0.0 110.97 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -92.24 -26.6 18.1 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.328 2.251 . . . . 0.0 113.816 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -110.7 -170.74 19.53 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 29.8 mt -125.02 134.57 66.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 127.225 2.21 . . . . 0.0 110.078 -175.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 14.1 mt -68.69 122.73 19.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.357 1.063 . . . . 0.0 109.815 164.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 77.7 t -95.7 -49.82 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.593 0.757 . . . . 0.0 109.861 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 18.9 m -76.76 157.0 31.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.416 0.627 . . . . 0.0 110.695 171.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 18.1 m -57.9 156.17 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.428 1.491 . . . . 0.0 113.066 177.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -122.41 79.57 45.86 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.963 1.305 . . . . 0.0 111.292 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -79.18 -166.23 0.4 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 124.68 3.587 . . . . 0.0 113.106 171.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 39.9 pt -100.67 164.12 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.069 1.748 . . . . 0.0 111.503 168.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -62.93 113.78 3.27 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.329 1.051 . . . . 0.0 109.534 159.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 93.6 p -66.85 -33.4 75.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.159 1.384 . . . . 0.0 112.596 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 2.6 m -143.42 153.54 42.77 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.029 2.532 . . . . 0.0 106.467 -174.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.57 -23.05 66.8 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.411 -1.43 . . . . 0.0 114.649 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -86.8 8.87 20.94 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.402 1.481 . . . . 0.0 113.355 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.64 154.3 9.08 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.561 -1.337 . . . . 0.0 114.306 -169.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -154.22 114.84 3.97 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.536 -1.211 . . . . 0.0 113.242 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.83 155.37 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.247 1.019 . . . . 0.0 109.441 -170.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -101.1 120.07 39.67 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.806 2.443 . . . . 0.0 108.169 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.71 129.11 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.895 0.878 . . . . 0.0 111.151 -171.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -89.51 140.56 29.41 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.725 1.21 . . . . 0.0 111.926 158.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.84 151.19 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.383 1.473 . . . . 0.0 110.53 170.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -117.08 113.33 39.46 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.03 1.732 . . . . 0.0 110.067 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -80.31 160.84 22.97 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.848 2.365 . . . . 0.0 111.295 162.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.5 171.08 17.85 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.403 2.069 . . . . 0.0 110.272 161.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -62.22 142.01 57.91 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.695 -0.628 . . . . 0.0 111.182 171.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 103.68 -145.5 16.17 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.902 0.763 . . . . 0.0 112.095 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -83.11 162.49 21.3 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.734 1.213 . . . . 0.0 113.08 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 14.3 m -165.81 160.17 16.78 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.812 1.245 . . . . 0.0 111.717 161.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -121.09 118.19 29.11 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 172.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 13.9 mm -92.96 122.08 44.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 125.269 1.428 . . . . 0.0 107.852 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.02 142.35 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.512 0.725 . . . . 0.0 110.631 -174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.69 110.97 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 127.28 2.232 . . . . 0.0 108.81 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.9 -178.26 22.9 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.596 1.093 . . . . 0.0 114.587 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.4 m -135.71 167.09 21.78 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.853 2.061 . . . . 0.0 110.146 170.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 79.52 -167.25 51.72 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.568 -0.707 . . . . 0.0 112.683 -173.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -25.93 66.37 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.856 -0.79 . . . . 0.0 112.6 169.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.3 m -74.44 -2.74 26.81 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 129.008 2.923 . . . . 0.0 115.163 -172.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -84.68 130.54 34.69 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.625 0.77 . . . . 0.0 111.876 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 13.7 mt -94.22 156.09 16.72 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.745 0.418 . . . . 0.0 110.37 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.6 t -138.4 148.27 44.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.038 0.935 . . . . 0.0 111.921 -170.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -145.32 118.96 9.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.386 1.474 . . . . 0.0 110.012 -176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -71.28 128.04 34.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.462 0.705 . . . . 0.0 110.808 176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -127.05 152.57 47.09 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.077 0.951 . . . . 0.0 110.662 170.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.19 141.79 51.79 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.626 1.17 . . . . 0.0 108.592 175.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -125.23 126.79 45.73 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.087 1.355 . . . . 0.0 109.976 -174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -56.56 166.48 0.9 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.106 2.562 . . . . 0.0 112.552 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -75.73 72.61 1.76 Allowed Glycine 0 CA--C 1.529 0.933 0 O-C-N 121.391 -0.818 . . . . 0.0 111.55 174.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 37.2 m -54.44 2.58 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 117.433 2.382 . . . . 0.0 117.433 -170.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 28.7 t -62.73 -10.58 13.21 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.605 -1.309 . . . . 0.0 113.627 159.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 6.2 tp -104.05 5.94 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.395 1.478 . . . . 0.0 112.281 165.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 96.33 173.1 35.45 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 126.286 1.898 . . . . 0.0 113.836 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.434 ' HE2' ' HA2' ' A' ' 314' ' ' GLY . 0.5 OUTLIER . . . . . 0 C--O 1.257 1.487 0 C-N-CA 129.689 3.196 . . . . 0.0 118.054 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 10.2 mmt . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 90.1 p -118.96 -0.98 11.06 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -172.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.43 -53.92 47.69 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.226 0.921 . . . . 0.0 113.032 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.32 122.9 16.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 171.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.5 t -47.17 158.2 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.699 2.0 . . . . 0.0 116.353 -167.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.3 mm? -61.37 119.58 8.8 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.074 1.75 . . . . 0.0 111.51 -164.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 2.4 mptp? -65.44 115.2 5.44 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.195 1.398 . . . . 0.0 110.557 -172.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 76.79 -48.07 2.6 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.983 1.278 . . . . 0.0 112.902 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 46.3 m -63.25 -1.53 1.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.386 2.274 . . . . 0.0 113.245 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 20.0 m -155.33 156.76 36.06 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 119.149 -2.22 . . . . 0.0 112.143 170.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -84.44 164.28 18.96 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.411 1.084 . . . . 0.0 113.513 -169.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 151.04 46.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.952 1.301 . . . . 0.0 113.214 -175.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 77.7 mtm -68.31 167.65 14.06 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.046 2.538 . . . . 0.0 114.66 -171.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.6 m -86.0 148.54 25.7 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.89 0.876 . . . . 0.0 111.456 176.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 6.7 p -136.95 23.08 3.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.097 1.359 . . . . 0.0 112.799 172.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -84.21 156.71 21.9 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.26 -0.9 . . . . 0.0 108.988 155.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . 0.45 ' H ' ' HE2' ' A' ' 303' ' ' LYS . 0.2 OUTLIER -65.53 106.33 1.41 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.542 1.537 . . . . 0.0 111.575 -166.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 63.9 mtp -92.32 171.87 8.77 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.413 1.085 . . . . 0.0 112.839 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 24.8 m -163.69 162.33 24.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.663 1.185 . . . . 0.0 111.761 167.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.0 116.81 18.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.643 0.777 . . . . 0.0 110.21 169.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.16 -35.1 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.333 1.453 . . . . 0.0 110.288 163.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -134.64 129.84 35.48 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.385 1.474 . . . . 0.0 108.67 165.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -63.18 156.29 69.41 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.663 0.785 . . . . 0.0 112.275 173.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -62.58 132.46 38.02 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.132 1.888 . . . . 0.0 110.797 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 60.4 p -133.79 135.07 43.62 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.957 2.103 . . . . 0.0 108.79 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.55 140.15 58.84 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.075 0.852 . . . . 0.0 111.829 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 41.0 p -67.77 -17.49 64.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.598 1.959 . . . . 0.0 113.633 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 91.39 -6.66 80.72 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.349 0.976 . . . . 0.0 112.175 -164.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -98.51 1.16 46.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.724 1.21 . . . . 0.0 112.089 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 77.5 43.67 14.92 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 119.069 0.85 . . . . 0.0 111.094 -172.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 63.3 p -144.41 137.04 26.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.561 1.944 . . . . 0.0 108.194 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.8 m -110.66 125.06 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 119.223 0.919 . . . . 0.0 111.304 -172.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.87 131.03 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.753 1.621 . . . . 0.0 111.873 -173.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 11.2 ptp -141.83 166.1 25.65 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.998 2.119 . . . . 0.0 112.15 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -133.41 134.57 43.81 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.901 0.88 . . . . 0.0 110.38 171.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.8 m -132.01 135.31 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.221 1.008 . . . . 0.0 113.036 -165.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -89.73 131.86 35.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.29 1.836 . . . . 0.0 112.426 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 t -104.64 145.79 31.38 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.016 -1.469 . . . . 0.0 107.866 156.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -105.29 -72.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.356 0 C-N-CA 122.617 2.211 . . . . 0.0 115.969 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.89 170.91 16.08 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 119.633 -1.917 . . . . 0.0 114.803 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.5 -4.24 3.01 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 126.18 1.848 . . . . 0.0 117.114 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -120.58 94.18 48.72 Favored Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 118.903 1.352 . . . . 0.0 112.063 -165.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.56 121.97 8.7 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.288 1.992 . . . . 0.0 108.952 163.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.2 p -157.84 154.45 28.03 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -77.13 142.01 39.92 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 156.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 14.5 pt -63.83 118.16 42.59 Favored Pre-proline 0 CA--C 1.555 1.156 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -167.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -87.58 91.3 0.51 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.349 3.366 . . . . 0.0 113.178 -169.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.19 139.28 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.805 0.842 . . . . 0.0 109.703 169.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.63 147.11 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.371 1.468 . . . . 0.0 108.697 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 74.8 t -120.17 106.08 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -114.55 162.12 17.14 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -163.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.53 -9.62 57.13 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.854 2.062 . . . . 0.0 112.902 165.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -133.48 140.62 47.36 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.668 1.187 . . . . 0.0 110.528 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.28 -17.45 42.49 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -173.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.9 t -106.03 5.09 30.01 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.171 1.788 . . . . 0.0 113.601 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 42.57 78.91 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 129.557 3.143 . . . . 0.0 116.721 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.34 -36.91 11.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.398 1.479 . . . . 0.0 112.36 156.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 94.7 mt -103.12 136.06 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.135 1.374 . . . . 0.0 109.972 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.02 98.68 8.35 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.827 1.651 . . . . 0.0 110.02 -177.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -84.69 -52.32 6.17 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.249 2.62 . . . . 0.0 112.664 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -87.77 -172.91 47.76 Favored Glycine 0 CA--C 1.536 1.374 0 N-CA-C 116.204 1.242 . . . . 0.0 116.204 -170.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 45.5 mt -126.75 143.15 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.118 1.767 . . . . 0.0 111.048 -172.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 86.6 mt -68.84 138.45 54.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.033 0.933 . . . . 0.0 111.14 168.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -122.06 -42.8 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.267 0.485 . . . . 0.0 111.433 169.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 m -76.28 149.72 37.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.901 0.773 . . . . 0.0 109.491 158.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.98 157.59 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.296 1.038 . . . . 0.0 111.898 170.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -114.52 78.14 4.74 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.838 1.655 . . . . 0.0 110.647 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.12 -170.93 0.94 Allowed 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 124.747 3.632 . . . . 0.0 114.013 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 42.8 pt -95.58 166.89 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.194 1.798 . . . . 0.0 111.657 172.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -70.15 124.47 24.19 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.681 0.792 . . . . 0.0 109.853 156.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.8 p -80.07 -40.31 27.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.136 1.375 . . . . 0.0 111.984 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.86 148.5 38.47 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.313 1.845 . . . . 0.0 108.399 159.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -59.92 -20.65 58.57 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -92.08 8.28 38.5 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.209 1.403 . . . . 0.0 112.954 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -61.45 155.12 22.54 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 119.983 -1.698 . . . . 0.0 113.779 -176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -132.92 95.49 3.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.965 1.306 . . . . 0.0 111.9 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.75 145.65 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.846 1.258 . . . . 0.0 111.922 -160.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 51.8 tp -102.61 127.16 49.82 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.099 2.96 . . . . 0.0 110.668 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.66 147.06 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.174 1.39 . . . . 0.0 110.907 -173.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -120.93 149.55 42.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.367 1.067 . . . . 0.0 113.632 161.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 2.4 m -137.42 158.21 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 126.855 2.062 . . . . 0.0 110.754 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -111.71 102.54 53.69 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.892 1.677 . . . . 0.0 110.793 -177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.87 139.12 27.03 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.553 2.169 . . . . 0.0 110.031 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.9 171.54 15.52 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.193 1.929 . . . . 0.0 111.208 170.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -64.55 150.57 46.54 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.703 -0.623 . . . . 0.0 112.21 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 92.57 -150.36 20.03 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -159.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -89.41 158.56 17.7 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.728 1.611 . . . . 0.0 113.22 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.4 m -158.72 151.26 21.83 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.174 -1.579 . . . . 0.0 112.04 166.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -118.39 109.28 16.08 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.84 108.63 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 175.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.91 142.19 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 174.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.01 112.32 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 125.355 1.462 . . . . 0.0 108.646 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 110.4 177.9 20.79 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.262 1.411 . . . . 0.0 114.995 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.5 m -136.08 161.05 36.77 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.043 1.737 . . . . 0.0 109.357 169.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.53 -166.73 54.58 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 121.558 0.532 . . . . 0.0 112.501 -170.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -27.34 14.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.708 1.603 . . . . 0.0 113.631 172.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 75.7 m -69.9 -4.15 19.14 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 129.199 3.0 . . . . 0.0 115.308 -175.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -91.72 123.62 35.25 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.8 0.727 . . . . 0.0 112.928 -167.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.48 168.08 11.09 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.411 0.684 . . . . 0.0 111.289 173.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.1 t -140.09 149.22 42.82 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.172 1.389 . . . . 0.0 111.369 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -145.94 123.16 11.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.291 1.836 . . . . 0.0 109.923 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.43 133.01 39.99 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.268 -0.895 . . . . 0.0 111.85 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -121.59 162.86 19.88 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.332 1.053 . . . . 0.0 111.031 160.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -142.86 145.77 33.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.926 1.29 . . . . 0.0 108.708 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -133.84 114.3 13.2 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.214 1.405 . . . . 0.0 110.221 -177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -84.23 173.67 10.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.802 0.841 . . . . 0.0 111.918 172.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 76.74 78.11 0.74 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.754 0.693 . . . . 0.0 113.129 173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.7 t -57.3 -12.98 2.77 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 73.8 p -90.16 -1.9 58.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.299 1.84 . . . . 0.0 114.163 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 10.9 tt -66.51 -12.1 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 119.946 1.248 . . . . 0.0 112.971 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 73.91 -28.84 0.93 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.413 1.958 . . . . 0.0 115.825 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 C-N-CA 125.713 1.605 . . . . 0.0 112.881 -175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 56.1 mmm . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 81.8 p -101.34 -0.47 35.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -54.93 -31.48 60.36 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.9 tt -98.8 125.25 44.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 161.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.9 t -53.58 162.94 0.73 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.593 1.157 . . . . 0.0 113.883 -171.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.502 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.7 mm? -49.88 110.49 0.39 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.636 1.974 . . . . 0.0 111.161 -162.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -55.43 124.05 15.91 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.901 1.681 . . . . 0.0 110.421 -168.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 59.92 9.2 9.73 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.98 1.276 . . . . 0.0 115.445 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 20.3 m -134.15 10.01 3.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.762 2.025 . . . . 0.0 110.181 -160.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 6.6 m -161.48 158.19 26.2 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 119.709 -1.869 . . . . 0.0 110.612 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -79.2 172.23 14.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.102 0.961 . . . . 0.0 112.976 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -71.57 160.12 33.24 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -172.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -77.8 152.66 33.38 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.409 2.284 . . . . 0.0 112.26 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.2 m -71.47 144.64 49.63 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.572 -0.705 . . . . 0.0 112.574 -178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.8 p -134.56 17.35 3.63 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.149 1.38 . . . . 0.0 113.391 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -75.65 161.19 29.31 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.928 -1.107 . . . . 0.0 109.009 154.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.8 87.58 0.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.991 1.316 . . . . 0.0 111.347 -168.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 55.9 mtp -70.05 172.97 7.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.906 2.082 . . . . 0.0 114.277 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 35.8 m -157.85 164.7 36.7 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.98 0.912 . . . . 0.0 111.998 158.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.95 121.61 25.67 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.263 0.625 . . . . 0.0 110.407 166.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.5 -37.14 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.107 1.363 . . . . 0.0 110.121 166.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -131.93 123.13 26.8 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.905 1.282 . . . . 0.0 108.91 169.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -63.43 149.87 90.97 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.132 0.973 . . . . 0.0 111.682 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.45 139.41 70.66 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.716 2.277 . . . . 0.0 112.327 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 49.0 p -141.94 129.59 21.53 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.36 1.864 . . . . 0.0 109.875 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -56.51 126.43 26.49 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 118.781 0.719 . . . . 0.0 111.679 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 66.5 p -68.64 -15.6 63.58 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.8 2.04 . . . . 0.0 113.51 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 93.76 -21.75 39.67 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.748 1.642 . . . . 0.0 112.047 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -74.38 -20.17 60.17 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.386 1.093 . . . . 0.0 112.426 172.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 103.01 18.77 14.16 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.444 1.02 . . . . 0.0 112.503 -168.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.5 p -120.93 149.28 42.88 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 126.548 1.939 . . . . 0.0 108.208 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 33.7 m -118.75 123.61 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 124.144 0.978 . . . . 0.0 110.096 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 8.0 p -96.79 127.16 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.968 1.307 . . . . 0.0 111.342 -174.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.1 ptm -147.67 161.43 41.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.526 1.531 . . . . 0.0 112.934 -172.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -134.26 134.21 41.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.972 0.909 . . . . 0.0 110.622 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 23.8 m -131.04 122.36 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.414 1.086 . . . . 0.0 113.353 -162.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -89.75 123.34 33.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.257 2.223 . . . . 0.0 112.247 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.79 146.36 31.25 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 117.235 -1.364 . . . . 0.0 108.235 156.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -101.25 -71.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.722 2.281 . . . . 0.0 115.896 174.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.47 163.96 34.02 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 119.534 -1.979 . . . . 0.0 114.701 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 61.74 7.79 12.89 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.681 1.61 . . . . 0.0 116.333 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.23 88.76 33.58 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 118.612 1.206 . . . . 0.0 112.319 -162.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.02 118.54 5.74 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.15 1.9 . . . . 0.0 108.377 161.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.7 p -157.48 156.59 32.35 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.731 0.777 . . . . 0.0 112.998 -177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -77.63 142.51 38.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.904 1.682 . . . . 0.0 108.397 163.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.42 123.38 73.3 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 119.287 0.948 . . . . 0.0 111.346 -172.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -102.04 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.583 2.855 . . . . 0.0 113.524 -164.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.24 120.56 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.641 0.776 . . . . 0.0 109.017 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.68 158.47 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.581 1.153 . . . . 0.0 110.465 -174.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.74 104.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.943 2.097 . . . . 0.0 108.085 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.03 159.14 36.88 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.709 1.004 . . . . 0.0 113.709 -160.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.21 -14.33 61.32 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.718 2.007 . . . . 0.0 112.944 166.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -129.86 140.56 50.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.531 1.532 . . . . 0.0 111.022 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.92 -20.99 60.46 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -173.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.4 t -101.22 7.3 43.09 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.866 1.667 . . . . 0.0 113.649 -176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 43.18 63.96 1.36 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 127.799 2.44 . . . . 0.0 115.668 -177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.13 -50.7 13.92 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.736 0.814 . . . . 0.0 110.876 155.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 15.4 mm -84.41 160.94 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.356 0.598 . . . . 0.0 109.617 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -138.66 61.52 1.57 Allowed 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.03 -1.044 . . . . 0.0 111.679 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -53.28 -50.81 64.1 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 128.067 2.547 . . . . 0.0 113.72 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -80.5 -172.0 44.54 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 116.059 1.184 . . . . 0.0 116.059 -168.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.7 mt -123.99 137.35 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.556 1.543 . . . . 0.0 110.175 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.8 mp -77.16 126.62 31.24 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 161.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.97 -46.43 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.557 1.143 . . . . 0.0 109.62 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 31.6 m -73.82 161.01 30.64 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.448 0.642 . . . . 0.0 110.488 167.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 352' ' ' VAL . 3.6 t -53.54 153.09 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.94 1.696 . . . . 0.0 111.026 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -111.61 76.59 1.59 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.07 1.348 . . . . 0.0 110.991 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -75.74 -174.47 2.04 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.947 3.098 . . . . 0.0 112.8 174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 35.2 pt -91.36 168.16 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.049 1.339 . . . . 0.0 111.715 168.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.92 110.13 2.34 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 154.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 84.4 p -72.04 -37.3 69.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.166 1.386 . . . . 0.0 112.146 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.37 158.0 29.24 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.573 1.949 . . . . 0.0 109.306 158.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -62.1 -20.06 63.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -100.35 11.1 40.19 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.653 1.581 . . . . 0.0 112.408 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -60.6 148.57 37.77 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.596 -1.315 . . . . 0.0 113.705 -175.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -132.17 82.19 2.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.811 1.644 . . . . 0.0 110.688 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 11.5 t -94.91 146.39 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.335 1.054 . . . . 0.0 111.202 -164.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 39.8 tp -104.7 123.38 47.52 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.417 2.687 . . . . 0.0 111.073 -173.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 2.9 mp -141.14 141.17 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.533 1.933 . . . . 0.0 111.041 -170.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -94.04 139.61 30.75 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.637 1.175 . . . . 0.0 111.94 158.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.04 166.24 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.022 1.329 . . . . 0.0 111.004 168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -129.55 108.61 17.37 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 125.894 1.678 . . . . 0.0 110.11 -174.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.64 149.43 26.82 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.568 2.179 . . . . 0.0 110.231 158.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.81 170.16 20.31 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.224 1.949 . . . . 0.0 111.472 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -57.78 129.59 42.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.003 0.921 . . . . 0.0 110.225 168.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 110.76 -139.05 15.32 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.984 0.802 . . . . 0.0 111.898 -169.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -86.85 167.15 14.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.264 1.025 . . . . 0.0 113.287 -175.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 25.2 m -178.23 163.46 1.66 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.762 2.425 . . . . 0.0 111.04 158.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -127.2 126.58 43.04 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.628 1.571 . . . . 0.0 107.698 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.0 mm -95.26 122.05 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.214 1.406 . . . . 0.0 108.016 -178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.1 142.81 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.611 0.764 . . . . 0.0 110.2 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 67.9 t -115.92 109.1 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.943 1.697 . . . . 0.0 108.653 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.05 -173.5 20.72 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 123.358 1.532 . . . . 0.0 115.338 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 55.0 m -140.4 163.91 31.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.487 1.515 . . . . 0.0 109.843 171.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 73.19 -167.85 54.02 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 121.65 0.583 . . . . 0.0 112.775 -171.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.51 -29.14 6.28 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.34 1.856 . . . . 0.0 114.028 174.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.0 m -71.34 -11.77 61.08 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.401 2.681 . . . . 0.0 114.693 -176.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -79.69 109.45 14.1 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -164.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.16 158.0 33.72 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.11 -0.369 . . . . 0.0 110.779 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 2.7 t -136.26 143.93 44.53 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.754 1.222 . . . . 0.0 111.006 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -144.67 123.17 12.41 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.595 1.558 . . . . 0.0 110.134 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.39 124.86 24.99 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.359 -0.838 . . . . 0.0 111.945 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -130.1 123.37 30.25 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.213 0.605 . . . . 0.0 110.397 161.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -123.37 146.76 47.7 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -128.59 115.05 17.49 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.276 1.031 . . . . 0.0 110.496 -162.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.27 161.31 27.55 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.008 0.923 . . . . 0.0 112.131 172.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -70.46 27.73 0.46 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 126.352 1.929 . . . . 0.0 116.676 -169.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . 0.457 ' O ' ' HE3' ' A' ' 398' ' ' LYS . 60.4 m -66.0 89.96 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.844 1.322 . . . . 0.0 110.756 176.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 82.7 p -114.62 1.0 14.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.221 1.408 . . . . 0.0 114.682 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 18.6 tt -140.32 154.47 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.54 1.536 . . . . 0.0 110.416 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 79.93 3.51 89.35 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 116.084 1.193 . . . . 0.0 116.084 171.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 394' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.41 1.884 . . . . 0.0 111.754 -175.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.477 0.92 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.3 p -97.08 -7.05 33.68 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.76 95.09 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.527 1.058 . . . . 0.0 112.696 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.9 tt -63.06 129.62 41.16 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 169.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 7.5 t -49.45 163.45 0.11 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.299 1.44 . . . . 0.0 114.537 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -73.53 93.63 2.03 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.027 1.331 . . . . 0.0 111.134 -160.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.616 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 2.1 mptt -39.01 111.25 0.17 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.519 3.128 . . . . 0.0 112.417 -176.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 71.01 -32.25 0.52 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.415 1.96 . . . . 0.0 115.111 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 62.7 m -70.98 -3.45 19.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.87 2.468 . . . . 0.0 112.304 171.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 19.9 m -156.66 154.23 29.78 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 119.311 -2.118 . . . . 0.0 111.199 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -78.71 174.58 11.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.12 1.368 . . . . 0.0 113.178 -173.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -65.27 161.09 20.15 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.041 1.336 . . . . 0.0 114.442 -170.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 71.3 mtm -91.21 150.47 21.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.139 2.175 . . . . 0.0 111.627 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.5 m -69.41 147.57 50.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.077 0.951 . . . . 0.0 112.571 -174.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 2.6 p -136.38 11.12 3.24 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -76.82 165.04 25.25 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 119.433 1.015 . . . . 0.0 109.553 161.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.48 89.63 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.225 1.41 . . . . 0.0 113.727 -167.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 44.7 mtp -76.64 167.18 22.28 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.639 1.176 . . . . 0.0 113.659 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 38.5 m -160.69 162.78 32.7 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.875 1.27 . . . . 0.0 110.555 161.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.7 130.57 34.53 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 121.978 -0.452 . . . . 0.0 110.727 164.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.36 -28.85 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.634 1.573 . . . . 0.0 110.197 167.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -129.99 116.94 19.3 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.531 1.532 . . . . 0.0 108.257 163.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -55.94 150.12 30.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.784 1.234 . . . . 0.0 111.081 169.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.5 138.31 69.79 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.81 1.673 . . . . 0.0 110.808 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 389' ' ' TRP . 0.9 OUTLIER -144.28 142.59 30.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.089 0.556 . . . . 0.0 110.158 175.061 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -63.48 126.3 27.03 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.727 1.611 . . . . 0.0 112.413 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 82.5 p -73.84 -25.89 60.31 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.001 1.32 . . . . 0.0 112.68 173.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 84.98 -2.41 88.32 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.501 1.524 . . . . 0.0 114.538 -164.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -87.2 6.06 34.92 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.334 1.453 . . . . 0.0 112.038 171.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 83.1 20.08 61.56 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 121.094 -1.004 . . . . 0.0 112.829 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.428 ' OG1' ' OE1' ' A' ' 366' ' ' GLU . 33.4 p -131.9 154.22 49.44 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.056 1.343 . . . . 0.0 110.688 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 24.1 m -122.81 128.95 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.685 1.194 . . . . 0.0 109.347 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.9 p -113.41 132.88 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.467 1.107 . . . . 0.0 112.21 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -141.8 162.42 35.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.658 1.583 . . . . 0.0 113.778 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -121.48 114.14 20.83 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.472 2.309 . . . . 0.0 107.006 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 362' ' ' GLU . 35.4 m -118.95 138.31 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.693 1.197 . . . . 0.0 111.018 -167.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -119.63 136.64 54.3 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 8.5 t -102.46 150.33 37.52 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 127.301 2.24 . . . . 0.0 108.591 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -102.62 -74.03 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 122.907 2.405 . . . . 0.0 115.888 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.18 162.36 34.46 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 120.785 1.63 . . . . 0.0 114.498 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 59.94 -0.18 0.88 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 127.193 2.33 . . . . 0.0 118.272 170.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -111.38 94.67 23.12 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 119.681 1.741 . . . . 0.0 113.304 -164.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.64 115.79 4.45 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.461 2.107 . . . . 0.0 108.935 163.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 3.0 p -150.77 155.41 39.2 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.924 0.869 . . . . 0.0 112.715 -175.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -74.14 136.36 42.9 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.262 1.425 . . . . 0.0 107.977 163.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 333' ' ' PRO 0.273 2.6 pp -62.27 129.44 92.28 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 119.514 -0.874 . . . . 0.0 111.415 -169.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 16.3 Cg_endo -100.43 89.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.005 2.47 . . . . 0.0 113.635 -160.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 94.4 t -118.22 130.71 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.994 1.318 . . . . 0.0 109.602 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.33 151.67 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 111.51 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 59.7 t -126.82 104.18 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.415 1.886 . . . . 0.0 107.508 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -115.1 161.81 17.88 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -163.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.71 -11.73 58.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.222 1.809 . . . . 0.0 112.722 163.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -134.65 146.37 49.46 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.724 1.21 . . . . 0.0 111.75 -176.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.05 -16.14 63.66 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -99.63 5.27 45.9 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.558 1.143 . . . . 0.0 112.983 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.549 ' HB2' HD13 ' A' ' 377' ' ' ILE . . . 37.8 77.83 0.04 OUTLIER 'General case' 0 C--O 1.239 0.548 0 C-N-CA 129.124 2.97 . . . . 0.0 115.115 -169.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -106.72 -25.43 11.75 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.394 1.877 . . . . 0.0 112.918 166.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 4.4 mp -127.95 119.72 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.599 1.56 . . . . 0.0 109.436 177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.1 123.54 50.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -170.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -107.85 -16.93 14.2 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -93.52 -177.59 39.96 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-N 119.853 1.206 . . . . 0.0 116.046 -176.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 86.9 mt -126.63 136.2 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 127.926 2.491 . . . . 0.0 110.058 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.8 mt -72.73 136.99 45.64 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.186 0.995 . . . . 0.0 110.882 168.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.14 -46.66 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.257 0.623 . . . . 0.0 111.466 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 47.6 m -68.99 153.12 44.35 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 118.384 0.538 . . . . 0.0 109.787 159.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 1.2 m -61.38 161.28 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.574 1.149 . . . . 0.0 113.028 174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -118.04 79.13 13.77 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.284 1.434 . . . . 0.0 111.105 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -78.88 -171.22 1.18 Allowed 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 123.731 2.954 . . . . 0.0 112.332 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.27 167.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.091 1.357 . . . . 0.0 111.383 171.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -69.1 117.01 10.2 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 156.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 86.0 p -67.28 -28.41 68.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.589 1.156 . . . . 0.0 112.809 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 21.5 m -137.23 151.28 48.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 128.254 2.621 . . . . 0.0 106.717 -172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.9 -26.63 66.07 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.524 -1.36 . . . . 0.0 113.684 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -89.14 2.51 54.06 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.328 1.851 . . . . 0.0 113.413 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -58.58 154.37 14.39 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.933 1.349 . . . . 0.0 113.25 -166.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 322' ' ' VAL . 7.7 pt-20 -144.53 95.32 2.69 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.945 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.87 149.54 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.106 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 45.2 tp -93.99 124.62 38.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.485 2.314 . . . . 0.0 109.412 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.23 135.1 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.746 0.818 . . . . 0.0 110.551 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . 0.428 ' OE1' ' OG1' ' A' ' 317' ' ' THR . 3.5 pt-20 -106.01 140.07 39.57 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.21 1.005 . . . . 0.0 112.402 158.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.19 151.53 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.974 2.11 . . . . 0.0 110.025 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -108.92 113.01 59.85 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.296 1.838 . . . . 0.0 109.774 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.62 159.42 25.22 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.538 2.159 . . . . 0.0 111.108 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.17 173.17 3.43 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.703 2.269 . . . . 0.0 112.176 163.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -64.35 141.0 58.93 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.785 -0.572 . . . . 0.0 110.149 163.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 99.47 -140.59 15.06 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.575 0.607 . . . . 0.0 111.787 -174.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -88.24 164.71 15.49 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.713 1.205 . . . . 0.0 113.393 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 13.2 m -167.31 152.96 7.55 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.38 1.472 . . . . 0.0 111.821 165.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -118.95 113.92 21.75 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 31.9 mm -88.48 115.02 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 125.864 1.666 . . . . 0.0 107.734 -175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 342' ' ' ALA . 2.1 mp -113.51 140.83 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 122.021 0.915 . . . . 0.0 111.263 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 89.8 t -118.59 114.07 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 127.02 2.128 . . . . 0.0 108.251 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 98.36 178.09 32.81 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 122.662 1.146 . . . . 0.0 114.76 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 48.6 m -130.45 165.62 22.23 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.279 1.832 . . . . 0.0 109.353 171.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 75.87 -171.97 54.26 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 121.675 -0.64 . . . . 0.0 113.059 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.23 -23.1 33.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.33 1.452 . . . . 0.0 113.999 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 68.3 m -82.84 -2.73 55.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.482 2.313 . . . . 0.0 114.909 -176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -76.79 126.53 31.14 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.456 1.025 . . . . 0.0 113.068 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -90.05 161.89 15.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.147 0.579 . . . . 0.0 111.652 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.3 t -137.78 151.36 48.06 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.192 1.397 . . . . 0.0 112.59 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -150.13 131.77 14.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.314 1.846 . . . . 0.0 110.328 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.51 136.43 36.9 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.969 -1.082 . . . . 0.0 111.98 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . 0.41 ' CZ2' ' HA ' ' A' ' 311' ' ' THR . 21.2 m95 -125.53 152.73 44.64 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.698 0.761 . . . . 0.0 112.243 161.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -133.3 134.15 43.49 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.053 1.341 . . . . 0.0 108.365 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -127.82 118.9 24.57 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.351 1.46 . . . . 0.0 110.747 -167.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 157.42 16.46 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.329 2.252 . . . . 0.0 111.914 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -76.83 41.73 1.74 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.61 1.1 . . . . 0.0 114.131 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.53 -63.5 0.67 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.905 1.682 . . . . 0.0 110.929 -173.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.4 m -78.22 52.2 1.09 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.78 2.032 . . . . 0.0 110.262 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 15.9 tt -127.92 -14.02 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 130.612 3.565 . . . . 0.0 111.322 167.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -108.06 16.87 35.61 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.579 1.561 . . . . 0.0 114.224 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp . . . . . 0 C--O 1.248 0.997 0 C-N-CA 125.017 1.327 . . . . 0.0 109.687 171.142 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 20.0 m -103.23 11.28 37.08 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.094 1.357 . . . . 0.0 113.344 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -72.25 -39.28 68.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.609 1.095 . . . . 0.0 111.011 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.5 tt -72.68 138.76 46.84 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 164.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 3.4 t -55.73 176.91 0.06 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.142 1.777 . . . . 0.0 114.973 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -68.58 83.49 0.28 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.846 1.658 . . . . 0.0 110.451 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.553 ' HD2' ' H ' ' A' ' 293' ' ' LYS . 1.8 mptt -38.12 119.53 0.79 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.238 2.615 . . . . 0.0 112.481 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 74.86 -37.38 1.06 Allowed Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.745 1.64 . . . . 0.0 114.696 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 58.3 m -75.01 1.39 13.09 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.503 2.321 . . . . 0.0 112.593 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 25.0 m -158.19 149.93 21.53 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 119.037 -2.289 . . . . 0.0 111.715 -178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -84.71 178.78 7.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.972 1.309 . . . . 0.0 113.302 -169.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -63.93 162.19 14.29 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.263 1.425 . . . . 0.0 114.254 -170.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -69.92 157.41 37.49 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.641 1.576 . . . . 0.0 111.853 166.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 2.7 m -75.29 145.8 41.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.194 0.598 . . . . 0.0 110.255 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.0 p -133.67 21.0 3.9 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.909 1.283 . . . . 0.0 112.022 170.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -82.88 168.48 17.04 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 155.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.45 100.71 0.27 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.244 1.418 . . . . 0.0 112.067 -166.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 16.7 mtp -86.41 166.14 15.78 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.022 0.915 . . . . 0.0 112.21 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 18.9 m -163.58 163.31 24.57 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.261 1.024 . . . . 0.0 111.122 169.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.8 114.45 22.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.475 0.71 . . . . 0.0 109.129 163.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.26 -37.91 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.571 1.149 . . . . 0.0 109.552 161.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -135.16 120.49 19.04 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.682 1.593 . . . . 0.0 108.405 168.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -59.62 152.8 54.83 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.31 1.044 . . . . 0.0 110.977 172.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.38 137.06 63.0 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.094 1.863 . . . . 0.0 111.489 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 4.3 m -132.88 135.01 45.33 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.858 1.263 . . . . 0.0 109.225 173.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.06 130.12 43.3 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.253 0.549 . . . . 0.0 111.97 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 70.3 p -79.43 -21.06 46.06 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.709 1.203 . . . . 0.0 113.333 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 80.98 -8.34 57.43 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.761 1.172 . . . . 0.0 114.364 -161.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -87.97 6.26 36.75 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.298 1.439 . . . . 0.0 112.06 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 88.51 14.49 61.6 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.282 0.944 . . . . 0.0 113.092 -171.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 50.5 p -131.63 161.17 33.34 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.111 1.364 . . . . 0.0 111.259 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.27 133.02 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 125.253 1.421 . . . . 0.0 109.222 169.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 13.4 p -115.58 131.87 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.908 1.283 . . . . 0.0 112.05 -172.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 15.8 ptm -144.95 163.18 34.95 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.406 2.282 . . . . 0.0 112.069 -169.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -132.61 130.84 40.76 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.756 0.822 . . . . 0.0 108.915 173.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.47 145.15 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.171 0.988 . . . . 0.0 111.379 -165.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -105.17 135.82 45.82 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.737 1.215 . . . . 0.0 112.429 -175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.6 t -114.74 135.55 22.38 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.891 1.676 . . . . 0.0 107.714 163.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -100.65 -61.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 122.899 2.399 . . . . 0.0 115.164 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.96 176.11 11.82 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.714 -1.241 . . . . 0.0 113.091 -176.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 66.66 -23.19 0.18 Allowed Glycine 0 CA--C 1.537 1.415 0 C-N-CA 128.097 2.76 . . . . 0.0 118.683 160.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -109.11 104.09 54.09 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 119.257 1.529 . . . . 0.0 112.766 -166.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -67.76 114.04 3.19 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.583 1.522 . . . . 0.0 108.502 159.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 4.7 p -148.8 154.55 39.69 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.997 0.903 . . . . 0.0 112.233 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -78.14 134.92 37.6 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.321 1.448 . . . . 0.0 107.573 161.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.1 pp -60.08 117.71 26.24 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-N 118.574 0.625 . . . . 0.0 111.308 -171.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -96.93 88.54 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.348 2.699 . . . . 0.0 113.752 -166.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 60.6 t -107.75 136.26 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 164.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.05 161.07 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 124.897 1.279 . . . . 0.0 111.104 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 93.0 t -139.34 106.24 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.05 1.74 . . . . 0.0 109.071 -174.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -129.24 163.01 26.56 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -158.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -87.34 -17.73 31.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.468 1.907 . . . . 0.0 112.883 163.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -123.64 153.05 41.3 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.598 1.159 . . . . 0.0 111.108 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 54.1 mt -69.23 -2.38 10.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.445 1.098 . . . . 0.0 113.883 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 2.2 t -129.4 18.61 5.85 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.579 1.551 . . . . 0.0 112.198 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 49.62 31.25 4.09 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -62.5 -25.87 68.24 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.745 -0.597 . . . . 0.0 112.388 166.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 31.9 mt -121.95 117.52 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.533 2.333 . . . . 0.0 107.693 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.94 115.66 29.88 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.91 0.777 . . . . 0.0 111.279 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -103.16 -10.44 18.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -174.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -99.33 -167.97 30.18 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 54.5 mt -132.04 133.69 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 127.86 2.464 . . . . 0.0 110.45 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 23.0 mt -65.25 121.0 13.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.932 1.293 . . . . 0.0 109.942 160.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 50.5 t -102.59 -51.89 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 122.924 0.49 . . . . 0.0 110.635 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.4 m -69.85 163.41 25.92 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.509 0.595 . . . . 0.0 110.424 168.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 21.4 t -52.81 147.19 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.587 1.155 . . . . 0.0 110.437 170.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -112.13 78.68 2.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.068 1.347 . . . . 0.0 110.2 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.15 -174.2 2.15 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 123.909 3.073 . . . . 0.0 113.349 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.546 ' H ' HD13 ' A' ' 355' ' ' ILE . 0.2 OUTLIER -94.01 168.37 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.521 1.528 . . . . 0.0 110.948 167.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -67.54 110.99 3.89 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 156.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 83.3 p -73.27 -36.99 66.44 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.094 1.358 . . . . 0.0 112.073 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.79 154.36 37.09 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.721 2.008 . . . . 0.0 109.093 160.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -64.82 -19.0 65.61 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -174.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.48 0.87 56.57 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.017 1.727 . . . . 0.0 112.919 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -57.84 149.54 22.27 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.503 -1.373 . . . . 0.0 114.074 -171.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -138.91 86.76 2.16 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.118 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.03 145.88 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.794 1.237 . . . . 0.0 111.6 -170.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 45.8 tp -92.35 126.42 37.43 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.059 2.944 . . . . 0.0 110.502 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.8 145.14 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.662 1.585 . . . . 0.0 109.823 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -116.79 149.57 39.75 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.099 0.952 . . . . 0.0 111.948 159.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.19 154.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 125.564 1.546 . . . . 0.0 110.162 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -103.24 114.18 65.23 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.659 1.184 . . . . 0.0 110.22 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.57 143.8 15.38 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.019 2.48 . . . . 0.0 110.969 162.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -74.86 167.68 26.54 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.862 2.375 . . . . 0.0 111.242 169.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -53.63 140.37 29.15 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.734 1.214 . . . . 0.0 112.206 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.9 -147.57 17.0 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -172.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -82.09 164.16 21.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.61 1.564 . . . . 0.0 112.083 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 33.4 m -161.39 148.25 14.64 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.662 -1.274 . . . . 0.0 112.419 158.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -110.14 106.41 15.86 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.104 0.961 . . . . 0.0 108.499 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.4 mm -84.14 114.97 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 125.836 1.655 . . . . 0.0 107.95 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.2 mt -115.64 143.78 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.502 1.121 . . . . 0.0 109.891 -169.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 52.5 t -120.84 113.84 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.679 1.592 . . . . 0.0 108.556 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 90.42 179.54 43.78 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 53.1 m -132.51 165.83 23.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.696 1.998 . . . . 0.0 109.341 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.17 -170.1 55.04 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.808 -0.557 . . . . 0.0 112.783 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -28.15 56.53 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.762 1.225 . . . . 0.0 113.643 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 74.0 m -78.21 -3.91 45.06 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 127.513 2.325 . . . . 0.0 115.041 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -78.91 144.33 34.99 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.694 0.679 . . . . 0.0 112.822 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 10.3 mt -111.07 163.88 13.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.615 0.766 . . . . 0.0 110.922 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 13.5 t -139.52 154.01 47.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.732 1.213 . . . . 0.0 111.459 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -149.19 135.73 19.43 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.89 1.676 . . . . 0.0 109.892 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.77 131.6 38.97 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.415 -0.803 . . . . 0.0 111.662 -172.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -123.72 166.23 15.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.115 0.966 . . . . 0.0 112.04 167.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -138.98 129.94 26.46 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.073 1.749 . . . . 0.0 108.368 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -111.82 119.58 39.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.81 1.644 . . . . 0.0 110.7 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.37 163.59 13.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 129.701 3.2 . . . . 0.0 111.202 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -77.28 42.29 1.9 Allowed Glycine 0 CA--C 1.534 1.223 0 O-C-N 120.911 -1.118 . . . . 0.0 114.202 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 3.5 p -138.0 -54.72 0.65 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.638 1.219 . . . . 0.0 113.09 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 2.8 m -82.98 54.2 2.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.565 1.946 . . . . 0.0 109.474 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 15.9 tt -135.26 -16.89 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 126.436 1.895 . . . . 0.0 113.73 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -135.1 37.13 1.97 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.934 1.254 . . . . 0.0 113.098 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.674 0 C-N-CA 125.813 1.645 . . . . 0.0 110.288 -173.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.0 t -119.49 9.9 11.68 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.801 1.24 . . . . 0.0 113.374 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.44 ' HB1' ' H ' ' A' ' 336' ' ' VAL . . . -65.57 -46.7 78.45 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.041 0.837 . . . . 0.0 110.909 167.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.07 129.15 38.88 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 164.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 5.7 t -57.02 171.33 0.36 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.163 1.385 . . . . 0.0 114.269 -173.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.1 mm? -64.34 109.08 1.79 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.614 1.965 . . . . 0.0 110.721 -167.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -63.78 114.61 4.14 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.989 2.116 . . . . 0.0 110.578 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 78.91 -40.84 2.12 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.827 1.203 . . . . 0.0 113.322 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 5.2 m -65.69 -0.81 2.3 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.752 2.421 . . . . 0.0 114.013 174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 5.0 m -153.08 151.69 30.49 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 118.994 -2.316 . . . . 0.0 113.65 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -73.82 173.48 9.82 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.359 1.864 . . . . 0.0 112.827 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -71.47 152.77 42.77 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.338 1.055 . . . . 0.0 113.785 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -70.2 157.55 37.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.819 2.048 . . . . 0.0 112.337 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 5.4 m -69.82 140.51 53.3 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.546 -0.721 . . . . 0.0 111.735 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 17.2 p -128.18 7.1 5.95 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -73.67 166.46 23.24 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.016 0.825 . . . . 0.0 110.888 164.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -71.03 84.15 0.7 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.016 1.727 . . . . 0.0 111.197 -170.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 41.3 mtp -66.63 172.46 4.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.383 1.873 . . . . 0.0 114.337 -174.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 33.5 m -157.69 159.34 36.81 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.489 1.116 . . . . 0.0 111.249 164.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.97 117.1 19.72 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 169.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.45 -33.49 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.025 0.53 . . . . 0.0 109.659 161.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -137.43 124.08 21.03 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.785 1.634 . . . . 0.0 108.026 164.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -59.18 160.91 10.71 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 123.211 0.604 . . . . 0.0 111.599 171.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -61.33 135.66 59.23 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.903 1.735 . . . . 0.0 110.589 167.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 3.0 m -138.48 138.44 38.1 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.766 1.226 . . . . 0.0 108.985 171.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.18 128.57 37.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 124.09 0.868 . . . . 0.0 111.567 175.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 73.8 p -79.63 -12.62 59.82 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.252 1.021 . . . . 0.0 113.723 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 75.45 0.69 63.13 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.394 0.997 . . . . 0.0 113.978 -164.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -111.67 14.52 21.21 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.189 1.796 . . . . 0.0 112.32 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 84.8 15.17 68.38 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.766 0.698 . . . . 0.0 113.501 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 43.4 p -134.61 162.67 31.64 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.691 1.197 . . . . 0.0 111.176 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.73 130.42 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.597 1.159 . . . . 0.0 109.625 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 14.8 p -115.33 132.9 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.843 1.257 . . . . 0.0 111.802 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 4.8 ptp -143.84 166.03 26.05 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.117 1.767 . . . . 0.0 112.345 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -133.88 128.71 35.18 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.679 1.192 . . . . 0.0 109.904 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.79 121.56 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.076 0.951 . . . . 0.0 112.22 -161.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -84.23 130.13 34.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.512 1.525 . . . . 0.0 112.028 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 4.3 t -102.29 137.4 19.42 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.985 1.314 . . . . 0.0 108.201 159.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -91.88 -77.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 122.9 2.4 . . . . 0.0 116.256 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 139.16 20.38 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -171.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 83.8 4.74 88.61 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.808 1.194 . . . . 0.0 115.422 174.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -114.61 89.43 18.53 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 118.664 1.232 . . . . 0.0 112.325 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.1 127.13 13.89 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.215 1.943 . . . . 0.0 108.676 159.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 5.0 p -162.77 162.9 26.88 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -74.4 143.37 44.82 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.04 1.736 . . . . 0.0 109.85 161.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 19.0 pt -66.37 123.91 86.72 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 118.713 0.688 . . . . 0.0 111.213 -176.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 1.8 Cg_endo -108.48 82.26 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.292 1.994 . . . . 0.0 115.186 -153.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 80.1 t -114.35 131.48 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.369 -0.832 . . . . 0.0 109.818 172.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.67 128.88 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.33 1.052 . . . . 0.0 110.07 177.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . 0.44 ' H ' ' HB1' ' A' ' 289' ' ' ALA . 58.9 t -99.99 119.53 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.586 1.555 . . . . 0.0 107.516 170.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -130.26 161.12 31.93 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -166.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.71 -18.26 58.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.331 1.853 . . . . 0.0 112.98 164.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -128.22 146.02 50.86 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.746 1.218 . . . . 0.0 111.618 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.74 -17.9 38.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.0 t -105.12 5.93 32.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.427 1.491 . . . . 0.0 113.417 -176.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 40.16 75.96 0.07 Allowed 'General case' 0 C--O 1.239 0.519 0 C-N-CA 129.042 2.937 . . . . 0.0 115.801 -171.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.74 -51.3 4.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.069 1.347 . . . . 0.0 111.655 157.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 72.1 mt -102.57 104.73 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.697 1.599 . . . . 0.0 109.1 -174.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -84.16 115.58 22.48 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -95.3 -11.58 27.63 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.159 2.583 . . . . 0.0 114.562 -173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -115.12 -168.47 15.65 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 -175.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.6 mt -129.44 135.38 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 127.404 2.281 . . . . 0.0 110.184 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.1 mt -65.04 122.8 17.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.302 1.041 . . . . 0.0 110.555 164.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 73.5 t -102.22 -50.11 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.848 0.859 . . . . 0.0 109.861 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 23.0 m -69.35 153.27 43.86 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.279 0.562 . . . . 0.0 110.038 166.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 16.5 m -56.17 159.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.443 1.097 . . . . 0.0 112.236 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -120.93 75.45 28.39 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.043 0.937 . . . . 0.0 112.454 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -57.35 -167.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.127 1 C-N-CA 126.131 4.554 . . . . 0.0 117.221 162.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 27.5 pt -112.14 166.88 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.703 2.401 . . . . 0.0 111.324 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -68.31 105.34 2.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.988 0.915 . . . . 0.0 109.022 155.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 91.5 p -72.79 -50.45 24.22 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.391 1.476 . . . . 0.0 111.314 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.59 152.34 19.15 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.991 1.317 . . . . 0.0 108.825 156.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -60.61 -19.02 56.67 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.11 0.39 56.75 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.107 1.763 . . . . 0.0 112.955 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -58.66 147.4 32.85 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.471 -1.393 . . . . 0.0 113.653 -172.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -132.79 79.54 1.85 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.519 1.528 . . . . 0.0 111.252 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.35 148.56 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.569 1.148 . . . . 0.0 111.502 -165.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -93.53 127.23 39.09 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.908 2.883 . . . . 0.0 109.798 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.57 141.76 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.002 1.321 . . . . 0.0 109.86 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -119.19 152.35 36.75 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 122.453 1.12 . . . . 0.0 112.573 162.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.8 m -140.89 156.65 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.943 1.697 . . . . 0.0 110.72 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -109.91 116.3 54.0 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 125.844 1.658 . . . . 0.0 110.772 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.45 160.83 12.82 Favored 'Trans proline' 0 CA--C 1.551 1.369 0 C-N-CA 123.766 2.978 . . . . 0.0 112.095 161.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -76.23 176.35 10.16 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.415 2.743 . . . . 0.0 110.895 164.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -60.02 145.25 47.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.187 0.595 . . . . 0.0 111.247 168.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 98.33 -152.02 19.71 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.634 0.635 . . . . 0.0 111.664 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.9 167.17 20.17 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.556 1.169 . . . . 0.0 113.154 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 30.8 m -162.64 152.24 15.75 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.441 1.096 . . . . 0.0 110.905 157.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -107.44 119.36 39.19 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 12.7 mm -99.37 104.69 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 125.778 1.631 . . . . 0.0 107.594 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.38 141.21 18.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.944 1.298 . . . . 0.0 109.799 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 65.7 t -120.56 111.14 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 126.584 1.954 . . . . 0.0 108.442 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 102.38 -177.43 26.02 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 123.27 1.483 . . . . 0.0 114.658 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 53.7 m -138.35 167.26 22.25 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.236 1.815 . . . . 0.0 109.575 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 74.38 -175.02 49.45 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 121.741 0.634 . . . . 0.0 112.674 -170.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -23.15 65.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.676 1.19 . . . . 0.0 113.054 175.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 54.0 m -64.57 -15.59 61.26 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 171.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -71.11 138.8 49.99 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.144 1.338 . . . . 0.0 112.813 -169.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 42.3 mt -103.56 161.57 13.78 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.728 1.211 . . . . 0.0 110.864 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 6.1 t -143.05 145.1 32.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.004 0.921 . . . . 0.0 112.248 -171.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -150.22 121.8 8.0 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.704 1.602 . . . . 0.0 110.199 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.71 131.44 39.87 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.468 -1.395 . . . . 0.0 111.815 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -119.28 168.84 10.52 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.793 0.837 . . . . 0.0 111.615 159.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.58 145.93 34.07 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.707 1.603 . . . . 0.0 108.971 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -133.15 124.81 28.18 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.081 1.352 . . . . 0.0 110.633 -174.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.64 164.27 11.88 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.721 2.408 . . . . 0.0 111.908 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -76.1 40.49 1.46 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.919 1.247 . . . . 0.0 114.303 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.66 -62.15 0.37 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.675 1.19 . . . . 0.0 112.999 -169.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 3.6 m -83.74 63.09 7.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.848 1.259 . . . . 0.0 110.386 -169.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.1 tt -129.88 15.42 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.291 1.836 . . . . 0.0 113.367 -168.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -169.53 13.12 0.05 OUTLIER Glycine 0 CA--C 1.532 1.154 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.3 0 CA-C-N 119.383 1.591 . . . . 0.0 110.679 175.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.8 m -97.5 -7.12 32.18 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.274 1.03 . . . . 0.0 113.562 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -66.33 -35.38 80.22 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.323 0.965 . . . . 0.0 113.009 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 53.6 tp -74.65 126.9 31.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 160.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 6.5 t -55.99 168.5 0.47 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.501 1.12 . . . . 0.0 113.836 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.548 HD22 ' H ' ' A' ' 292' ' ' LEU . 1.8 mm? -59.99 118.04 5.79 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.799 1.639 . . . . 0.0 110.557 -167.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -70.22 108.01 3.97 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.402 1.481 . . . . 0.0 109.512 -163.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 77.15 -45.2 2.25 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.985 1.278 . . . . 0.0 112.768 -170.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 38.9 m -63.37 7.46 0.1 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 128.636 2.775 . . . . 0.0 113.925 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 4.1 m -157.14 158.69 36.79 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 118.766 -2.458 . . . . 0.0 112.012 167.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -77.62 172.89 12.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.226 1.41 . . . . 0.0 113.023 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -70.28 154.6 41.73 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -171.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -67.6 157.7 33.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.346 2.258 . . . . 0.0 112.275 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 11.2 m -71.68 141.47 49.88 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.442 -0.786 . . . . 0.0 111.333 174.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 12.7 p -134.67 11.13 3.71 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -84.4 177.58 8.08 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.933 0.788 . . . . 0.0 109.518 163.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -71.2 81.37 0.72 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.372 1.869 . . . . 0.0 111.738 -166.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 20.7 mtp -66.15 167.3 10.32 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.928 1.291 . . . . 0.0 112.814 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 28.7 m -158.51 168.6 26.49 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.108 0.963 . . . . 0.0 111.146 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.01 115.12 26.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.815 1.246 . . . . 0.0 110.479 172.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.86 -34.92 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.917 1.287 . . . . 0.0 110.259 167.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -138.18 126.11 22.6 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.036 1.735 . . . . 0.0 108.629 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -61.27 160.58 22.37 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.206 1.002 . . . . 0.0 111.77 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.69 121.62 8.1 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.679 1.586 . . . . 0.0 110.073 169.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 13.6 p -124.32 140.6 52.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.407 1.083 . . . . 0.0 110.499 170.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -60.69 140.94 57.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.599 0.76 . . . . 0.0 112.13 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 76.2 p -97.86 -15.92 20.0 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.205 1.402 . . . . 0.0 113.221 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 75.35 -10.36 11.48 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-O 118.469 -1.184 . . . . 0.0 114.493 -163.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -69.11 -11.33 60.7 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.868 1.834 . . . . 0.0 112.464 173.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 92.83 15.95 50.31 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.354 0.978 . . . . 0.0 112.749 -159.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 24.6 p -132.63 168.54 18.09 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.402 1.481 . . . . 0.0 110.995 -171.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.7 140.13 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.22 1.408 . . . . 0.0 109.047 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.3 p -112.95 132.11 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.703 1.201 . . . . 0.0 110.973 -178.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 20.6 ptm -144.31 165.7 27.15 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.964 1.305 . . . . 0.0 112.806 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -130.19 134.8 47.55 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.274 1.03 . . . . 0.0 109.641 172.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.93 170.45 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.783 1.233 . . . . 0.0 111.46 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.45 137.62 51.92 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.28 2.232 . . . . 0.0 110.001 173.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.78 145.7 32.21 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.936 1.694 . . . . 0.0 107.407 161.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -102.83 -70.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 123.208 2.605 . . . . 0.0 115.228 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.81 175.56 9.91 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.602 1.561 . . . . 0.0 111.759 -174.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.32 -15.07 0.09 OUTLIER Glycine 0 CA--C 1.535 1.339 0 C-N-CA 127.549 2.499 . . . . 0.0 118.358 165.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -112.13 92.05 17.5 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 119.135 1.468 . . . . 0.0 112.768 -165.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.28 116.3 4.29 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.832 1.688 . . . . 0.0 108.078 154.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 5.6 p -154.68 157.59 38.33 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 121.639 -0.663 . . . . 0.0 112.281 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -75.58 140.62 42.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.625 1.57 . . . . 0.0 109.505 165.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 20.5 pt -64.06 121.83 73.9 Favored Pre-proline 0 CA--C 1.557 1.215 0 CA-C-N 119.211 0.914 . . . . 0.0 111.447 -174.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 332' ' ' ILE . 5.3 Cg_endo -109.04 85.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.36 2.707 . . . . 0.0 114.471 -164.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 23.3 t -119.54 104.09 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 121.285 -0.884 . . . . 0.0 110.045 171.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.9 160.31 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.662 1.585 . . . . 0.0 110.2 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 60.6 t -136.27 105.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 125.591 1.556 . . . . 0.0 108.153 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -122.36 158.37 29.78 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.611 1.165 . . . . 0.0 114.071 -163.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.65 -10.38 59.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.504 2.321 . . . . 0.0 112.875 169.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -137.71 150.72 47.54 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.173 1.389 . . . . 0.0 112.462 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 28.8 mt -63.45 -16.4 60.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.623 1.569 . . . . 0.0 114.721 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 13.2 t -109.2 7.42 25.41 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.135 -0.936 . . . . 0.0 112.824 -177.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 35.28 65.01 0.41 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 128.502 2.721 . . . . 0.0 114.211 -168.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -75.35 -40.93 57.68 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.426 1.09 . . . . 0.0 111.394 159.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 7.8 mm -99.74 169.85 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 125.3 1.44 . . . . 0.0 109.387 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -146.04 116.98 7.74 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.444 -1.41 . . . . 0.0 112.009 167.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -98.62 -27.16 14.13 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.345 1.858 . . . . 0.0 113.294 -177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -95.58 -174.53 36.95 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 116.21 1.244 . . . . 0.0 116.21 -173.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.3 mt -124.51 134.91 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.617 1.967 . . . . 0.0 110.102 -174.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.0 mt -70.49 121.52 17.95 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.14 0.976 . . . . 0.0 109.364 162.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.78 -42.64 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.54 0.736 . . . . 0.0 109.914 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 38.6 m -69.96 153.52 43.14 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.143 0.497 . . . . 0.0 110.411 166.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 17.5 t -56.09 152.75 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.129 1.372 . . . . 0.0 110.346 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -113.16 82.73 5.75 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.16 0.984 . . . . 0.0 111.845 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.46 -168.87 0.68 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 125.27 3.98 . . . . 0.0 112.693 169.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 36.0 pt -93.0 167.37 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.982 1.713 . . . . 0.0 111.89 167.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -64.82 111.18 2.69 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 152.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 88.5 p -76.09 -45.07 35.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.052 1.341 . . . . 0.0 111.758 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.43 151.52 22.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.044 1.337 . . . . 0.0 108.735 158.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -59.31 -20.33 53.56 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 170.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -101.94 10.9 39.33 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.636 1.574 . . . . 0.0 112.956 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -58.89 152.28 19.79 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.208 -1.557 . . . . 0.0 113.632 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -133.81 83.35 2.04 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.344 1.058 . . . . 0.0 113.096 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 25.9 t -90.47 152.13 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.943 1.697 . . . . 0.0 112.037 -166.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 25.8 tp -109.17 131.39 55.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 129.024 2.93 . . . . 0.0 110.35 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 4.5 mp -143.2 132.51 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.278 1.431 . . . . 0.0 111.424 -167.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -92.82 135.04 34.48 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.914 1.286 . . . . 0.0 111.597 157.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.59 155.26 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.789 1.235 . . . . 0.0 111.31 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -111.92 108.11 55.77 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 126.157 1.783 . . . . 0.0 110.925 -173.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.21 119.17 4.15 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.984 3.123 . . . . 0.0 111.031 160.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -60.1 169.24 5.06 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.413 2.742 . . . . 0.0 113.091 167.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -53.56 138.21 34.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.357 1.063 . . . . 0.0 112.277 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 102.21 -142.34 15.58 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.775 0.702 . . . . 0.0 112.584 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -75.99 163.92 26.68 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.159 0.984 . . . . 0.0 112.69 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 18.0 m -175.47 167.3 3.29 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.885 2.074 . . . . 0.0 111.192 161.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -133.66 126.51 30.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.661 1.984 . . . . 0.0 108.098 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 19.6 mm -81.76 129.04 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 2.1 mp -121.03 141.05 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.222 1.009 . . . . 0.0 109.565 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 95.7 t -115.73 113.47 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.806 1.642 . . . . 0.0 108.929 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 96.22 -177.54 33.78 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 122.205 0.892 . . . . 0.0 115.155 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 27.7 m -133.26 159.3 40.63 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.232 1.813 . . . . 0.0 110.154 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 77.16 -174.82 54.39 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 123.866 0.746 . . . . 0.0 113.237 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -54.04 -24.63 17.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.588 1.555 . . . . 0.0 114.354 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 66.9 m -80.8 -4.1 53.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.714 2.006 . . . . 0.0 113.986 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -73.65 128.85 36.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.671 1.123 . . . . 0.0 112.295 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 23.9 mt -100.3 170.03 8.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.113 0.965 . . . . 0.0 111.232 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.8 t -145.92 162.45 37.75 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -148.12 127.86 13.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.12 2.168 . . . . 0.0 108.273 169.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -73.56 137.28 44.23 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.252 -0.905 . . . . 0.0 111.783 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -141.54 133.26 27.17 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.442 1.097 . . . . 0.0 109.172 166.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -124.77 153.71 42.03 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -133.17 101.55 5.24 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.786 0.803 . . . . 0.0 111.994 -160.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -94.54 170.76 9.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.79 1.636 . . . . 0.0 111.042 167.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -92.42 76.17 1.29 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 123.917 0.77 . . . . 0.0 112.622 -165.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 46.5 p -67.8 -47.37 69.28 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 117.881 0.84 . . . . 0.0 112.462 168.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 10.3 m -69.12 47.53 0.07 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.75 2.42 . . . . 0.0 114.916 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 41.8 pt -60.8 2.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 128.375 2.67 . . . . 0.0 117.768 -170.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 73.39 -54.12 1.93 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.28 1.895 . . . . 0.0 115.842 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.066 1.746 . . . . 0.0 111.878 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 15.9 m -104.34 4.27 33.35 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -60.9 -49.23 78.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.062 0.945 . . . . 0.0 111.995 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 6.2 tt -71.13 132.98 45.85 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.256 -0.903 . . . . 0.0 108.837 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.7 t -56.86 169.79 0.48 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.171 1.788 . . . . 0.0 115.076 -168.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.0 mm? -65.23 104.59 0.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.601 1.56 . . . . 0.0 111.392 -168.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 295' ' ' THR . 0.7 OUTLIER -59.97 135.98 57.87 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.64 1.176 . . . . 0.0 111.458 -169.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 62.33 -23.23 0.07 OUTLIER Glycine 0 CA--C 1.541 1.69 0 C-N-CA 126.975 2.226 . . . . 0.0 115.74 -170.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 293' ' ' LYS . 9.2 m -94.63 3.08 55.53 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 130.164 3.386 . . . . 0.0 111.037 -172.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' SER . . . . . . . . . . . . . 17.7 m -163.34 159.69 22.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 119.83 -1.794 . . . . 0.0 111.907 -176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -87.0 175.33 8.18 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.899 1.28 . . . . 0.0 113.432 -171.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -72.64 159.43 33.87 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.067 1.347 . . . . 0.0 114.498 -171.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' MET . . . . . . . . . . . . . 18.0 mmt -75.28 157.4 34.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.693 1.997 . . . . 0.0 111.702 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' CYS . . . . . . . . . . . . . 3.1 m -75.53 144.76 41.77 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.472 -0.768 . . . . 0.0 110.776 172.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 8.3 p -131.87 5.55 4.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.34 167.18 22.16 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.374 0.988 . . . . 0.0 109.792 161.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -68.77 101.29 1.3 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.089 1.355 . . . . 0.0 112.022 -161.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' MET . . . . . . . . . . . . . 24.7 mtp -86.53 168.48 13.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.056 0.931 . . . . 0.0 112.969 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 31.3 m -161.08 160.99 31.1 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.686 1.194 . . . . 0.0 110.866 165.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.31 112.92 18.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.401 0.68 . . . . 0.0 110.126 168.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 77.3 t -63.26 -35.16 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.417 1.487 . . . . 0.0 110.24 163.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -133.78 123.99 25.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.448 1.499 . . . . 0.0 108.183 165.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -60.42 152.79 63.36 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.72 0.808 . . . . 0.0 111.475 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.35 133.29 45.41 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.133 1.889 . . . . 0.0 110.956 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.9 m -136.19 137.06 40.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.739 1.215 . . . . 0.0 109.183 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -70.08 139.5 52.58 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.298 0.639 . . . . 0.0 112.454 -175.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 72.6 p -88.94 -13.08 39.84 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.053 0.941 . . . . 0.0 113.346 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . 66.27 -3.07 3.59 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 119.319 0.963 . . . . 0.0 114.408 -164.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -96.66 10.94 37.11 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.811 1.645 . . . . 0.0 111.519 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 96.98 13.12 47.43 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.179 1.371 . . . . 0.0 114.248 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 30.6 p -138.13 163.96 30.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.574 1.187 . . . . 0.0 112.225 -170.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.19 132.37 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.489 1.516 . . . . 0.0 109.653 167.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.41 132.47 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.276 1.43 . . . . 0.0 111.693 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' MET . . . . . . . . . . . . . 21.0 ptm -148.37 166.18 28.84 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.342 1.457 . . . . 0.0 113.104 -175.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -136.12 139.44 42.95 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.643 1.177 . . . . 0.0 109.097 174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.42 155.92 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.341 1.056 . . . . 0.0 111.474 -169.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -111.76 133.07 54.23 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.876 1.271 . . . . 0.0 112.189 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 3.2 t -104.39 131.7 21.64 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.148 1.379 . . . . 0.0 107.891 160.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' PRO . . . . . 0.4 ' HG2' ' H ' ' A' ' 326' ' ' LYS . 94.7 Cg_endo -94.44 -67.77 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.097 2.531 . . . . 0.0 114.891 -178.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 325' ' ' PRO . 0.0 OUTLIER -145.82 176.65 9.51 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.546 1.938 . . . . 0.0 110.552 -177.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 63.29 -14.74 0.09 OUTLIER Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.788 2.137 . . . . 0.0 118.14 169.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.54 90.48 39.43 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 119.265 1.532 . . . . 0.0 112.894 -162.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.93 115.63 4.38 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.114 1.876 . . . . 0.0 108.203 156.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 2.4 p -152.25 157.4 41.37 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -172.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.68 130.71 38.15 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.206 1.802 . . . . 0.0 108.973 165.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 15.2 pt -60.4 114.96 11.4 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-N 118.572 0.624 . . . . 0.0 111.837 -166.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -100.16 87.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.569 2.846 . . . . 0.0 114.333 -160.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 44.2 t -112.09 128.75 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 167.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.05 155.08 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.442 1.097 . . . . 0.0 110.619 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' VAL . . . . . . . . . . . . . 61.3 t -130.1 117.33 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.19 1.796 . . . . 0.0 107.364 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -126.62 165.78 18.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.126 0.97 . . . . 0.0 113.315 -166.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -83.61 -8.19 59.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.078 1.751 . . . . 0.0 112.382 162.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -137.3 137.46 39.0 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.401 1.48 . . . . 0.0 111.235 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.5 mp -58.13 -20.6 41.59 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -174.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 15.3 t -97.79 3.16 50.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.563 1.945 . . . . 0.0 113.673 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . 39.21 69.47 0.28 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.963 2.905 . . . . 0.0 115.525 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.19 -34.55 16.62 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.035 1.334 . . . . 0.0 112.116 158.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ILE . . . . . . . . . . . . . 35.4 mm -96.78 153.14 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.43 1.092 . . . . 0.0 109.37 172.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.71 103.21 6.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.553 1.541 . . . . 0.0 109.062 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -94.22 -51.57 4.75 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.663 2.385 . . . . 0.0 113.019 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -82.91 -164.93 36.49 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 -169.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.2 140.68 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 127.374 2.27 . . . . 0.0 109.856 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.51 118.54 14.46 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.563 1.145 . . . . 0.0 109.528 161.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 35.1 t -94.7 -51.04 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 122.831 0.453 . . . . 0.0 110.472 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 36.9 m -70.14 157.48 37.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.102 0.477 . . . . 0.0 110.329 171.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 22.5 m -52.0 147.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.519 1.128 . . . . 0.0 111.916 171.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -123.0 77.69 50.8 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 123.914 0.886 . . . . 0.0 111.209 -174.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -83.29 -173.15 1.56 Allowed 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 124.872 3.714 . . . . 0.0 112.499 170.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 47.9 pt -84.67 165.75 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.66 1.184 . . . . 0.0 112.15 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . . . . . . . . . . . -65.76 124.83 23.49 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 156.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' SER . . . . . . . . . . . . . 95.6 p -66.66 -29.83 69.94 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.621 0.768 . . . . 0.0 112.801 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 11.7 m -143.86 153.25 42.15 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.832 2.453 . . . . 0.0 106.983 -168.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.33 -21.01 61.54 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.926 -1.109 . . . . 0.0 113.646 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -95.26 4.11 53.84 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.81 2.444 . . . . 0.0 112.929 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -63.29 157.99 21.43 Favored 'General case' 0 CA--C 1.549 0.938 0 O-C-N 120.236 -1.54 . . . . 0.0 113.872 -171.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -150.69 86.27 1.39 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.86 149.58 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.886 1.274 . . . . 0.0 112.134 -167.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -92.91 126.06 37.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 129.95 3.3 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' ILE . . . . . . . . . . . . . 3.2 mp -138.89 141.56 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.462 1.505 . . . . 0.0 110.768 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.47 141.63 32.0 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.131 1.372 . . . . 0.0 112.198 160.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.68 156.65 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 124.26 1.024 . . . . 0.0 111.418 168.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -113.05 114.3 48.86 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 125.381 1.472 . . . . 0.0 110.717 -172.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -85.27 160.82 11.31 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.753 2.969 . . . . 0.0 111.446 163.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -74.12 175.99 10.16 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.842 2.362 . . . . 0.0 110.476 160.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -61.59 142.68 56.96 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.653 -0.654 . . . . 0.0 110.635 159.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' GLY . . . . . . . . . . . . . . . 87.96 -146.83 20.01 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 122.128 -0.358 . . . . 0.0 113.055 -173.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -61.81 145.37 52.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.961 2.105 . . . . 0.0 114.522 -171.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 28.9 m -167.64 162.08 13.92 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.491 1.917 . . . . 0.0 112.041 158.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -130.84 128.03 39.81 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.346 1.458 . . . . 0.0 108.46 169.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 29.3 mm -94.95 120.8 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.422 1.489 . . . . 0.0 108.274 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.2 144.95 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.433 1.093 . . . . 0.0 109.492 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.29 116.19 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.456 1.502 . . . . 0.0 109.332 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 89.76 -178.83 44.14 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 122.548 1.082 . . . . 0.0 114.614 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' THR . . . . . . . . . . . . . 92.7 m -127.6 164.12 22.71 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.979 1.312 . . . . 0.0 109.852 172.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 80.64 -173.57 54.78 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 121.855 0.697 . . . . 0.0 112.996 -174.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -23.83 66.45 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.956 1.302 . . . . 0.0 112.762 173.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' SER . . . . . . . . . . . . . 73.4 m -63.62 -10.53 19.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 170.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -78.36 125.49 29.43 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.078 1.308 . . . . 0.0 113.146 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 4.4 mt -88.19 162.24 16.79 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.071 -0.393 . . . . 0.0 111.167 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.8 t -142.43 149.04 38.76 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.883 1.273 . . . . 0.0 111.497 -174.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -151.65 126.68 9.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.731 1.612 . . . . 0.0 110.434 -177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -73.28 128.91 36.82 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.28 -0.888 . . . . 0.0 111.442 177.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -136.39 125.26 24.1 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.282 0.633 . . . . 0.0 110.298 167.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.27 122.76 32.44 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -94.66 138.79 32.07 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.144 0.978 . . . . 0.0 111.394 -169.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 12.2 pm0 -39.65 111.23 0.18 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.935 3.294 . . . . 0.0 115.075 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -76.37 54.62 3.22 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.585 1.564 . . . . 0.0 114.503 -174.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 25.2 m -61.64 -18.75 60.75 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.418 1.487 . . . . 0.0 114.651 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.4 m -72.63 41.29 0.09 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.878 2.471 . . . . 0.0 115.824 -167.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 8.7 tp -69.92 -34.23 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.161 0.891 . . . . 0.0 112.305 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.87 12.18 47.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.906 1.241 . . . . 0.0 116.067 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 2.0 tppm? . . . . . 0 C--O 1.25 1.114 0 C-N-CA 125.843 1.657 . . . . 0.0 110.471 -173.872 . . . . . . . . 0 0 . 1 stop_ save_